data_4uei_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 4uei _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 . . . . . 0 C--O 1.233 0.237 0 CA-C-O 121.14 0.495 . . . . 0.0 110.668 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.409 ' HA ' ' CD1' ' A' ' 23' ' ' PHE . 3.3 Cg_exo -70.45 -18.65 33.63 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 123.183 2.589 . . . . 0.0 112.628 -173.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -67.14 -28.21 67.95 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.745 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -77.37 -7.73 56.55 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.692 -177.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.409 ' CD1' ' HA ' ' A' ' 20' ' ' PRO . 27.7 m-85 -80.88 148.08 30.07 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 177.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -67.84 -31.21 70.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.142 0.496 . . . . 0.0 109.95 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.493 HG11 HG12 ' A' ' 96' ' ' VAL . 1.7 m -68.36 -16.82 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.563 -177.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 1.661 ' HD1' ' CD2' ' A' ' 26' ' ' PHE . 84.1 t80 -54.03 -57.17 12.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.006 0.431 . . . . 0.0 110.648 -177.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.53 ' HZ1' HG23 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -70.17 -33.06 71.28 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.741 -178.114 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 1.649 ' HD2' ' CD1' ' A' ' 28' ' ' TYR . 39.7 m-85 -69.92 -46.4 65.45 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.581 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.446 ' CE ' HD12 ' A' ' 68' ' ' ILE . 53.6 mtp -71.96 -26.15 62.15 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.949 0.404 . . . . 0.0 110.435 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.435 ' HD2' ' HA ' ' A' ' 30' ' ' LYS . 24.8 mmmt -68.45 -36.68 79.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.066 175.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.53 HG23 ' HZ1' ' A' ' 27' ' ' LYS . 17.6 pt -83.31 -26.72 7.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.171 176.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.0 tt -53.93 -50.56 66.16 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 171.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.546 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 10.5 tt0 -43.6 -55.19 4.46 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.69 176.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -71.17 -53.65 13.74 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.497 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.12 -40.19 80.6 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -167.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 91.3 mmm -56.89 -43.52 81.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.046 0.45 . . . . 0.0 111.291 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -91.37 -17.71 25.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.27 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -64.9 -22.51 67.01 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.009 -175.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -59.28 130.06 45.09 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 172.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.7 -27.39 62.88 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.827 -173.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -100.83 18.48 19.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.809 -0.178 . . . . 0.0 110.961 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 27.5 70.52 0.05 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.912 1.285 . . . . 0.0 112.568 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.1 mt -62.83 -6.14 3.46 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.392 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.1 tp -60.62 -27.14 39.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.665 178.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.454 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 22.9 mt-10 -74.28 -21.59 59.68 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-O 120.743 0.306 . . . . 0.0 111.255 -178.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -77.92 -36.97 48.77 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.475 0.655 . . . . 0.0 110.153 177.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.474 ' O ' HG23 ' A' ' 47' ' ' VAL . 14.6 p -112.29 31.73 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.657 -172.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.454 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 53.1 mtt180 -51.33 111.86 0.64 Allowed 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.62 0.724 . . . . 0.0 111.524 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.51 ' O ' ' HB1' ' A' ' 70' ' ' ALA . . . -170.14 168.67 41.61 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.752 -175.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.458 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 54.1 mt -108.7 124.42 65.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 1.637 ' HE2' ' CE1' ' A' ' 51' ' ' TYR . 12.8 m-85 -106.63 130.97 54.29 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.265 -174.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -107.87 117.36 5.13 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.303 176.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 1.622 ' HE2' ' CE1' ' A' ' 53' ' ' PHE . 3.4 m-85 -103.65 100.07 9.89 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 120.978 0.418 . . . . 0.0 111.509 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 90' ' ' THR . 56.5 mtmt -89.32 101.99 14.66 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.453 174.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.1 t -104.71 124.71 59.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.588 -176.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 45.6 mtp180 -114.4 -179.75 3.72 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.99 -178.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 61.64 47.19 6.59 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.926 0.393 . . . . 0.0 110.876 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.71 -172.16 15.71 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.478 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -38.57 -60.43 0.48 Allowed 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 124.115 3.21 . . . . 0.0 113.497 -175.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -123.99 62.88 1.07 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.11 0.481 . . . . 0.0 110.326 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.84 22.61 78.95 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.846 -0.692 . . . . 0.0 111.926 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.36 169.77 17.28 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.31 0.576 . . . . 0.0 111.581 -177.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -141.61 139.07 33.0 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.69 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.45 162.82 24.08 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.648 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -150.3 115.29 5.34 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.949 0.404 . . . . 0.0 110.811 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 10.5 m-90 -117.81 145.05 44.82 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 40.6 t -113.3 124.68 70.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.52 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.469 ' N ' HD13 ' A' ' 68' ' ' ILE . 3.8 mp -100.36 107.02 20.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -83.48 98.35 9.48 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.031 0.443 . . . . 0.0 110.205 178.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.51 ' HB1' ' O ' ' A' ' 49' ' ' GLY . . . -108.32 -2.61 19.07 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.971 175.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -61.25 -37.49 83.3 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -83.06 -2.44 55.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.106 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.38 18.2 67.13 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.005 -178.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.515 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 11.8 mmpt? -93.17 -61.44 1.57 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.683 -0.258 . . . . 0.0 110.786 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.6 35.52 6.48 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.154 -1.022 . . . . 0.0 112.34 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.546 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 19.1 pttm -96.35 142.34 28.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.692 0.246 . . . . 0.0 110.347 -176.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.7 OUTLIER -108.0 133.44 52.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.37 0.605 . . . . 0.0 109.555 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.2 t -138.11 134.33 34.51 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.641 -176.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 1.638 ' HD2' ' CD1' ' A' ' 79' ' ' TYR . 15.9 t80 -68.0 135.3 52.11 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 42.38 73.4 0.14 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.857 0.836 . . . . 0.0 111.064 -172.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.58 -40.02 97.28 Favored Glycine 0 C--N 1.33 0.212 0 CA-C-N 115.108 -0.951 . . . . 0.0 113.591 -173.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 92.18 -14.33 64.79 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.23 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.515 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 1.7 pt-20 -97.95 153.09 18.59 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 122.15 0.18 . . . . 0.0 110.925 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 60.4 pttt -79.2 110.11 13.7 Favored Pre-proline 0 N--CA 1.449 -0.477 0 CA-C-O 121.284 0.564 . . . . 0.0 111.323 178.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.515 ' HD3' ' O ' ' A' ' 83' ' ' GLU . 14.3 Cg_exo -69.84 130.58 19.49 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.529 2.152 . . . . 0.0 111.579 177.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -58.87 -37.17 75.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.799 176.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.608 ' HB ' ' CD1' ' A' ' 117' ' ' ILE . 14.3 m -138.72 138.98 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.691 177.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.65 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 44.9 m -124.32 136.1 53.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.516 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 1.644 ' HD1' ' CD2' ' A' ' 89' ' ' PHE . 34.7 m-85 -111.31 153.32 26.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.766 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.535 ' HB ' ' HB3' ' A' ' 116' ' ' LYS . 1.1 m -132.26 108.39 9.2 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 175.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.47 HG23 ' N ' ' A' ' 92' ' ' SER . 64.4 mt -134.18 159.47 42.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.523 0.729 . . . . 0.0 109.36 -173.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.47 ' N ' HG23 ' A' ' 91' ' ' ILE . 15.4 m -89.02 139.67 30.22 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.907 0.384 . . . . 0.0 110.096 174.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.487 ' OD1' HG12 ' A' ' 25' ' ' VAL . 35.1 t70 -53.03 -25.83 13.68 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.176 0.991 . . . . 0.0 111.63 -179.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -78.71 -38.93 37.9 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.711 -177.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -89.16 -19.72 25.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.54 -172.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.562 ' O ' HG13 ' A' ' 100' ' ' ILE . 0.5 OUTLIER -55.4 -32.56 29.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.082 0.468 . . . . 0.0 110.527 -179.192 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.6 m -67.23 -28.93 44.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.269 -173.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -84.79 -32.94 23.1 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 74.0 mt -68.72 -47.9 65.18 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.826 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.562 HG13 ' O ' ' A' ' 96' ' ' VAL . 10.6 mt -74.98 -18.95 16.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.908 -177.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.6 t -88.47 -20.49 25.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.868 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.55 9.25 61.67 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.124 -177.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -83.0 -41.15 19.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.011 0.434 . . . . 0.0 110.843 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.6 tp -102.97 127.31 50.24 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.051 178.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -71.6 121.87 85.61 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.115 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.35 -20.52 66.54 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.763 1.642 . . . . 0.0 110.708 175.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -64.91 -58.77 5.28 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.818 172.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.541 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -66.03 -32.92 74.68 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.335 0.588 . . . . 0.0 109.566 -178.503 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.541 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -66.79 -40.11 88.01 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.552 178.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -58.3 -47.55 83.31 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.359 0.6 . . . . 0.0 109.718 175.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -63.87 -38.54 91.48 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.276 -177.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.431 HE21 ' HB3' ' A' ' 112' ' ' GLN . 7.8 mt-30 -91.53 6.0 47.32 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -174.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.23 2.22 80.53 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.827 173.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.1 mmpt? -77.34 -19.85 55.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.172 0.51 . . . . 0.0 110.443 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.485 HG22 HG21 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -127.94 110.37 21.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.861 178.599 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.535 ' HB3' ' HB ' ' A' ' 90' ' ' THR . 19.3 tptm -111.75 99.78 8.42 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.114 174.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.65 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.322 -0.597 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.946 -176.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.406 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 89.5 m-20 . . . . . 0 N--CA 1.455 -0.18 0 CA-C-O 121.036 0.446 . . . . 0.0 110.173 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.406 ' HG3' ' CD1' ' A' ' 79' ' ' TYR . 15.1 Cg_exo -62.99 -30.26 76.39 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 123.173 2.582 . . . . 0.0 112.268 -173.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -68.61 -23.36 64.44 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.794 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.406 ' OD2' ' HB2' ' A' ' 19' ' ' ASN . 23.2 m-20 -76.06 -16.24 59.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.243 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -90.2 152.92 20.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.14 0.495 . . . . 0.0 110.525 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -80.46 -26.1 38.51 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.411 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.518 ' HB ' ' SD ' ' A' ' 29' ' ' MET . 1.0 OUTLIER -66.62 -17.59 22.8 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.536 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.973 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.415 ' O ' ' HB2' ' A' ' 30' ' ' LYS . 55.9 t80 -53.89 -51.9 62.23 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.814 0.34 . . . . 0.0 110.492 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.467 ' HZ1' HG22 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -67.25 -36.48 81.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.508 -179.246 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 1.6 ' HE1' ' CE2' ' A' ' 28' ' ' TYR . 48.0 m-85 -70.17 -53.32 17.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.501 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.518 ' SD ' ' HB ' ' A' ' 25' ' ' VAL . 0.1 OUTLIER -61.04 -32.1 71.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.767 0.317 . . . . 0.0 110.898 177.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.458 ' HD3' ' HA ' ' A' ' 30' ' ' LYS . 34.0 mmtt -74.53 -27.94 60.75 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.467 HG22 ' HZ1' ' A' ' 27' ' ' LYS . 15.5 pt -89.77 -18.43 7.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.714 173.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.9 tt -62.69 -52.54 62.88 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 169.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.53 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 11.9 tt0 -42.47 -55.17 3.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.141 -1.39 . . . . 0.0 110.688 173.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -65.07 -53.82 39.68 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.757 -1.11 . . . . 0.0 111.876 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.68 -36.94 84.51 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -167.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.482 ' HA ' ' HE3' ' A' ' 36' ' ' MET . 5.1 mmt -60.92 -43.37 98.69 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.686 0.279 . . . . 0.0 111.304 -177.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -92.64 -15.1 27.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.988 0.423 . . . . 0.0 110.499 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -64.02 -35.35 80.42 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.064 0.459 . . . . 0.0 110.221 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -70.12 123.25 21.13 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 173.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.81 -24.07 65.55 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.652 -172.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -74.44 -17.58 60.77 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.7 p30 34.27 70.36 0.13 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.924 0.889 . . . . 0.0 112.391 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.4 mt -70.36 1.67 4.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.262 -178.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -62.05 -31.47 51.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.259 -177.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.526 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 46.3 mt-10 -73.13 -20.56 60.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.475 -173.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -72.81 -19.55 61.31 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.344 0.592 . . . . 0.0 110.241 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -131.01 33.44 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.338 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.526 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 57.8 mtt180 -45.31 110.31 0.23 Allowed 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.469 0.652 . . . . 0.0 111.853 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.502 ' O ' ' HB1' ' A' ' 70' ' ' ALA . . . -174.95 175.27 47.04 Favored Glycine 0 C--N 1.31 -0.867 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.306 -176.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 67.3 mt -107.98 124.83 64.46 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-O 121.284 0.564 . . . . 0.0 111.248 -177.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 1.655 ' HD1' ' CD2' ' A' ' 51' ' ' TYR . 4.3 m-85 -105.98 111.62 24.34 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.827 -176.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -93.16 126.92 8.79 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.691 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -111.28 103.04 11.41 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.05 0.452 . . . . 0.0 111.777 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -87.88 102.06 14.34 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.11 173.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 23.0 t -101.88 125.18 56.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.251 0.548 . . . . 0.0 111.238 -173.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.615 ' NE ' HG23 ' A' ' 90' ' ' THR . 51.6 mtm180 -109.77 175.53 5.41 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.985 -174.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 60.82 49.07 6.34 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 122.684 0.394 . . . . 0.0 111.849 176.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.88 -160.01 10.5 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.28 175.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.44 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 80.2 Cg_exo -41.62 -61.4 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.678 2.919 . . . . 0.0 113.573 -177.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -125.1 63.78 1.15 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.368 0.604 . . . . 0.0 109.573 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.0 26.7 73.27 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.401 -177.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.44 ' HB1' ' HD2' ' A' ' 59' ' ' PRO . . . -77.72 152.86 33.46 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.182 0.515 . . . . 0.0 111.149 -178.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -129.38 112.84 14.24 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.043 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.06 164.93 18.41 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.106 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 1.606 ' HD2' ' CD1' ' A' ' 65' ' ' TYR . 28.0 t80 -147.75 117.06 6.92 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.874 0.368 . . . . 0.0 110.941 -176.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 16.0 m-90 -119.35 147.55 44.2 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.826 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 19.7 t -116.44 115.52 49.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.461 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.464 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 4.2 mp -91.29 103.56 14.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -84.88 97.88 10.0 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.168 0.509 . . . . 0.0 110.138 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.502 ' HB1' ' O ' ' A' ' 49' ' ' GLY . . . -100.97 -0.47 36.55 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.472 174.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -59.74 -40.3 87.62 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.318 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -74.88 -13.74 60.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.033 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.64 9.23 75.48 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -172.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -90.32 -59.79 2.09 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.356 -0.422 . . . . 0.0 110.872 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.55 36.45 5.86 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.066 -1.064 . . . . 0.0 112.149 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.53 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 16.3 pttm -95.72 144.47 26.09 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -175.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.7 OUTLIER -108.08 133.42 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-O 121.433 0.635 . . . . 0.0 109.866 -178.897 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.412 HG21 ' HA2' ' A' ' 81' ' ' GLY . 1.8 t -136.89 141.21 42.74 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.294 -177.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.411 ' C ' ' H ' ' A' ' 81' ' ' GLY . 80.1 t80 -62.38 123.6 18.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.349 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 72.75 -38.64 0.42 Allowed 'General case' 0 N--CA 1.471 0.623 0 O-C-N 123.984 0.802 . . . . 0.0 111.993 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.412 ' HA2' HG21 ' A' ' 78' ' ' THR . . . 76.0 -41.63 1.53 Allowed Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 114.158 0.423 . . . . 0.0 114.158 176.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.99 0.76 53.63 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.102 -176.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -107.08 166.83 10.32 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.416 ' HZ3' ' HB2' ' A' ' 84' ' ' LYS . 9.6 mtmp? -98.25 108.39 46.94 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 175.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -67.28 132.6 28.07 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 123.138 2.558 . . . . 0.0 113.194 -177.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -64.0 -39.94 95.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.001 174.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.409 ' HB ' ' CD1' ' A' ' 117' ' ' ILE . 6.2 m -136.21 134.18 50.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.656 175.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.606 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 21.2 m -122.81 132.35 54.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.627 -178.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.579 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 41.4 m-85 -111.68 136.86 50.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.917 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.615 HG23 ' NE ' ' A' ' 56' ' ' ARG . 2.2 m -109.04 99.67 8.95 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.057 0.456 . . . . 0.0 109.853 175.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 86.4 mt -122.72 159.07 26.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -176.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.472 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 4.9 m -99.34 138.38 36.52 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 177.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -44.54 -50.11 9.74 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.14 0.576 . . . . 0.0 111.376 -176.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -59.02 -34.6 72.08 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.5 -1.227 . . . . 0.0 111.575 -176.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.472 ' OD2' ' HB2' ' A' ' 92' ' ' SER . 23.0 m-20 -91.09 -21.72 21.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.064 -177.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.59 ' O ' HG13 ' A' ' 100' ' ' ILE . 0.4 OUTLIER -57.71 -34.21 47.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 121.221 0.534 . . . . 0.0 109.824 -179.101 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.0 m -67.21 -27.71 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.971 -174.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -83.68 -34.41 24.99 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.403 ' HG ' HD21 ' A' ' 104' ' ' LEU . 79.8 mt -71.45 -36.25 71.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.219 -177.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.59 HG13 ' O ' ' A' ' 96' ' ' VAL . 17.4 mt -85.15 -22.2 7.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.348 -177.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 37.0 p -85.29 -20.85 29.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.004 0.431 . . . . 0.0 111.062 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 96.17 11.99 53.09 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.663 -177.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -85.67 -41.98 14.69 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.941 0.401 . . . . 0.0 111.125 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.403 HD21 ' HG ' ' A' ' 99' ' ' LEU . 49.2 tp -102.89 131.29 49.91 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.274 177.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.469 ' HB2' ' HB2' ' A' ' 108' ' ' LYS . 16.1 m120 -78.73 118.32 71.7 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.475 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -65.45 -27.14 54.64 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 121.978 1.785 . . . . 0.0 111.001 177.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -66.93 -55.21 15.57 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.454 173.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.629 ' HE3' ' HG3' ' A' ' 112' ' ' GLN . 13.6 ttpt -53.51 -48.85 68.61 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.056 175.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.545 ' HB3' ' HB3' ' A' ' 114' ' ' LYS . . . -65.03 -31.71 73.07 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.68 -175.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 1.633 ' HD2' ' CD1' ' A' ' 110' ' ' PHE . 47.6 t80 -60.08 -45.7 92.04 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 174.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -67.08 -38.0 84.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.427 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.629 ' HG3' ' HE3' ' A' ' 108' ' ' LYS . 15.2 mm100 -71.06 -23.41 62.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.762 -177.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 101.39 8.67 46.2 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.399 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.562 ' HA ' ' HE3' ' A' ' 114' ' ' LYS . 1.1 tpmt? -83.31 -32.09 26.51 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-O 121.398 0.618 . . . . 0.0 110.386 -176.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.533 HG22 HG21 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -111.99 122.43 66.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.005 -174.163 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.423 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 47.3 mmtm -112.59 106.13 14.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.481 173.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.606 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.319 -0.73 0 CA-C-O 120.986 0.422 . . . . 0.0 111.079 -178.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.459 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 95.6 m-20 . . . . . 0 C--O 1.234 0.26 0 CA-C-O 121.463 0.649 . . . . 0.0 111.569 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.478 ' HA ' ' CD1' ' A' ' 23' ' ' PHE . 15.4 Cg_exo -62.96 -26.72 74.2 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.644 2.896 . . . . 0.0 111.681 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -59.24 -37.52 77.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.718 177.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -81.04 -2.94 50.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.872 0.368 . . . . 0.0 111.46 -174.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 1.65 ' HE2' ' CE1' ' A' ' 23' ' ' PHE . 29.9 m-85 -73.95 144.06 45.42 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 172.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.434 ' O ' ' HD2' ' A' ' 28' ' ' TYR . 64.4 mmtt -66.94 -30.5 70.66 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 175.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.506 ' CG1' HG12 ' A' ' 96' ' ' VAL . 0.8 OUTLIER -65.01 -20.19 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.786 -178.03 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -59.02 -54.44 47.07 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.497 ' HZ3' HG22 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -71.32 -37.71 71.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.61 179.012 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.434 ' HD2' ' O ' ' A' ' 24' ' ' LYS . 28.2 m-85 -69.35 -41.96 75.92 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 61.1 mtt -74.88 -27.95 60.45 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.359 178.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.429 ' HD2' ' HA ' ' A' ' 30' ' ' LYS . 19.4 mmmt -66.09 -34.24 77.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.078 175.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.497 HG22 ' HZ3' ' A' ' 27' ' ' LYS . 18.2 pt -86.32 -21.3 7.54 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.592 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.271 175.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.5 tt -61.83 -48.33 81.04 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 173.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.47 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 3.4 tt0 -45.62 -49.34 14.34 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.878 174.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -75.44 -61.48 1.89 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.755 -1.112 . . . . 0.0 111.703 -177.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.71 -38.95 73.02 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -167.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 95.3 mmm -59.64 -38.82 82.43 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.491 0.182 . . . . 0.0 111.491 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -91.48 -31.44 15.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.135 0.493 . . . . 0.0 111.049 176.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -65.3 -27.53 68.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.923 -176.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -56.67 142.03 41.46 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.414 177.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.3 p -48.99 -45.27 42.06 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.098 0.475 . . . . 0.0 111.406 -177.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -90.28 -8.59 50.55 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.227 -176.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.517 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 6.1 p30 36.51 71.77 0.12 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.865 0.841 . . . . 0.0 110.984 -175.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.5 mt -60.53 -5.34 1.17 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.945 -175.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.8 tp -62.14 -27.62 42.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.59 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' A' ' 42' ' ' ASN . 14.5 pt-20 -67.13 -28.75 68.4 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.793 0.33 . . . . 0.0 111.259 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -78.53 -24.73 45.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.145 0.498 . . . . 0.0 110.642 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.502 HG23 ' OH ' ' A' ' 51' ' ' TYR . 8.3 p -124.91 32.39 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.759 0.79 . . . . 0.0 110.955 -168.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -65.6 125.34 24.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.568 0.699 . . . . 0.0 111.778 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.14 -174.29 46.3 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.38 -178.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.2 mt -111.42 125.71 68.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 117.978 0.889 . . . . 0.0 110.589 175.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.514 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 19.1 m-85 -115.99 111.29 20.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.609 -174.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.29 111.83 4.11 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.686 -0.769 . . . . 0.0 111.314 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -100.88 109.61 21.59 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.291 0.567 . . . . 0.0 111.141 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -97.41 99.88 11.31 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.116 176.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 12.2 t -99.14 127.22 52.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.656 -172.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.471 ' O ' ' HA ' ' A' ' 92' ' ' SER . 54.8 mtp180 -118.15 176.19 5.33 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.253 -177.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 59.44 46.71 12.02 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.127 0.489 . . . . 0.0 111.242 178.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -79.55 -148.75 4.87 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.081 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.412 ' HD2' ' HB2' ' A' ' 62' ' ' ALA . 94.7 Cg_exo -40.97 -60.72 0.58 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 124.261 3.307 . . . . 0.0 114.109 -176.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -132.02 66.19 1.56 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.127 0.489 . . . . 0.0 109.683 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.12 24.52 71.87 Favored Glycine 0 N--CA 1.453 -0.199 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 -176.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.412 ' HB2' ' HD2' ' A' ' 59' ' ' PRO . . . -81.43 165.08 21.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.354 -0.423 . . . . 0.0 111.652 -175.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -139.4 142.9 37.48 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.596 -178.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -140.11 168.54 25.06 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.699 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -147.45 116.09 6.72 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.801 0.334 . . . . 0.0 110.881 -176.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 14.1 m-90 -119.49 142.95 47.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.818 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 42.4 t -111.01 114.51 47.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.661 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.514 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 4.3 mp -89.05 99.78 9.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 174.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -89.16 103.08 15.73 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.793 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -115.1 17.19 16.87 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.827 175.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -66.44 -40.04 89.24 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.256 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -85.25 -13.99 48.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.927 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.81 12.6 39.96 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.543 -0.753 . . . . 0.0 113.014 176.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.566 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 8.5 mmpt? -86.3 -38.01 17.95 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.986 -0.285 . . . . 0.0 111.603 -178.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.2 35.42 23.81 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.251 -0.976 . . . . 0.0 112.724 177.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 58.5 pttt -96.72 148.08 23.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.891 0.346 . . . . 0.0 110.884 -172.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -111.75 137.18 45.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 176.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.3 t -140.57 132.68 27.95 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.962 0.411 . . . . 0.0 110.847 -178.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -69.29 121.27 16.52 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 56.86 73.02 0.47 Allowed 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -174.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.73 -35.64 85.95 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.56 -0.746 . . . . 0.0 113.576 -174.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.27 1.07 90.42 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.401 -176.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -91.52 169.82 10.45 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -100.25 107.28 46.81 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.943 173.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.78 130.0 17.39 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.59 2.194 . . . . 0.0 112.203 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -67.59 -29.01 68.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.858 176.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.4 m -139.51 138.73 39.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.189 172.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.576 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 46.8 m -121.4 129.35 52.97 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.219 177.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.63 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 76.4 m-85 -116.51 126.39 53.28 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.091 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.508 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 2.8 m -102.85 125.53 49.64 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.602 ' CG1' HG13 ' A' ' 115' ' ' ILE . 0.3 OUTLIER -156.76 150.33 9.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.22 0.533 . . . . 0.0 111.104 -174.345 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -77.99 139.73 39.16 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.356 178.285 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -52.33 -29.8 25.35 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.263 177.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -68.97 -39.28 79.54 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.537 -178.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -90.14 -25.79 20.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.42 -174.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.506 HG12 ' CG1' ' A' ' 25' ' ' VAL . 0.4 OUTLIER -57.66 -32.56 42.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.02 0.438 . . . . 0.0 110.444 -177.767 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.7 m -69.14 -28.2 38.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.748 -174.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -81.5 -37.19 28.27 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 176.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.403 HD21 ' O ' ' A' ' 104' ' ' LEU . 88.4 mt -64.15 -48.97 73.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.794 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 96' ' ' VAL . 20.2 mt -73.28 -24.96 20.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.543 -176.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.3 t -89.07 -9.81 49.76 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.779 0.324 . . . . 0.0 111.173 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 86.46 16.9 61.35 Favored Glycine 0 N--CA 1.453 -0.177 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.204 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -89.54 -42.72 11.27 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.99 0.424 . . . . 0.0 110.763 -178.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.707 HD12 ' NZ ' ' A' ' 108' ' ' LYS . 49.6 tp -105.59 127.97 53.35 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.846 -178.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -72.97 124.14 90.38 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.471 175.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -65.7 -25.17 54.19 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.347 2.031 . . . . 0.0 110.262 176.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -57.43 -61.41 2.51 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.897 173.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.707 ' NZ ' HD12 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -63.02 -35.63 80.88 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.138 -178.783 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.555 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -69.12 -32.29 71.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.971 -176.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 1.597 ' HD2' ' CD1' ' A' ' 110' ' ' PHE . 46.6 t80 -62.93 -50.49 70.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.701 174.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -64.94 -31.89 73.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.111 -177.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -83.93 1.53 43.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.984 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.98 12.3 82.78 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.833 -0.698 . . . . 0.0 113.446 174.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.468 ' HA ' ' HE3' ' A' ' 114' ' ' LYS . 0.3 OUTLIER -87.34 -42.88 12.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.822 0.344 . . . . 0.0 110.496 178.166 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.602 HG13 ' CG1' ' A' ' 91' ' ' ILE . 0.1 OUTLIER -91.05 114.44 28.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.554 0.692 . . . . 0.0 110.004 178.237 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.508 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 29.0 mmmt -111.73 99.79 8.43 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.411 176.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.63 ' HB ' ' CD2' ' A' ' 89' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--N 1.319 -0.76 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.442 -178.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 . . . . . 0 CA--C 1.517 -0.32 0 CA-C-O 121.142 0.496 . . . . 0.0 110.528 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -52.73 -36.97 74.96 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 124.229 3.286 . . . . 0.0 112.081 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -54.22 -37.34 64.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.81 176.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -79.2 -5.05 53.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.335 -175.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 1.649 ' HD2' ' CD1' ' A' ' 23' ' ' PHE . 29.8 m-85 -78.9 148.58 32.68 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.128 0.489 . . . . 0.0 110.037 176.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.418 ' HD3' HG13 ' A' ' 97' ' ' VAL . 46.8 mttp -70.86 -25.71 62.94 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 176.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.529 ' CG1' HG12 ' A' ' 96' ' ' VAL . 0.9 OUTLIER -72.87 -17.75 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 114.988 -1.006 . . . . 0.0 111.022 -178.75 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -56.31 -53.78 53.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.825 0.345 . . . . 0.0 110.472 -176.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.408 ' HE2' HG21 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -70.59 -40.35 73.29 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.496 178.242 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 1.666 ' HE2' ' CE1' ' A' ' 28' ' ' TYR . 9.8 m-85 -64.67 -45.37 86.98 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -175.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.452 ' CE ' HD12 ' A' ' 68' ' ' ILE . 66.8 mtp -75.97 -22.81 55.5 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.371 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 30' ' ' LYS . 24.4 mmmt -71.63 -36.78 70.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.933 174.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.408 HG21 ' HE2' ' A' ' 27' ' ' LYS . 16.1 pt -82.22 -25.25 9.13 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.485 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.122 175.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.8 tt -56.54 -53.04 62.21 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 171.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.442 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 14.1 tt0 -43.82 -49.09 8.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.267 -1.333 . . . . 0.0 111.725 175.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -75.15 -55.57 5.6 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.533 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.412 ' HA ' ' HB3' ' A' ' 38' ' ' ASN . . . -56.21 -36.28 68.26 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -168.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 25.2 mmt -61.41 -43.86 98.13 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.678 0.275 . . . . 0.0 111.483 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -91.7 -17.01 26.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.28 0.562 . . . . 0.0 110.602 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.412 ' HB3' ' HA ' ' A' ' 35' ' ' ALA . 4.3 t-20 -66.34 -36.26 82.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.781 177.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -56.91 125.94 24.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.31 175.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.79 -26.33 34.01 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -175.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -92.16 -16.6 26.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.476 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.414 ' C ' ' H ' ' A' ' 44' ' ' ILE . 4.9 p-10 35.87 69.02 0.2 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.904 0.859 . . . . 0.0 111.104 -177.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.1 mt -65.18 -0.73 1.83 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.731 -174.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.457 HG13 ' HB2' ' A' ' 70' ' ' ALA . 4.9 tp -61.83 -26.54 40.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.296 -177.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.428 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 44.6 mt-10 -76.51 -22.46 54.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.894 0.378 . . . . 0.0 111.053 -176.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -76.45 -19.18 58.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.654 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.463 ' O ' HG23 ' A' ' 47' ' ' VAL . 10.6 p -130.02 32.4 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.633 0.73 . . . . 0.0 110.076 -176.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.428 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 55.4 mtt180 -46.86 119.8 2.69 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.992 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.471 ' O ' ' HB1' ' A' ' 70' ' ' ALA . . . -179.88 166.64 35.9 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.314 -177.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.436 HG13 ' HB2' ' A' ' 71' ' ' LYS . 55.1 mt -102.79 122.93 55.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.142 0.496 . . . . 0.0 110.842 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.438 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 21.6 m-85 -103.32 118.56 37.05 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.933 -177.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.43 111.76 4.3 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.389 -0.91 . . . . 0.0 111.279 177.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -97.86 104.91 16.98 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.059 0.457 . . . . 0.0 111.458 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -92.7 99.07 11.83 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.691 175.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.59 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 6.0 t -102.34 145.42 12.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.673 -178.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.548 ' CB ' ' HG2' ' A' ' 63' ' ' GLU . 1.1 ptm180 -154.21 -174.2 4.87 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.544 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 64.71 38.17 7.11 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.082 0.468 . . . . 0.0 110.216 -174.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.24 -154.55 4.45 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.824 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo -36.6 -60.0 0.4 Allowed 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 124.326 3.351 . . . . 0.0 113.938 -174.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -128.57 54.88 1.73 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.221 0.534 . . . . 0.0 109.882 178.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 74.53 28.4 63.55 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.544 -176.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.06 156.24 30.15 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 121.391 0.615 . . . . 0.0 111.204 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.548 ' HG2' ' CB ' ' A' ' 56' ' ' ARG . 34.7 mt-10 -125.14 147.58 48.96 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.296 -178.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -143.12 162.91 27.5 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.343 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 1.634 ' HD2' ' CD1' ' A' ' 65' ' ' TYR . 31.0 t80 -150.63 114.9 5.11 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.819 0.342 . . . . 0.0 110.97 -177.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 15.5 m-90 -120.47 136.28 54.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.13 0.49 . . . . 0.0 109.835 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 14.6 t -103.49 116.66 47.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.425 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.452 HD12 ' CE ' ' A' ' 29' ' ' MET . 4.3 mp -93.38 101.21 12.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 175.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -85.69 98.38 10.66 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.246 -177.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.471 ' HB1' ' O ' ' A' ' 49' ' ' GLY . . . -107.04 0.73 23.82 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.227 176.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.436 ' HB2' HG13 ' A' ' 50' ' ' ILE . 5.1 tppp? -63.54 -41.73 98.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.399 0.618 . . . . 0.0 109.918 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -76.47 -6.68 52.81 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.424 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.83 8.5 63.5 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.761 176.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -92.01 -55.73 3.34 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -176.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.2 34.93 7.81 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 119.824 -1.179 . . . . 0.0 111.889 -176.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.442 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 22.7 pttp -96.56 144.16 26.88 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -176.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.7 OUTLIER -107.63 131.7 57.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.536 0.684 . . . . 0.0 109.619 -178.787 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.412 HG21 ' HA2' ' A' ' 81' ' ' GLY . 1.8 t -139.83 135.35 32.89 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.563 -178.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -63.19 128.46 35.96 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -176.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 73.25 -42.69 0.53 Allowed 'General case' 0 N--CA 1.471 0.584 0 O-C-N 124.011 0.82 . . . . 0.0 111.578 -177.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.412 ' HA2' HG21 ' A' ' 78' ' ' THR . . . 73.81 -41.81 1.06 Allowed Glycine 0 N--CA 1.453 -0.189 0 N-CA-C 114.425 0.53 . . . . 0.0 114.425 175.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.81 5.94 76.38 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.659 -175.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.42 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 13.3 mm-40 -114.23 143.41 44.88 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -177.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -77.77 110.56 13.39 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 121.185 0.517 . . . . 0.0 110.792 174.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 83' ' ' GLU . 13.4 Cg_exo -70.16 130.05 18.19 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.861 2.374 . . . . 0.0 112.452 -178.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -63.57 -34.3 77.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.485 176.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.514 ' HB ' ' CD1' ' A' ' 117' ' ' ILE . 9.0 m -139.4 133.93 39.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.556 176.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.652 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 53.9 m -116.77 139.33 50.7 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.517 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.493 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 54.4 m-85 -118.06 132.92 56.32 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.489 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 5.7 m -110.1 128.67 55.57 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 175.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -161.99 144.23 3.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.071 0.462 . . . . 0.0 109.862 -177.214 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.6 147.24 29.69 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.316 0.579 . . . . 0.0 111.154 177.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -51.25 -29.16 13.63 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 114.449 -1.251 . . . . 0.0 112.033 -177.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -73.51 -34.26 65.19 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.32 -176.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -90.08 -27.39 19.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.843 -175.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.529 HG12 ' CG1' ' A' ' 25' ' ' VAL . 0.4 OUTLIER -56.82 -31.61 36.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.217 -174.889 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.418 HG13 ' HD3' ' A' ' 24' ' ' LYS . 12.8 m -69.34 -29.24 41.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.687 -170.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -83.96 -31.43 25.58 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 176.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.466 HD21 ' O ' ' A' ' 104' ' ' LEU . 91.2 mt -64.63 -51.55 62.05 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.269 0.557 . . . . 0.0 110.562 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 96' ' ' VAL . 14.9 mt -75.51 -16.75 15.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.395 -175.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 42.0 t -94.14 -4.29 49.47 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.207 -0.308 . . . . 0.0 111.322 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.57 30.92 55.73 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.705 -0.759 . . . . 0.0 111.939 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -106.7 -42.67 4.9 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.223 0.535 . . . . 0.0 110.571 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.466 ' O ' HD21 ' A' ' 99' ' ' LEU . 33.8 tp -103.32 120.74 41.35 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.694 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.423 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 5.9 m-20 -68.51 120.48 75.6 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.467 178.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -63.68 -21.47 69.98 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.21 1.94 . . . . 0.0 110.578 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -62.81 -58.69 6.55 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.958 174.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.53 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 1.2 ptmt -66.74 -33.95 76.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.015 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.53 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -65.87 -29.42 69.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.955 0.407 . . . . 0.0 110.098 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -65.39 -46.82 78.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.627 175.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 1.621 ' HE1' ' CE2' ' A' ' 111' ' ' PHE . 82.5 t80 -67.43 -37.2 82.64 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.1 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -79.71 10.92 3.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.857 -176.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.78 7.83 83.94 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 121.236 -0.507 . . . . 0.0 113.268 173.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -82.15 -53.4 6.11 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.117 0.484 . . . . 0.0 110.456 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.526 HG13 ' CG1' ' A' ' 91' ' ' ILE . 0.2 OUTLIER -88.52 115.12 28.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.585 -177.633 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.489 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 31.2 mmmt -111.06 103.22 11.65 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.524 176.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.652 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.447 -0.588 0 CA-C-O 121.159 0.504 . . . . 0.0 110.955 -176.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.6 m-20 . . . . . 0 CA--C 1.519 -0.247 0 CA-C-O 121.353 0.597 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -56.38 -35.29 96.02 Favored 'Trans proline' 0 CA--C 1.518 -0.293 0 C-N-CA 123.906 3.07 . . . . 0.0 112.397 -176.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.401 ' HA ' ' CD1' ' A' ' 26' ' ' PHE . 40.7 tt0 -60.49 -37.61 81.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.585 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -74.92 -18.14 60.45 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.683 0.278 . . . . 0.0 111.307 -173.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -67.84 154.82 40.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.501 0.667 . . . . 0.0 110.569 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.2 ttmm -80.43 -20.43 43.87 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.318 -0.855 . . . . 0.0 108.917 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.533 ' HB ' ' SD ' ' A' ' 29' ' ' MET . 1.3 m -77.27 -14.11 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.934 178.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 1.669 ' HE2' ' CE1' ' A' ' 26' ' ' PHE . 69.1 t80 -51.86 -56.06 16.27 Favored 'General case' 0 N--CA 1.462 0.135 0 O-C-N 123.055 0.222 . . . . 0.0 111.418 -175.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.3 -40.6 96.26 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.037 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -66.18 -49.2 68.15 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.548 -177.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.533 ' SD ' ' HB ' ' A' ' 25' ' ' VAL . 0.2 OUTLIER -61.73 -33.23 73.68 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.825 0.345 . . . . 0.0 110.954 175.531 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.8 mmmt -69.67 -39.6 76.91 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 11.2 pt -81.45 -22.06 10.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.108 177.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.6 tt -58.27 -48.05 81.69 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 171.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -48.14 -50.81 27.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.757 175.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 38' ' ' ASN . 25.5 tt0 -69.63 -52.14 28.58 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.84 -178.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.36 -37.28 82.96 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -166.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.8 mmt -58.06 -47.32 83.52 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.757 0.281 . . . . 0.0 111.757 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -91.08 -8.66 48.29 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.073 0.463 . . . . 0.0 110.558 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -67.82 -25.95 65.82 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 176.558 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -54.33 122.35 10.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.798 176.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.86 -39.79 59.5 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.857 -1.065 . . . . 0.0 113.001 -173.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.548 ' C ' HD21 ' A' ' 42' ' ' ASN . 44.5 mt-10 -103.35 19.01 20.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.839 -0.164 . . . . 0.0 111.385 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.548 HD21 ' C ' ' A' ' 41' ' ' GLU . 0.1 OUTLIER 21.88 76.36 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.157 1.383 . . . . 0.0 112.736 -177.139 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.8 mt -65.91 -1.77 3.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.065 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.2 tp -58.7 -26.73 32.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.69 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.507 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 31.5 mt-10 -77.67 -14.58 59.58 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.358 -177.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.9 mttm -89.33 -12.74 39.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.175 0.512 . . . . 0.0 110.384 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.476 ' O ' HG23 ' A' ' 47' ' ' VAL . 9.7 p -131.3 33.07 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.776 0.798 . . . . 0.0 109.774 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.507 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 51.0 mtt180 -52.5 109.86 0.44 Allowed 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.645 0.736 . . . . 0.0 111.361 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.582 ' O ' ' HB1' ' A' ' 70' ' ' ALA . . . -171.42 155.8 24.95 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 114.419 -1.264 . . . . 0.0 111.292 -176.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.453 HG13 ' HB2' ' A' ' 71' ' ' LYS . 73.6 mt -96.79 126.56 49.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 117.132 0.466 . . . . 0.0 110.768 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.456 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 9.9 m-85 -104.66 117.47 34.19 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.91 -176.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -98.68 109.75 3.86 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.273 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 1.667 ' HD1' ' CD2' ' A' ' 53' ' ' PHE . 7.4 m-85 -98.33 103.73 15.7 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.275 0.56 . . . . 0.0 111.457 -178.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -89.6 99.41 12.42 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.254 174.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 20.2 t -96.97 121.44 47.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.627 -174.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.42 ' HE ' ' CD ' ' A' ' 63' ' ' GLU . 51.7 mtp180 -108.37 178.24 4.55 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.874 -178.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 18.4 m120 61.05 43.74 11.01 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.242 0.544 . . . . 0.0 111.036 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.24 -155.94 7.31 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.531 -0.759 . . . . 0.0 113.239 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -43.53 -60.73 0.7 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.831 3.021 . . . . 0.0 113.486 -176.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -114.25 47.42 1.22 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 177.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.9 22.21 78.82 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.572 -0.823 . . . . 0.0 111.311 -174.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.94 169.73 16.27 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.441 0.638 . . . . 0.0 111.843 -175.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.42 ' CD ' ' HE ' ' A' ' 56' ' ' ARG . 20.5 mt-10 -131.66 110.54 10.99 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.844 -178.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -100.55 169.15 21.15 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.431 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -150.25 118.54 6.4 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.935 0.398 . . . . 0.0 111.087 -177.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 20.7 m-90 -122.0 137.5 54.78 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.832 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 37.2 t -109.61 115.47 49.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.57 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 4.2 mp -95.52 106.43 18.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -86.38 98.57 11.07 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.215 0.531 . . . . 0.0 110.148 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.582 ' HB1' ' O ' ' A' ' 49' ' ' GLY . . . -101.42 -2.65 30.33 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.744 174.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.477 ' O ' ' HD3' ' A' ' 48' ' ' ARG . 4.5 tppp? -64.24 -39.53 94.15 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.575 -178.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -87.03 9.38 19.8 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.995 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 76.3 23.32 71.29 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.913 175.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -100.41 -66.22 0.92 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.687 0.279 . . . . 0.0 111.249 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.48 34.63 5.98 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.093 -1.051 . . . . 0.0 111.323 -174.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.513 ' HB2' ' HZ3' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -96.82 145.46 25.83 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -177.705 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.534 ' O ' HG21 ' A' ' 77' ' ' VAL . 1.2 m -107.79 129.42 61.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.409 HG21 ' HA2' ' A' ' 81' ' ' GLY . 2.1 t -134.0 134.0 41.95 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.871 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.447 ' O ' ' HB3' ' A' ' 80' ' ' ASN . 51.8 t80 -61.93 123.35 17.81 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.208 -177.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.447 ' HB3' ' O ' ' A' ' 79' ' ' TYR . 9.4 t30 75.29 -40.57 0.43 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.485 0.714 . . . . 0.0 111.663 -177.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.409 ' HA2' HG21 ' A' ' 78' ' ' THR . . . 72.36 -42.64 0.83 Allowed Glycine 0 CA--C 1.517 0.158 0 N-CA-C 114.736 0.654 . . . . 0.0 114.736 174.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 71.93 19.89 78.53 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.337 -174.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -125.38 158.77 33.46 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -177.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -98.04 108.83 48.87 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-O 120.929 0.395 . . . . 0.0 110.231 175.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.407 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 21.1 Cg_exo -66.12 132.44 29.91 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 123.008 2.472 . . . . 0.0 112.911 -177.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -61.34 -32.68 72.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.746 174.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.9 m -139.73 131.67 34.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.82 174.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.631 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 32.2 m -114.43 133.28 55.85 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.104 177.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 1.621 ' HD2' ' CD1' ' A' ' 89' ' ' PHE . 72.0 m-85 -119.82 128.89 54.12 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 2.1 m -102.83 119.43 38.83 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 175.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.582 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 66.0 mt -143.01 151.7 17.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -173.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.51 146.75 27.41 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.325 0.584 . . . . 0.0 110.917 176.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -53.16 -26.06 15.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.679 179.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -80.75 -37.33 30.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.041 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -87.57 -22.89 24.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.341 -173.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.584 ' O ' HG13 ' A' ' 100' ' ' ILE . 0.4 OUTLIER -56.4 -34.64 41.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.0 0.428 . . . . 0.0 110.568 -179.178 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.3 m -69.76 -29.54 41.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.15 -172.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -82.82 -33.49 27.19 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.501 HD21 ' O ' ' A' ' 104' ' ' LEU . 80.8 mt -68.43 -45.36 72.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.84 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.584 HG13 ' O ' ' A' ' 96' ' ' VAL . 22.1 mt -77.09 -19.4 14.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.097 -177.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 31.4 t -94.56 -1.26 53.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.751 0.31 . . . . 0.0 110.955 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.68 20.35 76.6 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.232 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -94.78 -42.27 8.81 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.076 0.465 . . . . 0.0 110.972 -177.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.501 ' O ' HD21 ' A' ' 99' ' ' LEU . 42.8 tp -101.5 124.73 47.65 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.115 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -72.94 123.64 89.82 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.513 177.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -65.53 -21.39 59.98 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.043 1.829 . . . . 0.0 110.113 176.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -59.15 -61.51 2.58 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.795 172.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.532 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 0.6 OUTLIER -66.12 -33.81 76.63 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.054 -177.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.532 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -68.72 -31.27 70.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.408 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -65.77 -49.02 69.85 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 174.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -62.9 -43.65 98.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.153 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -77.26 9.35 3.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.875 -177.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.03 -19.65 44.81 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 121.039 -0.601 . . . . 0.0 113.68 170.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -57.98 -61.11 2.78 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.55 HG22 HG23 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -79.3 114.88 20.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.853 0.835 . . . . 0.0 111.233 -173.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.51 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 0.0 OUTLIER -107.03 98.99 8.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.801 -1.091 . . . . 0.0 109.163 173.128 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.631 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.319 -0.757 0 CA-C-O 121.123 0.487 . . . . 0.0 110.304 178.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 . . . . . 0 C--O 1.232 0.151 0 CA-C-O 121.224 0.535 . . . . 0.0 110.989 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -66.13 -22.12 54.74 Favored 'Trans proline' 0 CA--C 1.517 -0.327 0 C-N-CA 123.193 2.595 . . . . 0.0 111.734 -175.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.408 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 10.8 mt-10 -60.01 -36.54 77.43 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.028 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -76.39 -13.18 60.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.406 -174.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -77.75 141.4 39.31 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 177.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -74.97 -24.14 58.39 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.48 0.657 . . . . 0.0 109.261 -178.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.491 ' HB ' ' SD ' ' A' ' 29' ' ' MET . 0.8 OUTLIER -69.34 -15.62 19.76 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.305 176.251 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -58.71 -56.39 22.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.802 0.334 . . . . 0.0 110.462 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.483 ' HZ3' HG22 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -69.4 -33.51 73.11 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.468 -178.666 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.43 ' O ' HG12 ' A' ' 31' ' ' ILE . 13.1 m-85 -70.21 -50.8 36.26 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.457 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.495 ' HB3' HG22 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -62.14 -33.14 73.93 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.68 0.276 . . . . 0.0 111.274 176.111 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -67.6 -34.16 76.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.715 -0.221 . . . . 0.0 111.57 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.483 HG22 ' HZ3' ' A' ' 27' ' ' LYS . 17.7 pt -85.59 -21.56 7.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.026 176.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.8 tt -61.86 -48.31 81.12 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 171.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.468 ' HG2' ' HA ' ' A' ' 76' ' ' LYS . 2.0 tm-20 -43.9 -50.53 8.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.843 173.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -72.04 -53.46 12.84 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.675 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.9 -39.31 94.12 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -166.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 20.9 mmt -55.14 -43.69 74.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.603 0.239 . . . . 0.0 111.628 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -92.09 -18.77 23.1 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.236 -0.585 . . . . 0.0 111.241 177.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -69.8 -22.95 63.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.972 0.415 . . . . 0.0 110.261 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -59.57 126.81 29.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.136 174.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 13.7 m -57.28 -23.89 51.32 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.508 -175.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -100.09 4.33 44.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 119.296 -0.383 . . . . 0.0 111.9 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 32.4 p30 28.57 60.73 0.13 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.397 1.079 . . . . 0.0 111.976 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 36.1 mt -59.67 -12.73 7.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.424 -1.262 . . . . 0.0 111.922 -174.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.8 tp -60.69 -27.06 39.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.818 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -68.92 -26.88 65.31 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.555 -175.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -83.94 -22.45 31.5 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.979 0.418 . . . . 0.0 111.052 -178.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.488 ' O ' HG23 ' A' ' 47' ' ' VAL . 12.0 p -123.54 33.34 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.755 0.788 . . . . 0.0 110.421 -175.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -49.81 117.58 2.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.585 0.707 . . . . 0.0 111.137 177.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.462 ' O ' ' HB1' ' A' ' 70' ' ' ALA . . . -173.4 -171.3 37.86 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.264 -176.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 76.4 mt -126.92 131.19 71.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 117.998 0.899 . . . . 0.0 111.24 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 1.666 ' HE1' ' CE2' ' A' ' 51' ' ' TYR . 33.7 m-85 -110.33 132.2 54.39 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.116 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -109.34 112.15 3.36 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.493 -0.86 . . . . 0.0 111.409 175.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 1.622 ' HE2' ' CE1' ' A' ' 53' ' ' PHE . 4.5 m-85 -98.44 105.7 17.88 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.948 0.404 . . . . 0.0 111.28 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -91.28 99.78 12.7 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.175 173.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 19.4 t -97.84 123.95 50.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.663 -174.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 44.9 mtp180 -112.57 -178.53 3.42 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.3 m120 61.96 44.83 7.9 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.246 0.546 . . . . 0.0 110.792 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.01 -177.02 47.05 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.576 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -35.77 -61.12 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 124.849 3.699 . . . . 0.0 114.315 -175.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -110.91 41.91 1.72 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.159 0.504 . . . . 0.0 110.597 -177.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.45 30.94 63.8 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -173.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.27 173.35 10.43 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 114.769 -0.715 . . . . 0.0 111.836 -176.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -140.01 135.45 32.71 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.972 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -127.06 163.05 21.07 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.938 -0.648 . . . . 0.0 111.688 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -141.37 120.53 12.95 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.842 0.353 . . . . 0.0 110.642 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 22.7 m-90 -122.97 130.35 52.71 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.071 0.462 . . . . 0.0 109.805 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.1 t -101.84 118.91 49.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.34 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.651 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 4.3 mp -94.47 103.32 14.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.162 0.506 . . . . 0.0 109.816 178.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -85.87 98.3 10.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.986 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' A' ' 49' ' ' GLY . . . -95.94 -10.92 27.49 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.927 173.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.1 tttt -51.44 -46.55 63.05 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.533 -178.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -89.42 12.97 14.83 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.169 0.509 . . . . 0.0 111.84 -175.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 88.67 -1.39 83.69 Favored Glycine 0 C--N 1.319 -0.376 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.987 175.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.523 ' HB3' ' HZ1' ' A' ' 74' ' ' LYS . 2.4 mmmp? -78.68 -74.62 0.27 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.79 0.329 . . . . 0.0 111.729 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.24 34.89 5.69 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 -167.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.651 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 16.3 ptmt -97.33 151.14 20.21 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.312 -0.444 . . . . 0.0 110.022 -174.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.495 HG22 ' HB3' ' A' ' 29' ' ' MET . 0.7 OUTLIER -107.4 143.08 18.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 120.311 -0.555 . . . . 0.0 109.743 176.765 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.2 t -139.22 132.4 29.76 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.188 177.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -68.34 121.63 16.68 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.161 -178.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 64.8 t30 52.21 62.64 2.6 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.993 -176.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -59.13 -36.58 89.21 Favored Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 115.329 -0.85 . . . . 0.0 113.416 -175.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.5 -16.04 51.43 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.061 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.445 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 8.5 mm-40 -75.68 148.18 38.85 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 176.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 29.9 mmmt -86.55 109.03 20.55 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-O 121.017 0.437 . . . . 0.0 110.128 177.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 83' ' ' GLU . 16.8 Cg_exo -67.65 142.5 58.69 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.018 2.479 . . . . 0.0 112.512 -176.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -62.38 -33.76 75.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.759 171.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.2 m -141.76 139.1 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.059 174.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.584 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 29.5 m -115.41 137.21 52.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.222 176.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 1.648 ' HE2' ' CE1' ' A' ' 89' ' ' PHE . 81.9 m-85 -121.27 136.09 55.02 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 178.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.446 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 3.6 m -110.36 116.76 32.01 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 176.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.531 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 69.9 mt -140.44 152.05 21.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.694 -172.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.12 145.47 25.92 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.184 0.516 . . . . 0.0 110.536 174.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -53.05 -25.6 13.08 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.416 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -75.29 -36.53 61.15 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.73 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -89.55 -23.86 21.9 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.153 -173.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.484 ' O ' HG12 ' A' ' 100' ' ' ILE . 0.5 OUTLIER -55.55 -35.86 39.72 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.337 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.903 -178.108 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 m -61.69 -30.78 49.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.589 -171.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.407 ' HA ' ' OG ' ' A' ' 101' ' ' SER . 34.0 m-20 -91.46 -25.93 19.07 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.696 0.284 . . . . 0.0 110.404 177.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 89.3 mt -71.87 -39.96 69.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.99 0.424 . . . . 0.0 110.293 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 96' ' ' VAL . 3.0 mm -67.73 -44.49 85.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.039 177.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.572 ' OG ' ' HD3' ' A' ' 103' ' ' LYS . 58.2 p -76.87 -28.54 55.46 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.686 -174.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.97 -1.31 38.44 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.125 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.572 ' HD3' ' OG ' ' A' ' 101' ' ' SER . 1.8 mptm? -66.51 -40.08 89.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.831 0.348 . . . . 0.0 111.522 177.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.712 HD12 ' NZ ' ' A' ' 108' ' ' LYS . 47.9 tp -102.27 130.01 48.85 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.799 -176.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.427 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 19.2 m120 -77.65 123.29 86.61 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.07 176.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -64.49 -25.65 62.84 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.037 1.825 . . . . 0.0 110.419 175.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -60.38 -58.77 7.07 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.144 174.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.712 ' NZ ' HD12 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -63.82 -36.34 83.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.0 -179.618 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.544 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -66.75 -34.38 77.71 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.626 -0.43 . . . . 0.0 109.958 -177.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -57.84 -52.78 64.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.84 175.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -62.95 -32.01 73.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.921 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -84.87 -1.66 56.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.775 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.48 4.45 80.23 Favored Glycine 0 CA--C 1.517 0.19 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.24 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.609 ' CE ' ' HA ' ' A' ' 114' ' ' LYS . 1.4 mmpt? -94.85 10.91 33.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.084 0.469 . . . . 0.0 111.283 -177.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.538 HG22 HG23 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -146.83 109.66 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.828 0.823 . . . . 0.0 109.532 174.878 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.446 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 73.1 mmtt -109.09 99.74 9.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.99 -1.004 . . . . 0.0 108.963 176.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.597 ' HB ' ' CD1' ' A' ' 89' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--N 1.319 -0.724 0 CA-C-O 121.25 0.547 . . . . 0.0 110.597 -177.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.4 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 13.8 m120 . . . . . 0 CA--C 1.519 -0.217 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 19' ' ' ASN . 31.2 Cg_exo -56.7 -42.71 62.08 Favored 'Trans proline' 0 N--CA 1.466 -0.097 0 C-N-CA 123.014 2.476 . . . . 0.0 112.244 -176.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -58.58 -33.73 70.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.606 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -70.32 -14.58 62.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.554 -178.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 1.661 ' HD1' ' CD2' ' A' ' 23' ' ' PHE . 73.5 m-85 -80.39 144.58 32.57 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 174.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -79.18 -18.28 53.34 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.54 ' HB ' ' SD ' ' A' ' 29' ' ' MET . 1.0 OUTLIER -75.73 -12.1 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.774 177.859 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.426 ' O ' ' HB2' ' A' ' 30' ' ' LYS . 78.8 t80 -58.77 -51.52 69.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.827 0.346 . . . . 0.0 110.793 -178.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.465 ' HZ3' HG22 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -69.6 -26.8 64.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.846 179.542 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -79.88 -51.71 8.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.763 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.54 ' SD ' ' HB ' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -59.83 -35.78 75.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.714 0.293 . . . . 0.0 111.266 177.829 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 26' ' ' PHE . 4.9 mmtp -68.94 -31.4 70.26 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.465 HG22 ' HZ3' ' A' ' 27' ' ' LYS . 10.4 pt -90.7 -16.79 8.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.308 176.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.6 tt -61.04 -47.28 87.15 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 171.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.596 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 7.6 tt0 -48.75 -48.73 40.54 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.562 175.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -64.77 -60.69 2.8 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.724 -1.126 . . . . 0.0 111.081 177.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.98 -46.7 75.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.395 -0.82 . . . . 0.0 113.156 -167.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 35.3 mtt -56.51 -43.62 79.94 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -177.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -92.39 -16.85 25.42 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.103 0.477 . . . . 0.0 110.419 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -63.97 -28.87 70.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.141 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -61.07 126.17 26.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.473 176.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.2 p -68.25 -16.8 64.11 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.315 -174.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -94.02 -3.63 51.0 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 177.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 24.34 72.75 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 O-C-N 124.689 1.243 . . . . 0.0 112.591 -177.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 66.5 mt -64.26 -8.58 13.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.577 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.5 tp -60.24 -27.97 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.62 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.443 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 60.7 mm-40 -70.35 -27.86 64.68 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-O 121.022 0.439 . . . . 0.0 111.338 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -85.19 -14.51 46.64 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.77 -176.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.484 ' O ' HG23 ' A' ' 47' ' ' VAL . 14.6 p -130.52 31.04 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.883 0.849 . . . . 0.0 110.221 -177.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.443 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 19.5 mtp180 -51.23 112.97 0.82 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.825 0.821 . . . . 0.0 111.991 -177.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.466 ' O ' ' HB1' ' A' ' 70' ' ' ALA . . . -168.88 171.1 42.76 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 114.131 -1.395 . . . . 0.0 111.356 -174.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.463 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 56.9 mt -106.32 127.61 61.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 117.375 0.587 . . . . 0.0 110.78 178.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.462 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 14.7 m-85 -108.69 114.44 28.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.017 -178.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.89 112.08 4.35 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.179 -1.01 . . . . 0.0 111.241 177.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -96.1 105.88 17.98 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.987 0.423 . . . . 0.0 111.343 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.619 ' NZ ' HG22 ' A' ' 88' ' ' THR . 54.6 mttp -91.09 101.46 14.21 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.261 174.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.566 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 21.2 t -100.78 111.54 30.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.679 -174.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.9 mtp180 -104.96 176.85 5.03 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.851 -177.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 59.97 46.65 10.74 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.714 176.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.16 -157.47 9.98 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.203 174.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -41.47 -61.12 0.54 Allowed 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 124.028 3.152 . . . . 0.0 113.727 -175.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -115.29 44.16 1.89 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.08 23.17 72.3 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.705 -0.759 . . . . 0.0 111.231 -175.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.67 140.46 56.8 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.498 0.666 . . . . 0.0 111.156 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -114.09 109.48 18.5 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.335 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.08 165.43 16.02 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -148.58 120.54 8.21 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.954 0.406 . . . . 0.0 111.039 -176.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 19.9 m-90 -123.06 129.35 51.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.058 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 55.1 t -99.18 114.44 37.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.657 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.609 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 4.5 mp -92.32 100.21 10.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 175.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -87.93 98.73 11.66 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.297 -177.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.466 ' HB1' ' O ' ' A' ' 49' ' ' GLY . . . -105.63 4.3 30.08 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.078 175.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.431 ' HB2' HG13 ' A' ' 50' ' ' ILE . 3.1 tppp? -60.89 -46.58 90.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.458 -177.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -90.59 20.82 4.34 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.329 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.79 16.43 78.04 Favored Glycine 0 C--N 1.32 -0.315 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.688 175.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -83.88 -55.24 4.35 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.787 -0.206 . . . . 0.0 111.51 -177.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.54 33.62 55.66 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.375 -0.917 . . . . 0.0 111.542 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.609 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -99.58 161.61 13.51 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.652 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.7 OUTLIER -120.8 138.84 49.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.906 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.8 t -137.61 136.9 37.96 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.485 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -70.33 117.55 12.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.872 -179.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 52.37 65.54 1.48 Allowed 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.655 0.597 . . . . 0.0 110.295 -175.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -61.0 -40.63 98.76 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.785 -173.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.63 -20.26 47.89 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.803 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.516 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 9.6 mm-40 -68.75 150.19 48.16 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 174.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -82.22 114.1 48.61 Favored Pre-proline 0 N--CA 1.437 -1.078 0 CA-C-O 121.289 0.566 . . . . 0.0 110.844 177.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.516 ' HD3' ' O ' ' A' ' 83' ' ' GLU . 13.2 Cg_exo -68.75 129.61 19.02 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.108 2.539 . . . . 0.0 111.57 174.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -66.47 -32.1 73.26 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 173.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.547 ' HB ' ' CD1' ' A' ' 117' ' ' ILE . 15.6 m -140.7 131.66 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.39 175.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.658 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 59.5 m -111.81 130.07 55.93 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.261 177.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 1.652 ' HE2' ' CE1' ' A' ' 89' ' ' PHE . 58.7 m-85 -109.88 125.03 52.36 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 177.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.489 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 12.4 m -104.27 125.82 50.86 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 174.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -157.25 152.8 7.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 123.523 0.514 . . . . 0.0 109.708 -175.96 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.7 m -85.47 148.0 26.19 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.983 -176.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -50.32 -27.47 6.25 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.067 -0.969 . . . . 0.0 111.118 177.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -74.95 -47.43 29.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.976 -177.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -79.99 -26.37 39.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.547 -173.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.527 ' O ' HG13 ' A' ' 100' ' ' ILE . 0.4 OUTLIER -55.2 -33.32 30.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.273 -174.509 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.1 m -69.46 -31.17 48.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.481 -169.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -82.95 -32.33 27.19 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 76.4 mt -65.37 -49.54 68.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.837 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.527 HG13 ' O ' ' A' ' 96' ' ' VAL . 18.7 mt -75.45 -21.35 16.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.6 -174.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.3 t -84.5 -26.19 28.3 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.019 0.438 . . . . 0.0 110.798 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.2 21.54 15.07 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.866 -176.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -97.9 -41.47 8.0 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.949 0.404 . . . . 0.0 111.336 -176.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.694 HD12 ' NZ ' ' A' ' 108' ' ' LYS . 37.0 tp -101.86 127.01 48.87 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.721 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -68.76 122.0 83.31 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.249 176.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -67.99 -21.21 43.69 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.067 1.845 . . . . 0.0 110.033 176.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -64.01 -56.28 16.18 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.685 175.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.694 ' NZ ' HD12 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -64.83 -37.37 87.39 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.78 178.186 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.554 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -67.25 -33.66 75.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.023 0.44 . . . . 0.0 109.956 -178.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 1.615 ' HE1' ' CE2' ' A' ' 110' ' ' PHE . 46.0 t80 -61.17 -50.78 71.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.052 175.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 1.651 ' HD2' ' CD1' ' A' ' 111' ' ' PHE . 73.8 t80 -61.87 -40.16 94.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.843 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -76.26 6.96 4.74 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.993 -177.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.79 6.66 82.35 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.895 175.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -79.39 -47.65 15.38 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.917 0.389 . . . . 0.0 110.585 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.524 HG13 ' CG1' ' A' ' 91' ' ' ILE . 0.2 OUTLIER -92.02 110.78 23.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.025 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.511 ' HE2' ' HA ' ' A' ' 116' ' ' LYS . 10.8 mmpt? -108.11 105.32 15.02 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.663 176.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.658 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.32 -0.693 0 CA-C-O 121.322 0.582 . . . . 0.0 111.457 -173.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 13.3 m120 . . . . . 0 CA--C 1.517 -0.312 0 CA-C-O 121.694 0.759 . . . . 0.0 110.449 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -65.73 -21.27 58.68 Favored 'Trans proline' 0 C--N 1.328 -0.517 0 C-N-CA 123.84 3.027 . . . . 0.0 112.17 -174.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.618 ' HA ' ' CG ' ' A' ' 26' ' ' PHE . 8.6 mt-10 -86.17 -16.73 36.94 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.214 -178.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -84.61 -8.12 59.0 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.905 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -72.1 163.19 28.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.827 177.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.442 ' HG2' ' CG1' ' A' ' 97' ' ' VAL . 5.5 tppp? -79.34 -31.98 43.22 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 174.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.466 ' CG1' HG12 ' A' ' 96' ' ' VAL . 1.3 m -70.24 -14.88 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.85 -178.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 1.665 ' HD1' ' CD2' ' A' ' 26' ' ' PHE . 57.6 t80 -56.76 -55.2 37.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.691 0.282 . . . . 0.0 110.594 -178.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.402 ' HE2' HG21 ' A' ' 31' ' ' ILE . 0.6 OUTLIER -67.65 -40.78 84.52 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 120.765 0.317 . . . . 0.0 110.549 178.42 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 1.653 ' HE1' ' CE2' ' A' ' 28' ' ' TYR . 14.4 m-85 -61.43 -45.85 92.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.794 -178.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 64.2 mtp -75.41 -26.56 58.5 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.67 0.271 . . . . 0.0 110.99 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.419 ' HD3' ' HA ' ' A' ' 30' ' ' LYS . 24.5 mmtp -67.73 -40.15 84.22 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 121.064 -0.254 . . . . 0.0 110.687 174.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.402 HG21 ' HE2' ' A' ' 27' ' ' LYS . 10.9 pt -79.67 -23.0 12.07 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.401 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.159 177.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.9 tt -57.23 -54.25 48.96 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 172.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -44.2 -48.52 9.3 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.707 177.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -75.36 -61.18 1.99 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.511 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.79 -34.86 65.67 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -166.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 93.3 mmm -61.17 -43.04 99.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.69 0.281 . . . . 0.0 111.387 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -92.12 -27.03 17.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.158 0.504 . . . . 0.0 110.987 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -66.95 -27.38 67.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.763 -177.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -60.44 139.94 57.47 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 173.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 p -62.27 -13.95 33.73 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -174.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -97.03 -9.34 28.34 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 119.094 -0.479 . . . . 0.0 111.892 177.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.2 p30 35.49 66.26 0.35 Allowed 'General case' 0 C--N 1.348 0.54 0 CA-C-O 122.129 0.966 . . . . 0.0 110.588 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.5 mt -62.94 -12.02 22.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 113.884 -1.507 . . . . 0.0 112.014 -170.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.9 tp -64.69 -29.09 46.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.878 0.37 . . . . 0.0 111.01 -175.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -72.55 -29.04 63.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.037 -177.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -75.18 -21.48 58.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.312 0.577 . . . . 0.0 110.751 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.475 ' O ' HG23 ' A' ' 47' ' ' VAL . 13.3 p -130.06 32.02 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.701 -173.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -44.87 116.28 1.05 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.5 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.487 ' O ' ' HB1' ' A' ' 70' ' ' ALA . . . 179.86 164.27 31.87 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.878 -176.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.48 HG13 ' HB2' ' A' ' 71' ' ' LYS . 51.8 mt -97.05 127.51 49.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 117.467 0.633 . . . . 0.0 110.682 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 1.663 ' HE2' ' CE1' ' A' ' 51' ' ' TYR . 9.6 m-85 -108.95 122.48 47.32 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.671 -178.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.54 115.52 5.32 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.369 -0.92 . . . . 0.0 111.396 177.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 1.658 ' HE1' ' CE2' ' A' ' 53' ' ' PHE . 3.2 m-85 -101.61 107.41 18.66 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.253 0.549 . . . . 0.0 111.545 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -97.54 99.14 10.54 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.54 176.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.579 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 20.4 t -102.42 125.21 56.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.025 0.441 . . . . 0.0 110.73 -175.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -115.41 177.84 4.52 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.174 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.6 m120 58.72 44.51 17.11 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.015 0.436 . . . . 0.0 111.562 177.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.93 -154.68 8.18 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.936 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -36.63 -59.94 0.41 Allowed 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 124.575 3.517 . . . . 0.0 114.298 -176.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -128.46 61.99 1.47 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 177.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.55 29.17 74.35 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.211 -176.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.89 154.09 34.09 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.184 0.516 . . . . 0.0 111.173 -177.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -132.55 110.59 10.58 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.494 -177.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.41 163.18 12.55 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.429 -177.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -147.89 116.89 6.8 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.88 0.371 . . . . 0.0 110.62 -178.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 18.9 m-90 -121.2 141.09 51.18 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.273 0.558 . . . . 0.0 109.682 179.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 16.4 t -107.63 117.98 54.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.164 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.466 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 4.1 mp -93.37 99.77 10.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -87.05 99.8 12.17 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.576 -176.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.487 ' HB1' ' O ' ' A' ' 49' ' ' GLY . . . -113.54 13.97 18.9 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.175 175.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.48 ' HB2' HG13 ' A' ' 50' ' ' ILE . 17.8 tppt? -64.48 -44.82 89.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.221 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -82.13 -0.73 46.14 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.672 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.8 27.28 32.35 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.308 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -93.36 -62.67 1.32 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.687 0.279 . . . . 0.0 111.037 -178.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.54 34.26 8.04 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.15 -1.024 . . . . 0.0 111.893 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 59.0 pttt -97.86 146.27 25.6 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -177.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.7 OUTLIER -110.82 131.47 61.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.355 0.598 . . . . 0.0 109.859 178.448 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.6 t -137.97 139.23 39.6 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.984 -178.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 1.658 ' HE1' ' CE2' ' A' ' 79' ' ' TYR . 24.2 t80 -65.1 128.11 34.42 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -178.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.413 ' HB3' ' O ' ' A' ' 79' ' ' TYR . 26.0 t-20 74.92 -45.8 0.58 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.677 0.791 . . . . 0.0 111.999 -178.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.81 -43.14 0.6 Allowed Glycine 0 CA--C 1.52 0.387 0 N-CA-C 114.764 0.666 . . . . 0.0 114.764 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.58 -18.84 6.58 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.026 -175.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -82.63 157.89 23.23 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 122.602 0.361 . . . . 0.0 110.358 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -95.43 109.24 44.28 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 174.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.401 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 23.2 Cg_exo -64.72 137.18 52.87 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.034 2.489 . . . . 0.0 112.712 -177.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -68.53 -32.48 72.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.107 -0.952 . . . . 0.0 109.546 176.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.9 m -140.27 130.41 28.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.316 172.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.576 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 28.2 m -114.91 133.87 55.63 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.375 176.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 1.637 ' HE1' ' CE2' ' A' ' 89' ' ' PHE . 53.0 m-85 -118.18 128.71 54.97 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.539 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 5.9 m -106.4 128.34 53.97 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 174.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.579 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -159.27 149.52 7.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.172 0.51 . . . . 0.0 110.294 -175.146 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.38 143.53 36.75 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.329 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -49.01 -29.01 4.37 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 114.869 -1.059 . . . . 0.0 111.091 176.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -73.22 -44.38 59.69 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.217 -176.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -81.51 -25.74 35.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.036 -176.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.497 ' O ' HG13 ' A' ' 100' ' ' ILE . 0.5 OUTLIER -56.62 -33.92 41.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.303 -175.007 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.442 ' CG1' ' HG2' ' A' ' 24' ' ' LYS . 3.9 m -68.35 -27.94 38.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.992 -170.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -87.23 -29.86 21.37 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 177.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 77.9 mt -68.2 -46.5 70.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.799 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 96' ' ' VAL . 20.1 mt -75.1 -24.41 17.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.296 -176.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.1 p -85.48 -18.11 34.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.036 0.446 . . . . 0.0 111.022 178.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.39 13.24 58.78 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.084 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -85.39 -41.43 15.45 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.133 0.492 . . . . 0.0 111.164 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.693 HD12 ' NZ ' ' A' ' 108' ' ' LYS . 44.4 tp -99.46 125.54 45.21 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.426 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -71.99 122.23 86.74 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.561 177.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -64.87 -23.34 62.27 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.213 1.942 . . . . 0.0 110.385 176.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -54.96 -62.3 1.75 Allowed 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.935 171.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.693 ' NZ ' HD12 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -64.11 -36.06 82.81 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.314 -176.368 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.555 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -69.78 -33.64 72.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.154 -178.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -64.17 -49.89 70.3 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 175.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -58.79 -40.64 84.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.029 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -84.8 13.68 5.57 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.248 -176.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.533 ' O ' ' HE3' ' A' ' 116' ' ' LYS . . . 70.17 14.68 71.48 Favored Glycine 0 CA--C 1.519 0.293 0 CA-C-N 116.152 -0.476 . . . . 0.0 113.992 172.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.55 -43.55 11.93 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 117.115 0.458 . . . . 0.0 110.219 177.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.544 HG13 ' CG1' ' A' ' 91' ' ' ILE . 0.1 OUTLIER -89.14 114.18 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.703 176.471 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.539 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 35.2 mmtp -110.79 99.4 8.33 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.474 175.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.656 ' HB ' ' CD2' ' A' ' 89' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--N 1.318 -0.79 0 CA-C-O 120.958 0.409 . . . . 0.0 110.153 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 12.6 m120 . . . . . 0 CA--C 1.517 -0.295 0 CA-C-O 121.656 0.741 . . . . 0.0 111.603 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.65 -38.25 62.85 Favored 'Trans proline' 0 CA--C 1.521 -0.142 0 C-N-CA 124.021 3.148 . . . . 0.0 111.947 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.45 ' HA ' ' CD1' ' A' ' 26' ' ' PHE . 35.5 tt0 -60.23 -31.33 70.08 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.713 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.35 -8.83 57.58 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.047 0.451 . . . . 0.0 111.058 -175.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 1.663 ' HD1' ' CD2' ' A' ' 23' ' ' PHE . 41.8 m-85 -80.69 153.2 28.02 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.288 -0.414 . . . . 0.0 109.941 175.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 49.3 mmtm -70.56 -29.53 66.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.646 0.736 . . . . 0.0 109.234 177.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.497 ' CG1' HG12 ' A' ' 96' ' ' VAL . 0.7 OUTLIER -68.4 -17.39 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 114.526 -1.216 . . . . 0.0 111.056 -174.897 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 1.626 ' HE2' ' CE1' ' A' ' 26' ' ' PHE . 75.3 t80 -55.51 -54.52 42.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.369 -179.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.402 ' HE2' ' CG2' ' A' ' 31' ' ' ILE . 0.5 OUTLIER -72.68 -43.7 62.76 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.56 177.363 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 1.666 ' HE1' ' CE2' ' A' ' 28' ' ' TYR . 12.9 m-85 -59.15 -46.25 88.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.416 . . . . 0.0 112.106 -175.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.432 ' CE ' HD12 ' A' ' 68' ' ' ILE . 73.4 mtp -77.53 -24.76 49.91 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.778 0.323 . . . . 0.0 110.894 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.459 ' HD3' ' HA ' ' A' ' 30' ' ' LYS . 43.0 mmtt -75.87 -31.28 59.18 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.268 177.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.402 ' CG2' ' HE2' ' A' ' 27' ' ' LYS . 13.6 pt -82.94 -27.44 8.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 173.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.8 tt -54.16 -51.83 63.06 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 168.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.54 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 9.2 tt0 -43.6 -58.03 2.86 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 114.23 -1.35 . . . . 0.0 111.296 177.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -67.81 -54.12 21.58 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.546 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.49 -37.61 65.49 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -169.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 95.0 mmm -63.34 -37.36 86.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.668 0.271 . . . . 0.0 111.654 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -90.09 -20.64 22.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.439 0.638 . . . . 0.0 110.225 177.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -69.31 -25.2 64.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.59 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -58.57 133.35 55.77 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 175.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.65 -30.12 41.56 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.752 -174.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -101.55 -5.46 25.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 119.468 -0.301 . . . . 0.0 111.538 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.401 ' C ' ' H ' ' A' ' 44' ' ' ILE . 5.3 p-10 36.11 73.67 0.08 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.718 0.77 . . . . 0.0 111.513 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 72.6 mt -64.36 -1.07 1.5 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.87 -174.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.409 HG13 ' HB2' ' A' ' 70' ' ' ALA . 4.2 tp -60.35 -25.91 35.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.699 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -79.78 -17.38 53.54 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.096 -177.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -86.58 -36.08 19.09 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.243 0.544 . . . . 0.0 110.188 177.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.421 ' O ' HG23 ' A' ' 47' ' ' VAL . 12.3 p -105.38 32.97 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.496 -178.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -53.33 109.96 0.5 Allowed 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.926 0.869 . . . . 0.0 111.523 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.519 ' O ' ' HB1' ' A' ' 70' ' ' ALA . . . -173.1 175.01 46.07 Favored Glycine 0 C--N 1.312 -0.788 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.788 -175.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.422 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 42.6 mt -113.09 127.13 70.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 117.904 0.852 . . . . 0.0 111.419 -177.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 1.651 ' HD1' ' CD2' ' A' ' 51' ' ' TYR . 3.0 m-85 -109.39 129.16 55.55 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.438 -178.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -108.79 118.4 5.29 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.318 -0.944 . . . . 0.0 111.291 176.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -102.09 103.29 13.85 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.188 0.518 . . . . 0.0 111.312 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.539 ' HZ2' HG22 ' A' ' 88' ' ' THR . 58.4 mttp -89.95 99.46 12.47 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.151 174.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 18.4 t -101.78 117.09 46.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.151 -176.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 39.7 mtp180 -117.9 -179.72 3.84 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.496 -176.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.413 ' HB2' ' HB3' ' A' ' 92' ' ' SER . 92.7 m-20 59.06 46.75 12.91 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.229 0.538 . . . . 0.0 110.969 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.74 -159.0 11.07 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.529 178.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -37.5 -61.1 0.37 Allowed 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 124.324 3.349 . . . . 0.0 114.063 -174.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -130.59 68.11 1.48 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.171 0.51 . . . . 0.0 110.1 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.51 23.04 73.58 Favored Glycine 0 N--CA 1.452 -0.247 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.56 -178.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.4 167.48 20.8 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.071 0.462 . . . . 0.0 111.331 -177.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -142.5 143.81 32.7 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.462 -176.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -136.72 159.92 24.68 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 111.141 -0.783 . . . . 0.0 111.141 178.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 1.639 ' HE1' ' CE2' ' A' ' 65' ' ' TYR . 16.2 t80 -148.08 113.11 5.48 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.936 0.368 . . . . 0.0 110.719 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 18.3 m-90 -118.25 134.85 54.66 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.867 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 25.1 t -104.56 119.92 54.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.547 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.54 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 3.7 mp -95.1 100.98 11.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -86.77 97.58 10.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.221 0.534 . . . . 0.0 109.967 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.519 ' HB1' ' O ' ' A' ' 49' ' ' GLY . . . -98.56 -6.74 29.49 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.243 173.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.409 ' HB2' HG13 ' A' ' 50' ' ' ILE . 21.9 tttt -54.79 -49.4 71.02 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.898 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -80.13 3.48 20.38 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.008 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.14 11.83 83.13 Favored Glycine 0 N--CA 1.452 -0.274 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.956 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -83.26 -59.64 2.4 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.739 0.304 . . . . 0.0 110.803 -177.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.35 34.08 24.04 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.223 -0.989 . . . . 0.0 110.65 -173.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.54 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 14.8 ptmm? -98.03 145.68 26.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.427 -0.387 . . . . 0.0 109.969 -175.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.8 OUTLIER -111.91 132.9 59.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.234 0.54 . . . . 0.0 109.644 178.812 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.0 t -139.36 135.58 33.86 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.918 -176.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 1.667 ' HE1' ' CE2' ' A' ' 79' ' ' TYR . 21.9 t80 -69.89 122.08 18.58 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 53.66 71.59 0.5 Allowed 'General case' 0 C--O 1.234 0.247 0 O-C-N 123.699 0.624 . . . . 0.0 109.83 -173.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -63.12 -34.48 90.07 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.259 -0.882 . . . . 0.0 113.656 -172.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.92 -2.28 87.77 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.526 -176.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.444 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 54.6 mm-40 -91.58 163.25 14.2 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -94.55 107.64 31.43 Favored Pre-proline 0 N--CA 1.445 -0.688 0 CA-C-O 121.281 0.562 . . . . 0.0 110.331 173.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 83' ' ' GLU . 8.1 Cg_exo -73.79 121.86 7.33 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.657 2.238 . . . . 0.0 112.048 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -59.59 -43.41 93.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.863 176.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.403 ' HB ' ' CD1' ' A' ' 117' ' ' ILE . 13.5 m -126.32 127.61 70.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.601 176.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.727 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 43.1 m -117.35 129.42 55.86 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.087 178.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 1.652 ' HE2' ' CE1' ' A' ' 89' ' ' PHE . 61.7 m-85 -110.52 130.06 55.65 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.545 ' HB ' ' HB3' ' A' ' 116' ' ' LYS . 2.9 m -108.29 107.13 17.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.763 0.316 . . . . 0.0 110.249 178.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 47.2 mt -131.23 156.75 42.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.537 -174.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.432 ' N ' HG23 ' A' ' 91' ' ' ILE . 23.7 m -92.7 140.72 29.24 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.355 175.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -43.29 -51.12 6.43 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.46 0.648 . . . . 0.0 111.66 -177.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.16 -35.61 69.75 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.441 -1.254 . . . . 0.0 112.205 -176.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.417 ' OD2' ' HB2' ' A' ' 92' ' ' SER . 12.0 m-20 -90.4 -23.13 21.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.697 0.284 . . . . 0.0 111.252 -175.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.497 HG12 ' CG1' ' A' ' 25' ' ' VAL . 0.4 OUTLIER -59.02 -31.84 46.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.034 0.445 . . . . 0.0 110.434 -177.857 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.7 m -67.03 -30.9 51.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.182 -172.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -83.14 -32.37 26.71 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.426 HD21 ' O ' ' A' ' 104' ' ' LEU . 75.7 mt -66.48 -51.24 58.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.472 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 96' ' ' VAL . 17.7 mt -70.97 -26.25 27.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.082 -176.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.6 t -82.04 -15.2 54.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.702 0.286 . . . . 0.0 111.059 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.23 20.49 48.88 Favored Glycine 0 N--CA 1.454 -0.16 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.005 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -96.9 -41.56 8.36 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.142 0.496 . . . . 0.0 111.023 -178.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.426 ' O ' HD21 ' A' ' 99' ' ' LEU . 34.1 tp -100.3 125.24 46.49 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.385 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.434 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 12.1 m120 -69.67 122.5 85.99 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.252 177.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -65.81 -21.6 57.75 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.015 1.81 . . . . 0.0 110.843 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 tm0? -65.79 -56.86 9.75 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.722 175.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.504 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -64.99 -32.35 74.03 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.435 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.504 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -66.8 -39.49 87.78 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.9 177.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 1.61 ' HE1' ' CE2' ' A' ' 110' ' ' PHE . 53.6 t80 -57.16 -52.95 63.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.879 175.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 1.649 ' HD2' ' CD1' ' A' ' 111' ' ' PHE . 78.6 t80 -60.75 -42.83 98.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.53 -178.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.411 ' OE1' ' HA ' ' A' ' 112' ' ' GLN . 16.0 mm-40 -75.78 -11.54 60.01 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.025 -175.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.26 7.71 55.78 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.767 176.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.2 mmpt? -87.17 -14.24 41.73 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.99 0.424 . . . . 0.0 110.728 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.503 HG22 HG23 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -129.55 109.48 18.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.926 0.87 . . . . 0.0 110.251 179.164 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.545 ' HB3' ' HB ' ' A' ' 90' ' ' THR . 38.1 tptt -109.35 110.24 21.34 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.331 173.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.727 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.319 -0.737 0 CA-C-O 121.411 0.624 . . . . 0.0 111.604 -172.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 . . . . . 0 CA--C 1.52 -0.193 0 CA-C-O 122.03 0.919 . . . . 0.0 112.023 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.545 ' HA ' ' CD1' ' A' ' 23' ' ' PHE . 20.6 Cg_endo -63.65 -14.21 41.33 Favored 'Trans proline' 0 C--N 1.334 -0.189 0 C-N-CA 124.35 3.367 . . . . 0.0 112.864 -177.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -75.52 -20.44 58.72 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.345 -178.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -88.32 -10.93 47.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.371 -0.832 . . . . 0.0 111.175 -176.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 1.662 ' HD2' ' CD1' ' A' ' 23' ' ' PHE . 18.0 m-85 -69.08 158.65 34.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.671 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -77.05 -27.0 54.26 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 174.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.501 ' HB ' ' SD ' ' A' ' 29' ' ' MET . 0.8 OUTLIER -72.04 -13.69 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.365 -179.06 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -57.02 -57.53 12.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.757 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.526 ' HZ1' HG22 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -72.0 -30.54 65.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.708 -178.449 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.44 ' O ' HG12 ' A' ' 31' ' ' ILE . 21.4 m-85 -70.92 -52.11 21.98 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.588 0.218 . . . . 0.0 111.588 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.501 ' SD ' ' HB ' ' A' ' 25' ' ' VAL . 0.1 OUTLIER -61.9 -31.14 71.41 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.734 0.302 . . . . 0.0 110.971 177.196 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.411 ' HA ' ' HD2' ' A' ' 30' ' ' LYS . 25.7 mmmt -69.3 -33.47 73.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.546 178.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.526 HG22 ' HZ1' ' A' ' 27' ' ' LYS . 13.3 pt -88.1 -24.37 6.2 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.451 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.2 176.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.5 tt -58.02 -47.22 83.74 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 171.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.595 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 6.8 tt0 -46.21 -50.9 15.24 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.489 175.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -75.0 -58.87 3.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.45 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.02 -40.17 66.78 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -167.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 95.6 mmm -60.6 -41.29 94.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.702 0.287 . . . . 0.0 111.493 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -90.79 -26.02 19.66 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.969 0.414 . . . . 0.0 110.072 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -65.04 -17.11 64.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.57 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -57.62 130.28 45.66 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.381 172.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 22.3 p -65.31 -21.92 66.77 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.952 -173.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -101.09 0.07 37.19 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.832 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 26.19 68.53 0.05 Allowed 'General case' 0 N--CA 1.472 0.63 0 O-C-N 124.481 1.113 . . . . 0.0 112.678 -177.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.4 mt -65.09 -4.12 4.48 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.201 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.9 tp -60.51 -26.33 37.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.748 178.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -72.65 -23.19 60.87 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.188 -178.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -79.23 -43.64 23.39 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.361 0.6 . . . . 0.0 110.535 178.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.451 ' O ' HG23 ' A' ' 47' ' ' VAL . 15.0 p -102.67 32.51 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.719 -176.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 41.8 mtm180 -51.2 117.14 2.39 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.633 0.73 . . . . 0.0 111.427 178.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.457 ' O ' ' HB1' ' A' ' 70' ' ' ALA . . . -172.89 176.28 45.73 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.616 -176.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.405 HD13 ' HD2' ' A' ' 71' ' ' LYS . 53.8 mt -115.17 124.42 71.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 117.669 0.734 . . . . 0.0 111.358 -178.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 1.669 ' HE1' ' CE2' ' A' ' 51' ' ' TYR . 27.7 m-85 -106.09 118.46 36.68 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.051 -177.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.49 111.51 4.18 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.322 177.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.404 ' O ' ' HA ' ' A' ' 65' ' ' TYR . 4.0 m-85 -96.27 111.14 23.31 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.955 0.407 . . . . 0.0 111.679 -178.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -95.47 105.42 17.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.34 173.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 22.6 t -105.83 107.39 22.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 120.972 0.415 . . . . 0.0 111.099 -174.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.427 ' HD2' ' N ' ' A' ' 56' ' ' ARG . 1.3 mpt_? -92.48 -179.64 5.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.628 176.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 13.8 m120 58.87 44.74 16.29 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.8 176.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -81.15 -165.02 33.42 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.33 176.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -35.6 -60.93 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 124.619 3.546 . . . . 0.0 114.696 -176.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.463 ' OD1' ' HB1' ' A' ' 62' ' ' ALA . 25.4 p-10 -114.22 43.51 1.86 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.353 0.596 . . . . 0.0 110.328 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.83 24.16 76.55 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 -170.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.463 ' HB1' ' OD1' ' A' ' 60' ' ' ASN . . . -70.7 155.53 40.64 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 114.511 -0.845 . . . . 0.0 111.754 -175.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -115.59 139.27 50.25 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.666 177.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -129.42 152.76 19.63 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 176.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.404 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 44.7 t80 -140.1 116.93 10.97 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.869 0.366 . . . . 0.0 110.656 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 26.9 m-90 -122.72 132.41 54.23 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.278 -178.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 55.4 t -102.76 112.22 35.34 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.201 178.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.501 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 4.3 mp -89.92 102.92 13.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.155 -0.684 . . . . 0.0 109.155 176.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.406 ' OD1' ' HB3' ' A' ' 71' ' ' LYS . 44.1 t-20 -85.59 96.94 9.82 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.868 -178.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.457 ' HB1' ' O ' ' A' ' 49' ' ' GLY . . . -99.89 -2.18 35.46 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.829 173.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.406 ' HB3' ' OD1' ' A' ' 69' ' ' ASN . 65.4 tttt -51.4 -50.77 58.98 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.15 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -84.0 -3.54 58.08 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.143 -176.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.19 7.49 76.82 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.254 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.7 tppt? -83.3 -44.76 14.56 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-O 120.884 0.373 . . . . 0.0 110.652 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.07 35.07 35.62 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.756 175.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.595 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -97.0 165.34 12.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.113 0.456 . . . . 0.0 110.085 -177.178 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.8 OUTLIER -123.02 136.89 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-O 121.177 0.513 . . . . 0.0 109.627 178.672 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.1 t -135.28 136.01 41.3 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.041 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 1.63 ' HD2' ' CD1' ' A' ' 79' ' ' TYR . 37.2 t80 -69.85 116.73 10.57 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -178.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 60.3 t30 52.76 74.08 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.836 0.71 . . . . 0.0 110.093 -173.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -63.59 -28.5 72.59 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.385 -0.825 . . . . 0.0 113.152 -177.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.61 -20.26 42.7 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.846 -0.692 . . . . 0.0 111.657 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.42 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 69.2 mm-40 -73.02 156.02 39.21 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 177.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.447 ' HB3' ' HZ3' ' A' ' 84' ' ' LYS . 3.0 mmmp? -91.84 108.2 28.12 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 173.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 83' ' ' GLU . 22.1 Cg_exo -65.36 135.45 42.94 Favored 'Trans proline' 0 CA--C 1.517 -0.361 0 C-N-CA 122.95 2.433 . . . . 0.0 112.369 -176.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -62.69 -30.4 71.37 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.776 176.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.5 m -142.63 134.74 25.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.771 176.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.65 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 17.4 m -113.37 141.06 47.5 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.275 -0.421 . . . . 0.0 109.938 177.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.646 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 29.6 m-85 -126.21 134.6 51.19 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 176.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.7 m -111.14 118.64 36.53 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.899 0.381 . . . . 0.0 110.528 176.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.524 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 80.4 mt -141.51 157.2 21.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.484 -0.78 . . . . 0.0 108.933 -175.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.421 ' OG ' ' HE3' ' A' ' 114' ' ' LYS . 6.1 p -93.02 144.81 24.88 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 111.496 0.184 . . . . 0.0 111.496 176.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -41.18 -56.23 2.43 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 122.172 0.987 . . . . 0.0 111.714 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -60.26 -34.04 73.16 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 113.272 -1.785 . . . . 0.0 112.621 -171.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.68 -19.43 22.66 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -177.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.573 ' O ' HG13 ' A' ' 100' ' ' ILE . 0.5 OUTLIER -56.52 -34.13 40.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.21 0.529 . . . . 0.0 110.026 -178.958 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.3 m -66.36 -28.97 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.031 -173.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -84.69 -35.5 22.52 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.44 HD21 ' O ' ' A' ' 104' ' ' LEU . 74.8 mt -68.76 -42.25 77.76 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.96 -177.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.573 HG13 ' O ' ' A' ' 96' ' ' VAL . 15.4 mt -76.27 -22.54 15.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.808 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.2 t -88.58 -19.69 25.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.966 0.412 . . . . 0.0 110.776 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.32 0.11 65.57 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.831 -177.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -67.85 -42.11 81.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.027 0.441 . . . . 0.0 110.791 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.44 ' O ' HD21 ' A' ' 99' ' ' LEU . 36.8 tp -104.38 126.38 51.43 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.873 178.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.423 ' HB3' ' HG2' ' A' ' 108' ' ' LYS . 1.8 t-20 -72.97 121.41 85.02 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.828 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -65.68 -20.7 59.44 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.932 1.755 . . . . 0.0 110.775 177.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.11 -55.82 8.47 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.749 174.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.535 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 0.4 OUTLIER -62.06 -35.71 79.45 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.457 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.535 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -68.53 -35.58 77.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.33 177.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 1.654 ' HD2' ' CD1' ' A' ' 110' ' ' PHE . 27.8 t80 -59.85 -49.05 79.24 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 175.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 1.627 ' HD2' ' CD1' ' A' ' 111' ' ' PHE . 70.9 t80 -64.87 -33.53 76.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.93 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.522 ' HA ' HE21 ' A' ' 112' ' ' GLN . 0.0 OUTLIER -87.49 10.42 17.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.751 -178.168 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.37 1.76 82.34 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 121.285 -0.483 . . . . 0.0 113.661 172.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.551 ' NZ ' ' HB3' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -94.02 11.33 30.13 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -177.081 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.519 HG22 HG23 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -140.95 109.56 2.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-O 121.976 0.893 . . . . 0.0 109.19 172.551 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -109.0 98.45 7.93 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.744 -1.117 . . . . 0.0 109.274 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.65 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.319 -0.743 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.845 178.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.439 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 15.1 m120 . . . . . 0 CA--C 1.52 -0.186 0 CA-C-O 121.152 0.501 . . . . 0.0 111.003 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 19' ' ' ASN . 23.8 Cg_exo -58.98 -31.08 95.01 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 123.413 2.742 . . . . 0.0 111.529 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.484 ' HA ' ' CD1' ' A' ' 26' ' ' PHE . 24.5 tt0 -62.47 -35.44 79.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.254 176.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -81.25 1.54 31.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.96 -174.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -77.95 153.86 32.11 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 173.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -76.81 -24.27 52.8 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.498 ' CG1' HG12 ' A' ' 96' ' ' VAL . 1.3 m -73.84 -14.84 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.038 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 1.642 ' HD1' ' CD2' ' A' ' 26' ' ' PHE . 83.1 t80 -56.75 -50.25 72.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.718 0.294 . . . . 0.0 110.372 -176.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.61 -44.32 86.87 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.582 178.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 1.629 ' HD2' ' CD1' ' A' ' 28' ' ' TYR . 52.0 m-85 -62.47 -46.7 87.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.866 -177.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.435 ' HB3' HG23 ' A' ' 77' ' ' VAL . 56.2 mtt -73.88 -26.69 60.69 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.059 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.422 ' HD3' ' HA ' ' A' ' 30' ' ' LYS . 40.8 mmtt -71.15 -38.9 72.22 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.19 176.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 13.6 pt -78.04 -25.17 14.18 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.427 0 C-N-CA 120.329 -0.548 . . . . 0.0 109.793 175.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.3 tt -60.3 -52.76 63.91 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 173.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.503 ' HG2' ' HA ' ' A' ' 76' ' ' LYS . 1.5 tm-20 -43.37 -48.05 6.92 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 114.814 -1.084 . . . . 0.0 111.018 176.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -77.19 -53.29 7.93 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.933 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.52 -38.9 82.18 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -168.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 25.9 mmt -60.01 -40.76 90.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.713 0.292 . . . . 0.0 111.624 -178.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -91.39 -19.52 22.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.099 0.476 . . . . 0.0 111.138 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -66.38 -23.5 66.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.247 0.546 . . . . 0.0 110.028 178.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -62.14 133.81 55.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.441 173.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.8 p -62.84 -32.88 74.19 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.037 -174.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -92.06 0.66 57.47 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-O 119.303 -0.379 . . . . 0.0 111.385 178.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.6 p30 34.11 63.32 0.42 Allowed 'General case' 0 N--CA 1.468 0.433 0 O-C-N 124.172 0.92 . . . . 0.0 110.557 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.5 mt -56.97 -12.12 1.84 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 114.427 -1.26 . . . . 0.0 112.056 -173.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.2 tp -61.48 -30.99 49.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.81 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.492 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 9.6 tt0 -75.2 -27.03 59.44 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.12 0.486 . . . . 0.0 110.909 -176.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -73.37 -15.92 61.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.592 -179.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.496 ' O ' HG23 ' A' ' 47' ' ' VAL . 15.0 p -131.07 31.84 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.276 -178.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.492 ' HG3' ' O ' ' A' ' 45' ' ' GLU . 59.7 mtm180 -49.21 109.44 0.26 Allowed 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.942 0.877 . . . . 0.0 112.647 -176.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.503 ' O ' ' HB1' ' A' ' 70' ' ' ALA . . . -159.6 170.75 35.89 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 113.88 -1.509 . . . . 0.0 110.493 -178.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.441 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 54.6 mt -106.47 125.45 62.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 117.416 0.608 . . . . 0.0 110.749 179.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 1.641 ' HE2' ' CE1' ' A' ' 51' ' ' TYR . 16.5 m-85 -107.75 116.26 31.63 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.95 -178.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -97.76 111.72 4.31 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.024 177.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -101.32 104.52 15.53 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.061 0.457 . . . . 0.0 111.488 -178.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -91.95 101.51 14.07 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.449 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 10.4 t -100.98 118.21 47.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.888 -173.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.436 ' O ' ' HA ' ' A' ' 92' ' ' SER . 50.4 mtp180 -110.28 177.66 4.63 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.686 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.423 ' HB2' ' HB3' ' A' ' 92' ' ' SER . 3.3 m-20 57.91 41.7 24.19 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.954 0.407 . . . . 0.0 110.979 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -74.08 -153.28 2.91 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.603 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -32.18 -60.14 0.19 Allowed 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 124.499 3.466 . . . . 0.0 114.233 -177.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -141.51 70.37 1.34 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.045 0.45 . . . . 0.0 109.891 176.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.81 18.15 78.71 Favored Glycine 0 N--CA 1.453 -0.176 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.702 -177.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.58 162.22 26.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.011 0.434 . . . . 0.0 111.246 -177.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -136.25 132.3 35.62 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.788 -177.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -131.98 162.4 23.88 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.453 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 1.673 ' HE1' ' CE2' ' A' ' 65' ' ' TYR . 15.5 t80 -146.56 113.7 6.21 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.829 0.347 . . . . 0.0 110.917 -177.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 16.3 m-90 -113.45 140.21 48.28 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.867 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 45.7 t -106.97 114.53 46.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.902 177.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.548 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 3.9 mp -91.04 99.67 10.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 175.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -87.54 99.03 11.74 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.247 -177.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.503 ' HB1' ' O ' ' A' ' 49' ' ' GLY . . . -101.18 -6.7 23.91 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.892 174.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.41 ' HB2' ' HE3' ' A' ' 71' ' ' LYS . 3.6 tppp? -58.76 -47.53 84.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.996 -176.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -73.52 -6.32 45.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.203 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 94.88 14.35 49.73 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.033 -0.603 . . . . 0.0 111.727 -178.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.475 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 9.1 mmpt? -86.32 -70.05 0.63 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.718 0.294 . . . . 0.0 111.112 -177.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.83 32.16 13.56 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -170.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.548 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 21.8 ptmt -99.16 147.21 25.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.234 -0.483 . . . . 0.0 109.948 -177.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.435 HG23 ' HB3' ' A' ' 29' ' ' MET . 0.6 OUTLIER -107.51 127.34 63.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 176.868 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.2 t -130.71 127.68 39.31 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.473 -178.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 1.654 ' HE1' ' CE2' ' A' ' 79' ' ' TYR . 62.5 t80 -67.59 122.5 18.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.96 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 56.3 t30 54.62 72.61 0.45 Allowed 'General case' 0 C--O 1.233 0.235 0 O-C-N 123.786 0.679 . . . . 0.0 109.928 -174.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.85 -40.34 64.1 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.948 -175.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.14 -20.52 45.51 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.974 -0.632 . . . . 0.0 111.641 -176.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.512 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 40.4 mm-40 -74.08 148.2 42.08 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.646 -0.277 . . . . 0.0 110.295 178.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -80.08 109.38 12.15 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-O 121.202 0.525 . . . . 0.0 110.915 176.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 83' ' ' GLU . 17.9 Cg_exo -67.6 136.25 38.7 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.847 2.365 . . . . 0.0 112.566 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -69.93 -31.6 69.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.701 175.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.5 m -140.68 127.53 21.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.604 173.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.575 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 64.2 m -110.96 127.39 55.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.342 176.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.546 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 83.0 m-85 -113.6 120.36 40.66 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 177.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.457 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 5.0 m -96.6 122.21 39.28 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 175.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.564 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -155.64 155.95 5.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.05 0.452 . . . . 0.0 110.794 -172.891 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 56' ' ' ARG . 13.3 m -83.75 143.2 30.15 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.322 -177.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -53.66 -27.73 29.2 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.226 1.011 . . . . 0.0 110.908 178.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -77.14 -38.12 52.58 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.436 -178.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -90.78 -22.17 21.16 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.763 -173.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.498 HG12 ' CG1' ' A' ' 25' ' ' VAL . 0.4 OUTLIER -57.31 -32.47 41.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.12 0.486 . . . . 0.0 110.383 -178.133 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.6 m -68.82 -32.62 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.739 -172.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -77.72 -35.69 51.72 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 177.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.437 HD21 ' O ' ' A' ' 104' ' ' LEU . 84.7 mt -65.92 -48.67 70.66 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.761 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 96' ' ' VAL . 29.9 mt -70.84 -29.9 39.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.112 -177.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.7 t -78.09 -30.15 49.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.865 178.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 102.5 11.96 34.35 Favored Glycine 0 CA--C 1.516 0.105 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.672 -176.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -84.01 -41.63 17.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.096 0.474 . . . . 0.0 110.82 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.437 ' O ' HD21 ' A' ' 99' ' ' LEU . 43.2 tp -102.95 123.85 47.35 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.981 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.441 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 6.1 m-20 -73.52 117.95 64.91 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.287 178.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -60.13 -22.45 69.93 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.009 1.806 . . . . 0.0 111.214 176.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -64.35 -55.44 21.18 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.002 173.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.483 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 0.7 OUTLIER -66.83 -31.54 72.22 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.767 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.483 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -70.61 -32.65 70.07 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.085 0.469 . . . . 0.0 109.945 177.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -65.83 -46.6 77.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.331 174.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 1.647 ' HE2' ' CE1' ' A' ' 111' ' ' PHE . 81.0 t80 -63.16 -44.48 95.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.205 178.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.484 ' HA ' ' OE1' ' A' ' 112' ' ' GLN . 14.5 mm-40 -79.63 2.24 23.23 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -176.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.31 6.75 89.08 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.774 171.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.09 -37.79 37.87 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.031 0.443 . . . . 0.0 110.767 177.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.546 HG13 ' CG1' ' A' ' 91' ' ' ILE . 0.1 OUTLIER -93.13 117.27 36.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.942 178.736 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.457 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 23.9 mmmt -109.31 99.13 8.44 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.575 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.321 -0.667 0 CA-C-O 121.081 0.467 . . . . 0.0 110.521 -177.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 . . . . . 0 C--O 1.232 0.172 0 CA-C-O 121.371 0.605 . . . . 0.0 111.794 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.496 ' O ' ' HB2' ' A' ' 26' ' ' PHE . 4.9 Cg_exo -67.63 -22.25 44.41 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.997 2.464 . . . . 0.0 111.025 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -65.07 -31.64 72.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.743 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -73.77 -18.69 60.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.273 -178.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 1.668 ' HE2' ' CE1' ' A' ' 23' ' ' PHE . 66.5 m-85 -77.65 142.33 38.92 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 174.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -70.38 -23.21 62.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.664 0.745 . . . . 0.0 109.16 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.484 ' CG1' HG12 ' A' ' 96' ' ' VAL . 1.0 OUTLIER -69.4 -17.36 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.002 -179.027 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 1.621 ' HD1' ' CD2' ' A' ' 26' ' ' PHE . 75.3 t80 -58.15 -44.16 87.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.258 0.552 . . . . 0.0 110.232 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.479 ' HZ1' HG22 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -77.17 -42.33 38.14 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.475 178.851 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 1.614 ' HD2' ' CD1' ' A' ' 28' ' ' TYR . 24.6 m-85 -66.56 -44.39 82.46 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -177.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.43 ' CE ' HD12 ' A' ' 68' ' ' ILE . 73.9 mtp -77.56 -20.27 54.34 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.835 0.35 . . . . 0.0 110.542 -178.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 26' ' ' PHE . 19.8 mmtt -76.4 -36.67 57.94 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.871 175.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.479 HG22 ' HZ1' ' A' ' 27' ' ' LYS . 14.1 pt -77.22 -23.87 14.79 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.354 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 174.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.4 tt -58.8 -51.66 69.02 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 171.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -45.79 -47.6 15.62 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.293 176.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -75.04 -54.5 7.05 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.54 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.6 -33.83 73.32 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -169.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.2 mmt -62.28 -39.38 92.74 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -90.96 -29.41 17.43 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.088 0.47 . . . . 0.0 110.838 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -64.61 -32.08 73.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.377 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -57.04 138.36 54.51 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.097 177.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.2 p -58.31 -24.57 60.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.027 -0.988 . . . . 0.0 113.063 -172.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -94.04 -28.42 15.75 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.8 p30 36.11 63.28 0.61 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.763 0.792 . . . . 0.0 111.181 -176.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 93.0 mt -69.52 2.75 2.85 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.859 -175.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.405 HG13 ' HB2' ' A' ' 70' ' ' ALA . 1.9 tp -56.91 -31.38 36.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.262 -177.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -76.75 -19.81 57.21 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.901 0.381 . . . . 0.0 111.164 -177.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -85.54 -35.01 21.37 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.25 0.548 . . . . 0.0 110.137 177.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.449 ' O ' HG23 ' A' ' 47' ' ' VAL . 13.2 p -108.3 32.97 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.875 0.845 . . . . 0.0 110.472 -177.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.0 mtm180 -52.66 124.41 13.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.521 0.677 . . . . 0.0 111.309 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.423 ' O ' ' HB1' ' A' ' 70' ' ' ALA . . . 179.74 -174.84 46.38 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 114.524 -1.216 . . . . 0.0 110.663 -175.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 63.3 mt -123.66 125.72 71.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 117.853 0.826 . . . . 0.0 111.391 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 1.649 ' HE1' ' CE2' ' A' ' 51' ' ' TYR . 22.7 m-85 -106.09 116.02 31.23 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.788 -178.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.38 115.59 5.23 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.533 -0.842 . . . . 0.0 111.357 177.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -100.92 109.63 21.6 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.039 0.447 . . . . 0.0 111.448 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -94.35 99.34 11.57 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 172.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 18.6 t -101.03 107.35 21.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.096 0.474 . . . . 0.0 110.582 -174.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.452 ' O ' ' HA ' ' A' ' 92' ' ' SER . 35.9 mtp180 -103.18 174.36 5.9 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.087 -176.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 61.47 48.48 5.87 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.095 0.474 . . . . 0.0 111.239 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.08 -145.27 1.58 Allowed Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.245 175.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.411 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 73.8 Cg_exo -40.6 -60.91 0.53 Allowed 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.665 2.91 . . . . 0.0 113.633 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -146.94 77.48 1.46 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.311 0.576 . . . . 0.0 110.487 177.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.58 13.33 83.58 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.88 178.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.411 ' HB1' ' HD2' ' A' ' 59' ' ' PRO . . . -72.73 143.78 47.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.987 0.423 . . . . 0.0 110.823 179.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -129.53 114.46 16.12 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.13 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -107.98 168.88 14.06 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.636 -178.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -150.2 120.34 7.25 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.754 0.311 . . . . 0.0 110.765 -177.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 16.9 m-90 -123.49 149.94 44.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.976 0.417 . . . . 0.0 109.919 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 38.2 t -118.25 118.1 56.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.645 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 4.1 mp -92.56 105.45 16.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 175.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -91.15 97.47 11.16 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.514 -176.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.423 ' HB1' ' O ' ' A' ' 49' ' ' GLY . . . -98.1 -10.32 24.45 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.322 174.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.55 ' HD2' ' HG3' ' A' ' 72' ' ' GLU . 1.2 tmmt? -59.71 -34.88 73.49 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.212 -178.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.55 ' HG3' ' HD2' ' A' ' 71' ' ' LYS . 40.5 mt-10 -95.09 12.61 28.03 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.334 0.587 . . . . 0.0 111.24 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.53 -12.96 43.91 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.401 -0.818 . . . . 0.0 113.507 174.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.476 ' HB3' ' HZ3' ' A' ' 74' ' ' LYS . 2.6 mmmp? -74.11 -56.23 5.17 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.706 0.289 . . . . 0.0 111.22 -176.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.89 35.06 9.36 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.198 -1.001 . . . . 0.0 111.736 -177.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 16.3 pttm -96.89 151.43 19.69 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 -175.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.8 OUTLIER -108.22 132.3 56.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 108.984 -0.746 . . . . 0.0 108.984 177.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.3 t -136.53 134.33 37.41 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.186 -177.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 1.642 ' HE2' ' CE1' ' A' ' 79' ' ' TYR . 70.0 t80 -66.54 125.32 25.37 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.28 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 51.78 63.16 2.35 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.275 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -59.21 -40.41 95.76 Favored Glycine 0 C--N 1.33 0.224 0 CA-C-N 115.324 -0.853 . . . . 0.0 113.847 -173.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.65 -20.61 47.69 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.931 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.511 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 15.6 mm-40 -70.19 150.57 46.33 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 174.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -85.04 107.82 13.14 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 178.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 83' ' ' GLU . 16.6 Cg_exo -67.95 128.89 18.51 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.855 2.37 . . . . 0.0 112.425 -177.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -62.16 -33.43 74.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.775 175.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.499 ' HB ' ' CD1' ' A' ' 117' ' ' ILE . 2.9 m -137.68 142.45 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.406 175.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.694 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 34.1 m -126.11 126.15 43.71 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.472 -179.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.413 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 55.0 m-85 -108.85 124.96 51.45 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.404 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 6.7 m -98.98 114.62 27.35 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 173.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.533 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 89.3 mt -137.54 150.35 25.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.811 -174.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 56' ' ' ARG . 51.1 m -90.52 137.3 32.46 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.866 176.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -43.23 -51.72 6.01 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 123.658 0.599 . . . . 0.0 111.826 -177.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.03 -41.17 67.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.374 -177.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -90.18 -18.36 25.89 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -174.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.484 HG12 ' CG1' ' A' ' 25' ' ' VAL . 0.3 OUTLIER -57.39 -31.02 37.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.078 0.466 . . . . 0.0 110.066 -178.55 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.9 m -69.29 -28.71 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.836 -174.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -79.46 -39.59 31.88 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 176.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.466 HD21 ' O ' ' A' ' 104' ' ' LEU . 86.8 mt -68.17 -41.88 80.84 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.814 -176.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 96' ' ' VAL . 19.5 mt -72.96 -25.35 21.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.35 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 10.3 t -95.75 -5.27 42.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.093 -178.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.49 15.12 76.94 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.139 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -82.22 -42.52 18.84 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.336 0.589 . . . . 0.0 110.408 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.466 ' O ' HD21 ' A' ' 99' ' ' LEU . 41.4 tp -104.76 124.18 48.95 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.867 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.462 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 17.5 m120 -71.05 116.32 45.44 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.353 178.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -60.37 -22.9 73.0 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.067 1.845 . . . . 0.0 111.301 178.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -62.15 -59.42 5.08 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.956 173.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.519 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -64.75 -33.58 76.31 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.888 -177.676 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.537 ' HB3' ' HB3' ' A' ' 114' ' ' LYS . . . -71.32 -29.9 65.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.395 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -66.31 -45.03 81.72 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 175.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 1.607 ' HD2' ' CD1' ' A' ' 111' ' ' PHE . 84.7 t80 -66.93 -37.67 84.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.363 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -82.02 -6.38 59.1 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.053 -177.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.03 15.41 61.03 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.261 175.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.537 ' HB3' ' HB3' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -81.76 -41.6 20.95 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.567 0.699 . . . . 0.0 109.266 176.671 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.517 HG22 HG21 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -104.25 126.88 58.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.601 -176.995 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.404 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 34.2 mmtp -120.58 99.63 6.66 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 174.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.694 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.484 0 CA-C-O 121.035 0.445 . . . . 0.0 111.567 -176.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.3 m120 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.985 0.422 . . . . 0.0 110.626 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.421 ' O ' ' HB2' ' A' ' 26' ' ' PHE . 11.8 Cg_exo -64.76 -29.16 59.55 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.206 2.604 . . . . 0.0 112.005 -175.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -63.73 -34.87 78.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.544 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -70.23 -11.63 61.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.355 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 1.64 ' HE2' ' CE1' ' A' ' 23' ' ' PHE . 50.0 m-85 -81.23 143.31 32.4 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.174 0.512 . . . . 0.0 110.186 177.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -74.29 -21.11 59.89 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.569 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.507 HG12 ' OD1' ' A' ' 93' ' ' ASP . 2.5 m -75.16 -17.23 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.075 177.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 1.609 ' HE2' ' CE1' ' A' ' 26' ' ' PHE . 73.2 t80 -54.19 -57.24 11.91 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.871 0.367 . . . . 0.0 110.57 -176.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.516 ' HZ3' HG22 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -64.96 -32.68 74.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.8 -177.576 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 1.608 ' HE2' ' CE1' ' A' ' 28' ' ' TYR . 10.5 m-85 -70.59 -46.75 62.84 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.298 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.692 ' HE3' ' CE2' ' A' ' 66' ' ' TRP . 29.6 mtm -66.17 -30.51 70.99 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.833 176.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 26' ' ' PHE . 29.4 mmmt -64.63 -35.38 80.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.061 177.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.516 HG22 ' HZ3' ' A' ' 27' ' ' LYS . 9.6 pt -88.35 -16.18 8.93 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.565 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.231 176.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.3 tt -64.5 -51.42 63.02 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 168.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.529 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 6.3 tt0 -44.35 -45.51 8.86 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 114.447 -1.251 . . . . 0.0 110.865 173.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -73.16 -59.57 2.65 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.499 178.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.84 -37.23 68.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.668 -0.697 . . . . 0.0 112.769 -167.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.434 ' HB3' HD11 ' A' ' 44' ' ' ILE . 25.9 mmt -59.43 -42.76 92.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.788 -179.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -92.34 -24.15 19.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.094 0.473 . . . . 0.0 111.015 178.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -64.92 -30.02 70.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.01 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -54.64 135.96 46.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.559 0.695 . . . . 0.0 110.041 176.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 16.2 p -52.73 -38.58 61.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.257 -1.338 . . . . 0.0 112.973 -173.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -102.78 8.89 39.31 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 119.227 -0.416 . . . . 0.0 111.258 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.421 ' C ' ' H ' ' A' ' 44' ' ' ILE . 3.7 p-10 34.2 67.8 0.2 Allowed 'General case' 0 C--O 1.238 0.461 0 O-C-N 124.183 0.927 . . . . 0.0 110.752 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.402 ' O ' HG13 ' A' ' 47' ' ' VAL . 69.1 mt -62.08 -0.4 0.51 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.273 -1.33 . . . . 0.0 112.403 -171.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.434 HD11 ' HB3' ' A' ' 36' ' ' MET . 4.2 tp -63.23 -28.21 44.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.3 178.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -76.6 -10.86 59.69 Favored 'General case' 0 N--CA 1.46 0.053 0 CA-C-O 121.235 0.54 . . . . 0.0 110.645 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -100.53 -14.8 18.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.804 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.459 ' O ' HG23 ' A' ' 47' ' ' VAL . 14.6 p -131.18 33.05 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.662 0.744 . . . . 0.0 110.364 -177.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 50.8 mtt180 -51.89 109.45 0.37 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.738 0.78 . . . . 0.0 111.826 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.589 ' O ' ' HB1' ' A' ' 70' ' ' ALA . . . -167.41 167.38 39.88 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.398 -177.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.432 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 32.9 mt -105.89 125.71 61.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 118.481 1.14 . . . . 0.0 111.145 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.538 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 17.0 m-85 -104.25 122.55 45.64 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.607 -177.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.47 125.14 8.48 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.236 176.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 1.62 ' HD2' ' CD1' ' A' ' 53' ' ' PHE . 5.6 m-85 -108.12 99.85 9.24 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.171 0.51 . . . . 0.0 111.331 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -94.78 100.82 12.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.141 173.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.56 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 19.8 t -108.47 117.72 54.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.1 0.476 . . . . 0.0 111.141 -173.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 47.0 mtp180 -102.25 -179.72 4.07 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.218 -177.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.437 ' HB2' ' HB3' ' A' ' 92' ' ' SER . 3.5 m-20 59.89 44.72 13.29 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 123.288 0.368 . . . . 0.0 111.34 178.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.97 -157.27 6.9 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.692 177.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -43.3 -59.74 0.95 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.675 2.917 . . . . 0.0 112.888 -178.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -113.47 46.88 1.21 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 175.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.6 15.44 77.63 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.837 -176.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.0 143.44 57.77 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.729 0.776 . . . . 0.0 111.606 -177.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -107.98 109.63 21.15 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.917 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.65 154.03 19.63 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 1.649 ' HD1' ' CD2' ' A' ' 65' ' ' TYR . 35.1 t80 -139.25 117.38 11.82 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.95 0.405 . . . . 0.0 111.173 -178.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.692 ' CE2' ' HE3' ' A' ' 29' ' ' MET . 10.2 m-90 -119.71 161.7 20.28 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.2 t -126.36 118.8 52.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.265 178.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.538 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 3.1 mp -96.36 100.54 11.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 176.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -82.4 98.22 8.76 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.166 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.589 ' HB1' ' O ' ' A' ' 49' ' ' GLY . . . -100.64 -5.11 27.13 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.975 175.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.47 ' HE3' ' HA2' ' A' ' 49' ' ' GLY . 4.1 tppp? -66.05 -39.23 89.95 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.256 -178.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -81.0 0.54 35.18 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.019 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.75 13.59 83.29 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.198 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.504 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 10.8 mmpt? -86.22 -50.5 6.93 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.68 0.276 . . . . 0.0 110.566 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.44 33.07 61.57 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.455 -0.879 . . . . 0.0 111.004 -176.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.529 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 52.2 pttt -98.5 149.24 22.92 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.504 -0.348 . . . . 0.0 110.197 -177.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.442 HG13 HG13 ' A' ' 68' ' ' ILE . 0.9 OUTLIER -108.11 123.01 63.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.699 0.761 . . . . 0.0 109.565 -178.383 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.5 t -130.36 134.46 47.18 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.582 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -64.68 129.66 40.63 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 -176.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 72.68 -43.19 0.56 Allowed 'General case' 0 N--CA 1.47 0.557 0 O-C-N 124.001 0.813 . . . . 0.0 111.944 -177.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.91 -42.68 0.76 Allowed Glycine 0 CA--C 1.518 0.259 0 CA-C-N 116.151 -0.477 . . . . 0.0 114.222 177.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.79 13.22 78.6 Favored Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 -174.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -116.25 166.74 11.69 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -177.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -100.7 109.01 56.37 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.204 177.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.432 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 12.6 Cg_exo -71.48 127.95 13.88 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 122.994 2.462 . . . . 0.0 112.789 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -60.97 -46.5 90.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.587 173.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.446 ' HB ' ' CD1' ' A' ' 117' ' ' ILE . 8.7 m -125.11 125.12 68.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.65 178.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.714 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 15.2 m -122.77 125.69 45.98 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.35 -178.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.507 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 86.2 m-85 -105.18 136.24 45.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.609 0.242 . . . . 0.0 110.39 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.55 ' HB ' ' HB3' ' A' ' 116' ' ' LYS . 2.2 m -109.72 99.63 8.77 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 175.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 49.0 mt -125.46 162.47 28.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -175.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.506 ' N ' HG23 ' A' ' 91' ' ' ILE . 20.3 m -97.86 145.53 26.34 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.987 0.422 . . . . 0.0 110.364 176.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.507 ' OD1' HG12 ' A' ' 25' ' ' VAL . 36.6 t70 -54.18 -24.03 16.64 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.016 -176.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -82.83 -35.38 26.4 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.982 -177.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -90.11 -26.44 20.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.711 -172.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.486 ' CG1' HG11 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -54.5 -33.13 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.011 0.434 . . . . 0.0 111.453 -176.648 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.4 m -66.34 -27.51 40.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.639 -169.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -89.69 -27.44 20.1 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 176.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.451 HD21 ' O ' ' A' ' 104' ' ' LEU . 76.1 mt -69.09 -42.97 75.46 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.204 0.526 . . . . 0.0 110.533 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 96' ' ' VAL . 16.7 mt -77.46 -27.64 15.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.137 -177.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.41 ' OG ' ' HD3' ' A' ' 103' ' ' LYS . 64.0 p -83.56 -27.55 29.21 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.978 0.418 . . . . 0.0 110.778 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.38 -5.23 31.5 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.876 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.41 ' HD3' ' OG ' ' A' ' 101' ' ' SER . 14.0 mptt -67.56 -42.06 83.24 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 179.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.451 ' O ' HD21 ' A' ' 99' ' ' LEU . 25.1 tp -99.93 119.88 38.92 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.141 0.495 . . . . 0.0 110.218 -177.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.451 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 15.3 m120 -67.62 118.06 53.58 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.183 178.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -64.16 -21.68 67.55 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.123 1.882 . . . . 0.0 110.989 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -64.02 -53.68 46.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.325 174.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.53 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -68.04 -33.39 74.49 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -178.861 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.53 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -67.46 -36.59 81.46 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.999 177.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -59.35 -48.01 83.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.845 176.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -67.96 -37.97 82.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.016 -177.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -82.84 2.9 31.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.969 -0.559 . . . . 0.0 112.275 -177.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 81.14 13.91 80.07 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.771 -0.728 . . . . 0.0 113.379 175.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -92.32 -10.58 37.8 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.196 0.522 . . . . 0.0 110.297 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.444 ' O ' HG21 ' A' ' 115' ' ' ILE . 0.3 OUTLIER -133.35 109.09 13.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.751 177.937 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.55 ' HB3' ' HB ' ' A' ' 90' ' ' THR . 45.9 tptt -112.77 107.1 15.61 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.3 174.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.714 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.323 -0.58 0 CA-C-O 121.058 0.456 . . . . 0.0 111.552 -170.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 38.9 m-80 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 121.029 0.442 . . . . 0.0 111.142 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 19' ' ' ASN . 4.8 Cg_exo -68.21 -21.39 42.05 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 123.143 2.562 . . . . 0.0 111.578 -176.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -72.42 -20.73 61.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.247 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -81.95 -0.06 42.21 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.006 178.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -90.12 152.56 21.07 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 175.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.409 ' O ' ' HD1' ' A' ' 28' ' ' TYR . 48.0 tptt -80.34 -26.05 38.92 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.604 ' HB ' ' SD ' ' A' ' 29' ' ' MET . 0.8 OUTLIER -68.93 -15.19 19.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.57 178.15 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 1.615 ' HE1' ' CE2' ' A' ' 26' ' ' PHE . 34.6 t80 -53.75 -60.15 3.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.207 0.527 . . . . 0.0 110.572 178.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.0 -33.51 65.83 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.609 -177.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 1.669 ' HE1' ' CE2' ' A' ' 28' ' ' TYR . 17.7 m-85 -67.76 -48.91 65.05 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.787 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.604 ' SD ' ' HB ' ' A' ' 25' ' ' VAL . 0.1 OUTLIER -63.25 -29.42 70.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.893 0.378 . . . . 0.0 110.74 175.889 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.427 ' HD3' ' HA ' ' A' ' 30' ' ' LYS . 37.8 mmtt -71.86 -34.36 69.16 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.787 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.491 HG12 ' O ' ' A' ' 28' ' ' TYR . 8.7 pt -82.24 -21.87 9.69 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.519 0 C-N-CA 119.971 -0.692 . . . . 0.0 109.705 174.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.5 tt -60.53 -50.97 71.4 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 170.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.475 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 6.4 tt0 -43.86 -48.51 8.36 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.183 174.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -76.33 -52.85 9.1 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.78 -177.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.21 -32.72 74.19 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -168.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 94.5 mmm -62.35 -43.59 98.48 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.491 0.182 . . . . 0.0 111.491 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -91.09 -16.26 28.14 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.737 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -65.81 -17.63 64.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.387 0.613 . . . . 0.0 109.943 175.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -54.83 128.94 35.33 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.055 172.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.6 p -62.38 -25.78 68.11 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.492 -0.777 . . . . 0.0 112.346 -175.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -100.09 -0.12 39.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.941 0.4 . . . . 0.0 111.02 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 39.22 52.84 2.18 Favored 'General case' 0 C--N 1.344 0.365 0 CA-C-N 114.614 -1.176 . . . . 0.0 111.742 -175.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.0 mt -60.9 -4.35 0.99 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.803 -175.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.1 tp -55.97 -30.16 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-O 120.766 0.317 . . . . 0.0 110.591 176.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.474 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 5.8 pt-20 -64.47 -36.03 82.87 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.346 -177.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -77.14 -15.8 59.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.996 0.427 . . . . 0.0 111.108 -175.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.427 ' O ' HG23 ' A' ' 47' ' ' VAL . 14.5 p -130.71 32.28 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.934 0.874 . . . . 0.0 110.24 -175.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.474 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 94.9 mtt180 -57.96 116.98 3.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.597 -0.728 . . . . 0.0 111.843 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.488 ' O ' ' HB1' ' A' ' 70' ' ' ALA . . . -171.23 173.98 44.84 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.188 -178.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.417 HG13 ' HB2' ' A' ' 71' ' ' LYS . 52.7 mt -104.99 125.42 59.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 117.485 0.642 . . . . 0.0 111.234 -178.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.542 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 3.1 m-85 -107.28 110.99 23.15 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.815 -177.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.15 116.29 5.32 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.419 -0.896 . . . . 0.0 111.47 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 1.641 ' HD2' ' CD1' ' A' ' 53' ' ' PHE . 5.1 m-85 -100.61 109.41 21.48 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.027 0.441 . . . . 0.0 111.636 -178.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -94.35 99.84 11.98 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.378 175.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.576 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 19.0 t -98.58 133.11 42.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.811 -175.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -122.33 173.26 7.74 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.117 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 59.81 49.7 7.73 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.103 0.478 . . . . 0.0 111.395 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.42 -140.07 1.61 Allowed Glycine 0 CA--C 1.522 0.48 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.437 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.466 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 54.1 Cg_exo -40.73 -61.6 0.46 Allowed 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.768 2.979 . . . . 0.0 114.098 178.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -152.06 82.23 1.26 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.187 0.518 . . . . 0.0 109.97 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 73.23 12.55 79.72 Favored Glycine 0 N--CA 1.453 -0.223 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.466 ' HB1' ' HD2' ' A' ' 59' ' ' PRO . . . -82.39 157.03 23.88 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.044 -0.578 . . . . 0.0 111.381 -175.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -133.22 143.08 48.92 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.667 -177.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.8 162.72 24.19 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.443 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 1.643 ' HE1' ' CE2' ' A' ' 65' ' ' TYR . 33.6 t80 -148.42 117.58 6.84 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.82 0.343 . . . . 0.0 110.881 -176.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 16.6 m-90 -120.82 139.32 53.31 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.9 t -107.65 112.75 41.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.448 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.542 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 3.9 mp -90.73 100.7 11.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 175.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -85.66 97.4 10.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.418 0.628 . . . . 0.0 109.887 -178.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.488 ' HB1' ' O ' ' A' ' 49' ' ' GLY . . . -102.22 -0.43 33.07 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.404 174.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.417 ' HB2' HG13 ' A' ' 50' ' ' ILE . 4.9 tppp? -63.33 -45.48 91.05 Favored 'General case' 0 CA--C 1.523 -0.079 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.166 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -72.76 -8.79 57.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.615 176.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.34 -4.14 86.37 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.897 -178.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -71.64 -39.93 70.07 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.884 0.373 . . . . 0.0 111.417 -177.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.6 34.16 54.41 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.562 176.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.475 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 19.7 ptmt -98.2 149.19 22.82 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 -175.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.43 HG23 ' HB3' ' A' ' 29' ' ' MET . 0.7 OUTLIER -109.52 132.43 57.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.674 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.0 t -133.84 129.23 36.19 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.387 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 1.66 ' HE1' ' CE2' ' A' ' 79' ' ' TYR . 83.7 t80 -66.49 122.5 17.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.37 -178.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 54.81 65.73 1.42 Allowed 'General case' 0 N--CA 1.464 0.226 0 O-C-N 123.765 0.666 . . . . 0.0 109.813 -176.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.04 -40.25 88.6 Favored Glycine 0 C--N 1.33 0.207 0 CA-C-N 115.57 -0.741 . . . . 0.0 113.707 -173.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.11 -21.27 40.98 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.041 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.467 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 7.4 mm-40 -71.26 143.19 50.46 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 175.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.441 ' HB3' ' HZ2' ' A' ' 84' ' ' LYS . 2.2 ttpm? -76.88 114.47 39.61 Favored Pre-proline 0 N--CA 1.438 -1.037 0 CA-C-O 121.39 0.614 . . . . 0.0 110.827 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 83' ' ' GLU . 13.9 Cg_exo -68.92 126.55 14.02 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.191 2.594 . . . . 0.0 112.16 177.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -60.66 -33.5 72.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.297 173.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.556 ' HB ' ' CD1' ' A' ' 117' ' ' ILE . 11.3 m -136.76 142.16 38.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.326 174.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.672 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 22.9 m -127.44 138.75 53.05 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.098 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 1.635 ' HD1' ' CD2' ' A' ' 89' ' ' PHE . 18.7 m-85 -122.69 120.92 35.1 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 123.177 0.298 . . . . 0.0 110.336 -177.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.2 m -93.56 113.18 25.24 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 171.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.576 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 81.5 mt -137.46 156.9 33.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -175.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 17.7 m -100.25 144.53 29.17 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.196 0.522 . . . . 0.0 110.326 177.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -51.8 -34.91 42.07 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 114.607 -1.179 . . . . 0.0 112.291 -175.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -71.05 -36.16 72.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.11 -177.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.453 ' CG ' ' HD2' ' A' ' 114' ' ' LYS . 7.4 m-20 -90.91 -19.25 23.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.187 -174.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.439 HG12 HG11 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -56.72 -33.57 40.9 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 CA-C-O 120.899 0.381 . . . . 0.0 110.696 -178.452 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.7 m -64.1 -27.35 42.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.38 -172.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -86.67 -29.4 22.51 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 177.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.487 HD21 ' O ' ' A' ' 104' ' ' LEU . 85.1 mt -76.02 -39.87 54.73 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.918 -178.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.477 HD13 ' SD ' ' A' ' 29' ' ' MET . 2.7 mm -67.39 -36.34 76.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.273 0.559 . . . . 0.0 110.374 177.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 36.4 p -79.92 -21.57 43.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.335 -176.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.66 11.32 60.74 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.62 -177.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -80.06 -42.85 22.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.047 0.451 . . . . 0.0 110.968 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.487 ' O ' HD21 ' A' ' 99' ' ' LEU . 43.3 tp -96.98 120.25 36.98 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.456 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 18.3 m120 -69.31 117.52 53.21 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.767 178.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -62.22 -22.91 74.92 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.013 1.809 . . . . 0.0 110.845 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -62.11 -56.14 21.84 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.191 173.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.547 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 0.7 OUTLIER -67.12 -33.95 76.56 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -177.942 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.547 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -69.5 -32.13 70.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.002 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -61.99 -50.93 70.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.469 175.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 1.636 ' HD1' ' CD2' ' A' ' 111' ' ' PHE . 63.3 t80 -64.19 -39.76 94.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.921 -178.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -76.69 -8.48 57.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.09 -177.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 95.34 -4.18 66.84 Favored Glycine 0 CA--C 1.517 0.181 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.346 173.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.453 ' HD2' ' CG ' ' A' ' 95' ' ' ASP . 0.2 OUTLIER -66.72 -39.62 88.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.112 0.482 . . . . 0.0 111.107 177.45 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.534 HG22 HG21 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -107.55 131.99 56.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.302 -174.113 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -120.88 99.37 6.48 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.042 173.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.672 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.455 0 CA-C-O 120.991 0.424 . . . . 0.0 111.534 -178.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 . . . . . 0 CA--C 1.515 -0.388 0 CA-C-O 121.794 0.807 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.03 -19.26 35.09 Favored 'Trans proline' 0 C--N 1.328 -0.502 0 C-N-CA 124.095 3.197 . . . . 0.0 111.922 -175.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.484 ' HA ' ' CG ' ' A' ' 26' ' ' PHE . 17.1 mt-10 -76.65 -23.86 53.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.368 -176.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -91.65 28.84 1.65 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.338 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -110.58 160.18 16.88 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.086 174.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -74.17 -35.49 64.02 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 172.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.524 HG11 HG12 ' A' ' 96' ' ' VAL . 0.8 OUTLIER -65.15 -20.54 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.568 -178.975 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 1.659 ' HE1' ' CE2' ' A' ' 26' ' ' PHE . 67.5 t80 -56.95 -46.59 82.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.963 0.411 . . . . 0.0 110.593 -179.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.403 ' HE2' HG21 ' A' ' 31' ' ' ILE . 0.6 OUTLIER -75.91 -44.99 37.65 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.474 177.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -63.9 -43.73 95.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.342 -175.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.439 ' CE ' HD12 ' A' ' 68' ' ' ILE . 71.9 mtp -76.59 -20.32 56.92 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.78 0.324 . . . . 0.0 110.811 -178.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -75.13 -46.67 32.88 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 175.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.403 HG21 ' HE2' ' A' ' 27' ' ' LYS . 10.8 pt -70.74 -24.53 25.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.782 175.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.0 tt -60.47 -56.03 26.38 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 171.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.507 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 11.2 tt0 -42.33 -52.95 4.37 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.169 176.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -69.64 -58.99 3.25 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.877 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.84 -38.53 72.8 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -168.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.2 mmt -59.21 -39.26 82.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.851 0.358 . . . . 0.0 111.592 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -90.62 -31.78 16.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.197 0.522 . . . . 0.0 110.698 178.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -66.57 -18.66 65.49 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.209 -174.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -55.98 145.17 26.07 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.045 177.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.7 p -47.29 -46.95 25.39 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 123.545 0.528 . . . . 0.0 111.713 -176.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -102.57 4.89 38.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.596 -176.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.455 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 4.1 p30 37.2 71.48 0.14 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 122.039 0.923 . . . . 0.0 110.89 -175.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.5 mt -64.51 0.26 1.13 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.443 -1.253 . . . . 0.0 112.103 -173.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.4 tp -61.62 -25.5 37.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.001 0.429 . . . . 0.0 110.442 177.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.469 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 17.0 pt-20 -74.26 -12.62 60.61 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.788 -178.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -86.89 -19.78 28.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.184 0.516 . . . . 0.0 110.538 178.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.465 ' O ' HG23 ' A' ' 47' ' ' VAL . 12.5 p -130.49 31.98 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.2 -173.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.469 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 58.4 mtm180 -54.99 116.63 2.87 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.971 0.891 . . . . 0.0 111.751 -176.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -178.54 173.03 45.45 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 114.055 -1.429 . . . . 0.0 111.193 -176.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.426 ' CG1' ' HB2' ' A' ' 71' ' ' LYS . 60.0 mt -105.04 129.47 57.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-O 120.971 0.415 . . . . 0.0 111.01 -178.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.448 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 5.4 m-85 -111.83 125.28 53.84 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.823 -178.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -104.06 121.55 7.06 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.421 -0.895 . . . . 0.0 111.408 176.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -107.31 109.38 21.13 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.135 0.493 . . . . 0.0 111.487 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -97.66 99.73 11.1 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.179 176.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.6 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 12.2 t -105.59 122.42 59.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.202 -171.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -107.21 -179.44 3.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.869 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 61.92 47.81 5.71 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.137 0.494 . . . . 0.0 111.586 177.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.28 -167.06 20.36 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.699 177.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -40.66 -60.88 0.53 Allowed 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 124.126 3.218 . . . . 0.0 113.558 -176.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -108.93 42.2 1.46 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.091 0.472 . . . . 0.0 109.986 177.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 74.99 19.56 79.88 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.476 -176.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.23 171.47 8.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.973 0.416 . . . . 0.0 111.279 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -131.25 135.32 47.24 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.697 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -124.3 153.68 17.65 Favored Glycine 0 N--CA 1.443 -0.876 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 1.657 ' HE1' ' CE2' ' A' ' 65' ' ' TYR . 44.5 t80 -141.22 119.35 12.04 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.791 0.329 . . . . 0.0 110.622 -179.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.409 ' HB2' ' HE2' ' A' ' 29' ' ' MET . 14.8 m-90 -122.49 144.92 48.77 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 40.1 t -110.46 115.1 48.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.052 177.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.448 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 4.0 mp -89.21 99.17 8.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 176.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -90.66 98.7 11.93 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.447 0.641 . . . . 0.0 109.999 -176.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -110.91 15.64 21.68 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.604 175.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.426 ' HB2' ' CG1' ' A' ' 50' ' ' ILE . 34.2 tttm -56.28 -50.21 72.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.752 -177.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -86.01 0.14 54.08 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.676 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 94.21 12.04 56.71 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.641 -0.708 . . . . 0.0 112.437 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -76.36 -63.49 1.32 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.483 0.182 . . . . 0.0 111.237 -178.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.82 34.2 7.43 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 119.967 -1.111 . . . . 0.0 112.068 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.507 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 15.3 pttm -98.1 143.27 28.81 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.259 -0.275 . . . . 0.0 110.259 -178.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.8 OUTLIER -110.04 131.84 59.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.359 0.6 . . . . 0.0 109.832 178.717 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.6 t -131.21 133.54 45.6 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.49 -176.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -68.7 119.85 13.76 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -178.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 53.6 70.35 0.61 Allowed 'General case' 0 C--N 1.331 -0.199 0 O-C-N 123.79 0.681 . . . . 0.0 109.901 -175.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.1 -34.57 90.1 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.381 -0.827 . . . . 0.0 113.737 -173.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.14 -14.98 56.14 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.976 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.402 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 55.1 mm-40 -73.33 165.73 24.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.809 0.338 . . . . 0.0 110.369 177.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.467 ' HD2' ' N ' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -100.14 106.82 44.02 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.15 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.415 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 16.2 Cg_exo -68.92 139.76 44.07 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.695 2.263 . . . . 0.0 113.018 -177.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -67.2 -31.2 71.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.566 173.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.6 m -139.78 149.26 22.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.516 172.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.598 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 54.8 m -135.3 128.33 31.6 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 175.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 1.629 ' HD2' ' CD1' ' A' ' 89' ' ' PHE . 61.4 m-85 -113.41 125.16 53.94 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.852 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.48 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 4.6 m -98.48 121.33 40.28 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 173.009 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.6 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -155.39 154.6 6.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 O-C-N 123.551 0.532 . . . . 0.0 109.618 -175.184 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.468 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 3.8 m -91.56 137.82 32.06 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.56 -178.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -43.28 -49.68 6.69 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.376 0.67 . . . . 0.0 111.495 -176.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -49.95 -38.79 38.1 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.067 -1.424 . . . . 0.0 111.772 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.468 ' OD2' ' HB2' ' A' ' 92' ' ' SER . 13.6 m-20 -91.02 -21.18 21.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.413 -175.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.524 HG12 HG11 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -60.88 -31.27 49.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 121.134 0.493 . . . . 0.0 110.447 -175.577 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.6 m -67.1 -28.7 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.088 -171.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -81.69 -35.26 30.04 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 176.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.429 HD21 ' O ' ' A' ' 104' ' ' LEU . 85.3 mt -66.07 -49.44 67.59 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.812 -178.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 96' ' ' VAL . 21.4 mt -70.03 -23.86 25.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.057 -176.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.1 t -91.55 -9.75 43.15 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.998 0.428 . . . . 0.0 110.972 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.97 17.57 69.6 Favored Glycine 0 C--N 1.329 0.182 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.257 -179.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -85.69 -41.58 15.03 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.05 0.452 . . . . 0.0 110.63 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.429 ' O ' HD21 ' A' ' 99' ' ' LEU . 38.9 tp -103.32 123.22 46.38 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.478 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.455 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 6.2 m-20 -69.09 120.75 78.59 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.548 177.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -65.41 -22.5 59.47 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.083 1.856 . . . . 0.0 111.241 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.49 -54.91 25.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.595 176.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.562 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 0.8 OUTLIER -67.4 -34.89 78.19 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.971 179.283 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.562 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -64.92 -34.34 78.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.178 178.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 1.665 ' HD2' ' CD1' ' A' ' 110' ' ' PHE . 15.1 t80 -61.58 -52.39 64.63 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 175.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -59.72 -39.68 85.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.546 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.484 ' HA ' ' OE1' ' A' ' 112' ' ' GLN . 13.4 mm-40 -85.05 17.08 3.08 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -174.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.42 12.12 76.73 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 121.105 -0.569 . . . . 0.0 113.563 173.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -87.47 -47.41 8.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.877 0.37 . . . . 0.0 110.71 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.564 HG22 HG23 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -96.03 121.4 46.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.994 -177.348 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.48 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 31.2 mmtp -116.52 99.06 6.9 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.877 173.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.63 ' HB ' ' CD2' ' A' ' 89' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--N 1.322 -0.625 0 CA-C-O 121.356 0.598 . . . . 0.0 110.665 -178.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.8 p30 . . . . . 0 C--O 1.232 0.169 0 CA-C-O 121.237 0.542 . . . . 0.0 110.801 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.415 ' HA ' ' CD1' ' A' ' 23' ' ' PHE . 4.9 Cg_exo -70.06 -17.56 36.13 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.695 2.263 . . . . 0.0 111.156 -177.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.456 ' HA ' ' CG ' ' A' ' 26' ' ' PHE . 13.3 mt-10 -74.09 -24.03 59.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.503 -178.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -74.67 -22.16 59.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.635 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.415 ' CD1' ' HA ' ' A' ' 20' ' ' PRO . 35.5 m-85 -65.64 145.53 55.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.667 177.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -74.77 -26.34 59.69 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.42 ' CG1' HG12 ' A' ' 96' ' ' VAL . 0.9 OUTLIER -68.85 -21.69 25.92 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.71 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.585 177.902 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 1.617 ' HE1' ' CE2' ' A' ' 26' ' ' PHE . 79.2 t80 -56.78 -47.5 80.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.774 0.321 . . . . 0.0 110.361 -178.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.417 ' HZ3' HG22 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -67.85 -34.88 77.57 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.727 179.836 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 1.65 ' HD2' ' CD1' ' A' ' 28' ' ' TYR . 37.4 m-85 -71.8 -53.5 13.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.756 0.312 . . . . 0.0 111.101 178.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.43 ' HB3' HG22 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -58.61 -32.8 69.35 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.104 176.939 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.2 mmtt -66.58 -41.78 88.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.601 177.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 28' ' ' TYR . 16.8 pt -78.09 -26.41 14.47 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 C-N-CA 120.294 -0.562 . . . . 0.0 109.865 177.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.6 tt -59.35 -47.94 83.5 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 173.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.528 ' HG2' ' HA ' ' A' ' 76' ' ' LYS . 0.8 OUTLIER -44.57 -50.9 9.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.522 176.021 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -78.64 -55.29 5.3 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.58 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.48 -40.21 74.53 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -167.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.4 mmt -61.29 -41.28 96.7 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -177.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -90.92 -16.82 27.47 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.582 177.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -71.27 -25.09 62.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.996 -176.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -52.85 135.22 36.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.212 0.53 . . . . 0.0 110.117 176.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 18.2 p -57.89 -29.24 64.9 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.621 -174.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -100.32 -5.3 27.6 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 122.467 0.307 . . . . 0.0 111.232 177.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.481 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 4.1 p-10 38.82 64.27 0.8 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.843 0.83 . . . . 0.0 111.294 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.4 mt -58.64 -11.32 2.94 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.137 -175.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.2 tp -57.35 -25.81 24.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.065 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 42' ' ' ASN . 3.7 pt-20 -60.03 -33.19 71.69 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.789 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -82.7 -18.84 39.47 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.865 0.364 . . . . 0.0 111.573 -173.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.464 ' O ' HG23 ' A' ' 47' ' ' VAL . 11.3 p -124.99 31.9 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 122.074 0.94 . . . . 0.0 109.813 -176.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 37.2 mtm180 -57.45 110.33 0.85 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.845 0.831 . . . . 0.0 112.118 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.475 ' O ' ' HB1' ' A' ' 70' ' ' ALA . . . -165.78 170.91 40.79 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 114.086 -1.415 . . . . 0.0 110.701 -178.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 53.2 mt -105.27 126.64 60.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 117.717 0.758 . . . . 0.0 111.136 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.481 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 25.7 m-85 -107.92 117.59 34.51 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.994 -178.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.91 106.59 3.37 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.262 -0.971 . . . . 0.0 111.231 177.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -95.21 105.62 17.57 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.253 0.549 . . . . 0.0 111.261 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -91.31 99.79 12.7 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.383 176.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.625 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 7.6 t -99.84 127.47 52.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.911 -172.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 -112.74 -178.14 3.32 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.792 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 62.67 47.47 4.76 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.13 0.49 . . . . 0.0 111.124 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.39 -169.48 32.45 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.577 177.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -37.69 -61.07 0.37 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.546 3.498 . . . . 0.0 114.217 -174.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -125.05 61.12 1.19 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.86 16.09 74.31 Favored Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.53 -177.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.53 168.8 18.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.028 0.442 . . . . 0.0 110.749 -178.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -136.73 136.2 38.77 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.915 -176.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -120.19 162.46 14.22 Favored Glycine 0 N--CA 1.442 -0.94 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.387 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 1.626 ' HD1' ' CD2' ' A' ' 65' ' ' TYR . 22.1 t80 -150.26 115.18 5.32 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.712 0.291 . . . . 0.0 110.243 -178.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 26.1 m-90 -118.97 126.1 50.96 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.2 0.524 . . . . 0.0 110.279 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 51.3 t -94.4 110.4 23.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.743 177.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.481 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 4.4 mp -88.91 99.24 8.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -83.11 105.6 14.23 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.5 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 49' ' ' GLY . . . -111.47 5.23 19.44 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 173.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -64.67 -36.7 85.13 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.957 -176.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -77.4 -30.3 53.54 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.624 0.726 . . . . 0.0 109.9 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 111.82 10.11 19.45 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.344 -176.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.459 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 9.5 mmpt? -88.01 -49.72 6.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.56 -0.32 . . . . 0.0 111.397 -178.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.01 34.39 15.11 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.16 -1.019 . . . . 0.0 111.793 -177.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.528 ' HA ' ' HG2' ' A' ' 33' ' ' GLU . 14.2 pttm -96.82 145.15 26.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.545 0.212 . . . . 0.0 110.783 -172.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.43 HG22 ' HB3' ' A' ' 29' ' ' MET . 0.7 OUTLIER -107.41 138.18 34.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.069 0.461 . . . . 0.0 109.764 178.035 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.6 t -133.64 133.9 42.51 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.135 177.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -71.17 118.24 13.7 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.821 -179.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 55.96 61.48 2.76 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 123.918 0.762 . . . . 0.0 109.683 -175.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -61.31 -40.64 98.9 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.344 -0.844 . . . . 0.0 113.442 -175.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.12 -21.07 32.99 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.947 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.585 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 65.2 mm-40 -64.89 149.23 49.95 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 175.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.465 ' HD3' ' N ' ' A' ' 84' ' ' LYS . 3.7 mppt? -79.56 108.71 9.44 Favored Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.585 ' HD3' ' O ' ' A' ' 83' ' ' GLU . 16.5 Cg_exo -68.76 130.69 21.07 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.61 2.207 . . . . 0.0 112.164 179.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -62.61 -38.2 89.25 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.57 174.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.6 m -136.95 134.29 48.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.592 174.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.59 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 30.8 m -113.53 137.19 51.92 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.217 177.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.648 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 41.0 m-85 -123.83 127.0 47.42 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.493 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 6.7 m -100.69 126.52 47.21 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 174.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.625 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -158.37 151.45 7.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.039 0.447 . . . . 0.0 110.536 -175.565 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.2 m -85.36 143.22 28.77 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.202 0.525 . . . . 0.0 110.977 -177.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -49.28 -33.75 13.75 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.625 -1.17 . . . . 0.0 112.121 -178.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -75.5 -32.46 60.55 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.899 -174.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -91.55 -21.27 20.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.904 -177.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.531 ' O ' HG13 ' A' ' 100' ' ' ILE . 0.4 OUTLIER -56.74 -33.19 40.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.101 0.477 . . . . 0.0 110.21 -177.855 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.3 m -68.07 -33.75 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.853 -173.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -77.47 -32.35 54.32 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.1 mt -69.39 -49.98 50.29 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.738 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.531 HG13 ' O ' ' A' ' 96' ' ' VAL . 28.3 mt -72.38 -30.38 34.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.577 -176.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 39.7 t -86.03 -4.8 59.25 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.671 0.249 . . . . 0.0 111.671 -178.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.03 43.53 16.67 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.301 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -116.03 -43.19 3.0 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.036 0.446 . . . . 0.0 110.898 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.4 tp -97.95 129.56 44.85 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.507 -179.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.48 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 11.6 m120 -73.63 119.68 77.26 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.054 176.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -66.2 -20.26 56.17 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 121.942 1.762 . . . . 0.0 110.196 176.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -60.83 -57.42 12.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.534 173.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.48 ' HG2' ' HB2' ' A' ' 105' ' ' ASN . 0.2 OUTLIER -70.35 -31.4 68.66 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.901 -178.834 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.475 ' HB1' HD13 ' A' ' 115' ' ' ILE . . . -68.22 -35.59 78.2 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.618 -0.433 . . . . 0.0 109.986 178.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -64.98 -45.88 83.8 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 174.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 1.625 ' HD2' ' CD1' ' A' ' 111' ' ' PHE . 91.5 t80 -63.73 -41.03 98.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.347 -178.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -80.12 7.06 9.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.919 -178.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.23 5.33 89.75 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.94 -0.647 . . . . 0.0 113.605 173.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp -78.91 -48.86 13.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.937 0.398 . . . . 0.0 111.07 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.558 HG22 HG23 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -87.72 118.24 33.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.539 -179.257 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.493 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 74.7 mmtt -114.73 98.77 7.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.659 174.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.648 ' HB ' ' CD2' ' A' ' 89' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--N 1.323 -0.583 0 CA-C-O 121.264 0.554 . . . . 0.0 110.361 178.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.407 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 58.1 m-20 . . . . . 0 CA--C 1.517 -0.304 0 CA-C-O 120.903 0.382 . . . . 0.0 110.192 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.416 ' O ' ' HB2' ' A' ' 26' ' ' PHE . 21.5 Cg_exo -61.47 -34.57 85.73 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 123.184 2.589 . . . . 0.0 111.606 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.429 ' HA ' ' CG ' ' A' ' 26' ' ' PHE . 25.8 tt0 -65.53 -35.55 81.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.519 179.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -75.45 -4.41 39.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.564 -175.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 1.662 ' HD2' ' CD1' ' A' ' 23' ' ' PHE . 59.2 m-85 -85.53 145.05 27.57 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 171.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -73.04 -20.29 61.02 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.551 ' CG1' HG12 ' A' ' 96' ' ' VAL . 1.0 OUTLIER -73.29 -16.01 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.152 179.126 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.437 ' O ' ' HB2' ' A' ' 30' ' ' LYS . 80.2 t80 -58.02 -52.32 66.01 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.883 0.373 . . . . 0.0 110.455 -178.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -42.98 90.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.278 178.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.455 ' O ' HG12 ' A' ' 31' ' ' ILE . 19.4 m-85 -64.73 -47.75 77.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.165 -0.471 . . . . 0.0 112.097 -177.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.418 ' HB3' HG22 ' A' ' 77' ' ' VAL . 58.6 mtt -71.68 -26.21 62.43 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 122.208 -0.307 . . . . 0.0 111.019 -179.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 26' ' ' PHE . 7.8 mmtt -72.07 -35.37 69.24 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.445 175.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.455 HG12 ' O ' ' A' ' 28' ' ' TYR . 14.7 pt -78.93 -21.35 12.79 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.481 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.662 174.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.7 tt -67.17 -48.84 66.78 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 171.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -44.19 -38.59 3.83 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.086 173.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -83.53 -55.6 4.2 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.242 175.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.51 -42.25 74.23 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -167.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 24.0 mmt -56.65 -43.29 80.18 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -178.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -91.68 -25.84 18.92 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.242 179.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -65.92 -28.33 68.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.04 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -52.93 133.54 37.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.689 174.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 23.6 p -59.82 -27.49 66.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.206 -173.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -96.67 -21.29 17.7 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.513 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 35.69 62.48 0.62 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.867 0.841 . . . . 0.0 110.837 -174.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.6 mt -72.03 2.79 5.14 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.744 -1.117 . . . . 0.0 111.761 -174.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.0 tp -56.01 -27.18 22.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.108 0.48 . . . . 0.0 110.858 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.466 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 49.9 mt-10 -76.08 -13.24 60.21 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.719 -176.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -85.93 -17.02 36.61 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.003 0.43 . . . . 0.0 111.04 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.423 ' O ' HG23 ' A' ' 47' ' ' VAL . 14.0 p -130.69 33.2 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.924 0.869 . . . . 0.0 109.804 -177.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.466 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 23.1 mtm180 -52.14 118.07 3.24 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.971 0.891 . . . . 0.0 112.279 -175.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.409 ' O ' ' HB1' ' A' ' 70' ' ' ALA . . . -170.13 -174.87 38.62 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 113.8 -1.545 . . . . 0.0 109.751 -178.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.409 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 43.9 mt -121.74 124.84 72.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-N 118.214 1.007 . . . . 0.0 111.545 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.531 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 2.6 m-85 -107.42 109.49 21.22 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.781 -176.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.74 113.41 4.35 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.391 -0.909 . . . . 0.0 111.065 177.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 1.623 ' HE1' ' CE2' ' A' ' 53' ' ' PHE . 3.9 m-85 -97.4 111.58 23.78 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.264 0.554 . . . . 0.0 111.647 -178.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -93.76 101.17 13.28 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.439 175.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.59 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 14.2 t -99.17 127.14 52.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.684 -175.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 30.2 mtp180 -118.55 -174.1 2.61 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.422 -177.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 61.74 39.93 13.58 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 123.449 0.468 . . . . 0.0 111.195 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.81 -164.47 26.78 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.095 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -39.12 -60.32 0.52 Allowed 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 124.342 3.361 . . . . 0.0 114.062 -176.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -109.88 41.9 1.62 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.065 0.459 . . . . 0.0 110.093 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.21 24.3 76.71 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -170.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.48 162.09 29.66 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 114.708 -0.746 . . . . 0.0 111.471 -175.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -124.89 140.74 52.65 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.877 -178.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -127.95 163.48 21.57 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.936 179.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 1.596 ' HD1' ' CD2' ' A' ' 65' ' ' TYR . 50.2 t80 -143.11 121.03 12.0 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 117.217 0.509 . . . . 0.0 111.375 -177.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 24.2 m-90 -125.96 134.29 51.56 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.924 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 40.3 t -99.78 114.4 37.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.247 178.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.531 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 4.1 mp -89.95 100.82 11.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 174.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -84.54 97.31 9.5 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.214 -176.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.409 ' HB1' ' O ' ' A' ' 49' ' ' GLY . . . -95.26 -12.13 26.76 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.219 174.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.443 ' HD2' ' HG3' ' A' ' 72' ' ' GLU . 1.6 tmmt? -58.2 -40.85 82.66 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.273 -177.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.443 ' HG3' ' HD2' ' A' ' 71' ' ' LYS . 51.7 mt-10 -91.72 12.15 22.2 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.337 0.589 . . . . 0.0 111.313 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 76.46 11.14 85.37 Favored Glycine 0 C--O 1.228 -0.228 0 CA-C-N 115.402 -0.817 . . . . 0.0 113.394 173.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -91.58 -45.05 8.71 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 122.717 -0.284 . . . . 0.0 111.174 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.97 33.82 62.37 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -176.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 19.8 ptmt -98.35 154.68 17.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.365 -0.418 . . . . 0.0 109.948 -175.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.481 HG11 HG13 ' A' ' 68' ' ' ILE . 0.7 OUTLIER -107.77 137.36 39.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 178.733 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.5 t -140.53 134.18 30.24 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.113 178.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 1.656 ' HE1' ' CE2' ' A' ' 79' ' ' TYR . 25.9 t80 -66.6 116.43 7.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.669 -175.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 65.0 t30 51.17 68.29 0.81 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 123.9 0.75 . . . . 0.0 110.161 -176.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -56.82 -34.59 65.33 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.106 -0.952 . . . . 0.0 113.936 -172.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.47 -16.9 60.34 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -176.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.473 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 16.9 mm-40 -75.62 155.11 36.21 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 175.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -90.88 108.9 31.13 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-O 120.771 0.32 . . . . 0.0 110.194 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 83' ' ' GLU . 20.1 Cg_exo -65.78 125.73 14.79 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.925 2.417 . . . . 0.0 112.879 -178.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -65.57 -34.47 78.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.129 -0.942 . . . . 0.0 109.746 174.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.6 m -135.57 139.04 47.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.503 175.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 19.0 m -118.14 135.63 54.1 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.606 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 72.6 m-85 -122.58 125.02 44.84 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.563 ' HB ' ' HB3' ' A' ' 116' ' ' LYS . 35.8 m -101.77 114.2 28.06 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 177.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 73.1 mt -137.87 148.12 25.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.554 -174.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.0 m -85.34 139.25 31.73 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.087 0.47 . . . . 0.0 110.425 176.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -47.18 -34.26 6.11 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 114.504 -1.225 . . . . 0.0 112.427 -178.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -70.92 -41.74 70.81 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.103 -173.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -91.28 -18.6 24.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.591 -175.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.551 HG12 ' CG1' ' A' ' 25' ' ' VAL . 0.3 OUTLIER -54.77 -31.55 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 121.121 0.486 . . . . 0.0 110.124 -179.801 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.0 m -67.05 -35.13 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.023 -173.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -77.08 -33.64 57.04 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.08 -48.09 63.56 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.403 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 96' ' ' VAL . 32.0 mt -66.19 -36.68 77.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.125 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.2 t -75.82 -30.3 58.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.817 0.342 . . . . 0.0 111.2 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 102.8 10.56 37.24 Favored Glycine 0 N--CA 1.453 -0.167 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.876 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -81.11 -40.32 24.24 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.23 0.538 . . . . 0.0 111.0 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.707 HD12 ' NZ ' ' A' ' 108' ' ' LYS . 52.4 tp -101.08 133.78 45.08 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.339 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -79.34 124.69 84.07 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.292 177.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -64.91 -24.86 60.27 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.124 1.882 . . . . 0.0 110.459 176.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -61.37 -60.18 4.12 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.627 173.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.707 ' NZ ' HD12 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -62.78 -35.11 78.78 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.124 0.487 . . . . 0.0 110.021 -177.763 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.551 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -70.93 -33.13 70.21 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.025 -177.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -61.27 -48.61 80.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.312 174.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 1.599 ' HD2' ' CD1' ' A' ' 111' ' ' PHE . 75.5 t80 -60.83 -44.01 97.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.943 179.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -74.39 -12.56 60.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.178 -176.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.77 18.25 45.09 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.158 175.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.35 -24.64 17.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.862 0.363 . . . . 0.0 110.868 176.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.535 HG22 HG23 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -109.79 111.11 34.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.807 0.813 . . . . 0.0 110.144 178.086 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.563 ' HB3' ' HB ' ' A' ' 90' ' ' THR . 13.8 tppt? -110.05 107.5 17.39 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.093 174.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.606 ' HB ' ' CD2' ' A' ' 89' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--N 1.318 -0.775 0 CA-C-O 121.257 0.551 . . . . 0.0 110.184 -177.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 . . . . . 0 N--CA 1.456 -0.127 0 CA-C-O 120.866 0.365 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.457 ' HA ' ' CD1' ' A' ' 23' ' ' PHE . 14.2 Cg_exo -64.46 -28.88 62.29 Favored 'Trans proline' 0 CA--C 1.518 -0.317 0 C-N-CA 123.276 2.651 . . . . 0.0 111.802 -177.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -65.9 -35.22 80.02 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.261 177.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -73.38 -14.62 61.31 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.562 -178.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 1.664 ' HE2' ' CE1' ' A' ' 23' ' ' PHE . 23.5 m-85 -66.25 148.76 51.36 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.404 0.621 . . . . 0.0 110.378 176.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -74.06 -26.36 60.35 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 176.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.508 ' HB ' ' SD ' ' A' ' 29' ' ' MET . 0.8 OUTLIER -73.9 -15.51 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.97 -179.009 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 1.622 ' HD2' ' CD1' ' A' ' 26' ' ' PHE . 73.4 t80 -56.74 -50.04 73.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.768 0.318 . . . . 0.0 110.307 -177.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.429 ' HE2' HG21 ' A' ' 31' ' ' ILE . 1.1 tpmt? -72.7 -38.23 67.6 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.863 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 1.604 ' HE1' ' CE2' ' A' ' 28' ' ' TYR . 14.3 m-85 -64.72 -50.91 65.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.569 -178.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.508 ' SD ' ' HB ' ' A' ' 25' ' ' VAL . 0.1 OUTLIER -62.9 -31.53 72.6 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.834 0.349 . . . . 0.0 110.928 177.289 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.434 ' HD2' ' HA ' ' A' ' 30' ' ' LYS . 21.6 mmmt -70.76 -37.81 73.43 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 178.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.429 HG21 ' HE2' ' A' ' 27' ' ' LYS . 10.5 pt -84.13 -19.69 9.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.133 176.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.6 tt -60.58 -46.85 88.69 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 171.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -46.85 -48.48 20.97 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.777 175.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -73.96 -50.41 20.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.706 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.89 -36.88 80.38 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -169.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.462 ' HA ' ' HE3' ' A' ' 36' ' ' MET . 33.1 mmt -59.63 -44.11 93.58 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.587 0.217 . . . . 0.0 111.587 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -91.4 -8.36 48.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.19 0.519 . . . . 0.0 110.723 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -73.69 -23.36 59.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.037 0.446 . . . . 0.0 109.984 178.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -59.14 132.16 53.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.772 175.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 13.9 p -57.44 -37.42 72.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.562 -173.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.506 ' C ' HD21 ' A' ' 42' ' ' ASN . 46.1 mt-10 -101.57 9.95 40.73 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 119.306 -0.378 . . . . 0.0 110.96 178.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.538 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 0.1 OUTLIER 25.52 70.37 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.114 0.965 . . . . 0.0 111.275 -173.59 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.7 mt -58.4 -4.45 0.39 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 114.414 -1.267 . . . . 0.0 111.921 -176.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.459 HG13 ' HB2' ' A' ' 70' ' ' ALA . 4.2 tp -60.75 -25.42 35.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.663 178.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.538 ' HG2' ' O ' ' A' ' 42' ' ' ASN . 10.9 pt-20 -76.51 -16.7 59.57 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.237 -179.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -95.53 -13.24 24.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.263 0.554 . . . . 0.0 110.731 -177.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.47 ' O ' HG23 ' A' ' 47' ' ' VAL . 11.9 p -130.43 32.24 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.845 0.831 . . . . 0.0 109.562 -177.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 55.6 mtt180 -52.49 117.11 2.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.397 -175.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.562 ' O ' ' HB1' ' A' ' 70' ' ' ALA . . . -167.16 164.76 38.12 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.221 -178.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.479 HG13 ' HB2' ' A' ' 71' ' ' LYS . 63.8 mt -103.13 124.93 57.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 117.217 0.509 . . . . 0.0 109.988 176.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 1.669 ' HE1' ' CE2' ' A' ' 51' ' ' TYR . 37.3 m-85 -105.72 115.66 30.62 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.203 -176.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.97 111.35 4.23 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.396 -0.907 . . . . 0.0 110.835 177.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 1.664 ' HD2' ' CD1' ' A' ' 53' ' ' PHE . 7.5 m-85 -98.18 108.37 21.06 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.024 0.44 . . . . 0.0 111.594 -178.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -95.71 99.69 11.5 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.638 175.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.516 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 17.4 t -98.12 119.78 46.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.782 -174.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -108.89 179.07 4.28 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.123 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.453 ' HB2' ' HB3' ' A' ' 92' ' ' SER . 3.3 m-20 60.23 42.23 15.53 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.93 0.395 . . . . 0.0 111.125 177.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.11 -166.59 28.93 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.572 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -31.5 -60.49 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 124.946 3.764 . . . . 0.0 114.404 -176.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -120.06 48.07 1.63 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.17 30.04 65.73 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -174.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.47 165.46 21.21 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.224 0.535 . . . . 0.0 111.356 -176.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -132.7 125.74 30.96 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.129 -0.942 . . . . 0.0 110.856 -178.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -115.14 164.13 12.14 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.317 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.425 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 30.9 t80 -147.36 118.34 7.68 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.854 0.359 . . . . 0.0 110.624 -178.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 22.3 m-90 -122.99 132.07 53.98 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.992 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 46.6 t -100.89 117.61 46.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.224 177.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.563 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 4.1 mp -95.31 104.97 16.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.062 0.458 . . . . 0.0 109.88 176.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.422 HD22 ' HG3' ' A' ' 72' ' ' GLU . 19.1 t-20 -79.42 99.38 7.16 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.142 177.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.562 ' HB1' ' O ' ' A' ' 49' ' ' GLY . . . -111.1 -1.68 16.14 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 172.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.479 ' HB2' HG13 ' A' ' 50' ' ' ILE . 2.2 tppp? -67.55 -38.09 83.66 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.385 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.422 ' HG3' HD22 ' A' ' 69' ' ' ASN . 42.6 mt-10 -84.79 -1.63 56.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.234 176.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.02 20.92 69.14 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.618 178.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -89.92 -37.53 14.33 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.953 0.406 . . . . 0.0 111.057 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.13 32.14 76.05 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.883 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.563 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 19.7 ptmt -98.7 163.1 12.78 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -177.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.427 HG22 ' HB3' ' A' ' 29' ' ' MET . 0.8 OUTLIER -124.42 139.64 50.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.784 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.0 t -135.38 134.7 40.01 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.284 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 1.669 ' HD1' ' CD2' ' A' ' 79' ' ' TYR . 72.4 t80 -68.65 119.23 12.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.975 -178.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 52.43 69.87 0.63 Allowed 'General case' 0 N--CA 1.464 0.258 0 O-C-N 123.745 0.653 . . . . 0.0 109.732 -175.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.37 -40.71 91.64 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.708 -0.678 . . . . 0.0 113.822 -173.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.63 -20.79 48.06 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.609 -177.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.55 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 34.8 mt-10 -65.86 143.26 57.57 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.468 -0.366 . . . . 0.0 110.085 175.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -78.64 108.82 8.8 Favored Pre-proline 0 N--CA 1.449 -0.525 0 CA-C-O 121.341 0.591 . . . . 0.0 110.278 175.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.55 ' HD3' ' O ' ' A' ' 83' ' ' GLU . 12.6 Cg_exo -71.36 129.18 15.54 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.581 2.187 . . . . 0.0 111.949 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -59.25 -31.67 69.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.184 174.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.44 ' HB ' ' CD1' ' A' ' 117' ' ' ILE . 2.7 m -141.12 128.9 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.629 175.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.738 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 35.5 m -118.13 121.85 41.58 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.885 177.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.4 ' HA ' ' HB ' ' A' ' 117' ' ' ILE . 5.5 m-85 -106.5 131.76 53.31 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -178.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.448 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 5.4 m -103.77 127.26 51.26 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 173.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.516 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -161.4 155.9 3.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -174.79 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.453 ' HB3' ' HB2' ' A' ' 57' ' ' ASN . 15.5 m -85.19 145.56 27.53 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.31 0.576 . . . . 0.0 111.502 -175.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -51.07 -32.35 21.81 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.734 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -73.68 -35.54 65.21 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.982 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.434 ' OD2' ' HB2' ' A' ' 92' ' ' SER . 12.3 m-20 -90.59 -22.55 21.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.535 -173.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.51 ' O ' HG13 ' A' ' 100' ' ' ILE . 0.4 OUTLIER -57.36 -33.06 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 121.086 0.47 . . . . 0.0 110.446 -178.155 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.5 m -68.09 -27.68 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.241 -170.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -86.54 -30.21 22.09 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 177.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.439 HD21 ' O ' ' A' ' 104' ' ' LEU . 77.2 mt -67.74 -45.82 73.9 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.201 0.524 . . . . 0.0 110.578 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.51 HG13 ' O ' ' A' ' 96' ' ' VAL . 23.5 mt -75.8 -23.26 16.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.381 -176.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 27.7 p -85.54 -22.4 28.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.811 0.339 . . . . 0.0 110.839 178.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 96.97 8.33 56.94 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.934 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -80.42 -41.01 25.31 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.149 0.499 . . . . 0.0 111.131 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.439 ' O ' HD21 ' A' ' 99' ' ' LEU . 42.2 tp -102.78 120.7 41.05 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.844 -178.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -69.41 124.46 90.53 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.207 175.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -70.1 -14.11 34.6 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 121.816 1.678 . . . . 0.0 110.564 177.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -66.13 -58.42 5.47 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.257 171.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.515 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 1.1 ptmt -66.65 -31.46 72.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.653 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.515 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -66.8 -31.53 72.22 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.905 177.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 1.651 ' HD1' ' CD2' ' A' ' 110' ' ' PHE . 23.7 t80 -66.09 -50.85 62.65 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 1.634 ' HD1' ' CD2' ' A' ' 111' ' ' PHE . 80.0 t80 -63.27 -34.21 77.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.331 -178.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -85.27 11.15 10.63 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.65 15.12 73.13 Favored Glycine 0 CA--C 1.517 0.185 0 C-N-CA 121.218 -0.515 . . . . 0.0 113.133 175.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -85.3 -45.07 12.29 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.91 0.386 . . . . 0.0 110.554 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.722 HG22 ' CG2' ' A' ' 117' ' ' ILE . 0.6 OUTLIER -97.39 122.96 49.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.93 -178.208 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.448 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 29.5 mmmt -120.71 99.34 6.48 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 173.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.738 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.318 -0.762 0 CA-C-O 121.275 0.559 . . . . 0.0 111.68 -170.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 CA--C 1.518 -0.287 0 CA-C-O 121.968 0.889 . . . . 0.0 111.496 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.63 -15.9 37.82 Favored 'Trans proline' 0 C--N 1.329 -0.46 0 C-N-CA 123.956 3.104 . . . . 0.0 112.068 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -75.01 -28.86 60.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.507 -177.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -82.83 -7.54 59.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.957 -176.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 1.659 ' HD1' ' CD2' ' A' ' 23' ' ' PHE . 40.3 m-85 -73.12 146.49 45.68 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 174.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.435 ' HD3' HG12 ' A' ' 97' ' ' VAL . 78.6 tttt -78.46 -21.76 48.6 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.468 HG11 HG12 ' A' ' 96' ' ' VAL . 1.3 m -71.83 -13.68 16.94 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.535 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.648 175.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -56.51 -58.17 9.17 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.135 -0.321 . . . . 0.0 110.135 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.35 -42.55 96.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.161 0.505 . . . . 0.0 110.494 178.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.428 ' O ' HG12 ' A' ' 31' ' ' ILE . 18.0 m-85 -65.81 -42.04 91.13 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.613 -175.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.422 ' CE ' HD12 ' A' ' 68' ' ' ILE . 67.5 mtp -80.16 -24.29 40.49 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.117 -0.365 . . . . 0.0 110.354 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 50.5 mmtt -66.61 -41.53 88.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.506 173.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.449 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 4.8 pt -78.97 -26.08 13.23 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.56 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.188 176.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.1 tt -55.15 -51.56 66.08 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 170.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.496 ' HG2' ' HA ' ' A' ' 76' ' ' LYS . 0.7 OUTLIER -47.24 -53.91 12.14 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.962 177.748 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 31' ' ' ILE . 7.6 pt-20 -74.01 -39.4 63.63 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.288 -175.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.01 -37.46 85.95 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.661 -174.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 19.8 mmt -58.48 -44.18 89.25 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.645 0.26 . . . . 0.0 111.543 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -91.24 -7.89 49.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.932 0.396 . . . . 0.0 110.578 177.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 22.0 t-20 -64.94 -34.56 78.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.304 -178.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -61.12 132.27 53.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.653 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.55 -24.85 65.72 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.463 -175.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -102.27 10.83 38.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 119.463 -0.304 . . . . 0.0 111.562 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 26.2 p30 30.86 70.8 0.08 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.382 1.073 . . . . 0.0 112.248 178.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.8 mt -62.64 -2.81 1.22 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.128 -174.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.8 tp -64.02 -27.45 42.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.274 0.559 . . . . 0.0 110.288 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -63.5 -25.62 68.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.396 -177.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -81.81 -19.75 40.51 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.164 -177.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.3 m -129.65 32.31 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.791 -175.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 72.3 mtt180 -49.45 112.03 0.58 Allowed 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.763 0.792 . . . . 0.0 111.04 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.496 ' O ' ' HB1' ' A' ' 70' ' ' ALA . . . -178.28 161.57 28.44 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.705 -175.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.499 HG13 ' HB2' ' A' ' 71' ' ' LYS . 64.9 mt -96.57 126.88 49.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 117.28 0.54 . . . . 0.0 110.865 -178.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 1.658 ' HE2' ' CE1' ' A' ' 51' ' ' TYR . 9.4 m-85 -106.07 118.89 37.79 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.708 -179.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.28 113.92 4.85 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.514 -0.85 . . . . 0.0 111.327 177.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -101.26 110.47 22.49 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.122 0.487 . . . . 0.0 111.694 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -94.3 99.75 11.92 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.312 174.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 19.9 t -100.83 112.49 33.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.045 0.45 . . . . 0.0 110.878 -174.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 76.2 mtp85 -104.05 179.71 4.19 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.577 -177.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 64.68 37.29 7.71 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 123.348 0.405 . . . . 0.0 111.311 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.38 -161.17 9.26 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.796 178.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -34.74 -60.72 0.27 Allowed 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 124.605 3.537 . . . . 0.0 114.493 -174.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -115.89 38.49 3.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.38 0.61 . . . . 0.0 110.343 178.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 78.38 24.46 63.21 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -171.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.79 156.34 39.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.14 -0.53 . . . . 0.0 110.725 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -118.3 116.0 25.86 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.182 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.41 161.09 16.27 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.019 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 1.668 ' HE1' ' CE2' ' A' ' 65' ' ' TYR . 39.5 t80 -145.95 118.83 8.7 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.977 0.418 . . . . 0.0 110.897 -176.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.4 ' CE2' ' HD2' ' A' ' 79' ' ' TYR . 20.9 m-90 -121.23 136.27 55.0 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.812 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 39.0 t -106.19 117.23 51.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.555 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.67 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 3.7 mp -93.56 99.79 10.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 175.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -86.25 98.35 10.89 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.348 -177.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.496 ' HB1' ' O ' ' A' ' 49' ' ' GLY . . . -109.3 6.94 24.97 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.177 175.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.499 ' HB2' HG13 ' A' ' 50' ' ' ILE . 5.4 tppp? -60.49 -42.97 97.38 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.522 -178.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -94.27 5.34 52.06 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.223 -178.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.8 -13.51 59.21 Favored Glycine 0 C--N 1.318 -0.431 0 CA-C-N 115.703 -0.68 . . . . 0.0 113.63 174.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.43 -67.05 0.42 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.87 34.7 14.56 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 119.797 -1.192 . . . . 0.0 111.249 -175.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.67 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 54.6 pttt -98.0 148.64 23.28 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 -177.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -107.04 135.12 46.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 177.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.4 t -140.11 132.86 29.03 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.606 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 1.651 ' HD1' ' CD2' ' A' ' 79' ' ' TYR . 45.5 t80 -68.93 121.42 16.56 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 56.49 74.75 0.38 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.552 0.692 . . . . 0.0 109.474 -173.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.86 -41.18 73.77 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.916 -176.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.45 -13.58 61.79 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.93 -179.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.526 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 12.9 mm-40 -81.15 159.41 24.66 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 177.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -87.68 109.08 23.92 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 123.18 0.3 . . . . 0.0 110.518 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.526 ' HD3' ' O ' ' A' ' 83' ' ' GLU . 18.0 Cg_exo -67.26 134.2 32.95 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.815 2.343 . . . . 0.0 112.787 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -66.95 -33.26 75.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.493 -0.776 . . . . 0.0 108.949 172.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 8.5 m -140.58 134.27 33.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.256 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.617 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 27.9 m -119.4 132.77 55.89 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 175.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.526 ' CD1' ' HB ' ' A' ' 117' ' ' ILE . 68.2 m-85 -119.4 125.79 49.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.219 -179.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.436 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 25.4 m -99.83 126.16 45.89 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 173.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.554 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -157.31 144.26 9.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.888 -176.342 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.14 141.97 41.76 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.451 178.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -49.13 -27.47 3.5 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.707 1.203 . . . . 0.0 111.986 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -78.08 -34.44 50.27 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.226 -174.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -90.99 -20.45 22.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.239 -175.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.468 HG12 HG11 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -57.92 -31.73 41.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.023 -175.116 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.435 HG12 ' HD3' ' A' ' 24' ' ' LYS . 4.9 m -63.91 -29.53 47.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.461 -170.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -81.87 -32.63 30.98 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.494 HD21 ' O ' ' A' ' 104' ' ' LEU . 91.6 mt -69.36 -42.86 74.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.381 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.408 HG22 ' HB3' ' A' ' 28' ' ' TYR . 1.6 mm -65.34 -25.67 37.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.681 178.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.6 t -96.86 -11.41 24.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.646 -176.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.49 9.86 82.77 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.128 -177.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -77.76 -42.35 34.42 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.266 0.555 . . . . 0.0 110.261 178.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.494 ' O ' HD21 ' A' ' 99' ' ' LEU . 48.3 tp -100.02 125.1 46.03 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.723 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.484 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 6.1 m-20 -77.34 124.19 86.96 Favored Pre-proline 0 C--N 1.317 -0.805 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.013 178.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -64.99 -22.28 62.74 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.022 1.815 . . . . 0.0 110.529 179.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 77.0 mm-40 -64.24 -56.7 12.84 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.133 173.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.484 ' HG2' ' HB2' ' A' ' 105' ' ' ASN . 0.1 OUTLIER -67.75 -31.37 71.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.078 -178.514 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.458 ' HB1' HD13 ' A' ' 115' ' ' ILE . . . -69.91 -32.79 71.28 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 177.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 1.616 ' HD1' ' CD2' ' A' ' 110' ' ' PHE . 50.9 t80 -62.51 -52.13 64.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.595 174.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 1.616 ' HD1' ' CD2' ' A' ' 111' ' ' PHE . 52.1 t80 -63.16 -42.14 99.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.88 -178.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -71.33 -7.68 48.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.883 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 95.76 -5.02 66.45 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.667 -0.777 . . . . 0.0 113.432 173.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -68.38 -53.16 25.75 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.95 0.405 . . . . 0.0 111.43 177.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.542 HG13 ' CG1' ' A' ' 91' ' ' ILE . 0.1 OUTLIER -85.94 116.72 29.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.653 0.74 . . . . 0.0 111.038 -175.35 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.436 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 33.7 mmtp -108.37 104.27 13.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.987 175.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.617 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.321 -0.635 0 CA-C-O 121.145 0.498 . . . . 0.0 111.101 -177.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.5 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 82.0 m-20 . . . . . 0 CA--C 1.514 -0.418 0 CA-C-O 121.575 0.702 . . . . 0.0 110.509 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -68.54 -18.37 43.2 Favored 'Trans proline' 0 C--N 1.327 -0.598 0 C-N-CA 123.745 2.964 . . . . 0.0 112.346 -176.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.4 ' HA ' ' CG ' ' A' ' 26' ' ' PHE . 15.0 mt-10 -84.05 -27.29 28.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.438 -177.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.5 ' OD2' ' HB2' ' A' ' 19' ' ' ASN . 42.9 m-20 -76.49 -9.4 58.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.13 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -73.31 145.55 45.95 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.756 174.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -76.04 -17.7 59.55 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.453 ' CG1' HG12 ' A' ' 96' ' ' VAL . 1.2 m -78.02 -15.87 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.267 177.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 1.642 ' HE2' ' CE1' ' A' ' 26' ' ' PHE . 78.7 t80 -54.74 -55.93 24.7 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 123.123 0.264 . . . . 0.0 110.73 -174.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.458 ' HZ1' HG22 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -65.72 -35.33 80.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.647 -179.072 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 1.666 ' HE2' ' CE1' ' A' ' 28' ' ' TYR . 12.7 m-85 -66.89 -48.52 68.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.529 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 63.7 mtt -70.7 -30.79 67.45 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.017 178.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.423 ' HD2' ' HA ' ' A' ' 30' ' ' LYS . 27.7 mmmt -67.02 -34.74 78.38 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.236 176.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.458 HG22 ' HZ1' ' A' ' 27' ' ' LYS . 12.6 pt -86.55 -18.57 8.57 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.798 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.389 175.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.1 tt -63.74 -52.19 61.56 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 169.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.466 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 21.1 tt0 -42.11 -53.18 4.07 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.239 -1.346 . . . . 0.0 111.32 171.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -73.51 -62.45 1.48 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.336 -1.302 . . . . 0.0 112.175 -176.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.91 -42.63 72.43 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -169.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.6 mmt -61.21 -37.84 84.44 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -176.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -91.8 -23.54 19.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.139 0.495 . . . . 0.0 110.162 178.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -64.28 -32.93 74.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.219 178.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -54.7 134.59 47.38 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.614 175.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.9 p -63.08 -28.97 70.45 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.539 -176.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -81.96 -25.16 35.06 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.652 176.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.414 ' C ' ' H ' ' A' ' 44' ' ' ILE . 4.9 p30 36.96 73.62 0.09 Allowed 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.984 0.897 . . . . 0.0 110.728 -174.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.45 ' O ' HG13 ' A' ' 47' ' ' VAL . 66.9 mt -63.16 -3.11 1.6 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.717 -175.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.419 HG13 ' HB2' ' A' ' 70' ' ' ALA . 4.1 tp -60.28 -26.48 36.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.268 -177.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -83.08 -14.49 53.63 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 120.823 0.344 . . . . 0.0 111.141 -178.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -92.65 -13.93 28.82 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.267 0.556 . . . . 0.0 110.183 178.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.469 ' O ' HG23 ' A' ' 47' ' ' VAL . 13.9 p -130.11 32.69 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.867 0.842 . . . . 0.0 109.872 -177.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -52.51 111.65 0.68 Allowed 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.556 -178.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.667 ' O ' ' HB1' ' A' ' 70' ' ' ALA . . . -175.37 147.56 8.95 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.818 -176.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.464 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 66.7 mt -89.18 126.94 42.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 117.39 0.595 . . . . 0.0 110.794 -177.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 1.645 ' HD1' ' CD2' ' A' ' 51' ' ' TYR . 5.0 m-85 -104.31 116.54 32.33 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.758 -177.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.96 111.58 4.28 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.116 177.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 1.645 ' HD1' ' CD2' ' A' ' 53' ' ' PHE . 6.7 m-85 -100.48 103.43 14.78 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.164 0.507 . . . . 0.0 111.568 -178.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -88.36 99.5 12.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.397 175.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 10.8 t -98.13 134.92 34.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.127 -177.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 31.7 mtp-105 -125.58 175.78 7.32 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.475 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 57.51 42.88 23.68 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 123.426 0.454 . . . . 0.0 111.758 177.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.12 -160.52 8.24 Favored Glycine 0 CA--C 1.521 0.423 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.621 177.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -37.93 -60.82 0.4 Allowed 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 124.284 3.323 . . . . 0.0 113.737 -177.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.429 ' OD1' ' HB3' ' A' ' 62' ' ' ALA . 28.6 p-10 -109.52 34.92 3.53 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.295 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.38 28.54 59.66 Favored Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -173.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.429 ' HB3' ' OD1' ' A' ' 60' ' ' ASN . . . -76.45 146.91 38.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.662 0.744 . . . . 0.0 112.168 -175.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -108.4 108.16 19.01 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.186 176.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -100.58 152.55 19.16 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 1.636 ' HE2' ' CE1' ' A' ' 65' ' ' TYR . 25.2 t80 -137.76 116.47 12.21 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 117.089 0.445 . . . . 0.0 110.905 -178.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 24.3 m-90 -119.3 139.84 51.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.709 178.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 30.5 t -109.85 113.43 44.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.152 178.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.51 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 3.9 mp -91.46 102.61 13.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -85.62 98.03 10.43 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.341 0.591 . . . . 0.0 110.341 -176.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.667 ' HB1' ' O ' ' A' ' 49' ' ' GLY . . . -97.4 -4.5 38.19 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.758 174.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.412 ' HB2' HG13 ' A' ' 50' ' ' ILE . 15.8 tppt? -63.5 -42.74 98.51 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.162 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -73.71 -6.59 47.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.237 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.58 12.28 81.93 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.929 -177.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -91.37 -52.48 4.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.686 0.279 . . . . 0.0 110.766 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.84 34.45 24.56 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.349 -0.929 . . . . 0.0 111.504 -177.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 21.8 ptmt -97.54 150.42 21.12 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -176.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -108.02 125.38 64.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.8 t -128.38 134.49 48.85 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.784 -178.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 1.648 ' HD1' ' CD2' ' A' ' 79' ' ' TYR . 34.3 t80 -63.24 125.38 23.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.213 -176.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 74.08 -42.05 0.5 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.833 0.853 . . . . 0.0 111.699 -178.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.82 -43.09 0.6 Allowed Glycine 0 CA--C 1.519 0.302 0 N-CA-C 114.483 0.553 . . . . 0.0 114.483 177.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 69.32 17.25 72.13 Favored Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 -174.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.409 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 38.7 mm-40 -117.82 162.94 17.28 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 122.576 0.35 . . . . 0.0 110.332 -176.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -95.34 109.04 42.97 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.98 176.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.464 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 17.2 Cg_exo -68.09 133.74 29.71 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.888 2.392 . . . . 0.0 112.73 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -65.32 -32.58 74.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.5 174.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.9 m -141.02 132.77 29.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.552 173.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.66 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 86.3 m -115.92 131.1 57.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.318 176.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 1.641 ' HD1' ' CD2' ' A' ' 89' ' ' PHE . 75.8 m-85 -116.56 123.55 47.65 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.45 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 3.5 m -99.7 119.74 38.59 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 176.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.602 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 59.0 mt -143.86 154.22 15.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -174.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.451 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 37.5 m -89.25 144.25 26.24 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.505 175.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -42.38 -52.09 4.7 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.378 0.671 . . . . 0.0 111.968 -177.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.97 -42.35 89.73 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.162 -176.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.451 ' OD2' ' HB2' ' A' ' 92' ' ' SER . 7.8 m-20 -80.4 -21.67 42.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.594 0.235 . . . . 0.0 111.535 -173.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.484 ' O ' HG13 ' A' ' 100' ' ' ILE . 0.5 OUTLIER -58.62 -34.23 50.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.085 -176.463 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.1 m -68.09 -30.46 48.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.22 -171.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -81.14 -33.46 33.15 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 177.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.464 HD21 ' O ' ' A' ' 104' ' ' LEU . 74.0 mt -69.77 -47.91 61.2 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.011 -177.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 96' ' ' VAL . 25.5 mt -70.34 -26.03 28.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.055 -178.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 27.3 t -88.2 -8.67 54.97 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.512 -178.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.51 19.6 61.75 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.322 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -94.2 -41.76 9.31 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.096 0.474 . . . . 0.0 110.979 -178.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.718 HD12 ' NZ ' ' A' ' 108' ' ' LYS . 37.6 tp -101.1 128.74 47.04 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.334 179.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.624 ' OD1' ' HB2' ' A' ' 107' ' ' GLN . 2.8 t-20 -69.68 122.33 85.45 Favored Pre-proline 0 C--N 1.321 -0.63 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.057 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -68.39 -24.44 36.9 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.896 1.731 . . . . 0.0 110.692 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.624 ' HB2' ' OD1' ' A' ' 105' ' ' ASN . 1.7 mp0 -64.83 -59.15 4.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.453 173.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.718 ' NZ ' HD12 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -60.41 -37.93 82.4 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.818 -179.365 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.539 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -68.83 -34.88 76.23 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.553 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -62.23 -52.93 61.78 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 174.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 1.656 ' HD2' ' CD1' ' A' ' 111' ' ' PHE . 79.5 t80 -56.9 -42.25 79.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.094 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.427 ' HA ' HE21 ' A' ' 112' ' ' GLN . 0.0 OUTLIER -74.97 -1.69 23.75 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.963 -177.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 96.5 -12.94 66.07 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.32 173.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -62.41 -61.17 2.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.061 0.458 . . . . 0.0 111.77 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.552 HG22 HG23 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -80.85 121.8 34.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.062 -175.253 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.45 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 35.9 mmtm -115.4 99.63 7.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.319 172.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.66 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.322 -0.614 0 CA-C-O 121.092 0.472 . . . . 0.0 110.155 177.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.763 0 N-CA-C 112.166 -0.374 . . . . 0.0 112.166 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.678 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 17.0 p -57.74 116.42 3.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.655 0.264 . . . . 0.0 110.718 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.5 m -124.37 100.52 6.72 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.111 0.481 . . . . 0.0 111.283 -177.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.39 174.26 47.91 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.118 175.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -60.36 146.69 83.81 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 121.14 0.495 . . . . 0.0 110.668 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.409 ' HA ' ' CD1' ' A' ' 23' ' ' PHE . 3.3 Cg_exo -70.45 -18.65 33.63 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 123.183 2.589 . . . . 0.0 112.628 -173.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -67.14 -28.21 67.95 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.745 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -77.37 -7.73 56.55 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.692 -177.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.409 ' CD1' ' HA ' ' A' ' 20' ' ' PRO . 27.7 m-85 -80.88 148.08 30.07 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 177.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -67.84 -31.21 70.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.142 0.496 . . . . 0.0 109.95 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.493 HG11 HG12 ' A' ' 96' ' ' VAL . 1.7 m -68.36 -16.82 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.563 -177.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 1.661 ' HD1' ' CD2' ' A' ' 26' ' ' PHE . 84.1 t80 -54.03 -57.17 12.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.006 0.431 . . . . 0.0 110.648 -177.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.53 ' HZ1' HG23 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -70.17 -33.06 71.28 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.741 -178.114 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 1.649 ' HD2' ' CD1' ' A' ' 28' ' ' TYR . 39.7 m-85 -69.92 -46.4 65.45 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.581 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.446 ' CE ' HD12 ' A' ' 68' ' ' ILE . 53.6 mtp -71.96 -26.15 62.15 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.949 0.404 . . . . 0.0 110.435 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.435 ' HD2' ' HA ' ' A' ' 30' ' ' LYS . 24.8 mmmt -68.45 -36.68 79.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.066 175.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.53 HG23 ' HZ1' ' A' ' 27' ' ' LYS . 17.6 pt -83.31 -26.72 7.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.171 176.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.0 tt -53.93 -50.56 66.16 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 171.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.546 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 10.5 tt0 -43.6 -55.19 4.46 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.69 176.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -71.17 -53.65 13.74 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.497 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.12 -40.19 80.6 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -167.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 91.3 mmm -56.89 -43.52 81.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.046 0.45 . . . . 0.0 111.291 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -91.37 -17.71 25.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.27 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -64.9 -22.51 67.01 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.009 -175.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -59.28 130.06 45.09 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 172.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.7 -27.39 62.88 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.827 -173.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -100.83 18.48 19.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.809 -0.178 . . . . 0.0 110.961 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 27.5 70.52 0.05 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.912 1.285 . . . . 0.0 112.568 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.1 mt -62.83 -6.14 3.46 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.392 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.1 tp -60.62 -27.14 39.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.665 178.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.454 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 22.9 mt-10 -74.28 -21.59 59.68 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-O 120.743 0.306 . . . . 0.0 111.255 -178.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.524 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 95.1 mttt -77.92 -36.97 48.77 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.475 0.655 . . . . 0.0 110.153 177.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.474 ' O ' HG23 ' A' ' 47' ' ' VAL . 14.6 p -112.29 31.73 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.657 -172.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.454 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 53.1 mtt180 -51.33 111.86 0.64 Allowed 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.62 0.724 . . . . 0.0 111.524 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.51 ' O ' ' HB1' ' A' ' 70' ' ' ALA . . . -170.14 168.67 41.61 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.752 -175.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.458 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 54.1 mt -108.7 124.42 65.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 1.637 ' HE2' ' CE1' ' A' ' 51' ' ' TYR . 12.8 m-85 -106.63 130.97 54.29 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.265 -174.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -107.87 117.36 5.13 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.303 176.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 1.622 ' HE2' ' CE1' ' A' ' 53' ' ' PHE . 3.4 m-85 -103.65 100.07 9.89 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 120.978 0.418 . . . . 0.0 111.509 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 90' ' ' THR . 56.5 mtmt -89.32 101.99 14.66 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.453 174.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.1 t -104.71 124.71 59.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.588 -176.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 45.6 mtp180 -114.4 -179.75 3.72 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.99 -178.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 61.64 47.19 6.59 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.926 0.393 . . . . 0.0 110.876 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.71 -172.16 15.71 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.478 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -38.57 -60.43 0.48 Allowed 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 124.115 3.21 . . . . 0.0 113.497 -175.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -123.99 62.88 1.07 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.11 0.481 . . . . 0.0 110.326 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.84 22.61 78.95 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.846 -0.692 . . . . 0.0 111.926 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.678 ' HA ' ' O ' ' A' ' 16' ' ' SER . . . -80.36 169.77 17.28 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.31 0.576 . . . . 0.0 111.581 -177.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -141.61 139.07 33.0 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.69 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.45 162.82 24.08 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.648 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -150.3 115.29 5.34 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.949 0.404 . . . . 0.0 110.811 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 10.5 m-90 -117.81 145.05 44.82 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 40.6 t -113.3 124.68 70.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.52 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.469 ' N ' HD13 ' A' ' 68' ' ' ILE . 3.8 mp -100.36 107.02 20.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -83.48 98.35 9.48 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.031 0.443 . . . . 0.0 110.205 178.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.51 ' HB1' ' O ' ' A' ' 49' ' ' GLY . . . -108.32 -2.61 19.07 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.971 175.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -61.25 -37.49 83.3 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -83.06 -2.44 55.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.106 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.38 18.2 67.13 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.005 -178.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.515 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 11.8 mmpt? -93.17 -61.44 1.57 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.683 -0.258 . . . . 0.0 110.786 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.6 35.52 6.48 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.154 -1.022 . . . . 0.0 112.34 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.546 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 19.1 pttm -96.35 142.34 28.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.692 0.246 . . . . 0.0 110.347 -176.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.7 OUTLIER -108.0 133.44 52.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.37 0.605 . . . . 0.0 109.555 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.2 t -138.11 134.33 34.51 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.641 -176.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 1.638 ' HD2' ' CD1' ' A' ' 79' ' ' TYR . 15.9 t80 -68.0 135.3 52.11 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 42.38 73.4 0.14 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.857 0.836 . . . . 0.0 111.064 -172.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.58 -40.02 97.28 Favored Glycine 0 C--N 1.33 0.212 0 CA-C-N 115.108 -0.951 . . . . 0.0 113.591 -173.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 92.18 -14.33 64.79 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.23 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.515 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 1.7 pt-20 -97.95 153.09 18.59 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 122.15 0.18 . . . . 0.0 110.925 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 60.4 pttt -79.2 110.11 13.7 Favored Pre-proline 0 N--CA 1.449 -0.477 0 CA-C-O 121.284 0.564 . . . . 0.0 111.323 178.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.515 ' HD3' ' O ' ' A' ' 83' ' ' GLU . 14.3 Cg_exo -69.84 130.58 19.49 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.529 2.152 . . . . 0.0 111.579 177.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -58.87 -37.17 75.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.799 176.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.608 ' HB ' ' CD1' ' A' ' 117' ' ' ILE . 14.3 m -138.72 138.98 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.691 177.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.65 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 44.9 m -124.32 136.1 53.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.516 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 1.644 ' HD1' ' CD2' ' A' ' 89' ' ' PHE . 34.7 m-85 -111.31 153.32 26.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.766 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.535 ' HB ' ' HB3' ' A' ' 116' ' ' LYS . 1.1 m -132.26 108.39 9.2 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 175.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.47 HG23 ' N ' ' A' ' 92' ' ' SER . 64.4 mt -134.18 159.47 42.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.523 0.729 . . . . 0.0 109.36 -173.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.47 ' N ' HG23 ' A' ' 91' ' ' ILE . 15.4 m -89.02 139.67 30.22 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.907 0.384 . . . . 0.0 110.096 174.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.487 ' OD1' HG12 ' A' ' 25' ' ' VAL . 35.1 t70 -53.03 -25.83 13.68 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.176 0.991 . . . . 0.0 111.63 -179.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -78.71 -38.93 37.9 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.711 -177.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -89.16 -19.72 25.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.54 -172.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.562 ' O ' HG13 ' A' ' 100' ' ' ILE . 0.5 OUTLIER -55.4 -32.56 29.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.082 0.468 . . . . 0.0 110.527 -179.192 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.6 m -67.23 -28.93 44.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.269 -173.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -84.79 -32.94 23.1 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 74.0 mt -68.72 -47.9 65.18 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.826 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.562 HG13 ' O ' ' A' ' 96' ' ' VAL . 10.6 mt -74.98 -18.95 16.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.908 -177.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.6 t -88.47 -20.49 25.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.868 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.55 9.25 61.67 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.124 -177.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -83.0 -41.15 19.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.011 0.434 . . . . 0.0 110.843 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.6 tp -102.97 127.31 50.24 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.051 178.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -71.6 121.87 85.61 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.115 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.35 -20.52 66.54 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.763 1.642 . . . . 0.0 110.708 175.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -64.91 -58.77 5.28 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.818 172.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.541 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -66.03 -32.92 74.68 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.335 0.588 . . . . 0.0 109.566 -178.503 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.541 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -66.79 -40.11 88.01 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.552 178.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -58.3 -47.55 83.31 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.359 0.6 . . . . 0.0 109.718 175.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -63.87 -38.54 91.48 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.276 -177.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.431 HE21 ' HB3' ' A' ' 112' ' ' GLN . 7.8 mt-30 -91.53 6.0 47.32 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -174.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.23 2.22 80.53 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.827 173.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.1 mmpt? -77.34 -19.85 55.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.172 0.51 . . . . 0.0 110.443 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.485 HG22 HG21 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -127.94 110.37 21.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.861 178.599 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.535 ' HB3' ' HB ' ' A' ' 90' ' ' THR . 19.3 tptm -111.75 99.78 8.42 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.114 174.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.65 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER -124.78 133.34 69.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.946 -176.065 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.546 ' O ' HG13 ' A' ' 87' ' ' VAL . 44.0 mt-30 -85.57 96.55 9.68 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 176.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -70.99 124.63 11.62 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.985 -0.626 . . . . 0.0 114.185 -170.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -90.41 123.97 34.57 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 168.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 24.2 mmt -57.95 -32.28 67.66 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -169.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -91.62 -53.47 2.11 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.251 -0.976 . . . . 0.0 112.695 177.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.452 HD13 ' HA3' ' A' ' 49' ' ' GLY . 2.8 tt -70.74 -47.24 60.72 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 122.908 0.483 . . . . 0.0 112.228 -169.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.491 ' HA ' HD22 ' A' ' 127' ' ' LEU . . . -70.5 -15.52 62.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.598 0.237 . . . . 0.0 111.401 -174.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.585 ' O ' ' HB ' ' A' ' 128' ' ' THR . 17.1 mmt -77.7 -31.79 52.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.969 0.414 . . . . 0.0 110.207 175.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.524 ' HD2' ' O ' ' A' ' 46' ' ' LYS . 13.3 mttp -78.63 -27.77 45.48 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.232 0.539 . . . . 0.0 110.075 174.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.491 HD22 ' HA ' ' A' ' 124' ' ' ALA . 0.1 OUTLIER -66.93 -36.38 82.11 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 170.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.585 ' HB ' ' O ' ' A' ' 125' ' ' MET . 23.8 m -61.53 -31.71 71.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.919 172.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.466 ' O ' ' HB2' ' A' ' 132' ' ' ARG . 20.6 t70 -71.47 -43.59 66.35 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.376 176.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -66.1 -38.82 89.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.21 -178.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.479 ' HG3' ' O ' ' A' ' 128' ' ' THR . 5.2 pp0? -65.11 -22.84 67.0 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.816 -0.353 . . . . 0.0 110.724 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' A' ' 129' ' ' ASP . 75.1 mtp180 -62.14 -38.0 87.34 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 120.95 0.405 . . . . 0.0 109.924 173.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -76.09 -35.13 59.49 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.316 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.2 -20.03 63.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.351 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.18 -32.4 73.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.353 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 72.99 26.7 70.37 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.691 -0.686 . . . . 0.0 113.032 174.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -95.53 135.45 37.17 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.214 0.531 . . . . 0.0 110.934 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 8.5 tp -114.94 -22.35 4.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.532 0.682 . . . . 0.0 110.25 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -99.04 160.33 14.34 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.355 -170.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 35.5 p -100.0 137.82 37.92 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.223 176.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.4 tp . . . . . 0 C--O 1.25 1.099 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.856 179.272 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.785 0 N-CA-C 112.171 -0.372 . . . . 0.0 112.171 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.2 p -81.47 51.37 1.64 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.02 0.438 . . . . 0.0 111.568 -177.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.9 m -136.78 -172.37 3.16 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.202 -178.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -55.38 148.44 25.61 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.406 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.406 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 89.5 m-20 -70.57 148.22 95.09 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 121.036 0.446 . . . . 0.0 110.173 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.406 ' HG3' ' CD1' ' A' ' 79' ' ' TYR . 15.1 Cg_exo -62.99 -30.26 76.39 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 123.173 2.582 . . . . 0.0 112.268 -173.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -68.61 -23.36 64.44 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.794 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.406 ' OD2' ' HB2' ' A' ' 19' ' ' ASN . 23.2 m-20 -76.06 -16.24 59.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.243 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -90.2 152.92 20.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.14 0.495 . . . . 0.0 110.525 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -80.46 -26.1 38.51 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.411 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.518 ' HB ' ' SD ' ' A' ' 29' ' ' MET . 1.0 OUTLIER -66.62 -17.59 22.8 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.536 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.973 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.415 ' O ' ' HB2' ' A' ' 30' ' ' LYS . 55.9 t80 -53.89 -51.9 62.23 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.814 0.34 . . . . 0.0 110.492 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.467 ' HZ1' HG22 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -67.25 -36.48 81.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.508 -179.246 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 1.6 ' HE1' ' CE2' ' A' ' 28' ' ' TYR . 48.0 m-85 -70.17 -53.32 17.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.501 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.518 ' SD ' ' HB ' ' A' ' 25' ' ' VAL . 0.1 OUTLIER -61.04 -32.1 71.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.767 0.317 . . . . 0.0 110.898 177.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.458 ' HD3' ' HA ' ' A' ' 30' ' ' LYS . 34.0 mmtt -74.53 -27.94 60.75 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.467 HG22 ' HZ1' ' A' ' 27' ' ' LYS . 15.5 pt -89.77 -18.43 7.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.714 173.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.9 tt -62.69 -52.54 62.88 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 169.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.53 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 11.9 tt0 -42.47 -55.17 3.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.141 -1.39 . . . . 0.0 110.688 173.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -65.07 -53.82 39.68 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.757 -1.11 . . . . 0.0 111.876 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.68 -36.94 84.51 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -167.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.482 ' HA ' ' HE3' ' A' ' 36' ' ' MET . 5.1 mmt -60.92 -43.37 98.69 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.686 0.279 . . . . 0.0 111.304 -177.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -92.64 -15.1 27.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.988 0.423 . . . . 0.0 110.499 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -64.02 -35.35 80.42 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.064 0.459 . . . . 0.0 110.221 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -70.12 123.25 21.13 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 173.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.81 -24.07 65.55 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.652 -172.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -74.44 -17.58 60.77 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.7 p30 34.27 70.36 0.13 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.924 0.889 . . . . 0.0 112.391 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.4 mt -70.36 1.67 4.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.262 -178.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -62.05 -31.47 51.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.259 -177.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.526 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 46.3 mt-10 -73.13 -20.56 60.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.475 -173.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -72.81 -19.55 61.31 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.344 0.592 . . . . 0.0 110.241 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -131.01 33.44 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.338 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.526 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 57.8 mtt180 -45.31 110.31 0.23 Allowed 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.469 0.652 . . . . 0.0 111.853 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.502 ' O ' ' HB1' ' A' ' 70' ' ' ALA . . . -174.95 175.27 47.04 Favored Glycine 0 C--N 1.31 -0.867 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.306 -176.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 67.3 mt -107.98 124.83 64.46 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-O 121.284 0.564 . . . . 0.0 111.248 -177.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 1.655 ' HD1' ' CD2' ' A' ' 51' ' ' TYR . 4.3 m-85 -105.98 111.62 24.34 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.827 -176.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -93.16 126.92 8.79 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.691 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -111.28 103.04 11.41 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.05 0.452 . . . . 0.0 111.777 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -87.88 102.06 14.34 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.11 173.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 23.0 t -101.88 125.18 56.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.251 0.548 . . . . 0.0 111.238 -173.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.615 ' NE ' HG23 ' A' ' 90' ' ' THR . 51.6 mtm180 -109.77 175.53 5.41 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.985 -174.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 60.82 49.07 6.34 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 122.684 0.394 . . . . 0.0 111.849 176.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.88 -160.01 10.5 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.28 175.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.44 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 80.2 Cg_exo -41.62 -61.4 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.678 2.919 . . . . 0.0 113.573 -177.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -125.1 63.78 1.15 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.368 0.604 . . . . 0.0 109.573 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.0 26.7 73.27 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.401 -177.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.44 ' HB1' ' HD2' ' A' ' 59' ' ' PRO . . . -77.72 152.86 33.46 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.182 0.515 . . . . 0.0 111.149 -178.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -129.38 112.84 14.24 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.043 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.06 164.93 18.41 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.106 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 1.606 ' HD2' ' CD1' ' A' ' 65' ' ' TYR . 28.0 t80 -147.75 117.06 6.92 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.874 0.368 . . . . 0.0 110.941 -176.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 16.0 m-90 -119.35 147.55 44.2 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.826 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 19.7 t -116.44 115.52 49.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.461 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.464 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 4.2 mp -91.29 103.56 14.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -84.88 97.88 10.0 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.168 0.509 . . . . 0.0 110.138 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.502 ' HB1' ' O ' ' A' ' 49' ' ' GLY . . . -100.97 -0.47 36.55 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.472 174.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -59.74 -40.3 87.62 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.318 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -74.88 -13.74 60.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.033 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.64 9.23 75.48 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -172.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -90.32 -59.79 2.09 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.356 -0.422 . . . . 0.0 110.872 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.55 36.45 5.86 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.066 -1.064 . . . . 0.0 112.149 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.53 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 16.3 pttm -95.72 144.47 26.09 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -175.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.7 OUTLIER -108.08 133.42 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-O 121.433 0.635 . . . . 0.0 109.866 -178.897 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.412 HG21 ' HA2' ' A' ' 81' ' ' GLY . 1.8 t -136.89 141.21 42.74 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.294 -177.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.411 ' C ' ' H ' ' A' ' 81' ' ' GLY . 80.1 t80 -62.38 123.6 18.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.349 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 72.75 -38.64 0.42 Allowed 'General case' 0 N--CA 1.471 0.623 0 O-C-N 123.984 0.802 . . . . 0.0 111.993 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.412 ' HA2' HG21 ' A' ' 78' ' ' THR . . . 76.0 -41.63 1.53 Allowed Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 114.158 0.423 . . . . 0.0 114.158 176.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.99 0.76 53.63 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.102 -176.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -107.08 166.83 10.32 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.416 ' HZ3' ' HB2' ' A' ' 84' ' ' LYS . 9.6 mtmp? -98.25 108.39 46.94 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 175.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -67.28 132.6 28.07 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 123.138 2.558 . . . . 0.0 113.194 -177.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.506 ' HB2' HD23 ' A' ' 123' ' ' LEU . 8.3 m-20 -64.0 -39.94 95.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.001 174.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.569 HG13 ' O ' ' A' ' 118' ' ' GLN . 6.2 m -136.21 134.18 50.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.656 175.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.606 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 21.2 m -122.81 132.35 54.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.627 -178.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.579 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 41.4 m-85 -111.68 136.86 50.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.917 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.615 HG23 ' NE ' ' A' ' 56' ' ' ARG . 2.2 m -109.04 99.67 8.95 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.057 0.456 . . . . 0.0 109.853 175.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 86.4 mt -122.72 159.07 26.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -176.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.472 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 4.9 m -99.34 138.38 36.52 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 177.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -44.54 -50.11 9.74 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.14 0.576 . . . . 0.0 111.376 -176.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -59.02 -34.6 72.08 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.5 -1.227 . . . . 0.0 111.575 -176.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.472 ' OD2' ' HB2' ' A' ' 92' ' ' SER . 23.0 m-20 -91.09 -21.72 21.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.064 -177.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.59 ' O ' HG13 ' A' ' 100' ' ' ILE . 0.4 OUTLIER -57.71 -34.21 47.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 121.221 0.534 . . . . 0.0 109.824 -179.101 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.0 m -67.21 -27.71 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.971 -174.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -83.68 -34.41 24.99 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.403 ' HG ' HD21 ' A' ' 104' ' ' LEU . 79.8 mt -71.45 -36.25 71.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.219 -177.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.59 HG13 ' O ' ' A' ' 96' ' ' VAL . 17.4 mt -85.15 -22.2 7.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.348 -177.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 37.0 p -85.29 -20.85 29.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.004 0.431 . . . . 0.0 111.062 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 96.17 11.99 53.09 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.663 -177.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -85.67 -41.98 14.69 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.941 0.401 . . . . 0.0 111.125 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.403 HD21 ' HG ' ' A' ' 99' ' ' LEU . 49.2 tp -102.89 131.29 49.91 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.274 177.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.469 ' HB2' ' HB2' ' A' ' 108' ' ' LYS . 16.1 m120 -78.73 118.32 71.7 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.475 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -65.45 -27.14 54.64 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 121.978 1.785 . . . . 0.0 111.001 177.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -66.93 -55.21 15.57 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.454 173.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.629 ' HE3' ' HG3' ' A' ' 112' ' ' GLN . 13.6 ttpt -53.51 -48.85 68.61 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.056 175.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.545 ' HB3' ' HB3' ' A' ' 114' ' ' LYS . . . -65.03 -31.71 73.07 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.68 -175.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 1.633 ' HD2' ' CD1' ' A' ' 110' ' ' PHE . 47.6 t80 -60.08 -45.7 92.04 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 174.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -67.08 -38.0 84.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.427 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.629 ' HG3' ' HE3' ' A' ' 108' ' ' LYS . 15.2 mm100 -71.06 -23.41 62.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.762 -177.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 101.39 8.67 46.2 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.399 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.562 ' HA ' ' HE3' ' A' ' 114' ' ' LYS . 1.1 tpmt? -83.31 -32.09 26.51 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-O 121.398 0.618 . . . . 0.0 110.386 -176.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.533 HG22 HG21 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -111.99 122.43 66.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.005 -174.163 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.423 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 47.3 mmtm -112.59 106.13 14.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.481 173.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.606 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER -128.08 129.17 69.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 120.986 0.422 . . . . 0.0 111.079 -178.148 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.569 ' O ' HG13 ' A' ' 87' ' ' VAL . 1.1 tm0? -86.46 117.16 25.06 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 176.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -85.84 98.93 2.33 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.741 -0.743 . . . . 0.0 113.893 -172.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -64.95 120.39 12.49 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 167.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.549 ' O ' ' HB3' ' A' ' 125' ' ' MET . 2.0 mpt? -57.86 -30.38 65.76 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.758 0.661 . . . . 0.0 112.472 -169.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.47 ' O ' ' HE3' ' A' ' 125' ' ' MET . . . -92.25 -27.21 16.25 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.527 -0.844 . . . . 0.0 113.181 -179.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.506 HD23 ' HB2' ' A' ' 86' ' ' ASP . 0.6 OUTLIER -91.77 -61.72 1.58 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.693 0.759 . . . . 0.0 110.755 -173.613 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.507 ' HB3' HG12 ' A' ' 87' ' ' VAL . . . -74.62 -5.56 43.67 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.493 -173.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.549 ' HB3' ' O ' ' A' ' 121' ' ' MET . 26.0 ptt? -66.28 -21.4 66.27 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.189 176.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -85.23 -26.08 26.92 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.011 -0.675 . . . . 0.0 110.059 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 39.4 mt -70.13 -27.91 64.95 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 169.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.5 ' HB ' ' O ' ' A' ' 125' ' ' MET . 43.4 m -73.4 -20.02 60.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 113.801 -1.545 . . . . 0.0 111.313 177.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -58.22 -25.94 62.25 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.283 0.563 . . . . 0.0 111.374 -175.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.6 mt -61.72 -23.18 65.96 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.915 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.428 ' HG2' ' O ' ' A' ' 128' ' ' THR . 1.8 pt20 -70.49 -17.48 62.96 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 120.567 0.223 . . . . 0.0 110.878 -178.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -62.92 -22.75 66.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.039 0.447 . . . . 0.0 110.893 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -90.36 -21.08 22.17 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.466 0.65 . . . . 0.0 109.861 175.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -106.72 19.29 20.7 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.915 -176.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.79 -13.69 62.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.484 -175.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 95.37 28.57 9.61 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.07 178.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 67.63 -172.42 0.19 Allowed 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 122.654 0.382 . . . . 0.0 111.081 178.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 10.4 tp -66.47 -33.67 65.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.271 0.557 . . . . 0.0 110.981 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -100.38 119.65 38.77 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.798 -174.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 31.7 p -166.43 20.86 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.338 -177.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 48.0 mm . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.784 -0.627 . . . . 0.0 110.237 -178.638 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.69 0 N-CA-C 111.775 -0.53 . . . . 0.0 111.775 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.7 p -71.54 -38.03 71.07 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.977 0.389 . . . . 0.0 111.165 -178.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.6 p -92.01 110.33 21.69 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.683 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.31 149.79 47.61 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 173.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.459 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 95.6 m-20 -66.87 145.74 98.97 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 121.463 0.649 . . . . 0.0 111.569 -174.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.478 ' HA ' ' CD1' ' A' ' 23' ' ' PHE . 15.4 Cg_exo -62.96 -26.72 74.2 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.644 2.896 . . . . 0.0 111.681 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -59.24 -37.52 77.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.718 177.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -81.04 -2.94 50.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.872 0.368 . . . . 0.0 111.46 -174.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 1.65 ' HE2' ' CE1' ' A' ' 23' ' ' PHE . 29.9 m-85 -73.95 144.06 45.42 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 172.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.434 ' O ' ' HD2' ' A' ' 28' ' ' TYR . 64.4 mmtt -66.94 -30.5 70.66 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 175.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.506 ' CG1' HG12 ' A' ' 96' ' ' VAL . 0.8 OUTLIER -65.01 -20.19 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.786 -178.03 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -59.02 -54.44 47.07 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.497 ' HZ3' HG22 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -71.32 -37.71 71.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.61 179.012 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.434 ' HD2' ' O ' ' A' ' 24' ' ' LYS . 28.2 m-85 -69.35 -41.96 75.92 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 61.1 mtt -74.88 -27.95 60.45 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.359 178.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.429 ' HD2' ' HA ' ' A' ' 30' ' ' LYS . 19.4 mmmt -66.09 -34.24 77.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.078 175.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.497 HG22 ' HZ3' ' A' ' 27' ' ' LYS . 18.2 pt -86.32 -21.3 7.54 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.592 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.271 175.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.5 tt -61.83 -48.33 81.04 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 173.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.47 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 3.4 tt0 -45.62 -49.34 14.34 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.878 174.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -75.44 -61.48 1.89 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.755 -1.112 . . . . 0.0 111.703 -177.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.71 -38.95 73.02 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -167.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 95.3 mmm -59.64 -38.82 82.43 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.491 0.182 . . . . 0.0 111.491 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -91.48 -31.44 15.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.135 0.493 . . . . 0.0 111.049 176.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -65.3 -27.53 68.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.923 -176.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -56.67 142.03 41.46 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.414 177.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.3 p -48.99 -45.27 42.06 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.098 0.475 . . . . 0.0 111.406 -177.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -90.28 -8.59 50.55 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.227 -176.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.517 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 6.1 p30 36.51 71.77 0.12 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.865 0.841 . . . . 0.0 110.984 -175.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.5 mt -60.53 -5.34 1.17 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.945 -175.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.8 tp -62.14 -27.62 42.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.59 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' A' ' 42' ' ' ASN . 14.5 pt-20 -67.13 -28.75 68.4 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.793 0.33 . . . . 0.0 111.259 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.428 ' O ' ' HG2' ' A' ' 126' ' ' LYS . 52.2 mtpt -78.53 -24.73 45.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.145 0.498 . . . . 0.0 110.642 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.502 HG23 ' OH ' ' A' ' 51' ' ' TYR . 8.3 p -124.91 32.39 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.759 0.79 . . . . 0.0 110.955 -168.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -65.6 125.34 24.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.568 0.699 . . . . 0.0 111.778 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.14 -174.29 46.3 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.38 -178.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.2 mt -111.42 125.71 68.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 117.978 0.889 . . . . 0.0 110.589 175.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.514 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 19.1 m-85 -115.99 111.29 20.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.609 -174.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.29 111.83 4.11 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.686 -0.769 . . . . 0.0 111.314 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -100.88 109.61 21.59 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.291 0.567 . . . . 0.0 111.141 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -97.41 99.88 11.31 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.116 176.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 12.2 t -99.14 127.22 52.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.656 -172.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.471 ' O ' ' HA ' ' A' ' 92' ' ' SER . 54.8 mtp180 -118.15 176.19 5.33 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.253 -177.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 59.44 46.71 12.02 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.127 0.489 . . . . 0.0 111.242 178.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -79.55 -148.75 4.87 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.081 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.412 ' HD2' ' HB2' ' A' ' 62' ' ' ALA . 94.7 Cg_exo -40.97 -60.72 0.58 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 124.261 3.307 . . . . 0.0 114.109 -176.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -132.02 66.19 1.56 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.127 0.489 . . . . 0.0 109.683 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.12 24.52 71.87 Favored Glycine 0 N--CA 1.453 -0.199 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 -176.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.412 ' HB2' ' HD2' ' A' ' 59' ' ' PRO . . . -81.43 165.08 21.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.354 -0.423 . . . . 0.0 111.652 -175.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -139.4 142.9 37.48 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.596 -178.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -140.11 168.54 25.06 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.699 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -147.45 116.09 6.72 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.801 0.334 . . . . 0.0 110.881 -176.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 14.1 m-90 -119.49 142.95 47.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.818 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 42.4 t -111.01 114.51 47.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.661 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.514 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 4.3 mp -89.05 99.78 9.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 174.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -89.16 103.08 15.73 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.793 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -115.1 17.19 16.87 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.827 175.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -66.44 -40.04 89.24 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.256 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -85.25 -13.99 48.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.927 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.81 12.6 39.96 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.543 -0.753 . . . . 0.0 113.014 176.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.566 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 8.5 mmpt? -86.3 -38.01 17.95 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.986 -0.285 . . . . 0.0 111.603 -178.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.2 35.42 23.81 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.251 -0.976 . . . . 0.0 112.724 177.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 58.5 pttt -96.72 148.08 23.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.891 0.346 . . . . 0.0 110.884 -172.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -111.75 137.18 45.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 176.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.3 t -140.57 132.68 27.95 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.962 0.411 . . . . 0.0 110.847 -178.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -69.29 121.27 16.52 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 56.86 73.02 0.47 Allowed 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -174.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.73 -35.64 85.95 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.56 -0.746 . . . . 0.0 113.576 -174.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.27 1.07 90.42 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.401 -176.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -91.52 169.82 10.45 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -100.25 107.28 46.81 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.943 173.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.78 130.0 17.39 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.59 2.194 . . . . 0.0 112.203 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.475 ' HB2' HD21 ' A' ' 123' ' ' LEU . 30.8 m-20 -67.59 -29.01 68.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.858 176.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.501 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 4.4 m -139.51 138.73 39.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.189 172.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.576 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 46.8 m -121.4 129.35 52.97 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.219 177.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.63 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 76.4 m-85 -116.51 126.39 53.28 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.091 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.508 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 2.8 m -102.85 125.53 49.64 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.602 ' CG1' HG13 ' A' ' 115' ' ' ILE . 0.3 OUTLIER -156.76 150.33 9.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.22 0.533 . . . . 0.0 111.104 -174.345 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -77.99 139.73 39.16 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.356 178.285 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -52.33 -29.8 25.35 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.263 177.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -68.97 -39.28 79.54 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.537 -178.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -90.14 -25.79 20.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.42 -174.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.506 HG12 ' CG1' ' A' ' 25' ' ' VAL . 0.4 OUTLIER -57.66 -32.56 42.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.02 0.438 . . . . 0.0 110.444 -177.767 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.7 m -69.14 -28.2 38.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.748 -174.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -81.5 -37.19 28.27 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 176.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.403 HD21 ' O ' ' A' ' 104' ' ' LEU . 88.4 mt -64.15 -48.97 73.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.794 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 96' ' ' VAL . 20.2 mt -73.28 -24.96 20.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.543 -176.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.3 t -89.07 -9.81 49.76 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.779 0.324 . . . . 0.0 111.173 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 86.46 16.9 61.35 Favored Glycine 0 N--CA 1.453 -0.177 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.204 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -89.54 -42.72 11.27 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.99 0.424 . . . . 0.0 110.763 -178.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.707 HD12 ' NZ ' ' A' ' 108' ' ' LYS . 49.6 tp -105.59 127.97 53.35 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.846 -178.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -72.97 124.14 90.38 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.471 175.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -65.7 -25.17 54.19 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.347 2.031 . . . . 0.0 110.262 176.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -57.43 -61.41 2.51 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.897 173.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.707 ' NZ ' HD12 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -63.02 -35.63 80.88 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.138 -178.783 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.555 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -69.12 -32.29 71.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.971 -176.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 1.597 ' HD2' ' CD1' ' A' ' 110' ' ' PHE . 46.6 t80 -62.93 -50.49 70.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.701 174.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -64.94 -31.89 73.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.111 -177.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -83.93 1.53 43.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.984 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.98 12.3 82.78 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.833 -0.698 . . . . 0.0 113.446 174.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.468 ' HA ' ' HE3' ' A' ' 114' ' ' LYS . 0.3 OUTLIER -87.34 -42.88 12.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.822 0.344 . . . . 0.0 110.496 178.166 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.602 HG13 ' CG1' ' A' ' 91' ' ' ILE . 0.1 OUTLIER -91.05 114.44 28.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.554 0.692 . . . . 0.0 110.004 178.237 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.508 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 29.0 mmmt -111.73 99.79 8.43 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.411 176.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.63 ' HB ' ' CD2' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -118.58 138.49 49.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.442 -178.497 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -146.31 82.1 1.59 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -174.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.501 ' HA3' ' HA ' ' A' ' 87' ' ' VAL . . . -161.03 172.69 37.35 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.959 -171.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -50.37 113.66 0.93 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.066 0.46 . . . . 0.0 110.211 178.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.543 ' O ' ' HG3' ' A' ' 125' ' ' MET . 50.0 ttm -63.78 -29.75 70.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.564 -173.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -66.95 -38.1 92.6 Favored Glycine 0 C--O 1.226 -0.359 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.921 -176.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.475 HD21 ' HB2' ' A' ' 86' ' ' ASP . 3.4 tp -63.48 -49.35 73.96 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.322 0.582 . . . . 0.0 109.75 176.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -68.98 -20.36 64.17 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.968 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.543 ' HG3' ' O ' ' A' ' 121' ' ' MET . 78.4 mtp -66.14 -24.34 66.65 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.13 177.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 46' ' ' LYS . 13.7 mptt -76.53 -16.25 59.68 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.472 176.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 78.7 mt -75.77 -35.6 60.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.102 0.477 . . . . 0.0 109.875 176.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.455 HG23 ' O ' ' A' ' 125' ' ' MET . 5.8 t -83.67 -17.46 41.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.957 178.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.52 ' O ' ' HG3' ' A' ' 132' ' ' ARG . 18.0 t70 -59.08 -29.18 67.15 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.476 0.655 . . . . 0.0 110.26 175.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.1 mt -56.09 -16.3 4.88 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.998 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -58.97 -19.75 46.12 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 122.6 0.36 . . . . 0.0 111.799 -178.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.52 ' HG3' ' O ' ' A' ' 129' ' ' ASP . 47.8 mtt180 -53.43 -54.61 34.45 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 120.906 0.384 . . . . 0.0 110.529 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -91.24 -32.64 15.68 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.826 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.74 -11.05 53.07 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -174.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -83.63 12.6 5.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.926 0.393 . . . . 0.0 111.231 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.1 13.54 66.05 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.982 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -82.01 88.81 6.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.161 0.505 . . . . 0.0 110.198 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 9.4 tp -128.28 -28.31 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.411 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -100.06 162.73 12.79 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.781 -172.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.6 m -138.16 82.9 1.94 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.462 0.649 . . . . 0.0 110.305 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.1 mt . . . . . 0 C--O 1.246 0.911 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.846 179.715 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.759 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.0 m -77.22 95.36 4.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.014 0.435 . . . . 0.0 110.152 176.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.3 m -93.75 -168.58 1.92 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.392 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -51.99 139.89 27.93 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 121.272 -0.49 . . . . 0.0 112.775 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -72.3 142.68 84.81 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-O 121.142 0.496 . . . . 0.0 110.528 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -52.73 -36.97 74.96 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 124.229 3.286 . . . . 0.0 112.081 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -54.22 -37.34 64.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.81 176.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -79.2 -5.05 53.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.335 -175.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 1.649 ' HD2' ' CD1' ' A' ' 23' ' ' PHE . 29.8 m-85 -78.9 148.58 32.68 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.128 0.489 . . . . 0.0 110.037 176.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.418 ' HD3' HG13 ' A' ' 97' ' ' VAL . 46.8 mttp -70.86 -25.71 62.94 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 176.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.529 ' CG1' HG12 ' A' ' 96' ' ' VAL . 0.9 OUTLIER -72.87 -17.75 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 114.988 -1.006 . . . . 0.0 111.022 -178.75 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -56.31 -53.78 53.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.825 0.345 . . . . 0.0 110.472 -176.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.408 ' HE2' HG21 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -70.59 -40.35 73.29 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.496 178.242 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 1.666 ' HE2' ' CE1' ' A' ' 28' ' ' TYR . 9.8 m-85 -64.67 -45.37 86.98 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -175.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.452 ' CE ' HD12 ' A' ' 68' ' ' ILE . 66.8 mtp -75.97 -22.81 55.5 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.371 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 30' ' ' LYS . 24.4 mmmt -71.63 -36.78 70.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.933 174.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.408 HG21 ' HE2' ' A' ' 27' ' ' LYS . 16.1 pt -82.22 -25.25 9.13 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.485 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.122 175.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.8 tt -56.54 -53.04 62.21 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 171.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.442 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 14.1 tt0 -43.82 -49.09 8.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.267 -1.333 . . . . 0.0 111.725 175.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -75.15 -55.57 5.6 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.533 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.412 ' HA ' ' HB3' ' A' ' 38' ' ' ASN . . . -56.21 -36.28 68.26 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -168.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 25.2 mmt -61.41 -43.86 98.13 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.678 0.275 . . . . 0.0 111.483 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -91.7 -17.01 26.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.28 0.562 . . . . 0.0 110.602 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.412 ' HB3' ' HA ' ' A' ' 35' ' ' ALA . 4.3 t-20 -66.34 -36.26 82.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.781 177.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -56.91 125.94 24.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.31 175.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.79 -26.33 34.01 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -175.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -92.16 -16.6 26.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.476 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.414 ' C ' ' H ' ' A' ' 44' ' ' ILE . 4.9 p-10 35.87 69.02 0.2 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.904 0.859 . . . . 0.0 111.104 -177.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.1 mt -65.18 -0.73 1.83 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.731 -174.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.457 HG13 ' HB2' ' A' ' 70' ' ' ALA . 4.9 tp -61.83 -26.54 40.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.296 -177.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.428 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 44.6 mt-10 -76.51 -22.46 54.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.894 0.378 . . . . 0.0 111.053 -176.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -76.45 -19.18 58.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.654 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.463 ' O ' HG23 ' A' ' 47' ' ' VAL . 10.6 p -130.02 32.4 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.633 0.73 . . . . 0.0 110.076 -176.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.428 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 55.4 mtt180 -46.86 119.8 2.69 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.992 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.471 ' O ' ' HB1' ' A' ' 70' ' ' ALA . . . -179.88 166.64 35.9 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.314 -177.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.436 HG13 ' HB2' ' A' ' 71' ' ' LYS . 55.1 mt -102.79 122.93 55.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.142 0.496 . . . . 0.0 110.842 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.438 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 21.6 m-85 -103.32 118.56 37.05 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.933 -177.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.43 111.76 4.3 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.389 -0.91 . . . . 0.0 111.279 177.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -97.86 104.91 16.98 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.059 0.457 . . . . 0.0 111.458 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -92.7 99.07 11.83 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.691 175.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.59 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 6.0 t -102.34 145.42 12.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.673 -178.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.548 ' CB ' ' HG2' ' A' ' 63' ' ' GLU . 1.1 ptm180 -154.21 -174.2 4.87 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.544 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 64.71 38.17 7.11 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.082 0.468 . . . . 0.0 110.216 -174.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.24 -154.55 4.45 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.824 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo -36.6 -60.0 0.4 Allowed 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 124.326 3.351 . . . . 0.0 113.938 -174.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -128.57 54.88 1.73 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.221 0.534 . . . . 0.0 109.882 178.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 74.53 28.4 63.55 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.544 -176.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.06 156.24 30.15 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 121.391 0.615 . . . . 0.0 111.204 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.548 ' HG2' ' CB ' ' A' ' 56' ' ' ARG . 34.7 mt-10 -125.14 147.58 48.96 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.296 -178.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -143.12 162.91 27.5 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.343 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 1.634 ' HD2' ' CD1' ' A' ' 65' ' ' TYR . 31.0 t80 -150.63 114.9 5.11 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.819 0.342 . . . . 0.0 110.97 -177.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 15.5 m-90 -120.47 136.28 54.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.13 0.49 . . . . 0.0 109.835 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 14.6 t -103.49 116.66 47.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.425 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.452 HD12 ' CE ' ' A' ' 29' ' ' MET . 4.3 mp -93.38 101.21 12.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 175.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -85.69 98.38 10.66 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.246 -177.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.471 ' HB1' ' O ' ' A' ' 49' ' ' GLY . . . -107.04 0.73 23.82 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.227 176.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.436 ' HB2' HG13 ' A' ' 50' ' ' ILE . 5.1 tppp? -63.54 -41.73 98.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.399 0.618 . . . . 0.0 109.918 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -76.47 -6.68 52.81 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.424 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.83 8.5 63.5 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.761 176.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -92.01 -55.73 3.34 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -176.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.2 34.93 7.81 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 119.824 -1.179 . . . . 0.0 111.889 -176.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.442 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 22.7 pttp -96.56 144.16 26.88 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -176.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.7 OUTLIER -107.63 131.7 57.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.536 0.684 . . . . 0.0 109.619 -178.787 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.412 HG21 ' HA2' ' A' ' 81' ' ' GLY . 1.8 t -139.83 135.35 32.89 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.563 -178.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -63.19 128.46 35.96 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -176.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 73.25 -42.69 0.53 Allowed 'General case' 0 N--CA 1.471 0.584 0 O-C-N 124.011 0.82 . . . . 0.0 111.578 -177.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.412 ' HA2' HG21 ' A' ' 78' ' ' THR . . . 73.81 -41.81 1.06 Allowed Glycine 0 N--CA 1.453 -0.189 0 N-CA-C 114.425 0.53 . . . . 0.0 114.425 175.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.81 5.94 76.38 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.659 -175.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.42 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 13.3 mm-40 -114.23 143.41 44.88 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -177.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -77.77 110.56 13.39 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 121.185 0.517 . . . . 0.0 110.792 174.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 83' ' ' GLU . 13.4 Cg_exo -70.16 130.05 18.19 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.861 2.374 . . . . 0.0 112.452 -178.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -63.57 -34.3 77.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.485 176.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.514 ' HB ' ' CD1' ' A' ' 117' ' ' ILE . 9.0 m -139.4 133.93 39.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.556 176.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.652 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 53.9 m -116.77 139.33 50.7 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.517 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.493 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 54.4 m-85 -118.06 132.92 56.32 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.489 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 5.7 m -110.1 128.67 55.57 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 175.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -161.99 144.23 3.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.071 0.462 . . . . 0.0 109.862 -177.214 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.6 147.24 29.69 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.316 0.579 . . . . 0.0 111.154 177.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -51.25 -29.16 13.63 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 114.449 -1.251 . . . . 0.0 112.033 -177.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -73.51 -34.26 65.19 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.32 -176.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -90.08 -27.39 19.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.843 -175.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.529 HG12 ' CG1' ' A' ' 25' ' ' VAL . 0.4 OUTLIER -56.82 -31.61 36.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.217 -174.889 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.418 HG13 ' HD3' ' A' ' 24' ' ' LYS . 12.8 m -69.34 -29.24 41.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.687 -170.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -83.96 -31.43 25.58 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 176.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.466 HD21 ' O ' ' A' ' 104' ' ' LEU . 91.2 mt -64.63 -51.55 62.05 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.269 0.557 . . . . 0.0 110.562 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 96' ' ' VAL . 14.9 mt -75.51 -16.75 15.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.395 -175.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 42.0 t -94.14 -4.29 49.47 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.207 -0.308 . . . . 0.0 111.322 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.57 30.92 55.73 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.705 -0.759 . . . . 0.0 111.939 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -106.7 -42.67 4.9 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.223 0.535 . . . . 0.0 110.571 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.466 ' O ' HD21 ' A' ' 99' ' ' LEU . 33.8 tp -103.32 120.74 41.35 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.694 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.423 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 5.9 m-20 -68.51 120.48 75.6 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.467 178.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -63.68 -21.47 69.98 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.21 1.94 . . . . 0.0 110.578 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -62.81 -58.69 6.55 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.958 174.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.53 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 1.2 ptmt -66.74 -33.95 76.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.015 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.53 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -65.87 -29.42 69.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.955 0.407 . . . . 0.0 110.098 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -65.39 -46.82 78.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.627 175.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 1.621 ' HE1' ' CE2' ' A' ' 111' ' ' PHE . 82.5 t80 -67.43 -37.2 82.64 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.1 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -79.71 10.92 3.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.857 -176.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.78 7.83 83.94 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 121.236 -0.507 . . . . 0.0 113.268 173.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -82.15 -53.4 6.11 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.117 0.484 . . . . 0.0 110.456 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.526 HG13 ' CG1' ' A' ' 91' ' ' ILE . 0.2 OUTLIER -88.52 115.12 28.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.585 -177.633 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.489 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 31.2 mmmt -111.06 103.22 11.65 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.524 176.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.652 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER -130.95 130.27 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-O 121.159 0.504 . . . . 0.0 110.955 -176.665 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.495 ' O ' HG13 ' A' ' 87' ' ' VAL . 0.8 OUTLIER -83.48 94.24 7.98 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 175.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -71.08 100.54 0.86 Allowed Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.969 -0.559 . . . . 0.0 113.643 -172.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 39.1 t-20 -64.71 115.57 5.38 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 171.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 25.2 ptt? -57.53 -27.79 62.92 Favored 'General case' 0 C--O 1.223 -0.342 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -171.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -90.8 -37.11 6.52 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.017 -1.087 . . . . 0.0 113.076 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.47 HD13 ' HA3' ' A' ' 49' ' ' GLY . 4.0 tt -90.82 -48.39 7.06 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.704 0.288 . . . . 0.0 111.461 -172.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.509 ' HB3' HG12 ' A' ' 87' ' ' VAL . . . -76.58 -15.26 59.89 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.556 -173.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 46.5 mtt -71.71 -18.12 62.17 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.722 177.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.524 ' O ' ' HG ' ' A' ' 130' ' ' LEU . 5.6 mptp? -76.77 -22.45 53.74 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.36 176.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.71 -46.15 86.72 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.056 177.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.668 ' O ' ' HG2' ' A' ' 132' ' ' ARG . 9.0 t -75.26 -36.65 61.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.027 177.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -54.85 -42.76 72.36 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.921 0.391 . . . . 0.0 111.022 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 126' ' ' LYS . 7.4 mt -55.68 -40.64 72.61 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.132 178.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -88.22 -19.91 26.22 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.275 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.668 ' HG2' ' O ' ' A' ' 128' ' ' THR . 21.5 mmt180 -64.86 -43.98 91.21 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.06 0.457 . . . . 0.0 109.851 175.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.407 ' HA ' ' HG2' ' A' ' 137' ' ' ARG . 12.7 pt20 -79.1 -7.25 58.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.944 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -101.36 0.42 37.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.111 174.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -96.16 -6.98 37.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.045 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.62 48.76 3.13 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.841 178.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.407 ' HG2' ' HA ' ' A' ' 133' ' ' GLN . 11.4 ptm180 -88.66 106.7 18.5 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.365 0.603 . . . . 0.0 110.142 178.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.3 mp -76.37 -68.41 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.09 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -101.4 150.44 23.03 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.366 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.8 m -76.51 94.84 3.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.399 -175.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 49.0 mm . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.282 -0.866 . . . . 0.0 109.516 176.315 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.595 0 N-CA-C 111.787 -0.525 . . . . 0.0 111.787 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.2 m -68.38 -23.46 64.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.1 0.476 . . . . 0.0 110.811 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.1 m -75.65 149.38 38.19 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.5 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.42 165.87 49.18 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.276 174.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.6 m-20 -67.72 138.71 93.35 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-O 121.353 0.597 . . . . 0.0 110.711 -176.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -56.38 -35.29 96.02 Favored 'Trans proline' 0 CA--C 1.518 -0.293 0 C-N-CA 123.906 3.07 . . . . 0.0 112.397 -176.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.401 ' HA ' ' CD1' ' A' ' 26' ' ' PHE . 40.7 tt0 -60.49 -37.61 81.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.585 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -74.92 -18.14 60.45 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.683 0.278 . . . . 0.0 111.307 -173.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -67.84 154.82 40.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.501 0.667 . . . . 0.0 110.569 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.2 ttmm -80.43 -20.43 43.87 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.318 -0.855 . . . . 0.0 108.917 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.533 ' HB ' ' SD ' ' A' ' 29' ' ' MET . 1.3 m -77.27 -14.11 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.934 178.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 1.669 ' HE2' ' CE1' ' A' ' 26' ' ' PHE . 69.1 t80 -51.86 -56.06 16.27 Favored 'General case' 0 N--CA 1.462 0.135 0 O-C-N 123.055 0.222 . . . . 0.0 111.418 -175.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.3 -40.6 96.26 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.037 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -66.18 -49.2 68.15 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.548 -177.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.533 ' SD ' ' HB ' ' A' ' 25' ' ' VAL . 0.2 OUTLIER -61.73 -33.23 73.68 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.825 0.345 . . . . 0.0 110.954 175.531 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.8 mmmt -69.67 -39.6 76.91 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 11.2 pt -81.45 -22.06 10.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.108 177.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.6 tt -58.27 -48.05 81.69 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 171.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -48.14 -50.81 27.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.757 175.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 38' ' ' ASN . 25.5 tt0 -69.63 -52.14 28.58 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.84 -178.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.36 -37.28 82.96 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -166.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.8 mmt -58.06 -47.32 83.52 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.757 0.281 . . . . 0.0 111.757 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -91.08 -8.66 48.29 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.073 0.463 . . . . 0.0 110.558 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -67.82 -25.95 65.82 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 176.558 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -54.33 122.35 10.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.798 176.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.86 -39.79 59.5 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.857 -1.065 . . . . 0.0 113.001 -173.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.548 ' C ' HD21 ' A' ' 42' ' ' ASN . 44.5 mt-10 -103.35 19.01 20.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.839 -0.164 . . . . 0.0 111.385 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.548 HD21 ' C ' ' A' ' 41' ' ' GLU . 0.1 OUTLIER 21.88 76.36 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.157 1.383 . . . . 0.0 112.736 -177.139 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.8 mt -65.91 -1.77 3.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.065 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.2 tp -58.7 -26.73 32.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.69 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.507 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 31.5 mt-10 -77.67 -14.58 59.58 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.358 -177.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.9 mttm -89.33 -12.74 39.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.175 0.512 . . . . 0.0 110.384 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.476 ' O ' HG23 ' A' ' 47' ' ' VAL . 9.7 p -131.3 33.07 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.776 0.798 . . . . 0.0 109.774 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.507 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 51.0 mtt180 -52.5 109.86 0.44 Allowed 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.645 0.736 . . . . 0.0 111.361 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.582 ' O ' ' HB1' ' A' ' 70' ' ' ALA . . . -171.42 155.8 24.95 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 114.419 -1.264 . . . . 0.0 111.292 -176.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.453 HG13 ' HB2' ' A' ' 71' ' ' LYS . 73.6 mt -96.79 126.56 49.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 117.132 0.466 . . . . 0.0 110.768 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.456 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 9.9 m-85 -104.66 117.47 34.19 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.91 -176.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -98.68 109.75 3.86 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.273 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 1.667 ' HD1' ' CD2' ' A' ' 53' ' ' PHE . 7.4 m-85 -98.33 103.73 15.7 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.275 0.56 . . . . 0.0 111.457 -178.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -89.6 99.41 12.42 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.254 174.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 20.2 t -96.97 121.44 47.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.627 -174.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.42 ' HE ' ' CD ' ' A' ' 63' ' ' GLU . 51.7 mtp180 -108.37 178.24 4.55 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.874 -178.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 18.4 m120 61.05 43.74 11.01 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.242 0.544 . . . . 0.0 111.036 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.24 -155.94 7.31 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.531 -0.759 . . . . 0.0 113.239 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -43.53 -60.73 0.7 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.831 3.021 . . . . 0.0 113.486 -176.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -114.25 47.42 1.22 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 177.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.9 22.21 78.82 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.572 -0.823 . . . . 0.0 111.311 -174.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.94 169.73 16.27 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.441 0.638 . . . . 0.0 111.843 -175.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.42 ' CD ' ' HE ' ' A' ' 56' ' ' ARG . 20.5 mt-10 -131.66 110.54 10.99 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.844 -178.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -100.55 169.15 21.15 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.431 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -150.25 118.54 6.4 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.935 0.398 . . . . 0.0 111.087 -177.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 20.7 m-90 -122.0 137.5 54.78 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.832 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 37.2 t -109.61 115.47 49.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.57 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 4.2 mp -95.52 106.43 18.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -86.38 98.57 11.07 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.215 0.531 . . . . 0.0 110.148 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.582 ' HB1' ' O ' ' A' ' 49' ' ' GLY . . . -101.42 -2.65 30.33 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.744 174.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.477 ' O ' ' HD3' ' A' ' 48' ' ' ARG . 4.5 tppp? -64.24 -39.53 94.15 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.575 -178.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -87.03 9.38 19.8 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.995 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 76.3 23.32 71.29 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.913 175.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -100.41 -66.22 0.92 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.687 0.279 . . . . 0.0 111.249 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.48 34.63 5.98 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.093 -1.051 . . . . 0.0 111.323 -174.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.513 ' HB2' ' HZ3' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -96.82 145.46 25.83 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -177.705 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.534 ' O ' HG21 ' A' ' 77' ' ' VAL . 1.2 m -107.79 129.42 61.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.409 HG21 ' HA2' ' A' ' 81' ' ' GLY . 2.1 t -134.0 134.0 41.95 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.871 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.447 ' O ' ' HB3' ' A' ' 80' ' ' ASN . 51.8 t80 -61.93 123.35 17.81 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.208 -177.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.447 ' HB3' ' O ' ' A' ' 79' ' ' TYR . 9.4 t30 75.29 -40.57 0.43 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.485 0.714 . . . . 0.0 111.663 -177.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.409 ' HA2' HG21 ' A' ' 78' ' ' THR . . . 72.36 -42.64 0.83 Allowed Glycine 0 CA--C 1.517 0.158 0 N-CA-C 114.736 0.654 . . . . 0.0 114.736 174.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 71.93 19.89 78.53 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.337 -174.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -125.38 158.77 33.46 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -177.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -98.04 108.83 48.87 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-O 120.929 0.395 . . . . 0.0 110.231 175.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.407 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 21.1 Cg_exo -66.12 132.44 29.91 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 123.008 2.472 . . . . 0.0 112.911 -177.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -61.34 -32.68 72.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.746 174.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.495 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 3.9 m -139.73 131.67 34.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.82 174.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.631 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 32.2 m -114.43 133.28 55.85 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.104 177.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 1.621 ' HD2' ' CD1' ' A' ' 89' ' ' PHE . 72.0 m-85 -119.82 128.89 54.12 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 2.1 m -102.83 119.43 38.83 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 175.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.582 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 66.0 mt -143.01 151.7 17.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -173.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.51 146.75 27.41 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.325 0.584 . . . . 0.0 110.917 176.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -53.16 -26.06 15.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.679 179.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -80.75 -37.33 30.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.041 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -87.57 -22.89 24.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.341 -173.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.584 ' O ' HG13 ' A' ' 100' ' ' ILE . 0.4 OUTLIER -56.4 -34.64 41.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.0 0.428 . . . . 0.0 110.568 -179.178 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.3 m -69.76 -29.54 41.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.15 -172.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -82.82 -33.49 27.19 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.501 HD21 ' O ' ' A' ' 104' ' ' LEU . 80.8 mt -68.43 -45.36 72.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.84 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.584 HG13 ' O ' ' A' ' 96' ' ' VAL . 22.1 mt -77.09 -19.4 14.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.097 -177.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 31.4 t -94.56 -1.26 53.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.751 0.31 . . . . 0.0 110.955 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.68 20.35 76.6 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.232 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -94.78 -42.27 8.81 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.076 0.465 . . . . 0.0 110.972 -177.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.501 ' O ' HD21 ' A' ' 99' ' ' LEU . 42.8 tp -101.5 124.73 47.65 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.115 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -72.94 123.64 89.82 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.513 177.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -65.53 -21.39 59.98 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.043 1.829 . . . . 0.0 110.113 176.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -59.15 -61.51 2.58 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.795 172.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.532 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 0.6 OUTLIER -66.12 -33.81 76.63 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.054 -177.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.532 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -68.72 -31.27 70.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.408 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -65.77 -49.02 69.85 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 174.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -62.9 -43.65 98.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.153 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -77.26 9.35 3.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.875 -177.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.03 -19.65 44.81 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 121.039 -0.601 . . . . 0.0 113.68 170.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -57.98 -61.11 2.78 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.55 HG22 HG23 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -79.3 114.88 20.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.853 0.835 . . . . 0.0 111.233 -173.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.51 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 0.0 OUTLIER -107.03 98.99 8.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.801 -1.091 . . . . 0.0 109.163 173.128 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.631 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER -116.48 133.7 62.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.123 0.487 . . . . 0.0 110.304 178.354 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.86 83.7 1.81 Allowed 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 -175.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.495 ' HA3' ' HA ' ' A' ' 87' ' ' VAL . . . -160.75 172.58 37.11 Favored Glycine 0 N--CA 1.439 -1.166 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.461 -170.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -53.57 107.69 0.27 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 123.998 0.469 . . . . 0.0 110.365 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.525 ' O ' ' HG3' ' A' ' 125' ' ' MET . 26.2 mmt -73.53 -23.17 59.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.498 -174.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.415 ' HA2' ' HE3' ' A' ' 125' ' ' MET . . . -69.01 -21.83 75.61 Favored Glycine 0 N--CA 1.451 -0.322 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 178.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.3 tt -90.31 -43.06 10.61 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.381 -0.909 . . . . 0.0 109.395 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.458 ' HB3' HG12 ' A' ' 87' ' ' VAL . . . -69.04 -23.15 64.03 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.409 -178.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.525 ' HG3' ' O ' ' A' ' 121' ' ' MET . 54.3 mtm -61.73 -23.76 66.35 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.549 0.214 . . . . 0.0 111.189 177.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.431 ' O ' ' HG ' ' A' ' 130' ' ' LEU . 30.5 mmmt -78.7 -21.99 47.32 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.995 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.2 mt -69.19 -44.14 72.77 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.158 0.504 . . . . 0.0 109.939 177.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 7.7 t -73.33 -14.97 61.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.476 0.655 . . . . 0.0 110.258 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -85.54 -44.03 13.02 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.301 175.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 126' ' ' LYS . 3.9 mt -63.39 -37.37 87.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.439 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -62.91 -17.93 62.39 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.159 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.507 ' NE ' ' HA ' ' A' ' 132' ' ' ARG . 3.5 mmp_? -68.81 -40.09 79.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.89 0.376 . . . . 0.0 110.295 177.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.451 ' HG2' ' NH1' ' A' ' 137' ' ' ARG . 44.5 mt-30 -85.64 -30.85 22.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.242 177.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.97 15.94 3.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.564 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -89.57 22.7 2.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.004 0.431 . . . . 0.0 110.475 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 78.57 44.64 10.49 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 111.119 -0.793 . . . . 0.0 111.119 -176.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.451 ' NH1' ' HG2' ' A' ' 133' ' ' GLN . 39.8 ttm180 -73.53 89.29 1.68 Allowed 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.754 0.788 . . . . 0.0 110.658 -176.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 14.2 mm -74.48 -55.01 13.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.309 177.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -101.0 160.65 14.2 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.822 -173.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.3 m -154.78 -38.71 0.09 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.303 178.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 48.7 mt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.279 -0.867 . . . . 0.0 109.95 -179.107 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.627 0 N-CA-C 111.832 -0.507 . . . . 0.0 111.832 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.4 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 28.2 t -143.55 108.59 4.97 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.44 ' HA ' ' HB2' ' A' ' 62' ' ' ALA . 49.0 m -136.83 103.85 5.31 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.123 178.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.03 174.45 40.52 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 173.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -56.92 144.2 68.55 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 121.224 0.535 . . . . 0.0 110.989 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -66.13 -22.12 54.74 Favored 'Trans proline' 0 CA--C 1.517 -0.327 0 C-N-CA 123.193 2.595 . . . . 0.0 111.734 -175.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.408 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 10.8 mt-10 -60.01 -36.54 77.43 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.028 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -76.39 -13.18 60.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.406 -174.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -77.75 141.4 39.31 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 177.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -74.97 -24.14 58.39 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.48 0.657 . . . . 0.0 109.261 -178.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.491 ' HB ' ' SD ' ' A' ' 29' ' ' MET . 0.8 OUTLIER -69.34 -15.62 19.76 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.305 176.251 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -58.71 -56.39 22.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.802 0.334 . . . . 0.0 110.462 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.483 ' HZ3' HG22 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -69.4 -33.51 73.11 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.468 -178.666 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.43 ' O ' HG12 ' A' ' 31' ' ' ILE . 13.1 m-85 -70.21 -50.8 36.26 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.457 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.495 ' HB3' HG22 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -62.14 -33.14 73.93 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.68 0.276 . . . . 0.0 111.274 176.111 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -67.6 -34.16 76.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.715 -0.221 . . . . 0.0 111.57 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.483 HG22 ' HZ3' ' A' ' 27' ' ' LYS . 17.7 pt -85.59 -21.56 7.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.026 176.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.8 tt -61.86 -48.31 81.12 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 171.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.468 ' HG2' ' HA ' ' A' ' 76' ' ' LYS . 2.0 tm-20 -43.9 -50.53 8.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.843 173.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -72.04 -53.46 12.84 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.675 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.9 -39.31 94.12 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -166.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 20.9 mmt -55.14 -43.69 74.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.603 0.239 . . . . 0.0 111.628 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -92.09 -18.77 23.1 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.236 -0.585 . . . . 0.0 111.241 177.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -69.8 -22.95 63.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.972 0.415 . . . . 0.0 110.261 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -59.57 126.81 29.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.136 174.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 13.7 m -57.28 -23.89 51.32 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.508 -175.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -100.09 4.33 44.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 119.296 -0.383 . . . . 0.0 111.9 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 32.4 p30 28.57 60.73 0.13 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.397 1.079 . . . . 0.0 111.976 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 36.1 mt -59.67 -12.73 7.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.424 -1.262 . . . . 0.0 111.922 -174.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.8 tp -60.69 -27.06 39.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.818 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -68.92 -26.88 65.31 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.555 -175.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -83.94 -22.45 31.5 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.979 0.418 . . . . 0.0 111.052 -178.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.488 ' O ' HG23 ' A' ' 47' ' ' VAL . 12.0 p -123.54 33.34 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.755 0.788 . . . . 0.0 110.421 -175.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -49.81 117.58 2.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.585 0.707 . . . . 0.0 111.137 177.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.462 ' O ' ' HB1' ' A' ' 70' ' ' ALA . . . -173.4 -171.3 37.86 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.264 -176.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 76.4 mt -126.92 131.19 71.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 117.998 0.899 . . . . 0.0 111.24 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 1.666 ' HE1' ' CE2' ' A' ' 51' ' ' TYR . 33.7 m-85 -110.33 132.2 54.39 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.116 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -109.34 112.15 3.36 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.493 -0.86 . . . . 0.0 111.409 175.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 1.622 ' HE2' ' CE1' ' A' ' 53' ' ' PHE . 4.5 m-85 -98.44 105.7 17.88 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.948 0.404 . . . . 0.0 111.28 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -91.28 99.78 12.7 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.175 173.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 19.4 t -97.84 123.95 50.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.663 -174.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 44.9 mtp180 -112.57 -178.53 3.42 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.3 m120 61.96 44.83 7.9 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.246 0.546 . . . . 0.0 110.792 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.01 -177.02 47.05 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.576 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -35.77 -61.12 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 124.849 3.699 . . . . 0.0 114.315 -175.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -110.91 41.91 1.72 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.159 0.504 . . . . 0.0 110.597 -177.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.45 30.94 63.8 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -173.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.44 ' HB2' ' HA ' ' A' ' 17' ' ' SER . . . -85.27 173.35 10.43 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 114.769 -0.715 . . . . 0.0 111.836 -176.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -140.01 135.45 32.71 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.972 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -127.06 163.05 21.07 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.938 -0.648 . . . . 0.0 111.688 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -141.37 120.53 12.95 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.842 0.353 . . . . 0.0 110.642 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 22.7 m-90 -122.97 130.35 52.71 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.071 0.462 . . . . 0.0 109.805 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.1 t -101.84 118.91 49.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.34 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.651 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 4.3 mp -94.47 103.32 14.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.162 0.506 . . . . 0.0 109.816 178.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -85.87 98.3 10.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.986 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' A' ' 49' ' ' GLY . . . -95.94 -10.92 27.49 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.927 173.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.1 tttt -51.44 -46.55 63.05 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.533 -178.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -89.42 12.97 14.83 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.169 0.509 . . . . 0.0 111.84 -175.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 88.67 -1.39 83.69 Favored Glycine 0 C--N 1.319 -0.376 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.987 175.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.523 ' HB3' ' HZ1' ' A' ' 74' ' ' LYS . 2.4 mmmp? -78.68 -74.62 0.27 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.79 0.329 . . . . 0.0 111.729 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.24 34.89 5.69 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 -167.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.651 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 16.3 ptmt -97.33 151.14 20.21 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.312 -0.444 . . . . 0.0 110.022 -174.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.495 HG22 ' HB3' ' A' ' 29' ' ' MET . 0.7 OUTLIER -107.4 143.08 18.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 120.311 -0.555 . . . . 0.0 109.743 176.765 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.2 t -139.22 132.4 29.76 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.188 177.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -68.34 121.63 16.68 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.161 -178.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 64.8 t30 52.21 62.64 2.6 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.993 -176.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -59.13 -36.58 89.21 Favored Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 115.329 -0.85 . . . . 0.0 113.416 -175.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.5 -16.04 51.43 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.061 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.445 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 8.5 mm-40 -75.68 148.18 38.85 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 176.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 29.9 mmmt -86.55 109.03 20.55 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-O 121.017 0.437 . . . . 0.0 110.128 177.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 83' ' ' GLU . 16.8 Cg_exo -67.65 142.5 58.69 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.018 2.479 . . . . 0.0 112.512 -176.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.501 ' CB ' ' HG ' ' A' ' 123' ' ' LEU . 6.7 m-20 -62.38 -33.76 75.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.759 171.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.51 HG13 ' HA3' ' A' ' 119' ' ' GLY . 4.2 m -141.76 139.1 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.059 174.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.584 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 29.5 m -115.41 137.21 52.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.222 176.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 1.648 ' HE2' ' CE1' ' A' ' 89' ' ' PHE . 81.9 m-85 -121.27 136.09 55.02 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 178.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.446 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 3.6 m -110.36 116.76 32.01 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 176.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.531 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 69.9 mt -140.44 152.05 21.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.694 -172.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.12 145.47 25.92 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.184 0.516 . . . . 0.0 110.536 174.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -53.05 -25.6 13.08 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.416 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -75.29 -36.53 61.15 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.73 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -89.55 -23.86 21.9 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.153 -173.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.484 ' O ' HG12 ' A' ' 100' ' ' ILE . 0.5 OUTLIER -55.55 -35.86 39.72 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.337 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.903 -178.108 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 m -61.69 -30.78 49.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.589 -171.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.407 ' HA ' ' OG ' ' A' ' 101' ' ' SER . 34.0 m-20 -91.46 -25.93 19.07 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.696 0.284 . . . . 0.0 110.404 177.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 89.3 mt -71.87 -39.96 69.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.99 0.424 . . . . 0.0 110.293 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 96' ' ' VAL . 3.0 mm -67.73 -44.49 85.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.039 177.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.572 ' OG ' ' HD3' ' A' ' 103' ' ' LYS . 58.2 p -76.87 -28.54 55.46 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.686 -174.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.97 -1.31 38.44 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.125 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.572 ' HD3' ' OG ' ' A' ' 101' ' ' SER . 1.8 mptm? -66.51 -40.08 89.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.831 0.348 . . . . 0.0 111.522 177.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.712 HD12 ' NZ ' ' A' ' 108' ' ' LYS . 47.9 tp -102.27 130.01 48.85 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.799 -176.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.427 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 19.2 m120 -77.65 123.29 86.61 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.07 176.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -64.49 -25.65 62.84 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.037 1.825 . . . . 0.0 110.419 175.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.507 ' NE2' HE22 ' A' ' 131' ' ' GLN . 44.9 mt-30 -60.38 -58.77 7.07 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.144 174.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.712 ' NZ ' HD12 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -63.82 -36.34 83.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.0 -179.618 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.544 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -66.75 -34.38 77.71 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.626 -0.43 . . . . 0.0 109.958 -177.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -57.84 -52.78 64.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.84 175.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -62.95 -32.01 73.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.921 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -84.87 -1.66 56.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.775 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.48 4.45 80.23 Favored Glycine 0 CA--C 1.517 0.19 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.24 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.609 ' CE ' ' HA ' ' A' ' 114' ' ' LYS . 1.4 mmpt? -94.85 10.91 33.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.084 0.469 . . . . 0.0 111.283 -177.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.538 HG22 HG23 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -146.83 109.66 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.828 0.823 . . . . 0.0 109.532 174.878 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.446 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 73.1 mmtt -109.09 99.74 9.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.99 -1.004 . . . . 0.0 108.963 176.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.597 ' HB ' ' CD1' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -115.49 137.43 49.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.25 0.547 . . . . 0.0 110.597 -177.737 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -147.95 96.48 2.65 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -177.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.51 ' HA3' HG13 ' A' ' 87' ' ' VAL . . . -161.1 173.5 37.55 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 119.827 -1.177 . . . . 0.0 113.599 -169.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.424 ' HB3' ' HB2' ' A' ' 123' ' ' LEU . 54.5 t-20 -48.38 119.9 3.31 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.735 -0.733 . . . . 0.0 110.134 176.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 89.2 mtp -64.03 -43.95 94.0 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.155 -176.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -66.09 -26.44 72.41 Favored Glycine 0 CA--C 1.509 -0.308 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.603 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.501 ' HG ' ' CB ' ' A' ' 86' ' ' ASP . 1.6 tm? -70.97 -56.41 6.26 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.931 -0.634 . . . . 0.0 109.861 177.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.543 ' O ' ' HB2' ' A' ' 127' ' ' LEU . . . -73.6 -16.06 61.25 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.703 -177.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 52.4 mtp -65.44 -28.57 69.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.803 0.335 . . . . 0.0 110.192 173.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 19.7 mttt -72.05 -27.2 62.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.781 176.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.543 ' HB2' ' O ' ' A' ' 124' ' ' ALA . 0.5 OUTLIER -67.83 -48.36 66.42 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.866 178.494 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.432 ' O ' ' HG2' ' A' ' 131' ' ' GLN . 5.2 t -77.83 -12.77 60.01 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.475 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -80.83 -47.21 14.16 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.597 173.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.0 -37.35 79.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.951 -179.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.507 HE22 ' NE2' ' A' ' 107' ' ' GLN . 18.6 pt20 -61.55 -24.79 66.88 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.511 0.196 . . . . 0.0 111.283 -178.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -72.55 -40.47 66.69 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 177.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -66.5 -39.39 88.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.793 174.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.73 -26.77 68.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.64 176.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -82.48 -18.47 41.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.757 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 126.93 -30.2 4.21 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.388 -0.911 . . . . 0.0 114.091 174.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -124.6 106.43 10.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.921 0.86 . . . . 0.0 112.209 -176.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 10.6 tp -115.74 -38.11 2.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.067 174.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -100.89 169.86 8.69 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.961 -177.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 13.2 t -146.91 109.23 4.5 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.801 0.334 . . . . 0.0 110.209 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 37.1 mm . . . . . 0 C--O 1.245 0.867 0 CA-C-O 118.538 -0.744 . . . . 0.0 109.634 178.059 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.761 0 N-CA-C 112.063 -0.415 . . . . 0.0 112.063 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.9 m -62.61 111.5 2.1 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.942 0.401 . . . . 0.0 110.442 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.7 m -109.7 -179.78 3.91 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.386 -176.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -57.08 131.52 52.09 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.157 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.4 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 13.8 m120 -68.88 146.8 97.67 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 19' ' ' ASN . 31.2 Cg_exo -56.7 -42.71 62.08 Favored 'Trans proline' 0 N--CA 1.466 -0.097 0 C-N-CA 123.014 2.476 . . . . 0.0 112.244 -176.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -58.58 -33.73 70.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.606 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -70.32 -14.58 62.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.554 -178.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 1.661 ' HD1' ' CD2' ' A' ' 23' ' ' PHE . 73.5 m-85 -80.39 144.58 32.57 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 174.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -79.18 -18.28 53.34 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.54 ' HB ' ' SD ' ' A' ' 29' ' ' MET . 1.0 OUTLIER -75.73 -12.1 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.774 177.859 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.426 ' O ' ' HB2' ' A' ' 30' ' ' LYS . 78.8 t80 -58.77 -51.52 69.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.827 0.346 . . . . 0.0 110.793 -178.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.465 ' HZ3' HG22 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -69.6 -26.8 64.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.846 179.542 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -79.88 -51.71 8.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.763 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.54 ' SD ' ' HB ' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -59.83 -35.78 75.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.714 0.293 . . . . 0.0 111.266 177.829 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 26' ' ' PHE . 4.9 mmtp -68.94 -31.4 70.26 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.465 HG22 ' HZ3' ' A' ' 27' ' ' LYS . 10.4 pt -90.7 -16.79 8.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.308 176.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.6 tt -61.04 -47.28 87.15 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 171.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.596 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 7.6 tt0 -48.75 -48.73 40.54 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.562 175.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -64.77 -60.69 2.8 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.724 -1.126 . . . . 0.0 111.081 177.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.98 -46.7 75.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.395 -0.82 . . . . 0.0 113.156 -167.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 35.3 mtt -56.51 -43.62 79.94 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -177.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -92.39 -16.85 25.42 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.103 0.477 . . . . 0.0 110.419 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -63.97 -28.87 70.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.141 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -61.07 126.17 26.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.473 176.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.2 p -68.25 -16.8 64.11 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.315 -174.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -94.02 -3.63 51.0 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 177.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 24.34 72.75 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 O-C-N 124.689 1.243 . . . . 0.0 112.591 -177.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 66.5 mt -64.26 -8.58 13.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.577 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.5 tp -60.24 -27.97 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.62 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.443 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 60.7 mm-40 -70.35 -27.86 64.68 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-O 121.022 0.439 . . . . 0.0 111.338 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -85.19 -14.51 46.64 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.77 -176.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.484 ' O ' HG23 ' A' ' 47' ' ' VAL . 14.6 p -130.52 31.04 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.883 0.849 . . . . 0.0 110.221 -177.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.443 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 19.5 mtp180 -51.23 112.97 0.82 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.825 0.821 . . . . 0.0 111.991 -177.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.469 ' HA3' HD12 ' A' ' 123' ' ' LEU . . . -168.88 171.1 42.76 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 114.131 -1.395 . . . . 0.0 111.356 -174.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.463 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 56.9 mt -106.32 127.61 61.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 117.375 0.587 . . . . 0.0 110.78 178.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.462 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 14.7 m-85 -108.69 114.44 28.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.017 -178.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.89 112.08 4.35 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.179 -1.01 . . . . 0.0 111.241 177.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -96.1 105.88 17.98 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.987 0.423 . . . . 0.0 111.343 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.619 ' NZ ' HG22 ' A' ' 88' ' ' THR . 54.6 mttp -91.09 101.46 14.21 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.261 174.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.566 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 21.2 t -100.78 111.54 30.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.679 -174.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.9 mtp180 -104.96 176.85 5.03 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.851 -177.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 59.97 46.65 10.74 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.714 176.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.16 -157.47 9.98 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.203 174.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -41.47 -61.12 0.54 Allowed 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 124.028 3.152 . . . . 0.0 113.727 -175.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -115.29 44.16 1.89 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.08 23.17 72.3 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.705 -0.759 . . . . 0.0 111.231 -175.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.67 140.46 56.8 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.498 0.666 . . . . 0.0 111.156 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -114.09 109.48 18.5 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.335 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.08 165.43 16.02 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -148.58 120.54 8.21 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.954 0.406 . . . . 0.0 111.039 -176.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 19.9 m-90 -123.06 129.35 51.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.058 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 55.1 t -99.18 114.44 37.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.657 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.609 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 4.5 mp -92.32 100.21 10.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 175.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -87.93 98.73 11.66 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.297 -177.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.466 ' HB1' ' O ' ' A' ' 49' ' ' GLY . . . -105.63 4.3 30.08 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.078 175.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.431 ' HB2' HG13 ' A' ' 50' ' ' ILE . 3.1 tppp? -60.89 -46.58 90.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.458 -177.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -90.59 20.82 4.34 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.329 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.79 16.43 78.04 Favored Glycine 0 C--N 1.32 -0.315 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.688 175.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -83.88 -55.24 4.35 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.787 -0.206 . . . . 0.0 111.51 -177.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.54 33.62 55.66 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.375 -0.917 . . . . 0.0 111.542 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.609 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -99.58 161.61 13.51 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.652 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.7 OUTLIER -120.8 138.84 49.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.906 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.8 t -137.61 136.9 37.96 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.485 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -70.33 117.55 12.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.872 -179.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 52.37 65.54 1.48 Allowed 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.655 0.597 . . . . 0.0 110.295 -175.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -61.0 -40.63 98.76 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.785 -173.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.63 -20.26 47.89 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.803 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.516 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 9.6 mm-40 -68.75 150.19 48.16 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 174.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -82.22 114.1 48.61 Favored Pre-proline 0 N--CA 1.437 -1.078 0 CA-C-O 121.289 0.566 . . . . 0.0 110.844 177.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.516 ' HD3' ' O ' ' A' ' 83' ' ' GLU . 13.2 Cg_exo -68.75 129.61 19.02 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.108 2.539 . . . . 0.0 111.57 174.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -66.47 -32.1 73.26 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 173.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.547 ' HB ' ' CD1' ' A' ' 117' ' ' ILE . 15.6 m -140.7 131.66 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.39 175.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.658 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 59.5 m -111.81 130.07 55.93 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.261 177.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 1.652 ' HE2' ' CE1' ' A' ' 89' ' ' PHE . 58.7 m-85 -109.88 125.03 52.36 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 177.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.489 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 12.4 m -104.27 125.82 50.86 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 174.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -157.25 152.8 7.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 123.523 0.514 . . . . 0.0 109.708 -175.96 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.7 m -85.47 148.0 26.19 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.983 -176.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -50.32 -27.47 6.25 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.067 -0.969 . . . . 0.0 111.118 177.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -74.95 -47.43 29.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.976 -177.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -79.99 -26.37 39.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.547 -173.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.527 ' O ' HG13 ' A' ' 100' ' ' ILE . 0.4 OUTLIER -55.2 -33.32 30.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.273 -174.509 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.1 m -69.46 -31.17 48.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.481 -169.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -82.95 -32.33 27.19 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 76.4 mt -65.37 -49.54 68.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.837 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.527 HG13 ' O ' ' A' ' 96' ' ' VAL . 18.7 mt -75.45 -21.35 16.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.6 -174.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.3 t -84.5 -26.19 28.3 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.019 0.438 . . . . 0.0 110.798 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.2 21.54 15.07 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.866 -176.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -97.9 -41.47 8.0 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.949 0.404 . . . . 0.0 111.336 -176.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.694 HD12 ' NZ ' ' A' ' 108' ' ' LYS . 37.0 tp -101.86 127.01 48.87 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.721 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -68.76 122.0 83.31 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.249 176.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -67.99 -21.21 43.69 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.067 1.845 . . . . 0.0 110.033 176.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -64.01 -56.28 16.18 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.685 175.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.694 ' NZ ' HD12 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -64.83 -37.37 87.39 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.78 178.186 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.554 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -67.25 -33.66 75.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.023 0.44 . . . . 0.0 109.956 -178.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 1.615 ' HE1' ' CE2' ' A' ' 110' ' ' PHE . 46.0 t80 -61.17 -50.78 71.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.052 175.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 1.651 ' HD2' ' CD1' ' A' ' 111' ' ' PHE . 73.8 t80 -61.87 -40.16 94.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.843 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -76.26 6.96 4.74 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.993 -177.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.79 6.66 82.35 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.895 175.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -79.39 -47.65 15.38 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.917 0.389 . . . . 0.0 110.585 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.524 HG13 ' CG1' ' A' ' 91' ' ' ILE . 0.2 OUTLIER -92.02 110.78 23.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.025 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.511 ' HE2' ' HA ' ' A' ' 116' ' ' LYS . 10.8 mmpt? -108.11 105.32 15.02 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.663 176.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.658 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER -123.6 129.65 74.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.322 0.582 . . . . 0.0 111.457 -173.864 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -61.99 131.03 48.31 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.692 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -78.94 88.52 1.17 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.455 -0.879 . . . . 0.0 114.061 -172.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -107.48 89.79 3.1 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 166.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -45.44 -58.38 3.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.757 -1.11 . . . . 0.0 113.113 -168.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -70.14 -22.38 77.32 Favored Glycine 0 C--N 1.321 -0.265 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.823 -170.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.469 HD12 ' HA3' ' A' ' 49' ' ' GLY . 2.2 tt -91.14 -53.86 4.19 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.012 0.434 . . . . 0.0 110.63 -176.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.478 ' HB3' HG12 ' A' ' 87' ' ' VAL . . . -74.04 -14.0 60.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.838 -175.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 16.4 mmt -72.06 -21.36 61.53 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.925 174.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.504 ' HZ1' ' HB2' ' A' ' 126' ' ' LYS . 0.1 OUTLIER -84.88 -31.06 23.93 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 174.5 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.457 ' HB2' ' O ' ' A' ' 124' ' ' ALA . 1.2 mm? -56.26 -45.38 80.08 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 167.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.548 ' O ' ' HG3' ' A' ' 131' ' ' GLN . 52.2 m -61.33 -45.3 95.02 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 113.892 -1.504 . . . . 0.0 110.814 173.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -58.07 -38.77 76.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.82 -178.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.7 mt -58.47 -46.21 87.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.344 178.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.548 ' HG3' ' O ' ' A' ' 128' ' ' THR . 0.3 OUTLIER -79.9 -18.52 50.37 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.932 179.426 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.434 ' HG2' ' O ' ' A' ' 128' ' ' THR . 34.8 mmt180 -68.98 -51.16 42.35 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.8 0.333 . . . . 0.0 110.328 174.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -65.78 -31.55 72.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.033 0.444 . . . . 0.0 110.359 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -76.9 4.46 9.82 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.689 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.53 15.69 5.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.852 0.358 . . . . 0.0 110.94 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 76.41 48.41 9.32 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.028 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -79.09 135.37 36.84 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.198 0.523 . . . . 0.0 111.129 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.5 mp -88.06 -64.46 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.002 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -101.41 154.79 18.5 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.603 -177.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 7.5 t 65.24 57.9 0.9 Allowed 'General case' 0 C--O 1.232 0.137 0 O-C-N 123.792 0.683 . . . . 0.0 109.718 -178.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.0 tp . . . . . 0 C--O 1.247 0.966 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.532 -176.22 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.772 0 N-CA-C 111.76 -0.536 . . . . 0.0 111.76 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.4 m -82.44 74.75 9.4 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.305 0.574 . . . . 0.0 110.808 -178.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.4 t -121.47 -166.96 1.44 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.526 178.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.73 151.18 51.12 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.046 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -57.69 130.96 82.25 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.694 0.759 . . . . 0.0 110.449 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -65.73 -21.27 58.68 Favored 'Trans proline' 0 C--N 1.328 -0.517 0 C-N-CA 123.84 3.027 . . . . 0.0 112.17 -174.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.618 ' HA ' ' CG ' ' A' ' 26' ' ' PHE . 8.6 mt-10 -86.17 -16.73 36.94 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.214 -178.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -84.61 -8.12 59.0 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.905 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -72.1 163.19 28.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.827 177.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.442 ' HG2' ' CG1' ' A' ' 97' ' ' VAL . 5.5 tppp? -79.34 -31.98 43.22 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 174.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.466 ' CG1' HG12 ' A' ' 96' ' ' VAL . 1.3 m -70.24 -14.88 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.85 -178.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 1.665 ' HD1' ' CD2' ' A' ' 26' ' ' PHE . 57.6 t80 -56.76 -55.2 37.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.691 0.282 . . . . 0.0 110.594 -178.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.402 ' HE2' HG21 ' A' ' 31' ' ' ILE . 0.6 OUTLIER -67.65 -40.78 84.52 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 120.765 0.317 . . . . 0.0 110.549 178.42 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 1.653 ' HE1' ' CE2' ' A' ' 28' ' ' TYR . 14.4 m-85 -61.43 -45.85 92.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.794 -178.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 64.2 mtp -75.41 -26.56 58.5 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.67 0.271 . . . . 0.0 110.99 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.419 ' HD3' ' HA ' ' A' ' 30' ' ' LYS . 24.5 mmtp -67.73 -40.15 84.22 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 121.064 -0.254 . . . . 0.0 110.687 174.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.402 HG21 ' HE2' ' A' ' 27' ' ' LYS . 10.9 pt -79.67 -23.0 12.07 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.401 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.159 177.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.9 tt -57.23 -54.25 48.96 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 172.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -44.2 -48.52 9.3 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.707 177.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -75.36 -61.18 1.99 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.511 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.79 -34.86 65.67 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -166.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 93.3 mmm -61.17 -43.04 99.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.69 0.281 . . . . 0.0 111.387 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -92.12 -27.03 17.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.158 0.504 . . . . 0.0 110.987 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -66.95 -27.38 67.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.763 -177.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -60.44 139.94 57.47 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 173.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 p -62.27 -13.95 33.73 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -174.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -97.03 -9.34 28.34 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 119.094 -0.479 . . . . 0.0 111.892 177.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.2 p30 35.49 66.26 0.35 Allowed 'General case' 0 C--N 1.348 0.54 0 CA-C-O 122.129 0.966 . . . . 0.0 110.588 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.5 mt -62.94 -12.02 22.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 113.884 -1.507 . . . . 0.0 112.014 -170.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.9 tp -64.69 -29.09 46.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.878 0.37 . . . . 0.0 111.01 -175.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -72.55 -29.04 63.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.037 -177.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -75.18 -21.48 58.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.312 0.577 . . . . 0.0 110.751 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.475 ' O ' HG23 ' A' ' 47' ' ' VAL . 13.3 p -130.06 32.02 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.701 -173.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -44.87 116.28 1.05 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.5 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.487 ' O ' ' HB1' ' A' ' 70' ' ' ALA . . . 179.86 164.27 31.87 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.878 -176.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.48 HG13 ' HB2' ' A' ' 71' ' ' LYS . 51.8 mt -97.05 127.51 49.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 117.467 0.633 . . . . 0.0 110.682 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 1.663 ' HE2' ' CE1' ' A' ' 51' ' ' TYR . 9.6 m-85 -108.95 122.48 47.32 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.671 -178.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.54 115.52 5.32 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.369 -0.92 . . . . 0.0 111.396 177.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 1.658 ' HE1' ' CE2' ' A' ' 53' ' ' PHE . 3.2 m-85 -101.61 107.41 18.66 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.253 0.549 . . . . 0.0 111.545 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -97.54 99.14 10.54 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.54 176.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.579 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 20.4 t -102.42 125.21 56.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.025 0.441 . . . . 0.0 110.73 -175.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -115.41 177.84 4.52 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.174 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.6 m120 58.72 44.51 17.11 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.015 0.436 . . . . 0.0 111.562 177.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.93 -154.68 8.18 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.936 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -36.63 -59.94 0.41 Allowed 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 124.575 3.517 . . . . 0.0 114.298 -176.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -128.46 61.99 1.47 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 177.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.55 29.17 74.35 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.211 -176.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.89 154.09 34.09 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.184 0.516 . . . . 0.0 111.173 -177.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -132.55 110.59 10.58 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.494 -177.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.41 163.18 12.55 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.429 -177.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -147.89 116.89 6.8 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.88 0.371 . . . . 0.0 110.62 -178.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 18.9 m-90 -121.2 141.09 51.18 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.273 0.558 . . . . 0.0 109.682 179.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 16.4 t -107.63 117.98 54.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.164 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.466 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 4.1 mp -93.37 99.77 10.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -87.05 99.8 12.17 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.576 -176.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.487 ' HB1' ' O ' ' A' ' 49' ' ' GLY . . . -113.54 13.97 18.9 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.175 175.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.48 ' HB2' HG13 ' A' ' 50' ' ' ILE . 17.8 tppt? -64.48 -44.82 89.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.221 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -82.13 -0.73 46.14 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.672 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.8 27.28 32.35 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.308 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -93.36 -62.67 1.32 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.687 0.279 . . . . 0.0 111.037 -178.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.54 34.26 8.04 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.15 -1.024 . . . . 0.0 111.893 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 59.0 pttt -97.86 146.27 25.6 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -177.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.7 OUTLIER -110.82 131.47 61.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.355 0.598 . . . . 0.0 109.859 178.448 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.6 t -137.97 139.23 39.6 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.984 -178.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 1.658 ' HE1' ' CE2' ' A' ' 79' ' ' TYR . 24.2 t80 -65.1 128.11 34.42 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -178.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.413 ' HB3' ' O ' ' A' ' 79' ' ' TYR . 26.0 t-20 74.92 -45.8 0.58 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.677 0.791 . . . . 0.0 111.999 -178.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.81 -43.14 0.6 Allowed Glycine 0 CA--C 1.52 0.387 0 N-CA-C 114.764 0.666 . . . . 0.0 114.764 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.58 -18.84 6.58 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.026 -175.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -82.63 157.89 23.23 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 122.602 0.361 . . . . 0.0 110.358 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -95.43 109.24 44.28 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 174.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.401 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 23.2 Cg_exo -64.72 137.18 52.87 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.034 2.489 . . . . 0.0 112.712 -177.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -68.53 -32.48 72.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.107 -0.952 . . . . 0.0 109.546 176.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.528 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 4.9 m -140.27 130.41 28.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.316 172.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.576 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 28.2 m -114.91 133.87 55.63 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.375 176.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 1.637 ' HE1' ' CE2' ' A' ' 89' ' ' PHE . 53.0 m-85 -118.18 128.71 54.97 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.539 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 5.9 m -106.4 128.34 53.97 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 174.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.579 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -159.27 149.52 7.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.172 0.51 . . . . 0.0 110.294 -175.146 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.38 143.53 36.75 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.329 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -49.01 -29.01 4.37 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 114.869 -1.059 . . . . 0.0 111.091 176.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -73.22 -44.38 59.69 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.217 -176.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -81.51 -25.74 35.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.036 -176.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.497 ' O ' HG13 ' A' ' 100' ' ' ILE . 0.5 OUTLIER -56.62 -33.92 41.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.303 -175.007 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.442 ' CG1' ' HG2' ' A' ' 24' ' ' LYS . 3.9 m -68.35 -27.94 38.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.992 -170.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -87.23 -29.86 21.37 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 177.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 77.9 mt -68.2 -46.5 70.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.799 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 96' ' ' VAL . 20.1 mt -75.1 -24.41 17.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.296 -176.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.1 p -85.48 -18.11 34.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.036 0.446 . . . . 0.0 111.022 178.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.39 13.24 58.78 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.084 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -85.39 -41.43 15.45 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.133 0.492 . . . . 0.0 111.164 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.693 HD12 ' NZ ' ' A' ' 108' ' ' LYS . 44.4 tp -99.46 125.54 45.21 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.426 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -71.99 122.23 86.74 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.561 177.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -64.87 -23.34 62.27 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.213 1.942 . . . . 0.0 110.385 176.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -54.96 -62.3 1.75 Allowed 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.935 171.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.693 ' NZ ' HD12 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -64.11 -36.06 82.81 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.314 -176.368 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.555 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -69.78 -33.64 72.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.154 -178.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -64.17 -49.89 70.3 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 175.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -58.79 -40.64 84.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.029 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -84.8 13.68 5.57 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.248 -176.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.533 ' O ' ' HE3' ' A' ' 116' ' ' LYS . . . 70.17 14.68 71.48 Favored Glycine 0 CA--C 1.519 0.293 0 CA-C-N 116.152 -0.476 . . . . 0.0 113.992 172.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.55 -43.55 11.93 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 117.115 0.458 . . . . 0.0 110.219 177.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.544 HG13 ' CG1' ' A' ' 91' ' ' ILE . 0.1 OUTLIER -89.14 114.18 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.703 176.471 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.539 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 35.2 mmtp -110.79 99.4 8.33 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.474 175.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.656 ' HB ' ' CD2' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -115.18 136.41 51.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 120.958 0.409 . . . . 0.0 110.153 179.346 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -145.87 85.74 1.7 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -175.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.528 ' HA3' ' HA ' ' A' ' 87' ' ' VAL . . . -160.63 171.81 36.85 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.928 -170.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.462 ' ND2' ' HB2' ' A' ' 123' ' ' LEU . 30.6 t30 -52.45 108.51 0.3 Allowed 'General case' 0 C--N 1.327 -0.385 0 O-C-N 124.076 0.515 . . . . 0.0 110.481 178.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.48 ' O ' ' HG3' ' A' ' 125' ' ' MET . 94.8 mmm -67.82 -28.14 67.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.311 -174.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.77 -20.47 75.92 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.405 -0.903 . . . . 0.0 111.086 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.462 ' HB2' ' ND2' ' A' ' 120' ' ' ASN . 7.0 tt -88.67 -41.28 12.7 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.877 -0.661 . . . . 0.0 109.405 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.416 ' HB3' HG12 ' A' ' 87' ' ' VAL . . . -75.18 -15.36 60.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.197 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.48 ' HG3' ' O ' ' A' ' 121' ' ' MET . 64.0 mtp -64.8 -21.22 66.73 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.739 0.304 . . . . 0.0 111.102 175.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.583 ' O ' ' HG ' ' A' ' 130' ' ' LEU . 15.8 tppt? -85.22 -32.95 22.35 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.151 -0.62 . . . . 0.0 109.423 174.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.1 mt -61.56 -40.71 95.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.055 0.455 . . . . 0.0 110.328 176.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.5 t -73.12 -13.93 61.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.799 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -88.01 -46.27 9.49 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 173.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 126' ' ' LYS . 9.7 mt -57.69 -34.17 69.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.242 -177.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -59.21 -22.24 60.72 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -177.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -67.54 -43.91 79.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.187 0.518 . . . . 0.0 109.876 177.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -82.39 -32.63 29.08 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.37 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -78.56 17.55 0.67 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.437 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -87.51 -3.37 59.0 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.002 0.43 . . . . 0.0 110.734 178.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 65.8 30.33 76.98 Favored Glycine 0 C--N 1.332 0.332 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.634 177.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 53.38 88.27 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.297 0.57 . . . . 0.0 111.401 -177.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 7.9 tp -126.27 -46.71 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.051 0.453 . . . . 0.0 110.519 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -102.47 143.78 31.75 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.415 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 22.3 t -86.98 66.15 9.29 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.096 0.474 . . . . 0.0 109.911 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.0 tp . . . . . 0 C--O 1.249 1.059 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.783 -178.595 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.703 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.3 t -72.86 -14.94 61.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.426 0.632 . . . . 0.0 109.295 174.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.7 m -151.14 -169.3 3.35 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.501 175.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.61 171.17 9.11 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 121.188 -0.529 . . . . 0.0 113.206 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -64.57 133.24 95.63 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 121.656 0.741 . . . . 0.0 111.603 -176.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.65 -38.25 62.85 Favored 'Trans proline' 0 CA--C 1.521 -0.142 0 C-N-CA 124.021 3.148 . . . . 0.0 111.947 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.45 ' HA ' ' CD1' ' A' ' 26' ' ' PHE . 35.5 tt0 -60.23 -31.33 70.08 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.713 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.35 -8.83 57.58 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.047 0.451 . . . . 0.0 111.058 -175.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 1.663 ' HD1' ' CD2' ' A' ' 23' ' ' PHE . 41.8 m-85 -80.69 153.2 28.02 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.288 -0.414 . . . . 0.0 109.941 175.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 49.3 mmtm -70.56 -29.53 66.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.646 0.736 . . . . 0.0 109.234 177.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.497 ' CG1' HG12 ' A' ' 96' ' ' VAL . 0.7 OUTLIER -68.4 -17.39 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 114.526 -1.216 . . . . 0.0 111.056 -174.897 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 1.626 ' HE2' ' CE1' ' A' ' 26' ' ' PHE . 75.3 t80 -55.51 -54.52 42.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.369 -179.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.402 ' HE2' ' CG2' ' A' ' 31' ' ' ILE . 0.5 OUTLIER -72.68 -43.7 62.76 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.56 177.363 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 1.666 ' HE1' ' CE2' ' A' ' 28' ' ' TYR . 12.9 m-85 -59.15 -46.25 88.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.416 . . . . 0.0 112.106 -175.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.432 ' CE ' HD12 ' A' ' 68' ' ' ILE . 73.4 mtp -77.53 -24.76 49.91 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.778 0.323 . . . . 0.0 110.894 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.459 ' HD3' ' HA ' ' A' ' 30' ' ' LYS . 43.0 mmtt -75.87 -31.28 59.18 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.268 177.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.402 ' CG2' ' HE2' ' A' ' 27' ' ' LYS . 13.6 pt -82.94 -27.44 8.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 173.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.8 tt -54.16 -51.83 63.06 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 168.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.54 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 9.2 tt0 -43.6 -58.03 2.86 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 114.23 -1.35 . . . . 0.0 111.296 177.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -67.81 -54.12 21.58 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.546 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.49 -37.61 65.49 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -169.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 95.0 mmm -63.34 -37.36 86.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.668 0.271 . . . . 0.0 111.654 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -90.09 -20.64 22.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.439 0.638 . . . . 0.0 110.225 177.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -69.31 -25.2 64.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.59 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -58.57 133.35 55.77 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 175.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.65 -30.12 41.56 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.752 -174.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -101.55 -5.46 25.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 119.468 -0.301 . . . . 0.0 111.538 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.401 ' C ' ' H ' ' A' ' 44' ' ' ILE . 5.3 p-10 36.11 73.67 0.08 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.718 0.77 . . . . 0.0 111.513 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 72.6 mt -64.36 -1.07 1.5 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.87 -174.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.409 HG13 ' HB2' ' A' ' 70' ' ' ALA . 4.2 tp -60.35 -25.91 35.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.699 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -79.78 -17.38 53.54 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.096 -177.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -86.58 -36.08 19.09 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.243 0.544 . . . . 0.0 110.188 177.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.421 ' O ' HG23 ' A' ' 47' ' ' VAL . 12.3 p -105.38 32.97 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.496 -178.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -53.33 109.96 0.5 Allowed 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.926 0.869 . . . . 0.0 111.523 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.519 ' O ' ' HB1' ' A' ' 70' ' ' ALA . . . -173.1 175.01 46.07 Favored Glycine 0 C--N 1.312 -0.788 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.788 -175.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.422 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 42.6 mt -113.09 127.13 70.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 117.904 0.852 . . . . 0.0 111.419 -177.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 1.651 ' HD1' ' CD2' ' A' ' 51' ' ' TYR . 3.0 m-85 -109.39 129.16 55.55 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.438 -178.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -108.79 118.4 5.29 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.318 -0.944 . . . . 0.0 111.291 176.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -102.09 103.29 13.85 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.188 0.518 . . . . 0.0 111.312 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.539 ' HZ2' HG22 ' A' ' 88' ' ' THR . 58.4 mttp -89.95 99.46 12.47 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.151 174.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 18.4 t -101.78 117.09 46.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.151 -176.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 39.7 mtp180 -117.9 -179.72 3.84 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.496 -176.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.413 ' HB2' ' HB3' ' A' ' 92' ' ' SER . 92.7 m-20 59.06 46.75 12.91 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.229 0.538 . . . . 0.0 110.969 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.74 -159.0 11.07 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.529 178.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -37.5 -61.1 0.37 Allowed 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 124.324 3.349 . . . . 0.0 114.063 -174.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -130.59 68.11 1.48 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.171 0.51 . . . . 0.0 110.1 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.51 23.04 73.58 Favored Glycine 0 N--CA 1.452 -0.247 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.56 -178.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.4 167.48 20.8 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.071 0.462 . . . . 0.0 111.331 -177.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -142.5 143.81 32.7 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.462 -176.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -136.72 159.92 24.68 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 111.141 -0.783 . . . . 0.0 111.141 178.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 1.639 ' HE1' ' CE2' ' A' ' 65' ' ' TYR . 16.2 t80 -148.08 113.11 5.48 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.936 0.368 . . . . 0.0 110.719 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 18.3 m-90 -118.25 134.85 54.66 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.867 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 25.1 t -104.56 119.92 54.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.547 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.54 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 3.7 mp -95.1 100.98 11.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -86.77 97.58 10.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.221 0.534 . . . . 0.0 109.967 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.519 ' HB1' ' O ' ' A' ' 49' ' ' GLY . . . -98.56 -6.74 29.49 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.243 173.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.409 ' HB2' HG13 ' A' ' 50' ' ' ILE . 21.9 tttt -54.79 -49.4 71.02 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.898 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -80.13 3.48 20.38 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.008 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.14 11.83 83.13 Favored Glycine 0 N--CA 1.452 -0.274 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.956 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -83.26 -59.64 2.4 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.739 0.304 . . . . 0.0 110.803 -177.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.35 34.08 24.04 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.223 -0.989 . . . . 0.0 110.65 -173.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.54 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 14.8 ptmm? -98.03 145.68 26.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.427 -0.387 . . . . 0.0 109.969 -175.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.8 OUTLIER -111.91 132.9 59.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.234 0.54 . . . . 0.0 109.644 178.812 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.0 t -139.36 135.58 33.86 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.918 -176.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 1.667 ' HE1' ' CE2' ' A' ' 79' ' ' TYR . 21.9 t80 -69.89 122.08 18.58 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 53.66 71.59 0.5 Allowed 'General case' 0 C--O 1.234 0.247 0 O-C-N 123.699 0.624 . . . . 0.0 109.83 -173.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -63.12 -34.48 90.07 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.259 -0.882 . . . . 0.0 113.656 -172.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.92 -2.28 87.77 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.526 -176.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.444 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 54.6 mm-40 -91.58 163.25 14.2 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -94.55 107.64 31.43 Favored Pre-proline 0 N--CA 1.445 -0.688 0 CA-C-O 121.281 0.562 . . . . 0.0 110.331 173.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 83' ' ' GLU . 8.1 Cg_exo -73.79 121.86 7.33 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.657 2.238 . . . . 0.0 112.048 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -59.59 -43.41 93.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.863 176.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.438 HG12 ' HB3' ' A' ' 124' ' ' ALA . 13.5 m -126.32 127.61 70.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.601 176.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.727 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 43.1 m -117.35 129.42 55.86 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.087 178.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 1.652 ' HE2' ' CE1' ' A' ' 89' ' ' PHE . 61.7 m-85 -110.52 130.06 55.65 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.545 ' HB ' ' HB3' ' A' ' 116' ' ' LYS . 2.9 m -108.29 107.13 17.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.763 0.316 . . . . 0.0 110.249 178.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 47.2 mt -131.23 156.75 42.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.537 -174.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.432 ' N ' HG23 ' A' ' 91' ' ' ILE . 23.7 m -92.7 140.72 29.24 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.355 175.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -43.29 -51.12 6.43 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.46 0.648 . . . . 0.0 111.66 -177.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.16 -35.61 69.75 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.441 -1.254 . . . . 0.0 112.205 -176.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.417 ' OD2' ' HB2' ' A' ' 92' ' ' SER . 12.0 m-20 -90.4 -23.13 21.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.697 0.284 . . . . 0.0 111.252 -175.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.497 HG12 ' CG1' ' A' ' 25' ' ' VAL . 0.4 OUTLIER -59.02 -31.84 46.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.034 0.445 . . . . 0.0 110.434 -177.857 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.7 m -67.03 -30.9 51.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.182 -172.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -83.14 -32.37 26.71 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.426 HD21 ' O ' ' A' ' 104' ' ' LEU . 75.7 mt -66.48 -51.24 58.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.472 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 96' ' ' VAL . 17.7 mt -70.97 -26.25 27.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.082 -176.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.6 t -82.04 -15.2 54.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.702 0.286 . . . . 0.0 111.059 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.23 20.49 48.88 Favored Glycine 0 N--CA 1.454 -0.16 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.005 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -96.9 -41.56 8.36 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.142 0.496 . . . . 0.0 111.023 -178.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.426 ' O ' HD21 ' A' ' 99' ' ' LEU . 34.1 tp -100.3 125.24 46.49 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.385 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.434 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 12.1 m120 -69.67 122.5 85.99 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.252 177.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -65.81 -21.6 57.75 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.015 1.81 . . . . 0.0 110.843 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 tm0? -65.79 -56.86 9.75 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.722 175.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.504 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -64.99 -32.35 74.03 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.435 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.504 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -66.8 -39.49 87.78 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.9 177.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 1.61 ' HE1' ' CE2' ' A' ' 110' ' ' PHE . 53.6 t80 -57.16 -52.95 63.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.879 175.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 1.649 ' HD2' ' CD1' ' A' ' 111' ' ' PHE . 78.6 t80 -60.75 -42.83 98.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.53 -178.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.411 ' OE1' ' HA ' ' A' ' 112' ' ' GLN . 16.0 mm-40 -75.78 -11.54 60.01 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.025 -175.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.26 7.71 55.78 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.767 176.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.2 mmpt? -87.17 -14.24 41.73 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.99 0.424 . . . . 0.0 110.728 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.503 HG22 HG23 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -129.55 109.48 18.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.926 0.87 . . . . 0.0 110.251 179.164 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.545 ' HB3' ' HB ' ' A' ' 90' ' ' THR . 38.1 tptt -109.35 110.24 21.34 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.331 173.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.727 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER -125.65 131.43 72.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.411 0.624 . . . . 0.0 111.604 -172.083 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -67.97 121.26 15.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.324 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -70.85 90.11 0.4 Allowed Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 114.479 0.552 . . . . 0.0 114.479 -169.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.46 89.63 3.15 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 165.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.554 ' O ' ' HG3' ' A' ' 125' ' ' MET . 92.9 mmm -60.51 -46.65 89.35 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.197 -168.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.02 -26.14 73.3 Favored Glycine 0 CA--C 1.511 -0.21 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.164 -171.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.2 tt -90.46 -40.37 12.07 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.987 0.422 . . . . 0.0 110.617 -176.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.438 ' HB3' HG12 ' A' ' 87' ' ' VAL . . . -79.14 -13.76 59.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.204 -177.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.554 ' HG3' ' O ' ' A' ' 121' ' ' MET . 50.1 mtt -60.63 -35.11 75.37 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.975 0.417 . . . . 0.0 110.198 173.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.405 ' HB2' HG21 ' A' ' 47' ' ' VAL . 15.3 mttm -76.43 -16.63 59.65 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.587 179.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.6 mt -80.14 -41.78 24.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.935 176.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.521 ' O ' ' HG2' ' A' ' 131' ' ' GLN . 3.2 t -75.32 -17.48 60.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.537 0.684 . . . . 0.0 109.432 177.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -64.48 -41.85 96.24 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.123 171.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.84 -46.68 87.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.754 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.521 ' HG2' ' O ' ' A' ' 128' ' ' THR . 18.1 pt20 -66.58 -24.27 66.32 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 121.216 -0.194 . . . . 0.0 111.326 -175.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -65.26 -47.17 77.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.21 0.529 . . . . 0.0 109.693 176.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -69.25 -33.52 73.39 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.471 177.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.8 -35.33 80.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.152 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.1 -31.69 61.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.05 0.452 . . . . 0.0 110.748 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 101.48 -20.57 46.14 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.297 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 75.2 mtt180 -85.98 87.9 7.49 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.236 0.541 . . . . 0.0 110.187 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 16.0 tt -114.37 -27.92 2.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.546 176.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.75 169.69 8.84 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.141 -172.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.0 m -113.81 92.69 4.07 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.948 0.404 . . . . 0.0 110.853 -177.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.1 tp . . . . . 0 C--O 1.249 1.06 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.122 176.785 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.67 0 N-CA-C 111.898 -0.481 . . . . 0.0 111.898 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.8 m -76.42 81.38 3.14 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.282 0.563 . . . . 0.0 110.676 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 63.0 m -97.2 138.91 33.96 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.793 -178.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.02 160.66 34.42 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.591 176.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -54.53 135.65 62.7 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 122.03 0.919 . . . . 0.0 112.023 -176.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.545 ' HA ' ' CD1' ' A' ' 23' ' ' PHE . 20.6 Cg_endo -63.65 -14.21 41.33 Favored 'Trans proline' 0 C--N 1.334 -0.189 0 C-N-CA 124.35 3.367 . . . . 0.0 112.864 -177.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -75.52 -20.44 58.72 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.345 -178.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -88.32 -10.93 47.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.371 -0.832 . . . . 0.0 111.175 -176.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 1.662 ' HD2' ' CD1' ' A' ' 23' ' ' PHE . 18.0 m-85 -69.08 158.65 34.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.671 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -77.05 -27.0 54.26 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 174.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.501 ' HB ' ' SD ' ' A' ' 29' ' ' MET . 0.8 OUTLIER -72.04 -13.69 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.365 -179.06 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -57.02 -57.53 12.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.757 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.526 ' HZ1' HG22 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -72.0 -30.54 65.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.708 -178.449 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.44 ' O ' HG12 ' A' ' 31' ' ' ILE . 21.4 m-85 -70.92 -52.11 21.98 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.588 0.218 . . . . 0.0 111.588 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.501 ' SD ' ' HB ' ' A' ' 25' ' ' VAL . 0.1 OUTLIER -61.9 -31.14 71.41 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.734 0.302 . . . . 0.0 110.971 177.196 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.411 ' HA ' ' HD2' ' A' ' 30' ' ' LYS . 25.7 mmmt -69.3 -33.47 73.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.546 178.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.526 HG22 ' HZ1' ' A' ' 27' ' ' LYS . 13.3 pt -88.1 -24.37 6.2 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.451 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.2 176.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.5 tt -58.02 -47.22 83.74 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 171.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.595 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 6.8 tt0 -46.21 -50.9 15.24 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.489 175.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -75.0 -58.87 3.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.45 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.02 -40.17 66.78 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -167.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 95.6 mmm -60.6 -41.29 94.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.702 0.287 . . . . 0.0 111.493 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -90.79 -26.02 19.66 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.969 0.414 . . . . 0.0 110.072 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -65.04 -17.11 64.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.57 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -57.62 130.28 45.66 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.381 172.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 22.3 p -65.31 -21.92 66.77 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.952 -173.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -101.09 0.07 37.19 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.832 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 26.19 68.53 0.05 Allowed 'General case' 0 N--CA 1.472 0.63 0 O-C-N 124.481 1.113 . . . . 0.0 112.678 -177.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.4 mt -65.09 -4.12 4.48 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.201 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.9 tp -60.51 -26.33 37.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.748 178.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -72.65 -23.19 60.87 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.188 -178.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -79.23 -43.64 23.39 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.361 0.6 . . . . 0.0 110.535 178.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.451 ' O ' HG23 ' A' ' 47' ' ' VAL . 15.0 p -102.67 32.51 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.719 -176.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 41.8 mtm180 -51.2 117.14 2.39 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.633 0.73 . . . . 0.0 111.427 178.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.457 ' O ' ' HB1' ' A' ' 70' ' ' ALA . . . -172.89 176.28 45.73 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.616 -176.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.405 HD13 ' HD2' ' A' ' 71' ' ' LYS . 53.8 mt -115.17 124.42 71.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 117.669 0.734 . . . . 0.0 111.358 -178.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 1.669 ' HE1' ' CE2' ' A' ' 51' ' ' TYR . 27.7 m-85 -106.09 118.46 36.68 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.051 -177.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.49 111.51 4.18 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.322 177.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.404 ' O ' ' HA ' ' A' ' 65' ' ' TYR . 4.0 m-85 -96.27 111.14 23.31 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.955 0.407 . . . . 0.0 111.679 -178.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -95.47 105.42 17.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.34 173.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 22.6 t -105.83 107.39 22.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 120.972 0.415 . . . . 0.0 111.099 -174.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.427 ' HD2' ' N ' ' A' ' 56' ' ' ARG . 1.3 mpt_? -92.48 -179.64 5.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.628 176.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 13.8 m120 58.87 44.74 16.29 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.8 176.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -81.15 -165.02 33.42 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.33 176.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -35.6 -60.93 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 124.619 3.546 . . . . 0.0 114.696 -176.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.463 ' OD1' ' HB1' ' A' ' 62' ' ' ALA . 25.4 p-10 -114.22 43.51 1.86 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.353 0.596 . . . . 0.0 110.328 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.83 24.16 76.55 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 -170.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.463 ' HB1' ' OD1' ' A' ' 60' ' ' ASN . . . -70.7 155.53 40.64 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 114.511 -0.845 . . . . 0.0 111.754 -175.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -115.59 139.27 50.25 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.666 177.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -129.42 152.76 19.63 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 176.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.404 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 44.7 t80 -140.1 116.93 10.97 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.869 0.366 . . . . 0.0 110.656 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 26.9 m-90 -122.72 132.41 54.23 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.278 -178.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 55.4 t -102.76 112.22 35.34 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.201 178.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.501 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 4.3 mp -89.92 102.92 13.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.155 -0.684 . . . . 0.0 109.155 176.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.406 ' OD1' ' HB3' ' A' ' 71' ' ' LYS . 44.1 t-20 -85.59 96.94 9.82 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.868 -178.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.457 ' HB1' ' O ' ' A' ' 49' ' ' GLY . . . -99.89 -2.18 35.46 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.829 173.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.406 ' HB3' ' OD1' ' A' ' 69' ' ' ASN . 65.4 tttt -51.4 -50.77 58.98 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.15 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -84.0 -3.54 58.08 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.143 -176.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.19 7.49 76.82 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.254 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.7 tppt? -83.3 -44.76 14.56 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-O 120.884 0.373 . . . . 0.0 110.652 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.07 35.07 35.62 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.756 175.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.595 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -97.0 165.34 12.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.113 0.456 . . . . 0.0 110.085 -177.178 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.8 OUTLIER -123.02 136.89 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-O 121.177 0.513 . . . . 0.0 109.627 178.672 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.1 t -135.28 136.01 41.3 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.041 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 1.63 ' HD2' ' CD1' ' A' ' 79' ' ' TYR . 37.2 t80 -69.85 116.73 10.57 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -178.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 60.3 t30 52.76 74.08 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.836 0.71 . . . . 0.0 110.093 -173.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -63.59 -28.5 72.59 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.385 -0.825 . . . . 0.0 113.152 -177.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.61 -20.26 42.7 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.846 -0.692 . . . . 0.0 111.657 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.42 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 69.2 mm-40 -73.02 156.02 39.21 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 177.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.447 ' HB3' ' HZ3' ' A' ' 84' ' ' LYS . 3.0 mmmp? -91.84 108.2 28.12 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 173.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 83' ' ' GLU . 22.1 Cg_exo -65.36 135.45 42.94 Favored 'Trans proline' 0 CA--C 1.517 -0.361 0 C-N-CA 122.95 2.433 . . . . 0.0 112.369 -176.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -62.69 -30.4 71.37 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.776 176.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.505 HG12 ' HB3' ' A' ' 124' ' ' ALA . 3.5 m -142.63 134.74 25.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.771 176.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.65 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 17.4 m -113.37 141.06 47.5 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.275 -0.421 . . . . 0.0 109.938 177.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.646 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 29.6 m-85 -126.21 134.6 51.19 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 176.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.7 m -111.14 118.64 36.53 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.899 0.381 . . . . 0.0 110.528 176.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.524 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 80.4 mt -141.51 157.2 21.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.484 -0.78 . . . . 0.0 108.933 -175.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.421 ' OG ' ' HE3' ' A' ' 114' ' ' LYS . 6.1 p -93.02 144.81 24.88 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 111.496 0.184 . . . . 0.0 111.496 176.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -41.18 -56.23 2.43 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 122.172 0.987 . . . . 0.0 111.714 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -60.26 -34.04 73.16 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 113.272 -1.785 . . . . 0.0 112.621 -171.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.68 -19.43 22.66 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -177.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.573 ' O ' HG13 ' A' ' 100' ' ' ILE . 0.5 OUTLIER -56.52 -34.13 40.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.21 0.529 . . . . 0.0 110.026 -178.958 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.3 m -66.36 -28.97 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.031 -173.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -84.69 -35.5 22.52 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.44 HD21 ' O ' ' A' ' 104' ' ' LEU . 74.8 mt -68.76 -42.25 77.76 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.96 -177.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.573 HG13 ' O ' ' A' ' 96' ' ' VAL . 15.4 mt -76.27 -22.54 15.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.808 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.2 t -88.58 -19.69 25.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.966 0.412 . . . . 0.0 110.776 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.32 0.11 65.57 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.831 -177.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -67.85 -42.11 81.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.027 0.441 . . . . 0.0 110.791 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.44 ' O ' HD21 ' A' ' 99' ' ' LEU . 36.8 tp -104.38 126.38 51.43 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.873 178.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.423 ' HB3' ' HG2' ' A' ' 108' ' ' LYS . 1.8 t-20 -72.97 121.41 85.02 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.828 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -65.68 -20.7 59.44 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.932 1.755 . . . . 0.0 110.775 177.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.11 -55.82 8.47 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.749 174.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.535 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 0.4 OUTLIER -62.06 -35.71 79.45 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.457 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.535 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -68.53 -35.58 77.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.33 177.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 1.654 ' HD2' ' CD1' ' A' ' 110' ' ' PHE . 27.8 t80 -59.85 -49.05 79.24 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 175.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 1.627 ' HD2' ' CD1' ' A' ' 111' ' ' PHE . 70.9 t80 -64.87 -33.53 76.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.93 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.522 ' HA ' HE21 ' A' ' 112' ' ' GLN . 0.0 OUTLIER -87.49 10.42 17.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.751 -178.168 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.37 1.76 82.34 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 121.285 -0.483 . . . . 0.0 113.661 172.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.551 ' NZ ' ' HB3' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -94.02 11.33 30.13 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -177.081 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.519 HG22 HG23 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -140.95 109.56 2.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-O 121.976 0.893 . . . . 0.0 109.19 172.551 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -109.0 98.45 7.93 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.744 -1.117 . . . . 0.0 109.274 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.65 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER -114.27 125.02 71.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.845 178.597 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -138.46 91.22 2.53 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -174.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.483 ' HA3' ' CG1' ' A' ' 87' ' ' VAL . . . -160.98 172.81 37.34 Favored Glycine 0 N--CA 1.438 -1.202 0 C-N-CA 120.403 -0.903 . . . . 0.0 113.166 -170.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -48.95 110.76 0.39 Allowed 'General case' 0 C--N 1.328 -0.335 0 O-C-N 124.248 0.617 . . . . 0.0 110.5 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -63.43 -33.17 74.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.952 -175.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -71.95 -20.59 78.94 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.684 -0.77 . . . . 0.0 111.488 -177.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.2 tt -90.5 -46.81 8.09 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.505 ' HB3' HG12 ' A' ' 87' ' ' VAL . . . -72.99 -17.36 61.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.581 -177.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -68.36 -21.1 64.74 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.549 -0.461 . . . . 0.0 110.621 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 11.5 mttp -69.16 -25.0 64.15 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.882 0.372 . . . . 0.0 110.744 175.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.4 mt -68.81 -23.71 64.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.482 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.44 ' O ' ' HG2' ' A' ' 131' ' ' GLN . 27.8 p -82.25 -22.94 35.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.186 0.517 . . . . 0.0 110.71 -178.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.572 ' O ' ' HG2' ' A' ' 133' ' ' GLN . 30.0 t70 -55.08 -42.53 72.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.38 -176.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -54.78 -35.74 64.16 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.272 -176.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.44 ' HG2' ' O ' ' A' ' 128' ' ' THR . 20.3 pt20 -91.1 -31.08 16.39 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -177.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.513 ' CG ' ' HA ' ' A' ' 129' ' ' ASP . 0.1 OUTLIER -71.69 -36.49 70.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.844 0.354 . . . . 0.0 110.677 179.847 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.572 ' HG2' ' O ' ' A' ' 129' ' ' ASP . 7.9 pt20 -73.48 -26.85 61.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.975 175.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.79 -39.87 87.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.08 176.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.89 -55.19 11.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.288 176.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 108.73 -11.91 35.29 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.199 175.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 61.24 90.43 0.07 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.131 0.491 . . . . 0.0 110.938 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.63 -35.92 8.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.173 0.511 . . . . 0.0 109.918 178.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.413 ' C ' ' HG ' ' A' ' 140' ' ' SER . 31.2 tt0 -100.33 132.77 45.52 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.019 -174.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.413 ' HG ' ' C ' ' A' ' 139' ' ' GLU . 94.8 p 57.45 -178.51 0.06 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.264 1.026 . . . . 0.0 112.609 176.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 18.8 pt . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.114 -0.946 . . . . 0.0 110.161 174.952 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.733 0 N-CA-C 111.865 -0.494 . . . . 0.0 111.865 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.6 m -107.23 -54.45 2.47 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.99 0.424 . . . . 0.0 110.26 178.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.2 p -162.17 107.53 1.24 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.289 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.85 155.28 34.43 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.927 175.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.439 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 15.1 m120 -58.79 144.84 80.15 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-O 121.152 0.501 . . . . 0.0 111.003 -178.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 19' ' ' ASN . 23.8 Cg_exo -58.98 -31.08 95.01 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 123.413 2.742 . . . . 0.0 111.529 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.484 ' HA ' ' CD1' ' A' ' 26' ' ' PHE . 24.5 tt0 -62.47 -35.44 79.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.254 176.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -81.25 1.54 31.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.96 -174.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -77.95 153.86 32.11 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 173.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -76.81 -24.27 52.8 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.498 ' CG1' HG12 ' A' ' 96' ' ' VAL . 1.3 m -73.84 -14.84 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.038 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 1.642 ' HD1' ' CD2' ' A' ' 26' ' ' PHE . 83.1 t80 -56.75 -50.25 72.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.718 0.294 . . . . 0.0 110.372 -176.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.61 -44.32 86.87 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.582 178.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 1.629 ' HD2' ' CD1' ' A' ' 28' ' ' TYR . 52.0 m-85 -62.47 -46.7 87.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.866 -177.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.435 ' HB3' HG23 ' A' ' 77' ' ' VAL . 56.2 mtt -73.88 -26.69 60.69 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.059 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.422 ' HD3' ' HA ' ' A' ' 30' ' ' LYS . 40.8 mmtt -71.15 -38.9 72.22 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.19 176.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 13.6 pt -78.04 -25.17 14.18 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.427 0 C-N-CA 120.329 -0.548 . . . . 0.0 109.793 175.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.3 tt -60.3 -52.76 63.91 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 173.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.503 ' HG2' ' HA ' ' A' ' 76' ' ' LYS . 1.5 tm-20 -43.37 -48.05 6.92 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 114.814 -1.084 . . . . 0.0 111.018 176.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -77.19 -53.29 7.93 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.933 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.52 -38.9 82.18 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -168.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 25.9 mmt -60.01 -40.76 90.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.713 0.292 . . . . 0.0 111.624 -178.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -91.39 -19.52 22.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.099 0.476 . . . . 0.0 111.138 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -66.38 -23.5 66.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.247 0.546 . . . . 0.0 110.028 178.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -62.14 133.81 55.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.441 173.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.8 p -62.84 -32.88 74.19 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.037 -174.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -92.06 0.66 57.47 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-O 119.303 -0.379 . . . . 0.0 111.385 178.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.6 p30 34.11 63.32 0.42 Allowed 'General case' 0 N--CA 1.468 0.433 0 O-C-N 124.172 0.92 . . . . 0.0 110.557 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.5 mt -56.97 -12.12 1.84 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 114.427 -1.26 . . . . 0.0 112.056 -173.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.2 tp -61.48 -30.99 49.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.81 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.492 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 9.6 tt0 -75.2 -27.03 59.44 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.12 0.486 . . . . 0.0 110.909 -176.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -73.37 -15.92 61.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.592 -179.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.496 ' O ' HG23 ' A' ' 47' ' ' VAL . 15.0 p -131.07 31.84 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.276 -178.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.492 ' HG3' ' O ' ' A' ' 45' ' ' GLU . 59.7 mtm180 -49.21 109.44 0.26 Allowed 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.942 0.877 . . . . 0.0 112.647 -176.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.503 ' O ' ' HB1' ' A' ' 70' ' ' ALA . . . -159.6 170.75 35.89 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 113.88 -1.509 . . . . 0.0 110.493 -178.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.441 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 54.6 mt -106.47 125.45 62.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 117.416 0.608 . . . . 0.0 110.749 179.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 1.641 ' HE2' ' CE1' ' A' ' 51' ' ' TYR . 16.5 m-85 -107.75 116.26 31.63 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.95 -178.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -97.76 111.72 4.31 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.024 177.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -101.32 104.52 15.53 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.061 0.457 . . . . 0.0 111.488 -178.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -91.95 101.51 14.07 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.449 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 10.4 t -100.98 118.21 47.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.888 -173.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.436 ' O ' ' HA ' ' A' ' 92' ' ' SER . 50.4 mtp180 -110.28 177.66 4.63 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.686 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.423 ' HB2' ' HB3' ' A' ' 92' ' ' SER . 3.3 m-20 57.91 41.7 24.19 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.954 0.407 . . . . 0.0 110.979 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -74.08 -153.28 2.91 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.603 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -32.18 -60.14 0.19 Allowed 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 124.499 3.466 . . . . 0.0 114.233 -177.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -141.51 70.37 1.34 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.045 0.45 . . . . 0.0 109.891 176.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.81 18.15 78.71 Favored Glycine 0 N--CA 1.453 -0.176 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.702 -177.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.58 162.22 26.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.011 0.434 . . . . 0.0 111.246 -177.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -136.25 132.3 35.62 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.788 -177.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -131.98 162.4 23.88 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.453 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 1.673 ' HE1' ' CE2' ' A' ' 65' ' ' TYR . 15.5 t80 -146.56 113.7 6.21 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.829 0.347 . . . . 0.0 110.917 -177.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 16.3 m-90 -113.45 140.21 48.28 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.867 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 45.7 t -106.97 114.53 46.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.902 177.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.548 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 3.9 mp -91.04 99.67 10.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 175.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -87.54 99.03 11.74 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.247 -177.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.503 ' HB1' ' O ' ' A' ' 49' ' ' GLY . . . -101.18 -6.7 23.91 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.892 174.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.41 ' HB2' ' HE3' ' A' ' 71' ' ' LYS . 3.6 tppp? -58.76 -47.53 84.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.996 -176.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -73.52 -6.32 45.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.203 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 94.88 14.35 49.73 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.033 -0.603 . . . . 0.0 111.727 -178.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.475 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 9.1 mmpt? -86.32 -70.05 0.63 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.718 0.294 . . . . 0.0 111.112 -177.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.83 32.16 13.56 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -170.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.548 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 21.8 ptmt -99.16 147.21 25.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.234 -0.483 . . . . 0.0 109.948 -177.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.435 HG23 ' HB3' ' A' ' 29' ' ' MET . 0.6 OUTLIER -107.51 127.34 63.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 176.868 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.2 t -130.71 127.68 39.31 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.473 -178.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 1.654 ' HE1' ' CE2' ' A' ' 79' ' ' TYR . 62.5 t80 -67.59 122.5 18.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.96 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 56.3 t30 54.62 72.61 0.45 Allowed 'General case' 0 C--O 1.233 0.235 0 O-C-N 123.786 0.679 . . . . 0.0 109.928 -174.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.85 -40.34 64.1 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.948 -175.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.14 -20.52 45.51 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.974 -0.632 . . . . 0.0 111.641 -176.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.512 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 40.4 mm-40 -74.08 148.2 42.08 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.646 -0.277 . . . . 0.0 110.295 178.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -80.08 109.38 12.15 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-O 121.202 0.525 . . . . 0.0 110.915 176.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 83' ' ' GLU . 17.9 Cg_exo -67.6 136.25 38.7 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.847 2.365 . . . . 0.0 112.566 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.453 ' HB2' HD23 ' A' ' 123' ' ' LEU . 11.8 m-20 -69.93 -31.6 69.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.701 175.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.47 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 4.5 m -140.68 127.53 21.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.604 173.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.575 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 64.2 m -110.96 127.39 55.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.342 176.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.546 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 83.0 m-85 -113.6 120.36 40.66 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 177.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.457 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 5.0 m -96.6 122.21 39.28 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 175.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.564 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -155.64 155.95 5.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.05 0.452 . . . . 0.0 110.794 -172.891 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 56' ' ' ARG . 13.3 m -83.75 143.2 30.15 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.322 -177.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -53.66 -27.73 29.2 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.226 1.011 . . . . 0.0 110.908 178.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -77.14 -38.12 52.58 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.436 -178.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -90.78 -22.17 21.16 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.763 -173.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.498 HG12 ' CG1' ' A' ' 25' ' ' VAL . 0.4 OUTLIER -57.31 -32.47 41.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.12 0.486 . . . . 0.0 110.383 -178.133 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.6 m -68.82 -32.62 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.739 -172.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -77.72 -35.69 51.72 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 177.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.437 HD21 ' O ' ' A' ' 104' ' ' LEU . 84.7 mt -65.92 -48.67 70.66 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.761 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 96' ' ' VAL . 29.9 mt -70.84 -29.9 39.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.112 -177.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.7 t -78.09 -30.15 49.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.865 178.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 102.5 11.96 34.35 Favored Glycine 0 CA--C 1.516 0.105 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.672 -176.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -84.01 -41.63 17.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.096 0.474 . . . . 0.0 110.82 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.437 ' O ' HD21 ' A' ' 99' ' ' LEU . 43.2 tp -102.95 123.85 47.35 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.981 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.441 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 6.1 m-20 -73.52 117.95 64.91 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.287 178.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -60.13 -22.45 69.93 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.009 1.806 . . . . 0.0 111.214 176.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.439 ' HB2' ' OE1' ' A' ' 131' ' ' GLN . 5.5 tt0 -64.35 -55.44 21.18 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.002 173.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.483 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 0.7 OUTLIER -66.83 -31.54 72.22 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.767 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.483 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -70.61 -32.65 70.07 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.085 0.469 . . . . 0.0 109.945 177.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -65.83 -46.6 77.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.331 174.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 1.647 ' HE2' ' CE1' ' A' ' 111' ' ' PHE . 81.0 t80 -63.16 -44.48 95.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.205 178.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.484 ' HA ' ' OE1' ' A' ' 112' ' ' GLN . 14.5 mm-40 -79.63 2.24 23.23 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -176.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.31 6.75 89.08 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.774 171.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.09 -37.79 37.87 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.031 0.443 . . . . 0.0 110.767 177.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.546 HG13 ' CG1' ' A' ' 91' ' ' ILE . 0.1 OUTLIER -93.13 117.27 36.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.942 178.736 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.457 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 23.9 mmmt -109.31 99.13 8.44 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.575 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER -123.57 136.46 60.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.081 0.467 . . . . 0.0 110.521 -177.93 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -147.14 81.73 1.54 Allowed 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -175.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.47 ' HA3' ' HA ' ' A' ' 87' ' ' VAL . . . -154.56 171.86 33.02 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 120.406 -0.902 . . . . 0.0 113.482 -169.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -51.59 112.88 0.83 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.446 0.698 . . . . 0.0 110.849 -178.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -66.5 -29.94 70.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.735 -176.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -70.56 -14.12 71.97 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.563 -178.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.453 HD23 ' HB2' ' A' ' 86' ' ' ASP . 3.5 tp -92.61 -51.15 5.25 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.789 0.804 . . . . 0.0 109.365 176.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.97 -12.39 61.51 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.869 -1.059 . . . . 0.0 111.253 -174.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 27.7 ptm -61.81 -24.12 66.66 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.842 0.353 . . . . 0.0 110.646 175.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 52.9 mmtt -83.44 -20.18 34.56 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 120.999 0.428 . . . . 0.0 110.597 177.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.9 mt -83.81 -41.75 17.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.964 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.561 ' O ' ' HG3' ' A' ' 132' ' ' ARG . 15.2 t -66.84 -22.16 66.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.348 0.594 . . . . 0.0 109.986 177.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -59.58 -47.28 86.18 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.705 175.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.9 mt -61.67 -41.92 98.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.404 -0.817 . . . . 0.0 112.06 -177.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.439 ' OE1' ' HB2' ' A' ' 107' ' ' GLN . 25.1 pt20 -67.91 -24.25 65.18 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.29 -175.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.561 ' HG3' ' O ' ' A' ' 128' ' ' THR . 65.7 mtm180 -63.84 -42.41 97.6 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 176.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -67.94 -39.45 83.45 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.746 177.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.88 -23.5 66.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.336 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.426 ' HB1' HD22 ' A' ' 105' ' ' ASN . . . -97.23 -3.81 40.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.017 0.437 . . . . 0.0 111.234 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 68.42 31.63 74.33 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.939 -177.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 18.7 tpp180 -94.65 105.91 17.87 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.952 0.406 . . . . 0.0 110.084 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 3.0 mp -68.21 -68.24 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.496 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -102.41 128.2 49.1 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.012 -178.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.553 ' OG ' ' HD2' ' A' ' 132' ' ' ARG . 12.2 m -94.26 139.01 31.59 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.764 -176.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 41.8 mm . . . . . 0 C--O 1.246 0.893 0 CA-C-O 118.568 -0.729 . . . . 0.0 109.786 -178.159 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.584 0 N-CA-C 111.771 -0.532 . . . . 0.0 111.771 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 45.8 t -102.4 -49.22 3.93 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.086 0.469 . . . . 0.0 110.362 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 52.2 m -154.46 -161.6 1.25 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.075 -176.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.07 172.32 4.39 Favored Glycine 0 CA--C 1.52 0.397 0 C-N-CA 121.31 -0.471 . . . . 0.0 112.785 175.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -55.45 150.04 25.88 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.371 0.605 . . . . 0.0 111.794 -178.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.496 ' O ' ' HB2' ' A' ' 26' ' ' PHE . 4.9 Cg_exo -67.63 -22.25 44.41 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.997 2.464 . . . . 0.0 111.025 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -65.07 -31.64 72.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.743 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -73.77 -18.69 60.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.273 -178.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 1.668 ' HE2' ' CE1' ' A' ' 23' ' ' PHE . 66.5 m-85 -77.65 142.33 38.92 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 174.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -70.38 -23.21 62.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.664 0.745 . . . . 0.0 109.16 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.484 ' CG1' HG12 ' A' ' 96' ' ' VAL . 1.0 OUTLIER -69.4 -17.36 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.002 -179.027 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 1.621 ' HD1' ' CD2' ' A' ' 26' ' ' PHE . 75.3 t80 -58.15 -44.16 87.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.258 0.552 . . . . 0.0 110.232 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.479 ' HZ1' HG22 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -77.17 -42.33 38.14 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.475 178.851 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 1.614 ' HD2' ' CD1' ' A' ' 28' ' ' TYR . 24.6 m-85 -66.56 -44.39 82.46 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -177.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.43 ' CE ' HD12 ' A' ' 68' ' ' ILE . 73.9 mtp -77.56 -20.27 54.34 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.835 0.35 . . . . 0.0 110.542 -178.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 26' ' ' PHE . 19.8 mmtt -76.4 -36.67 57.94 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.871 175.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.479 HG22 ' HZ1' ' A' ' 27' ' ' LYS . 14.1 pt -77.22 -23.87 14.79 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.354 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 174.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.4 tt -58.8 -51.66 69.02 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 171.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -45.79 -47.6 15.62 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.293 176.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -75.04 -54.5 7.05 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.54 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.6 -33.83 73.32 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -169.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.2 mmt -62.28 -39.38 92.74 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -90.96 -29.41 17.43 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.088 0.47 . . . . 0.0 110.838 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -64.61 -32.08 73.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.377 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -57.04 138.36 54.51 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.097 177.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.2 p -58.31 -24.57 60.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.027 -0.988 . . . . 0.0 113.063 -172.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -94.04 -28.42 15.75 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.8 p30 36.11 63.28 0.61 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.763 0.792 . . . . 0.0 111.181 -176.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 93.0 mt -69.52 2.75 2.85 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.859 -175.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.405 HG13 ' HB2' ' A' ' 70' ' ' ALA . 1.9 tp -56.91 -31.38 36.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.262 -177.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -76.75 -19.81 57.21 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.901 0.381 . . . . 0.0 111.164 -177.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -85.54 -35.01 21.37 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.25 0.548 . . . . 0.0 110.137 177.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.449 ' O ' HG23 ' A' ' 47' ' ' VAL . 13.2 p -108.3 32.97 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.875 0.845 . . . . 0.0 110.472 -177.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.0 mtm180 -52.66 124.41 13.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.521 0.677 . . . . 0.0 111.309 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.472 ' HA3' HD12 ' A' ' 123' ' ' LEU . . . 179.74 -174.84 46.38 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 114.524 -1.216 . . . . 0.0 110.663 -175.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 63.3 mt -123.66 125.72 71.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 117.853 0.826 . . . . 0.0 111.391 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 1.649 ' HE1' ' CE2' ' A' ' 51' ' ' TYR . 22.7 m-85 -106.09 116.02 31.23 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.788 -178.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.38 115.59 5.23 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.533 -0.842 . . . . 0.0 111.357 177.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -100.92 109.63 21.6 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.039 0.447 . . . . 0.0 111.448 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -94.35 99.34 11.57 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 172.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 18.6 t -101.03 107.35 21.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.096 0.474 . . . . 0.0 110.582 -174.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.452 ' O ' ' HA ' ' A' ' 92' ' ' SER . 35.9 mtp180 -103.18 174.36 5.9 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.087 -176.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 61.47 48.48 5.87 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.095 0.474 . . . . 0.0 111.239 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.08 -145.27 1.58 Allowed Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.245 175.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.411 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 73.8 Cg_exo -40.6 -60.91 0.53 Allowed 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.665 2.91 . . . . 0.0 113.633 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -146.94 77.48 1.46 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.311 0.576 . . . . 0.0 110.487 177.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.58 13.33 83.58 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.88 178.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.411 ' HB1' ' HD2' ' A' ' 59' ' ' PRO . . . -72.73 143.78 47.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.987 0.423 . . . . 0.0 110.823 179.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -129.53 114.46 16.12 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.13 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -107.98 168.88 14.06 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.636 -178.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -150.2 120.34 7.25 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.754 0.311 . . . . 0.0 110.765 -177.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 16.9 m-90 -123.49 149.94 44.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.976 0.417 . . . . 0.0 109.919 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 38.2 t -118.25 118.1 56.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.645 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 4.1 mp -92.56 105.45 16.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 175.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -91.15 97.47 11.16 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.514 -176.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.423 ' HB1' ' O ' ' A' ' 49' ' ' GLY . . . -98.1 -10.32 24.45 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.322 174.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.55 ' HD2' ' HG3' ' A' ' 72' ' ' GLU . 1.2 tmmt? -59.71 -34.88 73.49 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.212 -178.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.55 ' HG3' ' HD2' ' A' ' 71' ' ' LYS . 40.5 mt-10 -95.09 12.61 28.03 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.334 0.587 . . . . 0.0 111.24 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.53 -12.96 43.91 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.401 -0.818 . . . . 0.0 113.507 174.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.476 ' HB3' ' HZ3' ' A' ' 74' ' ' LYS . 2.6 mmmp? -74.11 -56.23 5.17 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.706 0.289 . . . . 0.0 111.22 -176.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.89 35.06 9.36 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.198 -1.001 . . . . 0.0 111.736 -177.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 16.3 pttm -96.89 151.43 19.69 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 -175.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.8 OUTLIER -108.22 132.3 56.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 108.984 -0.746 . . . . 0.0 108.984 177.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.3 t -136.53 134.33 37.41 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.186 -177.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 1.642 ' HE2' ' CE1' ' A' ' 79' ' ' TYR . 70.0 t80 -66.54 125.32 25.37 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.28 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 51.78 63.16 2.35 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.275 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -59.21 -40.41 95.76 Favored Glycine 0 C--N 1.33 0.224 0 CA-C-N 115.324 -0.853 . . . . 0.0 113.847 -173.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.65 -20.61 47.69 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.931 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.511 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 15.6 mm-40 -70.19 150.57 46.33 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 174.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -85.04 107.82 13.14 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 178.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 83' ' ' GLU . 16.6 Cg_exo -67.95 128.89 18.51 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.855 2.37 . . . . 0.0 112.425 -177.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -62.16 -33.43 74.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.775 175.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.549 HG13 ' O ' ' A' ' 118' ' ' GLN . 2.9 m -137.68 142.45 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.406 175.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.694 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 34.1 m -126.11 126.15 43.71 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.472 -179.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.413 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 55.0 m-85 -108.85 124.96 51.45 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.404 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 6.7 m -98.98 114.62 27.35 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 173.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.533 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 89.3 mt -137.54 150.35 25.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.811 -174.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 56' ' ' ARG . 51.1 m -90.52 137.3 32.46 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.866 176.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -43.23 -51.72 6.01 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 123.658 0.599 . . . . 0.0 111.826 -177.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.03 -41.17 67.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.374 -177.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -90.18 -18.36 25.89 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -174.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.484 HG12 ' CG1' ' A' ' 25' ' ' VAL . 0.3 OUTLIER -57.39 -31.02 37.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.078 0.466 . . . . 0.0 110.066 -178.55 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.9 m -69.29 -28.71 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.836 -174.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -79.46 -39.59 31.88 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 176.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.466 HD21 ' O ' ' A' ' 104' ' ' LEU . 86.8 mt -68.17 -41.88 80.84 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.814 -176.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 96' ' ' VAL . 19.5 mt -72.96 -25.35 21.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.35 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 10.3 t -95.75 -5.27 42.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.093 -178.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.49 15.12 76.94 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.139 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -82.22 -42.52 18.84 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.336 0.589 . . . . 0.0 110.408 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.466 ' O ' HD21 ' A' ' 99' ' ' LEU . 41.4 tp -104.76 124.18 48.95 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.867 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.462 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 17.5 m120 -71.05 116.32 45.44 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.353 178.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -60.37 -22.9 73.0 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.067 1.845 . . . . 0.0 111.301 178.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -62.15 -59.42 5.08 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.956 173.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.519 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -64.75 -33.58 76.31 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.888 -177.676 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.537 ' HB3' ' HB3' ' A' ' 114' ' ' LYS . . . -71.32 -29.9 65.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.395 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -66.31 -45.03 81.72 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 175.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 1.607 ' HD2' ' CD1' ' A' ' 111' ' ' PHE . 84.7 t80 -66.93 -37.67 84.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.363 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -82.02 -6.38 59.1 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.053 -177.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.03 15.41 61.03 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.261 175.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.537 ' HB3' ' HB3' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -81.76 -41.6 20.95 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.567 0.699 . . . . 0.0 109.266 176.671 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.517 HG22 HG21 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -104.25 126.88 58.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.601 -176.995 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.404 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 34.2 mmtp -120.58 99.63 6.66 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 174.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.694 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER -126.06 131.3 71.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.035 0.445 . . . . 0.0 111.567 -176.727 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.549 ' O ' HG13 ' A' ' 87' ' ' VAL . 22.6 mt-30 -75.3 110.7 9.86 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 174.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -78.47 89.68 1.13 Allowed Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.44 -172.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -64.58 109.71 2.08 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 170.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.498 ' O ' ' HG3' ' A' ' 125' ' ' MET . 28.1 ttt -46.43 -53.17 11.62 Favored 'General case' 0 C--O 1.224 -0.271 0 O-C-N 124.281 0.988 . . . . 0.0 112.32 -168.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -82.5 -37.79 13.63 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.035 -1.079 . . . . 0.0 112.878 -173.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.472 HD12 ' HA3' ' A' ' 49' ' ' GLY . 5.0 tt -80.59 -44.25 19.27 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.601 0.239 . . . . 0.0 111.445 -170.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.543 ' HB3' HG12 ' A' ' 87' ' ' VAL . . . -78.69 -16.0 57.8 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.654 -175.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.498 ' HG3' ' O ' ' A' ' 121' ' ' MET . 44.9 mtm -66.76 -28.46 68.42 Favored 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.39 175.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.4 mttp -65.93 -20.5 66.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.942 0.401 . . . . 0.0 110.931 177.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 68.9 mt -78.42 -24.15 46.33 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.456 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 21.4 p -79.76 -23.77 41.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.256 0.55 . . . . 0.0 110.423 -178.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -51.11 -43.95 61.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.133 177.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -59.88 -65.15 0.72 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.081 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -57.52 -36.93 72.22 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -176.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -55.94 -56.51 19.81 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.769 0.318 . . . . 0.0 111.156 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -76.54 -22.66 54.08 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.149 -178.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.37 -50.24 64.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.807 0.337 . . . . 0.0 110.808 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -77.79 -33.76 52.49 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.902 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 88.78 -31.05 5.12 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.83 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 137' ' ' ARG . 12.0 ptt180 -159.04 132.87 7.5 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 175.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 88.1 mt -122.25 -75.26 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.403 -179.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -101.84 151.44 22.08 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.578 -175.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 29.1 t -146.78 152.53 38.93 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -177.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 74.8 mt . . . . . 0 C--O 1.251 1.161 0 CA-C-O 118.414 -0.803 . . . . 0.0 110.115 179.376 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.893 0 N-CA-C 112.086 -0.406 . . . . 0.0 112.086 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.3 t -107.92 29.88 6.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.594 0.712 . . . . 0.0 110.3 -177.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.5 p -88.52 161.56 16.9 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.506 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -83.78 166.44 43.12 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.545 177.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -63.61 147.46 95.58 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-O 120.985 0.422 . . . . 0.0 110.626 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.421 ' O ' ' HB2' ' A' ' 26' ' ' PHE . 11.8 Cg_exo -64.76 -29.16 59.55 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.206 2.604 . . . . 0.0 112.005 -175.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -63.73 -34.87 78.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.544 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -70.23 -11.63 61.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.355 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 1.64 ' HE2' ' CE1' ' A' ' 23' ' ' PHE . 50.0 m-85 -81.23 143.31 32.4 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.174 0.512 . . . . 0.0 110.186 177.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -74.29 -21.11 59.89 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.569 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.507 HG12 ' OD1' ' A' ' 93' ' ' ASP . 2.5 m -75.16 -17.23 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.075 177.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 1.609 ' HE2' ' CE1' ' A' ' 26' ' ' PHE . 73.2 t80 -54.19 -57.24 11.91 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.871 0.367 . . . . 0.0 110.57 -176.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.516 ' HZ3' HG22 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -64.96 -32.68 74.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.8 -177.576 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 1.608 ' HE2' ' CE1' ' A' ' 28' ' ' TYR . 10.5 m-85 -70.59 -46.75 62.84 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.298 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.692 ' HE3' ' CE2' ' A' ' 66' ' ' TRP . 29.6 mtm -66.17 -30.51 70.99 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.833 176.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 26' ' ' PHE . 29.4 mmmt -64.63 -35.38 80.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.061 177.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.516 HG22 ' HZ3' ' A' ' 27' ' ' LYS . 9.6 pt -88.35 -16.18 8.93 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.565 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.231 176.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.3 tt -64.5 -51.42 63.02 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 168.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.529 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 6.3 tt0 -44.35 -45.51 8.86 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 114.447 -1.251 . . . . 0.0 110.865 173.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -73.16 -59.57 2.65 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.499 178.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.84 -37.23 68.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.668 -0.697 . . . . 0.0 112.769 -167.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.434 ' HB3' HD11 ' A' ' 44' ' ' ILE . 25.9 mmt -59.43 -42.76 92.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.788 -179.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -92.34 -24.15 19.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.094 0.473 . . . . 0.0 111.015 178.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -64.92 -30.02 70.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.01 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -54.64 135.96 46.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.559 0.695 . . . . 0.0 110.041 176.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 16.2 p -52.73 -38.58 61.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.257 -1.338 . . . . 0.0 112.973 -173.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -102.78 8.89 39.31 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 119.227 -0.416 . . . . 0.0 111.258 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.421 ' C ' ' H ' ' A' ' 44' ' ' ILE . 3.7 p-10 34.2 67.8 0.2 Allowed 'General case' 0 C--O 1.238 0.461 0 O-C-N 124.183 0.927 . . . . 0.0 110.752 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.402 ' O ' HG13 ' A' ' 47' ' ' VAL . 69.1 mt -62.08 -0.4 0.51 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.273 -1.33 . . . . 0.0 112.403 -171.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.434 HD11 ' HB3' ' A' ' 36' ' ' MET . 4.2 tp -63.23 -28.21 44.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.3 178.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -76.6 -10.86 59.69 Favored 'General case' 0 N--CA 1.46 0.053 0 CA-C-O 121.235 0.54 . . . . 0.0 110.645 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -100.53 -14.8 18.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.804 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.459 ' O ' HG23 ' A' ' 47' ' ' VAL . 14.6 p -131.18 33.05 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.662 0.744 . . . . 0.0 110.364 -177.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 50.8 mtt180 -51.89 109.45 0.37 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.738 0.78 . . . . 0.0 111.826 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.589 ' O ' ' HB1' ' A' ' 70' ' ' ALA . . . -167.41 167.38 39.88 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.398 -177.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.432 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 32.9 mt -105.89 125.71 61.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 118.481 1.14 . . . . 0.0 111.145 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.538 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 17.0 m-85 -104.25 122.55 45.64 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.607 -177.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.47 125.14 8.48 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.236 176.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 1.62 ' HD2' ' CD1' ' A' ' 53' ' ' PHE . 5.6 m-85 -108.12 99.85 9.24 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.171 0.51 . . . . 0.0 111.331 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -94.78 100.82 12.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.141 173.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.56 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 19.8 t -108.47 117.72 54.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.1 0.476 . . . . 0.0 111.141 -173.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 47.0 mtp180 -102.25 -179.72 4.07 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.218 -177.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.437 ' HB2' ' HB3' ' A' ' 92' ' ' SER . 3.5 m-20 59.89 44.72 13.29 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 123.288 0.368 . . . . 0.0 111.34 178.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.97 -157.27 6.9 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.692 177.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -43.3 -59.74 0.95 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.675 2.917 . . . . 0.0 112.888 -178.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -113.47 46.88 1.21 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 175.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.6 15.44 77.63 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.837 -176.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.0 143.44 57.77 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.729 0.776 . . . . 0.0 111.606 -177.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -107.98 109.63 21.15 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.917 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.65 154.03 19.63 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 1.649 ' HD1' ' CD2' ' A' ' 65' ' ' TYR . 35.1 t80 -139.25 117.38 11.82 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.95 0.405 . . . . 0.0 111.173 -178.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.692 ' CE2' ' HE3' ' A' ' 29' ' ' MET . 10.2 m-90 -119.71 161.7 20.28 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.2 t -126.36 118.8 52.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.265 178.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.538 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 3.1 mp -96.36 100.54 11.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 176.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -82.4 98.22 8.76 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.166 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.589 ' HB1' ' O ' ' A' ' 49' ' ' GLY . . . -100.64 -5.11 27.13 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.975 175.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.47 ' HE3' ' HA2' ' A' ' 49' ' ' GLY . 4.1 tppp? -66.05 -39.23 89.95 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.256 -178.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -81.0 0.54 35.18 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.019 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.75 13.59 83.29 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.198 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.504 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 10.8 mmpt? -86.22 -50.5 6.93 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.68 0.276 . . . . 0.0 110.566 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.44 33.07 61.57 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.455 -0.879 . . . . 0.0 111.004 -176.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.529 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 52.2 pttt -98.5 149.24 22.92 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.504 -0.348 . . . . 0.0 110.197 -177.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.442 HG13 HG13 ' A' ' 68' ' ' ILE . 0.9 OUTLIER -108.11 123.01 63.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.699 0.761 . . . . 0.0 109.565 -178.383 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.5 t -130.36 134.46 47.18 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.582 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -64.68 129.66 40.63 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 -176.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 72.68 -43.19 0.56 Allowed 'General case' 0 N--CA 1.47 0.557 0 O-C-N 124.001 0.813 . . . . 0.0 111.944 -177.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.91 -42.68 0.76 Allowed Glycine 0 CA--C 1.518 0.259 0 CA-C-N 116.151 -0.477 . . . . 0.0 114.222 177.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.79 13.22 78.6 Favored Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 -174.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -116.25 166.74 11.69 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -177.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -100.7 109.01 56.37 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.204 177.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.432 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 12.6 Cg_exo -71.48 127.95 13.88 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 122.994 2.462 . . . . 0.0 112.789 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -60.97 -46.5 90.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.587 173.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.48 HG12 ' HB3' ' A' ' 124' ' ' ALA . 8.7 m -125.11 125.12 68.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.65 178.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.714 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 15.2 m -122.77 125.69 45.98 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.35 -178.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.507 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 86.2 m-85 -105.18 136.24 45.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.609 0.242 . . . . 0.0 110.39 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.55 ' HB ' ' HB3' ' A' ' 116' ' ' LYS . 2.2 m -109.72 99.63 8.77 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 175.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 49.0 mt -125.46 162.47 28.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -175.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.506 ' N ' HG23 ' A' ' 91' ' ' ILE . 20.3 m -97.86 145.53 26.34 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.987 0.422 . . . . 0.0 110.364 176.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.507 ' OD1' HG12 ' A' ' 25' ' ' VAL . 36.6 t70 -54.18 -24.03 16.64 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.016 -176.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -82.83 -35.38 26.4 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.982 -177.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -90.11 -26.44 20.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.711 -172.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.486 ' CG1' HG11 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -54.5 -33.13 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.011 0.434 . . . . 0.0 111.453 -176.648 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.4 m -66.34 -27.51 40.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.639 -169.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -89.69 -27.44 20.1 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 176.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.451 HD21 ' O ' ' A' ' 104' ' ' LEU . 76.1 mt -69.09 -42.97 75.46 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.204 0.526 . . . . 0.0 110.533 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 96' ' ' VAL . 16.7 mt -77.46 -27.64 15.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.137 -177.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.41 ' OG ' ' HD3' ' A' ' 103' ' ' LYS . 64.0 p -83.56 -27.55 29.21 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.978 0.418 . . . . 0.0 110.778 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.38 -5.23 31.5 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.876 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.41 ' HD3' ' OG ' ' A' ' 101' ' ' SER . 14.0 mptt -67.56 -42.06 83.24 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 179.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.451 ' O ' HD21 ' A' ' 99' ' ' LEU . 25.1 tp -99.93 119.88 38.92 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.141 0.495 . . . . 0.0 110.218 -177.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.451 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 15.3 m120 -67.62 118.06 53.58 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.183 178.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -64.16 -21.68 67.55 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.123 1.882 . . . . 0.0 110.989 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -64.02 -53.68 46.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.325 174.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.53 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -68.04 -33.39 74.49 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -178.861 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.53 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -67.46 -36.59 81.46 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.999 177.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -59.35 -48.01 83.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.845 176.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -67.96 -37.97 82.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.016 -177.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -82.84 2.9 31.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.969 -0.559 . . . . 0.0 112.275 -177.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 81.14 13.91 80.07 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.771 -0.728 . . . . 0.0 113.379 175.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -92.32 -10.58 37.8 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.196 0.522 . . . . 0.0 110.297 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.444 ' O ' HG21 ' A' ' 115' ' ' ILE . 0.3 OUTLIER -133.35 109.09 13.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.751 177.937 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.55 ' HB3' ' HB ' ' A' ' 90' ' ' THR . 45.9 tptt -112.77 107.1 15.61 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.3 174.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.714 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER -133.9 136.94 53.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.058 0.456 . . . . 0.0 111.552 -170.147 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -67.89 123.36 20.36 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.163 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -77.0 88.64 0.97 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.221 -175.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -107.05 97.02 6.84 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 170.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.555 ' O ' ' HB3' ' A' ' 125' ' ' MET . 26.9 ttt -59.34 -50.72 72.9 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.562 -168.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -73.48 -9.66 78.2 Favored Glycine 0 N--CA 1.459 0.232 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.15 -175.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.34 -55.86 3.15 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.65 0.738 . . . . 0.0 109.809 -177.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.48 ' HB3' HG12 ' A' ' 87' ' ' VAL . . . -90.49 -3.72 57.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.311 -172.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.555 ' HB3' ' O ' ' A' ' 121' ' ' MET . 27.1 ptt? -62.28 -24.09 67.09 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.214 178.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.514 ' O ' ' HG ' ' A' ' 130' ' ' LEU . 30.0 mmmt -73.87 -16.54 61.12 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.283 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 75.6 mt -74.55 -52.29 12.28 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 176.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.469 ' HA ' ' HG2' ' A' ' 131' ' ' GLN . 8.8 t -66.59 -33.26 75.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.856 177.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -55.19 -47.59 75.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.804 177.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 126' ' ' LYS . 5.0 mt -66.25 -47.55 73.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.954 -178.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.469 ' HG2' ' HA ' ' A' ' 128' ' ' THR . 16.5 pt20 -71.38 -35.37 71.04 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -175.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 24.8 mtp180 -67.91 -38.87 83.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.175 0.512 . . . . 0.0 110.076 176.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -71.19 -26.94 63.17 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.041 177.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.87 -32.83 74.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.689 177.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -94.42 -12.41 27.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.675 177.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 65.92 17.2 65.04 Favored Glycine 0 C--N 1.332 0.313 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.419 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 65.5 mtm180 -150.43 -177.85 6.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.805 0.336 . . . . 0.0 110.237 -173.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.435 HG23 ' N ' ' A' ' 139' ' ' GLU . 40.5 mt -90.39 164.07 2.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 171.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.435 ' N ' HG23 ' A' ' 138' ' ' ILE . 7.8 mm-40 -42.23 118.21 1.12 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.217 0.532 . . . . 0.0 111.685 174.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 19.0 m -115.59 101.86 9.25 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.669 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 pt . . . . . 0 C--O 1.247 0.926 0 CA-C-O 118.364 -0.827 . . . . 0.0 110.968 -176.047 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.849 0 N-CA-C 111.74 -0.544 . . . . 0.0 111.74 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 24.8 m -69.22 -49.56 55.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.058 0.456 . . . . 0.0 110.453 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.2 m -96.17 118.63 33.13 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.534 177.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.12 173.22 15.06 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.629 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 38.9 m-80 -54.22 147.35 27.2 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.029 0.442 . . . . 0.0 111.142 -177.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 19' ' ' ASN . 4.8 Cg_exo -68.21 -21.39 42.05 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 123.143 2.562 . . . . 0.0 111.578 -176.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -72.42 -20.73 61.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.247 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -81.95 -0.06 42.21 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.006 178.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -90.12 152.56 21.07 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 175.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.409 ' O ' ' HD1' ' A' ' 28' ' ' TYR . 48.0 tptt -80.34 -26.05 38.92 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.604 ' HB ' ' SD ' ' A' ' 29' ' ' MET . 0.8 OUTLIER -68.93 -15.19 19.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.57 178.15 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 1.615 ' HE1' ' CE2' ' A' ' 26' ' ' PHE . 34.6 t80 -53.75 -60.15 3.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.207 0.527 . . . . 0.0 110.572 178.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.0 -33.51 65.83 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.609 -177.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 1.669 ' HE1' ' CE2' ' A' ' 28' ' ' TYR . 17.7 m-85 -67.76 -48.91 65.05 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.787 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.604 ' SD ' ' HB ' ' A' ' 25' ' ' VAL . 0.1 OUTLIER -63.25 -29.42 70.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.893 0.378 . . . . 0.0 110.74 175.889 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.427 ' HD3' ' HA ' ' A' ' 30' ' ' LYS . 37.8 mmtt -71.86 -34.36 69.16 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.787 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.491 HG12 ' O ' ' A' ' 28' ' ' TYR . 8.7 pt -82.24 -21.87 9.69 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.519 0 C-N-CA 119.971 -0.692 . . . . 0.0 109.705 174.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.5 tt -60.53 -50.97 71.4 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 170.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.475 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 6.4 tt0 -43.86 -48.51 8.36 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.183 174.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -76.33 -52.85 9.1 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.78 -177.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.21 -32.72 74.19 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -168.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 94.5 mmm -62.35 -43.59 98.48 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.491 0.182 . . . . 0.0 111.491 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -91.09 -16.26 28.14 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.737 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -65.81 -17.63 64.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.387 0.613 . . . . 0.0 109.943 175.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -54.83 128.94 35.33 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.055 172.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.6 p -62.38 -25.78 68.11 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.492 -0.777 . . . . 0.0 112.346 -175.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -100.09 -0.12 39.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.941 0.4 . . . . 0.0 111.02 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 39.22 52.84 2.18 Favored 'General case' 0 C--N 1.344 0.365 0 CA-C-N 114.614 -1.176 . . . . 0.0 111.742 -175.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.0 mt -60.9 -4.35 0.99 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.803 -175.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.1 tp -55.97 -30.16 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-O 120.766 0.317 . . . . 0.0 110.591 176.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.474 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 5.8 pt-20 -64.47 -36.03 82.87 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.346 -177.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -77.14 -15.8 59.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.996 0.427 . . . . 0.0 111.108 -175.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.427 ' O ' HG23 ' A' ' 47' ' ' VAL . 14.5 p -130.71 32.28 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.934 0.874 . . . . 0.0 110.24 -175.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.474 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 94.9 mtt180 -57.96 116.98 3.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.597 -0.728 . . . . 0.0 111.843 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.488 ' O ' ' HB1' ' A' ' 70' ' ' ALA . . . -171.23 173.98 44.84 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.188 -178.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.417 HG13 ' HB2' ' A' ' 71' ' ' LYS . 52.7 mt -104.99 125.42 59.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 117.485 0.642 . . . . 0.0 111.234 -178.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.542 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 3.1 m-85 -107.28 110.99 23.15 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.815 -177.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.15 116.29 5.32 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.419 -0.896 . . . . 0.0 111.47 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 1.641 ' HD2' ' CD1' ' A' ' 53' ' ' PHE . 5.1 m-85 -100.61 109.41 21.48 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.027 0.441 . . . . 0.0 111.636 -178.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -94.35 99.84 11.98 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.378 175.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.576 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 19.0 t -98.58 133.11 42.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.811 -175.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -122.33 173.26 7.74 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.117 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 59.81 49.7 7.73 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.103 0.478 . . . . 0.0 111.395 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.42 -140.07 1.61 Allowed Glycine 0 CA--C 1.522 0.48 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.437 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.466 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 54.1 Cg_exo -40.73 -61.6 0.46 Allowed 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.768 2.979 . . . . 0.0 114.098 178.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -152.06 82.23 1.26 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.187 0.518 . . . . 0.0 109.97 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 73.23 12.55 79.72 Favored Glycine 0 N--CA 1.453 -0.223 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.466 ' HB1' ' HD2' ' A' ' 59' ' ' PRO . . . -82.39 157.03 23.88 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.044 -0.578 . . . . 0.0 111.381 -175.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -133.22 143.08 48.92 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.667 -177.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.8 162.72 24.19 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.443 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 1.643 ' HE1' ' CE2' ' A' ' 65' ' ' TYR . 33.6 t80 -148.42 117.58 6.84 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.82 0.343 . . . . 0.0 110.881 -176.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 16.6 m-90 -120.82 139.32 53.31 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.9 t -107.65 112.75 41.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.448 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.542 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 3.9 mp -90.73 100.7 11.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 175.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -85.66 97.4 10.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.418 0.628 . . . . 0.0 109.887 -178.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.488 ' HB1' ' O ' ' A' ' 49' ' ' GLY . . . -102.22 -0.43 33.07 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.404 174.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.417 ' HB2' HG13 ' A' ' 50' ' ' ILE . 4.9 tppp? -63.33 -45.48 91.05 Favored 'General case' 0 CA--C 1.523 -0.079 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.166 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -72.76 -8.79 57.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.615 176.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.34 -4.14 86.37 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.897 -178.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -71.64 -39.93 70.07 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.884 0.373 . . . . 0.0 111.417 -177.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.6 34.16 54.41 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.562 176.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.475 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 19.7 ptmt -98.2 149.19 22.82 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 -175.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.43 HG23 ' HB3' ' A' ' 29' ' ' MET . 0.7 OUTLIER -109.52 132.43 57.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.674 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.0 t -133.84 129.23 36.19 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.387 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 1.66 ' HE1' ' CE2' ' A' ' 79' ' ' TYR . 83.7 t80 -66.49 122.5 17.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.37 -178.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 54.81 65.73 1.42 Allowed 'General case' 0 N--CA 1.464 0.226 0 O-C-N 123.765 0.666 . . . . 0.0 109.813 -176.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.04 -40.25 88.6 Favored Glycine 0 C--N 1.33 0.207 0 CA-C-N 115.57 -0.741 . . . . 0.0 113.707 -173.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.11 -21.27 40.98 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.041 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.467 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 7.4 mm-40 -71.26 143.19 50.46 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 175.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.441 ' HB3' ' HZ2' ' A' ' 84' ' ' LYS . 2.2 ttpm? -76.88 114.47 39.61 Favored Pre-proline 0 N--CA 1.438 -1.037 0 CA-C-O 121.39 0.614 . . . . 0.0 110.827 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 83' ' ' GLU . 13.9 Cg_exo -68.92 126.55 14.02 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.191 2.594 . . . . 0.0 112.16 177.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.492 ' HB2' HD23 ' A' ' 123' ' ' LEU . 5.1 m-20 -60.66 -33.5 72.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.297 173.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.556 ' HB ' ' CD1' ' A' ' 117' ' ' ILE . 11.3 m -136.76 142.16 38.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.326 174.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.672 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 22.9 m -127.44 138.75 53.05 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.098 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 1.635 ' HD1' ' CD2' ' A' ' 89' ' ' PHE . 18.7 m-85 -122.69 120.92 35.1 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 123.177 0.298 . . . . 0.0 110.336 -177.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.2 m -93.56 113.18 25.24 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 171.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.576 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 81.5 mt -137.46 156.9 33.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -175.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 17.7 m -100.25 144.53 29.17 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.196 0.522 . . . . 0.0 110.326 177.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -51.8 -34.91 42.07 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 114.607 -1.179 . . . . 0.0 112.291 -175.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -71.05 -36.16 72.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.11 -177.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.453 ' CG ' ' HD2' ' A' ' 114' ' ' LYS . 7.4 m-20 -90.91 -19.25 23.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.187 -174.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.439 HG12 HG11 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -56.72 -33.57 40.9 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 CA-C-O 120.899 0.381 . . . . 0.0 110.696 -178.452 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.7 m -64.1 -27.35 42.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.38 -172.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -86.67 -29.4 22.51 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 177.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.487 HD21 ' O ' ' A' ' 104' ' ' LEU . 85.1 mt -76.02 -39.87 54.73 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.918 -178.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.477 HD13 ' SD ' ' A' ' 29' ' ' MET . 2.7 mm -67.39 -36.34 76.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.273 0.559 . . . . 0.0 110.374 177.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 36.4 p -79.92 -21.57 43.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.335 -176.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.66 11.32 60.74 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.62 -177.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -80.06 -42.85 22.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.047 0.451 . . . . 0.0 110.968 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.487 ' O ' HD21 ' A' ' 99' ' ' LEU . 43.3 tp -96.98 120.25 36.98 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.456 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 18.3 m120 -69.31 117.52 53.21 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.767 178.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -62.22 -22.91 74.92 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.013 1.809 . . . . 0.0 110.845 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.471 ' NE2' HE22 ' A' ' 131' ' ' GLN . 92.1 mt-30 -62.11 -56.14 21.84 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.191 173.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.547 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 0.7 OUTLIER -67.12 -33.95 76.56 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -177.942 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.547 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -69.5 -32.13 70.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.002 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -61.99 -50.93 70.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.469 175.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 1.636 ' HD1' ' CD2' ' A' ' 111' ' ' PHE . 63.3 t80 -64.19 -39.76 94.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.921 -178.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -76.69 -8.48 57.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.09 -177.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 95.34 -4.18 66.84 Favored Glycine 0 CA--C 1.517 0.181 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.346 173.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.453 ' HD2' ' CG ' ' A' ' 95' ' ' ASP . 0.2 OUTLIER -66.72 -39.62 88.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.112 0.482 . . . . 0.0 111.107 177.45 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.534 HG22 HG21 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -107.55 131.99 56.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.302 -174.113 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -120.88 99.37 6.48 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.042 173.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.672 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.2 OUTLIER -127.34 130.48 70.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.991 0.424 . . . . 0.0 111.534 -178.587 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.525 ' O ' HG13 ' A' ' 87' ' ' VAL . 45.4 tt0 -82.35 99.36 9.33 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 173.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -72.91 103.07 1.3 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.81 -0.71 . . . . 0.0 113.525 -172.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -68.18 123.55 21.02 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 171.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 65.6 mtt -54.69 -29.72 53.7 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 123.951 0.782 . . . . 0.0 112.631 -171.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -92.27 -51.11 2.45 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.259 -0.972 . . . . 0.0 112.316 177.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.492 HD23 ' HB2' ' A' ' 86' ' ' ASP . 0.9 OUTLIER -68.52 -67.12 0.49 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.094 -0.553 . . . . 0.0 112.233 -171.821 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.491 ' HA ' HD22 ' A' ' 127' ' ' LEU . . . -64.41 -24.74 67.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.976 -173.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -71.12 -31.18 67.44 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.728 178.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 8.4 mmtm -71.13 -46.15 62.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.483 0.659 . . . . 0.0 109.247 169.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.491 HD22 ' HA ' ' A' ' 124' ' ' ALA . 0.1 OUTLIER -59.42 -43.29 93.07 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.289 -175.943 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.409 ' N ' ' HG ' ' A' ' 127' ' ' LEU . 6.8 t -76.61 -22.25 54.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.122 0.487 . . . . 0.0 110.79 -178.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -75.45 -25.5 57.51 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.396 0.617 . . . . 0.0 110.613 -178.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -65.89 -13.37 59.54 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.41 178.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.471 HE22 ' NE2' ' A' ' 107' ' ' GLN . 10.5 pt20 -60.52 -19.6 57.58 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -175.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -61.04 -60.52 3.64 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.035 0.445 . . . . 0.0 110.216 -178.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -74.96 -20.62 59.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.704 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.18 -32.58 74.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.198 0.523 . . . . 0.0 110.303 175.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -93.25 -8.64 41.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.483 175.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 75.19 30.64 58.56 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.578 178.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 60.5 mtm180 -121.09 106.77 11.87 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.734 0.302 . . . . 0.0 110.875 -179.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 15.7 tt -84.9 -29.18 6.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.606 0.717 . . . . 0.0 109.5 175.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -100.13 132.95 45.19 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.923 -175.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 36.5 p -108.96 -31.39 7.66 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.413 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 63.7 mt . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.67 -0.681 . . . . 0.0 110.11 -179.814 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.746 0 N-CA-C 112.086 -0.406 . . . . 0.0 112.086 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.4 m -94.17 -35.1 12.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.354 0.597 . . . . 0.0 110.011 177.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.9 m -153.38 -163.38 1.66 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.474 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -54.88 149.93 19.68 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.853 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -62.49 126.88 89.13 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 121.794 0.807 . . . . 0.0 111.092 -176.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.03 -19.26 35.09 Favored 'Trans proline' 0 C--N 1.328 -0.502 0 C-N-CA 124.095 3.197 . . . . 0.0 111.922 -175.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.484 ' HA ' ' CG ' ' A' ' 26' ' ' PHE . 17.1 mt-10 -76.65 -23.86 53.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.368 -176.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -91.65 28.84 1.65 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.338 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -110.58 160.18 16.88 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.086 174.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -74.17 -35.49 64.02 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 172.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.524 HG11 HG12 ' A' ' 96' ' ' VAL . 0.8 OUTLIER -65.15 -20.54 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.568 -178.975 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 1.659 ' HE1' ' CE2' ' A' ' 26' ' ' PHE . 67.5 t80 -56.95 -46.59 82.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.963 0.411 . . . . 0.0 110.593 -179.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.403 ' HE2' HG21 ' A' ' 31' ' ' ILE . 0.6 OUTLIER -75.91 -44.99 37.65 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.474 177.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -63.9 -43.73 95.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.342 -175.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.439 ' CE ' HD12 ' A' ' 68' ' ' ILE . 71.9 mtp -76.59 -20.32 56.92 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.78 0.324 . . . . 0.0 110.811 -178.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -75.13 -46.67 32.88 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 175.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.403 HG21 ' HE2' ' A' ' 27' ' ' LYS . 10.8 pt -70.74 -24.53 25.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.782 175.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.0 tt -60.47 -56.03 26.38 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 171.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.507 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 11.2 tt0 -42.33 -52.95 4.37 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.169 176.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -69.64 -58.99 3.25 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.877 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.84 -38.53 72.8 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -168.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.2 mmt -59.21 -39.26 82.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.851 0.358 . . . . 0.0 111.592 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -90.62 -31.78 16.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.197 0.522 . . . . 0.0 110.698 178.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -66.57 -18.66 65.49 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.209 -174.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -55.98 145.17 26.07 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.045 177.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.7 p -47.29 -46.95 25.39 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 123.545 0.528 . . . . 0.0 111.713 -176.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -102.57 4.89 38.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.596 -176.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.455 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 4.1 p30 37.2 71.48 0.14 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 122.039 0.923 . . . . 0.0 110.89 -175.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.5 mt -64.51 0.26 1.13 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.443 -1.253 . . . . 0.0 112.103 -173.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.4 tp -61.62 -25.5 37.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.001 0.429 . . . . 0.0 110.442 177.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.469 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 17.0 pt-20 -74.26 -12.62 60.61 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.788 -178.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -86.89 -19.78 28.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.184 0.516 . . . . 0.0 110.538 178.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.465 ' O ' HG23 ' A' ' 47' ' ' VAL . 12.5 p -130.49 31.98 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.2 -173.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.469 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 58.4 mtm180 -54.99 116.63 2.87 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.971 0.891 . . . . 0.0 111.751 -176.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -178.54 173.03 45.45 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 114.055 -1.429 . . . . 0.0 111.193 -176.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.426 ' CG1' ' HB2' ' A' ' 71' ' ' LYS . 60.0 mt -105.04 129.47 57.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-O 120.971 0.415 . . . . 0.0 111.01 -178.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.448 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 5.4 m-85 -111.83 125.28 53.84 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.823 -178.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -104.06 121.55 7.06 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.421 -0.895 . . . . 0.0 111.408 176.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -107.31 109.38 21.13 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.135 0.493 . . . . 0.0 111.487 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -97.66 99.73 11.1 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.179 176.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.6 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 12.2 t -105.59 122.42 59.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.202 -171.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -107.21 -179.44 3.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.869 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 61.92 47.81 5.71 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.137 0.494 . . . . 0.0 111.586 177.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.28 -167.06 20.36 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.699 177.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -40.66 -60.88 0.53 Allowed 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 124.126 3.218 . . . . 0.0 113.558 -176.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -108.93 42.2 1.46 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.091 0.472 . . . . 0.0 109.986 177.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 74.99 19.56 79.88 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.476 -176.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.23 171.47 8.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.973 0.416 . . . . 0.0 111.279 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -131.25 135.32 47.24 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.697 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -124.3 153.68 17.65 Favored Glycine 0 N--CA 1.443 -0.876 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 1.657 ' HE1' ' CE2' ' A' ' 65' ' ' TYR . 44.5 t80 -141.22 119.35 12.04 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.791 0.329 . . . . 0.0 110.622 -179.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.409 ' HB2' ' HE2' ' A' ' 29' ' ' MET . 14.8 m-90 -122.49 144.92 48.77 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 40.1 t -110.46 115.1 48.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.052 177.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.448 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 4.0 mp -89.21 99.17 8.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 176.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -90.66 98.7 11.93 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.447 0.641 . . . . 0.0 109.999 -176.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -110.91 15.64 21.68 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.604 175.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.426 ' HB2' ' CG1' ' A' ' 50' ' ' ILE . 34.2 tttm -56.28 -50.21 72.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.752 -177.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -86.01 0.14 54.08 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.676 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 94.21 12.04 56.71 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.641 -0.708 . . . . 0.0 112.437 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -76.36 -63.49 1.32 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.483 0.182 . . . . 0.0 111.237 -178.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.82 34.2 7.43 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 119.967 -1.111 . . . . 0.0 112.068 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.507 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 15.3 pttm -98.1 143.27 28.81 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.259 -0.275 . . . . 0.0 110.259 -178.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.8 OUTLIER -110.04 131.84 59.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.359 0.6 . . . . 0.0 109.832 178.717 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.6 t -131.21 133.54 45.6 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.49 -176.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -68.7 119.85 13.76 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -178.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 53.6 70.35 0.61 Allowed 'General case' 0 C--N 1.331 -0.199 0 O-C-N 123.79 0.681 . . . . 0.0 109.901 -175.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.1 -34.57 90.1 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.381 -0.827 . . . . 0.0 113.737 -173.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.14 -14.98 56.14 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.976 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.402 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 55.1 mm-40 -73.33 165.73 24.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.809 0.338 . . . . 0.0 110.369 177.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.467 ' HD2' ' N ' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -100.14 106.82 44.02 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.15 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.415 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 16.2 Cg_exo -68.92 139.76 44.07 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.695 2.263 . . . . 0.0 113.018 -177.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.409 ' HB3' ' HG ' ' A' ' 123' ' ' LEU . 31.0 m-20 -67.2 -31.2 71.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.566 173.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.468 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 4.6 m -139.78 149.26 22.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.516 172.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.598 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 54.8 m -135.3 128.33 31.6 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 175.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 1.629 ' HD2' ' CD1' ' A' ' 89' ' ' PHE . 61.4 m-85 -113.41 125.16 53.94 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.852 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.48 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 4.6 m -98.48 121.33 40.28 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 173.009 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.6 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -155.39 154.6 6.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 O-C-N 123.551 0.532 . . . . 0.0 109.618 -175.184 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.468 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 3.8 m -91.56 137.82 32.06 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.56 -178.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -43.28 -49.68 6.69 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.376 0.67 . . . . 0.0 111.495 -176.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -49.95 -38.79 38.1 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.067 -1.424 . . . . 0.0 111.772 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.468 ' OD2' ' HB2' ' A' ' 92' ' ' SER . 13.6 m-20 -91.02 -21.18 21.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.413 -175.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.524 HG12 HG11 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -60.88 -31.27 49.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 121.134 0.493 . . . . 0.0 110.447 -175.577 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.6 m -67.1 -28.7 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.088 -171.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -81.69 -35.26 30.04 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 176.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.429 HD21 ' O ' ' A' ' 104' ' ' LEU . 85.3 mt -66.07 -49.44 67.59 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.812 -178.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 96' ' ' VAL . 21.4 mt -70.03 -23.86 25.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.057 -176.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.1 t -91.55 -9.75 43.15 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.998 0.428 . . . . 0.0 110.972 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.97 17.57 69.6 Favored Glycine 0 C--N 1.329 0.182 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.257 -179.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -85.69 -41.58 15.03 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.05 0.452 . . . . 0.0 110.63 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.429 ' O ' HD21 ' A' ' 99' ' ' LEU . 38.9 tp -103.32 123.22 46.38 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.478 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.455 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 6.2 m-20 -69.09 120.75 78.59 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.548 177.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -65.41 -22.5 59.47 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.083 1.856 . . . . 0.0 111.241 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.49 -54.91 25.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.595 176.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.562 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 0.8 OUTLIER -67.4 -34.89 78.19 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.971 179.283 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.562 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -64.92 -34.34 78.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.178 178.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 1.665 ' HD2' ' CD1' ' A' ' 110' ' ' PHE . 15.1 t80 -61.58 -52.39 64.63 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 175.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -59.72 -39.68 85.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.546 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.484 ' HA ' ' OE1' ' A' ' 112' ' ' GLN . 13.4 mm-40 -85.05 17.08 3.08 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -174.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.42 12.12 76.73 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 121.105 -0.569 . . . . 0.0 113.563 173.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -87.47 -47.41 8.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.877 0.37 . . . . 0.0 110.71 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.564 HG22 HG23 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -96.03 121.4 46.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.994 -177.348 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.48 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 31.2 mmtp -116.52 99.06 6.9 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.877 173.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.63 ' HB ' ' CD2' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -115.96 128.85 73.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.356 0.598 . . . . 0.0 110.665 -178.659 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -134.03 81.28 1.91 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -174.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.468 ' HA3' ' HA ' ' A' ' 87' ' ' VAL . . . -161.51 171.94 37.6 Favored Glycine 0 N--CA 1.439 -1.148 0 C-N-CA 119.936 -1.125 . . . . 0.0 113.515 -170.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -49.23 123.9 8.14 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.339 0.67 . . . . 0.0 111.147 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.44 -45.25 88.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.655 -175.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.19 -32.02 79.01 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.521 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.409 ' HG ' ' HB3' ' A' ' 86' ' ' ASP . 1.2 tm? -60.97 -48.94 79.52 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.026 -0.587 . . . . 0.0 110.437 178.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -82.67 -23.94 33.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.635 -176.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 51.8 mmm -57.4 -36.2 70.99 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 120.758 0.314 . . . . 0.0 111.238 177.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.3 mttp -70.62 -18.71 62.87 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.52 -179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 68.3 mt -73.9 -45.39 51.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.893 0.378 . . . . 0.0 110.229 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.453 ' O ' ' HG3' ' A' ' 132' ' ' ARG . 15.0 t -78.11 -26.16 47.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.986 0.422 . . . . 0.0 109.956 178.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -64.23 -39.48 94.05 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.3 175.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.18 -45.41 79.77 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.941 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -76.61 -20.36 56.84 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.199 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 128' ' ' THR . 77.6 mtp180 -70.58 -51.01 31.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.804 0.335 . . . . 0.0 110.306 175.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -67.92 -22.04 65.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.227 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.21 -22.87 66.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.967 177.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -85.32 -17.81 35.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.22 0.533 . . . . 0.0 110.48 177.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 68.8 33.59 75.8 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 115.285 -0.87 . . . . 0.0 113.335 175.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 137' ' ' ARG . 49.5 mtt180 -127.64 135.82 50.77 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.954 0.377 . . . . 0.0 110.565 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.566 HG13 ' H ' ' A' ' 139' ' ' GLU . 5.5 tp -144.83 -171.43 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -178.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.566 ' H ' HG13 ' A' ' 138' ' ' ILE . 35.0 tt0 -32.47 123.62 0.33 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.545 0.738 . . . . 0.0 112.453 174.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 38.1 m -136.9 93.35 2.84 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.083 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 58.1 mt . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.457 -0.782 . . . . 0.0 110.16 -178.528 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.619 0 N-CA-C 112.053 -0.419 . . . . 0.0 112.053 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.8 m -93.37 86.35 5.25 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.178 0.513 . . . . 0.0 110.908 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.8 m -74.95 101.42 4.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.844 175.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.4 166.04 54.1 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 121.026 -0.606 . . . . 0.0 112.343 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -62.76 152.44 82.14 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-O 121.237 0.542 . . . . 0.0 110.801 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.415 ' HA ' ' CD1' ' A' ' 23' ' ' PHE . 4.9 Cg_exo -70.06 -17.56 36.13 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.695 2.263 . . . . 0.0 111.156 -177.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.456 ' HA ' ' CG ' ' A' ' 26' ' ' PHE . 13.3 mt-10 -74.09 -24.03 59.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.503 -178.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -74.67 -22.16 59.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.635 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.415 ' CD1' ' HA ' ' A' ' 20' ' ' PRO . 35.5 m-85 -65.64 145.53 55.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.667 177.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -74.77 -26.34 59.69 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.42 ' CG1' HG12 ' A' ' 96' ' ' VAL . 0.9 OUTLIER -68.85 -21.69 25.92 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.71 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.585 177.902 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 1.617 ' HE1' ' CE2' ' A' ' 26' ' ' PHE . 79.2 t80 -56.78 -47.5 80.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.774 0.321 . . . . 0.0 110.361 -178.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.417 ' HZ3' HG22 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -67.85 -34.88 77.57 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.727 179.836 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 1.65 ' HD2' ' CD1' ' A' ' 28' ' ' TYR . 37.4 m-85 -71.8 -53.5 13.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.756 0.312 . . . . 0.0 111.101 178.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.43 ' HB3' HG22 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -58.61 -32.8 69.35 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.104 176.939 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.2 mmtt -66.58 -41.78 88.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.601 177.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 28' ' ' TYR . 16.8 pt -78.09 -26.41 14.47 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 C-N-CA 120.294 -0.562 . . . . 0.0 109.865 177.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.6 tt -59.35 -47.94 83.5 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 173.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.528 ' HG2' ' HA ' ' A' ' 76' ' ' LYS . 0.8 OUTLIER -44.57 -50.9 9.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.522 176.021 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -78.64 -55.29 5.3 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.58 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.48 -40.21 74.53 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -167.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.4 mmt -61.29 -41.28 96.7 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -177.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -90.92 -16.82 27.47 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.582 177.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -71.27 -25.09 62.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.996 -176.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -52.85 135.22 36.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.212 0.53 . . . . 0.0 110.117 176.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 18.2 p -57.89 -29.24 64.9 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.621 -174.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -100.32 -5.3 27.6 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 122.467 0.307 . . . . 0.0 111.232 177.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.481 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 4.1 p-10 38.82 64.27 0.8 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.843 0.83 . . . . 0.0 111.294 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.4 mt -58.64 -11.32 2.94 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.137 -175.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.2 tp -57.35 -25.81 24.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.065 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 42' ' ' ASN . 3.7 pt-20 -60.03 -33.19 71.69 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.789 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -82.7 -18.84 39.47 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.865 0.364 . . . . 0.0 111.573 -173.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.464 ' O ' HG23 ' A' ' 47' ' ' VAL . 11.3 p -124.99 31.9 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 122.074 0.94 . . . . 0.0 109.813 -176.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 37.2 mtm180 -57.45 110.33 0.85 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.845 0.831 . . . . 0.0 112.118 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.475 ' O ' ' HB1' ' A' ' 70' ' ' ALA . . . -165.78 170.91 40.79 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 114.086 -1.415 . . . . 0.0 110.701 -178.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 53.2 mt -105.27 126.64 60.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 117.717 0.758 . . . . 0.0 111.136 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.481 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 25.7 m-85 -107.92 117.59 34.51 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.994 -178.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.91 106.59 3.37 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.262 -0.971 . . . . 0.0 111.231 177.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -95.21 105.62 17.57 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.253 0.549 . . . . 0.0 111.261 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -91.31 99.79 12.7 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.383 176.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.625 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 7.6 t -99.84 127.47 52.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.911 -172.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 -112.74 -178.14 3.32 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.792 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 62.67 47.47 4.76 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.13 0.49 . . . . 0.0 111.124 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.39 -169.48 32.45 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.577 177.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -37.69 -61.07 0.37 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.546 3.498 . . . . 0.0 114.217 -174.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -125.05 61.12 1.19 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.86 16.09 74.31 Favored Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.53 -177.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.53 168.8 18.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.028 0.442 . . . . 0.0 110.749 -178.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -136.73 136.2 38.77 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.915 -176.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -120.19 162.46 14.22 Favored Glycine 0 N--CA 1.442 -0.94 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.387 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 1.626 ' HD1' ' CD2' ' A' ' 65' ' ' TYR . 22.1 t80 -150.26 115.18 5.32 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.712 0.291 . . . . 0.0 110.243 -178.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 26.1 m-90 -118.97 126.1 50.96 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.2 0.524 . . . . 0.0 110.279 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 51.3 t -94.4 110.4 23.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.743 177.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.481 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 4.4 mp -88.91 99.24 8.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -83.11 105.6 14.23 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.5 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 49' ' ' GLY . . . -111.47 5.23 19.44 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 173.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -64.67 -36.7 85.13 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.957 -176.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -77.4 -30.3 53.54 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.624 0.726 . . . . 0.0 109.9 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 111.82 10.11 19.45 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.344 -176.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.459 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 9.5 mmpt? -88.01 -49.72 6.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.56 -0.32 . . . . 0.0 111.397 -178.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.01 34.39 15.11 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.16 -1.019 . . . . 0.0 111.793 -177.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.528 ' HA ' ' HG2' ' A' ' 33' ' ' GLU . 14.2 pttm -96.82 145.15 26.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.545 0.212 . . . . 0.0 110.783 -172.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.43 HG22 ' HB3' ' A' ' 29' ' ' MET . 0.7 OUTLIER -107.41 138.18 34.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.069 0.461 . . . . 0.0 109.764 178.035 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.6 t -133.64 133.9 42.51 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.135 177.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -71.17 118.24 13.7 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.821 -179.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 55.96 61.48 2.76 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 123.918 0.762 . . . . 0.0 109.683 -175.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -61.31 -40.64 98.9 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.344 -0.844 . . . . 0.0 113.442 -175.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.12 -21.07 32.99 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.947 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.585 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 65.2 mm-40 -64.89 149.23 49.95 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 175.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.465 ' HD3' ' N ' ' A' ' 84' ' ' LYS . 3.7 mppt? -79.56 108.71 9.44 Favored Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.585 ' HD3' ' O ' ' A' ' 83' ' ' GLU . 16.5 Cg_exo -68.76 130.69 21.07 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.61 2.207 . . . . 0.0 112.164 179.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.475 ' HB2' HD23 ' A' ' 123' ' ' LEU . 5.1 m-20 -62.61 -38.2 89.25 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.57 174.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.508 HG13 ' HA3' ' A' ' 119' ' ' GLY . 3.6 m -136.95 134.29 48.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.592 174.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.59 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 30.8 m -113.53 137.19 51.92 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.217 177.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.648 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 41.0 m-85 -123.83 127.0 47.42 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.493 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 6.7 m -100.69 126.52 47.21 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 174.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.625 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -158.37 151.45 7.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.039 0.447 . . . . 0.0 110.536 -175.565 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.2 m -85.36 143.22 28.77 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.202 0.525 . . . . 0.0 110.977 -177.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -49.28 -33.75 13.75 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.625 -1.17 . . . . 0.0 112.121 -178.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -75.5 -32.46 60.55 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.899 -174.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -91.55 -21.27 20.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.904 -177.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.531 ' O ' HG13 ' A' ' 100' ' ' ILE . 0.4 OUTLIER -56.74 -33.19 40.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.101 0.477 . . . . 0.0 110.21 -177.855 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.3 m -68.07 -33.75 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.853 -173.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -77.47 -32.35 54.32 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.1 mt -69.39 -49.98 50.29 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.738 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.531 HG13 ' O ' ' A' ' 96' ' ' VAL . 28.3 mt -72.38 -30.38 34.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.577 -176.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 39.7 t -86.03 -4.8 59.25 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.671 0.249 . . . . 0.0 111.671 -178.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.03 43.53 16.67 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.301 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -116.03 -43.19 3.0 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.036 0.446 . . . . 0.0 110.898 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.4 tp -97.95 129.56 44.85 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.507 -179.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.48 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 11.6 m120 -73.63 119.68 77.26 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.054 176.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -66.2 -20.26 56.17 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 121.942 1.762 . . . . 0.0 110.196 176.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -60.83 -57.42 12.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.534 173.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.48 ' HG2' ' HB2' ' A' ' 105' ' ' ASN . 0.2 OUTLIER -70.35 -31.4 68.66 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.901 -178.834 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.475 ' HB1' HD13 ' A' ' 115' ' ' ILE . . . -68.22 -35.59 78.2 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.618 -0.433 . . . . 0.0 109.986 178.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -64.98 -45.88 83.8 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 174.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 1.625 ' HD2' ' CD1' ' A' ' 111' ' ' PHE . 91.5 t80 -63.73 -41.03 98.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.347 -178.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -80.12 7.06 9.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.919 -178.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.23 5.33 89.75 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.94 -0.647 . . . . 0.0 113.605 173.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp -78.91 -48.86 13.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.937 0.398 . . . . 0.0 111.07 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.558 HG22 HG23 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -87.72 118.24 33.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.539 -179.257 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.493 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 74.7 mmtt -114.73 98.77 7.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.659 174.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.648 ' HB ' ' CD2' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -114.72 131.29 67.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.264 0.554 . . . . 0.0 110.361 178.735 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.5 ' HA ' HE21 ' A' ' 118' ' ' GLN . 0.0 OUTLIER -144.5 91.79 2.22 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -177.317 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.508 ' HA3' HG13 ' A' ' 87' ' ' VAL . . . -160.82 172.28 37.1 Favored Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 119.944 -1.122 . . . . 0.0 113.75 -169.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -48.43 113.32 0.73 Allowed 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.792 0.837 . . . . 0.0 110.978 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 24.7 ptm -60.07 -33.13 71.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.649 -178.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -70.78 -23.35 77.95 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.43 -176.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.476 ' O ' ' HB2' ' A' ' 126' ' ' LYS . 1.4 tp -88.17 -46.81 8.96 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.979 0.418 . . . . 0.0 110.478 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.8 -23.02 62.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.166 -177.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 46.0 mtt -66.02 -28.98 69.28 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.066 173.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.543 ' HA ' ' HB3' ' A' ' 129' ' ' ASP . 9.5 mmtm -66.41 -26.53 67.28 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.45 176.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.0 mt -62.01 -38.41 88.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.532 177.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.649 ' O ' ' HG2' ' A' ' 132' ' ' ARG . 12.9 t -90.44 -25.49 20.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.073 0.463 . . . . 0.0 110.397 177.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.543 ' HB3' ' HA ' ' A' ' 126' ' ' LYS . 35.3 t70 -60.63 -49.95 75.46 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.781 177.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.96 -34.37 74.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.144 -177.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.567 ' HG2' ' O ' ' A' ' 128' ' ' THR . 4.5 pt20 -74.57 -28.12 60.79 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.496 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.649 ' HG2' ' O ' ' A' ' 128' ' ' THR . 24.1 mmt180 -70.94 -40.24 72.18 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 173.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.525 ' HG2' ' O ' ' A' ' 129' ' ' ASP . 34.4 mm-40 -62.12 -41.52 98.32 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.976 174.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.12 -43.63 95.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.097 178.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.97 -34.39 73.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.854 179.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.22 -30.73 8.97 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.036 177.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -107.88 125.54 51.59 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 179.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.406 HG21 ' N ' ' A' ' 139' ' ' GLU . 7.6 tp -175.37 -43.64 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.859 178.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.406 ' N ' HG21 ' A' ' 138' ' ' ILE . 8.0 tp10 -87.32 150.05 24.11 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.43 -173.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 22.8 t -75.11 145.28 42.37 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.85 -176.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 55.1 mt . . . . . 0 C--O 1.247 0.965 0 O-C-N 123.896 0.747 . . . . 0.0 110.574 -178.223 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.794 0 N-CA-C 111.761 -0.536 . . . . 0.0 111.761 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.1 p -72.1 -41.73 66.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.05 0.452 . . . . 0.0 110.752 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.8 m -85.23 171.21 12.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.474 178.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -96.14 166.89 24.78 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.873 -0.679 . . . . 0.0 111.744 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.407 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 58.1 m-20 -70.66 143.58 89.99 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-O 120.903 0.382 . . . . 0.0 110.192 -178.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.416 ' O ' ' HB2' ' A' ' 26' ' ' PHE . 21.5 Cg_exo -61.47 -34.57 85.73 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 123.184 2.589 . . . . 0.0 111.606 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.429 ' HA ' ' CG ' ' A' ' 26' ' ' PHE . 25.8 tt0 -65.53 -35.55 81.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.519 179.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -75.45 -4.41 39.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.564 -175.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 1.662 ' HD2' ' CD1' ' A' ' 23' ' ' PHE . 59.2 m-85 -85.53 145.05 27.57 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 171.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -73.04 -20.29 61.02 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.551 ' CG1' HG12 ' A' ' 96' ' ' VAL . 1.0 OUTLIER -73.29 -16.01 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.152 179.126 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.437 ' O ' ' HB2' ' A' ' 30' ' ' LYS . 80.2 t80 -58.02 -52.32 66.01 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.883 0.373 . . . . 0.0 110.455 -178.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -42.98 90.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.278 178.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.455 ' O ' HG12 ' A' ' 31' ' ' ILE . 19.4 m-85 -64.73 -47.75 77.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.165 -0.471 . . . . 0.0 112.097 -177.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.418 ' HB3' HG22 ' A' ' 77' ' ' VAL . 58.6 mtt -71.68 -26.21 62.43 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 122.208 -0.307 . . . . 0.0 111.019 -179.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 26' ' ' PHE . 7.8 mmtt -72.07 -35.37 69.24 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.445 175.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.455 HG12 ' O ' ' A' ' 28' ' ' TYR . 14.7 pt -78.93 -21.35 12.79 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.481 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.662 174.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.7 tt -67.17 -48.84 66.78 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 171.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -44.19 -38.59 3.83 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.086 173.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -83.53 -55.6 4.2 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.242 175.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.51 -42.25 74.23 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -167.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 24.0 mmt -56.65 -43.29 80.18 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -178.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -91.68 -25.84 18.92 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.242 179.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -65.92 -28.33 68.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.04 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -52.93 133.54 37.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.689 174.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 23.6 p -59.82 -27.49 66.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.206 -173.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -96.67 -21.29 17.7 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.513 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 35.69 62.48 0.62 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.867 0.841 . . . . 0.0 110.837 -174.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.6 mt -72.03 2.79 5.14 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.744 -1.117 . . . . 0.0 111.761 -174.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.0 tp -56.01 -27.18 22.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.108 0.48 . . . . 0.0 110.858 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.466 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 49.9 mt-10 -76.08 -13.24 60.21 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.719 -176.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -85.93 -17.02 36.61 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.003 0.43 . . . . 0.0 111.04 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.423 ' O ' HG23 ' A' ' 47' ' ' VAL . 14.0 p -130.69 33.2 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.924 0.869 . . . . 0.0 109.804 -177.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.466 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 23.1 mtm180 -52.14 118.07 3.24 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.971 0.891 . . . . 0.0 112.279 -175.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.427 ' HA3' HD13 ' A' ' 123' ' ' LEU . . . -170.13 -174.87 38.62 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 113.8 -1.545 . . . . 0.0 109.751 -178.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.409 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 43.9 mt -121.74 124.84 72.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-N 118.214 1.007 . . . . 0.0 111.545 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.531 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 2.6 m-85 -107.42 109.49 21.22 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.781 -176.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.74 113.41 4.35 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.391 -0.909 . . . . 0.0 111.065 177.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 1.623 ' HE1' ' CE2' ' A' ' 53' ' ' PHE . 3.9 m-85 -97.4 111.58 23.78 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.264 0.554 . . . . 0.0 111.647 -178.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -93.76 101.17 13.28 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.439 175.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.59 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 14.2 t -99.17 127.14 52.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.684 -175.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 30.2 mtp180 -118.55 -174.1 2.61 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.422 -177.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 61.74 39.93 13.58 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 123.449 0.468 . . . . 0.0 111.195 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.81 -164.47 26.78 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.095 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -39.12 -60.32 0.52 Allowed 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 124.342 3.361 . . . . 0.0 114.062 -176.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -109.88 41.9 1.62 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.065 0.459 . . . . 0.0 110.093 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.21 24.3 76.71 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -170.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.48 162.09 29.66 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 114.708 -0.746 . . . . 0.0 111.471 -175.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -124.89 140.74 52.65 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.877 -178.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -127.95 163.48 21.57 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.936 179.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 1.596 ' HD1' ' CD2' ' A' ' 65' ' ' TYR . 50.2 t80 -143.11 121.03 12.0 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 117.217 0.509 . . . . 0.0 111.375 -177.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 24.2 m-90 -125.96 134.29 51.56 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.924 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 40.3 t -99.78 114.4 37.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.247 178.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.531 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 4.1 mp -89.95 100.82 11.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 174.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -84.54 97.31 9.5 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.214 -176.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.409 ' HB1' ' O ' ' A' ' 49' ' ' GLY . . . -95.26 -12.13 26.76 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.219 174.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.443 ' HD2' ' HG3' ' A' ' 72' ' ' GLU . 1.6 tmmt? -58.2 -40.85 82.66 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.273 -177.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.443 ' HG3' ' HD2' ' A' ' 71' ' ' LYS . 51.7 mt-10 -91.72 12.15 22.2 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.337 0.589 . . . . 0.0 111.313 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 76.46 11.14 85.37 Favored Glycine 0 C--O 1.228 -0.228 0 CA-C-N 115.402 -0.817 . . . . 0.0 113.394 173.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -91.58 -45.05 8.71 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 122.717 -0.284 . . . . 0.0 111.174 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.97 33.82 62.37 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -176.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 19.8 ptmt -98.35 154.68 17.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.365 -0.418 . . . . 0.0 109.948 -175.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.481 HG11 HG13 ' A' ' 68' ' ' ILE . 0.7 OUTLIER -107.77 137.36 39.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 178.733 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.5 t -140.53 134.18 30.24 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.113 178.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 1.656 ' HE1' ' CE2' ' A' ' 79' ' ' TYR . 25.9 t80 -66.6 116.43 7.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.669 -175.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 65.0 t30 51.17 68.29 0.81 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 123.9 0.75 . . . . 0.0 110.161 -176.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -56.82 -34.59 65.33 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.106 -0.952 . . . . 0.0 113.936 -172.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.47 -16.9 60.34 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -176.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.473 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 16.9 mm-40 -75.62 155.11 36.21 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 175.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -90.88 108.9 31.13 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-O 120.771 0.32 . . . . 0.0 110.194 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 83' ' ' GLU . 20.1 Cg_exo -65.78 125.73 14.79 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.925 2.417 . . . . 0.0 112.879 -178.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.481 ' HB2' HD23 ' A' ' 123' ' ' LEU . 13.9 m-20 -65.57 -34.47 78.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.129 -0.942 . . . . 0.0 109.746 174.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.499 HG13 ' HA3' ' A' ' 119' ' ' GLY . 3.6 m -135.57 139.04 47.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.503 175.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 19.0 m -118.14 135.63 54.1 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.606 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 72.6 m-85 -122.58 125.02 44.84 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.563 ' HB ' ' HB3' ' A' ' 116' ' ' LYS . 35.8 m -101.77 114.2 28.06 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 177.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 73.1 mt -137.87 148.12 25.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.554 -174.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.0 m -85.34 139.25 31.73 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.087 0.47 . . . . 0.0 110.425 176.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -47.18 -34.26 6.11 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 114.504 -1.225 . . . . 0.0 112.427 -178.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -70.92 -41.74 70.81 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.103 -173.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -91.28 -18.6 24.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.591 -175.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.551 HG12 ' CG1' ' A' ' 25' ' ' VAL . 0.3 OUTLIER -54.77 -31.55 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 121.121 0.486 . . . . 0.0 110.124 -179.801 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.0 m -67.05 -35.13 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.023 -173.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -77.08 -33.64 57.04 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.08 -48.09 63.56 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.403 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 96' ' ' VAL . 32.0 mt -66.19 -36.68 77.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.125 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.2 t -75.82 -30.3 58.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.817 0.342 . . . . 0.0 111.2 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 102.8 10.56 37.24 Favored Glycine 0 N--CA 1.453 -0.167 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.876 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -81.11 -40.32 24.24 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.23 0.538 . . . . 0.0 111.0 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.707 HD12 ' NZ ' ' A' ' 108' ' ' LYS . 52.4 tp -101.08 133.78 45.08 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.339 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -79.34 124.69 84.07 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.292 177.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -64.91 -24.86 60.27 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.124 1.882 . . . . 0.0 110.459 176.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -61.37 -60.18 4.12 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.627 173.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.707 ' NZ ' HD12 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -62.78 -35.11 78.78 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.124 0.487 . . . . 0.0 110.021 -177.763 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.551 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -70.93 -33.13 70.21 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.025 -177.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -61.27 -48.61 80.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.312 174.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 1.599 ' HD2' ' CD1' ' A' ' 111' ' ' PHE . 75.5 t80 -60.83 -44.01 97.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.943 179.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -74.39 -12.56 60.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.178 -176.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.77 18.25 45.09 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.158 175.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.35 -24.64 17.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.862 0.363 . . . . 0.0 110.868 176.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.535 HG22 HG23 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -109.79 111.11 34.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.807 0.813 . . . . 0.0 110.144 178.086 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.563 ' HB3' ' HB ' ' A' ' 90' ' ' THR . 13.8 tppt? -110.05 107.5 17.39 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.093 174.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.606 ' HB ' ' CD2' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -126.5 133.85 67.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.257 0.551 . . . . 0.0 110.184 -177.806 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 29.5 tp60 -143.57 92.27 2.34 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -176.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.499 ' HA3' HG13 ' A' ' 87' ' ' VAL . . . -160.37 171.97 36.7 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.092 -1.052 . . . . 0.0 113.258 -170.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -49.11 118.3 2.58 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 124.362 0.683 . . . . 0.0 111.236 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.484 ' O ' ' HB3' ' A' ' 125' ' ' MET . 24.6 ttt -60.31 -35.56 75.9 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.541 -177.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.473 ' HA2' ' SD ' ' A' ' 125' ' ' MET . . . -69.28 -17.62 72.42 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.829 -0.7 . . . . 0.0 111.908 -174.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.481 HD23 ' HB2' ' A' ' 86' ' ' ASP . 2.9 tp -90.79 -58.54 2.45 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.389 0.614 . . . . 0.0 110.073 178.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.515 ' O ' ' HB2' ' A' ' 127' ' ' LEU . . . -68.75 -14.59 63.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.25 -175.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.484 ' HB3' ' O ' ' A' ' 121' ' ' MET . 25.0 ptm -65.63 -20.85 66.47 Favored 'General case' 0 C--N 1.332 -0.177 0 O-C-N 122.276 -0.265 . . . . 0.0 110.57 177.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -79.68 -30.29 41.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.404 0.621 . . . . 0.0 109.334 176.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.515 ' HB2' ' O ' ' A' ' 124' ' ' ALA . 0.7 OUTLIER -62.86 -44.62 95.64 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 172.435 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.602 ' O ' ' HG2' ' A' ' 131' ' ' GLN . 6.4 m -61.95 -41.94 98.55 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 113.81 -1.541 . . . . 0.0 111.599 173.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.662 ' O ' ' HG2' ' A' ' 132' ' ' ARG . 25.9 t70 -53.89 -35.73 61.91 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.138 0.575 . . . . 0.0 111.738 -177.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.5 mt -58.83 -17.2 21.59 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -176.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.602 ' HG2' ' O ' ' A' ' 128' ' ' THR . 10.9 pt20 -63.36 -30.82 71.89 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -177.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.662 ' HG2' ' O ' ' A' ' 129' ' ' ASP . 15.3 ptt180 -65.48 -33.36 75.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.272 0.558 . . . . 0.0 110.055 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -79.86 -38.05 33.58 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.95 177.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.91 -46.54 68.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.993 -177.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -88.11 -25.83 22.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.914 0.387 . . . . 0.0 111.516 -177.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.35 6.51 83.9 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.226 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -101.06 126.71 47.76 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.941 0.401 . . . . 0.0 110.097 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.9 mp -101.46 -67.22 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.133 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -102.17 163.72 12.08 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.658 -176.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 6.9 t -146.41 53.96 1.13 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.246 0.546 . . . . 0.0 109.69 177.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 6.8 pt . . . . . 0 C--O 1.25 1.094 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.727 -178.813 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.823 0 N-CA-C 111.947 -0.461 . . . . 0.0 111.947 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.0 t -74.79 111.84 10.4 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.816 0.341 . . . . 0.0 110.673 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.9 m -67.05 136.71 55.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.275 177.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.32 125.48 24.05 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.423 178.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -72.28 148.29 90.96 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 120.866 0.365 . . . . 0.0 110.229 -179.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.457 ' HA ' ' CD1' ' A' ' 23' ' ' PHE . 14.2 Cg_exo -64.46 -28.88 62.29 Favored 'Trans proline' 0 CA--C 1.518 -0.317 0 C-N-CA 123.276 2.651 . . . . 0.0 111.802 -177.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -65.9 -35.22 80.02 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.261 177.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -73.38 -14.62 61.31 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.562 -178.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 1.664 ' HE2' ' CE1' ' A' ' 23' ' ' PHE . 23.5 m-85 -66.25 148.76 51.36 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.404 0.621 . . . . 0.0 110.378 176.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -74.06 -26.36 60.35 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 176.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.508 ' HB ' ' SD ' ' A' ' 29' ' ' MET . 0.8 OUTLIER -73.9 -15.51 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.97 -179.009 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 1.622 ' HD2' ' CD1' ' A' ' 26' ' ' PHE . 73.4 t80 -56.74 -50.04 73.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.768 0.318 . . . . 0.0 110.307 -177.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.429 ' HE2' HG21 ' A' ' 31' ' ' ILE . 1.1 tpmt? -72.7 -38.23 67.6 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.863 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 1.604 ' HE1' ' CE2' ' A' ' 28' ' ' TYR . 14.3 m-85 -64.72 -50.91 65.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.569 -178.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.508 ' SD ' ' HB ' ' A' ' 25' ' ' VAL . 0.1 OUTLIER -62.9 -31.53 72.6 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.834 0.349 . . . . 0.0 110.928 177.289 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.434 ' HD2' ' HA ' ' A' ' 30' ' ' LYS . 21.6 mmmt -70.76 -37.81 73.43 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 178.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.429 HG21 ' HE2' ' A' ' 27' ' ' LYS . 10.5 pt -84.13 -19.69 9.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.133 176.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.6 tt -60.58 -46.85 88.69 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 171.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -46.85 -48.48 20.97 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.777 175.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -73.96 -50.41 20.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.706 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.89 -36.88 80.38 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -169.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.462 ' HA ' ' HE3' ' A' ' 36' ' ' MET . 33.1 mmt -59.63 -44.11 93.58 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.587 0.217 . . . . 0.0 111.587 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -91.4 -8.36 48.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.19 0.519 . . . . 0.0 110.723 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -73.69 -23.36 59.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.037 0.446 . . . . 0.0 109.984 178.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -59.14 132.16 53.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.772 175.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 13.9 p -57.44 -37.42 72.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.562 -173.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.506 ' C ' HD21 ' A' ' 42' ' ' ASN . 46.1 mt-10 -101.57 9.95 40.73 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 119.306 -0.378 . . . . 0.0 110.96 178.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.538 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 0.1 OUTLIER 25.52 70.37 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.114 0.965 . . . . 0.0 111.275 -173.59 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.7 mt -58.4 -4.45 0.39 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 114.414 -1.267 . . . . 0.0 111.921 -176.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.459 HG13 ' HB2' ' A' ' 70' ' ' ALA . 4.2 tp -60.75 -25.42 35.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.663 178.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.538 ' HG2' ' O ' ' A' ' 42' ' ' ASN . 10.9 pt-20 -76.51 -16.7 59.57 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.237 -179.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -95.53 -13.24 24.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.263 0.554 . . . . 0.0 110.731 -177.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.47 ' O ' HG23 ' A' ' 47' ' ' VAL . 11.9 p -130.43 32.24 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.845 0.831 . . . . 0.0 109.562 -177.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 55.6 mtt180 -52.49 117.11 2.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.397 -175.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.562 ' O ' ' HB1' ' A' ' 70' ' ' ALA . . . -167.16 164.76 38.12 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.221 -178.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.479 HG13 ' HB2' ' A' ' 71' ' ' LYS . 63.8 mt -103.13 124.93 57.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 117.217 0.509 . . . . 0.0 109.988 176.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 1.669 ' HE1' ' CE2' ' A' ' 51' ' ' TYR . 37.3 m-85 -105.72 115.66 30.62 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.203 -176.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.97 111.35 4.23 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.396 -0.907 . . . . 0.0 110.835 177.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 1.664 ' HD2' ' CD1' ' A' ' 53' ' ' PHE . 7.5 m-85 -98.18 108.37 21.06 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.024 0.44 . . . . 0.0 111.594 -178.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -95.71 99.69 11.5 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.638 175.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.516 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 17.4 t -98.12 119.78 46.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.782 -174.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -108.89 179.07 4.28 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.123 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.453 ' HB2' ' HB3' ' A' ' 92' ' ' SER . 3.3 m-20 60.23 42.23 15.53 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.93 0.395 . . . . 0.0 111.125 177.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.11 -166.59 28.93 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.572 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -31.5 -60.49 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 124.946 3.764 . . . . 0.0 114.404 -176.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -120.06 48.07 1.63 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.17 30.04 65.73 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -174.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.47 165.46 21.21 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.224 0.535 . . . . 0.0 111.356 -176.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -132.7 125.74 30.96 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.129 -0.942 . . . . 0.0 110.856 -178.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -115.14 164.13 12.14 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.317 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.425 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 30.9 t80 -147.36 118.34 7.68 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.854 0.359 . . . . 0.0 110.624 -178.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 22.3 m-90 -122.99 132.07 53.98 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.992 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 46.6 t -100.89 117.61 46.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.224 177.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.563 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 4.1 mp -95.31 104.97 16.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.062 0.458 . . . . 0.0 109.88 176.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.422 HD22 ' HG3' ' A' ' 72' ' ' GLU . 19.1 t-20 -79.42 99.38 7.16 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.142 177.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.562 ' HB1' ' O ' ' A' ' 49' ' ' GLY . . . -111.1 -1.68 16.14 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 172.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.479 ' HB2' HG13 ' A' ' 50' ' ' ILE . 2.2 tppp? -67.55 -38.09 83.66 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.385 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.422 ' HG3' HD22 ' A' ' 69' ' ' ASN . 42.6 mt-10 -84.79 -1.63 56.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.234 176.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.02 20.92 69.14 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.618 178.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -89.92 -37.53 14.33 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.953 0.406 . . . . 0.0 111.057 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.13 32.14 76.05 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.883 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.563 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 19.7 ptmt -98.7 163.1 12.78 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -177.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.427 HG22 ' HB3' ' A' ' 29' ' ' MET . 0.8 OUTLIER -124.42 139.64 50.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.784 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.0 t -135.38 134.7 40.01 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.284 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 1.669 ' HD1' ' CD2' ' A' ' 79' ' ' TYR . 72.4 t80 -68.65 119.23 12.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.975 -178.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 52.43 69.87 0.63 Allowed 'General case' 0 N--CA 1.464 0.258 0 O-C-N 123.745 0.653 . . . . 0.0 109.732 -175.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.37 -40.71 91.64 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.708 -0.678 . . . . 0.0 113.822 -173.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.63 -20.79 48.06 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.609 -177.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.55 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 34.8 mt-10 -65.86 143.26 57.57 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.468 -0.366 . . . . 0.0 110.085 175.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -78.64 108.82 8.8 Favored Pre-proline 0 N--CA 1.449 -0.525 0 CA-C-O 121.341 0.591 . . . . 0.0 110.278 175.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.55 ' HD3' ' O ' ' A' ' 83' ' ' GLU . 12.6 Cg_exo -71.36 129.18 15.54 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.581 2.187 . . . . 0.0 111.949 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -59.25 -31.67 69.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.184 174.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.554 HG12 ' HB3' ' A' ' 124' ' ' ALA . 2.7 m -141.12 128.9 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.629 175.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.738 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 35.5 m -118.13 121.85 41.58 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.885 177.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.4 ' HA ' ' HB ' ' A' ' 117' ' ' ILE . 5.5 m-85 -106.5 131.76 53.31 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -178.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.448 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 5.4 m -103.77 127.26 51.26 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 173.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.516 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -161.4 155.9 3.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -174.79 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.453 ' HB3' ' HB2' ' A' ' 57' ' ' ASN . 15.5 m -85.19 145.56 27.53 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.31 0.576 . . . . 0.0 111.502 -175.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -51.07 -32.35 21.81 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.734 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -73.68 -35.54 65.21 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.982 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.434 ' OD2' ' HB2' ' A' ' 92' ' ' SER . 12.3 m-20 -90.59 -22.55 21.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.535 -173.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.51 ' O ' HG13 ' A' ' 100' ' ' ILE . 0.4 OUTLIER -57.36 -33.06 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 121.086 0.47 . . . . 0.0 110.446 -178.155 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.5 m -68.09 -27.68 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.241 -170.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -86.54 -30.21 22.09 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 177.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.439 HD21 ' O ' ' A' ' 104' ' ' LEU . 77.2 mt -67.74 -45.82 73.9 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.201 0.524 . . . . 0.0 110.578 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.51 HG13 ' O ' ' A' ' 96' ' ' VAL . 23.5 mt -75.8 -23.26 16.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.381 -176.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 27.7 p -85.54 -22.4 28.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.811 0.339 . . . . 0.0 110.839 178.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 96.97 8.33 56.94 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.934 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -80.42 -41.01 25.31 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.149 0.499 . . . . 0.0 111.131 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.439 ' O ' HD21 ' A' ' 99' ' ' LEU . 42.2 tp -102.78 120.7 41.05 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.844 -178.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -69.41 124.46 90.53 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.207 175.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -70.1 -14.11 34.6 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 121.816 1.678 . . . . 0.0 110.564 177.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -66.13 -58.42 5.47 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.257 171.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.515 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 1.1 ptmt -66.65 -31.46 72.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.653 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.515 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -66.8 -31.53 72.22 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.905 177.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 1.651 ' HD1' ' CD2' ' A' ' 110' ' ' PHE . 23.7 t80 -66.09 -50.85 62.65 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 1.634 ' HD1' ' CD2' ' A' ' 111' ' ' PHE . 80.0 t80 -63.27 -34.21 77.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.331 -178.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -85.27 11.15 10.63 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.65 15.12 73.13 Favored Glycine 0 CA--C 1.517 0.185 0 C-N-CA 121.218 -0.515 . . . . 0.0 113.133 175.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -85.3 -45.07 12.29 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.91 0.386 . . . . 0.0 110.554 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.722 HG22 ' CG2' ' A' ' 117' ' ' ILE . 0.6 OUTLIER -97.39 122.96 49.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.93 -178.208 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.448 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 29.5 mmmt -120.71 99.34 6.48 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 173.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.738 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.2 OUTLIER -130.8 139.47 51.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.275 0.559 . . . . 0.0 111.68 -170.34 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.495 ' O ' HG13 ' A' ' 87' ' ' VAL . 61.4 tt0 -75.96 85.23 2.87 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.793 175.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -70.02 107.0 1.98 Allowed Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.828 -0.624 . . . . 0.0 113.26 -170.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -80.64 118.59 22.34 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 174.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 61.3 ttp -57.28 -35.97 70.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.688 -171.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -90.52 -44.7 4.53 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.02 -1.086 . . . . 0.0 112.956 -177.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.468 HD12 ' HA3' ' A' ' 49' ' ' GLY . 6.1 tt -77.41 -47.88 18.65 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.696 0.284 . . . . 0.0 111.496 -172.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.554 ' HB3' HG12 ' A' ' 87' ' ' VAL . . . -73.0 -20.52 61.0 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.486 -174.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 32.2 mtt -68.69 -18.54 64.28 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 120.872 0.368 . . . . 0.0 111.002 177.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.441 ' O ' ' HG ' ' A' ' 130' ' ' LEU . 2.1 mptm? -79.99 -27.31 39.65 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.489 175.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 78.2 mt -64.2 -42.0 96.82 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 174.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.519 ' O ' ' HG3' ' A' ' 132' ' ' ARG . 18.5 p -73.71 -30.41 62.84 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.172 -179.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -69.16 -36.19 77.11 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.264 177.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 126' ' ' LYS . 6.9 mt -65.65 -45.85 81.42 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.469 177.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.439 ' HA ' ' HB2' ' A' ' 134' ' ' ALA . 21.1 pt20 -65.54 -19.28 65.86 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.114 -176.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.519 ' HG3' ' O ' ' A' ' 128' ' ' THR . 85.1 mtp180 -55.38 -46.89 76.49 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.04 0.448 . . . . 0.0 110.313 175.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -90.26 -33.12 16.26 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.741 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.439 ' HB2' ' HA ' ' A' ' 131' ' ' GLN . . . -65.53 -35.43 80.83 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.683 -178.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -87.04 -8.02 57.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.263 0.554 . . . . 0.0 110.713 177.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 63.03 39.33 97.92 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.189 -0.914 . . . . 0.0 113.443 175.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 132' ' ' ARG . 15.3 ptm180 -69.47 117.28 10.89 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 117.037 0.419 . . . . 0.0 110.299 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.439 ' HB ' ' O ' ' A' ' 137' ' ' ARG . 29.5 mm 71.06 -73.54 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.923 -174.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -101.28 125.35 47.9 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.164 0.507 . . . . 0.0 110.74 -177.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 13.6 t -142.17 60.13 1.46 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.297 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 13.9 pt . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.158 -0.925 . . . . 0.0 111.016 -178.751 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.842 0 N-CA-C 112.052 -0.419 . . . . 0.0 112.052 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.7 t -79.69 -30.63 41.14 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.016 0.436 . . . . 0.0 110.333 -178.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.6 p -71.55 142.02 50.07 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.578 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.45 161.2 21.9 Favored Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.827 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -52.72 130.63 46.72 Favored Pre-proline 0 CA--C 1.518 -0.287 0 CA-C-O 121.968 0.889 . . . . 0.0 111.496 -176.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.63 -15.9 37.82 Favored 'Trans proline' 0 C--N 1.329 -0.46 0 C-N-CA 123.956 3.104 . . . . 0.0 112.068 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -75.01 -28.86 60.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.507 -177.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -82.83 -7.54 59.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.957 -176.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 1.659 ' HD1' ' CD2' ' A' ' 23' ' ' PHE . 40.3 m-85 -73.12 146.49 45.68 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 174.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.435 ' HD3' HG12 ' A' ' 97' ' ' VAL . 78.6 tttt -78.46 -21.76 48.6 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.468 HG11 HG12 ' A' ' 96' ' ' VAL . 1.3 m -71.83 -13.68 16.94 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.535 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.648 175.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -56.51 -58.17 9.17 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.135 -0.321 . . . . 0.0 110.135 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.35 -42.55 96.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.161 0.505 . . . . 0.0 110.494 178.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.428 ' O ' HG12 ' A' ' 31' ' ' ILE . 18.0 m-85 -65.81 -42.04 91.13 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.613 -175.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.422 ' CE ' HD12 ' A' ' 68' ' ' ILE . 67.5 mtp -80.16 -24.29 40.49 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.117 -0.365 . . . . 0.0 110.354 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 50.5 mmtt -66.61 -41.53 88.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.506 173.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.449 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 4.8 pt -78.97 -26.08 13.23 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.56 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.188 176.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.1 tt -55.15 -51.56 66.08 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 170.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.496 ' HG2' ' HA ' ' A' ' 76' ' ' LYS . 0.7 OUTLIER -47.24 -53.91 12.14 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.962 177.748 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 31' ' ' ILE . 7.6 pt-20 -74.01 -39.4 63.63 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.288 -175.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.01 -37.46 85.95 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.661 -174.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 19.8 mmt -58.48 -44.18 89.25 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.645 0.26 . . . . 0.0 111.543 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -91.24 -7.89 49.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.932 0.396 . . . . 0.0 110.578 177.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 22.0 t-20 -64.94 -34.56 78.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.304 -178.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -61.12 132.27 53.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.653 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.55 -24.85 65.72 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.463 -175.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -102.27 10.83 38.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 119.463 -0.304 . . . . 0.0 111.562 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 26.2 p30 30.86 70.8 0.08 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.382 1.073 . . . . 0.0 112.248 178.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.8 mt -62.64 -2.81 1.22 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.128 -174.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.8 tp -64.02 -27.45 42.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.274 0.559 . . . . 0.0 110.288 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -63.5 -25.62 68.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.396 -177.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -81.81 -19.75 40.51 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.164 -177.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.484 HG12 ' HB3' ' A' ' 126' ' ' LYS . 1.3 m -129.65 32.31 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.791 -175.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 72.3 mtt180 -49.45 112.03 0.58 Allowed 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.763 0.792 . . . . 0.0 111.04 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.496 ' O ' ' HB1' ' A' ' 70' ' ' ALA . . . -178.28 161.57 28.44 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.705 -175.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.499 HG13 ' HB2' ' A' ' 71' ' ' LYS . 64.9 mt -96.57 126.88 49.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 117.28 0.54 . . . . 0.0 110.865 -178.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 1.658 ' HE2' ' CE1' ' A' ' 51' ' ' TYR . 9.4 m-85 -106.07 118.89 37.79 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.708 -179.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.28 113.92 4.85 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.514 -0.85 . . . . 0.0 111.327 177.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -101.26 110.47 22.49 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.122 0.487 . . . . 0.0 111.694 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -94.3 99.75 11.92 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.312 174.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 19.9 t -100.83 112.49 33.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.045 0.45 . . . . 0.0 110.878 -174.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 76.2 mtp85 -104.05 179.71 4.19 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.577 -177.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 64.68 37.29 7.71 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 123.348 0.405 . . . . 0.0 111.311 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.38 -161.17 9.26 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.796 178.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -34.74 -60.72 0.27 Allowed 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 124.605 3.537 . . . . 0.0 114.493 -174.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -115.89 38.49 3.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.38 0.61 . . . . 0.0 110.343 178.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 78.38 24.46 63.21 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -171.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.79 156.34 39.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.14 -0.53 . . . . 0.0 110.725 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -118.3 116.0 25.86 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.182 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.41 161.09 16.27 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.019 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 1.668 ' HE1' ' CE2' ' A' ' 65' ' ' TYR . 39.5 t80 -145.95 118.83 8.7 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.977 0.418 . . . . 0.0 110.897 -176.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.4 ' CE2' ' HD2' ' A' ' 79' ' ' TYR . 20.9 m-90 -121.23 136.27 55.0 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.812 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 39.0 t -106.19 117.23 51.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.555 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.67 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 3.7 mp -93.56 99.79 10.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 175.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -86.25 98.35 10.89 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.348 -177.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.496 ' HB1' ' O ' ' A' ' 49' ' ' GLY . . . -109.3 6.94 24.97 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.177 175.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.499 ' HB2' HG13 ' A' ' 50' ' ' ILE . 5.4 tppp? -60.49 -42.97 97.38 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.522 -178.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -94.27 5.34 52.06 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.223 -178.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.8 -13.51 59.21 Favored Glycine 0 C--N 1.318 -0.431 0 CA-C-N 115.703 -0.68 . . . . 0.0 113.63 174.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.43 -67.05 0.42 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.87 34.7 14.56 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 119.797 -1.192 . . . . 0.0 111.249 -175.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.67 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 54.6 pttt -98.0 148.64 23.28 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 -177.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -107.04 135.12 46.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 177.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.4 t -140.11 132.86 29.03 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.606 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 1.651 ' HD1' ' CD2' ' A' ' 79' ' ' TYR . 45.5 t80 -68.93 121.42 16.56 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 56.49 74.75 0.38 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.552 0.692 . . . . 0.0 109.474 -173.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.86 -41.18 73.77 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.916 -176.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.45 -13.58 61.79 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.93 -179.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.526 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 12.9 mm-40 -81.15 159.41 24.66 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 177.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -87.68 109.08 23.92 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 123.18 0.3 . . . . 0.0 110.518 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.526 ' HD3' ' O ' ' A' ' 83' ' ' GLU . 18.0 Cg_exo -67.26 134.2 32.95 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.815 2.343 . . . . 0.0 112.787 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -66.95 -33.26 75.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.493 -0.776 . . . . 0.0 108.949 172.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.474 HG13 ' HA3' ' A' ' 119' ' ' GLY . 8.5 m -140.58 134.27 33.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.256 178.088 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.617 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 27.9 m -119.4 132.77 55.89 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 175.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.526 ' CD1' ' HB ' ' A' ' 117' ' ' ILE . 68.2 m-85 -119.4 125.79 49.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.219 -179.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.436 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 25.4 m -99.83 126.16 45.89 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 173.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.554 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -157.31 144.26 9.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.888 -176.342 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.14 141.97 41.76 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.451 178.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -49.13 -27.47 3.5 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.707 1.203 . . . . 0.0 111.986 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -78.08 -34.44 50.27 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.226 -174.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -90.99 -20.45 22.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.239 -175.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.468 HG12 HG11 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -57.92 -31.73 41.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.023 -175.116 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.435 HG12 ' HD3' ' A' ' 24' ' ' LYS . 4.9 m -63.91 -29.53 47.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.461 -170.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -81.87 -32.63 30.98 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.494 HD21 ' O ' ' A' ' 104' ' ' LEU . 91.6 mt -69.36 -42.86 74.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.381 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.408 HG22 ' HB3' ' A' ' 28' ' ' TYR . 1.6 mm -65.34 -25.67 37.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.681 178.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.6 t -96.86 -11.41 24.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.646 -176.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.49 9.86 82.77 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.128 -177.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -77.76 -42.35 34.42 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.266 0.555 . . . . 0.0 110.261 178.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.494 ' O ' HD21 ' A' ' 99' ' ' LEU . 48.3 tp -100.02 125.1 46.03 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.723 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.484 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 6.1 m-20 -77.34 124.19 86.96 Favored Pre-proline 0 C--N 1.317 -0.805 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.013 178.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -64.99 -22.28 62.74 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.022 1.815 . . . . 0.0 110.529 179.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.473 HE21 HG22 ' A' ' 128' ' ' THR . 77.0 mm-40 -64.24 -56.7 12.84 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.133 173.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.484 ' HG2' ' HB2' ' A' ' 105' ' ' ASN . 0.1 OUTLIER -67.75 -31.37 71.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.078 -178.514 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.458 ' HB1' HD13 ' A' ' 115' ' ' ILE . . . -69.91 -32.79 71.28 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 177.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 1.616 ' HD1' ' CD2' ' A' ' 110' ' ' PHE . 50.9 t80 -62.51 -52.13 64.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.595 174.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 1.616 ' HD1' ' CD2' ' A' ' 111' ' ' PHE . 52.1 t80 -63.16 -42.14 99.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.88 -178.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -71.33 -7.68 48.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.883 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 95.76 -5.02 66.45 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.667 -0.777 . . . . 0.0 113.432 173.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -68.38 -53.16 25.75 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.95 0.405 . . . . 0.0 111.43 177.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.542 HG13 ' CG1' ' A' ' 91' ' ' ILE . 0.1 OUTLIER -85.94 116.72 29.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.653 0.74 . . . . 0.0 111.038 -175.35 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.436 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 33.7 mmtp -108.37 104.27 13.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.987 175.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.617 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER -125.57 141.58 44.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.145 0.498 . . . . 0.0 111.101 -177.686 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -142.66 83.1 1.8 Allowed 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -177.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.474 ' HA3' HG13 ' A' ' 87' ' ' VAL . . . -161.05 172.56 37.34 Favored Glycine 0 N--CA 1.44 -1.059 0 C-N-CA 120.399 -0.905 . . . . 0.0 113.044 -170.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -49.31 117.01 1.94 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.522 0.677 . . . . 0.0 110.522 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -61.7 -51.13 69.68 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.994 -171.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -65.67 -26.97 72.21 Favored Glycine 0 CA--C 1.511 -0.163 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.764 -175.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.8 tt -72.54 -41.34 65.93 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.028 -0.586 . . . . 0.0 110.258 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.462 ' HB3' HG12 ' A' ' 87' ' ' VAL . . . -87.04 -28.48 22.57 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -177.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 68.7 mtm -67.71 -17.94 64.74 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.687 0.28 . . . . 0.0 111.618 -177.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.484 ' HB3' HG12 ' A' ' 47' ' ' VAL . 22.5 tptm -80.63 -30.63 36.69 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 175.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.0 mt -60.66 -44.68 96.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.757 -178.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.473 HG22 HE21 ' A' ' 107' ' ' GLN . 14.4 t -69.77 -26.36 64.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.904 -178.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -80.84 -33.09 34.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.594 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.9 mt -56.59 -38.66 72.32 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.824 178.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -77.11 -19.31 57.13 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.011 -178.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 52.6 mtp180 -65.47 -44.75 86.2 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 174.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -64.45 -41.01 96.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.351 177.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.39 -37.93 88.48 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.264 -178.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.46 -32.61 71.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.961 0.41 . . . . 0.0 110.77 178.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 93.95 -27.14 13.64 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.306 177.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 60.59 88.03 0.08 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.238 0.542 . . . . 0.0 110.745 -178.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 1.9 mp -81.33 -62.25 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.104 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -100.58 160.3 14.46 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.232 -178.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 22.8 t -134.75 93.74 3.07 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.015 0.436 . . . . 0.0 110.533 -178.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 6.9 tt . . . . . 0 C--O 1.246 0.876 0 CA-C-O 118.106 -0.95 . . . . 0.0 109.891 174.927 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.654 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.4 m -118.4 34.07 5.35 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.016 0.436 . . . . 0.0 110.627 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.0 m -129.82 -174.34 3.28 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.857 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.19 173.36 54.01 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.423 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.5 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 82.0 m-20 -63.01 131.49 94.73 Favored Pre-proline 0 CA--C 1.514 -0.418 0 CA-C-O 121.575 0.702 . . . . 0.0 110.509 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -68.54 -18.37 43.2 Favored 'Trans proline' 0 C--N 1.327 -0.598 0 C-N-CA 123.745 2.964 . . . . 0.0 112.346 -176.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.4 ' HA ' ' CG ' ' A' ' 26' ' ' PHE . 15.0 mt-10 -84.05 -27.29 28.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.438 -177.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.5 ' OD2' ' HB2' ' A' ' 19' ' ' ASN . 42.9 m-20 -76.49 -9.4 58.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.13 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -73.31 145.55 45.95 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.756 174.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -76.04 -17.7 59.55 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.453 ' CG1' HG12 ' A' ' 96' ' ' VAL . 1.2 m -78.02 -15.87 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.267 177.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 1.642 ' HE2' ' CE1' ' A' ' 26' ' ' PHE . 78.7 t80 -54.74 -55.93 24.7 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 123.123 0.264 . . . . 0.0 110.73 -174.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.458 ' HZ1' HG22 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -65.72 -35.33 80.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.647 -179.072 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 1.666 ' HE2' ' CE1' ' A' ' 28' ' ' TYR . 12.7 m-85 -66.89 -48.52 68.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.529 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 63.7 mtt -70.7 -30.79 67.45 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.017 178.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.423 ' HD2' ' HA ' ' A' ' 30' ' ' LYS . 27.7 mmmt -67.02 -34.74 78.38 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.236 176.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.458 HG22 ' HZ1' ' A' ' 27' ' ' LYS . 12.6 pt -86.55 -18.57 8.57 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.798 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.389 175.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.1 tt -63.74 -52.19 61.56 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 169.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.466 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 21.1 tt0 -42.11 -53.18 4.07 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.239 -1.346 . . . . 0.0 111.32 171.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -73.51 -62.45 1.48 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.336 -1.302 . . . . 0.0 112.175 -176.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.91 -42.63 72.43 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -169.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.6 mmt -61.21 -37.84 84.44 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -176.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -91.8 -23.54 19.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.139 0.495 . . . . 0.0 110.162 178.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -64.28 -32.93 74.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.219 178.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -54.7 134.59 47.38 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.614 175.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.9 p -63.08 -28.97 70.45 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.539 -176.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -81.96 -25.16 35.06 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.652 176.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.414 ' C ' ' H ' ' A' ' 44' ' ' ILE . 4.9 p30 36.96 73.62 0.09 Allowed 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.984 0.897 . . . . 0.0 110.728 -174.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.45 ' O ' HG13 ' A' ' 47' ' ' VAL . 66.9 mt -63.16 -3.11 1.6 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.717 -175.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.419 HG13 ' HB2' ' A' ' 70' ' ' ALA . 4.1 tp -60.28 -26.48 36.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.268 -177.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -83.08 -14.49 53.63 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 120.823 0.344 . . . . 0.0 111.141 -178.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -92.65 -13.93 28.82 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.267 0.556 . . . . 0.0 110.183 178.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.469 ' O ' HG23 ' A' ' 47' ' ' VAL . 13.9 p -130.11 32.69 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.867 0.842 . . . . 0.0 109.872 -177.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -52.51 111.65 0.68 Allowed 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.556 -178.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.667 ' O ' ' HB1' ' A' ' 70' ' ' ALA . . . -175.37 147.56 8.95 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.818 -176.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.464 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 66.7 mt -89.18 126.94 42.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 117.39 0.595 . . . . 0.0 110.794 -177.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 1.645 ' HD1' ' CD2' ' A' ' 51' ' ' TYR . 5.0 m-85 -104.31 116.54 32.33 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.758 -177.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.96 111.58 4.28 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.116 177.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 1.645 ' HD1' ' CD2' ' A' ' 53' ' ' PHE . 6.7 m-85 -100.48 103.43 14.78 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.164 0.507 . . . . 0.0 111.568 -178.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -88.36 99.5 12.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.397 175.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 10.8 t -98.13 134.92 34.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.127 -177.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 31.7 mtp-105 -125.58 175.78 7.32 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.475 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 57.51 42.88 23.68 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 123.426 0.454 . . . . 0.0 111.758 177.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.12 -160.52 8.24 Favored Glycine 0 CA--C 1.521 0.423 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.621 177.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -37.93 -60.82 0.4 Allowed 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 124.284 3.323 . . . . 0.0 113.737 -177.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.429 ' OD1' ' HB3' ' A' ' 62' ' ' ALA . 28.6 p-10 -109.52 34.92 3.53 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.295 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.38 28.54 59.66 Favored Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -173.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.429 ' HB3' ' OD1' ' A' ' 60' ' ' ASN . . . -76.45 146.91 38.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.662 0.744 . . . . 0.0 112.168 -175.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -108.4 108.16 19.01 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.186 176.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -100.58 152.55 19.16 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 1.636 ' HE2' ' CE1' ' A' ' 65' ' ' TYR . 25.2 t80 -137.76 116.47 12.21 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 117.089 0.445 . . . . 0.0 110.905 -178.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 24.3 m-90 -119.3 139.84 51.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.709 178.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 30.5 t -109.85 113.43 44.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.152 178.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.51 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 3.9 mp -91.46 102.61 13.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -85.62 98.03 10.43 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.341 0.591 . . . . 0.0 110.341 -176.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.667 ' HB1' ' O ' ' A' ' 49' ' ' GLY . . . -97.4 -4.5 38.19 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.758 174.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.412 ' HB2' HG13 ' A' ' 50' ' ' ILE . 15.8 tppt? -63.5 -42.74 98.51 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.162 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -73.71 -6.59 47.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.237 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.58 12.28 81.93 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.929 -177.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -91.37 -52.48 4.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.686 0.279 . . . . 0.0 110.766 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.84 34.45 24.56 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.349 -0.929 . . . . 0.0 111.504 -177.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 21.8 ptmt -97.54 150.42 21.12 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -176.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -108.02 125.38 64.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.8 t -128.38 134.49 48.85 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.784 -178.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 1.648 ' HD1' ' CD2' ' A' ' 79' ' ' TYR . 34.3 t80 -63.24 125.38 23.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.213 -176.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 74.08 -42.05 0.5 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.833 0.853 . . . . 0.0 111.699 -178.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.82 -43.09 0.6 Allowed Glycine 0 CA--C 1.519 0.302 0 N-CA-C 114.483 0.553 . . . . 0.0 114.483 177.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 69.32 17.25 72.13 Favored Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 -174.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.409 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 38.7 mm-40 -117.82 162.94 17.28 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 122.576 0.35 . . . . 0.0 110.332 -176.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -95.34 109.04 42.97 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.98 176.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.464 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 17.2 Cg_exo -68.09 133.74 29.71 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.888 2.392 . . . . 0.0 112.73 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -65.32 -32.58 74.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.5 174.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.433 HG13 ' HA3' ' A' ' 119' ' ' GLY . 4.9 m -141.02 132.77 29.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.552 173.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.66 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 86.3 m -115.92 131.1 57.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.318 176.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 1.641 ' HD1' ' CD2' ' A' ' 89' ' ' PHE . 75.8 m-85 -116.56 123.55 47.65 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.45 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 3.5 m -99.7 119.74 38.59 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 176.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.602 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 59.0 mt -143.86 154.22 15.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -174.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.451 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 37.5 m -89.25 144.25 26.24 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.505 175.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -42.38 -52.09 4.7 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.378 0.671 . . . . 0.0 111.968 -177.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.97 -42.35 89.73 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.162 -176.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.451 ' OD2' ' HB2' ' A' ' 92' ' ' SER . 7.8 m-20 -80.4 -21.67 42.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.594 0.235 . . . . 0.0 111.535 -173.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.484 ' O ' HG13 ' A' ' 100' ' ' ILE . 0.5 OUTLIER -58.62 -34.23 50.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.085 -176.463 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.1 m -68.09 -30.46 48.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.22 -171.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -81.14 -33.46 33.15 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 177.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.464 HD21 ' O ' ' A' ' 104' ' ' LEU . 74.0 mt -69.77 -47.91 61.2 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.011 -177.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 96' ' ' VAL . 25.5 mt -70.34 -26.03 28.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.055 -178.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 27.3 t -88.2 -8.67 54.97 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.512 -178.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.51 19.6 61.75 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.322 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -94.2 -41.76 9.31 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.096 0.474 . . . . 0.0 110.979 -178.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.718 HD12 ' NZ ' ' A' ' 108' ' ' LYS . 37.6 tp -101.1 128.74 47.04 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.334 179.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.624 ' OD1' ' HB2' ' A' ' 107' ' ' GLN . 2.8 t-20 -69.68 122.33 85.45 Favored Pre-proline 0 C--N 1.321 -0.63 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.057 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -68.39 -24.44 36.9 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.896 1.731 . . . . 0.0 110.692 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.624 ' HB2' ' OD1' ' A' ' 105' ' ' ASN . 1.7 mp0 -64.83 -59.15 4.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.453 173.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.718 ' NZ ' HD12 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -60.41 -37.93 82.4 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.818 -179.365 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.539 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -68.83 -34.88 76.23 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.553 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -62.23 -52.93 61.78 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 174.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 1.656 ' HD2' ' CD1' ' A' ' 111' ' ' PHE . 79.5 t80 -56.9 -42.25 79.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.094 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.427 ' HA ' HE21 ' A' ' 112' ' ' GLN . 0.0 OUTLIER -74.97 -1.69 23.75 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.963 -177.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 96.5 -12.94 66.07 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.32 173.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -62.41 -61.17 2.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.061 0.458 . . . . 0.0 111.77 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.552 HG22 HG23 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -80.85 121.8 34.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.062 -175.253 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.45 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 35.9 mmtm -115.4 99.63 7.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.319 172.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.66 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER -116.31 135.32 56.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.092 0.472 . . . . 0.0 110.155 177.631 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -144.01 80.26 1.65 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -174.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.433 ' HA3' HG13 ' A' ' 87' ' ' VAL . . . -160.47 173.89 37.1 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.324 -169.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -48.88 110.76 0.39 Allowed 'General case' 0 C--N 1.328 -0.327 0 O-C-N 124.066 0.51 . . . . 0.0 110.28 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.559 ' O ' ' HG3' ' A' ' 125' ' ' MET . 0.0 OUTLIER -65.1 -35.08 80.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.707 -173.96 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -70.0 -32.8 69.67 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.2 -178.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.484 ' O ' HD21 ' A' ' 127' ' ' LEU . 5.3 tt -71.07 -44.44 65.73 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' A' ' 127' ' ' LEU . . . -71.79 -15.5 62.16 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.21 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.559 ' HG3' ' O ' ' A' ' 121' ' ' MET . 78.2 mtp -68.34 -24.38 64.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.738 0.304 . . . . 0.0 110.767 175.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.459 ' O ' ' HG ' ' A' ' 130' ' ' LEU . 50.8 tptt -85.23 -33.06 22.3 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.234 174.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.486 HD22 ' CE1' ' A' ' 51' ' ' TYR . 1.4 mm? -53.55 -40.92 65.93 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 122.051 0.929 . . . . 0.0 108.664 168.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.481 ' HB ' ' O ' ' A' ' 125' ' ' MET . 72.8 m -62.02 -48.09 81.84 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 113.794 -1.548 . . . . 0.0 111.326 175.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.745 ' O ' ' HG2' ' A' ' 132' ' ' ARG . 36.1 t70 -67.33 -25.96 66.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.408 -177.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 126' ' ' LYS . 7.3 mt -54.06 -14.93 1.2 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.157 176.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -57.09 -25.17 58.29 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.483 176.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.745 ' HG2' ' O ' ' A' ' 129' ' ' ASP . 20.5 mmt180 -64.22 -43.62 94.42 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 177.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -69.55 -40.32 76.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.92 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.36 -31.76 71.65 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.403 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.1 0.57 47.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.306 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 73.32 43.0 40.16 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.861 -178.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 67.38 112.43 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.28 0.562 . . . . 0.0 110.98 -178.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.499 HG21 ' N ' ' A' ' 139' ' ' GLU . 55.9 mt -78.59 155.2 4.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.127 -178.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.499 ' N ' HG21 ' A' ' 138' ' ' ILE . 15.2 mm-40 -43.21 118.76 1.38 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.896 176.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.5 m -129.52 -11.22 4.51 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.254 178.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.3 tt . . . . . 0 C--O 1.246 0.881 0 CA-C-O 118.451 -0.785 . . . . 0.0 110.402 179.427 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 . . . . . 0 C--O 1.233 0.237 0 CA-C-O 121.14 0.495 . . . . 0.0 110.668 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.468 ' HA ' ' CD1' ' A' ' 23' ' ' PHE . 3.3 Cg_exo -70.45 -18.65 33.63 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 123.183 2.589 . . . . 0.0 112.628 -173.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -67.14 -28.21 67.95 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.745 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -77.37 -7.73 56.55 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.692 -177.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.468 ' CD1' ' HA ' ' A' ' 20' ' ' PRO . 27.7 m-85 -80.88 148.08 30.07 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 177.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -67.84 -31.21 70.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.142 0.496 . . . . 0.0 109.95 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.883 HG12 HG11 ' A' ' 96' ' ' VAL . 1.7 m -68.36 -16.82 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.563 -177.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -54.03 -57.17 12.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.006 0.431 . . . . 0.0 110.648 -177.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.421 ' HZ1' HD13 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -70.17 -33.06 71.28 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.741 -178.114 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.476 ' HB3' HD12 ' A' ' 100' ' ' ILE . 39.7 m-85 -69.92 -46.4 65.45 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.581 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.444 ' CE ' HD11 ' A' ' 68' ' ' ILE . 53.6 mtp -71.96 -26.15 62.15 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.949 0.404 . . . . 0.0 110.435 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.435 ' HA ' ' HD2' ' A' ' 30' ' ' LYS . 24.8 mmmt -68.45 -36.68 79.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.066 175.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.421 HD13 ' HZ1' ' A' ' 27' ' ' LYS . 17.6 pt -83.31 -26.72 7.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.171 176.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.0 tt -53.93 -50.56 66.16 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 171.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.594 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 10.5 tt0 -43.6 -55.19 4.46 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.69 176.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -71.17 -53.65 13.74 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.497 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.12 -40.19 80.6 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -167.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 91.3 mmm -56.89 -43.52 81.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.046 0.45 . . . . 0.0 111.291 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -91.37 -17.71 25.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.27 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -64.9 -22.51 67.01 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.009 -175.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -59.28 130.06 45.09 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 172.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.7 -27.39 62.88 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.827 -173.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -100.83 18.48 19.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.809 -0.178 . . . . 0.0 110.961 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 27.5 70.52 0.05 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.912 1.285 . . . . 0.0 112.568 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.1 mt -62.83 -6.14 3.46 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.392 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.1 tp -60.62 -27.14 39.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.665 178.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.49 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 22.9 mt-10 -74.28 -21.59 59.68 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-O 120.743 0.306 . . . . 0.0 111.255 -178.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -77.92 -36.97 48.77 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.475 0.655 . . . . 0.0 110.153 177.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 47' ' ' VAL . 14.6 p -112.29 31.73 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.657 -172.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.49 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 53.1 mtt180 -51.33 111.86 0.64 Allowed 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.62 0.724 . . . . 0.0 111.524 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.512 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . -170.14 168.67 41.61 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.752 -175.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.533 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 54.1 mt -108.7 124.42 65.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.455 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 12.8 m-85 -106.63 130.97 54.29 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.265 -174.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -107.87 117.36 5.13 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.303 176.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.415 ' O ' ' HA ' ' A' ' 65' ' ' TYR . 3.4 m-85 -103.65 100.07 9.89 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 120.978 0.418 . . . . 0.0 111.509 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 90' ' ' THR . 56.5 mtmt -89.32 101.99 14.66 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.453 174.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.698 HG11 HG11 ' A' ' 25' ' ' VAL . 16.1 t -104.71 124.71 59.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.588 -176.076 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 45.6 mtp180 -114.4 -179.75 3.72 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.99 -178.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 61.64 47.19 6.59 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.926 0.393 . . . . 0.0 110.876 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.71 -172.16 15.71 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.478 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -38.57 -60.43 0.48 Allowed 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 124.115 3.21 . . . . 0.0 113.497 -175.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -123.99 62.88 1.07 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.11 0.481 . . . . 0.0 110.326 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.84 22.61 78.95 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.846 -0.692 . . . . 0.0 111.926 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.36 169.77 17.28 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.31 0.576 . . . . 0.0 111.581 -177.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -141.61 139.07 33.0 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.69 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.45 162.82 24.08 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.648 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 26.0 t80 -150.3 115.29 5.34 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.949 0.404 . . . . 0.0 110.811 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 10.5 m-90 -117.81 145.05 44.82 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.437 HG11 ' HG3' ' A' ' 83' ' ' GLU . 40.6 t -113.3 124.68 70.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.52 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.464 ' N ' HD12 ' A' ' 68' ' ' ILE . 3.8 mp -100.36 107.02 20.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -83.48 98.35 9.48 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.031 0.443 . . . . 0.0 110.205 178.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -108.32 -2.61 19.07 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.971 175.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -61.25 -37.49 83.3 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -83.06 -2.44 55.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.106 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.38 18.2 67.13 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.005 -178.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.531 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 11.8 mmpt? -93.17 -61.44 1.57 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.683 -0.258 . . . . 0.0 110.786 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.6 35.52 6.48 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.154 -1.022 . . . . 0.0 112.34 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.594 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 19.1 pttm -96.35 142.34 28.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.692 0.246 . . . . 0.0 110.347 -176.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.7 OUTLIER -108.0 133.44 52.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.37 0.605 . . . . 0.0 109.555 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.2 t -138.11 134.33 34.51 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.641 -176.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -68.0 135.3 52.11 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 42.38 73.4 0.14 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.857 0.836 . . . . 0.0 111.064 -172.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.58 -40.02 97.28 Favored Glycine 0 C--N 1.33 0.212 0 CA-C-N 115.108 -0.951 . . . . 0.0 113.591 -173.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 92.18 -14.33 64.79 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.23 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.498 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 1.7 pt-20 -97.95 153.09 18.59 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 122.15 0.18 . . . . 0.0 110.925 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.412 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 60.4 pttt -79.2 110.11 13.7 Favored Pre-proline 0 N--CA 1.449 -0.477 0 CA-C-O 121.284 0.564 . . . . 0.0 111.323 178.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.533 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 14.3 Cg_exo -69.84 130.58 19.49 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.529 2.152 . . . . 0.0 111.579 177.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -58.87 -37.17 75.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.799 176.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.612 ' HB ' ' CD1' ' A' ' 117' ' ' ILE . 14.3 m -138.72 138.98 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.691 177.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.665 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 44.9 m -124.32 136.1 53.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.516 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.581 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 34.7 m-85 -111.31 153.32 26.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.766 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.556 ' HB ' ' HB3' ' A' ' 116' ' ' LYS . 1.1 m -132.26 108.39 9.2 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 175.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.454 HG12 HG13 ' A' ' 115' ' ' ILE . 64.4 mt -134.18 159.47 42.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.523 0.729 . . . . 0.0 109.36 -173.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.444 ' N ' HG22 ' A' ' 91' ' ' ILE . 15.4 m -89.02 139.67 30.22 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.907 0.384 . . . . 0.0 110.096 174.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.588 ' OD1' HG13 ' A' ' 25' ' ' VAL . 35.1 t70 -53.03 -25.83 13.68 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.176 0.991 . . . . 0.0 111.63 -179.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -78.71 -38.93 37.9 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.711 -177.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -89.16 -19.72 25.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.54 -172.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.883 HG11 HG12 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -55.4 -32.56 29.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.082 0.468 . . . . 0.0 110.527 -179.192 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.6 m -67.23 -28.93 44.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.269 -173.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -84.79 -32.94 23.1 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.423 HD12 HG21 ' A' ' 91' ' ' ILE . 74.0 mt -68.72 -47.9 65.18 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.826 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 96' ' ' VAL . 10.6 mt -74.98 -18.95 16.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.908 -177.111 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.6 t -88.47 -20.49 25.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.868 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.55 9.25 61.67 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.124 -177.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -83.0 -41.15 19.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.011 0.434 . . . . 0.0 110.843 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.6 tp -102.97 127.31 50.24 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.051 178.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -71.6 121.87 85.61 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.115 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.425 ' HA ' HD12 ' A' ' 115' ' ' ILE . 4.9 Cg_exo -64.35 -20.52 66.54 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.763 1.642 . . . . 0.0 110.708 175.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -64.91 -58.77 5.28 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.818 172.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.534 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -66.03 -32.92 74.68 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.335 0.588 . . . . 0.0 109.566 -178.503 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.534 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -66.79 -40.11 88.01 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.552 178.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -58.3 -47.55 83.31 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.359 0.6 . . . . 0.0 109.718 175.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -63.87 -38.54 91.48 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.276 -177.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -91.53 6.0 47.32 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -174.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.23 2.22 80.53 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.827 173.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.1 mmpt? -77.34 -19.85 55.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.172 0.51 . . . . 0.0 110.443 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.684 HG23 HG22 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -127.94 110.37 21.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.861 178.599 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.556 ' HB3' ' HB ' ' A' ' 90' ' ' THR . 19.3 tptm -111.75 99.78 8.42 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.114 174.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.684 HG22 HG23 ' A' ' 115' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.322 -0.597 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.946 -176.065 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.429 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 89.5 m-20 . . . . . 0 N--CA 1.455 -0.18 0 CA-C-O 121.036 0.446 . . . . 0.0 110.173 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 19' ' ' ASN . 15.1 Cg_exo -62.99 -30.26 76.39 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 123.173 2.582 . . . . 0.0 112.268 -173.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.406 ' HG3' ' H ' ' A' ' 21' ' ' GLU . 8.8 mt-10 -68.61 -23.36 64.44 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.794 -178.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.415 ' OD2' ' HB2' ' A' ' 19' ' ' ASN . 23.2 m-20 -76.06 -16.24 59.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.243 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -90.2 152.92 20.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.14 0.495 . . . . 0.0 110.525 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -80.46 -26.1 38.51 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.411 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.827 HG12 HG11 ' A' ' 96' ' ' VAL . 1.0 OUTLIER -66.62 -17.59 22.8 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.536 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.973 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -53.89 -51.9 62.23 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.814 0.34 . . . . 0.0 110.492 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.459 ' O ' HG23 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -67.25 -36.48 81.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.508 -179.246 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.408 ' O ' HG12 ' A' ' 31' ' ' ILE . 48.0 m-85 -70.17 -53.32 17.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.501 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.538 ' SD ' ' HB ' ' A' ' 25' ' ' VAL . 0.1 OUTLIER -61.04 -32.1 71.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.767 0.317 . . . . 0.0 110.898 177.938 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.475 ' HD3' ' HA ' ' A' ' 30' ' ' LYS . 34.0 mmtt -74.53 -27.94 60.75 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.459 HG23 ' O ' ' A' ' 27' ' ' LYS . 15.5 pt -89.77 -18.43 7.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.714 173.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.9 tt -62.69 -52.54 62.88 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 169.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.575 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 11.9 tt0 -42.47 -55.17 3.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.141 -1.39 . . . . 0.0 110.688 173.079 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -65.07 -53.82 39.68 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.757 -1.11 . . . . 0.0 111.876 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.68 -36.94 84.51 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -167.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.435 ' HA ' ' CE ' ' A' ' 36' ' ' MET . 5.1 mmt -60.92 -43.37 98.69 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.686 0.279 . . . . 0.0 111.304 -177.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -92.64 -15.1 27.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.988 0.423 . . . . 0.0 110.499 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -64.02 -35.35 80.42 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.064 0.459 . . . . 0.0 110.221 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -70.12 123.25 21.13 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 173.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.81 -24.07 65.55 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.652 -172.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -74.44 -17.58 60.77 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.7 p30 34.27 70.36 0.13 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.924 0.889 . . . . 0.0 112.391 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.4 mt -70.36 1.67 4.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.262 -178.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -62.05 -31.47 51.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.259 -177.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.577 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 46.3 mt-10 -73.13 -20.56 60.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.475 -173.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -72.81 -19.55 61.31 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.344 0.592 . . . . 0.0 110.241 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -131.01 33.44 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.338 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.577 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 57.8 mtt180 -45.31 110.31 0.23 Allowed 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.469 0.652 . . . . 0.0 111.853 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.507 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . -174.95 175.27 47.04 Favored Glycine 0 C--N 1.31 -0.867 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.306 -176.048 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.454 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 67.3 mt -107.98 124.83 64.46 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-O 121.284 0.564 . . . . 0.0 111.248 -177.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.491 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 4.3 m-85 -105.98 111.62 24.34 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.827 -176.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -93.16 126.92 8.79 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.691 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -111.28 103.04 11.41 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.05 0.452 . . . . 0.0 111.777 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -87.88 102.06 14.34 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.11 173.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.698 HG11 HG11 ' A' ' 25' ' ' VAL . 23.0 t -101.88 125.18 56.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.251 0.548 . . . . 0.0 111.238 -173.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.617 ' NE ' HG22 ' A' ' 90' ' ' THR . 51.6 mtm180 -109.77 175.53 5.41 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.985 -174.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 60.82 49.07 6.34 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 122.684 0.394 . . . . 0.0 111.849 176.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.88 -160.01 10.5 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.28 175.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 62' ' ' ALA . 80.2 Cg_exo -41.62 -61.4 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.678 2.919 . . . . 0.0 113.573 -177.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -125.1 63.78 1.15 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.368 0.604 . . . . 0.0 109.573 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.0 26.7 73.27 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.401 -177.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.464 ' HB3' ' HD2' ' A' ' 59' ' ' PRO . . . -77.72 152.86 33.46 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.182 0.515 . . . . 0.0 111.149 -178.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -129.38 112.84 14.24 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.043 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.06 164.93 18.41 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.106 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -147.75 117.06 6.92 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.874 0.368 . . . . 0.0 110.941 -176.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 16.0 m-90 -119.35 147.55 44.2 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.826 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 19.7 t -116.44 115.52 49.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.461 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.519 HG13 HG12 ' A' ' 77' ' ' VAL . 4.2 mp -91.29 103.56 14.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -84.88 97.88 10.0 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.168 0.509 . . . . 0.0 110.138 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -100.97 -0.47 36.55 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.472 174.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.426 ' HB2' HG13 ' A' ' 50' ' ' ILE . 15.9 tppt? -59.74 -40.3 87.62 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.318 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -74.88 -13.74 60.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.033 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.64 9.23 75.48 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -172.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -90.32 -59.79 2.09 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.356 -0.422 . . . . 0.0 110.872 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.55 36.45 5.86 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.066 -1.064 . . . . 0.0 112.149 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.575 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 16.3 pttm -95.72 144.47 26.09 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -175.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.519 HG12 HG13 ' A' ' 68' ' ' ILE . 0.7 OUTLIER -108.08 133.42 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-O 121.433 0.635 . . . . 0.0 109.866 -178.897 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.611 HG23 ' HA2' ' A' ' 81' ' ' GLY . 1.8 t -136.89 141.21 42.74 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.294 -177.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.42 ' CD1' ' HG3' ' A' ' 20' ' ' PRO . 80.1 t80 -62.38 123.6 18.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.349 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 72.75 -38.64 0.42 Allowed 'General case' 0 N--CA 1.471 0.623 0 O-C-N 123.984 0.802 . . . . 0.0 111.993 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.611 ' HA2' HG23 ' A' ' 78' ' ' THR . . . 76.0 -41.63 1.53 Allowed Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 114.158 0.423 . . . . 0.0 114.158 176.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.99 0.76 53.63 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.102 -176.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -107.08 166.83 10.32 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -98.25 108.39 46.94 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 175.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.454 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 21.3 Cg_exo -67.28 132.6 28.07 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 123.138 2.558 . . . . 0.0 113.194 -177.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -64.0 -39.94 95.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.001 174.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.403 ' HB ' ' CD1' ' A' ' 117' ' ' ILE . 6.2 m -136.21 134.18 50.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.656 175.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.619 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 21.2 m -122.81 132.35 54.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.627 -178.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.574 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 41.4 m-85 -111.68 136.86 50.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.917 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.617 HG22 ' NE ' ' A' ' 56' ' ' ARG . 2.2 m -109.04 99.67 8.95 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.057 0.456 . . . . 0.0 109.853 175.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 86.4 mt -122.72 159.07 26.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -176.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.476 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 4.9 m -99.34 138.38 36.52 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 177.082 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.414 ' OD2' HG13 ' A' ' 25' ' ' VAL . 13.2 t70 -44.54 -50.11 9.74 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.14 0.576 . . . . 0.0 111.376 -176.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -59.02 -34.6 72.08 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.5 -1.227 . . . . 0.0 111.575 -176.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.476 ' OD2' ' HB2' ' A' ' 92' ' ' SER . 23.0 m-20 -91.09 -21.72 21.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.064 -177.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.827 HG11 HG12 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -57.71 -34.21 47.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 121.221 0.534 . . . . 0.0 109.824 -179.101 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.0 m -67.21 -27.71 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.971 -174.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -83.68 -34.41 24.99 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.42 ' HG ' HD23 ' A' ' 104' ' ' LEU . 79.8 mt -71.45 -36.25 71.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.219 -177.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.583 HG13 ' O ' ' A' ' 96' ' ' VAL . 17.4 mt -85.15 -22.2 7.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.348 -177.134 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 37.0 p -85.29 -20.85 29.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.004 0.431 . . . . 0.0 111.062 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 96.17 11.99 53.09 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.663 -177.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -85.67 -41.98 14.69 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.941 0.401 . . . . 0.0 111.125 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.42 HD23 ' HG ' ' A' ' 99' ' ' LEU . 49.2 tp -102.89 131.29 49.91 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.274 177.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.489 ' HB2' ' HB2' ' A' ' 108' ' ' LYS . 16.1 m120 -78.73 118.32 71.7 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.475 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -65.45 -27.14 54.64 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 121.978 1.785 . . . . 0.0 111.001 177.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 76.0 mm-40 -66.93 -55.21 15.57 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.454 173.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.67 ' HE3' ' HG3' ' A' ' 112' ' ' GLN . 13.6 ttpt -53.51 -48.85 68.61 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.056 175.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.554 ' HB1' ' HB3' ' A' ' 114' ' ' LYS . . . -65.03 -31.71 73.07 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.68 -175.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -60.08 -45.7 92.04 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 174.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -67.08 -38.0 84.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.427 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.67 ' HG3' ' HE3' ' A' ' 108' ' ' LYS . 87.2 mm-40 -71.06 -23.41 62.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.762 -177.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 101.39 8.67 46.2 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.399 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.606 ' HA ' ' HE3' ' A' ' 114' ' ' LYS . 1.1 tpmt? -83.31 -32.09 26.51 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-O 121.398 0.618 . . . . 0.0 110.386 -176.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.644 HG23 HG22 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -111.99 122.43 66.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.005 -174.163 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.412 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 47.3 mmtm -112.59 106.13 14.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.481 173.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.644 HG22 HG23 ' A' ' 115' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.319 -0.73 0 CA-C-O 120.986 0.422 . . . . 0.0 111.079 -178.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.436 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 95.6 m-20 . . . . . 0 C--O 1.234 0.26 0 CA-C-O 121.463 0.649 . . . . 0.0 111.569 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.531 ' HA ' ' CD1' ' A' ' 23' ' ' PHE . 15.4 Cg_exo -62.96 -26.72 74.2 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.644 2.896 . . . . 0.0 111.681 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -59.24 -37.52 77.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.718 177.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -81.04 -2.94 50.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.872 0.368 . . . . 0.0 111.46 -174.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.531 ' CD1' ' HA ' ' A' ' 20' ' ' PRO . 29.9 m-85 -73.95 144.06 45.42 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 172.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.432 ' O ' ' HD2' ' A' ' 28' ' ' TYR . 64.4 mmtt -66.94 -30.5 70.66 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 175.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 1.086 HG12 HG11 ' A' ' 96' ' ' VAL . 0.8 OUTLIER -65.01 -20.19 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.786 -178.03 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -59.02 -54.44 47.07 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.409 ' O ' HG23 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -71.32 -37.71 71.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.61 179.012 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.434 ' HB2' ' HA ' ' A' ' 25' ' ' VAL . 28.2 m-85 -69.35 -41.96 75.92 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.493 ' HB3' HG21 ' A' ' 77' ' ' VAL . 61.1 mtt -74.88 -27.95 60.45 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.359 178.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.431 ' HD2' ' HA ' ' A' ' 30' ' ' LYS . 19.4 mmmt -66.09 -34.24 77.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.078 175.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.409 HG23 ' O ' ' A' ' 27' ' ' LYS . 18.2 pt -86.32 -21.3 7.54 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.592 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.271 175.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.5 tt -61.83 -48.33 81.04 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 173.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.517 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 3.4 tt0 -45.62 -49.34 14.34 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.878 174.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -75.44 -61.48 1.89 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.755 -1.112 . . . . 0.0 111.703 -177.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.71 -38.95 73.02 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -167.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 95.3 mmm -59.64 -38.82 82.43 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.491 0.182 . . . . 0.0 111.491 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -91.48 -31.44 15.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.135 0.493 . . . . 0.0 111.049 176.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -65.3 -27.53 68.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.923 -176.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -56.67 142.03 41.46 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.414 177.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.3 p -48.99 -45.27 42.06 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.098 0.475 . . . . 0.0 111.406 -177.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -90.28 -8.59 50.55 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.227 -176.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.527 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 6.1 p30 36.51 71.77 0.12 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.865 0.841 . . . . 0.0 110.984 -175.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.5 mt -60.53 -5.34 1.17 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.945 -175.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.8 tp -62.14 -27.62 42.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.59 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.527 ' HG2' ' O ' ' A' ' 42' ' ' ASN . 14.5 pt-20 -67.13 -28.75 68.4 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.793 0.33 . . . . 0.0 111.259 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -78.53 -24.73 45.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.145 0.498 . . . . 0.0 110.642 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.704 HG22 ' OH ' ' A' ' 51' ' ' TYR . 8.3 p -124.91 32.39 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.759 0.79 . . . . 0.0 110.955 -168.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -65.6 125.34 24.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.568 0.699 . . . . 0.0 111.778 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.14 -174.29 46.3 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.38 -178.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.425 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 48.2 mt -111.42 125.71 68.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 117.978 0.889 . . . . 0.0 110.589 175.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.704 ' OH ' HG22 ' A' ' 47' ' ' VAL . 19.1 m-85 -115.99 111.29 20.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.609 -174.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.29 111.83 4.11 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.686 -0.769 . . . . 0.0 111.314 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -100.88 109.61 21.59 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.291 0.567 . . . . 0.0 111.141 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -97.41 99.88 11.31 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.116 176.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.806 HG11 HG11 ' A' ' 25' ' ' VAL . 12.2 t -99.14 127.22 52.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.656 -172.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.502 ' O ' ' HA ' ' A' ' 92' ' ' SER . 54.8 mtp180 -118.15 176.19 5.33 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.253 -177.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 59.44 46.71 12.02 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.127 0.489 . . . . 0.0 111.242 178.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -79.55 -148.75 4.87 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.081 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' A' ' 62' ' ' ALA . 94.7 Cg_exo -40.97 -60.72 0.58 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 124.261 3.307 . . . . 0.0 114.109 -176.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -132.02 66.19 1.56 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.127 0.489 . . . . 0.0 109.683 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.12 24.52 71.87 Favored Glycine 0 N--CA 1.453 -0.199 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 -176.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.439 ' HB3' ' HD2' ' A' ' 59' ' ' PRO . . . -81.43 165.08 21.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.354 -0.423 . . . . 0.0 111.652 -175.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.425 ' HG2' ' HA ' ' A' ' 56' ' ' ARG . 23.0 mt-10 -139.4 142.9 37.48 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.596 -178.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -140.11 168.54 25.06 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.699 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -147.45 116.09 6.72 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.801 0.334 . . . . 0.0 110.881 -176.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 14.1 m-90 -119.49 142.95 47.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.818 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 42.4 t -111.01 114.51 47.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.661 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.542 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 4.3 mp -89.05 99.78 9.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 174.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -89.16 103.08 15.73 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.793 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -115.1 17.19 16.87 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.827 175.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -66.44 -40.04 89.24 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.256 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -85.25 -13.99 48.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.927 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.81 12.6 39.96 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.543 -0.753 . . . . 0.0 113.014 176.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.608 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 8.5 mmpt? -86.3 -38.01 17.95 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.986 -0.285 . . . . 0.0 111.603 -178.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.2 35.42 23.81 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.251 -0.976 . . . . 0.0 112.724 177.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.517 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 58.5 pttt -96.72 148.08 23.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.891 0.346 . . . . 0.0 110.884 -172.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.493 HG21 ' HB3' ' A' ' 29' ' ' MET . 0.7 OUTLIER -111.75 137.18 45.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 176.766 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.3 t -140.57 132.68 27.95 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.962 0.411 . . . . 0.0 110.847 -178.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -69.29 121.27 16.52 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 56.86 73.02 0.47 Allowed 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -174.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.73 -35.64 85.95 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.56 -0.746 . . . . 0.0 113.576 -174.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.27 1.07 90.42 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.401 -176.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -91.52 169.82 10.45 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -100.25 107.28 46.81 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.943 173.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.425 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 12.4 Cg_exo -70.78 130.0 17.39 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.59 2.194 . . . . 0.0 112.203 178.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -67.59 -29.01 68.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.858 176.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.4 m -139.51 138.73 39.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.189 172.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.595 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 46.8 m -121.4 129.35 52.97 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.219 177.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.628 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 76.4 m-85 -116.51 126.39 53.28 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.091 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.503 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 2.8 m -102.85 125.53 49.64 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.614 ' CG1' HG13 ' A' ' 115' ' ' ILE . 0.3 OUTLIER -156.76 150.33 9.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.22 0.533 . . . . 0.0 111.104 -174.345 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.502 ' HA ' ' O ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -77.99 139.73 39.16 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.356 178.285 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -52.33 -29.8 25.35 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.263 177.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -68.97 -39.28 79.54 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.537 -178.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -90.14 -25.79 20.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.42 -174.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 1.086 HG11 HG12 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -57.66 -32.56 42.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.02 0.438 . . . . 0.0 110.444 -177.767 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.7 m -69.14 -28.2 38.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.748 -174.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -81.5 -37.19 28.27 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 176.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.414 HD23 ' O ' ' A' ' 104' ' ' LEU . 88.4 mt -64.15 -48.97 73.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.794 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 96' ' ' VAL . 20.2 mt -73.28 -24.96 20.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.543 -176.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.3 t -89.07 -9.81 49.76 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.779 0.324 . . . . 0.0 111.173 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 86.46 16.9 61.35 Favored Glycine 0 N--CA 1.453 -0.177 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.204 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -89.54 -42.72 11.27 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.99 0.424 . . . . 0.0 110.763 -178.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.723 HD11 ' NZ ' ' A' ' 108' ' ' LYS . 49.6 tp -105.59 127.97 53.35 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.846 -178.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -72.97 124.14 90.38 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.471 175.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -65.7 -25.17 54.19 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.347 2.031 . . . . 0.0 110.262 176.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -57.43 -61.41 2.51 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.897 173.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.723 ' NZ ' HD11 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -63.02 -35.63 80.88 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.138 -178.783 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.548 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -69.12 -32.29 71.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.971 -176.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -62.93 -50.49 70.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.701 174.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -64.94 -31.89 73.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.111 -177.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -83.93 1.53 43.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.984 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.98 12.3 82.78 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.833 -0.698 . . . . 0.0 113.446 174.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.502 ' HA ' ' HE3' ' A' ' 114' ' ' LYS . 0.3 OUTLIER -87.34 -42.88 12.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.822 0.344 . . . . 0.0 110.496 178.166 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.614 HG13 ' CG1' ' A' ' 91' ' ' ILE . 0.1 OUTLIER -91.05 114.44 28.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.554 0.692 . . . . 0.0 110.004 178.237 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.503 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 29.0 mmmt -111.73 99.79 8.43 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.411 176.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.628 ' HB ' ' CD2' ' A' ' 89' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--N 1.319 -0.76 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.442 -178.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 . . . . . 0 CA--C 1.517 -0.32 0 CA-C-O 121.142 0.496 . . . . 0.0 110.528 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -52.73 -36.97 74.96 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 124.229 3.286 . . . . 0.0 112.081 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -54.22 -37.34 64.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.81 176.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -79.2 -5.05 53.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.335 -175.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -78.9 148.58 32.68 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.128 0.489 . . . . 0.0 110.037 176.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.478 ' HD3' HG11 ' A' ' 97' ' ' VAL . 46.8 mttp -70.86 -25.71 62.94 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 176.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 1.08 HG12 HG11 ' A' ' 96' ' ' VAL . 0.9 OUTLIER -72.87 -17.75 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 114.988 -1.006 . . . . 0.0 111.022 -178.75 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -56.31 -53.78 53.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.825 0.345 . . . . 0.0 110.472 -176.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.447 ' HE2' HG23 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -70.59 -40.35 73.29 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.496 178.242 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.443 ' HB3' HD12 ' A' ' 100' ' ' ILE . 9.8 m-85 -64.67 -45.37 86.98 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -175.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.463 ' CE ' HD11 ' A' ' 68' ' ' ILE . 66.8 mtp -75.97 -22.81 55.5 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.371 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.461 ' HA ' ' HD2' ' A' ' 30' ' ' LYS . 24.4 mmmt -71.63 -36.78 70.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.933 174.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.447 HG23 ' HE2' ' A' ' 27' ' ' LYS . 16.1 pt -82.22 -25.25 9.13 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.485 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.122 175.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.8 tt -56.54 -53.04 62.21 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 171.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.488 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 14.1 tt0 -43.82 -49.09 8.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.267 -1.333 . . . . 0.0 111.725 175.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -75.15 -55.57 5.6 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.533 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.477 ' HA ' ' HB3' ' A' ' 38' ' ' ASN . . . -56.21 -36.28 68.26 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -168.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 25.2 mmt -61.41 -43.86 98.13 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.678 0.275 . . . . 0.0 111.483 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -91.7 -17.01 26.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.28 0.562 . . . . 0.0 110.602 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.477 ' HB3' ' HA ' ' A' ' 35' ' ' ALA . 55.8 t30 -66.34 -36.26 82.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.781 177.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -56.91 125.94 24.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.31 175.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.79 -26.33 34.01 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -175.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -92.16 -16.6 26.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.476 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 35.87 69.02 0.2 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.904 0.859 . . . . 0.0 111.104 -177.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.1 mt -65.18 -0.73 1.83 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.731 -174.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.535 HG13 ' HB1' ' A' ' 70' ' ' ALA . 4.9 tp -61.83 -26.54 40.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.296 -177.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.467 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 44.6 mt-10 -76.51 -22.46 54.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.894 0.378 . . . . 0.0 111.053 -176.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -76.45 -19.18 58.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.654 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 47' ' ' VAL . 10.6 p -130.02 32.4 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.633 0.73 . . . . 0.0 110.076 -176.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.467 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 55.4 mtt180 -46.86 119.8 2.69 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.992 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . -179.88 166.64 35.9 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.314 -177.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.478 HG13 ' HB2' ' A' ' 71' ' ' LYS . 55.1 mt -102.79 122.93 55.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.142 0.496 . . . . 0.0 110.842 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.458 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 21.6 m-85 -103.32 118.56 37.05 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.933 -177.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.43 111.76 4.3 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.389 -0.91 . . . . 0.0 111.279 177.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -97.86 104.91 16.98 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.059 0.457 . . . . 0.0 111.458 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -92.7 99.07 11.83 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.691 175.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.792 HG11 HG11 ' A' ' 25' ' ' VAL . 6.0 t -102.34 145.42 12.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.673 -178.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.563 ' CB ' ' HG2' ' A' ' 63' ' ' GLU . 1.1 ptm180 -154.21 -174.2 4.87 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.544 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 64.71 38.17 7.11 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.082 0.468 . . . . 0.0 110.216 -174.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.24 -154.55 4.45 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.824 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo -36.6 -60.0 0.4 Allowed 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 124.326 3.351 . . . . 0.0 113.938 -174.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -128.57 54.88 1.73 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.221 0.534 . . . . 0.0 109.882 178.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 74.53 28.4 63.55 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.544 -176.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.06 156.24 30.15 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 121.391 0.615 . . . . 0.0 111.204 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.563 ' HG2' ' CB ' ' A' ' 56' ' ' ARG . 34.7 mt-10 -125.14 147.58 48.96 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.296 -178.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -143.12 162.91 27.5 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.343 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -150.63 114.9 5.11 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.819 0.342 . . . . 0.0 110.97 -177.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 15.5 m-90 -120.47 136.28 54.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.13 0.49 . . . . 0.0 109.835 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 14.6 t -103.49 116.66 47.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.425 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.463 HD11 ' CE ' ' A' ' 29' ' ' MET . 4.3 mp -93.38 101.21 12.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 175.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -85.69 98.38 10.66 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.246 -177.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.535 ' HB1' HG13 ' A' ' 44' ' ' ILE . . . -107.04 0.73 23.82 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.227 176.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.478 ' HB2' HG13 ' A' ' 50' ' ' ILE . 5.1 tppp? -63.54 -41.73 98.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.399 0.618 . . . . 0.0 109.918 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -76.47 -6.68 52.81 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.424 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.83 8.5 63.5 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.761 176.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -92.01 -55.73 3.34 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -176.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.2 34.93 7.81 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 119.824 -1.179 . . . . 0.0 111.889 -176.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.488 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 22.7 pttp -96.56 144.16 26.88 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -176.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.7 OUTLIER -107.63 131.7 57.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.536 0.684 . . . . 0.0 109.619 -178.787 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.549 HG23 ' HA2' ' A' ' 81' ' ' GLY . 1.8 t -139.83 135.35 32.89 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.563 -178.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -63.19 128.46 35.96 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -176.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 73.25 -42.69 0.53 Allowed 'General case' 0 N--CA 1.471 0.584 0 O-C-N 124.011 0.82 . . . . 0.0 111.578 -177.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.549 ' HA2' HG23 ' A' ' 78' ' ' THR . . . 73.81 -41.81 1.06 Allowed Glycine 0 N--CA 1.453 -0.189 0 N-CA-C 114.425 0.53 . . . . 0.0 114.425 175.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.81 5.94 76.38 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.659 -175.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.403 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 13.3 mm-40 -114.23 143.41 44.88 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -177.345 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -77.77 110.56 13.39 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 121.185 0.517 . . . . 0.0 110.792 174.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.427 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 13.4 Cg_exo -70.16 130.05 18.19 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.861 2.374 . . . . 0.0 112.452 -178.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -63.57 -34.3 77.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.485 176.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.516 ' HB ' ' CD1' ' A' ' 117' ' ' ILE . 9.0 m -139.4 133.93 39.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.556 176.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.662 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 53.9 m -116.77 139.33 50.7 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.517 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.49 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 54.4 m-85 -118.06 132.92 56.32 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.491 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 5.7 m -110.1 128.67 55.57 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 175.088 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.596 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -161.99 144.23 3.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.071 0.462 . . . . 0.0 109.862 -177.214 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -81.6 147.24 29.69 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.316 0.579 . . . . 0.0 111.154 177.988 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -51.25 -29.16 13.63 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 114.449 -1.251 . . . . 0.0 112.033 -177.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -73.51 -34.26 65.19 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.32 -176.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -90.08 -27.39 19.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.843 -175.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 1.08 HG11 HG12 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -56.82 -31.61 36.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.217 -174.889 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.478 HG11 ' HD3' ' A' ' 24' ' ' LYS . 12.8 m -69.34 -29.24 41.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.687 -170.317 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -83.96 -31.43 25.58 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 176.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.483 HD23 ' O ' ' A' ' 104' ' ' LEU . 91.2 mt -64.63 -51.55 62.05 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.269 0.557 . . . . 0.0 110.562 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 96' ' ' VAL . 14.9 mt -75.51 -16.75 15.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.395 -175.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 42.0 t -94.14 -4.29 49.47 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.207 -0.308 . . . . 0.0 111.322 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.57 30.92 55.73 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.705 -0.759 . . . . 0.0 111.939 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -106.7 -42.67 4.9 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.223 0.535 . . . . 0.0 110.571 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.483 ' O ' HD23 ' A' ' 99' ' ' LEU . 33.8 tp -103.32 120.74 41.35 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.694 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.46 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 5.9 m-20 -68.51 120.48 75.6 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.467 178.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -63.68 -21.47 69.98 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.21 1.94 . . . . 0.0 110.578 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -62.81 -58.69 6.55 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.958 174.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.526 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 1.2 ptmt -66.74 -33.95 76.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.015 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.526 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -65.87 -29.42 69.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.955 0.407 . . . . 0.0 110.098 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -65.39 -46.82 78.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.627 175.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -67.43 -37.2 82.64 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.1 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -79.71 10.92 3.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.857 -176.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.78 7.83 83.94 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 121.236 -0.507 . . . . 0.0 113.268 173.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -82.15 -53.4 6.11 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.117 0.484 . . . . 0.0 110.456 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.643 HG23 HG22 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -88.52 115.12 28.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.585 -177.633 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.491 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 31.2 mmmt -111.06 103.22 11.65 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.524 176.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.662 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.447 -0.588 0 CA-C-O 121.159 0.504 . . . . 0.0 110.955 -176.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 64.6 m-20 . . . . . 0 CA--C 1.519 -0.247 0 CA-C-O 121.353 0.597 . . . . 0.0 110.711 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 19' ' ' ASN . 25.6 Cg_exo -56.38 -35.29 96.02 Favored 'Trans proline' 0 CA--C 1.518 -0.293 0 C-N-CA 123.906 3.07 . . . . 0.0 112.397 -176.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.412 ' HA ' ' CD1' ' A' ' 26' ' ' PHE . 40.7 tt0 -60.49 -37.61 81.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.585 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -74.92 -18.14 60.45 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.683 0.278 . . . . 0.0 111.307 -173.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -67.84 154.82 40.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.501 0.667 . . . . 0.0 110.569 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.445 ' HD2' HG11 ' A' ' 97' ' ' VAL . 15.2 ttmm -80.43 -20.43 43.87 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.318 -0.855 . . . . 0.0 108.917 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.807 HG12 HG11 ' A' ' 96' ' ' VAL . 1.3 m -77.27 -14.11 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.934 178.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.412 ' CD1' ' HA ' ' A' ' 21' ' ' GLU . 69.1 t80 -51.86 -56.06 16.27 Favored 'General case' 0 N--CA 1.462 0.135 0 O-C-N 123.055 0.222 . . . . 0.0 111.418 -175.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.3 -40.6 96.26 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.037 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.427 ' HB3' HD12 ' A' ' 100' ' ' ILE . 32.8 m-85 -66.18 -49.2 68.15 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.548 -177.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.669 ' HB3' HG21 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -61.73 -33.23 73.68 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.825 0.345 . . . . 0.0 110.954 175.531 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.8 mmmt -69.67 -39.6 76.91 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 11.2 pt -81.45 -22.06 10.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.108 177.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.6 tt -58.27 -48.05 81.69 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 171.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -48.14 -50.81 27.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.757 175.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.456 ' O ' ' HB2' ' A' ' 38' ' ' ASN . 25.5 tt0 -69.63 -52.14 28.58 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.84 -178.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.36 -37.28 82.96 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -166.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.8 mmt -58.06 -47.32 83.52 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.757 0.281 . . . . 0.0 111.757 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -91.08 -8.66 48.29 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.073 0.463 . . . . 0.0 110.558 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -67.82 -25.95 65.82 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 176.558 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -54.33 122.35 10.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.798 176.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.86 -39.79 59.5 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.857 -1.065 . . . . 0.0 113.001 -173.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -103.35 19.01 20.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.839 -0.164 . . . . 0.0 111.385 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 21.88 76.36 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.157 1.383 . . . . 0.0 112.736 -177.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.8 mt -65.91 -1.77 3.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.065 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.2 tp -58.7 -26.73 32.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.69 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.557 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 31.5 mt-10 -77.67 -14.58 59.58 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.358 -177.204 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.9 mttm -89.33 -12.74 39.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.175 0.512 . . . . 0.0 110.384 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 47' ' ' VAL . 9.7 p -131.3 33.07 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.776 0.798 . . . . 0.0 109.774 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.557 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 51.0 mtt180 -52.5 109.86 0.44 Allowed 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.645 0.736 . . . . 0.0 111.361 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.581 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . -171.42 155.8 24.95 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 114.419 -1.264 . . . . 0.0 111.292 -176.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.491 HG13 ' HB2' ' A' ' 71' ' ' LYS . 73.6 mt -96.79 126.56 49.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 117.132 0.466 . . . . 0.0 110.768 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.47 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 9.9 m-85 -104.66 117.47 34.19 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.91 -176.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -98.68 109.75 3.86 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.273 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -98.33 103.73 15.7 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.275 0.56 . . . . 0.0 111.457 -178.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -89.6 99.41 12.42 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.254 174.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.666 HG11 HG11 ' A' ' 25' ' ' VAL . 20.2 t -96.97 121.44 47.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.627 -174.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.46 ' HE ' ' CD ' ' A' ' 63' ' ' GLU . 51.7 mtp180 -108.37 178.24 4.55 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.874 -178.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 18.4 m120 61.05 43.74 11.01 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.242 0.544 . . . . 0.0 111.036 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.24 -155.94 7.31 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.531 -0.759 . . . . 0.0 113.239 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -43.53 -60.73 0.7 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.831 3.021 . . . . 0.0 113.486 -176.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -114.25 47.42 1.22 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 177.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.9 22.21 78.82 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.572 -0.823 . . . . 0.0 111.311 -174.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.94 169.73 16.27 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.441 0.638 . . . . 0.0 111.843 -175.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.46 ' CD ' ' HE ' ' A' ' 56' ' ' ARG . 20.5 mt-10 -131.66 110.54 10.99 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.844 -178.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -100.55 169.15 21.15 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.431 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -150.25 118.54 6.4 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.935 0.398 . . . . 0.0 111.087 -177.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 20.7 m-90 -122.0 137.5 54.78 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.832 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 37.2 t -109.61 115.47 49.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.57 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.502 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 4.2 mp -95.52 106.43 18.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -86.38 98.57 11.07 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.215 0.531 . . . . 0.0 110.148 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -101.42 -2.65 30.33 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.744 174.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.491 ' HB2' HG13 ' A' ' 50' ' ' ILE . 4.5 tppp? -64.24 -39.53 94.15 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.575 -178.134 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -87.03 9.38 19.8 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.995 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 76.3 23.32 71.29 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.913 175.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -100.41 -66.22 0.92 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.687 0.279 . . . . 0.0 111.249 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.48 34.63 5.98 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.093 -1.051 . . . . 0.0 111.323 -174.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 0.1 OUTLIER -96.82 145.46 25.83 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -177.705 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.669 HG21 ' HB3' ' A' ' 29' ' ' MET . 1.2 m -107.79 129.42 61.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.591 HG23 ' HA2' ' A' ' 81' ' ' GLY . 2.1 t -134.0 134.0 41.95 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.871 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.452 ' O ' ' HB3' ' A' ' 80' ' ' ASN . 51.8 t80 -61.93 123.35 17.81 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.208 -177.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.452 ' HB3' ' O ' ' A' ' 79' ' ' TYR . 9.4 t30 75.29 -40.57 0.43 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.485 0.714 . . . . 0.0 111.663 -177.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.591 ' HA2' HG23 ' A' ' 78' ' ' THR . . . 72.36 -42.64 0.83 Allowed Glycine 0 CA--C 1.517 0.158 0 N-CA-C 114.736 0.654 . . . . 0.0 114.736 174.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 71.93 19.89 78.53 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.337 -174.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -125.38 158.77 33.46 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -177.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -98.04 108.83 48.87 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-O 120.929 0.395 . . . . 0.0 110.231 175.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.481 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 21.1 Cg_exo -66.12 132.44 29.91 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 123.008 2.472 . . . . 0.0 112.911 -177.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -61.34 -32.68 72.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.746 174.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.9 m -139.73 131.67 34.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.82 174.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.646 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 32.2 m -114.43 133.28 55.85 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.104 177.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.623 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 72.0 m-85 -119.82 128.89 54.12 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.512 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 2.1 m -102.83 119.43 38.83 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 175.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.586 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 66.0 mt -143.01 151.7 17.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -173.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.51 146.75 27.41 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.325 0.584 . . . . 0.0 110.917 176.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -53.16 -26.06 15.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.679 179.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -80.75 -37.33 30.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.041 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -87.57 -22.89 24.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.341 -173.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.807 HG11 HG12 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -56.4 -34.64 41.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.0 0.428 . . . . 0.0 110.568 -179.178 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.445 HG11 ' HD2' ' A' ' 24' ' ' LYS . 6.3 m -69.76 -29.54 41.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.15 -172.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -82.82 -33.49 27.19 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.511 HD23 ' O ' ' A' ' 104' ' ' LEU . 80.8 mt -68.43 -45.36 72.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.84 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.577 HG13 ' O ' ' A' ' 96' ' ' VAL . 22.1 mt -77.09 -19.4 14.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.097 -177.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 31.4 t -94.56 -1.26 53.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.751 0.31 . . . . 0.0 110.955 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.68 20.35 76.6 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.232 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -94.78 -42.27 8.81 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.076 0.465 . . . . 0.0 110.972 -177.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.511 ' O ' HD23 ' A' ' 99' ' ' LEU . 42.8 tp -101.5 124.73 47.65 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.115 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -72.94 123.64 89.82 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.513 177.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -65.53 -21.39 59.98 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.043 1.829 . . . . 0.0 110.113 176.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -59.15 -61.51 2.58 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.795 172.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.529 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 0.6 OUTLIER -66.12 -33.81 76.63 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.054 -177.848 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.55 ' HB3' HD12 ' A' ' 115' ' ' ILE . . . -68.72 -31.27 70.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.408 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -65.77 -49.02 69.85 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 174.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -62.9 -43.65 98.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.153 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -77.26 9.35 3.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.875 -177.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.03 -19.65 44.81 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 121.039 -0.601 . . . . 0.0 113.68 170.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -57.98 -61.11 2.78 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.659 HG23 HG22 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -79.3 114.88 20.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.853 0.835 . . . . 0.0 111.233 -173.929 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.512 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 0.0 OUTLIER -107.03 98.99 8.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.801 -1.091 . . . . 0.0 109.163 173.128 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.659 HG22 HG23 ' A' ' 115' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.319 -0.757 0 CA-C-O 121.123 0.487 . . . . 0.0 110.304 178.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.408 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 51.1 m-80 . . . . . 0 C--O 1.232 0.151 0 CA-C-O 121.224 0.535 . . . . 0.0 110.989 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 19' ' ' ASN . 5.0 Cg_exo -66.13 -22.12 54.74 Favored 'Trans proline' 0 CA--C 1.517 -0.327 0 C-N-CA 123.193 2.595 . . . . 0.0 111.734 -175.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.444 ' HG3' ' H ' ' A' ' 21' ' ' GLU . 10.8 mt-10 -60.01 -36.54 77.43 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.028 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -76.39 -13.18 60.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.406 -174.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -77.75 141.4 39.31 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 177.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -74.97 -24.14 58.39 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.48 0.657 . . . . 0.0 109.261 -178.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.701 HG12 HG11 ' A' ' 96' ' ' VAL . 0.8 OUTLIER -69.34 -15.62 19.76 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.305 176.251 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -58.71 -56.39 22.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.802 0.334 . . . . 0.0 110.462 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.468 ' O ' HG23 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -69.4 -33.51 73.11 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.468 -178.666 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.45 ' O ' HG12 ' A' ' 31' ' ' ILE . 13.1 m-85 -70.21 -50.8 36.26 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.457 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.762 ' HB3' HG21 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -62.14 -33.14 73.93 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.68 0.276 . . . . 0.0 111.274 176.111 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -67.6 -34.16 76.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.715 -0.221 . . . . 0.0 111.57 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.468 HG23 ' O ' ' A' ' 27' ' ' LYS . 17.7 pt -85.59 -21.56 7.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.026 176.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.8 tt -61.86 -48.31 81.12 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 171.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.474 ' HG2' ' HA ' ' A' ' 76' ' ' LYS . 2.0 tm-20 -43.9 -50.53 8.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.843 173.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -72.04 -53.46 12.84 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.675 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.404 ' HA ' ' HB3' ' A' ' 38' ' ' ASN . . . -62.9 -39.31 94.12 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -166.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 20.9 mmt -55.14 -43.69 74.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.603 0.239 . . . . 0.0 111.628 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -92.09 -18.77 23.1 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.236 -0.585 . . . . 0.0 111.241 177.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.404 ' HB3' ' HA ' ' A' ' 35' ' ' ALA . 66.7 t30 -69.8 -22.95 63.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.972 0.415 . . . . 0.0 110.261 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -59.57 126.81 29.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.136 174.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 13.7 m -57.28 -23.89 51.32 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.508 -175.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -100.09 4.33 44.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 119.296 -0.383 . . . . 0.0 111.9 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 32.4 p30 28.57 60.73 0.13 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.397 1.079 . . . . 0.0 111.976 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 36.1 mt -59.67 -12.73 7.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.424 -1.262 . . . . 0.0 111.922 -174.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.419 HG13 ' HB1' ' A' ' 70' ' ' ALA . 3.8 tp -60.69 -27.06 39.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.818 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -68.92 -26.88 65.31 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.555 -175.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -83.94 -22.45 31.5 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.979 0.418 . . . . 0.0 111.052 -178.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 47' ' ' VAL . 12.0 p -123.54 33.34 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.755 0.788 . . . . 0.0 110.421 -175.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -49.81 117.58 2.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.585 0.707 . . . . 0.0 111.137 177.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . -173.4 -171.3 37.86 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.264 -176.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 76.4 mt -126.92 131.19 71.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 117.998 0.899 . . . . 0.0 111.24 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.516 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 33.7 m-85 -110.33 132.2 54.39 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.116 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -109.34 112.15 3.36 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.493 -0.86 . . . . 0.0 111.409 175.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -98.44 105.7 17.88 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.948 0.404 . . . . 0.0 111.28 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -91.28 99.78 12.7 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.175 173.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.682 HG11 HG11 ' A' ' 25' ' ' VAL . 19.4 t -97.84 123.95 50.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.663 -174.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 44.9 mtp180 -112.57 -178.53 3.42 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.3 m120 61.96 44.83 7.9 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.246 0.546 . . . . 0.0 110.792 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.01 -177.02 47.05 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.576 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -35.77 -61.12 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 124.849 3.699 . . . . 0.0 114.315 -175.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -110.91 41.91 1.72 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.159 0.504 . . . . 0.0 110.597 -177.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.45 30.94 63.8 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -173.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.27 173.35 10.43 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 114.769 -0.715 . . . . 0.0 111.836 -176.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -140.01 135.45 32.71 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.972 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -127.06 163.05 21.07 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.938 -0.648 . . . . 0.0 111.688 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -141.37 120.53 12.95 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.842 0.353 . . . . 0.0 110.642 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 22.7 m-90 -122.97 130.35 52.71 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.071 0.462 . . . . 0.0 109.805 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.1 t -101.84 118.91 49.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.34 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.637 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 4.3 mp -94.47 103.32 14.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.162 0.506 . . . . 0.0 109.816 178.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -85.87 98.3 10.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.986 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -95.94 -10.92 27.49 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.927 173.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.1 tttt -51.44 -46.55 63.05 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.533 -178.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -89.42 12.97 14.83 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.169 0.509 . . . . 0.0 111.84 -175.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 88.67 -1.39 83.69 Favored Glycine 0 C--N 1.319 -0.376 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.987 175.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.4 mmmp? -78.68 -74.62 0.27 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.79 0.329 . . . . 0.0 111.729 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.24 34.89 5.69 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 -167.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.637 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 16.3 ptmt -97.33 151.14 20.21 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.312 -0.444 . . . . 0.0 110.022 -174.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.762 HG21 ' HB3' ' A' ' 29' ' ' MET . 0.7 OUTLIER -107.4 143.08 18.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 120.311 -0.555 . . . . 0.0 109.743 176.765 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.2 t -139.22 132.4 29.76 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.188 177.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -68.34 121.63 16.68 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.161 -178.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 64.8 t30 52.21 62.64 2.6 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.993 -176.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -59.13 -36.58 89.21 Favored Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 115.329 -0.85 . . . . 0.0 113.416 -175.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.5 -16.04 51.43 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.061 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.427 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 8.5 mm-40 -75.68 148.18 38.85 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 176.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 29.9 mmmt -86.55 109.03 20.55 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-O 121.017 0.437 . . . . 0.0 110.128 177.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 84' ' ' LYS . 16.8 Cg_exo -67.65 142.5 58.69 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.018 2.479 . . . . 0.0 112.512 -176.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -62.38 -33.76 75.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.759 171.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.2 m -141.76 139.1 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.059 174.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.605 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 29.5 m -115.41 137.21 52.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.222 176.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.593 ' CD1' ' HB ' ' A' ' 117' ' ' ILE . 81.9 m-85 -121.27 136.09 55.02 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 178.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.44 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 3.6 m -110.36 116.76 32.01 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 176.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.532 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 69.9 mt -140.44 152.05 21.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.694 -172.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.12 145.47 25.92 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.184 0.516 . . . . 0.0 110.536 174.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -53.05 -25.6 13.08 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.416 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -75.29 -36.53 61.15 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.73 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -89.55 -23.86 21.9 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.153 -173.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.701 HG11 HG12 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -55.55 -35.86 39.72 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.337 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.903 -178.108 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 m -61.69 -30.78 49.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.589 -171.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.416 ' HB2' ' HB2' ' A' ' 104' ' ' LEU . 34.0 m-20 -91.46 -25.93 19.07 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.696 0.284 . . . . 0.0 110.404 177.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 89.3 mt -71.87 -39.96 69.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.99 0.424 . . . . 0.0 110.293 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.506 HG12 ' O ' ' A' ' 96' ' ' VAL . 3.0 mm -67.73 -44.49 85.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.039 177.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.587 ' OG ' ' HD3' ' A' ' 103' ' ' LYS . 58.2 p -76.87 -28.54 55.46 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.686 -174.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.97 -1.31 38.44 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.125 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.587 ' HD3' ' OG ' ' A' ' 101' ' ' SER . 1.8 mptm? -66.51 -40.08 89.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.831 0.348 . . . . 0.0 111.522 177.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.732 HD11 ' NZ ' ' A' ' 108' ' ' LYS . 47.9 tp -102.27 130.01 48.85 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.799 -176.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.46 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 19.2 m120 -77.65 123.29 86.61 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.07 176.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -64.49 -25.65 62.84 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.037 1.825 . . . . 0.0 110.419 175.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -60.38 -58.77 7.07 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.144 174.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.732 ' NZ ' HD11 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -63.82 -36.34 83.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.0 -179.618 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.534 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -66.75 -34.38 77.71 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.626 -0.43 . . . . 0.0 109.958 -177.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -57.84 -52.78 64.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.84 175.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -62.95 -32.01 73.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.921 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -84.87 -1.66 56.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.775 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.48 4.45 80.23 Favored Glycine 0 CA--C 1.517 0.19 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.24 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.621 ' HA ' ' CE ' ' A' ' 114' ' ' LYS . 1.4 mmpt? -94.85 10.91 33.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.084 0.469 . . . . 0.0 111.283 -177.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.601 HG23 HG22 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -146.83 109.66 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.828 0.823 . . . . 0.0 109.532 174.878 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.44 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 73.1 mmtt -109.09 99.74 9.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.99 -1.004 . . . . 0.0 108.963 176.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.605 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.319 -0.724 0 CA-C-O 121.25 0.547 . . . . 0.0 110.597 -177.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 78.1 m-20 . . . . . 0 CA--C 1.519 -0.217 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 19' ' ' ASN . 31.2 Cg_exo -56.7 -42.71 62.08 Favored 'Trans proline' 0 N--CA 1.466 -0.097 0 C-N-CA 123.014 2.476 . . . . 0.0 112.244 -176.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -58.58 -33.73 70.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.606 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -70.32 -14.58 62.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.554 -178.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -80.39 144.58 32.57 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 174.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -79.18 -18.28 53.34 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.904 HG12 HG11 ' A' ' 96' ' ' VAL . 1.0 OUTLIER -75.73 -12.1 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.774 177.859 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.426 ' O ' ' HB2' ' A' ' 30' ' ' LYS . 78.8 t80 -58.77 -51.52 69.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.827 0.346 . . . . 0.0 110.793 -178.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.6 -26.8 64.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.846 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.41 ' O ' HG12 ' A' ' 31' ' ' ILE . 31.5 m-85 -79.88 -51.71 8.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.763 -178.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.561 ' SD ' ' HB ' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -59.83 -35.78 75.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.714 0.293 . . . . 0.0 111.266 177.829 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 26' ' ' PHE . 4.9 mmtp -68.94 -31.4 70.26 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.41 HG12 ' O ' ' A' ' 28' ' ' TYR . 10.4 pt -90.7 -16.79 8.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.308 176.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.6 tt -61.04 -47.28 87.15 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 171.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.652 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 7.6 tt0 -48.75 -48.73 40.54 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.562 175.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -64.77 -60.69 2.8 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.724 -1.126 . . . . 0.0 111.081 177.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.98 -46.7 75.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.395 -0.82 . . . . 0.0 113.156 -167.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 35.3 mtt -56.51 -43.62 79.94 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -177.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -92.39 -16.85 25.42 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.103 0.477 . . . . 0.0 110.419 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -63.97 -28.87 70.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.141 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -61.07 126.17 26.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.473 176.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.2 p -68.25 -16.8 64.11 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.315 -174.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -94.02 -3.63 51.0 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 177.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 24.34 72.75 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 O-C-N 124.689 1.243 . . . . 0.0 112.591 -177.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 66.5 mt -64.26 -8.58 13.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.577 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.423 HG13 ' HB1' ' A' ' 70' ' ' ALA . 3.5 tp -60.24 -27.97 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.62 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.475 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 60.7 mm-40 -70.35 -27.86 64.68 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-O 121.022 0.439 . . . . 0.0 111.338 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -85.19 -14.51 46.64 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.77 -176.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 47' ' ' VAL . 14.6 p -130.52 31.04 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.883 0.849 . . . . 0.0 110.221 -177.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.475 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 19.5 mtp180 -51.23 112.97 0.82 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.825 0.821 . . . . 0.0 111.991 -177.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.473 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . -168.88 171.1 42.76 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 114.131 -1.395 . . . . 0.0 111.356 -174.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.529 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 56.9 mt -106.32 127.61 61.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 117.375 0.587 . . . . 0.0 110.78 178.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.473 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 14.7 m-85 -108.69 114.44 28.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.017 -178.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.89 112.08 4.35 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.179 -1.01 . . . . 0.0 111.241 177.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -96.1 105.88 17.98 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.987 0.423 . . . . 0.0 111.343 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.623 ' NZ ' HG21 ' A' ' 88' ' ' THR . 54.6 mttp -91.09 101.46 14.21 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.261 174.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.793 HG11 HG11 ' A' ' 25' ' ' VAL . 21.2 t -100.78 111.54 30.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.679 -174.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' A' ' 92' ' ' SER . 46.9 mtp180 -104.96 176.85 5.03 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.851 -177.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 59.97 46.65 10.74 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.714 176.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.16 -157.47 9.98 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.203 174.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -41.47 -61.12 0.54 Allowed 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 124.028 3.152 . . . . 0.0 113.727 -175.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -115.29 44.16 1.89 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.08 23.17 72.3 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.705 -0.759 . . . . 0.0 111.231 -175.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.67 140.46 56.8 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.498 0.666 . . . . 0.0 111.156 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -114.09 109.48 18.5 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.335 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.08 165.43 16.02 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -148.58 120.54 8.21 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.954 0.406 . . . . 0.0 111.039 -176.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 19.9 m-90 -123.06 129.35 51.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.058 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 55.1 t -99.18 114.44 37.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.657 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.597 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 4.5 mp -92.32 100.21 10.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 175.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -87.93 98.73 11.66 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.297 -177.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -105.63 4.3 30.08 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.078 175.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.464 ' HB2' HG13 ' A' ' 50' ' ' ILE . 3.1 tppp? -60.89 -46.58 90.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.458 -177.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -90.59 20.82 4.34 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.329 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.79 16.43 78.04 Favored Glycine 0 C--N 1.32 -0.315 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.688 175.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -83.88 -55.24 4.35 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.787 -0.206 . . . . 0.0 111.51 -177.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.422 ' H ' ' HA ' ' A' ' 70' ' ' ALA . . . 74.54 33.62 55.66 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.375 -0.917 . . . . 0.0 111.542 -178.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.652 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -99.58 161.61 13.51 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.652 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.7 OUTLIER -120.8 138.84 49.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.906 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.8 t -137.61 136.9 37.96 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.485 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -70.33 117.55 12.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.872 -179.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 52.37 65.54 1.48 Allowed 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.655 0.597 . . . . 0.0 110.295 -175.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -61.0 -40.63 98.76 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.785 -173.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.63 -20.26 47.89 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.803 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.506 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 9.6 mm-40 -68.75 150.19 48.16 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 174.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -82.22 114.1 48.61 Favored Pre-proline 0 N--CA 1.437 -1.078 0 CA-C-O 121.289 0.566 . . . . 0.0 110.844 177.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.529 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 13.2 Cg_exo -68.75 129.61 19.02 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.108 2.539 . . . . 0.0 111.57 174.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -66.47 -32.1 73.26 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 173.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.549 ' HB ' ' CD1' ' A' ' 117' ' ' ILE . 15.6 m -140.7 131.66 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.39 175.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.676 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 59.5 m -111.81 130.07 55.93 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.261 177.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.583 ' CE2' HD13 ' A' ' 117' ' ' ILE . 58.7 m-85 -109.88 125.03 52.36 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 177.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.497 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 12.4 m -104.27 125.82 50.86 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 174.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -157.25 152.8 7.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 123.523 0.514 . . . . 0.0 109.708 -175.96 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 56' ' ' ARG . 11.7 m -85.47 148.0 26.19 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.983 -176.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -50.32 -27.47 6.25 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.067 -0.969 . . . . 0.0 111.118 177.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -74.95 -47.43 29.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.976 -177.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -79.99 -26.37 39.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.547 -173.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.904 HG11 HG12 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -55.2 -33.32 30.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.273 -174.509 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.1 m -69.46 -31.17 48.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.481 -169.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -82.95 -32.33 27.19 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 76.4 mt -65.37 -49.54 68.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.837 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.525 HG13 ' O ' ' A' ' 96' ' ' VAL . 18.7 mt -75.45 -21.35 16.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.6 -174.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.3 t -84.5 -26.19 28.3 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.019 0.438 . . . . 0.0 110.798 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.2 21.54 15.07 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.866 -176.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -97.9 -41.47 8.0 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.949 0.404 . . . . 0.0 111.336 -176.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.716 HD11 ' NZ ' ' A' ' 108' ' ' LYS . 37.0 tp -101.86 127.01 48.87 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.721 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.426 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 16.8 m120 -68.76 122.0 83.31 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.249 176.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -67.99 -21.21 43.69 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.067 1.845 . . . . 0.0 110.033 176.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -64.01 -56.28 16.18 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.685 175.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.716 ' NZ ' HD11 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -64.83 -37.37 87.39 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.78 178.186 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.547 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -67.25 -33.66 75.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.023 0.44 . . . . 0.0 109.956 -178.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -61.17 -50.78 71.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.052 175.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -61.87 -40.16 94.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.843 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -76.26 6.96 4.74 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.993 -177.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.79 6.66 82.35 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.895 175.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -79.39 -47.65 15.38 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.917 0.389 . . . . 0.0 110.585 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.592 HG23 HG22 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -92.02 110.78 23.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.025 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.559 ' HE2' ' HA ' ' A' ' 116' ' ' LYS . 10.8 mmpt? -108.11 105.32 15.02 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.663 176.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.676 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.32 -0.693 0 CA-C-O 121.322 0.582 . . . . 0.0 111.457 -173.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 . . . . . 0 CA--C 1.517 -0.312 0 CA-C-O 121.694 0.759 . . . . 0.0 110.449 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -65.73 -21.27 58.68 Favored 'Trans proline' 0 C--N 1.328 -0.517 0 C-N-CA 123.84 3.027 . . . . 0.0 112.17 -174.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.634 ' HA ' ' CG ' ' A' ' 26' ' ' PHE . 8.6 mt-10 -86.17 -16.73 36.94 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.214 -178.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -84.61 -8.12 59.0 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.905 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -72.1 163.19 28.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.827 177.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.466 ' HG2' ' CG1' ' A' ' 97' ' ' VAL . 5.5 tppp? -79.34 -31.98 43.22 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 174.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.973 HG12 HG11 ' A' ' 96' ' ' VAL . 1.3 m -70.24 -14.88 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.85 -178.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.634 ' CG ' ' HA ' ' A' ' 21' ' ' GLU . 57.6 t80 -56.76 -55.2 37.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.691 0.282 . . . . 0.0 110.594 -178.101 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.422 ' HE2' HG23 ' A' ' 31' ' ' ILE . 0.6 OUTLIER -67.65 -40.78 84.52 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 120.765 0.317 . . . . 0.0 110.549 178.42 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.4 ' O ' HG12 ' A' ' 31' ' ' ILE . 14.4 m-85 -61.43 -45.85 92.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.794 -178.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 64.2 mtp -75.41 -26.56 58.5 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.67 0.271 . . . . 0.0 110.99 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.437 ' HD3' ' HA ' ' A' ' 30' ' ' LYS . 24.5 mmtp -67.73 -40.15 84.22 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 121.064 -0.254 . . . . 0.0 110.687 174.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.422 HG23 ' HE2' ' A' ' 27' ' ' LYS . 10.9 pt -79.67 -23.0 12.07 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.401 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.159 177.12 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.9 tt -57.23 -54.25 48.96 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 172.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.424 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 9.6 tt0 -44.2 -48.52 9.3 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.707 177.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -75.36 -61.18 1.99 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.511 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.402 ' HA ' ' HB3' ' A' ' 38' ' ' ASN . . . -55.79 -34.86 65.67 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -166.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 93.3 mmm -61.17 -43.04 99.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.69 0.281 . . . . 0.0 111.387 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -92.12 -27.03 17.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.158 0.504 . . . . 0.0 110.987 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.402 ' HB3' ' HA ' ' A' ' 35' ' ' ALA . 10.0 t30 -66.95 -27.38 67.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.763 -177.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -60.44 139.94 57.47 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 173.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 p -62.27 -13.95 33.73 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -174.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -97.03 -9.34 28.34 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 119.094 -0.479 . . . . 0.0 111.892 177.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.2 p30 35.49 66.26 0.35 Allowed 'General case' 0 C--N 1.348 0.54 0 CA-C-O 122.129 0.966 . . . . 0.0 110.588 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.5 mt -62.94 -12.02 22.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 113.884 -1.507 . . . . 0.0 112.014 -170.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.9 tp -64.69 -29.09 46.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.878 0.37 . . . . 0.0 111.01 -175.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -72.55 -29.04 63.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.037 -177.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -75.18 -21.48 58.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.312 0.577 . . . . 0.0 110.751 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 47' ' ' VAL . 13.3 p -130.06 32.02 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.701 -173.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -44.87 116.28 1.05 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.5 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.493 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . 179.86 164.27 31.87 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.878 -176.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.515 HG13 ' HB2' ' A' ' 71' ' ' LYS . 51.8 mt -97.05 127.51 49.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 117.467 0.633 . . . . 0.0 110.682 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.488 ' OH ' HG13 ' A' ' 47' ' ' VAL . 9.6 m-85 -108.95 122.48 47.32 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.671 -178.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.54 115.52 5.32 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.369 -0.92 . . . . 0.0 111.396 177.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -101.61 107.41 18.66 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.253 0.549 . . . . 0.0 111.545 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -97.54 99.14 10.54 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.54 176.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.728 HG11 HG11 ' A' ' 25' ' ' VAL . 20.4 t -102.42 125.21 56.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.025 0.441 . . . . 0.0 110.73 -175.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -115.41 177.84 4.52 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.174 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.6 m120 58.72 44.51 17.11 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.015 0.436 . . . . 0.0 111.562 177.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.93 -154.68 8.18 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.936 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 62' ' ' ALA . 71.4 Cg_exo -36.63 -59.94 0.41 Allowed 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 124.575 3.517 . . . . 0.0 114.298 -176.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -128.46 61.99 1.47 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 177.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.55 29.17 74.35 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.211 -176.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.411 ' HB3' ' HD2' ' A' ' 59' ' ' PRO . . . -76.89 154.09 34.09 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.184 0.516 . . . . 0.0 111.173 -177.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -132.55 110.59 10.58 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.494 -177.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.41 163.18 12.55 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.429 -177.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -147.89 116.89 6.8 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.88 0.371 . . . . 0.0 110.62 -178.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 18.9 m-90 -121.2 141.09 51.18 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.273 0.558 . . . . 0.0 109.682 179.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 16.4 t -107.63 117.98 54.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.164 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.447 HG13 HG12 ' A' ' 77' ' ' VAL . 4.1 mp -93.37 99.77 10.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -87.05 99.8 12.17 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.576 -176.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -113.54 13.97 18.9 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.175 175.206 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.515 ' HB2' HG13 ' A' ' 50' ' ' ILE . 17.8 tppt? -64.48 -44.82 89.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.221 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -82.13 -0.73 46.14 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.672 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.8 27.28 32.35 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.308 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -93.36 -62.67 1.32 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.687 0.279 . . . . 0.0 111.037 -178.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.54 34.26 8.04 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.15 -1.024 . . . . 0.0 111.893 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 59.0 pttt -97.86 146.27 25.6 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -177.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.7 OUTLIER -110.82 131.47 61.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.355 0.598 . . . . 0.0 109.859 178.448 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.488 HG23 ' HA2' ' A' ' 81' ' ' GLY . 3.6 t -137.97 139.23 39.6 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.984 -178.048 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.423 ' O ' ' HB3' ' A' ' 80' ' ' ASN . 24.2 t80 -65.1 128.11 34.42 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -178.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.423 ' HB3' ' O ' ' A' ' 79' ' ' TYR . 26.0 t-20 74.92 -45.8 0.58 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.677 0.791 . . . . 0.0 111.999 -178.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.488 ' HA2' HG23 ' A' ' 78' ' ' THR . . . 70.81 -43.14 0.6 Allowed Glycine 0 CA--C 1.52 0.387 0 N-CA-C 114.764 0.666 . . . . 0.0 114.764 177.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.58 -18.84 6.58 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.026 -175.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -82.63 157.89 23.23 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 122.602 0.361 . . . . 0.0 110.358 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -95.43 109.24 44.28 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 174.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.464 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 23.2 Cg_exo -64.72 137.18 52.87 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.034 2.489 . . . . 0.0 112.712 -177.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -68.53 -32.48 72.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.107 -0.952 . . . . 0.0 109.546 176.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.9 m -140.27 130.41 28.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.316 172.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.594 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 28.2 m -114.91 133.87 55.63 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.375 176.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.654 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 53.0 m-85 -118.18 128.71 54.97 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.542 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 5.9 m -106.4 128.34 53.97 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 174.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -159.27 149.52 7.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.172 0.51 . . . . 0.0 110.294 -175.146 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.38 143.53 36.75 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.329 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -49.01 -29.01 4.37 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 114.869 -1.059 . . . . 0.0 111.091 176.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -73.22 -44.38 59.69 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.217 -176.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -81.51 -25.74 35.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.036 -176.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.973 HG11 HG12 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -56.62 -33.92 41.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.303 -175.007 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.466 ' CG1' ' HG2' ' A' ' 24' ' ' LYS . 3.9 m -68.35 -27.94 38.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.992 -170.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -87.23 -29.86 21.37 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 177.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 77.9 mt -68.2 -46.5 70.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.799 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 96' ' ' VAL . 20.1 mt -75.1 -24.41 17.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.296 -176.086 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.1 p -85.48 -18.11 34.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.036 0.446 . . . . 0.0 111.022 178.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.39 13.24 58.78 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.084 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -85.39 -41.43 15.45 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.133 0.492 . . . . 0.0 111.164 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.702 HD11 ' NZ ' ' A' ' 108' ' ' LYS . 44.4 tp -99.46 125.54 45.21 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.426 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -71.99 122.23 86.74 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.561 177.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -64.87 -23.34 62.27 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.213 1.942 . . . . 0.0 110.385 176.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -54.96 -62.3 1.75 Allowed 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.935 171.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.702 ' NZ ' HD11 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -64.11 -36.06 82.81 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.314 -176.368 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.563 ' HB3' HD12 ' A' ' 115' ' ' ILE . . . -69.78 -33.64 72.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.154 -178.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -64.17 -49.89 70.3 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 175.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -58.79 -40.64 84.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.029 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -84.8 13.68 5.57 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.248 -176.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.546 ' O ' ' HE3' ' A' ' 116' ' ' LYS . . . 70.17 14.68 71.48 Favored Glycine 0 CA--C 1.519 0.293 0 CA-C-N 116.152 -0.476 . . . . 0.0 113.992 172.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.428 ' HA ' ' HE3' ' A' ' 114' ' ' LYS . 0.4 OUTLIER -87.55 -43.55 11.93 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 117.115 0.458 . . . . 0.0 110.219 177.578 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.574 HG23 HG22 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -89.14 114.18 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.703 176.471 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.546 ' HE3' ' O ' ' A' ' 113' ' ' GLY . 35.2 mmtp -110.79 99.4 8.33 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.474 175.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.654 ' HB ' ' CD2' ' A' ' 89' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--N 1.318 -0.79 0 CA-C-O 120.958 0.409 . . . . 0.0 110.153 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 12.6 m120 . . . . . 0 CA--C 1.517 -0.295 0 CA-C-O 121.656 0.741 . . . . 0.0 111.603 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.65 -38.25 62.85 Favored 'Trans proline' 0 CA--C 1.521 -0.142 0 C-N-CA 124.021 3.148 . . . . 0.0 111.947 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.453 ' HA ' ' CD1' ' A' ' 26' ' ' PHE . 35.5 tt0 -60.23 -31.33 70.08 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.713 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.35 -8.83 57.58 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.047 0.451 . . . . 0.0 111.058 -175.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -80.69 153.2 28.02 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.288 -0.414 . . . . 0.0 109.941 175.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 49.3 mmtm -70.56 -29.53 66.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.646 0.736 . . . . 0.0 109.234 177.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.997 HG12 HG11 ' A' ' 96' ' ' VAL . 0.7 OUTLIER -68.4 -17.39 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 114.526 -1.216 . . . . 0.0 111.056 -174.897 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.453 ' CD1' ' HA ' ' A' ' 21' ' ' GLU . 75.3 t80 -55.51 -54.52 42.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.369 -179.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.436 ' O ' HG23 ' A' ' 31' ' ' ILE . 0.5 OUTLIER -72.68 -43.7 62.76 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.56 177.363 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.463 ' HB2' ' HA ' ' A' ' 25' ' ' VAL . 12.9 m-85 -59.15 -46.25 88.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.416 . . . . 0.0 112.106 -175.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.495 ' HE1' ' HB2' ' A' ' 53' ' ' PHE . 73.4 mtp -77.53 -24.76 49.91 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.778 0.323 . . . . 0.0 110.894 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.48 ' HD3' ' HA ' ' A' ' 30' ' ' LYS . 43.0 mmtt -75.87 -31.28 59.18 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.268 177.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.436 HG23 ' O ' ' A' ' 27' ' ' LYS . 13.6 pt -82.94 -27.44 8.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 173.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.403 ' HB3' ' O ' ' A' ' 29' ' ' MET . 5.8 tt -54.16 -51.83 63.06 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 168.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.592 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 9.2 tt0 -43.6 -58.03 2.86 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 114.23 -1.35 . . . . 0.0 111.296 177.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -67.81 -54.12 21.58 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.546 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.44 ' HA ' ' HB3' ' A' ' 38' ' ' ASN . . . -54.49 -37.61 65.49 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -169.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 95.0 mmm -63.34 -37.36 86.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.668 0.271 . . . . 0.0 111.654 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -90.09 -20.64 22.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.439 0.638 . . . . 0.0 110.225 177.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.44 ' HB3' ' HA ' ' A' ' 35' ' ' ALA . 62.7 t30 -69.31 -25.2 64.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.59 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -58.57 133.35 55.77 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 175.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.65 -30.12 41.56 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.752 -174.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -101.55 -5.46 25.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 119.468 -0.301 . . . . 0.0 111.538 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 36.11 73.67 0.08 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.718 0.77 . . . . 0.0 111.513 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 72.6 mt -64.36 -1.07 1.5 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.87 -174.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.447 HG13 ' HB1' ' A' ' 70' ' ' ALA . 4.2 tp -60.35 -25.91 35.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.699 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.43 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 32.9 mt-10 -79.78 -17.38 53.54 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.096 -177.193 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -86.58 -36.08 19.09 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.243 0.544 . . . . 0.0 110.188 177.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 47' ' ' VAL . 12.3 p -105.38 32.97 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.496 -178.017 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.43 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 51.7 mtt180 -53.33 109.96 0.5 Allowed 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.926 0.869 . . . . 0.0 111.523 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.52 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . -173.1 175.01 46.07 Favored Glycine 0 C--N 1.312 -0.788 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.788 -175.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.478 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 42.6 mt -113.09 127.13 70.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 117.904 0.852 . . . . 0.0 111.419 -177.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -109.39 129.16 55.55 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.438 -178.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -108.79 118.4 5.29 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.318 -0.944 . . . . 0.0 111.291 176.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.495 ' HB2' ' HE1' ' A' ' 29' ' ' MET . 4.0 m-85 -102.09 103.29 13.85 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.188 0.518 . . . . 0.0 111.312 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.473 ' NZ ' HG21 ' A' ' 88' ' ' THR . 58.4 mttp -89.95 99.46 12.47 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.151 174.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.753 HG11 HG11 ' A' ' 25' ' ' VAL . 18.4 t -101.78 117.09 46.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.151 -176.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 92' ' ' SER . 39.7 mtp180 -117.9 -179.72 3.84 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.496 -176.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.428 ' HB2' ' HB3' ' A' ' 92' ' ' SER . 92.7 m-20 59.06 46.75 12.91 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.229 0.538 . . . . 0.0 110.969 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.74 -159.0 11.07 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.529 178.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -37.5 -61.1 0.37 Allowed 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 124.324 3.349 . . . . 0.0 114.063 -174.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -130.59 68.11 1.48 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.171 0.51 . . . . 0.0 110.1 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.51 23.04 73.58 Favored Glycine 0 N--CA 1.452 -0.247 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.56 -178.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.4 167.48 20.8 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.071 0.462 . . . . 0.0 111.331 -177.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -142.5 143.81 32.7 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.462 -176.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -136.72 159.92 24.68 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 111.141 -0.783 . . . . 0.0 111.141 178.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.4 ' O ' ' HA ' ' A' ' 79' ' ' TYR . 16.2 t80 -148.08 113.11 5.48 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.936 0.368 . . . . 0.0 110.719 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 18.3 m-90 -118.25 134.85 54.66 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.867 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 25.1 t -104.56 119.92 54.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.547 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.52 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 3.7 mp -95.1 100.98 11.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -86.77 97.58 10.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.221 0.534 . . . . 0.0 109.967 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -98.56 -6.74 29.49 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.243 173.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.44 ' HB2' HG13 ' A' ' 50' ' ' ILE . 21.9 tttt -54.79 -49.4 71.02 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.898 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -80.13 3.48 20.38 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.008 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.14 11.83 83.13 Favored Glycine 0 N--CA 1.452 -0.274 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.956 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -83.26 -59.64 2.4 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.739 0.304 . . . . 0.0 110.803 -177.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.35 34.08 24.04 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.223 -0.989 . . . . 0.0 110.65 -173.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.592 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 14.8 ptmm? -98.03 145.68 26.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.427 -0.387 . . . . 0.0 109.969 -175.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.8 OUTLIER -111.91 132.9 59.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.234 0.54 . . . . 0.0 109.644 178.812 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.0 t -139.36 135.58 33.86 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.918 -176.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.4 ' HA ' ' O ' ' A' ' 65' ' ' TYR . 21.9 t80 -69.89 122.08 18.58 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 53.66 71.59 0.5 Allowed 'General case' 0 C--O 1.234 0.247 0 O-C-N 123.699 0.624 . . . . 0.0 109.83 -173.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -63.12 -34.48 90.07 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.259 -0.882 . . . . 0.0 113.656 -172.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.92 -2.28 87.77 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.526 -176.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.446 ' HB3' HD13 ' A' ' 50' ' ' ILE . 54.6 mm-40 -91.58 163.25 14.2 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.401 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 24.4 pttm -94.55 107.64 31.43 Favored Pre-proline 0 N--CA 1.445 -0.688 0 CA-C-O 121.281 0.562 . . . . 0.0 110.331 173.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.478 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 8.1 Cg_exo -73.79 121.86 7.33 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.657 2.238 . . . . 0.0 112.048 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -59.59 -43.41 93.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.863 176.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.402 ' HB ' ' CD1' ' A' ' 117' ' ' ILE . 13.5 m -126.32 127.61 70.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.601 176.172 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.746 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 43.1 m -117.35 129.42 55.86 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.087 178.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.587 ' CD1' ' HB ' ' A' ' 117' ' ' ILE . 61.7 m-85 -110.52 130.06 55.65 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.561 ' HB ' ' HB3' ' A' ' 116' ' ' LYS . 2.9 m -108.29 107.13 17.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.763 0.316 . . . . 0.0 110.249 178.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.453 HG21 HD12 ' A' ' 99' ' ' LEU . 47.2 mt -131.23 156.75 42.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.537 -174.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.428 ' HB3' ' HB2' ' A' ' 57' ' ' ASN . 23.7 m -92.7 140.72 29.24 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.355 175.056 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -43.29 -51.12 6.43 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.46 0.648 . . . . 0.0 111.66 -177.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.16 -35.61 69.75 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.441 -1.254 . . . . 0.0 112.205 -176.067 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.424 ' OD2' ' HB2' ' A' ' 92' ' ' SER . 12.0 m-20 -90.4 -23.13 21.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.697 0.284 . . . . 0.0 111.252 -175.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.997 HG11 HG12 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -59.02 -31.84 46.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.034 0.445 . . . . 0.0 110.434 -177.857 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.7 m -67.03 -30.9 51.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.182 -172.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -83.14 -32.37 26.71 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.453 HD12 HG21 ' A' ' 91' ' ' ILE . 75.7 mt -66.48 -51.24 58.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.472 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 96' ' ' VAL . 17.7 mt -70.97 -26.25 27.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.082 -176.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.6 t -82.04 -15.2 54.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.702 0.286 . . . . 0.0 111.059 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.23 20.49 48.88 Favored Glycine 0 N--CA 1.454 -0.16 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.005 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -96.9 -41.56 8.36 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.142 0.496 . . . . 0.0 111.023 -178.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.452 HD23 ' HG ' ' A' ' 99' ' ' LEU . 34.1 tp -100.3 125.24 46.49 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.385 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.469 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 12.1 m120 -69.67 122.5 85.99 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.252 177.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -65.81 -21.6 57.75 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.015 1.81 . . . . 0.0 110.843 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 tm0? -65.79 -56.86 9.75 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.722 175.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.497 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -64.99 -32.35 74.03 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.435 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.501 ' HB3' HD12 ' A' ' 115' ' ' ILE . . . -66.8 -39.49 87.78 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.9 177.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -57.16 -52.95 63.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.879 175.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -60.75 -42.83 98.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.53 -178.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.408 ' OE1' ' HA ' ' A' ' 112' ' ' GLN . 16.0 mm-40 -75.78 -11.54 60.01 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.025 -175.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.26 7.71 55.78 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.767 176.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.2 mmpt? -87.17 -14.24 41.73 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.99 0.424 . . . . 0.0 110.728 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.646 HG23 HG22 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -129.55 109.48 18.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.926 0.87 . . . . 0.0 110.251 179.164 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.561 ' HB3' ' HB ' ' A' ' 90' ' ' THR . 38.1 tptt -109.35 110.24 21.34 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.331 173.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.746 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.319 -0.737 0 CA-C-O 121.411 0.624 . . . . 0.0 111.604 -172.083 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 . . . . . 0 CA--C 1.52 -0.193 0 CA-C-O 122.03 0.919 . . . . 0.0 112.023 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.598 ' HA ' ' CD1' ' A' ' 23' ' ' PHE . 20.6 Cg_endo -63.65 -14.21 41.33 Favored 'Trans proline' 0 C--N 1.334 -0.189 0 C-N-CA 124.35 3.367 . . . . 0.0 112.864 -177.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.414 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 3.1 mm-40 -75.52 -20.44 58.72 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.345 -178.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -88.32 -10.93 47.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.371 -0.832 . . . . 0.0 111.175 -176.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.598 ' CD1' ' HA ' ' A' ' 20' ' ' PRO . 18.0 m-85 -69.08 158.65 34.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.671 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -77.05 -27.0 54.26 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 174.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.751 HG12 HG11 ' A' ' 96' ' ' VAL . 0.8 OUTLIER -72.04 -13.69 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.365 -179.06 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -57.02 -57.53 12.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.757 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.455 ' O ' HG23 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -72.0 -30.54 65.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.708 -178.449 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.477 ' HB3' HD12 ' A' ' 100' ' ' ILE . 21.4 m-85 -70.92 -52.11 21.98 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.588 0.218 . . . . 0.0 111.588 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.56 ' HB3' HG21 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -61.9 -31.14 71.41 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.734 0.302 . . . . 0.0 110.971 177.196 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.417 ' HA ' ' HD2' ' A' ' 30' ' ' LYS . 25.7 mmmt -69.3 -33.47 73.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.546 178.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 28' ' ' TYR . 13.3 pt -88.1 -24.37 6.2 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.451 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.2 176.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.5 tt -58.02 -47.22 83.74 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 171.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.642 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 6.8 tt0 -46.21 -50.9 15.24 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.489 175.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -75.0 -58.87 3.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.45 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.02 -40.17 66.78 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -167.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 95.6 mmm -60.6 -41.29 94.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.702 0.287 . . . . 0.0 111.493 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -90.79 -26.02 19.66 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.969 0.414 . . . . 0.0 110.072 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -65.04 -17.11 64.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.57 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -57.62 130.28 45.66 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.381 172.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 22.3 p -65.31 -21.92 66.77 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.952 -173.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -101.09 0.07 37.19 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.832 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 26.19 68.53 0.05 Allowed 'General case' 0 N--CA 1.472 0.63 0 O-C-N 124.481 1.113 . . . . 0.0 112.678 -177.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.4 mt -65.09 -4.12 4.48 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.201 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.9 tp -60.51 -26.33 37.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.748 178.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.417 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 41.3 mt-10 -72.65 -23.19 60.87 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.188 -178.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -79.23 -43.64 23.39 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.361 0.6 . . . . 0.0 110.535 178.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 47' ' ' VAL . 15.0 p -102.67 32.51 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.719 -176.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.417 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 41.8 mtm180 -51.2 117.14 2.39 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.633 0.73 . . . . 0.0 111.427 178.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . -172.89 176.28 45.73 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.616 -176.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 53.8 mt -115.17 124.42 71.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 117.669 0.734 . . . . 0.0 111.358 -178.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.488 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 27.7 m-85 -106.09 118.46 36.68 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.051 -177.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.49 111.51 4.18 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.322 177.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.419 ' O ' ' HA ' ' A' ' 65' ' ' TYR . 4.0 m-85 -96.27 111.14 23.31 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.955 0.407 . . . . 0.0 111.679 -178.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -95.47 105.42 17.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.34 173.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.682 HG11 HG11 ' A' ' 25' ' ' VAL . 22.6 t -105.83 107.39 22.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 120.972 0.415 . . . . 0.0 111.099 -174.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.434 ' N ' ' HD2' ' A' ' 56' ' ' ARG . 1.3 mpt_? -92.48 -179.64 5.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.628 176.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 13.8 m120 58.87 44.74 16.29 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.8 176.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -81.15 -165.02 33.42 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.33 176.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -35.6 -60.93 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 124.619 3.546 . . . . 0.0 114.696 -176.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.47 ' OD1' ' HB2' ' A' ' 62' ' ' ALA . 25.4 p-10 -114.22 43.51 1.86 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.353 0.596 . . . . 0.0 110.328 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.83 24.16 76.55 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 -170.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.47 ' HB2' ' OD1' ' A' ' 60' ' ' ASN . . . -70.7 155.53 40.64 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 114.511 -0.845 . . . . 0.0 111.754 -175.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -115.59 139.27 50.25 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.666 177.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -129.42 152.76 19.63 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 176.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.419 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 44.7 t80 -140.1 116.93 10.97 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.869 0.366 . . . . 0.0 110.656 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 26.9 m-90 -122.72 132.41 54.23 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.278 -178.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 55.4 t -102.76 112.22 35.34 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.201 178.412 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.488 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 4.3 mp -89.92 102.92 13.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.155 -0.684 . . . . 0.0 109.155 176.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.423 ' OD1' ' HB3' ' A' ' 71' ' ' LYS . 44.1 t-20 -85.59 96.94 9.82 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.868 -178.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -99.89 -2.18 35.46 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.829 173.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.423 ' HB3' ' OD1' ' A' ' 69' ' ' ASN . 65.4 tttt -51.4 -50.77 58.98 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.15 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -84.0 -3.54 58.08 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.143 -176.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.19 7.49 76.82 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.254 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.7 tppt? -83.3 -44.76 14.56 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-O 120.884 0.373 . . . . 0.0 110.652 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.07 35.07 35.62 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.756 175.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.642 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -97.0 165.34 12.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.113 0.456 . . . . 0.0 110.085 -177.178 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.56 HG21 ' HB3' ' A' ' 29' ' ' MET . 0.8 OUTLIER -123.02 136.89 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-O 121.177 0.513 . . . . 0.0 109.627 178.672 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.1 t -135.28 136.01 41.3 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.041 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -69.85 116.73 10.57 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 60.3 t30 52.76 74.08 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.836 0.71 . . . . 0.0 110.093 -173.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -63.59 -28.5 72.59 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.385 -0.825 . . . . 0.0 113.152 -177.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.61 -20.26 42.7 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.846 -0.692 . . . . 0.0 111.657 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.416 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 69.2 mm-40 -73.02 156.02 39.21 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 177.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -91.84 108.2 28.12 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 173.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 83' ' ' GLU . 22.1 Cg_exo -65.36 135.45 42.94 Favored 'Trans proline' 0 CA--C 1.517 -0.361 0 C-N-CA 122.95 2.433 . . . . 0.0 112.369 -176.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -62.69 -30.4 71.37 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.776 176.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.5 m -142.63 134.74 25.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.771 176.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.675 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 17.4 m -113.37 141.06 47.5 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.275 -0.421 . . . . 0.0 109.938 177.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.651 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 29.6 m-85 -126.21 134.6 51.19 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 176.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.7 m -111.14 118.64 36.53 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.899 0.381 . . . . 0.0 110.528 176.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.529 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 80.4 mt -141.51 157.2 21.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.484 -0.78 . . . . 0.0 108.933 -175.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.444 ' OG ' ' HE3' ' A' ' 114' ' ' LYS . 6.1 p -93.02 144.81 24.88 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 111.496 0.184 . . . . 0.0 111.496 176.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -41.18 -56.23 2.43 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 122.172 0.987 . . . . 0.0 111.714 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -60.26 -34.04 73.16 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 113.272 -1.785 . . . . 0.0 112.621 -171.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.68 -19.43 22.66 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -177.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.751 HG11 HG12 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -56.52 -34.13 40.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.21 0.529 . . . . 0.0 110.026 -178.958 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.3 m -66.36 -28.97 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.031 -173.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -84.69 -35.5 22.52 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.452 HD23 ' O ' ' A' ' 104' ' ' LEU . 74.8 mt -68.76 -42.25 77.76 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.96 -177.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.57 HG13 ' O ' ' A' ' 96' ' ' VAL . 15.4 mt -76.27 -22.54 15.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.808 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.2 t -88.58 -19.69 25.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.966 0.412 . . . . 0.0 110.776 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.32 0.11 65.57 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.831 -177.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -67.85 -42.11 81.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.027 0.441 . . . . 0.0 110.791 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.452 ' O ' HD23 ' A' ' 99' ' ' LEU . 36.8 tp -104.38 126.38 51.43 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.873 178.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.474 ' HB3' ' HG2' ' A' ' 108' ' ' LYS . 1.8 t-20 -72.97 121.41 85.02 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.828 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -65.68 -20.7 59.44 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.932 1.755 . . . . 0.0 110.775 177.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.11 -55.82 8.47 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.749 174.311 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.53 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 0.4 OUTLIER -62.06 -35.71 79.45 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.457 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.53 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -68.53 -35.58 77.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.33 177.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -59.85 -49.05 79.24 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 175.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -64.87 -33.53 76.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.93 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -87.49 10.42 17.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.751 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.37 1.76 82.34 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 121.285 -0.483 . . . . 0.0 113.661 172.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.643 ' HB3' ' HZ3' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -94.02 11.33 30.13 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -177.081 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.544 HG23 HG22 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -140.95 109.56 2.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-O 121.976 0.893 . . . . 0.0 109.19 172.551 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -109.0 98.45 7.93 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.744 -1.117 . . . . 0.0 109.274 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.675 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.319 -0.743 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.845 178.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.454 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 15.1 m120 . . . . . 0 CA--C 1.52 -0.186 0 CA-C-O 121.152 0.501 . . . . 0.0 111.003 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 19' ' ' ASN . 23.8 Cg_exo -58.98 -31.08 95.01 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 123.413 2.742 . . . . 0.0 111.529 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.496 ' HA ' ' CD1' ' A' ' 26' ' ' PHE . 24.5 tt0 -62.47 -35.44 79.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.254 176.16 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -81.25 1.54 31.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.96 -174.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -77.95 153.86 32.11 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 173.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -76.81 -24.27 52.8 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.986 HG12 HG11 ' A' ' 96' ' ' VAL . 1.3 m -73.84 -14.84 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.038 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.496 ' CD1' ' HA ' ' A' ' 21' ' ' GLU . 83.1 t80 -56.75 -50.25 72.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.718 0.294 . . . . 0.0 110.372 -176.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.61 -44.32 86.87 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.582 178.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -62.47 -46.7 87.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.866 -177.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.474 ' HB3' HG21 ' A' ' 77' ' ' VAL . 56.2 mtt -73.88 -26.69 60.69 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.059 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.44 ' HD3' ' HA ' ' A' ' 30' ' ' LYS . 40.8 mmtt -71.15 -38.9 72.22 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.19 176.132 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 13.6 pt -78.04 -25.17 14.18 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.427 0 C-N-CA 120.329 -0.548 . . . . 0.0 109.793 175.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.3 tt -60.3 -52.76 63.91 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 173.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.533 ' HG2' ' HA ' ' A' ' 76' ' ' LYS . 1.5 tm-20 -43.37 -48.05 6.92 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 114.814 -1.084 . . . . 0.0 111.018 176.179 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -77.19 -53.29 7.93 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.933 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.52 -38.9 82.18 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -168.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 25.9 mmt -60.01 -40.76 90.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.713 0.292 . . . . 0.0 111.624 -178.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -91.39 -19.52 22.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.099 0.476 . . . . 0.0 111.138 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -66.38 -23.5 66.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.247 0.546 . . . . 0.0 110.028 178.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -62.14 133.81 55.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.441 173.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.8 p -62.84 -32.88 74.19 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.037 -174.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -92.06 0.66 57.47 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-O 119.303 -0.379 . . . . 0.0 111.385 178.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.6 p30 34.11 63.32 0.42 Allowed 'General case' 0 N--CA 1.468 0.433 0 O-C-N 124.172 0.92 . . . . 0.0 110.557 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.5 mt -56.97 -12.12 1.84 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 114.427 -1.26 . . . . 0.0 112.056 -173.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.433 HG13 ' HB1' ' A' ' 70' ' ' ALA . 4.2 tp -61.48 -30.99 49.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.81 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.518 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 9.6 tt0 -75.2 -27.03 59.44 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.12 0.486 . . . . 0.0 110.909 -176.168 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -73.37 -15.92 61.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.592 -179.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 47' ' ' VAL . 15.0 p -131.07 31.84 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.276 -178.194 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.518 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 59.7 mtm180 -49.21 109.44 0.26 Allowed 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.942 0.877 . . . . 0.0 112.647 -176.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.495 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . -159.6 170.75 35.89 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 113.88 -1.509 . . . . 0.0 110.493 -178.231 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.513 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 54.6 mt -106.47 125.45 62.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 117.416 0.608 . . . . 0.0 110.749 179.004 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.509 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 16.5 m-85 -107.75 116.26 31.63 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.95 -178.092 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -97.76 111.72 4.31 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.024 177.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -101.32 104.52 15.53 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.061 0.457 . . . . 0.0 111.488 -178.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -91.95 101.51 14.07 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.449 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.711 HG11 HG11 ' A' ' 25' ' ' VAL . 10.4 t -100.98 118.21 47.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.888 -173.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.461 ' O ' ' HA ' ' A' ' 92' ' ' SER . 50.4 mtp180 -110.28 177.66 4.63 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.686 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.432 ' HB2' ' HB3' ' A' ' 92' ' ' SER . 3.3 m-20 57.91 41.7 24.19 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.954 0.407 . . . . 0.0 110.979 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -74.08 -153.28 2.91 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.603 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -32.18 -60.14 0.19 Allowed 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 124.499 3.466 . . . . 0.0 114.233 -177.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -141.51 70.37 1.34 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.045 0.45 . . . . 0.0 109.891 176.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.81 18.15 78.71 Favored Glycine 0 N--CA 1.453 -0.176 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.702 -177.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.58 162.22 26.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.011 0.434 . . . . 0.0 111.246 -177.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -136.25 132.3 35.62 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.788 -177.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -131.98 162.4 23.88 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.453 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -146.56 113.7 6.21 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.829 0.347 . . . . 0.0 110.917 -177.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 16.3 m-90 -113.45 140.21 48.28 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.867 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 45.7 t -106.97 114.53 46.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.902 177.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.534 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 3.9 mp -91.04 99.67 10.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 175.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -87.54 99.03 11.74 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.247 -177.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -101.18 -6.7 23.91 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.892 174.237 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.443 ' HB2' HG13 ' A' ' 50' ' ' ILE . 3.6 tppp? -58.76 -47.53 84.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.996 -176.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -73.52 -6.32 45.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.203 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 94.88 14.35 49.73 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.033 -0.603 . . . . 0.0 111.727 -178.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.501 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 9.1 mmpt? -86.32 -70.05 0.63 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.718 0.294 . . . . 0.0 111.112 -177.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.83 32.16 13.56 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -170.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.534 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 21.8 ptmt -99.16 147.21 25.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.234 -0.483 . . . . 0.0 109.948 -177.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.474 HG21 ' HB3' ' A' ' 29' ' ' MET . 0.6 OUTLIER -107.51 127.34 63.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 176.868 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.2 t -130.71 127.68 39.31 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.473 -178.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -67.59 122.5 18.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.96 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 56.3 t30 54.62 72.61 0.45 Allowed 'General case' 0 C--O 1.233 0.235 0 O-C-N 123.786 0.679 . . . . 0.0 109.928 -174.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.85 -40.34 64.1 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.948 -175.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.14 -20.52 45.51 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.974 -0.632 . . . . 0.0 111.641 -176.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.495 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 40.4 mm-40 -74.08 148.2 42.08 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.646 -0.277 . . . . 0.0 110.295 178.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 24.7 pttm -80.08 109.38 12.15 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-O 121.202 0.525 . . . . 0.0 110.915 176.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.513 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 17.9 Cg_exo -67.6 136.25 38.7 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.847 2.365 . . . . 0.0 112.566 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -69.93 -31.6 69.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.701 175.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.5 m -140.68 127.53 21.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.604 173.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.591 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 64.2 m -110.96 127.39 55.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.342 176.017 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.546 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 83.0 m-85 -113.6 120.36 40.66 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 177.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.447 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 5.0 m -96.6 122.21 39.28 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 175.162 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.567 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -155.64 155.95 5.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.05 0.452 . . . . 0.0 110.794 -172.891 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 56' ' ' ARG . 13.3 m -83.75 143.2 30.15 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.322 -177.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.524 ' OD1' HG13 ' A' ' 25' ' ' VAL . 31.2 t70 -53.66 -27.73 29.2 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.226 1.011 . . . . 0.0 110.908 178.146 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -77.14 -38.12 52.58 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.436 -178.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -90.78 -22.17 21.16 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.763 -173.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.986 HG11 HG12 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -57.31 -32.47 41.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.12 0.486 . . . . 0.0 110.383 -178.133 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.6 m -68.82 -32.62 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.739 -172.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -77.72 -35.69 51.72 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 177.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.456 HD23 ' O ' ' A' ' 104' ' ' LEU . 84.7 mt -65.92 -48.67 70.66 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.761 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 96' ' ' VAL . 29.9 mt -70.84 -29.9 39.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.112 -177.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.7 t -78.09 -30.15 49.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.865 178.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 102.5 11.96 34.35 Favored Glycine 0 CA--C 1.516 0.105 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.672 -176.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -84.01 -41.63 17.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.096 0.474 . . . . 0.0 110.82 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.456 ' O ' HD23 ' A' ' 99' ' ' LEU . 43.2 tp -102.95 123.85 47.35 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.981 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.478 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 6.1 m-20 -73.52 117.95 64.91 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.287 178.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -60.13 -22.45 69.93 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.009 1.806 . . . . 0.0 111.214 176.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -64.35 -55.44 21.18 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.002 173.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.479 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 0.7 OUTLIER -66.83 -31.54 72.22 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.767 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.594 ' HB3' HD12 ' A' ' 115' ' ' ILE . . . -70.61 -32.65 70.07 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.085 0.469 . . . . 0.0 109.945 177.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -65.83 -46.6 77.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.331 174.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -63.16 -44.48 95.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.205 178.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.474 ' HA ' ' OE1' ' A' ' 112' ' ' GLN . 14.5 mm-40 -79.63 2.24 23.23 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -176.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.31 6.75 89.08 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.774 171.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.09 -37.79 37.87 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.031 0.443 . . . . 0.0 110.767 177.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.675 HG23 HG22 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -93.13 117.27 36.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.942 178.736 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.447 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 23.9 mmmt -109.31 99.13 8.44 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.018 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.675 HG22 HG23 ' A' ' 115' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.321 -0.667 0 CA-C-O 121.081 0.467 . . . . 0.0 110.521 -177.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.408 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 6.3 m-20 . . . . . 0 C--O 1.232 0.172 0 CA-C-O 121.371 0.605 . . . . 0.0 111.794 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.504 ' O ' ' HB2' ' A' ' 26' ' ' PHE . 4.9 Cg_exo -67.63 -22.25 44.41 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.997 2.464 . . . . 0.0 111.025 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.423 ' HG3' ' H ' ' A' ' 21' ' ' GLU . 14.5 mt-10 -65.07 -31.64 72.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.743 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -73.77 -18.69 60.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.273 -178.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -77.65 142.33 38.92 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 174.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -70.38 -23.21 62.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.664 0.745 . . . . 0.0 109.16 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 1.036 HG12 HG11 ' A' ' 96' ' ' VAL . 1.0 OUTLIER -69.4 -17.36 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.002 -179.027 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.504 ' HB2' ' O ' ' A' ' 20' ' ' PRO . 75.3 t80 -58.15 -44.16 87.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.258 0.552 . . . . 0.0 110.232 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.456 ' O ' HG23 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -77.17 -42.33 38.14 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.475 178.851 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.461 ' O ' HG12 ' A' ' 31' ' ' ILE . 24.6 m-85 -66.56 -44.39 82.46 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -177.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.435 ' CE ' HD11 ' A' ' 68' ' ' ILE . 73.9 mtp -77.56 -20.27 54.34 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.835 0.35 . . . . 0.0 110.542 -178.121 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 26' ' ' PHE . 19.8 mmtt -76.4 -36.67 57.94 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.871 175.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 28' ' ' TYR . 14.1 pt -77.22 -23.87 14.79 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.354 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 174.041 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.4 tt -58.8 -51.66 69.02 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 171.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.432 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 3.6 tt0 -45.79 -47.6 15.62 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.293 176.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -75.04 -54.5 7.05 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.54 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.6 -33.83 73.32 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -169.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.2 mmt -62.28 -39.38 92.74 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -90.96 -29.41 17.43 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.088 0.47 . . . . 0.0 110.838 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -64.61 -32.08 73.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.377 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -57.04 138.36 54.51 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.097 177.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.2 p -58.31 -24.57 60.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.027 -0.988 . . . . 0.0 113.063 -172.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -94.04 -28.42 15.75 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.8 p30 36.11 63.28 0.61 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.763 0.792 . . . . 0.0 111.181 -176.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 93.0 mt -69.52 2.75 2.85 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.859 -175.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.466 HG13 ' HB1' ' A' ' 70' ' ' ALA . 1.9 tp -56.91 -31.38 36.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.262 -177.113 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.415 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 7.9 pt-20 -76.75 -19.81 57.21 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.901 0.381 . . . . 0.0 111.164 -177.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -85.54 -35.01 21.37 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.25 0.548 . . . . 0.0 110.137 177.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 47' ' ' VAL . 13.2 p -108.3 32.97 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.875 0.845 . . . . 0.0 110.472 -177.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.415 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 59.0 mtm180 -52.66 124.41 13.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.521 0.677 . . . . 0.0 111.309 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.406 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . 179.74 -174.84 46.38 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 114.524 -1.216 . . . . 0.0 110.663 -175.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 63.3 mt -123.66 125.72 71.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 117.853 0.826 . . . . 0.0 111.391 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.472 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 22.7 m-85 -106.09 116.02 31.23 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.788 -178.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.38 115.59 5.23 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.533 -0.842 . . . . 0.0 111.357 177.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.417 ' O ' ' HA ' ' A' ' 65' ' ' TYR . 4.3 m-85 -100.92 109.63 21.6 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.039 0.447 . . . . 0.0 111.448 -177.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -94.35 99.34 11.57 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 172.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.807 HG11 HG11 ' A' ' 25' ' ' VAL . 18.6 t -101.03 107.35 21.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.096 0.474 . . . . 0.0 110.582 -174.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.466 ' O ' ' HA ' ' A' ' 92' ' ' SER . 35.9 mtp180 -103.18 174.36 5.9 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.087 -176.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 61.47 48.48 5.87 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.095 0.474 . . . . 0.0 111.239 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.08 -145.27 1.58 Allowed Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.245 175.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 62' ' ' ALA . 73.8 Cg_exo -40.6 -60.91 0.53 Allowed 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.665 2.91 . . . . 0.0 113.633 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -146.94 77.48 1.46 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.311 0.576 . . . . 0.0 110.487 177.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.58 13.33 83.58 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.88 178.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.422 ' HB3' ' HD2' ' A' ' 59' ' ' PRO . . . -72.73 143.78 47.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.987 0.423 . . . . 0.0 110.823 179.081 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -129.53 114.46 16.12 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.13 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -107.98 168.88 14.06 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.636 -178.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.417 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 44.5 t80 -150.2 120.34 7.25 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.754 0.311 . . . . 0.0 110.765 -177.24 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 16.9 m-90 -123.49 149.94 44.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.976 0.417 . . . . 0.0 109.919 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 38.2 t -118.25 118.1 56.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.645 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.472 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 4.1 mp -92.56 105.45 16.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 175.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -91.15 97.47 11.16 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.514 -176.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.466 ' HB1' HG13 ' A' ' 44' ' ' ILE . . . -98.1 -10.32 24.45 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.322 174.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.59 ' HD2' ' HG3' ' A' ' 72' ' ' GLU . 1.2 tmmt? -59.71 -34.88 73.49 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.212 -178.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.59 ' HG3' ' HD2' ' A' ' 71' ' ' LYS . 40.5 mt-10 -95.09 12.61 28.03 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.334 0.587 . . . . 0.0 111.24 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.53 -12.96 43.91 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.401 -0.818 . . . . 0.0 113.507 174.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -74.11 -56.23 5.17 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.706 0.289 . . . . 0.0 111.22 -176.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.89 35.06 9.36 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.198 -1.001 . . . . 0.0 111.736 -177.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 16.3 pttm -96.89 151.43 19.69 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 -175.039 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.8 OUTLIER -108.22 132.3 56.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 108.984 -0.746 . . . . 0.0 108.984 177.928 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.3 t -136.53 134.33 37.41 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.186 -177.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -66.54 125.32 25.37 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.28 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 51.78 63.16 2.35 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.275 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -59.21 -40.41 95.76 Favored Glycine 0 C--N 1.33 0.224 0 CA-C-N 115.324 -0.853 . . . . 0.0 113.847 -173.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.65 -20.61 47.69 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.931 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.497 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 15.6 mm-40 -70.19 150.57 46.33 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 174.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -85.04 107.82 13.14 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 178.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 83' ' ' GLU . 16.6 Cg_exo -67.95 128.89 18.51 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.855 2.37 . . . . 0.0 112.425 -177.41 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -62.16 -33.43 74.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.775 175.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.505 ' HB ' ' CD1' ' A' ' 117' ' ' ILE . 2.9 m -137.68 142.45 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.406 175.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.703 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 34.1 m -126.11 126.15 43.71 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.472 -179.054 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.409 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 55.0 m-85 -108.85 124.96 51.45 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.404 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 6.7 m -98.98 114.62 27.35 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 173.291 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.531 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 89.3 mt -137.54 150.35 25.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.811 -174.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 56' ' ' ARG . 51.1 m -90.52 137.3 32.46 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.866 176.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -43.23 -51.72 6.01 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 123.658 0.599 . . . . 0.0 111.826 -177.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.03 -41.17 67.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.374 -177.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -90.18 -18.36 25.89 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -174.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 1.036 HG11 HG12 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -57.39 -31.02 37.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.078 0.466 . . . . 0.0 110.066 -178.55 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.9 m -69.29 -28.71 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.836 -174.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -79.46 -39.59 31.88 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 176.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.474 HD23 ' O ' ' A' ' 104' ' ' LEU . 86.8 mt -68.17 -41.88 80.84 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.814 -176.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 96' ' ' VAL . 19.5 mt -72.96 -25.35 21.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.35 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 10.3 t -95.75 -5.27 42.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.093 -178.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.49 15.12 76.94 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.139 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -82.22 -42.52 18.84 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.336 0.589 . . . . 0.0 110.408 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.474 ' O ' HD23 ' A' ' 99' ' ' LEU . 41.4 tp -104.76 124.18 48.95 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.867 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.495 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 17.5 m120 -71.05 116.32 45.44 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.353 178.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -60.37 -22.9 73.0 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.067 1.845 . . . . 0.0 111.301 178.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -62.15 -59.42 5.08 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.956 173.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.517 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -64.75 -33.58 76.31 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.888 -177.676 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.519 ' HB1' ' HB3' ' A' ' 114' ' ' LYS . . . -71.32 -29.9 65.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.395 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -66.31 -45.03 81.72 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 175.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -66.93 -37.67 84.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.363 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -82.02 -6.38 59.1 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.053 -177.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.03 15.41 61.03 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.261 175.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.519 ' HB3' ' HB1' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -81.76 -41.6 20.95 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.567 0.699 . . . . 0.0 109.266 176.671 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.663 HG23 HG22 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -104.25 126.88 58.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.601 -176.995 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.404 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 34.2 mmtp -120.58 99.63 6.66 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 174.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.703 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.484 0 CA-C-O 121.035 0.445 . . . . 0.0 111.567 -176.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.3 m120 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.985 0.422 . . . . 0.0 110.626 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' A' ' 26' ' ' PHE . 11.8 Cg_exo -64.76 -29.16 59.55 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.206 2.604 . . . . 0.0 112.005 -175.032 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -63.73 -34.87 78.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.544 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -70.23 -11.63 61.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.355 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -81.23 143.31 32.4 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.174 0.512 . . . . 0.0 110.186 177.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -74.29 -21.11 59.89 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.569 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.842 HG12 HG11 ' A' ' 96' ' ' VAL . 2.5 m -75.16 -17.23 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.075 177.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.457 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 73.2 t80 -54.19 -57.24 11.91 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.871 0.367 . . . . 0.0 110.57 -176.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.96 -32.68 74.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.8 -177.576 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.481 ' O ' HG12 ' A' ' 31' ' ' ILE . 10.5 m-85 -70.59 -46.75 62.84 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.298 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.426 ' HE2' ' HB2' ' A' ' 29' ' ' MET . 29.6 mtm -66.17 -30.51 70.99 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.833 176.342 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 26' ' ' PHE . 29.4 mmmt -64.63 -35.38 80.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.061 177.415 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 28' ' ' TYR . 9.6 pt -88.35 -16.18 8.93 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.565 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.231 176.308 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.3 tt -64.5 -51.42 63.02 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 168.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.581 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 6.3 tt0 -44.35 -45.51 8.86 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 114.447 -1.251 . . . . 0.0 110.865 173.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -73.16 -59.57 2.65 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.499 178.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.84 -37.23 68.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.668 -0.697 . . . . 0.0 112.769 -167.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.447 ' HB3' HD13 ' A' ' 44' ' ' ILE . 25.9 mmt -59.43 -42.76 92.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.788 -179.298 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -92.34 -24.15 19.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.094 0.473 . . . . 0.0 111.015 178.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.409 HD21 ' C ' ' A' ' 38' ' ' ASN . 0.2 OUTLIER -64.92 -30.02 70.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.01 179.457 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -54.64 135.96 46.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.559 0.695 . . . . 0.0 110.041 176.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 16.2 p -52.73 -38.58 61.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.257 -1.338 . . . . 0.0 112.973 -173.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -102.78 8.89 39.31 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 119.227 -0.416 . . . . 0.0 111.258 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 34.2 67.8 0.2 Allowed 'General case' 0 C--O 1.238 0.461 0 O-C-N 124.183 0.927 . . . . 0.0 110.752 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.401 ' O ' HG12 ' A' ' 47' ' ' VAL . 69.1 mt -62.08 -0.4 0.51 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.273 -1.33 . . . . 0.0 112.403 -171.473 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.447 HD13 ' HB3' ' A' ' 36' ' ' MET . 4.2 tp -63.23 -28.21 44.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.3 178.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -76.6 -10.86 59.69 Favored 'General case' 0 N--CA 1.46 0.053 0 CA-C-O 121.235 0.54 . . . . 0.0 110.645 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -100.53 -14.8 18.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.804 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 47' ' ' VAL . 14.6 p -131.18 33.05 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.662 0.744 . . . . 0.0 110.364 -177.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 50.8 mtt180 -51.89 109.45 0.37 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.738 0.78 . . . . 0.0 111.826 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.597 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . -167.41 167.38 39.88 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.398 -177.143 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.488 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 32.9 mt -105.89 125.71 61.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 118.481 1.14 . . . . 0.0 111.145 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.578 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 17.0 m-85 -104.25 122.55 45.64 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.607 -177.373 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.47 125.14 8.48 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.236 176.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.429 ' CD1' HD13 ' A' ' 68' ' ' ILE . 5.6 m-85 -108.12 99.85 9.24 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.171 0.51 . . . . 0.0 111.331 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -94.78 100.82 12.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.141 173.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.744 HG11 HG11 ' A' ' 25' ' ' VAL . 19.8 t -108.47 117.72 54.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.1 0.476 . . . . 0.0 111.141 -173.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 47.0 mtp180 -102.25 -179.72 4.07 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.218 -177.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.447 ' HB2' ' HB3' ' A' ' 92' ' ' SER . 3.5 m-20 59.89 44.72 13.29 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 123.288 0.368 . . . . 0.0 111.34 178.178 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.97 -157.27 6.9 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.692 177.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -43.3 -59.74 0.95 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.675 2.917 . . . . 0.0 112.888 -178.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -113.47 46.88 1.21 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 175.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.6 15.44 77.63 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.837 -176.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.0 143.44 57.77 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.729 0.776 . . . . 0.0 111.606 -177.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -107.98 109.63 21.15 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.917 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.65 154.03 19.63 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 35.1 t80 -139.25 117.38 11.82 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.95 0.405 . . . . 0.0 111.173 -178.068 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 10.2 m-90 -119.71 161.7 20.28 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.12 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.2 t -126.36 118.8 52.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.265 178.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.578 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 3.1 mp -96.36 100.54 11.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 176.215 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -82.4 98.22 8.76 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.166 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -100.64 -5.11 27.13 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.975 175.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.496 ' HE3' ' HA2' ' A' ' 49' ' ' GLY . 4.1 tppp? -66.05 -39.23 89.95 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.256 -178.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -81.0 0.54 35.18 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.019 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.75 13.59 83.29 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.198 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.513 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 10.8 mmpt? -86.22 -50.5 6.93 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.68 0.276 . . . . 0.0 110.566 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.44 33.07 61.57 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.455 -0.879 . . . . 0.0 111.004 -176.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.581 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 52.2 pttt -98.5 149.24 22.92 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.504 -0.348 . . . . 0.0 110.197 -177.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.49 HG12 HG13 ' A' ' 68' ' ' ILE . 0.9 OUTLIER -108.11 123.01 63.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.699 0.761 . . . . 0.0 109.565 -178.383 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.444 HG23 ' HA2' ' A' ' 81' ' ' GLY . 4.5 t -130.36 134.46 47.18 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.582 -178.422 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -64.68 129.66 40.63 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 -176.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 72.68 -43.19 0.56 Allowed 'General case' 0 N--CA 1.47 0.557 0 O-C-N 124.001 0.813 . . . . 0.0 111.944 -177.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.444 ' HA2' HG23 ' A' ' 78' ' ' THR . . . 71.91 -42.68 0.76 Allowed Glycine 0 CA--C 1.518 0.259 0 CA-C-N 116.151 -0.477 . . . . 0.0 114.222 177.282 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.79 13.22 78.6 Favored Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 -174.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -116.25 166.74 11.69 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -177.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -100.7 109.01 56.37 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.204 177.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.488 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 12.6 Cg_exo -71.48 127.95 13.88 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 122.994 2.462 . . . . 0.0 112.789 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -60.97 -46.5 90.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.587 173.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.455 ' HB ' ' CD1' ' A' ' 117' ' ' ILE . 8.7 m -125.11 125.12 68.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.65 178.308 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.718 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 15.2 m -122.77 125.69 45.98 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.35 -178.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.493 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 86.2 m-85 -105.18 136.24 45.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.609 0.242 . . . . 0.0 110.39 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.567 ' HB ' ' HB3' ' A' ' 116' ' ' LYS . 2.2 m -109.72 99.63 8.77 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 175.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.565 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 49.0 mt -125.46 162.47 28.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -175.08 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.487 ' N ' HG22 ' A' ' 91' ' ' ILE . 20.3 m -97.86 145.53 26.34 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.987 0.422 . . . . 0.0 110.364 176.119 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.583 ' OD1' HG13 ' A' ' 25' ' ' VAL . 36.6 t70 -54.18 -24.03 16.64 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.016 -176.086 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -82.83 -35.38 26.4 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.982 -177.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -90.11 -26.44 20.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.711 -172.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.842 HG11 HG12 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -54.5 -33.13 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.011 0.434 . . . . 0.0 111.453 -176.648 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.4 m -66.34 -27.51 40.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.639 -169.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.418 ' HA ' ' HG ' ' A' ' 101' ' ' SER . 33.5 m-20 -89.69 -27.44 20.1 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 176.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.467 HD12 HG21 ' A' ' 91' ' ' ILE . 76.1 mt -69.09 -42.97 75.46 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.204 0.526 . . . . 0.0 110.533 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 96' ' ' VAL . 16.7 mt -77.46 -27.64 15.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.137 -177.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.43 ' OG ' ' HD3' ' A' ' 103' ' ' LYS . 64.0 p -83.56 -27.55 29.21 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.978 0.418 . . . . 0.0 110.778 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.38 -5.23 31.5 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.876 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.43 ' HD3' ' OG ' ' A' ' 101' ' ' SER . 14.0 mptt -67.56 -42.06 83.24 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 179.094 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.464 ' O ' HD23 ' A' ' 99' ' ' LEU . 25.1 tp -99.93 119.88 38.92 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.141 0.495 . . . . 0.0 110.218 -177.184 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.489 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 15.3 m120 -67.62 118.06 53.58 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.183 178.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -64.16 -21.68 67.55 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.123 1.882 . . . . 0.0 110.989 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -64.02 -53.68 46.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.325 174.021 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.525 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -68.04 -33.39 74.49 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -178.861 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.526 ' HB3' HD12 ' A' ' 115' ' ' ILE . . . -67.46 -36.59 81.46 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.999 177.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -59.35 -48.01 83.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.845 176.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -67.96 -37.97 82.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.016 -177.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -82.84 2.9 31.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.969 -0.559 . . . . 0.0 112.275 -177.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 81.14 13.91 80.07 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.771 -0.728 . . . . 0.0 113.379 175.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -92.32 -10.58 37.8 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.196 0.522 . . . . 0.0 110.297 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.61 HG23 HG22 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -133.35 109.09 13.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.751 177.937 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.567 ' HB3' ' HB ' ' A' ' 90' ' ' THR . 45.9 tptt -112.77 107.1 15.61 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.3 174.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.718 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.323 -0.58 0 CA-C-O 121.058 0.456 . . . . 0.0 111.552 -170.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.431 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 38.9 m-80 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 121.029 0.442 . . . . 0.0 111.142 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.436 ' HA ' ' CD1' ' A' ' 23' ' ' PHE . 4.8 Cg_exo -68.21 -21.39 42.05 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 123.143 2.562 . . . . 0.0 111.578 -176.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -72.42 -20.73 61.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.247 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -81.95 -0.06 42.21 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.006 178.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.436 ' CD1' ' HA ' ' A' ' 20' ' ' PRO . 37.7 m-85 -90.12 152.56 21.07 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 175.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.408 ' O ' ' HD2' ' A' ' 28' ' ' TYR . 48.0 tptt -80.34 -26.05 38.92 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.258 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.718 HG12 HG11 ' A' ' 96' ' ' VAL . 0.8 OUTLIER -68.93 -15.19 19.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.57 178.15 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -53.75 -60.15 3.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.207 0.527 . . . . 0.0 110.572 178.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.0 -33.51 65.83 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.609 -177.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.512 ' O ' HG12 ' A' ' 31' ' ' ILE . 17.7 m-85 -67.76 -48.91 65.05 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.787 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.623 ' SD ' ' HB ' ' A' ' 25' ' ' VAL . 0.1 OUTLIER -63.25 -29.42 70.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.893 0.378 . . . . 0.0 110.74 175.889 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.44 ' HD3' ' HA ' ' A' ' 30' ' ' LYS . 37.8 mmtt -71.86 -34.36 69.16 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.787 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.512 HG12 ' O ' ' A' ' 28' ' ' TYR . 8.7 pt -82.24 -21.87 9.69 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.519 0 C-N-CA 119.971 -0.692 . . . . 0.0 109.705 174.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.405 ' O ' ' HG2' ' A' ' 36' ' ' MET . 6.5 tt -60.53 -50.97 71.4 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 170.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.521 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 6.4 tt0 -43.86 -48.51 8.36 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.183 174.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -76.33 -52.85 9.1 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.78 -177.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.433 ' HA ' ' HB3' ' A' ' 38' ' ' ASN . . . -63.21 -32.72 74.19 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -168.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.405 ' HG2' ' O ' ' A' ' 32' ' ' LEU . 94.5 mmm -62.35 -43.59 98.48 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.491 0.182 . . . . 0.0 111.491 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -91.09 -16.26 28.14 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.737 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.433 ' HB3' ' HA ' ' A' ' 35' ' ' ALA . 26.9 t-20 -65.81 -17.63 64.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.387 0.613 . . . . 0.0 109.943 175.504 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -54.83 128.94 35.33 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.055 172.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.6 p -62.38 -25.78 68.11 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.492 -0.777 . . . . 0.0 112.346 -175.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -100.09 -0.12 39.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.941 0.4 . . . . 0.0 111.02 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 39.22 52.84 2.18 Favored 'General case' 0 C--N 1.344 0.365 0 CA-C-N 114.614 -1.176 . . . . 0.0 111.742 -175.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.0 mt -60.9 -4.35 0.99 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.803 -175.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.425 HD11 ' CB ' ' A' ' 70' ' ' ALA . 1.1 tp -55.97 -30.16 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-O 120.766 0.317 . . . . 0.0 110.591 176.18 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.514 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 5.8 pt-20 -64.47 -36.03 82.87 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.346 -177.419 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -77.14 -15.8 59.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.996 0.427 . . . . 0.0 111.108 -175.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 47' ' ' VAL . 14.5 p -130.71 32.28 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.934 0.874 . . . . 0.0 110.24 -175.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.514 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 94.9 mtt180 -57.96 116.98 3.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.597 -0.728 . . . . 0.0 111.843 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.495 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . -171.23 173.98 44.84 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.188 -178.595 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.483 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 52.7 mt -104.99 125.42 59.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 117.485 0.642 . . . . 0.0 111.234 -178.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.573 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 3.1 m-85 -107.28 110.99 23.15 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.815 -177.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.15 116.29 5.32 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.419 -0.896 . . . . 0.0 111.47 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.428 ' O ' ' HA ' ' A' ' 65' ' ' TYR . 5.1 m-85 -100.61 109.41 21.48 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.027 0.441 . . . . 0.0 111.636 -178.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -94.35 99.84 11.98 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.378 175.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.675 HG11 HG11 ' A' ' 25' ' ' VAL . 19.0 t -98.58 133.11 42.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.811 -175.165 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -122.33 173.26 7.74 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.117 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 59.81 49.7 7.73 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.103 0.478 . . . . 0.0 111.395 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.42 -140.07 1.61 Allowed Glycine 0 CA--C 1.522 0.48 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.437 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 62' ' ' ALA . 54.1 Cg_exo -40.73 -61.6 0.46 Allowed 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.768 2.979 . . . . 0.0 114.098 178.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -152.06 82.23 1.26 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.187 0.518 . . . . 0.0 109.97 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 73.23 12.55 79.72 Favored Glycine 0 N--CA 1.453 -0.223 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.476 ' HB3' ' HD2' ' A' ' 59' ' ' PRO . . . -82.39 157.03 23.88 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.044 -0.578 . . . . 0.0 111.381 -175.189 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -133.22 143.08 48.92 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.667 -177.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.8 162.72 24.19 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.443 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.428 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 33.6 t80 -148.42 117.58 6.84 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.82 0.343 . . . . 0.0 110.881 -176.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 16.6 m-90 -120.82 139.32 53.31 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.9 t -107.65 112.75 41.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.448 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.573 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 3.9 mp -90.73 100.7 11.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 175.357 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -85.66 97.4 10.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.418 0.628 . . . . 0.0 109.887 -178.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -102.22 -0.43 33.07 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.404 174.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.451 ' HB2' HG13 ' A' ' 50' ' ' ILE . 4.9 tppp? -63.33 -45.48 91.05 Favored 'General case' 0 CA--C 1.523 -0.079 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.166 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -72.76 -8.79 57.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.615 176.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.34 -4.14 86.37 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.897 -178.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -71.64 -39.93 70.07 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.884 0.373 . . . . 0.0 111.417 -177.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.6 34.16 54.41 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.562 176.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.521 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 19.7 ptmt -98.2 149.19 22.82 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 -175.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.6 HG21 ' HB3' ' A' ' 29' ' ' MET . 0.7 OUTLIER -109.52 132.43 57.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.674 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.0 t -133.84 129.23 36.19 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.387 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -66.49 122.5 17.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.37 -178.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 54.81 65.73 1.42 Allowed 'General case' 0 N--CA 1.464 0.226 0 O-C-N 123.765 0.666 . . . . 0.0 109.813 -176.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.04 -40.25 88.6 Favored Glycine 0 C--N 1.33 0.207 0 CA-C-N 115.57 -0.741 . . . . 0.0 113.707 -173.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.11 -21.27 40.98 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.041 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.451 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 7.4 mm-40 -71.26 143.19 50.46 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 175.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? -76.88 114.47 39.61 Favored Pre-proline 0 N--CA 1.438 -1.037 0 CA-C-O 121.39 0.614 . . . . 0.0 110.827 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.483 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 13.9 Cg_exo -68.92 126.55 14.02 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.191 2.594 . . . . 0.0 112.16 177.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -60.66 -33.5 72.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.297 173.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.561 ' HB ' ' CD1' ' A' ' 117' ' ' ILE . 11.3 m -136.76 142.16 38.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.326 174.125 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.678 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 22.9 m -127.44 138.75 53.05 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.098 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.461 ' CE2' HD13 ' A' ' 117' ' ' ILE . 18.7 m-85 -122.69 120.92 35.1 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 123.177 0.298 . . . . 0.0 110.336 -177.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.2 m -93.56 113.18 25.24 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 171.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 81.5 mt -137.46 156.9 33.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -175.476 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.41 ' H ' ' HE2' ' A' ' 114' ' ' LYS . 17.7 m -100.25 144.53 29.17 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.196 0.522 . . . . 0.0 110.326 177.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -51.8 -34.91 42.07 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 114.607 -1.179 . . . . 0.0 112.291 -175.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -71.05 -36.16 72.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.11 -177.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.451 ' CG ' ' HD2' ' A' ' 114' ' ' LYS . 7.4 m-20 -90.91 -19.25 23.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.187 -174.517 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.718 HG11 HG12 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -56.72 -33.57 40.9 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 CA-C-O 120.899 0.381 . . . . 0.0 110.696 -178.452 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.7 m -64.1 -27.35 42.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.38 -172.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -86.67 -29.4 22.51 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 177.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.497 HD23 ' O ' ' A' ' 104' ' ' LEU . 85.1 mt -76.02 -39.87 54.73 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.918 -178.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.485 HG21 ' HD1' ' A' ' 28' ' ' TYR . 2.7 mm -67.39 -36.34 76.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.273 0.559 . . . . 0.0 110.374 177.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 36.4 p -79.92 -21.57 43.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.335 -176.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.66 11.32 60.74 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.62 -177.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -80.06 -42.85 22.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.047 0.451 . . . . 0.0 110.968 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.497 ' O ' HD23 ' A' ' 99' ' ' LEU . 43.3 tp -96.98 120.25 36.98 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.497 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 18.3 m120 -69.31 117.52 53.21 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.767 178.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -62.22 -22.91 74.92 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.013 1.809 . . . . 0.0 110.845 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -62.11 -56.14 21.84 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.191 173.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.547 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 0.7 OUTLIER -67.12 -33.95 76.56 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -177.942 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.591 ' HB3' HD12 ' A' ' 115' ' ' ILE . . . -69.5 -32.13 70.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.002 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -61.99 -50.93 70.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.469 175.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -64.19 -39.76 94.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.921 -178.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -76.69 -8.48 57.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.09 -177.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 95.34 -4.18 66.84 Favored Glycine 0 CA--C 1.517 0.181 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.346 173.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.451 ' HD2' ' CG ' ' A' ' 95' ' ' ASP . 0.2 OUTLIER -66.72 -39.62 88.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.112 0.482 . . . . 0.0 111.107 177.45 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.705 HG23 HG22 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -107.55 131.99 56.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.302 -174.113 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -120.88 99.37 6.48 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.042 173.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.705 HG22 HG23 ' A' ' 115' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.455 0 CA-C-O 120.991 0.424 . . . . 0.0 111.534 -178.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 . . . . . 0 CA--C 1.515 -0.388 0 CA-C-O 121.794 0.807 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.03 -19.26 35.09 Favored 'Trans proline' 0 C--N 1.328 -0.502 0 C-N-CA 124.095 3.197 . . . . 0.0 111.922 -175.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.496 ' HA ' ' CG ' ' A' ' 26' ' ' PHE . 17.1 mt-10 -76.65 -23.86 53.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.368 -176.282 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -91.65 28.84 1.65 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.338 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -110.58 160.18 16.88 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.086 174.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -74.17 -35.49 64.02 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 172.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 1.048 HG12 HG11 ' A' ' 96' ' ' VAL . 0.8 OUTLIER -65.15 -20.54 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.568 -178.975 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.496 ' CG ' ' HA ' ' A' ' 21' ' ' GLU . 67.5 t80 -56.95 -46.59 82.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.963 0.411 . . . . 0.0 110.593 -179.229 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.426 ' HE2' HG23 ' A' ' 31' ' ' ILE . 0.6 OUTLIER -75.91 -44.99 37.65 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.474 177.973 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -63.9 -43.73 95.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.342 -175.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.458 ' CE ' HD11 ' A' ' 68' ' ' ILE . 71.9 mtp -76.59 -20.32 56.92 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.78 0.324 . . . . 0.0 110.811 -178.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -75.13 -46.67 32.88 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 175.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.426 HG23 ' HE2' ' A' ' 27' ' ' LYS . 10.8 pt -70.74 -24.53 25.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.782 175.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.0 tt -60.47 -56.03 26.38 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 171.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.56 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 11.2 tt0 -42.33 -52.95 4.37 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.169 176.038 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -69.64 -58.99 3.25 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.877 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.84 -38.53 72.8 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -168.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.2 mmt -59.21 -39.26 82.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.851 0.358 . . . . 0.0 111.592 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -90.62 -31.78 16.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.197 0.522 . . . . 0.0 110.698 178.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -66.57 -18.66 65.49 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.209 -174.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -55.98 145.17 26.07 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.045 177.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.7 p -47.29 -46.95 25.39 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 123.545 0.528 . . . . 0.0 111.713 -176.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -102.57 4.89 38.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.596 -176.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.467 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 4.1 p30 37.2 71.48 0.14 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 122.039 0.923 . . . . 0.0 110.89 -175.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.5 mt -64.51 0.26 1.13 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.443 -1.253 . . . . 0.0 112.103 -173.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.4 tp -61.62 -25.5 37.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.001 0.429 . . . . 0.0 110.442 177.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.512 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 17.0 pt-20 -74.26 -12.62 60.61 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.788 -178.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -86.89 -19.78 28.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.184 0.516 . . . . 0.0 110.538 178.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 47' ' ' VAL . 12.5 p -130.49 31.98 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.2 -173.029 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.512 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 58.4 mtm180 -54.99 116.63 2.87 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.971 0.891 . . . . 0.0 111.751 -176.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -178.54 173.03 45.45 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 114.055 -1.429 . . . . 0.0 111.193 -176.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.485 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 60.0 mt -105.04 129.47 57.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-O 120.971 0.415 . . . . 0.0 111.01 -178.063 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.464 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 5.4 m-85 -111.83 125.28 53.84 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.823 -178.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 88' ' ' THR . . . -104.06 121.55 7.06 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.421 -0.895 . . . . 0.0 111.408 176.301 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -107.31 109.38 21.13 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.135 0.493 . . . . 0.0 111.487 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -97.66 99.73 11.1 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.179 176.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.739 HG11 HG11 ' A' ' 25' ' ' VAL . 12.2 t -105.59 122.42 59.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.202 -171.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -107.21 -179.44 3.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.869 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.408 ' HB2' ' HB3' ' A' ' 92' ' ' SER . 4.5 m-20 61.92 47.81 5.71 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.137 0.494 . . . . 0.0 111.586 177.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.28 -167.06 20.36 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.699 177.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -40.66 -60.88 0.53 Allowed 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 124.126 3.218 . . . . 0.0 113.558 -176.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -108.93 42.2 1.46 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.091 0.472 . . . . 0.0 109.986 177.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 74.99 19.56 79.88 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.476 -176.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.23 171.47 8.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.973 0.416 . . . . 0.0 111.279 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -131.25 135.32 47.24 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.697 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -124.3 153.68 17.65 Favored Glycine 0 N--CA 1.443 -0.876 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -141.22 119.35 12.04 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.791 0.329 . . . . 0.0 110.622 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 14.8 m-90 -122.49 144.92 48.77 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 40.1 t -110.46 115.1 48.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.052 177.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.464 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 4.0 mp -89.21 99.17 8.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 176.302 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -90.66 98.7 11.93 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.447 0.641 . . . . 0.0 109.999 -176.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -110.91 15.64 21.68 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.604 175.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.438 ' HB2' ' CG1' ' A' ' 50' ' ' ILE . 34.2 tttm -56.28 -50.21 72.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.752 -177.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -86.01 0.14 54.08 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.676 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 94.21 12.04 56.71 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.641 -0.708 . . . . 0.0 112.437 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -76.36 -63.49 1.32 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.483 0.182 . . . . 0.0 111.237 -178.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.82 34.2 7.43 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 119.967 -1.111 . . . . 0.0 112.068 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.56 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 15.3 pttm -98.1 143.27 28.81 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.259 -0.275 . . . . 0.0 110.259 -178.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.8 OUTLIER -110.04 131.84 59.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.359 0.6 . . . . 0.0 109.832 178.717 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.6 t -131.21 133.54 45.6 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.49 -176.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -68.7 119.85 13.76 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -178.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 53.6 70.35 0.61 Allowed 'General case' 0 C--N 1.331 -0.199 0 O-C-N 123.79 0.681 . . . . 0.0 109.901 -175.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.1 -34.57 90.1 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.381 -0.827 . . . . 0.0 113.737 -173.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.14 -14.98 56.14 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.976 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.401 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 55.1 mm-40 -73.33 165.73 24.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.809 0.338 . . . . 0.0 110.369 177.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.486 ' N ' ' HD2' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -100.14 106.82 44.02 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.15 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.485 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 16.2 Cg_exo -68.92 139.76 44.07 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.695 2.263 . . . . 0.0 113.018 -177.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -67.2 -31.2 71.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.566 173.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.6 m -139.78 149.26 22.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.516 172.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.616 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 54.8 m -135.3 128.33 31.6 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 175.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.632 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 61.4 m-85 -113.41 125.16 53.94 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.852 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.473 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 4.6 m -98.48 121.33 40.28 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 173.009 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.608 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -155.39 154.6 6.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 O-C-N 123.551 0.532 . . . . 0.0 109.618 -175.184 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.472 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 3.8 m -91.56 137.82 32.06 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.56 -178.146 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.533 ' OD1' HG13 ' A' ' 25' ' ' VAL . 27.7 t70 -43.28 -49.68 6.69 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.376 0.67 . . . . 0.0 111.495 -176.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -49.95 -38.79 38.1 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.067 -1.424 . . . . 0.0 111.772 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.472 ' OD2' ' HB2' ' A' ' 92' ' ' SER . 13.6 m-20 -91.02 -21.18 21.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.413 -175.132 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 1.048 HG11 HG12 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -60.88 -31.27 49.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 121.134 0.493 . . . . 0.0 110.447 -175.577 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.6 m -67.1 -28.7 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.088 -171.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -81.69 -35.26 30.04 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 176.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.44 HD23 ' O ' ' A' ' 104' ' ' LEU . 85.3 mt -66.07 -49.44 67.59 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.812 -178.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 96' ' ' VAL . 21.4 mt -70.03 -23.86 25.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.057 -176.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.1 t -91.55 -9.75 43.15 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.998 0.428 . . . . 0.0 110.972 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.97 17.57 69.6 Favored Glycine 0 C--N 1.329 0.182 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.257 -179.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -85.69 -41.58 15.03 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.05 0.452 . . . . 0.0 110.63 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.44 ' O ' HD23 ' A' ' 99' ' ' LEU . 38.9 tp -103.32 123.22 46.38 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.478 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.493 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 6.2 m-20 -69.09 120.75 78.59 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.548 177.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -65.41 -22.5 59.47 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.083 1.856 . . . . 0.0 111.241 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.49 -54.91 25.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.595 176.034 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.556 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 0.8 OUTLIER -67.4 -34.89 78.19 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.971 179.283 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.59 ' HB3' HD12 ' A' ' 115' ' ' ILE . . . -64.92 -34.34 78.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.178 178.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -61.58 -52.39 64.63 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 175.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -59.72 -39.68 85.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.546 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.468 ' HA ' ' OE1' ' A' ' 112' ' ' GLN . 13.4 mm-40 -85.05 17.08 3.08 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -174.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.42 12.12 76.73 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 121.105 -0.569 . . . . 0.0 113.563 173.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -87.47 -47.41 8.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.877 0.37 . . . . 0.0 110.71 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.626 HG23 HG22 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -96.03 121.4 46.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.994 -177.348 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.473 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 31.2 mmtp -116.52 99.06 6.9 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.877 173.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.632 ' HB ' ' CD2' ' A' ' 89' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--N 1.322 -0.625 0 CA-C-O 121.356 0.598 . . . . 0.0 110.665 -178.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.414 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 6.8 p30 . . . . . 0 C--O 1.232 0.169 0 CA-C-O 121.237 0.542 . . . . 0.0 110.801 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.465 ' HA ' ' CD1' ' A' ' 23' ' ' PHE . 4.9 Cg_exo -70.06 -17.56 36.13 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.695 2.263 . . . . 0.0 111.156 -177.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.467 ' HA ' ' CG ' ' A' ' 26' ' ' PHE . 13.3 mt-10 -74.09 -24.03 59.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.503 -178.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -74.67 -22.16 59.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.635 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.465 ' CD1' ' HA ' ' A' ' 20' ' ' PRO . 35.5 m-85 -65.64 145.53 55.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.667 177.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -74.77 -26.34 59.69 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.757 HG12 HG11 ' A' ' 96' ' ' VAL . 0.9 OUTLIER -68.85 -21.69 25.92 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.71 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.585 177.902 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.467 ' CG ' ' HA ' ' A' ' 21' ' ' GLU . 79.2 t80 -56.78 -47.5 80.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.774 0.321 . . . . 0.0 110.361 -178.626 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.85 -34.88 77.57 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.727 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.47 ' O ' HG12 ' A' ' 31' ' ' ILE . 37.4 m-85 -71.8 -53.5 13.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.756 0.312 . . . . 0.0 111.101 178.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.603 ' HB3' HG21 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -58.61 -32.8 69.35 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.104 176.939 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.2 mmtt -66.58 -41.78 88.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.601 177.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.47 HG12 ' O ' ' A' ' 28' ' ' TYR . 16.8 pt -78.09 -26.41 14.47 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 C-N-CA 120.294 -0.562 . . . . 0.0 109.865 177.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.6 tt -59.35 -47.94 83.5 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 173.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.54 ' HG2' ' HA ' ' A' ' 76' ' ' LYS . 0.8 OUTLIER -44.57 -50.9 9.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.522 176.021 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -78.64 -55.29 5.3 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.58 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.48 -40.21 74.53 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -167.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.4 mmt -61.29 -41.28 96.7 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -177.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -90.92 -16.82 27.47 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.582 177.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -71.27 -25.09 62.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.996 -176.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -52.85 135.22 36.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.212 0.53 . . . . 0.0 110.117 176.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 18.2 p -57.89 -29.24 64.9 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.621 -174.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -100.32 -5.3 27.6 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 122.467 0.307 . . . . 0.0 111.232 177.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.493 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 4.1 p-10 38.82 64.27 0.8 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.843 0.83 . . . . 0.0 111.294 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.4 mt -58.64 -11.32 2.94 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.137 -175.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.2 tp -57.35 -25.81 24.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.065 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.493 ' HG2' ' O ' ' A' ' 42' ' ' ASN . 3.7 pt-20 -60.03 -33.19 71.69 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.789 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -82.7 -18.84 39.47 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.865 0.364 . . . . 0.0 111.573 -173.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 47' ' ' VAL . 11.3 p -124.99 31.9 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 122.074 0.94 . . . . 0.0 109.813 -176.17 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 37.2 mtm180 -57.45 110.33 0.85 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.845 0.831 . . . . 0.0 112.118 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.484 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . -165.78 170.91 40.79 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 114.086 -1.415 . . . . 0.0 110.701 -178.401 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.447 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 53.2 mt -105.27 126.64 60.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 117.717 0.758 . . . . 0.0 111.136 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.5 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 25.7 m-85 -107.92 117.59 34.51 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.994 -178.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.91 106.59 3.37 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.262 -0.971 . . . . 0.0 111.231 177.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -95.21 105.62 17.57 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.253 0.549 . . . . 0.0 111.261 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -91.31 99.79 12.7 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.383 176.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.735 HG11 HG11 ' A' ' 25' ' ' VAL . 7.6 t -99.84 127.47 52.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.911 -172.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 -112.74 -178.14 3.32 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.792 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 62.67 47.47 4.76 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.13 0.49 . . . . 0.0 111.124 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.39 -169.48 32.45 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.577 177.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -37.69 -61.07 0.37 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.546 3.498 . . . . 0.0 114.217 -174.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -125.05 61.12 1.19 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.86 16.09 74.31 Favored Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.53 -177.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.53 168.8 18.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.028 0.442 . . . . 0.0 110.749 -178.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -136.73 136.2 38.77 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.915 -176.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -120.19 162.46 14.22 Favored Glycine 0 N--CA 1.442 -0.94 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.387 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -150.26 115.18 5.32 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.712 0.291 . . . . 0.0 110.243 -178.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 26.1 m-90 -118.97 126.1 50.96 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.2 0.524 . . . . 0.0 110.279 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 51.3 t -94.4 110.4 23.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.743 177.354 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.5 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 4.4 mp -88.91 99.24 8.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -83.11 105.6 14.23 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.5 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -111.47 5.23 19.44 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 173.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.411 ' HE3' ' HA2' ' A' ' 49' ' ' GLY . 4.4 tppp? -64.67 -36.7 85.13 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.957 -176.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -77.4 -30.3 53.54 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.624 0.726 . . . . 0.0 109.9 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 111.82 10.11 19.45 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.344 -176.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.459 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 9.5 mmpt? -88.01 -49.72 6.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.56 -0.32 . . . . 0.0 111.397 -178.591 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.01 34.39 15.11 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.16 -1.019 . . . . 0.0 111.793 -177.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.54 ' HA ' ' HG2' ' A' ' 33' ' ' GLU . 14.2 pttm -96.82 145.15 26.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.545 0.212 . . . . 0.0 110.783 -172.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.603 HG21 ' HB3' ' A' ' 29' ' ' MET . 0.7 OUTLIER -107.41 138.18 34.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.069 0.461 . . . . 0.0 109.764 178.035 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.6 t -133.64 133.9 42.51 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.135 177.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -71.17 118.24 13.7 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.821 -179.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 55.96 61.48 2.76 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 123.918 0.762 . . . . 0.0 109.683 -175.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -61.31 -40.64 98.9 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.344 -0.844 . . . . 0.0 113.442 -175.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.12 -21.07 32.99 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.947 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.569 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 65.2 mm-40 -64.89 149.23 49.95 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 175.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.463 ' HD3' ' N ' ' A' ' 84' ' ' LYS . 3.7 mppt? -79.56 108.71 9.44 Favored Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.569 ' HD3' ' O ' ' A' ' 83' ' ' GLU . 16.5 Cg_exo -68.76 130.69 21.07 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.61 2.207 . . . . 0.0 112.164 179.019 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -62.61 -38.2 89.25 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.57 174.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.6 m -136.95 134.29 48.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.592 174.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.602 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 30.8 m -113.53 137.19 51.92 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.217 177.403 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.652 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 41.0 m-85 -123.83 127.0 47.42 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.492 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 6.7 m -100.69 126.52 47.21 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 174.071 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.625 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -158.37 151.45 7.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.039 0.447 . . . . 0.0 110.536 -175.565 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.2 m -85.36 143.22 28.77 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.202 0.525 . . . . 0.0 110.977 -177.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.416 ' OD1' HG13 ' A' ' 25' ' ' VAL . 13.5 t70 -49.28 -33.75 13.75 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.625 -1.17 . . . . 0.0 112.121 -178.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -75.5 -32.46 60.55 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.899 -174.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -91.55 -21.27 20.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.904 -177.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.757 HG11 HG12 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -56.74 -33.19 40.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.101 0.477 . . . . 0.0 110.21 -177.855 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.3 m -68.07 -33.75 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.853 -173.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -77.47 -32.35 54.32 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.1 mt -69.39 -49.98 50.29 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.738 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 96' ' ' VAL . 28.3 mt -72.38 -30.38 34.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.577 -176.038 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 39.7 t -86.03 -4.8 59.25 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.671 0.249 . . . . 0.0 111.671 -178.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.03 43.53 16.67 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.301 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -116.03 -43.19 3.0 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.036 0.446 . . . . 0.0 110.898 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.4 tp -97.95 129.56 44.85 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.507 -179.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.522 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 94.4 m-20 -73.63 119.68 77.26 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.054 176.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -66.2 -20.26 56.17 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 121.942 1.762 . . . . 0.0 110.196 176.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -60.83 -57.42 12.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.534 173.108 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.522 ' HG2' ' HB2' ' A' ' 105' ' ' ASN . 0.2 OUTLIER -70.35 -31.4 68.66 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.901 -178.834 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.643 ' HB3' HD12 ' A' ' 115' ' ' ILE . . . -68.22 -35.59 78.2 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.618 -0.433 . . . . 0.0 109.986 178.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -64.98 -45.88 83.8 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 174.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -63.73 -41.03 98.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.347 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -80.12 7.06 9.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.919 -178.317 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.23 5.33 89.75 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.94 -0.647 . . . . 0.0 113.605 173.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp -78.91 -48.86 13.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.937 0.398 . . . . 0.0 111.07 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.643 HD12 ' HB3' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -87.72 118.24 33.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.539 -179.257 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.492 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 74.7 mmtt -114.73 98.77 7.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.659 174.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.652 ' HB ' ' CD2' ' A' ' 89' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--N 1.323 -0.583 0 CA-C-O 121.264 0.554 . . . . 0.0 110.361 178.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.413 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 58.1 m-20 . . . . . 0 CA--C 1.517 -0.304 0 CA-C-O 120.903 0.382 . . . . 0.0 110.192 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' A' ' 26' ' ' PHE . 21.5 Cg_exo -61.47 -34.57 85.73 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 123.184 2.589 . . . . 0.0 111.606 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.441 ' HA ' ' CG ' ' A' ' 26' ' ' PHE . 25.8 tt0 -65.53 -35.55 81.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.519 179.08 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -75.45 -4.41 39.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.564 -175.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -85.53 145.05 27.57 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 171.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -73.04 -20.29 61.02 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.975 HG12 HG11 ' A' ' 96' ' ' VAL . 1.0 OUTLIER -73.29 -16.01 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.152 179.126 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.441 ' CG ' ' HA ' ' A' ' 21' ' ' GLU . 80.2 t80 -58.02 -52.32 66.01 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.883 0.373 . . . . 0.0 110.455 -178.117 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -42.98 90.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.278 178.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.471 ' O ' HG12 ' A' ' 31' ' ' ILE . 19.4 m-85 -64.73 -47.75 77.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.165 -0.471 . . . . 0.0 112.097 -177.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.552 ' HB3' HG21 ' A' ' 77' ' ' VAL . 58.6 mtt -71.68 -26.21 62.43 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 122.208 -0.307 . . . . 0.0 111.019 -179.28 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 26' ' ' PHE . 7.8 mmtt -72.07 -35.37 69.24 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.445 175.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.471 HG12 ' O ' ' A' ' 28' ' ' TYR . 14.7 pt -78.93 -21.35 12.79 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.481 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.662 174.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.7 tt -67.17 -48.84 66.78 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 171.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -44.19 -38.59 3.83 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.086 173.389 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -83.53 -55.6 4.2 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.242 175.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.451 ' HA ' ' HB3' ' A' ' 38' ' ' ASN . . . -55.51 -42.25 74.23 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -167.223 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 24.0 mmt -56.65 -43.29 80.18 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -178.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -91.68 -25.84 18.92 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.242 179.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.451 ' HB3' ' HA ' ' A' ' 35' ' ' ALA . 46.9 t30 -65.92 -28.33 68.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.04 178.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -52.93 133.54 37.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.689 174.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 23.6 p -59.82 -27.49 66.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.206 -173.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -96.67 -21.29 17.7 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.513 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 35.69 62.48 0.62 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.867 0.841 . . . . 0.0 110.837 -174.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.411 HD22 ' HD3' ' A' ' 46' ' ' LYS . 80.6 mt -72.03 2.79 5.14 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.744 -1.117 . . . . 0.0 111.761 -174.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.414 HG13 ' HB1' ' A' ' 70' ' ' ALA . 3.0 tp -56.01 -27.18 22.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.108 0.48 . . . . 0.0 110.858 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.513 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 49.9 mt-10 -76.08 -13.24 60.21 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.719 -176.614 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.411 ' HD3' HD22 ' A' ' 43' ' ' LEU . 60.5 mtpt -85.93 -17.02 36.61 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.003 0.43 . . . . 0.0 111.04 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 47' ' ' VAL . 14.0 p -130.69 33.2 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.924 0.869 . . . . 0.0 109.804 -177.004 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.513 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 23.1 mtm180 -52.14 118.07 3.24 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.971 0.891 . . . . 0.0 112.279 -175.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.4 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . -170.13 -174.87 38.62 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 113.8 -1.545 . . . . 0.0 109.751 -178.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.483 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 43.9 mt -121.74 124.84 72.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-N 118.214 1.007 . . . . 0.0 111.545 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.559 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 2.6 m-85 -107.42 109.49 21.22 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.781 -176.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.74 113.41 4.35 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.391 -0.909 . . . . 0.0 111.065 177.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -97.4 111.58 23.78 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.264 0.554 . . . . 0.0 111.647 -178.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -93.76 101.17 13.28 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.439 175.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.716 HG11 HG11 ' A' ' 25' ' ' VAL . 14.2 t -99.17 127.14 52.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.684 -175.311 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 30.2 mtp180 -118.55 -174.1 2.61 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.422 -177.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 61.74 39.93 13.58 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 123.449 0.468 . . . . 0.0 111.195 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.81 -164.47 26.78 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.095 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -39.12 -60.32 0.52 Allowed 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 124.342 3.361 . . . . 0.0 114.062 -176.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -109.88 41.9 1.62 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.065 0.459 . . . . 0.0 110.093 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.21 24.3 76.71 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -170.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.48 162.09 29.66 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 114.708 -0.746 . . . . 0.0 111.471 -175.111 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -124.89 140.74 52.65 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.877 -178.021 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -127.95 163.48 21.57 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.936 179.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -143.11 121.03 12.0 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 117.217 0.509 . . . . 0.0 111.375 -177.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 24.2 m-90 -125.96 134.29 51.56 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.924 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 40.3 t -99.78 114.4 37.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.247 178.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.66 HG13 HG12 ' A' ' 77' ' ' VAL . 4.1 mp -89.95 100.82 11.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 174.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -84.54 97.31 9.5 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.214 -176.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.414 ' HB1' HG13 ' A' ' 44' ' ' ILE . . . -95.26 -12.13 26.76 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.219 174.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.476 ' HD2' ' HG3' ' A' ' 72' ' ' GLU . 1.6 tmmt? -58.2 -40.85 82.66 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.273 -177.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.476 ' HG3' ' HD2' ' A' ' 71' ' ' LYS . 51.7 mt-10 -91.72 12.15 22.2 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.337 0.589 . . . . 0.0 111.313 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 76.46 11.14 85.37 Favored Glycine 0 C--O 1.228 -0.228 0 CA-C-N 115.402 -0.817 . . . . 0.0 113.394 173.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -91.58 -45.05 8.71 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 122.717 -0.284 . . . . 0.0 111.174 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.97 33.82 62.37 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -176.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 19.8 ptmt -98.35 154.68 17.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.365 -0.418 . . . . 0.0 109.948 -175.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.66 HG12 HG13 ' A' ' 68' ' ' ILE . 0.7 OUTLIER -107.77 137.36 39.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 178.733 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.5 t -140.53 134.18 30.24 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.113 178.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -66.6 116.43 7.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.669 -175.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 65.0 t30 51.17 68.29 0.81 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 123.9 0.75 . . . . 0.0 110.161 -176.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -56.82 -34.59 65.33 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.106 -0.952 . . . . 0.0 113.936 -172.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.47 -16.9 60.34 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -176.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.463 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 16.9 mm-40 -75.62 155.11 36.21 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 175.557 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -90.88 108.9 31.13 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-O 120.771 0.32 . . . . 0.0 110.194 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.483 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 20.1 Cg_exo -65.78 125.73 14.79 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.925 2.417 . . . . 0.0 112.879 -178.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -65.57 -34.47 78.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.129 -0.942 . . . . 0.0 109.746 174.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.6 m -135.57 139.04 47.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.503 175.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.579 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 19.0 m -118.14 135.63 54.1 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.598 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 72.6 m-85 -122.58 125.02 44.84 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.585 ' HB ' ' HB3' ' A' ' 116' ' ' LYS . 35.8 m -101.77 114.2 28.06 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 177.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.594 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 73.1 mt -137.87 148.12 25.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.554 -174.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.0 m -85.34 139.25 31.73 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.087 0.47 . . . . 0.0 110.425 176.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.53 ' OD1' HG13 ' A' ' 25' ' ' VAL . 20.9 t70 -47.18 -34.26 6.11 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 114.504 -1.225 . . . . 0.0 112.427 -178.058 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -70.92 -41.74 70.81 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.103 -173.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -91.28 -18.6 24.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.591 -175.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.975 HG11 HG12 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -54.77 -31.55 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 121.121 0.486 . . . . 0.0 110.124 -179.801 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.0 m -67.05 -35.13 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.023 -173.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -77.08 -33.64 57.04 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.415 HD12 HG21 ' A' ' 91' ' ' ILE . 92.5 mt -69.08 -48.09 63.56 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.403 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 96' ' ' VAL . 32.0 mt -66.19 -36.68 77.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.125 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.2 t -75.82 -30.3 58.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.817 0.342 . . . . 0.0 111.2 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 102.8 10.56 37.24 Favored Glycine 0 N--CA 1.453 -0.167 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.876 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -81.11 -40.32 24.24 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.23 0.538 . . . . 0.0 111.0 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.728 HD11 ' NZ ' ' A' ' 108' ' ' LYS . 52.4 tp -101.08 133.78 45.08 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.339 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.418 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 94.1 m-20 -79.34 124.69 84.07 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.292 177.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -64.91 -24.86 60.27 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.124 1.882 . . . . 0.0 110.459 176.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -61.37 -60.18 4.12 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.627 173.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.728 ' NZ ' HD11 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -62.78 -35.11 78.78 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.124 0.487 . . . . 0.0 110.021 -177.763 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.561 ' HB3' HD12 ' A' ' 115' ' ' ILE . . . -70.93 -33.13 70.21 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.025 -177.486 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -61.27 -48.61 80.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.312 174.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -60.83 -44.01 97.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.943 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.407 ' HG3' ' HE3' ' A' ' 108' ' ' LYS . 74.8 mm-40 -74.39 -12.56 60.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.178 -176.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.77 18.25 45.09 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.158 175.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.35 -24.64 17.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.862 0.363 . . . . 0.0 110.868 176.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.582 HG23 HG22 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -109.79 111.11 34.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.807 0.813 . . . . 0.0 110.144 178.086 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.585 ' HB3' ' HB ' ' A' ' 90' ' ' THR . 13.8 tppt? -110.05 107.5 17.39 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.093 174.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.598 ' HB ' ' CD2' ' A' ' 89' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--N 1.318 -0.775 0 CA-C-O 121.257 0.551 . . . . 0.0 110.184 -177.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.401 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 43.1 m-80 . . . . . 0 N--CA 1.456 -0.127 0 CA-C-O 120.866 0.365 . . . . 0.0 110.229 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.507 ' HA ' ' CD1' ' A' ' 23' ' ' PHE . 14.2 Cg_exo -64.46 -28.88 62.29 Favored 'Trans proline' 0 CA--C 1.518 -0.317 0 C-N-CA 123.276 2.651 . . . . 0.0 111.802 -177.039 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -65.9 -35.22 80.02 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.261 177.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -73.38 -14.62 61.31 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.562 -178.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.507 ' CD1' ' HA ' ' A' ' 20' ' ' PRO . 23.5 m-85 -66.25 148.76 51.36 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.404 0.621 . . . . 0.0 110.378 176.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -74.06 -26.36 60.35 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 176.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.857 HG12 HG11 ' A' ' 96' ' ' VAL . 0.8 OUTLIER -73.9 -15.51 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.97 -179.009 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -56.74 -50.04 73.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.768 0.318 . . . . 0.0 110.307 -177.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.452 ' HE2' HG23 ' A' ' 31' ' ' ILE . 1.1 tpmt? -72.7 -38.23 67.6 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.863 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -64.72 -50.91 65.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.569 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.584 ' HB3' HG21 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -62.9 -31.53 72.6 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.834 0.349 . . . . 0.0 110.928 177.289 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.423 ' HD2' ' HA ' ' A' ' 30' ' ' LYS . 21.6 mmmt -70.76 -37.81 73.43 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 178.154 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.452 HG23 ' HE2' ' A' ' 27' ' ' LYS . 10.5 pt -84.13 -19.69 9.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.133 176.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.6 tt -60.58 -46.85 88.69 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 171.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -46.85 -48.48 20.97 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.777 175.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -73.96 -50.41 20.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.706 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.89 -36.88 80.38 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -169.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 33.1 mmt -59.63 -44.11 93.58 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.587 0.217 . . . . 0.0 111.587 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -91.4 -8.36 48.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.19 0.519 . . . . 0.0 110.723 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -73.69 -23.36 59.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.037 0.446 . . . . 0.0 109.984 178.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -59.14 132.16 53.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.772 175.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 13.9 p -57.44 -37.42 72.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.562 -173.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -101.57 9.95 40.73 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 119.306 -0.378 . . . . 0.0 110.96 178.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.545 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 19.0 p-10 25.52 70.37 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.114 0.965 . . . . 0.0 111.275 -173.59 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.7 mt -58.4 -4.45 0.39 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 114.414 -1.267 . . . . 0.0 111.921 -176.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.55 HG13 ' HB1' ' A' ' 70' ' ' ALA . 4.2 tp -60.75 -25.42 35.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.663 178.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 42' ' ' ASN . 10.9 pt-20 -76.51 -16.7 59.57 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.237 -179.283 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -95.53 -13.24 24.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.263 0.554 . . . . 0.0 110.731 -177.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 47' ' ' VAL . 11.9 p -130.43 32.24 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.845 0.831 . . . . 0.0 109.562 -177.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 55.6 mtt180 -52.49 117.11 2.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.397 -175.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.564 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . -167.16 164.76 38.12 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.221 -178.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.524 HG13 ' HB2' ' A' ' 71' ' ' LYS . 63.8 mt -103.13 124.93 57.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 117.217 0.509 . . . . 0.0 109.988 176.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.512 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 37.3 m-85 -105.72 115.66 30.62 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.203 -176.363 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.97 111.35 4.23 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.396 -0.907 . . . . 0.0 110.835 177.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.445 ' O ' ' HA ' ' A' ' 65' ' ' TYR . 7.5 m-85 -98.18 108.37 21.06 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.024 0.44 . . . . 0.0 111.594 -178.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -95.71 99.69 11.5 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.638 175.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.725 HG11 HG11 ' A' ' 25' ' ' VAL . 17.4 t -98.12 119.78 46.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.782 -174.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -108.89 179.07 4.28 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.123 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.458 ' HB2' ' HB3' ' A' ' 92' ' ' SER . 3.3 m-20 60.23 42.23 15.53 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.93 0.395 . . . . 0.0 111.125 177.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.11 -166.59 28.93 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.572 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -31.5 -60.49 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 124.946 3.764 . . . . 0.0 114.404 -176.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -120.06 48.07 1.63 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.17 30.04 65.73 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -174.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.47 165.46 21.21 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.224 0.535 . . . . 0.0 111.356 -176.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -132.7 125.74 30.96 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.129 -0.942 . . . . 0.0 110.856 -178.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -115.14 164.13 12.14 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.317 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 30.9 t80 -147.36 118.34 7.68 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.854 0.359 . . . . 0.0 110.624 -178.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 22.3 m-90 -122.99 132.07 53.98 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.992 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 46.6 t -100.89 117.61 46.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.224 177.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.549 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 4.1 mp -95.31 104.97 16.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.062 0.458 . . . . 0.0 109.88 176.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.448 HD21 ' HG3' ' A' ' 72' ' ' GLU . 19.1 t-20 -79.42 99.38 7.16 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.142 177.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -111.1 -1.68 16.14 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 172.267 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.524 ' HB2' HG13 ' A' ' 50' ' ' ILE . 2.2 tppp? -67.55 -38.09 83.66 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.385 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.448 ' HG3' HD21 ' A' ' 69' ' ' ASN . 42.6 mt-10 -84.79 -1.63 56.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.234 176.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.02 20.92 69.14 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.618 178.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -89.92 -37.53 14.33 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.953 0.406 . . . . 0.0 111.057 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.13 32.14 76.05 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.883 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 19.7 ptmt -98.7 163.1 12.78 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -177.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.584 HG21 ' HB3' ' A' ' 29' ' ' MET . 0.8 OUTLIER -124.42 139.64 50.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.784 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.0 t -135.38 134.7 40.01 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.284 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -68.65 119.23 12.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.975 -178.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 52.43 69.87 0.63 Allowed 'General case' 0 N--CA 1.464 0.258 0 O-C-N 123.745 0.653 . . . . 0.0 109.732 -175.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.37 -40.71 91.64 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.708 -0.678 . . . . 0.0 113.822 -173.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.63 -20.79 48.06 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.609 -177.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.539 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 34.8 mt-10 -65.86 143.26 57.57 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.468 -0.366 . . . . 0.0 110.085 175.46 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 24.5 pttm -78.64 108.82 8.8 Favored Pre-proline 0 N--CA 1.449 -0.525 0 CA-C-O 121.341 0.591 . . . . 0.0 110.278 175.513 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.539 ' HD3' ' O ' ' A' ' 83' ' ' GLU . 12.6 Cg_exo -71.36 129.18 15.54 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.581 2.187 . . . . 0.0 111.949 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -59.25 -31.67 69.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.184 174.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.442 ' HB ' ' CD1' ' A' ' 117' ' ' ILE . 2.7 m -141.12 128.9 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.629 175.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.749 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 35.5 m -118.13 121.85 41.58 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.885 177.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.432 ' HA ' ' HB ' ' A' ' 117' ' ' ILE . 5.5 m-85 -106.5 131.76 53.31 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -178.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.448 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 5.4 m -103.77 127.26 51.26 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 173.298 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.519 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -161.4 155.9 3.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -174.79 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.458 ' HB3' ' HB2' ' A' ' 57' ' ' ASN . 15.5 m -85.19 145.56 27.53 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.31 0.576 . . . . 0.0 111.502 -175.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -51.07 -32.35 21.81 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.734 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -73.68 -35.54 65.21 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.982 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.439 ' OD2' ' HB2' ' A' ' 92' ' ' SER . 12.3 m-20 -90.59 -22.55 21.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.535 -173.045 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.857 HG11 HG12 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -57.36 -33.06 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 121.086 0.47 . . . . 0.0 110.446 -178.155 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.5 m -68.09 -27.68 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.241 -170.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -86.54 -30.21 22.09 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 177.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.45 HD23 ' O ' ' A' ' 104' ' ' LEU . 77.2 mt -67.74 -45.82 73.9 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.201 0.524 . . . . 0.0 110.578 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 96' ' ' VAL . 23.5 mt -75.8 -23.26 16.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.381 -176.238 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 27.7 p -85.54 -22.4 28.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.811 0.339 . . . . 0.0 110.839 178.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 96.97 8.33 56.94 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.934 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -80.42 -41.01 25.31 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.149 0.499 . . . . 0.0 111.131 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.45 ' O ' HD23 ' A' ' 99' ' ' LEU . 42.2 tp -102.78 120.7 41.05 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.844 -178.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -69.41 124.46 90.53 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.207 175.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.485 ' HA ' ' HB3' ' A' ' 109' ' ' ALA . 1.0 OUTLIER -70.1 -14.11 34.6 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 121.816 1.678 . . . . 0.0 110.564 177.452 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -66.13 -58.42 5.47 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.257 171.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.518 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 1.1 ptmt -66.65 -31.46 72.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.653 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.518 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -66.8 -31.53 72.22 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.905 177.194 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.765 ' HA ' HG22 ' A' ' 115' ' ' ILE . 23.7 t80 -66.09 -50.85 62.65 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.047 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -63.27 -34.21 77.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.331 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -85.27 11.15 10.63 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.65 15.12 73.13 Favored Glycine 0 CA--C 1.517 0.185 0 C-N-CA 121.218 -0.515 . . . . 0.0 113.133 175.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -85.3 -45.07 12.29 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.91 0.386 . . . . 0.0 110.554 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.765 HG22 ' HA ' ' A' ' 110' ' ' PHE . 0.6 OUTLIER -97.39 122.96 49.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.93 -178.208 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.448 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 29.5 mmmt -120.71 99.34 6.48 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 173.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.749 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.318 -0.762 0 CA-C-O 121.275 0.559 . . . . 0.0 111.68 -170.34 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.617 ' N ' HD21 ' A' ' 19' ' ' ASN . 0.5 OUTLIER . . . . . 0 CA--C 1.518 -0.287 0 CA-C-O 121.968 0.889 . . . . 0.0 111.496 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.445 ' HA ' ' CD1' ' A' ' 23' ' ' PHE . 38.0 Cg_endo -69.63 -15.9 37.82 Favored 'Trans proline' 0 C--N 1.329 -0.46 0 C-N-CA 123.956 3.104 . . . . 0.0 112.068 -177.568 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -75.01 -28.86 60.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.507 -177.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -82.83 -7.54 59.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.957 -176.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.445 ' CD1' ' HA ' ' A' ' 20' ' ' PRO . 40.3 m-85 -73.12 146.49 45.68 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 174.647 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.438 ' HD3' HG11 ' A' ' 97' ' ' VAL . 78.6 tttt -78.46 -21.76 48.6 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.898 HG12 HG11 ' A' ' 96' ' ' VAL . 1.3 m -71.83 -13.68 16.94 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.535 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.648 175.483 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -56.51 -58.17 9.17 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.135 -0.321 . . . . 0.0 110.135 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.35 -42.55 96.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.161 0.505 . . . . 0.0 110.494 178.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.528 ' HB3' HD12 ' A' ' 100' ' ' ILE . 18.0 m-85 -65.81 -42.04 91.13 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.613 -175.412 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.43 ' CE ' HD11 ' A' ' 68' ' ' ILE . 67.5 mtp -80.16 -24.29 40.49 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.117 -0.365 . . . . 0.0 110.354 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.413 ' HD3' ' HA ' ' A' ' 30' ' ' LYS . 50.5 mmtt -66.61 -41.53 88.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.506 173.414 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.471 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 4.8 pt -78.97 -26.08 13.23 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.56 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.188 176.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.408 ' C ' HD23 ' A' ' 32' ' ' LEU . 6.1 tt -55.15 -51.56 66.08 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 170.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.51 ' HG2' ' HA ' ' A' ' 76' ' ' LYS . 0.7 OUTLIER -47.24 -53.91 12.14 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.962 177.748 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 31' ' ' ILE . 7.6 pt-20 -74.01 -39.4 63.63 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.288 -175.344 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.01 -37.46 85.95 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.661 -174.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 19.8 mmt -58.48 -44.18 89.25 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.645 0.26 . . . . 0.0 111.543 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -91.24 -7.89 49.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.932 0.396 . . . . 0.0 110.578 177.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 22.0 t-20 -64.94 -34.56 78.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.304 -178.55 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -61.12 132.27 53.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.653 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.55 -24.85 65.72 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.463 -175.149 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -102.27 10.83 38.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 119.463 -0.304 . . . . 0.0 111.562 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 26.2 p30 30.86 70.8 0.08 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.382 1.073 . . . . 0.0 112.248 178.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.8 mt -62.64 -2.81 1.22 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.128 -174.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.8 tp -64.02 -27.45 42.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.274 0.559 . . . . 0.0 110.288 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -63.5 -25.62 68.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.396 -177.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -81.81 -19.75 40.51 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.164 -177.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.3 m -129.65 32.31 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.791 -175.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 72.3 mtt180 -49.45 112.03 0.58 Allowed 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.763 0.792 . . . . 0.0 111.04 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.518 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . -178.28 161.57 28.44 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.705 -175.12 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.565 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 64.9 mt -96.57 126.88 49.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 117.28 0.54 . . . . 0.0 110.865 -178.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.446 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 9.4 m-85 -106.07 118.89 37.79 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.708 -179.181 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.28 113.92 4.85 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.514 -0.85 . . . . 0.0 111.327 177.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -101.26 110.47 22.49 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.122 0.487 . . . . 0.0 111.694 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -94.3 99.75 11.92 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.312 174.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.804 HG11 HG11 ' A' ' 25' ' ' VAL . 19.9 t -100.83 112.49 33.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.045 0.45 . . . . 0.0 110.878 -174.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 76.2 mtp85 -104.05 179.71 4.19 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.577 -177.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 64.68 37.29 7.71 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 123.348 0.405 . . . . 0.0 111.311 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.38 -161.17 9.26 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.796 178.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -34.74 -60.72 0.27 Allowed 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 124.605 3.537 . . . . 0.0 114.493 -174.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -115.89 38.49 3.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.38 0.61 . . . . 0.0 110.343 178.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 78.38 24.46 63.21 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -171.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.79 156.34 39.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.14 -0.53 . . . . 0.0 110.725 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -118.3 116.0 25.86 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.182 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.41 161.09 16.27 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.019 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -145.95 118.83 8.7 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.977 0.418 . . . . 0.0 110.897 -176.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.402 ' CE2' ' HD1' ' A' ' 79' ' ' TYR . 20.9 m-90 -121.23 136.27 55.0 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.812 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 39.0 t -106.19 117.23 51.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.555 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.65 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 3.7 mp -93.56 99.79 10.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 175.39 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -86.25 98.35 10.89 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.348 -177.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -109.3 6.94 24.97 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.177 175.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.54 ' HB2' HG13 ' A' ' 50' ' ' ILE . 5.4 tppp? -60.49 -42.97 97.38 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.522 -178.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -94.27 5.34 52.06 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.223 -178.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.8 -13.51 59.21 Favored Glycine 0 C--N 1.318 -0.431 0 CA-C-N 115.703 -0.68 . . . . 0.0 113.63 174.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.43 -67.05 0.42 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.87 34.7 14.56 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 119.797 -1.192 . . . . 0.0 111.249 -175.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.65 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 54.6 pttt -98.0 148.64 23.28 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 -177.267 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.401 HG12 HG13 ' A' ' 68' ' ' ILE . 0.8 OUTLIER -107.04 135.12 46.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 177.652 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.4 t -140.11 132.86 29.03 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.606 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.402 ' HD1' ' CE2' ' A' ' 66' ' ' TRP . 45.5 t80 -68.93 121.42 16.56 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 56.49 74.75 0.38 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.552 0.692 . . . . 0.0 109.474 -173.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.86 -41.18 73.77 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.916 -176.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.45 -13.58 61.79 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.93 -179.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.513 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 12.9 mm-40 -81.15 159.41 24.66 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 177.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -87.68 109.08 23.92 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 123.18 0.3 . . . . 0.0 110.518 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.565 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 18.0 Cg_exo -67.26 134.2 32.95 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.815 2.343 . . . . 0.0 112.787 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -66.95 -33.26 75.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.493 -0.776 . . . . 0.0 108.949 172.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 8.5 m -140.58 134.27 33.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.256 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.632 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 27.9 m -119.4 132.77 55.89 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 175.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.524 ' CD1' ' HB ' ' A' ' 117' ' ' ILE . 68.2 m-85 -119.4 125.79 49.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.219 -179.053 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.437 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 25.4 m -99.83 126.16 45.89 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 173.238 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.554 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -157.31 144.26 9.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.888 -176.342 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.14 141.97 41.76 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.451 178.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.486 ' OD1' HG13 ' A' ' 25' ' ' VAL . 22.3 t70 -49.13 -27.47 3.5 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.707 1.203 . . . . 0.0 111.986 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -78.08 -34.44 50.27 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.226 -174.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -90.99 -20.45 22.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.239 -175.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.898 HG11 HG12 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -57.92 -31.73 41.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.023 -175.116 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.438 HG11 ' HD3' ' A' ' 24' ' ' LYS . 4.9 m -63.91 -29.53 47.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.461 -170.418 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -81.87 -32.63 30.98 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.505 HD23 ' O ' ' A' ' 104' ' ' LEU . 91.6 mt -69.36 -42.86 74.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.381 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.528 HD12 ' HB3' ' A' ' 28' ' ' TYR . 1.6 mm -65.34 -25.67 37.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.681 178.685 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.6 t -96.86 -11.41 24.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.646 -176.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.49 9.86 82.77 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.128 -177.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -77.76 -42.35 34.42 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.266 0.555 . . . . 0.0 110.261 178.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.505 ' O ' HD23 ' A' ' 99' ' ' LEU . 48.3 tp -100.02 125.1 46.03 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.723 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.529 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 6.1 m-20 -77.34 124.19 86.96 Favored Pre-proline 0 C--N 1.317 -0.805 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.013 178.514 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -64.99 -22.28 62.74 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.022 1.815 . . . . 0.0 110.529 179.219 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 77.0 mm-40 -64.24 -56.7 12.84 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.133 173.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.529 ' HG2' ' HB2' ' A' ' 105' ' ' ASN . 0.1 OUTLIER -67.75 -31.37 71.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.078 -178.514 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.547 ' HB3' HD12 ' A' ' 115' ' ' ILE . . . -69.91 -32.79 71.28 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 177.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -62.51 -52.13 64.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.595 174.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -63.16 -42.14 99.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.88 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 75.5 mm-40 -71.33 -7.68 48.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.883 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 95.76 -5.02 66.45 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.667 -0.777 . . . . 0.0 113.432 173.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.408 ' HD2' ' HA ' ' A' ' 114' ' ' LYS . 28.3 mmmt -68.38 -53.16 25.75 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.95 0.405 . . . . 0.0 111.43 177.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.676 HG23 HG22 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -85.94 116.72 29.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.653 0.74 . . . . 0.0 111.038 -175.35 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.437 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 33.7 mmtp -108.37 104.27 13.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.987 175.046 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.676 HG22 HG23 ' A' ' 115' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.321 -0.635 0 CA-C-O 121.145 0.498 . . . . 0.0 111.101 -177.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.513 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 82.0 m-20 . . . . . 0 CA--C 1.514 -0.418 0 CA-C-O 121.575 0.702 . . . . 0.0 110.509 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -68.54 -18.37 43.2 Favored 'Trans proline' 0 C--N 1.327 -0.598 0 C-N-CA 123.745 2.964 . . . . 0.0 112.346 -176.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.412 ' HA ' ' CG ' ' A' ' 26' ' ' PHE . 15.0 mt-10 -84.05 -27.29 28.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.438 -177.327 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.513 ' OD2' ' HB2' ' A' ' 19' ' ' ASN . 42.9 m-20 -76.49 -9.4 58.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.13 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -73.31 145.55 45.95 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.756 174.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -76.04 -17.7 59.55 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.759 HG12 HG11 ' A' ' 96' ' ' VAL . 1.2 m -78.02 -15.87 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.267 177.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.412 ' CG ' ' HA ' ' A' ' 21' ' ' GLU . 78.7 t80 -54.74 -55.93 24.7 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 123.123 0.264 . . . . 0.0 110.73 -174.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.459 ' O ' HG23 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -65.72 -35.33 80.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.647 -179.072 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.443 ' HB3' HD12 ' A' ' 100' ' ' ILE . 12.7 m-85 -66.89 -48.52 68.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.529 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 63.7 mtt -70.7 -30.79 67.45 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.017 178.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.423 ' HD2' ' HA ' ' A' ' 30' ' ' LYS . 27.7 mmmt -67.02 -34.74 78.38 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.236 176.353 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.459 HG23 ' O ' ' A' ' 27' ' ' LYS . 12.6 pt -86.55 -18.57 8.57 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.798 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.389 175.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.1 tt -63.74 -52.19 61.56 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 169.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.516 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 21.1 tt0 -42.11 -53.18 4.07 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.239 -1.346 . . . . 0.0 111.32 171.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -73.51 -62.45 1.48 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.336 -1.302 . . . . 0.0 112.175 -176.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.418 ' HA ' ' HB3' ' A' ' 38' ' ' ASN . . . -54.91 -42.63 72.43 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -169.081 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.6 mmt -61.21 -37.84 84.44 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -176.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -91.8 -23.54 19.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.139 0.495 . . . . 0.0 110.162 178.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.418 ' HB3' ' HA ' ' A' ' 35' ' ' ALA . 26.7 t-20 -64.28 -32.93 74.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.219 178.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -54.7 134.59 47.38 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.614 175.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.9 p -63.08 -28.97 70.45 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.539 -176.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -81.96 -25.16 35.06 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.652 176.215 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.9 p30 36.96 73.62 0.09 Allowed 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.984 0.897 . . . . 0.0 110.728 -174.109 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.453 ' O ' HG12 ' A' ' 47' ' ' VAL . 66.9 mt -63.16 -3.11 1.6 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.717 -175.062 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.473 HG13 ' HB1' ' A' ' 70' ' ' ALA . 4.1 tp -60.28 -26.48 36.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.268 -177.26 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.423 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 25.8 mt-10 -83.08 -14.49 53.63 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 120.823 0.344 . . . . 0.0 111.141 -178.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -92.65 -13.93 28.82 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.267 0.556 . . . . 0.0 110.183 178.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 47' ' ' VAL . 13.9 p -130.11 32.69 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.867 0.842 . . . . 0.0 109.872 -177.295 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.423 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 60.1 mtt180 -52.51 111.65 0.68 Allowed 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.556 -178.404 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.655 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . -175.37 147.56 8.95 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.818 -176.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.53 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 66.7 mt -89.18 126.94 42.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 117.39 0.595 . . . . 0.0 110.794 -177.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.455 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 5.0 m-85 -104.31 116.54 32.33 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.758 -177.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.96 111.58 4.28 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.116 177.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -100.48 103.43 14.78 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.164 0.507 . . . . 0.0 111.568 -178.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -88.36 99.5 12.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.397 175.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 10.8 t -98.13 134.92 34.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.127 -177.291 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 31.7 mtp-105 -125.58 175.78 7.32 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.475 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 57.51 42.88 23.68 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 123.426 0.454 . . . . 0.0 111.758 177.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.12 -160.52 8.24 Favored Glycine 0 CA--C 1.521 0.423 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.621 177.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -37.93 -60.82 0.4 Allowed 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 124.284 3.323 . . . . 0.0 113.737 -177.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.454 ' OD1' ' HB2' ' A' ' 62' ' ' ALA . 28.6 p-10 -109.52 34.92 3.53 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.295 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.38 28.54 59.66 Favored Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -173.176 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.454 ' HB2' ' OD1' ' A' ' 60' ' ' ASN . . . -76.45 146.91 38.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.662 0.744 . . . . 0.0 112.168 -175.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -108.4 108.16 19.01 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.186 176.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -100.58 152.55 19.16 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -137.76 116.47 12.21 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 117.089 0.445 . . . . 0.0 110.905 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 24.3 m-90 -119.3 139.84 51.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.709 178.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 30.5 t -109.85 113.43 44.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.152 178.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.495 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 3.9 mp -91.46 102.61 13.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.01 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -85.62 98.03 10.43 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.341 0.591 . . . . 0.0 110.341 -176.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -97.4 -4.5 38.19 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.758 174.187 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.447 ' HB2' HG13 ' A' ' 50' ' ' ILE . 15.8 tppt? -63.5 -42.74 98.51 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.162 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -73.71 -6.59 47.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.237 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.58 12.28 81.93 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.929 -177.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -91.37 -52.48 4.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.686 0.279 . . . . 0.0 110.766 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.84 34.45 24.56 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.349 -0.929 . . . . 0.0 111.504 -177.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.516 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 21.8 ptmt -97.54 150.42 21.12 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -176.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -108.02 125.38 64.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.312 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.449 HG23 ' HA2' ' A' ' 81' ' ' GLY . 3.8 t -128.38 134.49 48.85 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.784 -178.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -63.24 125.38 23.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.213 -176.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 74.08 -42.05 0.5 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.833 0.853 . . . . 0.0 111.699 -178.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.449 ' HA2' HG23 ' A' ' 78' ' ' THR . . . 70.82 -43.09 0.6 Allowed Glycine 0 CA--C 1.519 0.302 0 N-CA-C 114.483 0.553 . . . . 0.0 114.483 177.491 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 69.32 17.25 72.13 Favored Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 -174.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.404 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 38.7 mm-40 -117.82 162.94 17.28 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 122.576 0.35 . . . . 0.0 110.332 -176.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 95.4 mttt -95.34 109.04 42.97 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.98 176.147 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.53 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 17.2 Cg_exo -68.09 133.74 29.71 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.888 2.392 . . . . 0.0 112.73 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -65.32 -32.58 74.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.5 174.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.9 m -141.02 132.77 29.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.552 173.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.673 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 86.3 m -115.92 131.1 57.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.318 176.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.534 ' CD1' ' HB ' ' A' ' 117' ' ' ILE . 75.8 m-85 -116.56 123.55 47.65 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.003 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.438 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 3.5 m -99.7 119.74 38.59 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 176.244 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 59.0 mt -143.86 154.22 15.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -174.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.461 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 37.5 m -89.25 144.25 26.24 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.505 175.284 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -42.38 -52.09 4.7 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.378 0.671 . . . . 0.0 111.968 -177.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.97 -42.35 89.73 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.162 -176.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.461 ' OD2' ' HB2' ' A' ' 92' ' ' SER . 7.8 m-20 -80.4 -21.67 42.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.594 0.235 . . . . 0.0 111.535 -173.061 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.759 HG11 HG12 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -58.62 -34.23 50.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.085 -176.463 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.1 m -68.09 -30.46 48.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.22 -171.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -81.14 -33.46 33.15 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 177.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.477 HD23 ' O ' ' A' ' 104' ' ' LEU . 74.0 mt -69.77 -47.91 61.2 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.011 -177.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 96' ' ' VAL . 25.5 mt -70.34 -26.03 28.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.055 -178.061 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 27.3 t -88.2 -8.67 54.97 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.512 -178.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.51 19.6 61.75 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.322 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -94.2 -41.76 9.31 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.096 0.474 . . . . 0.0 110.979 -178.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.736 HD11 ' NZ ' ' A' ' 108' ' ' LYS . 37.6 tp -101.1 128.74 47.04 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.334 179.014 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.637 ' OD1' ' HB2' ' A' ' 107' ' ' GLN . 2.8 t-20 -69.68 122.33 85.45 Favored Pre-proline 0 C--N 1.321 -0.63 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.057 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -68.39 -24.44 36.9 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.896 1.731 . . . . 0.0 110.692 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.637 ' HB2' ' OD1' ' A' ' 105' ' ' ASN . 1.7 mp0 -64.83 -59.15 4.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.453 173.479 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.736 ' NZ ' HD11 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -60.41 -37.93 82.4 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.818 -179.365 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.533 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -68.83 -34.88 76.23 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.553 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.428 ' CD2' HG22 ' A' ' 115' ' ' ILE . 20.3 t80 -62.23 -52.93 61.78 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 174.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -56.9 -42.25 79.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.094 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -74.97 -1.69 23.75 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.963 -177.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 96.5 -12.94 66.07 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.32 173.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -62.41 -61.17 2.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.061 0.458 . . . . 0.0 111.77 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.605 HG23 HG22 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -80.85 121.8 34.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.062 -175.253 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.438 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 35.9 mmtm -115.4 99.63 7.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.319 172.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.673 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.322 -0.614 0 CA-C-O 121.092 0.472 . . . . 0.0 110.155 177.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.763 0 N-CA-C 112.166 -0.374 . . . . 0.0 112.166 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.677 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 17.0 p -57.74 116.42 3.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.655 0.264 . . . . 0.0 110.718 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.5 m -124.37 100.52 6.72 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.111 0.481 . . . . 0.0 111.283 -177.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.39 174.26 47.91 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.118 175.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -60.36 146.69 83.81 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 121.14 0.495 . . . . 0.0 110.668 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.468 ' HA ' ' CD1' ' A' ' 23' ' ' PHE . 3.3 Cg_exo -70.45 -18.65 33.63 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 123.183 2.589 . . . . 0.0 112.628 -173.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -67.14 -28.21 67.95 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.745 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -77.37 -7.73 56.55 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.692 -177.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.468 ' CD1' ' HA ' ' A' ' 20' ' ' PRO . 27.7 m-85 -80.88 148.08 30.07 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 177.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -67.84 -31.21 70.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.142 0.496 . . . . 0.0 109.95 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.883 HG12 HG11 ' A' ' 96' ' ' VAL . 1.7 m -68.36 -16.82 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.563 -177.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -54.03 -57.17 12.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.006 0.431 . . . . 0.0 110.648 -177.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.421 ' HZ1' HD13 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -70.17 -33.06 71.28 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.741 -178.114 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.476 ' HB3' HD12 ' A' ' 100' ' ' ILE . 39.7 m-85 -69.92 -46.4 65.45 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.581 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.444 ' CE ' HD11 ' A' ' 68' ' ' ILE . 53.6 mtp -71.96 -26.15 62.15 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.949 0.404 . . . . 0.0 110.435 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.435 ' HA ' ' HD2' ' A' ' 30' ' ' LYS . 24.8 mmmt -68.45 -36.68 79.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.066 175.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.421 HD13 ' HZ1' ' A' ' 27' ' ' LYS . 17.6 pt -83.31 -26.72 7.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.171 176.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.0 tt -53.93 -50.56 66.16 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 171.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.594 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 10.5 tt0 -43.6 -55.19 4.46 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.69 176.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -71.17 -53.65 13.74 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.497 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.12 -40.19 80.6 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -167.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 91.3 mmm -56.89 -43.52 81.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.046 0.45 . . . . 0.0 111.291 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -91.37 -17.71 25.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.27 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -64.9 -22.51 67.01 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.009 -175.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -59.28 130.06 45.09 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 172.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.7 -27.39 62.88 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.827 -173.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -100.83 18.48 19.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.809 -0.178 . . . . 0.0 110.961 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 27.5 70.52 0.05 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.912 1.285 . . . . 0.0 112.568 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.1 mt -62.83 -6.14 3.46 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.392 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.1 tp -60.62 -27.14 39.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.665 178.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.49 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 22.9 mt-10 -74.28 -21.59 59.68 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-O 120.743 0.306 . . . . 0.0 111.255 -178.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.533 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 95.1 mttt -77.92 -36.97 48.77 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.475 0.655 . . . . 0.0 110.153 177.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 47' ' ' VAL . 14.6 p -112.29 31.73 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.657 -172.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.49 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 53.1 mtt180 -51.33 111.86 0.64 Allowed 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.62 0.724 . . . . 0.0 111.524 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.569 ' HA3' HD11 ' A' ' 123' ' ' LEU . . . -170.14 168.67 41.61 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.752 -175.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.533 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 54.1 mt -108.7 124.42 65.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.455 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 12.8 m-85 -106.63 130.97 54.29 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.265 -174.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -107.87 117.36 5.13 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.303 176.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.415 ' O ' ' HA ' ' A' ' 65' ' ' TYR . 3.4 m-85 -103.65 100.07 9.89 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 120.978 0.418 . . . . 0.0 111.509 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 90' ' ' THR . 56.5 mtmt -89.32 101.99 14.66 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.453 174.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.698 HG11 HG11 ' A' ' 25' ' ' VAL . 16.1 t -104.71 124.71 59.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.588 -176.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 45.6 mtp180 -114.4 -179.75 3.72 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.99 -178.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 61.64 47.19 6.59 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.926 0.393 . . . . 0.0 110.876 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.71 -172.16 15.71 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.478 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -38.57 -60.43 0.48 Allowed 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 124.115 3.21 . . . . 0.0 113.497 -175.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -123.99 62.88 1.07 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.11 0.481 . . . . 0.0 110.326 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.84 22.61 78.95 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.846 -0.692 . . . . 0.0 111.926 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.677 ' HA ' ' O ' ' A' ' 16' ' ' SER . . . -80.36 169.77 17.28 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.31 0.576 . . . . 0.0 111.581 -177.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -141.61 139.07 33.0 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.69 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.45 162.82 24.08 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.648 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 26.0 t80 -150.3 115.29 5.34 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.949 0.404 . . . . 0.0 110.811 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 10.5 m-90 -117.81 145.05 44.82 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.437 HG11 ' HG3' ' A' ' 83' ' ' GLU . 40.6 t -113.3 124.68 70.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.52 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.464 ' N ' HD12 ' A' ' 68' ' ' ILE . 3.8 mp -100.36 107.02 20.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -83.48 98.35 9.48 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.031 0.443 . . . . 0.0 110.205 178.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -108.32 -2.61 19.07 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.971 175.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -61.25 -37.49 83.3 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -83.06 -2.44 55.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.106 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.38 18.2 67.13 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.005 -178.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.531 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 11.8 mmpt? -93.17 -61.44 1.57 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.683 -0.258 . . . . 0.0 110.786 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.6 35.52 6.48 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.154 -1.022 . . . . 0.0 112.34 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.594 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 19.1 pttm -96.35 142.34 28.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.692 0.246 . . . . 0.0 110.347 -176.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.7 OUTLIER -108.0 133.44 52.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.37 0.605 . . . . 0.0 109.555 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.2 t -138.11 134.33 34.51 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.641 -176.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -68.0 135.3 52.11 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 42.38 73.4 0.14 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.857 0.836 . . . . 0.0 111.064 -172.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.58 -40.02 97.28 Favored Glycine 0 C--N 1.33 0.212 0 CA-C-N 115.108 -0.951 . . . . 0.0 113.591 -173.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 92.18 -14.33 64.79 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.23 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.498 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 1.7 pt-20 -97.95 153.09 18.59 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 122.15 0.18 . . . . 0.0 110.925 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.412 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 60.4 pttt -79.2 110.11 13.7 Favored Pre-proline 0 N--CA 1.449 -0.477 0 CA-C-O 121.284 0.564 . . . . 0.0 111.323 178.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.533 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 14.3 Cg_exo -69.84 130.58 19.49 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.529 2.152 . . . . 0.0 111.579 177.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -58.87 -37.17 75.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.799 176.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.612 ' HB ' ' CD1' ' A' ' 117' ' ' ILE . 14.3 m -138.72 138.98 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.691 177.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.665 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 44.9 m -124.32 136.1 53.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.516 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.581 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 34.7 m-85 -111.31 153.32 26.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.766 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.556 ' HB ' ' HB3' ' A' ' 116' ' ' LYS . 1.1 m -132.26 108.39 9.2 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 175.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.454 HG12 HG13 ' A' ' 115' ' ' ILE . 64.4 mt -134.18 159.47 42.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.523 0.729 . . . . 0.0 109.36 -173.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.444 ' N ' HG22 ' A' ' 91' ' ' ILE . 15.4 m -89.02 139.67 30.22 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.907 0.384 . . . . 0.0 110.096 174.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.588 ' OD1' HG13 ' A' ' 25' ' ' VAL . 35.1 t70 -53.03 -25.83 13.68 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.176 0.991 . . . . 0.0 111.63 -179.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -78.71 -38.93 37.9 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.711 -177.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -89.16 -19.72 25.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.54 -172.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.883 HG11 HG12 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -55.4 -32.56 29.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.082 0.468 . . . . 0.0 110.527 -179.192 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.6 m -67.23 -28.93 44.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.269 -173.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -84.79 -32.94 23.1 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.423 HD12 HG21 ' A' ' 91' ' ' ILE . 74.0 mt -68.72 -47.9 65.18 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.826 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 96' ' ' VAL . 10.6 mt -74.98 -18.95 16.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.908 -177.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.6 t -88.47 -20.49 25.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.868 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.55 9.25 61.67 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.124 -177.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -83.0 -41.15 19.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.011 0.434 . . . . 0.0 110.843 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.6 tp -102.97 127.31 50.24 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.051 178.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -71.6 121.87 85.61 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.115 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.425 ' HA ' HD12 ' A' ' 115' ' ' ILE . 4.9 Cg_exo -64.35 -20.52 66.54 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.763 1.642 . . . . 0.0 110.708 175.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -64.91 -58.77 5.28 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.818 172.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.534 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -66.03 -32.92 74.68 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.335 0.588 . . . . 0.0 109.566 -178.503 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.534 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -66.79 -40.11 88.01 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.552 178.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -58.3 -47.55 83.31 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.359 0.6 . . . . 0.0 109.718 175.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -63.87 -38.54 91.48 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.276 -177.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -91.53 6.0 47.32 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -174.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.23 2.22 80.53 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.827 173.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.1 mmpt? -77.34 -19.85 55.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.172 0.51 . . . . 0.0 110.443 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.684 HG23 HG22 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -127.94 110.37 21.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.861 178.599 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.556 ' HB3' ' HB ' ' A' ' 90' ' ' THR . 19.3 tptm -111.75 99.78 8.42 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.114 174.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.684 HG22 HG23 ' A' ' 115' ' ' ILE . 0.1 OUTLIER -124.78 133.34 69.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.946 -176.065 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.547 ' O ' HG12 ' A' ' 87' ' ' VAL . 44.0 mt-30 -85.57 96.55 9.68 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 176.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -70.99 124.63 11.62 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.985 -0.626 . . . . 0.0 114.185 -170.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -90.41 123.97 34.57 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 168.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 24.2 mmt -57.95 -32.28 67.66 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -169.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -91.62 -53.47 2.11 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.251 -0.976 . . . . 0.0 112.695 177.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.569 HD11 ' HA3' ' A' ' 49' ' ' GLY . 2.8 tt -70.74 -47.24 60.72 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 122.908 0.483 . . . . 0.0 112.228 -169.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.658 ' HA ' HD23 ' A' ' 127' ' ' LEU . . . -70.5 -15.52 62.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.598 0.237 . . . . 0.0 111.401 -174.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.605 ' O ' ' HB ' ' A' ' 128' ' ' THR . 17.1 mmt -77.7 -31.79 52.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.969 0.414 . . . . 0.0 110.207 175.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.533 ' HD2' ' O ' ' A' ' 46' ' ' LYS . 13.3 mttp -78.63 -27.77 45.48 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.232 0.539 . . . . 0.0 110.075 174.043 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.658 HD23 ' HA ' ' A' ' 124' ' ' ALA . 0.1 OUTLIER -66.93 -36.38 82.11 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 170.957 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.605 ' HB ' ' O ' ' A' ' 125' ' ' MET . 23.8 m -61.53 -31.71 71.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.919 172.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' A' ' 132' ' ' ARG . 20.6 t70 -71.47 -43.59 66.35 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.376 176.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -66.1 -38.82 89.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.21 -178.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.486 ' HG3' ' O ' ' A' ' 128' ' ' THR . 5.2 pp0? -65.11 -22.84 67.0 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.816 -0.353 . . . . 0.0 110.724 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 129' ' ' ASP . 75.1 mtp180 -62.14 -38.0 87.34 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 120.95 0.405 . . . . 0.0 109.924 173.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -76.09 -35.13 59.49 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.316 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.2 -20.03 63.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.351 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.18 -32.4 73.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.353 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 72.99 26.7 70.37 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.691 -0.686 . . . . 0.0 113.032 174.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -95.53 135.45 37.17 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.214 0.531 . . . . 0.0 110.934 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 8.5 tp -114.94 -22.35 4.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.532 0.682 . . . . 0.0 110.25 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -99.04 160.33 14.34 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.355 -170.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 35.5 p -100.0 137.82 37.92 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.223 176.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.4 tp . . . . . 0 C--O 1.25 1.099 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.856 179.272 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.685 ' N ' ' HH ' ' A' ' 79' ' ' TYR . . . . . . . . 0 N--CA 1.483 1.785 0 N-CA-C 112.171 -0.372 . . . . 0.0 112.171 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.2 p -81.47 51.37 1.64 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.02 0.438 . . . . 0.0 111.568 -177.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.9 m -136.78 -172.37 3.16 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.202 -178.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -55.38 148.44 25.61 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.406 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.429 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 89.5 m-20 -70.57 148.22 95.09 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 121.036 0.446 . . . . 0.0 110.173 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 19' ' ' ASN . 15.1 Cg_exo -62.99 -30.26 76.39 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 123.173 2.582 . . . . 0.0 112.268 -173.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.406 ' HG3' ' H ' ' A' ' 21' ' ' GLU . 8.8 mt-10 -68.61 -23.36 64.44 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.794 -178.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.415 ' OD2' ' HB2' ' A' ' 19' ' ' ASN . 23.2 m-20 -76.06 -16.24 59.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.243 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -90.2 152.92 20.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.14 0.495 . . . . 0.0 110.525 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -80.46 -26.1 38.51 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.411 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.827 HG12 HG11 ' A' ' 96' ' ' VAL . 1.0 OUTLIER -66.62 -17.59 22.8 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.536 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.973 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -53.89 -51.9 62.23 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.814 0.34 . . . . 0.0 110.492 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.459 ' O ' HG23 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -67.25 -36.48 81.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.508 -179.246 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.408 ' O ' HG12 ' A' ' 31' ' ' ILE . 48.0 m-85 -70.17 -53.32 17.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.501 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.538 ' SD ' ' HB ' ' A' ' 25' ' ' VAL . 0.1 OUTLIER -61.04 -32.1 71.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.767 0.317 . . . . 0.0 110.898 177.938 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.475 ' HD3' ' HA ' ' A' ' 30' ' ' LYS . 34.0 mmtt -74.53 -27.94 60.75 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.459 HG23 ' O ' ' A' ' 27' ' ' LYS . 15.5 pt -89.77 -18.43 7.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.714 173.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.9 tt -62.69 -52.54 62.88 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 169.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.575 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 11.9 tt0 -42.47 -55.17 3.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.141 -1.39 . . . . 0.0 110.688 173.079 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -65.07 -53.82 39.68 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.757 -1.11 . . . . 0.0 111.876 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.68 -36.94 84.51 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -167.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.435 ' HA ' ' CE ' ' A' ' 36' ' ' MET . 5.1 mmt -60.92 -43.37 98.69 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.686 0.279 . . . . 0.0 111.304 -177.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -92.64 -15.1 27.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.988 0.423 . . . . 0.0 110.499 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -64.02 -35.35 80.42 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.064 0.459 . . . . 0.0 110.221 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -70.12 123.25 21.13 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 173.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.81 -24.07 65.55 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.652 -172.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -74.44 -17.58 60.77 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.7 p30 34.27 70.36 0.13 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.924 0.889 . . . . 0.0 112.391 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.4 mt -70.36 1.67 4.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.262 -178.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -62.05 -31.47 51.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.259 -177.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.577 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 46.3 mt-10 -73.13 -20.56 60.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.475 -173.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -72.81 -19.55 61.31 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.344 0.592 . . . . 0.0 110.241 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -131.01 33.44 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.338 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.577 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 57.8 mtt180 -45.31 110.31 0.23 Allowed 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.469 0.652 . . . . 0.0 111.853 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.578 ' HA3' HD11 ' A' ' 123' ' ' LEU . . . -174.95 175.27 47.04 Favored Glycine 0 C--N 1.31 -0.867 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.306 -176.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.454 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 67.3 mt -107.98 124.83 64.46 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-O 121.284 0.564 . . . . 0.0 111.248 -177.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.491 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 4.3 m-85 -105.98 111.62 24.34 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.827 -176.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -93.16 126.92 8.79 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.691 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -111.28 103.04 11.41 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.05 0.452 . . . . 0.0 111.777 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -87.88 102.06 14.34 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.11 173.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.698 HG11 HG11 ' A' ' 25' ' ' VAL . 23.0 t -101.88 125.18 56.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.251 0.548 . . . . 0.0 111.238 -173.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.617 ' NE ' HG22 ' A' ' 90' ' ' THR . 51.6 mtm180 -109.77 175.53 5.41 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.985 -174.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 60.82 49.07 6.34 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 122.684 0.394 . . . . 0.0 111.849 176.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.88 -160.01 10.5 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.28 175.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 62' ' ' ALA . 80.2 Cg_exo -41.62 -61.4 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.678 2.919 . . . . 0.0 113.573 -177.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -125.1 63.78 1.15 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.368 0.604 . . . . 0.0 109.573 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.0 26.7 73.27 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.401 -177.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.464 ' HB3' ' HD2' ' A' ' 59' ' ' PRO . . . -77.72 152.86 33.46 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.182 0.515 . . . . 0.0 111.149 -178.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -129.38 112.84 14.24 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.043 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.06 164.93 18.41 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.106 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -147.75 117.06 6.92 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.874 0.368 . . . . 0.0 110.941 -176.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 16.0 m-90 -119.35 147.55 44.2 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.826 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 19.7 t -116.44 115.52 49.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.461 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.519 HG13 HG12 ' A' ' 77' ' ' VAL . 4.2 mp -91.29 103.56 14.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -84.88 97.88 10.0 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.168 0.509 . . . . 0.0 110.138 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -100.97 -0.47 36.55 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.472 174.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.426 ' HB2' HG13 ' A' ' 50' ' ' ILE . 15.9 tppt? -59.74 -40.3 87.62 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.318 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -74.88 -13.74 60.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.033 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.64 9.23 75.48 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -172.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -90.32 -59.79 2.09 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.356 -0.422 . . . . 0.0 110.872 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.55 36.45 5.86 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.066 -1.064 . . . . 0.0 112.149 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.575 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 16.3 pttm -95.72 144.47 26.09 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -175.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.519 HG12 HG13 ' A' ' 68' ' ' ILE . 0.7 OUTLIER -108.08 133.42 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-O 121.433 0.635 . . . . 0.0 109.866 -178.897 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.611 HG23 ' HA2' ' A' ' 81' ' ' GLY . 1.8 t -136.89 141.21 42.74 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.294 -177.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.685 ' HH ' ' N ' ' A' ' 15' ' ' GLY . 80.1 t80 -62.38 123.6 18.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.349 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 72.75 -38.64 0.42 Allowed 'General case' 0 N--CA 1.471 0.623 0 O-C-N 123.984 0.802 . . . . 0.0 111.993 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.611 ' HA2' HG23 ' A' ' 78' ' ' THR . . . 76.0 -41.63 1.53 Allowed Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 114.158 0.423 . . . . 0.0 114.158 176.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.99 0.76 53.63 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.102 -176.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -107.08 166.83 10.32 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -98.25 108.39 46.94 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 175.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.454 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 21.3 Cg_exo -67.28 132.6 28.07 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 123.138 2.558 . . . . 0.0 113.194 -177.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.575 ' HB2' HD22 ' A' ' 123' ' ' LEU . 8.3 m-20 -64.0 -39.94 95.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.001 174.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.726 HG11 ' HB2' ' A' ' 124' ' ' ALA . 6.2 m -136.21 134.18 50.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.656 175.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.619 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 21.2 m -122.81 132.35 54.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.627 -178.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.574 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 41.4 m-85 -111.68 136.86 50.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.917 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.617 HG22 ' NE ' ' A' ' 56' ' ' ARG . 2.2 m -109.04 99.67 8.95 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.057 0.456 . . . . 0.0 109.853 175.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 86.4 mt -122.72 159.07 26.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -176.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.476 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 4.9 m -99.34 138.38 36.52 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 177.082 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.414 ' OD2' HG13 ' A' ' 25' ' ' VAL . 13.2 t70 -44.54 -50.11 9.74 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.14 0.576 . . . . 0.0 111.376 -176.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -59.02 -34.6 72.08 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.5 -1.227 . . . . 0.0 111.575 -176.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.476 ' OD2' ' HB2' ' A' ' 92' ' ' SER . 23.0 m-20 -91.09 -21.72 21.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.064 -177.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.827 HG11 HG12 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -57.71 -34.21 47.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 121.221 0.534 . . . . 0.0 109.824 -179.101 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.0 m -67.21 -27.71 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.971 -174.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -83.68 -34.41 24.99 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.42 ' HG ' HD23 ' A' ' 104' ' ' LEU . 79.8 mt -71.45 -36.25 71.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.219 -177.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.583 HG13 ' O ' ' A' ' 96' ' ' VAL . 17.4 mt -85.15 -22.2 7.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.348 -177.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 37.0 p -85.29 -20.85 29.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.004 0.431 . . . . 0.0 111.062 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 96.17 11.99 53.09 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.663 -177.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -85.67 -41.98 14.69 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.941 0.401 . . . . 0.0 111.125 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.42 HD23 ' HG ' ' A' ' 99' ' ' LEU . 49.2 tp -102.89 131.29 49.91 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.274 177.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.489 ' HB2' ' HB2' ' A' ' 108' ' ' LYS . 16.1 m120 -78.73 118.32 71.7 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.475 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -65.45 -27.14 54.64 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 121.978 1.785 . . . . 0.0 111.001 177.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 76.0 mm-40 -66.93 -55.21 15.57 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.454 173.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.67 ' HE3' ' HG3' ' A' ' 112' ' ' GLN . 13.6 ttpt -53.51 -48.85 68.61 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.056 175.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.554 ' HB1' ' HB3' ' A' ' 114' ' ' LYS . . . -65.03 -31.71 73.07 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.68 -175.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -60.08 -45.7 92.04 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 174.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -67.08 -38.0 84.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.427 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.67 ' HG3' ' HE3' ' A' ' 108' ' ' LYS . 87.2 mm-40 -71.06 -23.41 62.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.762 -177.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 101.39 8.67 46.2 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.399 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.606 ' HA ' ' HE3' ' A' ' 114' ' ' LYS . 1.1 tpmt? -83.31 -32.09 26.51 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-O 121.398 0.618 . . . . 0.0 110.386 -176.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.644 HG23 HG22 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -111.99 122.43 66.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.005 -174.163 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.412 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 47.3 mmtm -112.59 106.13 14.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.481 173.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.644 HG22 HG23 ' A' ' 115' ' ' ILE . 0.1 OUTLIER -128.08 129.17 69.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 120.986 0.422 . . . . 0.0 111.079 -178.148 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.575 ' O ' HG12 ' A' ' 87' ' ' VAL . 22.9 tm0? -86.46 117.16 25.06 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 176.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -85.84 98.93 2.33 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.741 -0.743 . . . . 0.0 113.893 -172.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.445 ' H ' HG12 ' A' ' 87' ' ' VAL . 26.2 t-20 -64.95 120.39 12.49 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 167.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.548 ' O ' ' HB3' ' A' ' 125' ' ' MET . 2.0 mpt? -57.86 -30.38 65.76 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.758 0.661 . . . . 0.0 112.472 -169.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -92.25 -27.21 16.25 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.527 -0.844 . . . . 0.0 113.181 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.578 HD11 ' HA3' ' A' ' 49' ' ' GLY . 0.6 OUTLIER -91.77 -61.72 1.58 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.693 0.759 . . . . 0.0 110.755 -173.613 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.726 ' HB2' HG11 ' A' ' 87' ' ' VAL . . . -74.62 -5.56 43.67 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.493 -173.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.548 ' HB3' ' O ' ' A' ' 121' ' ' MET . 26.0 ptt? -66.28 -21.4 66.27 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.189 176.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -85.23 -26.08 26.92 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.011 -0.675 . . . . 0.0 110.059 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 39.4 mt -70.13 -27.91 64.95 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 169.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.521 ' HB ' ' O ' ' A' ' 125' ' ' MET . 43.4 m -73.4 -20.02 60.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 113.801 -1.545 . . . . 0.0 111.313 177.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -58.22 -25.94 62.25 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.283 0.563 . . . . 0.0 111.374 -175.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.6 mt -61.72 -23.18 65.96 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.915 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' A' ' 128' ' ' THR . 19.0 pt20 -70.49 -17.48 62.96 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 120.567 0.223 . . . . 0.0 110.878 -178.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -62.92 -22.75 66.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.039 0.447 . . . . 0.0 110.893 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -90.36 -21.08 22.17 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.466 0.65 . . . . 0.0 109.861 175.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -106.72 19.29 20.7 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.915 -176.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.79 -13.69 62.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.484 -175.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 95.37 28.57 9.61 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.07 178.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 67.63 -172.42 0.19 Allowed 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 122.654 0.382 . . . . 0.0 111.081 178.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 10.4 tp -66.47 -33.67 65.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.271 0.557 . . . . 0.0 110.981 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -100.38 119.65 38.77 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.798 -174.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 31.7 p -166.43 20.86 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.338 -177.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 48.0 mm . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.784 -0.627 . . . . 0.0 110.237 -178.638 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.69 0 N-CA-C 111.775 -0.53 . . . . 0.0 111.775 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.7 p -71.54 -38.03 71.07 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.977 0.389 . . . . 0.0 111.165 -178.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.6 p -92.01 110.33 21.69 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.683 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.427 ' H ' ' HB2' ' A' ' 62' ' ' ALA . . . -62.31 149.79 47.61 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 173.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.436 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 95.6 m-20 -66.87 145.74 98.97 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 121.463 0.649 . . . . 0.0 111.569 -174.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.531 ' HA ' ' CD1' ' A' ' 23' ' ' PHE . 15.4 Cg_exo -62.96 -26.72 74.2 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.644 2.896 . . . . 0.0 111.681 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -59.24 -37.52 77.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.718 177.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -81.04 -2.94 50.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.872 0.368 . . . . 0.0 111.46 -174.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.531 ' CD1' ' HA ' ' A' ' 20' ' ' PRO . 29.9 m-85 -73.95 144.06 45.42 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 172.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.432 ' O ' ' HD2' ' A' ' 28' ' ' TYR . 64.4 mmtt -66.94 -30.5 70.66 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 175.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 1.086 HG12 HG11 ' A' ' 96' ' ' VAL . 0.8 OUTLIER -65.01 -20.19 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.786 -178.03 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -59.02 -54.44 47.07 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.409 ' O ' HG23 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -71.32 -37.71 71.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.61 179.012 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.434 ' HB2' ' HA ' ' A' ' 25' ' ' VAL . 28.2 m-85 -69.35 -41.96 75.92 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.493 ' HB3' HG21 ' A' ' 77' ' ' VAL . 61.1 mtt -74.88 -27.95 60.45 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.359 178.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.431 ' HD2' ' HA ' ' A' ' 30' ' ' LYS . 19.4 mmmt -66.09 -34.24 77.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.078 175.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.409 HG23 ' O ' ' A' ' 27' ' ' LYS . 18.2 pt -86.32 -21.3 7.54 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.592 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.271 175.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.5 tt -61.83 -48.33 81.04 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 173.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.517 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 3.4 tt0 -45.62 -49.34 14.34 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.878 174.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -75.44 -61.48 1.89 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.755 -1.112 . . . . 0.0 111.703 -177.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.71 -38.95 73.02 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -167.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 95.3 mmm -59.64 -38.82 82.43 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.491 0.182 . . . . 0.0 111.491 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -91.48 -31.44 15.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.135 0.493 . . . . 0.0 111.049 176.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -65.3 -27.53 68.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.923 -176.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -56.67 142.03 41.46 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.414 177.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.3 p -48.99 -45.27 42.06 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.098 0.475 . . . . 0.0 111.406 -177.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -90.28 -8.59 50.55 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.227 -176.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.527 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 6.1 p30 36.51 71.77 0.12 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.865 0.841 . . . . 0.0 110.984 -175.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.5 mt -60.53 -5.34 1.17 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.945 -175.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.8 tp -62.14 -27.62 42.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.59 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.527 ' HG2' ' O ' ' A' ' 42' ' ' ASN . 14.5 pt-20 -67.13 -28.75 68.4 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.793 0.33 . . . . 0.0 111.259 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.439 ' O ' ' HG2' ' A' ' 126' ' ' LYS . 52.2 mtpt -78.53 -24.73 45.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.145 0.498 . . . . 0.0 110.642 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.704 HG22 ' OH ' ' A' ' 51' ' ' TYR . 8.3 p -124.91 32.39 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.759 0.79 . . . . 0.0 110.955 -168.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -65.6 125.34 24.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.568 0.699 . . . . 0.0 111.778 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.14 -174.29 46.3 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.38 -178.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.425 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 48.2 mt -111.42 125.71 68.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 117.978 0.889 . . . . 0.0 110.589 175.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.704 ' OH ' HG22 ' A' ' 47' ' ' VAL . 19.1 m-85 -115.99 111.29 20.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.609 -174.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.29 111.83 4.11 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.686 -0.769 . . . . 0.0 111.314 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -100.88 109.61 21.59 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.291 0.567 . . . . 0.0 111.141 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -97.41 99.88 11.31 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.116 176.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.806 HG11 HG11 ' A' ' 25' ' ' VAL . 12.2 t -99.14 127.22 52.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.656 -172.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.502 ' O ' ' HA ' ' A' ' 92' ' ' SER . 54.8 mtp180 -118.15 176.19 5.33 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.253 -177.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 59.44 46.71 12.02 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.127 0.489 . . . . 0.0 111.242 178.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -79.55 -148.75 4.87 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.081 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' A' ' 62' ' ' ALA . 94.7 Cg_exo -40.97 -60.72 0.58 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 124.261 3.307 . . . . 0.0 114.109 -176.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -132.02 66.19 1.56 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.127 0.489 . . . . 0.0 109.683 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.12 24.52 71.87 Favored Glycine 0 N--CA 1.453 -0.199 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 -176.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.439 ' HB3' ' HD2' ' A' ' 59' ' ' PRO . . . -81.43 165.08 21.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.354 -0.423 . . . . 0.0 111.652 -175.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.425 ' HG2' ' HA ' ' A' ' 56' ' ' ARG . 23.0 mt-10 -139.4 142.9 37.48 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.596 -178.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -140.11 168.54 25.06 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.699 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -147.45 116.09 6.72 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.801 0.334 . . . . 0.0 110.881 -176.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 14.1 m-90 -119.49 142.95 47.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.818 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 42.4 t -111.01 114.51 47.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.661 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.542 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 4.3 mp -89.05 99.78 9.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 174.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -89.16 103.08 15.73 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.793 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -115.1 17.19 16.87 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.827 175.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -66.44 -40.04 89.24 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.256 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -85.25 -13.99 48.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.927 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.81 12.6 39.96 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.543 -0.753 . . . . 0.0 113.014 176.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.608 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 8.5 mmpt? -86.3 -38.01 17.95 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.986 -0.285 . . . . 0.0 111.603 -178.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.2 35.42 23.81 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.251 -0.976 . . . . 0.0 112.724 177.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.517 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 58.5 pttt -96.72 148.08 23.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.891 0.346 . . . . 0.0 110.884 -172.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.493 HG21 ' HB3' ' A' ' 29' ' ' MET . 0.7 OUTLIER -111.75 137.18 45.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 176.766 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.3 t -140.57 132.68 27.95 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.962 0.411 . . . . 0.0 110.847 -178.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -69.29 121.27 16.52 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 56.86 73.02 0.47 Allowed 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -174.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.73 -35.64 85.95 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.56 -0.746 . . . . 0.0 113.576 -174.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.27 1.07 90.42 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.401 -176.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -91.52 169.82 10.45 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -100.25 107.28 46.81 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.943 173.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.425 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 12.4 Cg_exo -70.78 130.0 17.39 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.59 2.194 . . . . 0.0 112.203 178.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.632 ' HB2' HD22 ' A' ' 123' ' ' LEU . 30.8 m-20 -67.59 -29.01 68.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.858 176.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.54 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 4.4 m -139.51 138.73 39.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.189 172.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.595 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 46.8 m -121.4 129.35 52.97 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.219 177.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.628 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 76.4 m-85 -116.51 126.39 53.28 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.091 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.503 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 2.8 m -102.85 125.53 49.64 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.614 ' CG1' HG13 ' A' ' 115' ' ' ILE . 0.3 OUTLIER -156.76 150.33 9.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.22 0.533 . . . . 0.0 111.104 -174.345 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.502 ' HA ' ' O ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -77.99 139.73 39.16 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.356 178.285 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -52.33 -29.8 25.35 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.263 177.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -68.97 -39.28 79.54 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.537 -178.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -90.14 -25.79 20.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.42 -174.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 1.086 HG11 HG12 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -57.66 -32.56 42.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.02 0.438 . . . . 0.0 110.444 -177.767 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.7 m -69.14 -28.2 38.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.748 -174.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -81.5 -37.19 28.27 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 176.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.414 HD23 ' O ' ' A' ' 104' ' ' LEU . 88.4 mt -64.15 -48.97 73.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.794 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 96' ' ' VAL . 20.2 mt -73.28 -24.96 20.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.543 -176.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.3 t -89.07 -9.81 49.76 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.779 0.324 . . . . 0.0 111.173 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 86.46 16.9 61.35 Favored Glycine 0 N--CA 1.453 -0.177 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.204 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -89.54 -42.72 11.27 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.99 0.424 . . . . 0.0 110.763 -178.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.723 HD11 ' NZ ' ' A' ' 108' ' ' LYS . 49.6 tp -105.59 127.97 53.35 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.846 -178.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -72.97 124.14 90.38 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.471 175.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -65.7 -25.17 54.19 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.347 2.031 . . . . 0.0 110.262 176.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -57.43 -61.41 2.51 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.897 173.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.723 ' NZ ' HD11 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -63.02 -35.63 80.88 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.138 -178.783 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.548 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -69.12 -32.29 71.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.971 -176.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -62.93 -50.49 70.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.701 174.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -64.94 -31.89 73.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.111 -177.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -83.93 1.53 43.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.984 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.98 12.3 82.78 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.833 -0.698 . . . . 0.0 113.446 174.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.502 ' HA ' ' HE3' ' A' ' 114' ' ' LYS . 0.3 OUTLIER -87.34 -42.88 12.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.822 0.344 . . . . 0.0 110.496 178.166 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.614 HG13 ' CG1' ' A' ' 91' ' ' ILE . 0.1 OUTLIER -91.05 114.44 28.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.554 0.692 . . . . 0.0 110.004 178.237 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.503 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 29.0 mmmt -111.73 99.79 8.43 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.411 176.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.628 ' HB ' ' CD2' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -118.58 138.49 49.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.442 -178.497 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.4 ' N ' HD12 ' A' ' 117' ' ' ILE . 52.3 tt0 -146.31 82.1 1.59 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -174.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.54 ' HA3' ' HA ' ' A' ' 87' ' ' VAL . . . -161.03 172.69 37.35 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.959 -171.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -50.37 113.66 0.93 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.066 0.46 . . . . 0.0 110.211 178.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.543 ' O ' ' HG3' ' A' ' 125' ' ' MET . 50.0 ttm -63.78 -29.75 70.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.564 -173.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -66.95 -38.1 92.6 Favored Glycine 0 C--O 1.226 -0.359 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.921 -176.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.632 HD22 ' HB2' ' A' ' 86' ' ' ASP . 3.4 tp -63.48 -49.35 73.96 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.322 0.582 . . . . 0.0 109.75 176.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -68.98 -20.36 64.17 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.968 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.543 ' HG3' ' O ' ' A' ' 121' ' ' MET . 78.4 mtp -66.14 -24.34 66.65 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.13 177.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.699 ' HB2' HG23 ' A' ' 47' ' ' VAL . 13.7 mptt -76.53 -16.25 59.68 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.472 176.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 78.7 mt -75.77 -35.6 60.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.102 0.477 . . . . 0.0 109.875 176.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.453 HG22 ' O ' ' A' ' 125' ' ' MET . 5.8 t -83.67 -17.46 41.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.957 178.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.527 ' O ' ' HG3' ' A' ' 132' ' ' ARG . 18.0 t70 -59.08 -29.18 67.15 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.476 0.655 . . . . 0.0 110.26 175.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.1 mt -56.09 -16.3 4.88 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.998 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.447 ' HA ' ' HB3' ' A' ' 134' ' ' ALA . 12.8 pt20 -58.97 -19.75 46.12 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 122.6 0.36 . . . . 0.0 111.799 -178.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.527 ' HG3' ' O ' ' A' ' 129' ' ' ASP . 47.8 mtt180 -53.43 -54.61 34.45 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 120.906 0.384 . . . . 0.0 110.529 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -91.24 -32.64 15.68 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.826 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.447 ' HB3' ' HA ' ' A' ' 131' ' ' GLN . . . -66.74 -11.05 53.07 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -174.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -83.63 12.6 5.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.926 0.393 . . . . 0.0 111.231 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.1 13.54 66.05 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.982 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -82.01 88.81 6.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.161 0.505 . . . . 0.0 110.198 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 9.4 tp -128.28 -28.31 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.411 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -100.06 162.73 12.79 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.781 -172.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.6 m -138.16 82.9 1.94 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.462 0.649 . . . . 0.0 110.305 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.1 mt . . . . . 0 C--O 1.246 0.911 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.846 179.715 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.759 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.0 m -77.22 95.36 4.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.014 0.435 . . . . 0.0 110.152 176.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.3 m -93.75 -168.58 1.92 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.392 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -51.99 139.89 27.93 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 121.272 -0.49 . . . . 0.0 112.775 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -72.3 142.68 84.81 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-O 121.142 0.496 . . . . 0.0 110.528 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -52.73 -36.97 74.96 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 124.229 3.286 . . . . 0.0 112.081 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -54.22 -37.34 64.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.81 176.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -79.2 -5.05 53.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.335 -175.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -78.9 148.58 32.68 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.128 0.489 . . . . 0.0 110.037 176.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.478 ' HD3' HG11 ' A' ' 97' ' ' VAL . 46.8 mttp -70.86 -25.71 62.94 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 176.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 1.08 HG12 HG11 ' A' ' 96' ' ' VAL . 0.9 OUTLIER -72.87 -17.75 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 114.988 -1.006 . . . . 0.0 111.022 -178.75 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -56.31 -53.78 53.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.825 0.345 . . . . 0.0 110.472 -176.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.447 ' HE2' HG23 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -70.59 -40.35 73.29 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.496 178.242 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.443 ' HB3' HD12 ' A' ' 100' ' ' ILE . 9.8 m-85 -64.67 -45.37 86.98 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -175.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.463 ' CE ' HD11 ' A' ' 68' ' ' ILE . 66.8 mtp -75.97 -22.81 55.5 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.371 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.461 ' HA ' ' HD2' ' A' ' 30' ' ' LYS . 24.4 mmmt -71.63 -36.78 70.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.933 174.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.447 HG23 ' HE2' ' A' ' 27' ' ' LYS . 16.1 pt -82.22 -25.25 9.13 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.485 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.122 175.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.8 tt -56.54 -53.04 62.21 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 171.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.488 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 14.1 tt0 -43.82 -49.09 8.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.267 -1.333 . . . . 0.0 111.725 175.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -75.15 -55.57 5.6 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.533 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.477 ' HA ' ' HB3' ' A' ' 38' ' ' ASN . . . -56.21 -36.28 68.26 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -168.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 25.2 mmt -61.41 -43.86 98.13 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.678 0.275 . . . . 0.0 111.483 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -91.7 -17.01 26.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.28 0.562 . . . . 0.0 110.602 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.477 ' HB3' ' HA ' ' A' ' 35' ' ' ALA . 55.8 t30 -66.34 -36.26 82.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.781 177.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -56.91 125.94 24.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.31 175.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.79 -26.33 34.01 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -175.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -92.16 -16.6 26.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.476 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 35.87 69.02 0.2 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.904 0.859 . . . . 0.0 111.104 -177.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.1 mt -65.18 -0.73 1.83 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.731 -174.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.535 HG13 ' HB1' ' A' ' 70' ' ' ALA . 4.9 tp -61.83 -26.54 40.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.296 -177.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.467 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 44.6 mt-10 -76.51 -22.46 54.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.894 0.378 . . . . 0.0 111.053 -176.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -76.45 -19.18 58.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.654 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 47' ' ' VAL . 10.6 p -130.02 32.4 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.633 0.73 . . . . 0.0 110.076 -176.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.467 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 55.4 mtt180 -46.86 119.8 2.69 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.992 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.615 ' HA3' HD11 ' A' ' 123' ' ' LEU . . . -179.88 166.64 35.9 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.314 -177.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.478 HG13 ' HB2' ' A' ' 71' ' ' LYS . 55.1 mt -102.79 122.93 55.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.142 0.496 . . . . 0.0 110.842 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.458 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 21.6 m-85 -103.32 118.56 37.05 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.933 -177.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.43 111.76 4.3 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.389 -0.91 . . . . 0.0 111.279 177.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -97.86 104.91 16.98 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.059 0.457 . . . . 0.0 111.458 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -92.7 99.07 11.83 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.691 175.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.792 HG11 HG11 ' A' ' 25' ' ' VAL . 6.0 t -102.34 145.42 12.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.673 -178.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.563 ' CB ' ' HG2' ' A' ' 63' ' ' GLU . 1.1 ptm180 -154.21 -174.2 4.87 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.544 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 64.71 38.17 7.11 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.082 0.468 . . . . 0.0 110.216 -174.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.24 -154.55 4.45 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.824 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo -36.6 -60.0 0.4 Allowed 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 124.326 3.351 . . . . 0.0 113.938 -174.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -128.57 54.88 1.73 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.221 0.534 . . . . 0.0 109.882 178.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 74.53 28.4 63.55 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.544 -176.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.06 156.24 30.15 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 121.391 0.615 . . . . 0.0 111.204 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.563 ' HG2' ' CB ' ' A' ' 56' ' ' ARG . 34.7 mt-10 -125.14 147.58 48.96 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.296 -178.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -143.12 162.91 27.5 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.343 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -150.63 114.9 5.11 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.819 0.342 . . . . 0.0 110.97 -177.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 15.5 m-90 -120.47 136.28 54.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.13 0.49 . . . . 0.0 109.835 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 14.6 t -103.49 116.66 47.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.425 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.463 HD11 ' CE ' ' A' ' 29' ' ' MET . 4.3 mp -93.38 101.21 12.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 175.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -85.69 98.38 10.66 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.246 -177.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.535 ' HB1' HG13 ' A' ' 44' ' ' ILE . . . -107.04 0.73 23.82 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.227 176.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.478 ' HB2' HG13 ' A' ' 50' ' ' ILE . 5.1 tppp? -63.54 -41.73 98.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.399 0.618 . . . . 0.0 109.918 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -76.47 -6.68 52.81 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.424 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.83 8.5 63.5 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.761 176.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -92.01 -55.73 3.34 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -176.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.2 34.93 7.81 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 119.824 -1.179 . . . . 0.0 111.889 -176.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.488 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 22.7 pttp -96.56 144.16 26.88 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -176.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.7 OUTLIER -107.63 131.7 57.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.536 0.684 . . . . 0.0 109.619 -178.787 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.549 HG23 ' HA2' ' A' ' 81' ' ' GLY . 1.8 t -139.83 135.35 32.89 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.563 -178.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -63.19 128.46 35.96 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -176.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 73.25 -42.69 0.53 Allowed 'General case' 0 N--CA 1.471 0.584 0 O-C-N 124.011 0.82 . . . . 0.0 111.578 -177.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.549 ' HA2' HG23 ' A' ' 78' ' ' THR . . . 73.81 -41.81 1.06 Allowed Glycine 0 N--CA 1.453 -0.189 0 N-CA-C 114.425 0.53 . . . . 0.0 114.425 175.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.81 5.94 76.38 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.659 -175.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.403 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 13.3 mm-40 -114.23 143.41 44.88 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -177.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -77.77 110.56 13.39 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 121.185 0.517 . . . . 0.0 110.792 174.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.427 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 13.4 Cg_exo -70.16 130.05 18.19 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.861 2.374 . . . . 0.0 112.452 -178.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -63.57 -34.3 77.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.485 176.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.588 HG11 ' HB2' ' A' ' 124' ' ' ALA . 9.0 m -139.4 133.93 39.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.556 176.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.662 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 53.9 m -116.77 139.33 50.7 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.517 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.49 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 54.4 m-85 -118.06 132.92 56.32 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.491 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 5.7 m -110.1 128.67 55.57 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 175.088 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.596 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -161.99 144.23 3.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.071 0.462 . . . . 0.0 109.862 -177.214 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -81.6 147.24 29.69 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.316 0.579 . . . . 0.0 111.154 177.988 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -51.25 -29.16 13.63 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 114.449 -1.251 . . . . 0.0 112.033 -177.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -73.51 -34.26 65.19 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.32 -176.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -90.08 -27.39 19.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.843 -175.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 1.08 HG11 HG12 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -56.82 -31.61 36.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.217 -174.889 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.478 HG11 ' HD3' ' A' ' 24' ' ' LYS . 12.8 m -69.34 -29.24 41.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.687 -170.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -83.96 -31.43 25.58 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 176.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.483 HD23 ' O ' ' A' ' 104' ' ' LEU . 91.2 mt -64.63 -51.55 62.05 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.269 0.557 . . . . 0.0 110.562 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 96' ' ' VAL . 14.9 mt -75.51 -16.75 15.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.395 -175.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 42.0 t -94.14 -4.29 49.47 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.207 -0.308 . . . . 0.0 111.322 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.57 30.92 55.73 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.705 -0.759 . . . . 0.0 111.939 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -106.7 -42.67 4.9 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.223 0.535 . . . . 0.0 110.571 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.483 ' O ' HD23 ' A' ' 99' ' ' LEU . 33.8 tp -103.32 120.74 41.35 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.694 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.46 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 5.9 m-20 -68.51 120.48 75.6 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.467 178.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -63.68 -21.47 69.98 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.21 1.94 . . . . 0.0 110.578 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -62.81 -58.69 6.55 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.958 174.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.526 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 1.2 ptmt -66.74 -33.95 76.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.015 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.526 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -65.87 -29.42 69.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.955 0.407 . . . . 0.0 110.098 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -65.39 -46.82 78.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.627 175.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -67.43 -37.2 82.64 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.1 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -79.71 10.92 3.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.857 -176.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.78 7.83 83.94 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 121.236 -0.507 . . . . 0.0 113.268 173.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -82.15 -53.4 6.11 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.117 0.484 . . . . 0.0 110.456 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.643 HG23 HG22 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -88.52 115.12 28.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.585 -177.633 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.491 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 31.2 mmmt -111.06 103.22 11.65 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.524 176.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.662 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER -130.95 130.27 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-O 121.159 0.504 . . . . 0.0 110.955 -176.665 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.49 ' O ' HG12 ' A' ' 87' ' ' VAL . 0.8 OUTLIER -83.48 94.24 7.98 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 175.945 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -71.08 100.54 0.86 Allowed Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.969 -0.559 . . . . 0.0 113.643 -172.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 39.1 t-20 -64.71 115.57 5.38 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 171.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 25.2 ptt? -57.53 -27.79 62.92 Favored 'General case' 0 C--O 1.223 -0.342 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -171.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -90.8 -37.11 6.52 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.017 -1.087 . . . . 0.0 113.076 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.615 HD11 ' HA3' ' A' ' 49' ' ' GLY . 4.0 tt -90.82 -48.39 7.06 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.704 0.288 . . . . 0.0 111.461 -172.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.588 ' HB2' HG11 ' A' ' 87' ' ' VAL . . . -76.58 -15.26 59.89 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.556 -173.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 46.5 mtt -71.71 -18.12 62.17 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.722 177.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.548 ' O ' ' HG ' ' A' ' 130' ' ' LEU . 5.6 mptp? -76.77 -22.45 53.74 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.36 176.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.71 -46.15 86.72 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.056 177.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.673 ' O ' ' HG2' ' A' ' 132' ' ' ARG . 9.0 t -75.26 -36.65 61.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.027 177.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -54.85 -42.76 72.36 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.921 0.391 . . . . 0.0 111.022 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 126' ' ' LYS . 7.4 mt -55.68 -40.64 72.61 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.132 178.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -88.22 -19.91 26.22 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.275 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.673 ' HG2' ' O ' ' A' ' 128' ' ' THR . 21.5 mmt180 -64.86 -43.98 91.21 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.06 0.457 . . . . 0.0 109.851 175.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.433 ' HA ' ' HG2' ' A' ' 137' ' ' ARG . 12.7 pt20 -79.1 -7.25 58.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.944 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -101.36 0.42 37.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.111 174.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -96.16 -6.98 37.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.045 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.62 48.76 3.13 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.841 178.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.433 ' HG2' ' HA ' ' A' ' 133' ' ' GLN . 11.4 ptm180 -88.66 106.7 18.5 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.365 0.603 . . . . 0.0 110.142 178.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.3 mp -76.37 -68.41 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.09 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -101.4 150.44 23.03 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.366 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.8 m -76.51 94.84 3.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.399 -175.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 49.0 mm . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.282 -0.866 . . . . 0.0 109.516 176.315 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.595 0 N-CA-C 111.787 -0.525 . . . . 0.0 111.787 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.2 m -68.38 -23.46 64.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.1 0.476 . . . . 0.0 110.811 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.1 m -75.65 149.38 38.19 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.5 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.42 165.87 49.18 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.276 174.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 64.6 m-20 -67.72 138.71 93.35 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-O 121.353 0.597 . . . . 0.0 110.711 -176.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 19' ' ' ASN . 25.6 Cg_exo -56.38 -35.29 96.02 Favored 'Trans proline' 0 CA--C 1.518 -0.293 0 C-N-CA 123.906 3.07 . . . . 0.0 112.397 -176.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.412 ' HA ' ' CD1' ' A' ' 26' ' ' PHE . 40.7 tt0 -60.49 -37.61 81.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.585 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -74.92 -18.14 60.45 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.683 0.278 . . . . 0.0 111.307 -173.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -67.84 154.82 40.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.501 0.667 . . . . 0.0 110.569 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.445 ' HD2' HG11 ' A' ' 97' ' ' VAL . 15.2 ttmm -80.43 -20.43 43.87 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.318 -0.855 . . . . 0.0 108.917 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.807 HG12 HG11 ' A' ' 96' ' ' VAL . 1.3 m -77.27 -14.11 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.934 178.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.412 ' CD1' ' HA ' ' A' ' 21' ' ' GLU . 69.1 t80 -51.86 -56.06 16.27 Favored 'General case' 0 N--CA 1.462 0.135 0 O-C-N 123.055 0.222 . . . . 0.0 111.418 -175.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.3 -40.6 96.26 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.037 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.427 ' HB3' HD12 ' A' ' 100' ' ' ILE . 32.8 m-85 -66.18 -49.2 68.15 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.548 -177.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.669 ' HB3' HG21 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -61.73 -33.23 73.68 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.825 0.345 . . . . 0.0 110.954 175.531 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.8 mmmt -69.67 -39.6 76.91 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 11.2 pt -81.45 -22.06 10.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.108 177.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.6 tt -58.27 -48.05 81.69 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 171.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -48.14 -50.81 27.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.757 175.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.456 ' O ' ' HB2' ' A' ' 38' ' ' ASN . 25.5 tt0 -69.63 -52.14 28.58 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.84 -178.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.36 -37.28 82.96 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -166.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.8 mmt -58.06 -47.32 83.52 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.757 0.281 . . . . 0.0 111.757 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -91.08 -8.66 48.29 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.073 0.463 . . . . 0.0 110.558 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -67.82 -25.95 65.82 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 176.558 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -54.33 122.35 10.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.798 176.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.86 -39.79 59.5 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.857 -1.065 . . . . 0.0 113.001 -173.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -103.35 19.01 20.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.839 -0.164 . . . . 0.0 111.385 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 21.88 76.36 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.157 1.383 . . . . 0.0 112.736 -177.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.8 mt -65.91 -1.77 3.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.065 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.2 tp -58.7 -26.73 32.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.69 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.557 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 31.5 mt-10 -77.67 -14.58 59.58 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.358 -177.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.9 mttm -89.33 -12.74 39.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.175 0.512 . . . . 0.0 110.384 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 47' ' ' VAL . 9.7 p -131.3 33.07 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.776 0.798 . . . . 0.0 109.774 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.557 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 51.0 mtt180 -52.5 109.86 0.44 Allowed 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.645 0.736 . . . . 0.0 111.361 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.581 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . -171.42 155.8 24.95 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 114.419 -1.264 . . . . 0.0 111.292 -176.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.491 HG13 ' HB2' ' A' ' 71' ' ' LYS . 73.6 mt -96.79 126.56 49.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 117.132 0.466 . . . . 0.0 110.768 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.47 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 9.9 m-85 -104.66 117.47 34.19 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.91 -176.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -98.68 109.75 3.86 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.273 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -98.33 103.73 15.7 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.275 0.56 . . . . 0.0 111.457 -178.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -89.6 99.41 12.42 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.254 174.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.666 HG11 HG11 ' A' ' 25' ' ' VAL . 20.2 t -96.97 121.44 47.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.627 -174.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.46 ' HE ' ' CD ' ' A' ' 63' ' ' GLU . 51.7 mtp180 -108.37 178.24 4.55 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.874 -178.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 18.4 m120 61.05 43.74 11.01 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.242 0.544 . . . . 0.0 111.036 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.24 -155.94 7.31 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.531 -0.759 . . . . 0.0 113.239 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -43.53 -60.73 0.7 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.831 3.021 . . . . 0.0 113.486 -176.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -114.25 47.42 1.22 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 177.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.9 22.21 78.82 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.572 -0.823 . . . . 0.0 111.311 -174.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.94 169.73 16.27 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.441 0.638 . . . . 0.0 111.843 -175.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.46 ' CD ' ' HE ' ' A' ' 56' ' ' ARG . 20.5 mt-10 -131.66 110.54 10.99 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.844 -178.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -100.55 169.15 21.15 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.431 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -150.25 118.54 6.4 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.935 0.398 . . . . 0.0 111.087 -177.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 20.7 m-90 -122.0 137.5 54.78 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.832 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 37.2 t -109.61 115.47 49.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.57 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.502 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 4.2 mp -95.52 106.43 18.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -86.38 98.57 11.07 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.215 0.531 . . . . 0.0 110.148 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -101.42 -2.65 30.33 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.744 174.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.491 ' HB2' HG13 ' A' ' 50' ' ' ILE . 4.5 tppp? -64.24 -39.53 94.15 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.575 -178.134 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -87.03 9.38 19.8 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.995 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 76.3 23.32 71.29 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.913 175.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -100.41 -66.22 0.92 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.687 0.279 . . . . 0.0 111.249 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.48 34.63 5.98 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.093 -1.051 . . . . 0.0 111.323 -174.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 0.1 OUTLIER -96.82 145.46 25.83 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -177.705 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.669 HG21 ' HB3' ' A' ' 29' ' ' MET . 1.2 m -107.79 129.42 61.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.591 HG23 ' HA2' ' A' ' 81' ' ' GLY . 2.1 t -134.0 134.0 41.95 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.871 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.452 ' O ' ' HB3' ' A' ' 80' ' ' ASN . 51.8 t80 -61.93 123.35 17.81 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.208 -177.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.452 ' HB3' ' O ' ' A' ' 79' ' ' TYR . 9.4 t30 75.29 -40.57 0.43 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.485 0.714 . . . . 0.0 111.663 -177.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.591 ' HA2' HG23 ' A' ' 78' ' ' THR . . . 72.36 -42.64 0.83 Allowed Glycine 0 CA--C 1.517 0.158 0 N-CA-C 114.736 0.654 . . . . 0.0 114.736 174.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 71.93 19.89 78.53 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.337 -174.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -125.38 158.77 33.46 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -177.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -98.04 108.83 48.87 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-O 120.929 0.395 . . . . 0.0 110.231 175.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.481 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 21.1 Cg_exo -66.12 132.44 29.91 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 123.008 2.472 . . . . 0.0 112.911 -177.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -61.34 -32.68 72.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.746 174.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.652 HG12 ' HA3' ' A' ' 119' ' ' GLY . 3.9 m -139.73 131.67 34.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.82 174.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.646 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 32.2 m -114.43 133.28 55.85 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.104 177.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.623 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 72.0 m-85 -119.82 128.89 54.12 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.512 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 2.1 m -102.83 119.43 38.83 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 175.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.586 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 66.0 mt -143.01 151.7 17.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -173.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.51 146.75 27.41 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.325 0.584 . . . . 0.0 110.917 176.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -53.16 -26.06 15.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.679 179.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -80.75 -37.33 30.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.041 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -87.57 -22.89 24.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.341 -173.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.807 HG11 HG12 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -56.4 -34.64 41.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.0 0.428 . . . . 0.0 110.568 -179.178 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.445 HG11 ' HD2' ' A' ' 24' ' ' LYS . 6.3 m -69.76 -29.54 41.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.15 -172.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -82.82 -33.49 27.19 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.511 HD23 ' O ' ' A' ' 104' ' ' LEU . 80.8 mt -68.43 -45.36 72.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.84 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.577 HG13 ' O ' ' A' ' 96' ' ' VAL . 22.1 mt -77.09 -19.4 14.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.097 -177.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 31.4 t -94.56 -1.26 53.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.751 0.31 . . . . 0.0 110.955 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.68 20.35 76.6 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.232 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -94.78 -42.27 8.81 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.076 0.465 . . . . 0.0 110.972 -177.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.511 ' O ' HD23 ' A' ' 99' ' ' LEU . 42.8 tp -101.5 124.73 47.65 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.115 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -72.94 123.64 89.82 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.513 177.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -65.53 -21.39 59.98 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.043 1.829 . . . . 0.0 110.113 176.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -59.15 -61.51 2.58 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.795 172.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.529 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 0.6 OUTLIER -66.12 -33.81 76.63 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.054 -177.848 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.55 ' HB3' HD12 ' A' ' 115' ' ' ILE . . . -68.72 -31.27 70.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.408 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -65.77 -49.02 69.85 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 174.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -62.9 -43.65 98.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.153 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -77.26 9.35 3.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.875 -177.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.03 -19.65 44.81 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 121.039 -0.601 . . . . 0.0 113.68 170.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -57.98 -61.11 2.78 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.659 HG23 HG22 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -79.3 114.88 20.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.853 0.835 . . . . 0.0 111.233 -173.929 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.512 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 0.0 OUTLIER -107.03 98.99 8.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.801 -1.091 . . . . 0.0 109.163 173.128 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.659 HG22 HG23 ' A' ' 115' ' ' ILE . 0.1 OUTLIER -116.48 133.7 62.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.123 0.487 . . . . 0.0 110.304 178.354 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.86 83.7 1.81 Allowed 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 -175.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.652 ' HA3' HG12 ' A' ' 87' ' ' VAL . . . -160.75 172.58 37.11 Favored Glycine 0 N--CA 1.439 -1.166 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.461 -170.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -53.57 107.69 0.27 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 123.998 0.469 . . . . 0.0 110.365 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.526 ' O ' ' HG3' ' A' ' 125' ' ' MET . 26.2 mmt -73.53 -23.17 59.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.498 -174.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.01 -21.83 75.61 Favored Glycine 0 N--CA 1.451 -0.322 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.494 HD11 ' HA3' ' A' ' 49' ' ' GLY . 8.3 tt -90.31 -43.06 10.61 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.381 -0.909 . . . . 0.0 109.395 178.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.596 ' HB2' HG11 ' A' ' 87' ' ' VAL . . . -69.04 -23.15 64.03 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.409 -178.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.526 ' HG3' ' O ' ' A' ' 121' ' ' MET . 54.3 mtm -61.73 -23.76 66.35 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.549 0.214 . . . . 0.0 111.189 177.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.488 ' HB2' HG23 ' A' ' 47' ' ' VAL . 30.5 mmmt -78.7 -21.99 47.32 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.995 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.2 mt -69.19 -44.14 72.77 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.158 0.504 . . . . 0.0 109.939 177.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 7.7 t -73.33 -14.97 61.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.476 0.655 . . . . 0.0 110.258 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -85.54 -44.03 13.02 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.301 175.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 126' ' ' LYS . 3.9 mt -63.39 -37.37 87.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.439 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -62.91 -17.93 62.39 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.159 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.515 ' HA ' ' NE ' ' A' ' 132' ' ' ARG . 3.5 mmp_? -68.81 -40.09 79.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.89 0.376 . . . . 0.0 110.295 177.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.467 ' HG2' ' NH1' ' A' ' 137' ' ' ARG . 44.5 mt-30 -85.64 -30.85 22.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.242 177.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.97 15.94 3.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.564 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -89.57 22.7 2.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.004 0.431 . . . . 0.0 110.475 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 78.57 44.64 10.49 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 111.119 -0.793 . . . . 0.0 111.119 -176.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.467 ' NH1' ' HG2' ' A' ' 133' ' ' GLN . 39.8 ttm180 -73.53 89.29 1.68 Allowed 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.754 0.788 . . . . 0.0 110.658 -176.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.405 HD13 ' HA ' ' A' ' 138' ' ' ILE . 14.2 mm -74.48 -55.01 13.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.309 177.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -101.0 160.65 14.2 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.822 -173.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.3 m -154.78 -38.71 0.09 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.303 178.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 48.7 mt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.279 -0.867 . . . . 0.0 109.95 -179.107 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.627 0 N-CA-C 111.832 -0.507 . . . . 0.0 111.832 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.2 t -143.55 108.59 4.97 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.493 ' HA ' ' HB1' ' A' ' 62' ' ' ALA . 49.0 m -136.83 103.85 5.31 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.123 178.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.03 174.45 40.52 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 173.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.408 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 51.1 m-80 -56.92 144.2 68.55 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 121.224 0.535 . . . . 0.0 110.989 -178.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 19' ' ' ASN . 5.0 Cg_exo -66.13 -22.12 54.74 Favored 'Trans proline' 0 CA--C 1.517 -0.327 0 C-N-CA 123.193 2.595 . . . . 0.0 111.734 -175.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.444 ' HG3' ' H ' ' A' ' 21' ' ' GLU . 10.8 mt-10 -60.01 -36.54 77.43 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.028 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -76.39 -13.18 60.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.406 -174.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -77.75 141.4 39.31 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 177.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -74.97 -24.14 58.39 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.48 0.657 . . . . 0.0 109.261 -178.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.701 HG12 HG11 ' A' ' 96' ' ' VAL . 0.8 OUTLIER -69.34 -15.62 19.76 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.305 176.251 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -58.71 -56.39 22.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.802 0.334 . . . . 0.0 110.462 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.468 ' O ' HG23 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -69.4 -33.51 73.11 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.468 -178.666 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.45 ' O ' HG12 ' A' ' 31' ' ' ILE . 13.1 m-85 -70.21 -50.8 36.26 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.457 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.762 ' HB3' HG21 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -62.14 -33.14 73.93 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.68 0.276 . . . . 0.0 111.274 176.111 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -67.6 -34.16 76.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.715 -0.221 . . . . 0.0 111.57 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.468 HG23 ' O ' ' A' ' 27' ' ' LYS . 17.7 pt -85.59 -21.56 7.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.026 176.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.8 tt -61.86 -48.31 81.12 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 171.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.474 ' HG2' ' HA ' ' A' ' 76' ' ' LYS . 2.0 tm-20 -43.9 -50.53 8.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.843 173.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -72.04 -53.46 12.84 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.675 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.404 ' HA ' ' HB3' ' A' ' 38' ' ' ASN . . . -62.9 -39.31 94.12 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -166.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 20.9 mmt -55.14 -43.69 74.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.603 0.239 . . . . 0.0 111.628 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -92.09 -18.77 23.1 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.236 -0.585 . . . . 0.0 111.241 177.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.404 ' HB3' ' HA ' ' A' ' 35' ' ' ALA . 66.7 t30 -69.8 -22.95 63.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.972 0.415 . . . . 0.0 110.261 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -59.57 126.81 29.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.136 174.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 13.7 m -57.28 -23.89 51.32 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.508 -175.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -100.09 4.33 44.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 119.296 -0.383 . . . . 0.0 111.9 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 32.4 p30 28.57 60.73 0.13 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.397 1.079 . . . . 0.0 111.976 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 36.1 mt -59.67 -12.73 7.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.424 -1.262 . . . . 0.0 111.922 -174.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.419 HG13 ' HB1' ' A' ' 70' ' ' ALA . 3.8 tp -60.69 -27.06 39.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.818 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -68.92 -26.88 65.31 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.555 -175.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -83.94 -22.45 31.5 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.979 0.418 . . . . 0.0 111.052 -178.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 47' ' ' VAL . 12.0 p -123.54 33.34 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.755 0.788 . . . . 0.0 110.421 -175.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -49.81 117.58 2.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.585 0.707 . . . . 0.0 111.137 177.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . -173.4 -171.3 37.86 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.264 -176.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 76.4 mt -126.92 131.19 71.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 117.998 0.899 . . . . 0.0 111.24 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.516 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 33.7 m-85 -110.33 132.2 54.39 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.116 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -109.34 112.15 3.36 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.493 -0.86 . . . . 0.0 111.409 175.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -98.44 105.7 17.88 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.948 0.404 . . . . 0.0 111.28 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -91.28 99.78 12.7 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.175 173.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.682 HG11 HG11 ' A' ' 25' ' ' VAL . 19.4 t -97.84 123.95 50.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.663 -174.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 44.9 mtp180 -112.57 -178.53 3.42 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.3 m120 61.96 44.83 7.9 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.246 0.546 . . . . 0.0 110.792 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.01 -177.02 47.05 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.576 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -35.77 -61.12 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 124.849 3.699 . . . . 0.0 114.315 -175.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -110.91 41.91 1.72 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.159 0.504 . . . . 0.0 110.597 -177.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.45 30.94 63.8 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -173.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.493 ' HB1' ' HA ' ' A' ' 17' ' ' SER . . . -85.27 173.35 10.43 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 114.769 -0.715 . . . . 0.0 111.836 -176.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -140.01 135.45 32.71 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.972 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -127.06 163.05 21.07 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.938 -0.648 . . . . 0.0 111.688 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -141.37 120.53 12.95 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.842 0.353 . . . . 0.0 110.642 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 22.7 m-90 -122.97 130.35 52.71 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.071 0.462 . . . . 0.0 109.805 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.1 t -101.84 118.91 49.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.34 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.637 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 4.3 mp -94.47 103.32 14.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.162 0.506 . . . . 0.0 109.816 178.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -85.87 98.3 10.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.986 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -95.94 -10.92 27.49 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.927 173.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.1 tttt -51.44 -46.55 63.05 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.533 -178.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -89.42 12.97 14.83 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.169 0.509 . . . . 0.0 111.84 -175.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 88.67 -1.39 83.69 Favored Glycine 0 C--N 1.319 -0.376 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.987 175.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.4 mmmp? -78.68 -74.62 0.27 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.79 0.329 . . . . 0.0 111.729 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.24 34.89 5.69 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 -167.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.637 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 16.3 ptmt -97.33 151.14 20.21 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.312 -0.444 . . . . 0.0 110.022 -174.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.762 HG21 ' HB3' ' A' ' 29' ' ' MET . 0.7 OUTLIER -107.4 143.08 18.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 120.311 -0.555 . . . . 0.0 109.743 176.765 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.2 t -139.22 132.4 29.76 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.188 177.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -68.34 121.63 16.68 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.161 -178.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 64.8 t30 52.21 62.64 2.6 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.993 -176.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -59.13 -36.58 89.21 Favored Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 115.329 -0.85 . . . . 0.0 113.416 -175.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.5 -16.04 51.43 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.061 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.427 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 8.5 mm-40 -75.68 148.18 38.85 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 176.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 29.9 mmmt -86.55 109.03 20.55 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-O 121.017 0.437 . . . . 0.0 110.128 177.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 84' ' ' LYS . 16.8 Cg_exo -67.65 142.5 58.69 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.018 2.479 . . . . 0.0 112.512 -176.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.53 ' CB ' ' HG ' ' A' ' 123' ' ' LEU . 6.7 m-20 -62.38 -33.76 75.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.759 171.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.829 HG12 ' HA3' ' A' ' 119' ' ' GLY . 4.2 m -141.76 139.1 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.059 174.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.605 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 29.5 m -115.41 137.21 52.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.222 176.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.593 ' CD1' ' HB ' ' A' ' 117' ' ' ILE . 81.9 m-85 -121.27 136.09 55.02 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 178.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.44 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 3.6 m -110.36 116.76 32.01 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 176.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.532 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 69.9 mt -140.44 152.05 21.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.694 -172.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.12 145.47 25.92 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.184 0.516 . . . . 0.0 110.536 174.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -53.05 -25.6 13.08 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.416 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -75.29 -36.53 61.15 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.73 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -89.55 -23.86 21.9 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.153 -173.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.701 HG11 HG12 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -55.55 -35.86 39.72 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.337 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.903 -178.108 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 m -61.69 -30.78 49.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.589 -171.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.416 ' HB2' ' HB2' ' A' ' 104' ' ' LEU . 34.0 m-20 -91.46 -25.93 19.07 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.696 0.284 . . . . 0.0 110.404 177.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 89.3 mt -71.87 -39.96 69.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.99 0.424 . . . . 0.0 110.293 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.506 HG12 ' O ' ' A' ' 96' ' ' VAL . 3.0 mm -67.73 -44.49 85.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.039 177.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.587 ' OG ' ' HD3' ' A' ' 103' ' ' LYS . 58.2 p -76.87 -28.54 55.46 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.686 -174.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.97 -1.31 38.44 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.125 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.587 ' HD3' ' OG ' ' A' ' 101' ' ' SER . 1.8 mptm? -66.51 -40.08 89.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.831 0.348 . . . . 0.0 111.522 177.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.732 HD11 ' NZ ' ' A' ' 108' ' ' LYS . 47.9 tp -102.27 130.01 48.85 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.799 -176.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.46 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 19.2 m120 -77.65 123.29 86.61 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.07 176.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -64.49 -25.65 62.84 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.037 1.825 . . . . 0.0 110.419 175.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -60.38 -58.77 7.07 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.144 174.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.732 ' NZ ' HD11 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -63.82 -36.34 83.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.0 -179.618 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.534 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -66.75 -34.38 77.71 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.626 -0.43 . . . . 0.0 109.958 -177.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -57.84 -52.78 64.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.84 175.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -62.95 -32.01 73.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.921 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -84.87 -1.66 56.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.775 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.48 4.45 80.23 Favored Glycine 0 CA--C 1.517 0.19 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.24 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.621 ' HA ' ' CE ' ' A' ' 114' ' ' LYS . 1.4 mmpt? -94.85 10.91 33.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.084 0.469 . . . . 0.0 111.283 -177.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.601 HG23 HG22 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -146.83 109.66 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.828 0.823 . . . . 0.0 109.532 174.878 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.44 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 73.1 mmtt -109.09 99.74 9.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.99 -1.004 . . . . 0.0 108.963 176.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.605 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER -115.49 137.43 49.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.25 0.547 . . . . 0.0 110.597 -177.737 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -147.95 96.48 2.65 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -177.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.829 ' HA3' HG12 ' A' ' 87' ' ' VAL . . . -161.1 173.5 37.55 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 119.827 -1.177 . . . . 0.0 113.599 -169.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.433 ' HB3' ' HB2' ' A' ' 123' ' ' LEU . 54.5 t-20 -48.38 119.9 3.31 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.735 -0.733 . . . . 0.0 110.134 176.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 89.2 mtp -64.03 -43.95 94.0 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.155 -176.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -66.09 -26.44 72.41 Favored Glycine 0 CA--C 1.509 -0.308 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.603 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.53 ' HG ' ' CB ' ' A' ' 86' ' ' ASP . 1.6 tm? -70.97 -56.41 6.26 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.931 -0.634 . . . . 0.0 109.861 177.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.602 ' HB2' HG11 ' A' ' 87' ' ' VAL . . . -73.6 -16.06 61.25 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.703 -177.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 52.4 mtp -65.44 -28.57 69.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.803 0.335 . . . . 0.0 110.192 173.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 19.7 mttt -72.05 -27.2 62.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.781 176.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.549 ' HB2' ' O ' ' A' ' 124' ' ' ALA . 0.5 OUTLIER -67.83 -48.36 66.42 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.866 178.494 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.451 ' O ' ' HG2' ' A' ' 131' ' ' GLN . 5.2 t -77.83 -12.77 60.01 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.475 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -80.83 -47.21 14.16 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.597 173.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.422 ' HA ' HD22 ' A' ' 130' ' ' LEU . 0.4 OUTLIER -60.0 -37.35 79.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.951 -179.01 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.451 ' HG2' ' O ' ' A' ' 128' ' ' THR . 18.6 pt20 -61.55 -24.79 66.88 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.511 0.196 . . . . 0.0 111.283 -178.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -72.55 -40.47 66.69 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 177.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -66.5 -39.39 88.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.793 174.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.73 -26.77 68.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.64 176.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -82.48 -18.47 41.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.757 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 126.93 -30.2 4.21 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.388 -0.911 . . . . 0.0 114.091 174.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -124.6 106.43 10.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.921 0.86 . . . . 0.0 112.209 -176.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 10.6 tp -115.74 -38.11 2.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.067 174.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -100.89 169.86 8.69 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.961 -177.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 13.2 t -146.91 109.23 4.5 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.801 0.334 . . . . 0.0 110.209 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 37.1 mm . . . . . 0 C--O 1.245 0.867 0 CA-C-O 118.538 -0.744 . . . . 0.0 109.634 178.059 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.761 0 N-CA-C 112.063 -0.415 . . . . 0.0 112.063 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.9 m -62.61 111.5 2.1 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.942 0.401 . . . . 0.0 110.442 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.7 m -109.7 -179.78 3.91 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.386 -176.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -57.08 131.52 52.09 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.157 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 78.1 m-20 -68.88 146.8 97.67 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 19' ' ' ASN . 31.2 Cg_exo -56.7 -42.71 62.08 Favored 'Trans proline' 0 N--CA 1.466 -0.097 0 C-N-CA 123.014 2.476 . . . . 0.0 112.244 -176.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -58.58 -33.73 70.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.606 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -70.32 -14.58 62.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.554 -178.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -80.39 144.58 32.57 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 174.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -79.18 -18.28 53.34 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.904 HG12 HG11 ' A' ' 96' ' ' VAL . 1.0 OUTLIER -75.73 -12.1 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.774 177.859 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.426 ' O ' ' HB2' ' A' ' 30' ' ' LYS . 78.8 t80 -58.77 -51.52 69.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.827 0.346 . . . . 0.0 110.793 -178.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.6 -26.8 64.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.846 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.41 ' O ' HG12 ' A' ' 31' ' ' ILE . 31.5 m-85 -79.88 -51.71 8.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.763 -178.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.561 ' SD ' ' HB ' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -59.83 -35.78 75.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.714 0.293 . . . . 0.0 111.266 177.829 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 26' ' ' PHE . 4.9 mmtp -68.94 -31.4 70.26 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.41 HG12 ' O ' ' A' ' 28' ' ' TYR . 10.4 pt -90.7 -16.79 8.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.308 176.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.6 tt -61.04 -47.28 87.15 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 171.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.652 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 7.6 tt0 -48.75 -48.73 40.54 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.562 175.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -64.77 -60.69 2.8 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.724 -1.126 . . . . 0.0 111.081 177.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.98 -46.7 75.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.395 -0.82 . . . . 0.0 113.156 -167.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 35.3 mtt -56.51 -43.62 79.94 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -177.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -92.39 -16.85 25.42 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.103 0.477 . . . . 0.0 110.419 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -63.97 -28.87 70.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.141 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -61.07 126.17 26.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.473 176.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.2 p -68.25 -16.8 64.11 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.315 -174.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -94.02 -3.63 51.0 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 177.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 24.34 72.75 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 O-C-N 124.689 1.243 . . . . 0.0 112.591 -177.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 66.5 mt -64.26 -8.58 13.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.577 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.423 HG13 ' HB1' ' A' ' 70' ' ' ALA . 3.5 tp -60.24 -27.97 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.62 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.475 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 60.7 mm-40 -70.35 -27.86 64.68 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-O 121.022 0.439 . . . . 0.0 111.338 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -85.19 -14.51 46.64 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.77 -176.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.508 ' HB ' ' HG2' ' A' ' 126' ' ' LYS . 14.6 p -130.52 31.04 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.883 0.849 . . . . 0.0 110.221 -177.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.475 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 19.5 mtp180 -51.23 112.97 0.82 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.825 0.821 . . . . 0.0 111.991 -177.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.535 ' HA3' HD11 ' A' ' 123' ' ' LEU . . . -168.88 171.1 42.76 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 114.131 -1.395 . . . . 0.0 111.356 -174.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.529 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 56.9 mt -106.32 127.61 61.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 117.375 0.587 . . . . 0.0 110.78 178.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.473 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 14.7 m-85 -108.69 114.44 28.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.017 -178.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.89 112.08 4.35 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.179 -1.01 . . . . 0.0 111.241 177.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -96.1 105.88 17.98 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.987 0.423 . . . . 0.0 111.343 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.623 ' NZ ' HG21 ' A' ' 88' ' ' THR . 54.6 mttp -91.09 101.46 14.21 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.261 174.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.793 HG11 HG11 ' A' ' 25' ' ' VAL . 21.2 t -100.78 111.54 30.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.679 -174.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' A' ' 92' ' ' SER . 46.9 mtp180 -104.96 176.85 5.03 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.851 -177.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 59.97 46.65 10.74 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.714 176.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.16 -157.47 9.98 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.203 174.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -41.47 -61.12 0.54 Allowed 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 124.028 3.152 . . . . 0.0 113.727 -175.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -115.29 44.16 1.89 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.08 23.17 72.3 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.705 -0.759 . . . . 0.0 111.231 -175.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.67 140.46 56.8 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.498 0.666 . . . . 0.0 111.156 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -114.09 109.48 18.5 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.335 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.08 165.43 16.02 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -148.58 120.54 8.21 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.954 0.406 . . . . 0.0 111.039 -176.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 19.9 m-90 -123.06 129.35 51.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.058 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 55.1 t -99.18 114.44 37.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.657 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.597 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 4.5 mp -92.32 100.21 10.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 175.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -87.93 98.73 11.66 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.297 -177.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -105.63 4.3 30.08 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.078 175.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.464 ' HB2' HG13 ' A' ' 50' ' ' ILE . 3.1 tppp? -60.89 -46.58 90.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.458 -177.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -90.59 20.82 4.34 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.329 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.79 16.43 78.04 Favored Glycine 0 C--N 1.32 -0.315 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.688 175.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -83.88 -55.24 4.35 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.787 -0.206 . . . . 0.0 111.51 -177.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.422 ' H ' ' HA ' ' A' ' 70' ' ' ALA . . . 74.54 33.62 55.66 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.375 -0.917 . . . . 0.0 111.542 -178.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.652 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -99.58 161.61 13.51 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.652 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.7 OUTLIER -120.8 138.84 49.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.906 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.8 t -137.61 136.9 37.96 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.485 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -70.33 117.55 12.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.872 -179.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 52.37 65.54 1.48 Allowed 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.655 0.597 . . . . 0.0 110.295 -175.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -61.0 -40.63 98.76 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.785 -173.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.63 -20.26 47.89 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.803 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.506 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 9.6 mm-40 -68.75 150.19 48.16 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 174.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -82.22 114.1 48.61 Favored Pre-proline 0 N--CA 1.437 -1.078 0 CA-C-O 121.289 0.566 . . . . 0.0 110.844 177.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.529 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 13.2 Cg_exo -68.75 129.61 19.02 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.108 2.539 . . . . 0.0 111.57 174.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -66.47 -32.1 73.26 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 173.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.599 HG11 ' HB2' ' A' ' 124' ' ' ALA . 15.6 m -140.7 131.66 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.39 175.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.676 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 59.5 m -111.81 130.07 55.93 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.261 177.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.583 ' CE2' HD13 ' A' ' 117' ' ' ILE . 58.7 m-85 -109.88 125.03 52.36 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 177.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.497 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 12.4 m -104.27 125.82 50.86 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 174.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -157.25 152.8 7.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 123.523 0.514 . . . . 0.0 109.708 -175.96 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 56' ' ' ARG . 11.7 m -85.47 148.0 26.19 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.983 -176.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -50.32 -27.47 6.25 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.067 -0.969 . . . . 0.0 111.118 177.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -74.95 -47.43 29.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.976 -177.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -79.99 -26.37 39.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.547 -173.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.904 HG11 HG12 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -55.2 -33.32 30.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.273 -174.509 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.1 m -69.46 -31.17 48.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.481 -169.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -82.95 -32.33 27.19 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 76.4 mt -65.37 -49.54 68.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.837 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.525 HG13 ' O ' ' A' ' 96' ' ' VAL . 18.7 mt -75.45 -21.35 16.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.6 -174.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.3 t -84.5 -26.19 28.3 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.019 0.438 . . . . 0.0 110.798 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.2 21.54 15.07 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.866 -176.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -97.9 -41.47 8.0 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.949 0.404 . . . . 0.0 111.336 -176.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.716 HD11 ' NZ ' ' A' ' 108' ' ' LYS . 37.0 tp -101.86 127.01 48.87 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.721 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.426 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 16.8 m120 -68.76 122.0 83.31 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.249 176.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -67.99 -21.21 43.69 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.067 1.845 . . . . 0.0 110.033 176.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -64.01 -56.28 16.18 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.685 175.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.716 ' NZ ' HD11 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -64.83 -37.37 87.39 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.78 178.186 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.547 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -67.25 -33.66 75.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.023 0.44 . . . . 0.0 109.956 -178.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -61.17 -50.78 71.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.052 175.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -61.87 -40.16 94.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.843 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -76.26 6.96 4.74 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.993 -177.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.79 6.66 82.35 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.895 175.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -79.39 -47.65 15.38 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.917 0.389 . . . . 0.0 110.585 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.592 HG23 HG22 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -92.02 110.78 23.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.025 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.559 ' HE2' ' HA ' ' A' ' 116' ' ' LYS . 10.8 mmpt? -108.11 105.32 15.02 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.663 176.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.676 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER -123.6 129.65 74.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.322 0.582 . . . . 0.0 111.457 -173.864 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -61.99 131.03 48.31 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.692 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -78.94 88.52 1.17 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.455 -0.879 . . . . 0.0 114.061 -172.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.419 ' HB3' ' CG1' ' A' ' 87' ' ' VAL . 47.0 t-20 -107.48 89.79 3.1 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 166.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -45.44 -58.38 3.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.757 -1.11 . . . . 0.0 113.113 -168.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -70.14 -22.38 77.32 Favored Glycine 0 C--N 1.321 -0.265 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.823 -170.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.535 HD11 ' HA3' ' A' ' 49' ' ' GLY . 2.2 tt -91.14 -53.86 4.19 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.012 0.434 . . . . 0.0 110.63 -176.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.599 ' HB2' HG11 ' A' ' 87' ' ' VAL . . . -74.04 -14.0 60.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.838 -175.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 16.4 mmt -72.06 -21.36 61.53 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.925 174.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.508 ' HG2' ' HB ' ' A' ' 47' ' ' VAL . 0.1 OUTLIER -84.88 -31.06 23.93 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 174.5 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.466 HD23 ' O ' ' A' ' 123' ' ' LEU . 1.2 mm? -56.26 -45.38 80.08 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 167.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.549 ' O ' ' HG3' ' A' ' 131' ' ' GLN . 52.2 m -61.33 -45.3 95.02 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 113.892 -1.504 . . . . 0.0 110.814 173.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -58.07 -38.77 76.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.82 -178.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.7 mt -58.47 -46.21 87.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.344 178.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.549 ' HG3' ' O ' ' A' ' 128' ' ' THR . 0.3 OUTLIER -79.9 -18.52 50.37 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.932 179.426 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' ' 128' ' ' THR . 34.8 mmt180 -68.98 -51.16 42.35 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.8 0.333 . . . . 0.0 110.328 174.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -65.78 -31.55 72.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.033 0.444 . . . . 0.0 110.359 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -76.9 4.46 9.82 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.689 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.53 15.69 5.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.852 0.358 . . . . 0.0 110.94 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 76.41 48.41 9.32 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.028 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -79.09 135.37 36.84 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.198 0.523 . . . . 0.0 111.129 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.5 mp -88.06 -64.46 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.002 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -101.41 154.79 18.5 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.603 -177.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 7.5 t 65.24 57.9 0.9 Allowed 'General case' 0 C--O 1.232 0.137 0 O-C-N 123.792 0.683 . . . . 0.0 109.718 -178.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.0 tp . . . . . 0 C--O 1.247 0.966 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.532 -176.22 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.772 0 N-CA-C 111.76 -0.536 . . . . 0.0 111.76 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.4 m -82.44 74.75 9.4 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.305 0.574 . . . . 0.0 110.808 -178.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.4 t -121.47 -166.96 1.44 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.526 178.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.73 151.18 51.12 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.046 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -57.69 130.96 82.25 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.694 0.759 . . . . 0.0 110.449 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -65.73 -21.27 58.68 Favored 'Trans proline' 0 C--N 1.328 -0.517 0 C-N-CA 123.84 3.027 . . . . 0.0 112.17 -174.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.634 ' HA ' ' CG ' ' A' ' 26' ' ' PHE . 8.6 mt-10 -86.17 -16.73 36.94 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.214 -178.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -84.61 -8.12 59.0 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.905 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -72.1 163.19 28.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.827 177.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.466 ' HG2' ' CG1' ' A' ' 97' ' ' VAL . 5.5 tppp? -79.34 -31.98 43.22 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 174.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.973 HG12 HG11 ' A' ' 96' ' ' VAL . 1.3 m -70.24 -14.88 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.85 -178.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.634 ' CG ' ' HA ' ' A' ' 21' ' ' GLU . 57.6 t80 -56.76 -55.2 37.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.691 0.282 . . . . 0.0 110.594 -178.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.422 ' HE2' HG23 ' A' ' 31' ' ' ILE . 0.6 OUTLIER -67.65 -40.78 84.52 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 120.765 0.317 . . . . 0.0 110.549 178.42 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.4 ' O ' HG12 ' A' ' 31' ' ' ILE . 14.4 m-85 -61.43 -45.85 92.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.794 -178.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 64.2 mtp -75.41 -26.56 58.5 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.67 0.271 . . . . 0.0 110.99 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.437 ' HD3' ' HA ' ' A' ' 30' ' ' LYS . 24.5 mmtp -67.73 -40.15 84.22 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 121.064 -0.254 . . . . 0.0 110.687 174.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.422 HG23 ' HE2' ' A' ' 27' ' ' LYS . 10.9 pt -79.67 -23.0 12.07 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.401 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.159 177.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.9 tt -57.23 -54.25 48.96 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 172.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.424 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 9.6 tt0 -44.2 -48.52 9.3 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.707 177.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -75.36 -61.18 1.99 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.511 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.402 ' HA ' ' HB3' ' A' ' 38' ' ' ASN . . . -55.79 -34.86 65.67 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -166.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 93.3 mmm -61.17 -43.04 99.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.69 0.281 . . . . 0.0 111.387 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -92.12 -27.03 17.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.158 0.504 . . . . 0.0 110.987 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.402 ' HB3' ' HA ' ' A' ' 35' ' ' ALA . 10.0 t30 -66.95 -27.38 67.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.763 -177.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -60.44 139.94 57.47 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 173.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 p -62.27 -13.95 33.73 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -174.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -97.03 -9.34 28.34 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 119.094 -0.479 . . . . 0.0 111.892 177.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.2 p30 35.49 66.26 0.35 Allowed 'General case' 0 C--N 1.348 0.54 0 CA-C-O 122.129 0.966 . . . . 0.0 110.588 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.5 mt -62.94 -12.02 22.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 113.884 -1.507 . . . . 0.0 112.014 -170.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.9 tp -64.69 -29.09 46.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.878 0.37 . . . . 0.0 111.01 -175.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -72.55 -29.04 63.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.037 -177.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -75.18 -21.48 58.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.312 0.577 . . . . 0.0 110.751 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 47' ' ' VAL . 13.3 p -130.06 32.02 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.701 -173.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -44.87 116.28 1.05 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.5 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.493 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . 179.86 164.27 31.87 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.878 -176.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.515 HG13 ' HB2' ' A' ' 71' ' ' LYS . 51.8 mt -97.05 127.51 49.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 117.467 0.633 . . . . 0.0 110.682 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.488 ' OH ' HG13 ' A' ' 47' ' ' VAL . 9.6 m-85 -108.95 122.48 47.32 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.671 -178.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.54 115.52 5.32 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.369 -0.92 . . . . 0.0 111.396 177.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -101.61 107.41 18.66 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.253 0.549 . . . . 0.0 111.545 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -97.54 99.14 10.54 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.54 176.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.728 HG11 HG11 ' A' ' 25' ' ' VAL . 20.4 t -102.42 125.21 56.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.025 0.441 . . . . 0.0 110.73 -175.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -115.41 177.84 4.52 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.174 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.6 m120 58.72 44.51 17.11 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.015 0.436 . . . . 0.0 111.562 177.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.93 -154.68 8.18 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.936 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 62' ' ' ALA . 71.4 Cg_exo -36.63 -59.94 0.41 Allowed 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 124.575 3.517 . . . . 0.0 114.298 -176.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -128.46 61.99 1.47 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 177.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.55 29.17 74.35 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.211 -176.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.411 ' HB3' ' HD2' ' A' ' 59' ' ' PRO . . . -76.89 154.09 34.09 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.184 0.516 . . . . 0.0 111.173 -177.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -132.55 110.59 10.58 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.494 -177.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.41 163.18 12.55 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.429 -177.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -147.89 116.89 6.8 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.88 0.371 . . . . 0.0 110.62 -178.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 18.9 m-90 -121.2 141.09 51.18 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.273 0.558 . . . . 0.0 109.682 179.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 16.4 t -107.63 117.98 54.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.164 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.447 HG13 HG12 ' A' ' 77' ' ' VAL . 4.1 mp -93.37 99.77 10.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -87.05 99.8 12.17 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.576 -176.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -113.54 13.97 18.9 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.175 175.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.515 ' HB2' HG13 ' A' ' 50' ' ' ILE . 17.8 tppt? -64.48 -44.82 89.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.221 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -82.13 -0.73 46.14 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.672 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.8 27.28 32.35 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.308 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -93.36 -62.67 1.32 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.687 0.279 . . . . 0.0 111.037 -178.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.54 34.26 8.04 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.15 -1.024 . . . . 0.0 111.893 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 59.0 pttt -97.86 146.27 25.6 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -177.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.7 OUTLIER -110.82 131.47 61.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.355 0.598 . . . . 0.0 109.859 178.448 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.488 HG23 ' HA2' ' A' ' 81' ' ' GLY . 3.6 t -137.97 139.23 39.6 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.984 -178.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.423 ' O ' ' HB3' ' A' ' 80' ' ' ASN . 24.2 t80 -65.1 128.11 34.42 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -178.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.423 ' HB3' ' O ' ' A' ' 79' ' ' TYR . 26.0 t-20 74.92 -45.8 0.58 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.677 0.791 . . . . 0.0 111.999 -178.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.488 ' HA2' HG23 ' A' ' 78' ' ' THR . . . 70.81 -43.14 0.6 Allowed Glycine 0 CA--C 1.52 0.387 0 N-CA-C 114.764 0.666 . . . . 0.0 114.764 177.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.58 -18.84 6.58 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.026 -175.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -82.63 157.89 23.23 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 122.602 0.361 . . . . 0.0 110.358 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -95.43 109.24 44.28 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 174.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.464 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 23.2 Cg_exo -64.72 137.18 52.87 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.034 2.489 . . . . 0.0 112.712 -177.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -68.53 -32.48 72.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.107 -0.952 . . . . 0.0 109.546 176.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.645 HG12 ' HA3' ' A' ' 119' ' ' GLY . 4.9 m -140.27 130.41 28.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.316 172.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.594 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 28.2 m -114.91 133.87 55.63 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.375 176.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.654 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 53.0 m-85 -118.18 128.71 54.97 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.542 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 5.9 m -106.4 128.34 53.97 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 174.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -159.27 149.52 7.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.172 0.51 . . . . 0.0 110.294 -175.146 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.38 143.53 36.75 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.329 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -49.01 -29.01 4.37 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 114.869 -1.059 . . . . 0.0 111.091 176.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -73.22 -44.38 59.69 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.217 -176.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -81.51 -25.74 35.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.036 -176.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.973 HG11 HG12 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -56.62 -33.92 41.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.303 -175.007 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.466 ' CG1' ' HG2' ' A' ' 24' ' ' LYS . 3.9 m -68.35 -27.94 38.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.992 -170.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -87.23 -29.86 21.37 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 177.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 77.9 mt -68.2 -46.5 70.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.799 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 96' ' ' VAL . 20.1 mt -75.1 -24.41 17.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.296 -176.086 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.1 p -85.48 -18.11 34.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.036 0.446 . . . . 0.0 111.022 178.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.39 13.24 58.78 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.084 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -85.39 -41.43 15.45 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.133 0.492 . . . . 0.0 111.164 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.702 HD11 ' NZ ' ' A' ' 108' ' ' LYS . 44.4 tp -99.46 125.54 45.21 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.426 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -71.99 122.23 86.74 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.561 177.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -64.87 -23.34 62.27 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.213 1.942 . . . . 0.0 110.385 176.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -54.96 -62.3 1.75 Allowed 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.935 171.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.702 ' NZ ' HD11 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -64.11 -36.06 82.81 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.314 -176.368 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.563 ' HB3' HD12 ' A' ' 115' ' ' ILE . . . -69.78 -33.64 72.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.154 -178.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -64.17 -49.89 70.3 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 175.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -58.79 -40.64 84.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.029 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -84.8 13.68 5.57 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.248 -176.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.546 ' O ' ' HE3' ' A' ' 116' ' ' LYS . . . 70.17 14.68 71.48 Favored Glycine 0 CA--C 1.519 0.293 0 CA-C-N 116.152 -0.476 . . . . 0.0 113.992 172.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.428 ' HA ' ' HE3' ' A' ' 114' ' ' LYS . 0.4 OUTLIER -87.55 -43.55 11.93 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 117.115 0.458 . . . . 0.0 110.219 177.578 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.574 HG23 HG22 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -89.14 114.18 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.703 176.471 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.546 ' HE3' ' O ' ' A' ' 113' ' ' GLY . 35.2 mmtp -110.79 99.4 8.33 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.474 175.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.654 ' HB ' ' CD2' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -115.18 136.41 51.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 120.958 0.409 . . . . 0.0 110.153 179.346 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -145.87 85.74 1.7 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -175.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.645 ' HA3' HG12 ' A' ' 87' ' ' VAL . . . -160.63 171.81 36.85 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.928 -170.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.47 ' ND2' ' HB2' ' A' ' 123' ' ' LEU . 30.6 t30 -52.45 108.51 0.3 Allowed 'General case' 0 C--N 1.327 -0.385 0 O-C-N 124.076 0.515 . . . . 0.0 110.481 178.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.475 ' O ' ' HG3' ' A' ' 125' ' ' MET . 94.8 mmm -67.82 -28.14 67.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.311 -174.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.77 -20.47 75.92 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.405 -0.903 . . . . 0.0 111.086 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.47 ' HB2' ' ND2' ' A' ' 120' ' ' ASN . 7.0 tt -88.67 -41.28 12.7 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.877 -0.661 . . . . 0.0 109.405 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.55 ' HB2' HG11 ' A' ' 87' ' ' VAL . . . -75.18 -15.36 60.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.197 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.475 ' HG3' ' O ' ' A' ' 121' ' ' MET . 64.0 mtp -64.8 -21.22 66.73 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.739 0.304 . . . . 0.0 111.102 175.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.607 ' O ' ' HG ' ' A' ' 130' ' ' LEU . 15.8 tppt? -85.22 -32.95 22.35 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.151 -0.62 . . . . 0.0 109.423 174.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.1 mt -61.56 -40.71 95.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.055 0.455 . . . . 0.0 110.328 176.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.5 t -73.12 -13.93 61.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.799 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -88.01 -46.27 9.49 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 173.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.607 ' HG ' ' O ' ' A' ' 126' ' ' LYS . 9.7 mt -57.69 -34.17 69.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.242 -177.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -59.21 -22.24 60.72 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -177.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -67.54 -43.91 79.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.187 0.518 . . . . 0.0 109.876 177.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -82.39 -32.63 29.08 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.37 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -78.56 17.55 0.67 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.437 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -87.51 -3.37 59.0 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.002 0.43 . . . . 0.0 110.734 178.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 65.8 30.33 76.98 Favored Glycine 0 C--N 1.332 0.332 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.634 177.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 53.38 88.27 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.297 0.57 . . . . 0.0 111.401 -177.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.43 HG23 ' N ' ' A' ' 139' ' ' GLU . 7.9 tp -126.27 -46.71 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.051 0.453 . . . . 0.0 110.519 178.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.43 ' N ' HG23 ' A' ' 138' ' ' ILE . 12.9 pt-20 -102.47 143.78 31.75 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.415 -178.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 22.3 t -86.98 66.15 9.29 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.096 0.474 . . . . 0.0 109.911 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.401 HG22 ' H ' ' A' ' 141' ' ' ILE . 4.0 tp . . . . . 0 C--O 1.249 1.059 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.783 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.703 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.3 t -72.86 -14.94 61.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.426 0.632 . . . . 0.0 109.295 174.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.441 ' HB3' ' H ' ' A' ' 63' ' ' GLU . 48.7 m -151.14 -169.3 3.35 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.501 175.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.61 171.17 9.11 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 121.188 -0.529 . . . . 0.0 113.206 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -64.57 133.24 95.63 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 121.656 0.741 . . . . 0.0 111.603 -176.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.65 -38.25 62.85 Favored 'Trans proline' 0 CA--C 1.521 -0.142 0 C-N-CA 124.021 3.148 . . . . 0.0 111.947 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.453 ' HA ' ' CD1' ' A' ' 26' ' ' PHE . 35.5 tt0 -60.23 -31.33 70.08 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.713 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.35 -8.83 57.58 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.047 0.451 . . . . 0.0 111.058 -175.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -80.69 153.2 28.02 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.288 -0.414 . . . . 0.0 109.941 175.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 49.3 mmtm -70.56 -29.53 66.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.646 0.736 . . . . 0.0 109.234 177.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.997 HG12 HG11 ' A' ' 96' ' ' VAL . 0.7 OUTLIER -68.4 -17.39 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 114.526 -1.216 . . . . 0.0 111.056 -174.897 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.453 ' CD1' ' HA ' ' A' ' 21' ' ' GLU . 75.3 t80 -55.51 -54.52 42.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.369 -179.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.436 ' O ' HG23 ' A' ' 31' ' ' ILE . 0.5 OUTLIER -72.68 -43.7 62.76 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.56 177.363 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.463 ' HB2' ' HA ' ' A' ' 25' ' ' VAL . 12.9 m-85 -59.15 -46.25 88.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.416 . . . . 0.0 112.106 -175.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.495 ' HE1' ' HB2' ' A' ' 53' ' ' PHE . 73.4 mtp -77.53 -24.76 49.91 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.778 0.323 . . . . 0.0 110.894 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.48 ' HD3' ' HA ' ' A' ' 30' ' ' LYS . 43.0 mmtt -75.87 -31.28 59.18 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.268 177.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.436 HG23 ' O ' ' A' ' 27' ' ' LYS . 13.6 pt -82.94 -27.44 8.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 173.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.403 ' HB3' ' O ' ' A' ' 29' ' ' MET . 5.8 tt -54.16 -51.83 63.06 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 168.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.592 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 9.2 tt0 -43.6 -58.03 2.86 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 114.23 -1.35 . . . . 0.0 111.296 177.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -67.81 -54.12 21.58 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.546 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.44 ' HA ' ' HB3' ' A' ' 38' ' ' ASN . . . -54.49 -37.61 65.49 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -169.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 95.0 mmm -63.34 -37.36 86.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.668 0.271 . . . . 0.0 111.654 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -90.09 -20.64 22.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.439 0.638 . . . . 0.0 110.225 177.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.44 ' HB3' ' HA ' ' A' ' 35' ' ' ALA . 62.7 t30 -69.31 -25.2 64.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.59 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -58.57 133.35 55.77 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 175.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.65 -30.12 41.56 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.752 -174.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -101.55 -5.46 25.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 119.468 -0.301 . . . . 0.0 111.538 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 36.11 73.67 0.08 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.718 0.77 . . . . 0.0 111.513 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 72.6 mt -64.36 -1.07 1.5 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.87 -174.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.447 HG13 ' HB1' ' A' ' 70' ' ' ALA . 4.2 tp -60.35 -25.91 35.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.699 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.43 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 32.9 mt-10 -79.78 -17.38 53.54 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.096 -177.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -86.58 -36.08 19.09 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.243 0.544 . . . . 0.0 110.188 177.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.611 HG23 ' HB2' ' A' ' 126' ' ' LYS . 12.3 p -105.38 32.97 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.496 -178.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.43 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 51.7 mtt180 -53.33 109.96 0.5 Allowed 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.926 0.869 . . . . 0.0 111.523 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.52 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . -173.1 175.01 46.07 Favored Glycine 0 C--N 1.312 -0.788 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.788 -175.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.478 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 42.6 mt -113.09 127.13 70.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 117.904 0.852 . . . . 0.0 111.419 -177.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -109.39 129.16 55.55 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.438 -178.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -108.79 118.4 5.29 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.318 -0.944 . . . . 0.0 111.291 176.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.495 ' HB2' ' HE1' ' A' ' 29' ' ' MET . 4.0 m-85 -102.09 103.29 13.85 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.188 0.518 . . . . 0.0 111.312 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.473 ' NZ ' HG21 ' A' ' 88' ' ' THR . 58.4 mttp -89.95 99.46 12.47 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.151 174.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.753 HG11 HG11 ' A' ' 25' ' ' VAL . 18.4 t -101.78 117.09 46.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.151 -176.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 92' ' ' SER . 39.7 mtp180 -117.9 -179.72 3.84 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.496 -176.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.428 ' HB2' ' HB3' ' A' ' 92' ' ' SER . 92.7 m-20 59.06 46.75 12.91 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.229 0.538 . . . . 0.0 110.969 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.74 -159.0 11.07 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.529 178.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -37.5 -61.1 0.37 Allowed 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 124.324 3.349 . . . . 0.0 114.063 -174.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -130.59 68.11 1.48 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.171 0.51 . . . . 0.0 110.1 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.51 23.04 73.58 Favored Glycine 0 N--CA 1.452 -0.247 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.56 -178.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.4 167.48 20.8 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.071 0.462 . . . . 0.0 111.331 -177.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.441 ' H ' ' HB3' ' A' ' 17' ' ' SER . 27.7 mt-10 -142.5 143.81 32.7 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.462 -176.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -136.72 159.92 24.68 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 111.141 -0.783 . . . . 0.0 111.141 178.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.4 ' O ' ' HA ' ' A' ' 79' ' ' TYR . 16.2 t80 -148.08 113.11 5.48 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.936 0.368 . . . . 0.0 110.719 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 18.3 m-90 -118.25 134.85 54.66 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.867 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 25.1 t -104.56 119.92 54.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.547 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.52 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 3.7 mp -95.1 100.98 11.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -86.77 97.58 10.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.221 0.534 . . . . 0.0 109.967 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -98.56 -6.74 29.49 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.243 173.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.44 ' HB2' HG13 ' A' ' 50' ' ' ILE . 21.9 tttt -54.79 -49.4 71.02 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.898 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -80.13 3.48 20.38 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.008 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.14 11.83 83.13 Favored Glycine 0 N--CA 1.452 -0.274 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.956 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -83.26 -59.64 2.4 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.739 0.304 . . . . 0.0 110.803 -177.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.35 34.08 24.04 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.223 -0.989 . . . . 0.0 110.65 -173.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.592 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 14.8 ptmm? -98.03 145.68 26.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.427 -0.387 . . . . 0.0 109.969 -175.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.8 OUTLIER -111.91 132.9 59.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.234 0.54 . . . . 0.0 109.644 178.812 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.0 t -139.36 135.58 33.86 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.918 -176.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.4 ' HA ' ' O ' ' A' ' 65' ' ' TYR . 21.9 t80 -69.89 122.08 18.58 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 53.66 71.59 0.5 Allowed 'General case' 0 C--O 1.234 0.247 0 O-C-N 123.699 0.624 . . . . 0.0 109.83 -173.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -63.12 -34.48 90.07 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.259 -0.882 . . . . 0.0 113.656 -172.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.92 -2.28 87.77 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.526 -176.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.446 ' HB3' HD13 ' A' ' 50' ' ' ILE . 54.6 mm-40 -91.58 163.25 14.2 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.401 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 24.4 pttm -94.55 107.64 31.43 Favored Pre-proline 0 N--CA 1.445 -0.688 0 CA-C-O 121.281 0.562 . . . . 0.0 110.331 173.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.478 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 8.1 Cg_exo -73.79 121.86 7.33 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.657 2.238 . . . . 0.0 112.048 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -59.59 -43.41 93.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.863 176.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.484 HG11 ' HB2' ' A' ' 124' ' ' ALA . 13.5 m -126.32 127.61 70.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.601 176.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.746 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 43.1 m -117.35 129.42 55.86 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.087 178.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.587 ' CD1' ' HB ' ' A' ' 117' ' ' ILE . 61.7 m-85 -110.52 130.06 55.65 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.561 ' HB ' ' HB3' ' A' ' 116' ' ' LYS . 2.9 m -108.29 107.13 17.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.763 0.316 . . . . 0.0 110.249 178.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.453 HG21 HD12 ' A' ' 99' ' ' LEU . 47.2 mt -131.23 156.75 42.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.537 -174.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.428 ' HB3' ' HB2' ' A' ' 57' ' ' ASN . 23.7 m -92.7 140.72 29.24 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.355 175.056 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -43.29 -51.12 6.43 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.46 0.648 . . . . 0.0 111.66 -177.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.16 -35.61 69.75 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.441 -1.254 . . . . 0.0 112.205 -176.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.424 ' OD2' ' HB2' ' A' ' 92' ' ' SER . 12.0 m-20 -90.4 -23.13 21.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.697 0.284 . . . . 0.0 111.252 -175.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.997 HG11 HG12 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -59.02 -31.84 46.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.034 0.445 . . . . 0.0 110.434 -177.857 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.7 m -67.03 -30.9 51.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.182 -172.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -83.14 -32.37 26.71 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.453 HD12 HG21 ' A' ' 91' ' ' ILE . 75.7 mt -66.48 -51.24 58.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.472 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 96' ' ' VAL . 17.7 mt -70.97 -26.25 27.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.082 -176.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.6 t -82.04 -15.2 54.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.702 0.286 . . . . 0.0 111.059 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.23 20.49 48.88 Favored Glycine 0 N--CA 1.454 -0.16 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.005 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -96.9 -41.56 8.36 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.142 0.496 . . . . 0.0 111.023 -178.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.452 HD23 ' HG ' ' A' ' 99' ' ' LEU . 34.1 tp -100.3 125.24 46.49 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.385 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.469 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 12.1 m120 -69.67 122.5 85.99 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.252 177.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -65.81 -21.6 57.75 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.015 1.81 . . . . 0.0 110.843 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 tm0? -65.79 -56.86 9.75 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.722 175.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.497 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -64.99 -32.35 74.03 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.435 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.501 ' HB3' HD12 ' A' ' 115' ' ' ILE . . . -66.8 -39.49 87.78 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.9 177.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -57.16 -52.95 63.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.879 175.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -60.75 -42.83 98.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.53 -178.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.408 ' OE1' ' HA ' ' A' ' 112' ' ' GLN . 16.0 mm-40 -75.78 -11.54 60.01 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.025 -175.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.26 7.71 55.78 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.767 176.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.2 mmpt? -87.17 -14.24 41.73 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.99 0.424 . . . . 0.0 110.728 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.646 HG23 HG22 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -129.55 109.48 18.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.926 0.87 . . . . 0.0 110.251 179.164 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.561 ' HB3' ' HB ' ' A' ' 90' ' ' THR . 38.1 tptt -109.35 110.24 21.34 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.331 173.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.746 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER -125.65 131.43 72.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.411 0.624 . . . . 0.0 111.604 -172.083 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -67.97 121.26 15.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.324 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -70.85 90.11 0.4 Allowed Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 114.479 0.552 . . . . 0.0 114.479 -169.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -116.46 89.63 3.15 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 165.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.55 ' O ' ' HG3' ' A' ' 125' ' ' MET . 92.9 mmm -60.51 -46.65 89.35 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.197 -168.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.02 -26.14 73.3 Favored Glycine 0 CA--C 1.511 -0.21 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.164 -171.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.411 HD11 ' HA3' ' A' ' 49' ' ' GLY . 4.2 tt -90.46 -40.37 12.07 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.987 0.422 . . . . 0.0 110.617 -176.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.484 ' HB2' HG11 ' A' ' 87' ' ' VAL . . . -79.14 -13.76 59.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.204 -177.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.55 ' HG3' ' O ' ' A' ' 121' ' ' MET . 50.1 mtt -60.63 -35.11 75.37 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.975 0.417 . . . . 0.0 110.198 173.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.611 ' HB2' HG23 ' A' ' 47' ' ' VAL . 15.3 mttm -76.43 -16.63 59.65 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.587 179.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.6 mt -80.14 -41.78 24.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.935 176.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.543 ' O ' ' HG2' ' A' ' 131' ' ' GLN . 3.2 t -75.32 -17.48 60.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.537 0.684 . . . . 0.0 109.432 177.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -64.48 -41.85 96.24 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.123 171.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.431 HD22 ' HA ' ' A' ' 130' ' ' LEU . 0.7 OUTLIER -58.84 -46.68 87.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.754 178.72 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.543 ' HG2' ' O ' ' A' ' 128' ' ' THR . 18.1 pt20 -66.58 -24.27 66.32 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 121.216 -0.194 . . . . 0.0 111.326 -175.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -65.26 -47.17 77.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.21 0.529 . . . . 0.0 109.693 176.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -69.25 -33.52 73.39 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.471 177.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.8 -35.33 80.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.152 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.1 -31.69 61.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.05 0.452 . . . . 0.0 110.748 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 101.48 -20.57 46.14 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.297 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 75.2 mtt180 -85.98 87.9 7.49 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.236 0.541 . . . . 0.0 110.187 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 16.0 tt -114.37 -27.92 2.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.546 176.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.75 169.69 8.84 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.141 -172.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.0 m -113.81 92.69 4.07 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.948 0.404 . . . . 0.0 110.853 -177.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.1 tp . . . . . 0 C--O 1.249 1.06 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.122 176.785 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.67 0 N-CA-C 111.898 -0.481 . . . . 0.0 111.898 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.8 m -76.42 81.38 3.14 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.282 0.563 . . . . 0.0 110.676 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 63.0 m -97.2 138.91 33.96 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.793 -178.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.02 160.66 34.42 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.591 176.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -54.53 135.65 62.7 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 122.03 0.919 . . . . 0.0 112.023 -176.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.598 ' HA ' ' CD1' ' A' ' 23' ' ' PHE . 20.6 Cg_endo -63.65 -14.21 41.33 Favored 'Trans proline' 0 C--N 1.334 -0.189 0 C-N-CA 124.35 3.367 . . . . 0.0 112.864 -177.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.414 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 3.1 mm-40 -75.52 -20.44 58.72 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.345 -178.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -88.32 -10.93 47.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.371 -0.832 . . . . 0.0 111.175 -176.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.598 ' CD1' ' HA ' ' A' ' 20' ' ' PRO . 18.0 m-85 -69.08 158.65 34.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.671 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -77.05 -27.0 54.26 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 174.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.751 HG12 HG11 ' A' ' 96' ' ' VAL . 0.8 OUTLIER -72.04 -13.69 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.365 -179.06 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -57.02 -57.53 12.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.757 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.455 ' O ' HG23 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -72.0 -30.54 65.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.708 -178.449 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.477 ' HB3' HD12 ' A' ' 100' ' ' ILE . 21.4 m-85 -70.92 -52.11 21.98 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.588 0.218 . . . . 0.0 111.588 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.56 ' HB3' HG21 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -61.9 -31.14 71.41 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.734 0.302 . . . . 0.0 110.971 177.196 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.417 ' HA ' ' HD2' ' A' ' 30' ' ' LYS . 25.7 mmmt -69.3 -33.47 73.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.546 178.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 28' ' ' TYR . 13.3 pt -88.1 -24.37 6.2 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.451 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.2 176.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.5 tt -58.02 -47.22 83.74 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 171.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.642 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 6.8 tt0 -46.21 -50.9 15.24 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.489 175.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -75.0 -58.87 3.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.45 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.02 -40.17 66.78 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -167.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 95.6 mmm -60.6 -41.29 94.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.702 0.287 . . . . 0.0 111.493 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -90.79 -26.02 19.66 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.969 0.414 . . . . 0.0 110.072 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -65.04 -17.11 64.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.57 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -57.62 130.28 45.66 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.381 172.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 22.3 p -65.31 -21.92 66.77 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.952 -173.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -101.09 0.07 37.19 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.832 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 26.19 68.53 0.05 Allowed 'General case' 0 N--CA 1.472 0.63 0 O-C-N 124.481 1.113 . . . . 0.0 112.678 -177.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.4 mt -65.09 -4.12 4.48 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.201 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.9 tp -60.51 -26.33 37.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.748 178.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.417 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 41.3 mt-10 -72.65 -23.19 60.87 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.188 -178.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -79.23 -43.64 23.39 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.361 0.6 . . . . 0.0 110.535 178.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 47' ' ' VAL . 15.0 p -102.67 32.51 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.719 -176.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.417 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 41.8 mtm180 -51.2 117.14 2.39 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.633 0.73 . . . . 0.0 111.427 178.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . -172.89 176.28 45.73 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.616 -176.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 53.8 mt -115.17 124.42 71.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 117.669 0.734 . . . . 0.0 111.358 -178.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.488 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 27.7 m-85 -106.09 118.46 36.68 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.051 -177.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.49 111.51 4.18 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.322 177.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.419 ' O ' ' HA ' ' A' ' 65' ' ' TYR . 4.0 m-85 -96.27 111.14 23.31 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.955 0.407 . . . . 0.0 111.679 -178.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -95.47 105.42 17.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.34 173.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.682 HG11 HG11 ' A' ' 25' ' ' VAL . 22.6 t -105.83 107.39 22.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 120.972 0.415 . . . . 0.0 111.099 -174.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.434 ' N ' ' HD2' ' A' ' 56' ' ' ARG . 1.3 mpt_? -92.48 -179.64 5.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.628 176.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 13.8 m120 58.87 44.74 16.29 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.8 176.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -81.15 -165.02 33.42 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.33 176.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -35.6 -60.93 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 124.619 3.546 . . . . 0.0 114.696 -176.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.47 ' OD1' ' HB2' ' A' ' 62' ' ' ALA . 25.4 p-10 -114.22 43.51 1.86 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.353 0.596 . . . . 0.0 110.328 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.83 24.16 76.55 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 -170.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.47 ' HB2' ' OD1' ' A' ' 60' ' ' ASN . . . -70.7 155.53 40.64 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 114.511 -0.845 . . . . 0.0 111.754 -175.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -115.59 139.27 50.25 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.666 177.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -129.42 152.76 19.63 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 176.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.419 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 44.7 t80 -140.1 116.93 10.97 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.869 0.366 . . . . 0.0 110.656 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 26.9 m-90 -122.72 132.41 54.23 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.278 -178.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 55.4 t -102.76 112.22 35.34 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.201 178.412 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.488 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 4.3 mp -89.92 102.92 13.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.155 -0.684 . . . . 0.0 109.155 176.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.423 ' OD1' ' HB3' ' A' ' 71' ' ' LYS . 44.1 t-20 -85.59 96.94 9.82 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.868 -178.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -99.89 -2.18 35.46 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.829 173.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.423 ' HB3' ' OD1' ' A' ' 69' ' ' ASN . 65.4 tttt -51.4 -50.77 58.98 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.15 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -84.0 -3.54 58.08 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.143 -176.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.19 7.49 76.82 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.254 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.7 tppt? -83.3 -44.76 14.56 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-O 120.884 0.373 . . . . 0.0 110.652 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.07 35.07 35.62 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.756 175.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.642 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -97.0 165.34 12.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.113 0.456 . . . . 0.0 110.085 -177.178 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.56 HG21 ' HB3' ' A' ' 29' ' ' MET . 0.8 OUTLIER -123.02 136.89 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-O 121.177 0.513 . . . . 0.0 109.627 178.672 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.1 t -135.28 136.01 41.3 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.041 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -69.85 116.73 10.57 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 60.3 t30 52.76 74.08 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.836 0.71 . . . . 0.0 110.093 -173.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -63.59 -28.5 72.59 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.385 -0.825 . . . . 0.0 113.152 -177.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.61 -20.26 42.7 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.846 -0.692 . . . . 0.0 111.657 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.416 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 69.2 mm-40 -73.02 156.02 39.21 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 177.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -91.84 108.2 28.12 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 173.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 83' ' ' GLU . 22.1 Cg_exo -65.36 135.45 42.94 Favored 'Trans proline' 0 CA--C 1.517 -0.361 0 C-N-CA 122.95 2.433 . . . . 0.0 112.369 -176.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -62.69 -30.4 71.37 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.776 176.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.816 HG12 ' HA3' ' A' ' 119' ' ' GLY . 3.5 m -142.63 134.74 25.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.771 176.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.675 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 17.4 m -113.37 141.06 47.5 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.275 -0.421 . . . . 0.0 109.938 177.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.651 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 29.6 m-85 -126.21 134.6 51.19 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 176.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.7 m -111.14 118.64 36.53 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.899 0.381 . . . . 0.0 110.528 176.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.529 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 80.4 mt -141.51 157.2 21.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.484 -0.78 . . . . 0.0 108.933 -175.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.444 ' OG ' ' HE3' ' A' ' 114' ' ' LYS . 6.1 p -93.02 144.81 24.88 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 111.496 0.184 . . . . 0.0 111.496 176.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -41.18 -56.23 2.43 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 122.172 0.987 . . . . 0.0 111.714 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -60.26 -34.04 73.16 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 113.272 -1.785 . . . . 0.0 112.621 -171.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.68 -19.43 22.66 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -177.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.751 HG11 HG12 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -56.52 -34.13 40.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.21 0.529 . . . . 0.0 110.026 -178.958 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.3 m -66.36 -28.97 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.031 -173.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -84.69 -35.5 22.52 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.452 HD23 ' O ' ' A' ' 104' ' ' LEU . 74.8 mt -68.76 -42.25 77.76 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.96 -177.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.57 HG13 ' O ' ' A' ' 96' ' ' VAL . 15.4 mt -76.27 -22.54 15.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.808 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.2 t -88.58 -19.69 25.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.966 0.412 . . . . 0.0 110.776 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.32 0.11 65.57 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.831 -177.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -67.85 -42.11 81.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.027 0.441 . . . . 0.0 110.791 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.452 ' O ' HD23 ' A' ' 99' ' ' LEU . 36.8 tp -104.38 126.38 51.43 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.873 178.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.474 ' HB3' ' HG2' ' A' ' 108' ' ' LYS . 1.8 t-20 -72.97 121.41 85.02 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.828 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -65.68 -20.7 59.44 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.932 1.755 . . . . 0.0 110.775 177.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.11 -55.82 8.47 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.749 174.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.53 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 0.4 OUTLIER -62.06 -35.71 79.45 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.457 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.53 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -68.53 -35.58 77.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.33 177.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -59.85 -49.05 79.24 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 175.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -64.87 -33.53 76.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.93 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -87.49 10.42 17.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.751 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.37 1.76 82.34 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 121.285 -0.483 . . . . 0.0 113.661 172.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.643 ' HB3' ' HZ3' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -94.02 11.33 30.13 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -177.081 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.544 HG23 HG22 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -140.95 109.56 2.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-O 121.976 0.893 . . . . 0.0 109.19 172.551 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -109.0 98.45 7.93 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.744 -1.117 . . . . 0.0 109.274 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.675 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER -114.27 125.02 71.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.845 178.597 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -138.46 91.22 2.53 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -174.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.816 ' HA3' HG12 ' A' ' 87' ' ' VAL . . . -160.98 172.81 37.34 Favored Glycine 0 N--CA 1.438 -1.202 0 C-N-CA 120.403 -0.903 . . . . 0.0 113.166 -170.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -48.95 110.76 0.39 Allowed 'General case' 0 C--N 1.328 -0.335 0 O-C-N 124.248 0.617 . . . . 0.0 110.5 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -63.43 -33.17 74.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.952 -175.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -71.95 -20.59 78.94 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.684 -0.77 . . . . 0.0 111.488 -177.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.456 HD11 ' HA3' ' A' ' 49' ' ' GLY . 6.2 tt -90.5 -46.81 8.09 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.7 ' HB2' HG11 ' A' ' 87' ' ' VAL . . . -72.99 -17.36 61.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.581 -177.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -68.36 -21.1 64.74 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.549 -0.461 . . . . 0.0 110.621 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.496 ' HB2' HG23 ' A' ' 47' ' ' VAL . 11.5 mttp -69.16 -25.0 64.15 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.882 0.372 . . . . 0.0 110.744 175.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.4 mt -68.81 -23.71 64.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.482 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.463 ' O ' ' HG2' ' A' ' 131' ' ' GLN . 27.8 p -82.25 -22.94 35.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.186 0.517 . . . . 0.0 110.71 -178.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.58 ' O ' ' HG2' ' A' ' 133' ' ' GLN . 30.0 t70 -55.08 -42.53 72.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.38 -176.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.451 ' H ' HD22 ' A' ' 130' ' ' LEU . 3.2 mm? -54.78 -35.74 64.16 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.272 -176.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' A' ' 128' ' ' THR . 20.3 pt20 -91.1 -31.08 16.39 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -177.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.523 ' CG ' ' HA ' ' A' ' 129' ' ' ASP . 0.1 OUTLIER -71.69 -36.49 70.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.844 0.354 . . . . 0.0 110.677 179.847 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.58 ' HG2' ' O ' ' A' ' 129' ' ' ASP . 7.9 pt20 -73.48 -26.85 61.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.975 175.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.79 -39.87 87.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.08 176.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.89 -55.19 11.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.288 176.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 108.73 -11.91 35.29 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.199 175.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 61.24 90.43 0.07 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.131 0.491 . . . . 0.0 110.938 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.63 -35.92 8.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.173 0.511 . . . . 0.0 109.918 178.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -100.33 132.77 45.52 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.019 -174.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 94.8 p 57.45 -178.51 0.06 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.264 1.026 . . . . 0.0 112.609 176.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.414 HG13 ' OXT' ' A' ' 141' ' ' ILE . 18.8 pt . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.114 -0.946 . . . . 0.0 110.161 174.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.733 0 N-CA-C 111.865 -0.494 . . . . 0.0 111.865 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.6 m -107.23 -54.45 2.47 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.99 0.424 . . . . 0.0 110.26 178.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.2 p -162.17 107.53 1.24 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.289 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.85 155.28 34.43 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.927 175.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.454 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 15.1 m120 -58.79 144.84 80.15 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-O 121.152 0.501 . . . . 0.0 111.003 -178.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 19' ' ' ASN . 23.8 Cg_exo -58.98 -31.08 95.01 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 123.413 2.742 . . . . 0.0 111.529 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.496 ' HA ' ' CD1' ' A' ' 26' ' ' PHE . 24.5 tt0 -62.47 -35.44 79.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.254 176.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -81.25 1.54 31.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.96 -174.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -77.95 153.86 32.11 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 173.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -76.81 -24.27 52.8 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.986 HG12 HG11 ' A' ' 96' ' ' VAL . 1.3 m -73.84 -14.84 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.038 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.496 ' CD1' ' HA ' ' A' ' 21' ' ' GLU . 83.1 t80 -56.75 -50.25 72.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.718 0.294 . . . . 0.0 110.372 -176.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.61 -44.32 86.87 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.582 178.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -62.47 -46.7 87.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.866 -177.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.474 ' HB3' HG21 ' A' ' 77' ' ' VAL . 56.2 mtt -73.88 -26.69 60.69 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.059 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.44 ' HD3' ' HA ' ' A' ' 30' ' ' LYS . 40.8 mmtt -71.15 -38.9 72.22 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.19 176.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 13.6 pt -78.04 -25.17 14.18 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.427 0 C-N-CA 120.329 -0.548 . . . . 0.0 109.793 175.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.3 tt -60.3 -52.76 63.91 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 173.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.533 ' HG2' ' HA ' ' A' ' 76' ' ' LYS . 1.5 tm-20 -43.37 -48.05 6.92 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 114.814 -1.084 . . . . 0.0 111.018 176.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -77.19 -53.29 7.93 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.933 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.52 -38.9 82.18 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -168.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 25.9 mmt -60.01 -40.76 90.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.713 0.292 . . . . 0.0 111.624 -178.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -91.39 -19.52 22.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.099 0.476 . . . . 0.0 111.138 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -66.38 -23.5 66.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.247 0.546 . . . . 0.0 110.028 178.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -62.14 133.81 55.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.441 173.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.8 p -62.84 -32.88 74.19 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.037 -174.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -92.06 0.66 57.47 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-O 119.303 -0.379 . . . . 0.0 111.385 178.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.6 p30 34.11 63.32 0.42 Allowed 'General case' 0 N--CA 1.468 0.433 0 O-C-N 124.172 0.92 . . . . 0.0 110.557 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.5 mt -56.97 -12.12 1.84 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 114.427 -1.26 . . . . 0.0 112.056 -173.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.433 HG13 ' HB1' ' A' ' 70' ' ' ALA . 4.2 tp -61.48 -30.99 49.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.81 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.518 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 9.6 tt0 -75.2 -27.03 59.44 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.12 0.486 . . . . 0.0 110.909 -176.168 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -73.37 -15.92 61.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.592 -179.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 47' ' ' VAL . 15.0 p -131.07 31.84 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.276 -178.194 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.518 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 59.7 mtm180 -49.21 109.44 0.26 Allowed 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.942 0.877 . . . . 0.0 112.647 -176.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.497 ' HA3' HD11 ' A' ' 123' ' ' LEU . . . -159.6 170.75 35.89 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 113.88 -1.509 . . . . 0.0 110.493 -178.231 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.513 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 54.6 mt -106.47 125.45 62.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 117.416 0.608 . . . . 0.0 110.749 179.004 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.509 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 16.5 m-85 -107.75 116.26 31.63 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.95 -178.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -97.76 111.72 4.31 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.024 177.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -101.32 104.52 15.53 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.061 0.457 . . . . 0.0 111.488 -178.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -91.95 101.51 14.07 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.449 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.711 HG11 HG11 ' A' ' 25' ' ' VAL . 10.4 t -100.98 118.21 47.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.888 -173.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.461 ' O ' ' HA ' ' A' ' 92' ' ' SER . 50.4 mtp180 -110.28 177.66 4.63 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.686 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.432 ' HB2' ' HB3' ' A' ' 92' ' ' SER . 3.3 m-20 57.91 41.7 24.19 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.954 0.407 . . . . 0.0 110.979 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -74.08 -153.28 2.91 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.603 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -32.18 -60.14 0.19 Allowed 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 124.499 3.466 . . . . 0.0 114.233 -177.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -141.51 70.37 1.34 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.045 0.45 . . . . 0.0 109.891 176.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.81 18.15 78.71 Favored Glycine 0 N--CA 1.453 -0.176 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.702 -177.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.58 162.22 26.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.011 0.434 . . . . 0.0 111.246 -177.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -136.25 132.3 35.62 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.788 -177.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -131.98 162.4 23.88 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.453 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -146.56 113.7 6.21 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.829 0.347 . . . . 0.0 110.917 -177.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 16.3 m-90 -113.45 140.21 48.28 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.867 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 45.7 t -106.97 114.53 46.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.902 177.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.534 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 3.9 mp -91.04 99.67 10.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 175.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -87.54 99.03 11.74 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.247 -177.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -101.18 -6.7 23.91 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.892 174.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.443 ' HB2' HG13 ' A' ' 50' ' ' ILE . 3.6 tppp? -58.76 -47.53 84.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.996 -176.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -73.52 -6.32 45.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.203 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 94.88 14.35 49.73 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.033 -0.603 . . . . 0.0 111.727 -178.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.501 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 9.1 mmpt? -86.32 -70.05 0.63 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.718 0.294 . . . . 0.0 111.112 -177.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.83 32.16 13.56 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -170.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.534 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 21.8 ptmt -99.16 147.21 25.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.234 -0.483 . . . . 0.0 109.948 -177.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.474 HG21 ' HB3' ' A' ' 29' ' ' MET . 0.6 OUTLIER -107.51 127.34 63.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 176.868 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.2 t -130.71 127.68 39.31 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.473 -178.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -67.59 122.5 18.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.96 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 56.3 t30 54.62 72.61 0.45 Allowed 'General case' 0 C--O 1.233 0.235 0 O-C-N 123.786 0.679 . . . . 0.0 109.928 -174.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.85 -40.34 64.1 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.948 -175.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.14 -20.52 45.51 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.974 -0.632 . . . . 0.0 111.641 -176.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.495 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 40.4 mm-40 -74.08 148.2 42.08 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.646 -0.277 . . . . 0.0 110.295 178.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 24.7 pttm -80.08 109.38 12.15 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-O 121.202 0.525 . . . . 0.0 110.915 176.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.513 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 17.9 Cg_exo -67.6 136.25 38.7 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.847 2.365 . . . . 0.0 112.566 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.501 ' HB2' HD22 ' A' ' 123' ' ' LEU . 11.8 m-20 -69.93 -31.6 69.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.701 175.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.602 HG12 ' HA3' ' A' ' 119' ' ' GLY . 4.5 m -140.68 127.53 21.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.604 173.139 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.591 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 64.2 m -110.96 127.39 55.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.342 176.017 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.546 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 83.0 m-85 -113.6 120.36 40.66 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 177.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.447 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 5.0 m -96.6 122.21 39.28 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 175.162 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.567 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -155.64 155.95 5.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.05 0.452 . . . . 0.0 110.794 -172.891 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 56' ' ' ARG . 13.3 m -83.75 143.2 30.15 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.322 -177.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.524 ' OD1' HG13 ' A' ' 25' ' ' VAL . 31.2 t70 -53.66 -27.73 29.2 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.226 1.011 . . . . 0.0 110.908 178.146 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -77.14 -38.12 52.58 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.436 -178.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -90.78 -22.17 21.16 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.763 -173.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.986 HG11 HG12 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -57.31 -32.47 41.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.12 0.486 . . . . 0.0 110.383 -178.133 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.6 m -68.82 -32.62 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.739 -172.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -77.72 -35.69 51.72 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 177.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.456 HD23 ' O ' ' A' ' 104' ' ' LEU . 84.7 mt -65.92 -48.67 70.66 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.761 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 96' ' ' VAL . 29.9 mt -70.84 -29.9 39.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.112 -177.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.7 t -78.09 -30.15 49.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.865 178.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 102.5 11.96 34.35 Favored Glycine 0 CA--C 1.516 0.105 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.672 -176.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -84.01 -41.63 17.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.096 0.474 . . . . 0.0 110.82 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.456 ' O ' HD23 ' A' ' 99' ' ' LEU . 43.2 tp -102.95 123.85 47.35 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.981 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.478 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 0.9 OUTLIER -73.52 117.95 64.91 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.287 178.652 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -60.13 -22.45 69.93 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.009 1.806 . . . . 0.0 111.214 176.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.462 ' HB2' ' OE1' ' A' ' 131' ' ' GLN . 29.5 tt0 -64.35 -55.44 21.18 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.002 173.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.479 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 0.7 OUTLIER -66.83 -31.54 72.22 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.767 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.594 ' HB3' HD12 ' A' ' 115' ' ' ILE . . . -70.61 -32.65 70.07 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.085 0.469 . . . . 0.0 109.945 177.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -65.83 -46.6 77.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.331 174.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -63.16 -44.48 95.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.205 178.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.474 ' HA ' ' OE1' ' A' ' 112' ' ' GLN . 14.5 mm-40 -79.63 2.24 23.23 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -176.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.31 6.75 89.08 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.774 171.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.09 -37.79 37.87 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.031 0.443 . . . . 0.0 110.767 177.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.675 HG23 HG22 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -93.13 117.27 36.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.942 178.736 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.447 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 23.9 mmmt -109.31 99.13 8.44 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.018 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.675 HG22 HG23 ' A' ' 115' ' ' ILE . 0.1 OUTLIER -123.57 136.46 60.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.081 0.467 . . . . 0.0 110.521 -177.93 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -147.14 81.73 1.54 Allowed 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -175.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.602 ' HA3' HG12 ' A' ' 87' ' ' VAL . . . -154.56 171.86 33.02 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 120.406 -0.902 . . . . 0.0 113.482 -169.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -51.59 112.88 0.83 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.446 0.698 . . . . 0.0 110.849 -178.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -66.5 -29.94 70.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.735 -176.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -70.56 -14.12 71.97 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.563 -178.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.501 HD22 ' HB2' ' A' ' 86' ' ' ASP . 3.5 tp -92.61 -51.15 5.25 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.789 0.804 . . . . 0.0 109.365 176.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.545 ' HB2' HG11 ' A' ' 87' ' ' VAL . . . -70.97 -12.39 61.51 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.869 -1.059 . . . . 0.0 111.253 -174.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 27.7 ptm -61.81 -24.12 66.66 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.842 0.353 . . . . 0.0 110.646 175.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 52.9 mmtt -83.44 -20.18 34.56 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 120.999 0.428 . . . . 0.0 110.597 177.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.9 mt -83.81 -41.75 17.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.964 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.574 ' O ' ' HG3' ' A' ' 132' ' ' ARG . 15.2 t -66.84 -22.16 66.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.348 0.594 . . . . 0.0 109.986 177.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -59.58 -47.28 86.18 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.705 175.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.9 mt -61.67 -41.92 98.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.404 -0.817 . . . . 0.0 112.06 -177.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.462 ' OE1' ' HB2' ' A' ' 107' ' ' GLN . 25.1 pt20 -67.91 -24.25 65.18 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.29 -175.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.574 ' HG3' ' O ' ' A' ' 128' ' ' THR . 65.7 mtm180 -63.84 -42.41 97.6 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 176.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -67.94 -39.45 83.45 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.746 177.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.88 -23.5 66.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.336 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -97.23 -3.81 40.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.017 0.437 . . . . 0.0 111.234 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 68.42 31.63 74.33 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.939 -177.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 18.7 tpp180 -94.65 105.91 17.87 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.952 0.406 . . . . 0.0 110.084 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 3.0 mp -68.21 -68.24 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.496 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -102.41 128.2 49.1 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.012 -178.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.57 ' OG ' ' HD2' ' A' ' 132' ' ' ARG . 12.2 m -94.26 139.01 31.59 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.764 -176.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 41.8 mm . . . . . 0 C--O 1.246 0.893 0 CA-C-O 118.568 -0.729 . . . . 0.0 109.786 -178.159 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.584 0 N-CA-C 111.771 -0.532 . . . . 0.0 111.771 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 45.8 t -102.4 -49.22 3.93 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.086 0.469 . . . . 0.0 110.362 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 52.2 m -154.46 -161.6 1.25 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.075 -176.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.07 172.32 4.39 Favored Glycine 0 CA--C 1.52 0.397 0 C-N-CA 121.31 -0.471 . . . . 0.0 112.785 175.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.408 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 6.3 m-20 -55.45 150.04 25.88 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.371 0.605 . . . . 0.0 111.794 -178.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.504 ' O ' ' HB2' ' A' ' 26' ' ' PHE . 4.9 Cg_exo -67.63 -22.25 44.41 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.997 2.464 . . . . 0.0 111.025 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.423 ' HG3' ' H ' ' A' ' 21' ' ' GLU . 14.5 mt-10 -65.07 -31.64 72.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.743 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -73.77 -18.69 60.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.273 -178.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -77.65 142.33 38.92 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 174.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -70.38 -23.21 62.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.664 0.745 . . . . 0.0 109.16 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 1.036 HG12 HG11 ' A' ' 96' ' ' VAL . 1.0 OUTLIER -69.4 -17.36 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.002 -179.027 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.504 ' HB2' ' O ' ' A' ' 20' ' ' PRO . 75.3 t80 -58.15 -44.16 87.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.258 0.552 . . . . 0.0 110.232 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.456 ' O ' HG23 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -77.17 -42.33 38.14 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.475 178.851 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.461 ' O ' HG12 ' A' ' 31' ' ' ILE . 24.6 m-85 -66.56 -44.39 82.46 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -177.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.435 ' CE ' HD11 ' A' ' 68' ' ' ILE . 73.9 mtp -77.56 -20.27 54.34 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.835 0.35 . . . . 0.0 110.542 -178.121 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 26' ' ' PHE . 19.8 mmtt -76.4 -36.67 57.94 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.871 175.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 28' ' ' TYR . 14.1 pt -77.22 -23.87 14.79 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.354 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 174.041 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.4 tt -58.8 -51.66 69.02 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 171.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.432 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 3.6 tt0 -45.79 -47.6 15.62 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.293 176.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -75.04 -54.5 7.05 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.54 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.6 -33.83 73.32 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -169.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.2 mmt -62.28 -39.38 92.74 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -90.96 -29.41 17.43 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.088 0.47 . . . . 0.0 110.838 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -64.61 -32.08 73.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.377 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -57.04 138.36 54.51 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.097 177.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.2 p -58.31 -24.57 60.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.027 -0.988 . . . . 0.0 113.063 -172.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -94.04 -28.42 15.75 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.8 p30 36.11 63.28 0.61 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.763 0.792 . . . . 0.0 111.181 -176.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 93.0 mt -69.52 2.75 2.85 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.859 -175.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.466 HG13 ' HB1' ' A' ' 70' ' ' ALA . 1.9 tp -56.91 -31.38 36.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.262 -177.113 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.415 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 7.9 pt-20 -76.75 -19.81 57.21 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.901 0.381 . . . . 0.0 111.164 -177.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -85.54 -35.01 21.37 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.25 0.548 . . . . 0.0 110.137 177.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.522 HG23 ' HB2' ' A' ' 126' ' ' LYS . 13.2 p -108.3 32.97 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.875 0.845 . . . . 0.0 110.472 -177.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.415 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 59.0 mtm180 -52.66 124.41 13.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.521 0.677 . . . . 0.0 111.309 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.52 ' HA3' HD11 ' A' ' 123' ' ' LEU . . . 179.74 -174.84 46.38 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 114.524 -1.216 . . . . 0.0 110.663 -175.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 63.3 mt -123.66 125.72 71.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 117.853 0.826 . . . . 0.0 111.391 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.472 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 22.7 m-85 -106.09 116.02 31.23 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.788 -178.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.38 115.59 5.23 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.533 -0.842 . . . . 0.0 111.357 177.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.417 ' O ' ' HA ' ' A' ' 65' ' ' TYR . 4.3 m-85 -100.92 109.63 21.6 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.039 0.447 . . . . 0.0 111.448 -177.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -94.35 99.34 11.57 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 172.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.807 HG11 HG11 ' A' ' 25' ' ' VAL . 18.6 t -101.03 107.35 21.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.096 0.474 . . . . 0.0 110.582 -174.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.466 ' O ' ' HA ' ' A' ' 92' ' ' SER . 35.9 mtp180 -103.18 174.36 5.9 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.087 -176.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 61.47 48.48 5.87 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.095 0.474 . . . . 0.0 111.239 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.08 -145.27 1.58 Allowed Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.245 175.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 62' ' ' ALA . 73.8 Cg_exo -40.6 -60.91 0.53 Allowed 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.665 2.91 . . . . 0.0 113.633 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -146.94 77.48 1.46 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.311 0.576 . . . . 0.0 110.487 177.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.58 13.33 83.58 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.88 178.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.422 ' HB3' ' HD2' ' A' ' 59' ' ' PRO . . . -72.73 143.78 47.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.987 0.423 . . . . 0.0 110.823 179.081 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -129.53 114.46 16.12 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.13 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -107.98 168.88 14.06 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.636 -178.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.417 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 44.5 t80 -150.2 120.34 7.25 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.754 0.311 . . . . 0.0 110.765 -177.24 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 16.9 m-90 -123.49 149.94 44.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.976 0.417 . . . . 0.0 109.919 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 38.2 t -118.25 118.1 56.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.645 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.472 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 4.1 mp -92.56 105.45 16.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 175.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -91.15 97.47 11.16 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.514 -176.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.466 ' HB1' HG13 ' A' ' 44' ' ' ILE . . . -98.1 -10.32 24.45 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.322 174.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.59 ' HD2' ' HG3' ' A' ' 72' ' ' GLU . 1.2 tmmt? -59.71 -34.88 73.49 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.212 -178.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.59 ' HG3' ' HD2' ' A' ' 71' ' ' LYS . 40.5 mt-10 -95.09 12.61 28.03 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.334 0.587 . . . . 0.0 111.24 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.53 -12.96 43.91 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.401 -0.818 . . . . 0.0 113.507 174.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -74.11 -56.23 5.17 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.706 0.289 . . . . 0.0 111.22 -176.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.89 35.06 9.36 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.198 -1.001 . . . . 0.0 111.736 -177.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 16.3 pttm -96.89 151.43 19.69 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 -175.039 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.8 OUTLIER -108.22 132.3 56.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 108.984 -0.746 . . . . 0.0 108.984 177.928 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.3 t -136.53 134.33 37.41 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.186 -177.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -66.54 125.32 25.37 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.28 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 51.78 63.16 2.35 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.275 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -59.21 -40.41 95.76 Favored Glycine 0 C--N 1.33 0.224 0 CA-C-N 115.324 -0.853 . . . . 0.0 113.847 -173.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.65 -20.61 47.69 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.931 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.497 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 15.6 mm-40 -70.19 150.57 46.33 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 174.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -85.04 107.82 13.14 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 178.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 83' ' ' GLU . 16.6 Cg_exo -67.95 128.89 18.51 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.855 2.37 . . . . 0.0 112.425 -177.41 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -62.16 -33.43 74.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.775 175.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.608 HG11 ' HB2' ' A' ' 124' ' ' ALA . 2.9 m -137.68 142.45 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.406 175.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.703 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 34.1 m -126.11 126.15 43.71 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.472 -179.054 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.409 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 55.0 m-85 -108.85 124.96 51.45 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.404 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 6.7 m -98.98 114.62 27.35 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 173.291 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.531 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 89.3 mt -137.54 150.35 25.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.811 -174.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 56' ' ' ARG . 51.1 m -90.52 137.3 32.46 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.866 176.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -43.23 -51.72 6.01 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 123.658 0.599 . . . . 0.0 111.826 -177.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.03 -41.17 67.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.374 -177.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -90.18 -18.36 25.89 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -174.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 1.036 HG11 HG12 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -57.39 -31.02 37.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.078 0.466 . . . . 0.0 110.066 -178.55 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.9 m -69.29 -28.71 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.836 -174.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -79.46 -39.59 31.88 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 176.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.474 HD23 ' O ' ' A' ' 104' ' ' LEU . 86.8 mt -68.17 -41.88 80.84 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.814 -176.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 96' ' ' VAL . 19.5 mt -72.96 -25.35 21.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.35 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 10.3 t -95.75 -5.27 42.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.093 -178.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.49 15.12 76.94 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.139 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -82.22 -42.52 18.84 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.336 0.589 . . . . 0.0 110.408 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.474 ' O ' HD23 ' A' ' 99' ' ' LEU . 41.4 tp -104.76 124.18 48.95 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.867 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.495 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 17.5 m120 -71.05 116.32 45.44 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.353 178.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -60.37 -22.9 73.0 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.067 1.845 . . . . 0.0 111.301 178.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -62.15 -59.42 5.08 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.956 173.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.517 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -64.75 -33.58 76.31 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.888 -177.676 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.519 ' HB1' ' HB3' ' A' ' 114' ' ' LYS . . . -71.32 -29.9 65.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.395 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -66.31 -45.03 81.72 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 175.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -66.93 -37.67 84.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.363 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -82.02 -6.38 59.1 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.053 -177.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.03 15.41 61.03 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.261 175.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.519 ' HB3' ' HB1' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -81.76 -41.6 20.95 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.567 0.699 . . . . 0.0 109.266 176.671 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.663 HG23 HG22 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -104.25 126.88 58.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.601 -176.995 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.404 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 34.2 mmtp -120.58 99.63 6.66 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 174.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.703 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER -126.06 131.3 71.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.035 0.445 . . . . 0.0 111.567 -176.727 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.537 ' O ' HG12 ' A' ' 87' ' ' VAL . 88.7 mt-30 -75.3 110.7 9.86 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 174.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -78.47 89.68 1.13 Allowed Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.44 -172.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -64.58 109.71 2.08 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 170.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.491 ' O ' ' HG3' ' A' ' 125' ' ' MET . 28.1 ttt -46.43 -53.17 11.62 Favored 'General case' 0 C--O 1.224 -0.271 0 O-C-N 124.281 0.988 . . . . 0.0 112.32 -168.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -82.5 -37.79 13.63 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.035 -1.079 . . . . 0.0 112.878 -173.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.52 HD11 ' HA3' ' A' ' 49' ' ' GLY . 5.0 tt -80.59 -44.25 19.27 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.601 0.239 . . . . 0.0 111.445 -170.44 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.608 ' HB2' HG11 ' A' ' 87' ' ' VAL . . . -78.69 -16.0 57.8 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.654 -175.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.491 ' HG3' ' O ' ' A' ' 121' ' ' MET . 44.9 mtm -66.76 -28.46 68.42 Favored 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.39 175.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.522 ' HB2' HG23 ' A' ' 47' ' ' VAL . 12.4 mttp -65.93 -20.5 66.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.942 0.401 . . . . 0.0 110.931 177.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 68.9 mt -78.42 -24.15 46.33 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.456 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 21.4 p -79.76 -23.77 41.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.256 0.55 . . . . 0.0 110.423 -178.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -51.11 -43.95 61.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.133 177.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -59.88 -65.15 0.72 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.081 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -57.52 -36.93 72.22 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -176.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -55.94 -56.51 19.81 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.769 0.318 . . . . 0.0 111.156 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -76.54 -22.66 54.08 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.149 -178.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.37 -50.24 64.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.807 0.337 . . . . 0.0 110.808 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -77.79 -33.76 52.49 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.902 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 88.78 -31.05 5.12 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.83 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 12.0 ptt180 -159.04 132.87 7.5 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 175.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 88.1 mt -122.25 -75.26 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.403 -179.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -101.84 151.44 22.08 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.578 -175.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 29.1 t -146.78 152.53 38.93 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -177.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 74.8 mt . . . . . 0 C--O 1.251 1.161 0 CA-C-O 118.414 -0.803 . . . . 0.0 110.115 179.376 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.893 0 N-CA-C 112.086 -0.406 . . . . 0.0 112.086 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.3 t -107.92 29.88 6.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.594 0.712 . . . . 0.0 110.3 -177.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.5 p -88.52 161.56 16.9 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.506 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -83.78 166.44 43.12 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.545 177.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -63.61 147.46 95.58 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-O 120.985 0.422 . . . . 0.0 110.626 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' A' ' 26' ' ' PHE . 11.8 Cg_exo -64.76 -29.16 59.55 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.206 2.604 . . . . 0.0 112.005 -175.032 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -63.73 -34.87 78.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.544 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -70.23 -11.63 61.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.355 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -81.23 143.31 32.4 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.174 0.512 . . . . 0.0 110.186 177.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -74.29 -21.11 59.89 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.569 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.842 HG12 HG11 ' A' ' 96' ' ' VAL . 2.5 m -75.16 -17.23 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.075 177.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.457 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 73.2 t80 -54.19 -57.24 11.91 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.871 0.367 . . . . 0.0 110.57 -176.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.96 -32.68 74.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.8 -177.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.481 ' O ' HG12 ' A' ' 31' ' ' ILE . 10.5 m-85 -70.59 -46.75 62.84 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.298 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.426 ' HE2' ' HB2' ' A' ' 29' ' ' MET . 29.6 mtm -66.17 -30.51 70.99 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.833 176.342 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 26' ' ' PHE . 29.4 mmmt -64.63 -35.38 80.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.061 177.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 28' ' ' TYR . 9.6 pt -88.35 -16.18 8.93 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.565 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.231 176.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.3 tt -64.5 -51.42 63.02 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 168.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.581 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 6.3 tt0 -44.35 -45.51 8.86 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 114.447 -1.251 . . . . 0.0 110.865 173.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -73.16 -59.57 2.65 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.499 178.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.84 -37.23 68.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.668 -0.697 . . . . 0.0 112.769 -167.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.447 ' HB3' HD13 ' A' ' 44' ' ' ILE . 25.9 mmt -59.43 -42.76 92.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.788 -179.298 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -92.34 -24.15 19.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.094 0.473 . . . . 0.0 111.015 178.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.409 HD21 ' C ' ' A' ' 38' ' ' ASN . 0.2 OUTLIER -64.92 -30.02 70.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.01 179.457 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -54.64 135.96 46.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.559 0.695 . . . . 0.0 110.041 176.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 16.2 p -52.73 -38.58 61.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.257 -1.338 . . . . 0.0 112.973 -173.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -102.78 8.89 39.31 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 119.227 -0.416 . . . . 0.0 111.258 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 34.2 67.8 0.2 Allowed 'General case' 0 C--O 1.238 0.461 0 O-C-N 124.183 0.927 . . . . 0.0 110.752 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.401 ' O ' HG12 ' A' ' 47' ' ' VAL . 69.1 mt -62.08 -0.4 0.51 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.273 -1.33 . . . . 0.0 112.403 -171.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.447 HD13 ' HB3' ' A' ' 36' ' ' MET . 4.2 tp -63.23 -28.21 44.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.3 178.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -76.6 -10.86 59.69 Favored 'General case' 0 N--CA 1.46 0.053 0 CA-C-O 121.235 0.54 . . . . 0.0 110.645 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -100.53 -14.8 18.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.804 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 47' ' ' VAL . 14.6 p -131.18 33.05 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.662 0.744 . . . . 0.0 110.364 -177.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 50.8 mtt180 -51.89 109.45 0.37 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.738 0.78 . . . . 0.0 111.826 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.597 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . -167.41 167.38 39.88 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.398 -177.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.488 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 32.9 mt -105.89 125.71 61.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 118.481 1.14 . . . . 0.0 111.145 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.578 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 17.0 m-85 -104.25 122.55 45.64 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.607 -177.373 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.47 125.14 8.48 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.236 176.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.429 ' CD1' HD13 ' A' ' 68' ' ' ILE . 5.6 m-85 -108.12 99.85 9.24 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.171 0.51 . . . . 0.0 111.331 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -94.78 100.82 12.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.141 173.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.744 HG11 HG11 ' A' ' 25' ' ' VAL . 19.8 t -108.47 117.72 54.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.1 0.476 . . . . 0.0 111.141 -173.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 47.0 mtp180 -102.25 -179.72 4.07 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.218 -177.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.447 ' HB2' ' HB3' ' A' ' 92' ' ' SER . 3.5 m-20 59.89 44.72 13.29 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 123.288 0.368 . . . . 0.0 111.34 178.178 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.97 -157.27 6.9 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.692 177.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -43.3 -59.74 0.95 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.675 2.917 . . . . 0.0 112.888 -178.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -113.47 46.88 1.21 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 175.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.6 15.44 77.63 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.837 -176.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.0 143.44 57.77 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.729 0.776 . . . . 0.0 111.606 -177.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -107.98 109.63 21.15 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.917 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.65 154.03 19.63 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 35.1 t80 -139.25 117.38 11.82 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.95 0.405 . . . . 0.0 111.173 -178.068 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 10.2 m-90 -119.71 161.7 20.28 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.2 t -126.36 118.8 52.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.265 178.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.578 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 3.1 mp -96.36 100.54 11.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 176.215 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -82.4 98.22 8.76 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.166 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -100.64 -5.11 27.13 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.975 175.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.496 ' HE3' ' HA2' ' A' ' 49' ' ' GLY . 4.1 tppp? -66.05 -39.23 89.95 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.256 -178.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -81.0 0.54 35.18 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.019 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.75 13.59 83.29 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.198 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.513 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 10.8 mmpt? -86.22 -50.5 6.93 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.68 0.276 . . . . 0.0 110.566 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.44 33.07 61.57 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.455 -0.879 . . . . 0.0 111.004 -176.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.581 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 52.2 pttt -98.5 149.24 22.92 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.504 -0.348 . . . . 0.0 110.197 -177.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.49 HG12 HG13 ' A' ' 68' ' ' ILE . 0.9 OUTLIER -108.11 123.01 63.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.699 0.761 . . . . 0.0 109.565 -178.383 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.444 HG23 ' HA2' ' A' ' 81' ' ' GLY . 4.5 t -130.36 134.46 47.18 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.582 -178.422 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -64.68 129.66 40.63 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 -176.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 72.68 -43.19 0.56 Allowed 'General case' 0 N--CA 1.47 0.557 0 O-C-N 124.001 0.813 . . . . 0.0 111.944 -177.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.444 ' HA2' HG23 ' A' ' 78' ' ' THR . . . 71.91 -42.68 0.76 Allowed Glycine 0 CA--C 1.518 0.259 0 CA-C-N 116.151 -0.477 . . . . 0.0 114.222 177.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.79 13.22 78.6 Favored Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 -174.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -116.25 166.74 11.69 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -177.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -100.7 109.01 56.37 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.204 177.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.488 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 12.6 Cg_exo -71.48 127.95 13.88 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 122.994 2.462 . . . . 0.0 112.789 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -60.97 -46.5 90.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.587 173.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.597 HG11 ' HB2' ' A' ' 124' ' ' ALA . 8.7 m -125.11 125.12 68.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.65 178.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.718 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 15.2 m -122.77 125.69 45.98 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.35 -178.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.493 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 86.2 m-85 -105.18 136.24 45.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.609 0.242 . . . . 0.0 110.39 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.567 ' HB ' ' HB3' ' A' ' 116' ' ' LYS . 2.2 m -109.72 99.63 8.77 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 175.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.565 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 49.0 mt -125.46 162.47 28.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -175.08 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.487 ' N ' HG22 ' A' ' 91' ' ' ILE . 20.3 m -97.86 145.53 26.34 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.987 0.422 . . . . 0.0 110.364 176.119 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.583 ' OD1' HG13 ' A' ' 25' ' ' VAL . 36.6 t70 -54.18 -24.03 16.64 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.016 -176.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -82.83 -35.38 26.4 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.982 -177.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -90.11 -26.44 20.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.711 -172.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.842 HG11 HG12 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -54.5 -33.13 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.011 0.434 . . . . 0.0 111.453 -176.648 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.4 m -66.34 -27.51 40.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.639 -169.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.418 ' HA ' ' HG ' ' A' ' 101' ' ' SER . 33.5 m-20 -89.69 -27.44 20.1 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 176.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.467 HD12 HG21 ' A' ' 91' ' ' ILE . 76.1 mt -69.09 -42.97 75.46 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.204 0.526 . . . . 0.0 110.533 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 96' ' ' VAL . 16.7 mt -77.46 -27.64 15.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.137 -177.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.43 ' OG ' ' HD3' ' A' ' 103' ' ' LYS . 64.0 p -83.56 -27.55 29.21 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.978 0.418 . . . . 0.0 110.778 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.38 -5.23 31.5 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.876 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.43 ' HD3' ' OG ' ' A' ' 101' ' ' SER . 14.0 mptt -67.56 -42.06 83.24 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 179.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.464 ' O ' HD23 ' A' ' 99' ' ' LEU . 25.1 tp -99.93 119.88 38.92 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.141 0.495 . . . . 0.0 110.218 -177.184 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.489 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 15.3 m120 -67.62 118.06 53.58 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.183 178.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -64.16 -21.68 67.55 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.123 1.882 . . . . 0.0 110.989 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -64.02 -53.68 46.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.325 174.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.525 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -68.04 -33.39 74.49 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -178.861 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.526 ' HB3' HD12 ' A' ' 115' ' ' ILE . . . -67.46 -36.59 81.46 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.999 177.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -59.35 -48.01 83.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.845 176.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -67.96 -37.97 82.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.016 -177.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -82.84 2.9 31.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.969 -0.559 . . . . 0.0 112.275 -177.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 81.14 13.91 80.07 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.771 -0.728 . . . . 0.0 113.379 175.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -92.32 -10.58 37.8 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.196 0.522 . . . . 0.0 110.297 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.61 HG23 HG22 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -133.35 109.09 13.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.751 177.937 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.567 ' HB3' ' HB ' ' A' ' 90' ' ' THR . 45.9 tptt -112.77 107.1 15.61 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.3 174.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.718 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER -133.9 136.94 53.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.058 0.456 . . . . 0.0 111.552 -170.147 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -67.89 123.36 20.36 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.163 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -77.0 88.64 0.97 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.221 -175.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -107.05 97.02 6.84 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 170.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.541 ' O ' ' HB3' ' A' ' 125' ' ' MET . 26.9 ttt -59.34 -50.72 72.9 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.562 -168.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -73.48 -9.66 78.2 Favored Glycine 0 N--CA 1.459 0.232 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.15 -175.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 123' ' ' LEU . 0.5 OUTLIER -93.34 -55.86 3.15 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.65 0.738 . . . . 0.0 109.809 -177.93 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.597 ' HB2' HG11 ' A' ' 87' ' ' VAL . . . -90.49 -3.72 57.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.311 -172.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.541 ' HB3' ' O ' ' A' ' 121' ' ' MET . 27.1 ptt? -62.28 -24.09 67.09 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.214 178.216 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.535 ' O ' ' HG ' ' A' ' 130' ' ' LEU . 30.0 mmmt -73.87 -16.54 61.12 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.283 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 75.6 mt -74.55 -52.29 12.28 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 176.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.484 ' HA ' ' HG2' ' A' ' 131' ' ' GLN . 8.8 t -66.59 -33.26 75.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.856 177.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -55.19 -47.59 75.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.804 177.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 126' ' ' LYS . 5.0 mt -66.25 -47.55 73.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.954 -178.27 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.484 ' HG2' ' HA ' ' A' ' 128' ' ' THR . 16.5 pt20 -71.38 -35.37 71.04 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -175.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 24.8 mtp180 -67.91 -38.87 83.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.175 0.512 . . . . 0.0 110.076 176.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -71.19 -26.94 63.17 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.041 177.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.87 -32.83 74.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.689 177.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -94.42 -12.41 27.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.675 177.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 65.92 17.2 65.04 Favored Glycine 0 C--N 1.332 0.313 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.419 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 65.5 mtm180 -150.43 -177.85 6.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.805 0.336 . . . . 0.0 110.237 -173.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.446 HG22 ' N ' ' A' ' 139' ' ' GLU . 40.5 mt -90.39 164.07 2.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 171.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.446 ' N ' HG22 ' A' ' 138' ' ' ILE . 7.8 mm-40 -42.23 118.21 1.12 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.217 0.532 . . . . 0.0 111.685 174.126 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 19.0 m -115.59 101.86 9.25 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.669 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 pt . . . . . 0 C--O 1.247 0.926 0 CA-C-O 118.364 -0.827 . . . . 0.0 110.968 -176.047 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.849 0 N-CA-C 111.74 -0.544 . . . . 0.0 111.74 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 24.8 m -69.22 -49.56 55.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.058 0.456 . . . . 0.0 110.453 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.2 m -96.17 118.63 33.13 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.534 177.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.12 173.22 15.06 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.629 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.431 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 38.9 m-80 -54.22 147.35 27.2 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.029 0.442 . . . . 0.0 111.142 -177.077 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.436 ' HA ' ' CD1' ' A' ' 23' ' ' PHE . 4.8 Cg_exo -68.21 -21.39 42.05 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 123.143 2.562 . . . . 0.0 111.578 -176.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -72.42 -20.73 61.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.247 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -81.95 -0.06 42.21 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.006 178.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.436 ' CD1' ' HA ' ' A' ' 20' ' ' PRO . 37.7 m-85 -90.12 152.56 21.07 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 175.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.408 ' O ' ' HD2' ' A' ' 28' ' ' TYR . 48.0 tptt -80.34 -26.05 38.92 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.258 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.718 HG12 HG11 ' A' ' 96' ' ' VAL . 0.8 OUTLIER -68.93 -15.19 19.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.57 178.15 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -53.75 -60.15 3.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.207 0.527 . . . . 0.0 110.572 178.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.0 -33.51 65.83 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.609 -177.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.512 ' O ' HG12 ' A' ' 31' ' ' ILE . 17.7 m-85 -67.76 -48.91 65.05 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.787 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.623 ' SD ' ' HB ' ' A' ' 25' ' ' VAL . 0.1 OUTLIER -63.25 -29.42 70.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.893 0.378 . . . . 0.0 110.74 175.889 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.44 ' HD3' ' HA ' ' A' ' 30' ' ' LYS . 37.8 mmtt -71.86 -34.36 69.16 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.787 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.512 HG12 ' O ' ' A' ' 28' ' ' TYR . 8.7 pt -82.24 -21.87 9.69 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.519 0 C-N-CA 119.971 -0.692 . . . . 0.0 109.705 174.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.405 ' O ' ' HG2' ' A' ' 36' ' ' MET . 6.5 tt -60.53 -50.97 71.4 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 170.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.521 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 6.4 tt0 -43.86 -48.51 8.36 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.183 174.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -76.33 -52.85 9.1 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.78 -177.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.433 ' HA ' ' HB3' ' A' ' 38' ' ' ASN . . . -63.21 -32.72 74.19 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -168.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.405 ' HG2' ' O ' ' A' ' 32' ' ' LEU . 94.5 mmm -62.35 -43.59 98.48 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.491 0.182 . . . . 0.0 111.491 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -91.09 -16.26 28.14 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.737 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.433 ' HB3' ' HA ' ' A' ' 35' ' ' ALA . 26.9 t-20 -65.81 -17.63 64.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.387 0.613 . . . . 0.0 109.943 175.504 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -54.83 128.94 35.33 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.055 172.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.6 p -62.38 -25.78 68.11 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.492 -0.777 . . . . 0.0 112.346 -175.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -100.09 -0.12 39.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.941 0.4 . . . . 0.0 111.02 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 39.22 52.84 2.18 Favored 'General case' 0 C--N 1.344 0.365 0 CA-C-N 114.614 -1.176 . . . . 0.0 111.742 -175.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.0 mt -60.9 -4.35 0.99 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.803 -175.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.425 HD11 ' CB ' ' A' ' 70' ' ' ALA . 1.1 tp -55.97 -30.16 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-O 120.766 0.317 . . . . 0.0 110.591 176.18 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.514 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 5.8 pt-20 -64.47 -36.03 82.87 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.346 -177.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -77.14 -15.8 59.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.996 0.427 . . . . 0.0 111.108 -175.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 47' ' ' VAL . 14.5 p -130.71 32.28 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.934 0.874 . . . . 0.0 110.24 -175.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.514 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 94.9 mtt180 -57.96 116.98 3.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.597 -0.728 . . . . 0.0 111.843 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.556 ' HA3' HD11 ' A' ' 123' ' ' LEU . . . -171.23 173.98 44.84 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.188 -178.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.483 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 52.7 mt -104.99 125.42 59.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 117.485 0.642 . . . . 0.0 111.234 -178.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.573 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 3.1 m-85 -107.28 110.99 23.15 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.815 -177.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.15 116.29 5.32 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.419 -0.896 . . . . 0.0 111.47 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.428 ' O ' ' HA ' ' A' ' 65' ' ' TYR . 5.1 m-85 -100.61 109.41 21.48 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.027 0.441 . . . . 0.0 111.636 -178.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -94.35 99.84 11.98 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.378 175.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.675 HG11 HG11 ' A' ' 25' ' ' VAL . 19.0 t -98.58 133.11 42.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.811 -175.165 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -122.33 173.26 7.74 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.117 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 59.81 49.7 7.73 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.103 0.478 . . . . 0.0 111.395 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.42 -140.07 1.61 Allowed Glycine 0 CA--C 1.522 0.48 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.437 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 62' ' ' ALA . 54.1 Cg_exo -40.73 -61.6 0.46 Allowed 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.768 2.979 . . . . 0.0 114.098 178.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -152.06 82.23 1.26 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.187 0.518 . . . . 0.0 109.97 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 73.23 12.55 79.72 Favored Glycine 0 N--CA 1.453 -0.223 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.476 ' HB3' ' HD2' ' A' ' 59' ' ' PRO . . . -82.39 157.03 23.88 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.044 -0.578 . . . . 0.0 111.381 -175.189 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -133.22 143.08 48.92 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.667 -177.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.8 162.72 24.19 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.443 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.428 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 33.6 t80 -148.42 117.58 6.84 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.82 0.343 . . . . 0.0 110.881 -176.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 16.6 m-90 -120.82 139.32 53.31 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.9 t -107.65 112.75 41.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.448 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.573 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 3.9 mp -90.73 100.7 11.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 175.357 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -85.66 97.4 10.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.418 0.628 . . . . 0.0 109.887 -178.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -102.22 -0.43 33.07 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.404 174.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.451 ' HB2' HG13 ' A' ' 50' ' ' ILE . 4.9 tppp? -63.33 -45.48 91.05 Favored 'General case' 0 CA--C 1.523 -0.079 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.166 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -72.76 -8.79 57.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.615 176.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.34 -4.14 86.37 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.897 -178.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -71.64 -39.93 70.07 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.884 0.373 . . . . 0.0 111.417 -177.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.6 34.16 54.41 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.562 176.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.521 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 19.7 ptmt -98.2 149.19 22.82 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 -175.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.6 HG21 ' HB3' ' A' ' 29' ' ' MET . 0.7 OUTLIER -109.52 132.43 57.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.674 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.0 t -133.84 129.23 36.19 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.387 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -66.49 122.5 17.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.37 -178.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 54.81 65.73 1.42 Allowed 'General case' 0 N--CA 1.464 0.226 0 O-C-N 123.765 0.666 . . . . 0.0 109.813 -176.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.04 -40.25 88.6 Favored Glycine 0 C--N 1.33 0.207 0 CA-C-N 115.57 -0.741 . . . . 0.0 113.707 -173.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.11 -21.27 40.98 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.041 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.451 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 7.4 mm-40 -71.26 143.19 50.46 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 175.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? -76.88 114.47 39.61 Favored Pre-proline 0 N--CA 1.438 -1.037 0 CA-C-O 121.39 0.614 . . . . 0.0 110.827 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.483 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 13.9 Cg_exo -68.92 126.55 14.02 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.191 2.594 . . . . 0.0 112.16 177.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.552 ' HB2' HD22 ' A' ' 123' ' ' LEU . 5.1 m-20 -60.66 -33.5 72.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.297 173.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.562 HG11 ' HB2' ' A' ' 124' ' ' ALA . 11.3 m -136.76 142.16 38.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.326 174.125 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.678 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 22.9 m -127.44 138.75 53.05 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.098 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.461 ' CE2' HD13 ' A' ' 117' ' ' ILE . 18.7 m-85 -122.69 120.92 35.1 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 123.177 0.298 . . . . 0.0 110.336 -177.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.2 m -93.56 113.18 25.24 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 171.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 81.5 mt -137.46 156.9 33.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -175.476 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.41 ' H ' ' HE2' ' A' ' 114' ' ' LYS . 17.7 m -100.25 144.53 29.17 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.196 0.522 . . . . 0.0 110.326 177.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -51.8 -34.91 42.07 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 114.607 -1.179 . . . . 0.0 112.291 -175.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -71.05 -36.16 72.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.11 -177.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.451 ' CG ' ' HD2' ' A' ' 114' ' ' LYS . 7.4 m-20 -90.91 -19.25 23.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.187 -174.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.718 HG11 HG12 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -56.72 -33.57 40.9 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 CA-C-O 120.899 0.381 . . . . 0.0 110.696 -178.452 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.7 m -64.1 -27.35 42.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.38 -172.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -86.67 -29.4 22.51 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 177.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.497 HD23 ' O ' ' A' ' 104' ' ' LEU . 85.1 mt -76.02 -39.87 54.73 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.918 -178.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.485 HG21 ' HD1' ' A' ' 28' ' ' TYR . 2.7 mm -67.39 -36.34 76.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.273 0.559 . . . . 0.0 110.374 177.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 36.4 p -79.92 -21.57 43.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.335 -176.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.66 11.32 60.74 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.62 -177.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -80.06 -42.85 22.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.047 0.451 . . . . 0.0 110.968 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.497 ' O ' HD23 ' A' ' 99' ' ' LEU . 43.3 tp -96.98 120.25 36.98 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.497 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 18.3 m120 -69.31 117.52 53.21 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.767 178.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -62.22 -22.91 74.92 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.013 1.809 . . . . 0.0 110.845 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -62.11 -56.14 21.84 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.191 173.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.547 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 0.7 OUTLIER -67.12 -33.95 76.56 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -177.942 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.591 ' HB3' HD12 ' A' ' 115' ' ' ILE . . . -69.5 -32.13 70.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.002 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -61.99 -50.93 70.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.469 175.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -64.19 -39.76 94.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.921 -178.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -76.69 -8.48 57.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.09 -177.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 95.34 -4.18 66.84 Favored Glycine 0 CA--C 1.517 0.181 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.346 173.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.451 ' HD2' ' CG ' ' A' ' 95' ' ' ASP . 0.2 OUTLIER -66.72 -39.62 88.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.112 0.482 . . . . 0.0 111.107 177.45 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.705 HG23 HG22 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -107.55 131.99 56.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.302 -174.113 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -120.88 99.37 6.48 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.042 173.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.705 HG22 HG23 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -127.34 130.48 70.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.991 0.424 . . . . 0.0 111.534 -178.587 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.513 ' O ' HG12 ' A' ' 87' ' ' VAL . 45.4 tt0 -82.35 99.36 9.33 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 173.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -72.91 103.07 1.3 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.81 -0.71 . . . . 0.0 113.525 -172.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -68.18 123.55 21.02 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 171.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 65.6 mtt -54.69 -29.72 53.7 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 123.951 0.782 . . . . 0.0 112.631 -171.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -92.27 -51.11 2.45 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.259 -0.972 . . . . 0.0 112.316 177.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.556 HD11 ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -68.52 -67.12 0.49 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.094 -0.553 . . . . 0.0 112.233 -171.821 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.768 ' HA ' HD23 ' A' ' 127' ' ' LEU . . . -64.41 -24.74 67.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.976 -173.271 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -71.12 -31.18 67.44 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.728 178.067 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.402 ' O ' HD23 ' A' ' 130' ' ' LEU . 8.4 mmtm -71.13 -46.15 62.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.483 0.659 . . . . 0.0 109.247 169.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.768 HD23 ' HA ' ' A' ' 124' ' ' ALA . 0.1 OUTLIER -59.42 -43.29 93.07 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.289 -175.943 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.424 ' N ' ' HG ' ' A' ' 127' ' ' LEU . 6.8 t -76.61 -22.25 54.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.122 0.487 . . . . 0.0 110.79 -178.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -75.45 -25.5 57.51 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.396 0.617 . . . . 0.0 110.613 -178.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.402 HD23 ' O ' ' A' ' 126' ' ' LYS . 3.5 mm? -65.89 -13.37 59.54 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.41 178.187 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.4 ' HA ' ' HB3' ' A' ' 134' ' ' ALA . 19.8 pt20 -60.52 -19.6 57.58 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -175.053 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -61.04 -60.52 3.64 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.035 0.445 . . . . 0.0 110.216 -178.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -74.96 -20.62 59.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.704 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.4 ' HB3' ' HA ' ' A' ' 131' ' ' GLN . . . -65.18 -32.58 74.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.198 0.523 . . . . 0.0 110.303 175.223 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -93.25 -8.64 41.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.483 175.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 75.19 30.64 58.56 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.578 178.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 60.5 mtm180 -121.09 106.77 11.87 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.734 0.302 . . . . 0.0 110.875 -179.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 15.7 tt -84.9 -29.18 6.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.606 0.717 . . . . 0.0 109.5 175.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -100.13 132.95 45.19 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.923 -175.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 36.5 p -108.96 -31.39 7.66 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.413 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 63.7 mt . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.67 -0.681 . . . . 0.0 110.11 -179.814 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.746 0 N-CA-C 112.086 -0.406 . . . . 0.0 112.086 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.4 m -94.17 -35.1 12.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.354 0.597 . . . . 0.0 110.011 177.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.9 m -153.38 -163.38 1.66 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.474 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -54.88 149.93 19.68 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.853 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -62.49 126.88 89.13 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 121.794 0.807 . . . . 0.0 111.092 -176.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.03 -19.26 35.09 Favored 'Trans proline' 0 C--N 1.328 -0.502 0 C-N-CA 124.095 3.197 . . . . 0.0 111.922 -175.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.496 ' HA ' ' CG ' ' A' ' 26' ' ' PHE . 17.1 mt-10 -76.65 -23.86 53.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.368 -176.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -91.65 28.84 1.65 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.338 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -110.58 160.18 16.88 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.086 174.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -74.17 -35.49 64.02 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 172.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 1.048 HG12 HG11 ' A' ' 96' ' ' VAL . 0.8 OUTLIER -65.15 -20.54 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.568 -178.975 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.496 ' CG ' ' HA ' ' A' ' 21' ' ' GLU . 67.5 t80 -56.95 -46.59 82.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.963 0.411 . . . . 0.0 110.593 -179.229 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.426 ' HE2' HG23 ' A' ' 31' ' ' ILE . 0.6 OUTLIER -75.91 -44.99 37.65 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.474 177.973 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -63.9 -43.73 95.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.342 -175.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.458 ' CE ' HD11 ' A' ' 68' ' ' ILE . 71.9 mtp -76.59 -20.32 56.92 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.78 0.324 . . . . 0.0 110.811 -178.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -75.13 -46.67 32.88 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 175.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.426 HG23 ' HE2' ' A' ' 27' ' ' LYS . 10.8 pt -70.74 -24.53 25.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.782 175.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.0 tt -60.47 -56.03 26.38 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 171.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.56 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 11.2 tt0 -42.33 -52.95 4.37 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.169 176.038 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -69.64 -58.99 3.25 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.877 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.84 -38.53 72.8 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -168.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.2 mmt -59.21 -39.26 82.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.851 0.358 . . . . 0.0 111.592 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -90.62 -31.78 16.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.197 0.522 . . . . 0.0 110.698 178.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -66.57 -18.66 65.49 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.209 -174.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -55.98 145.17 26.07 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.045 177.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.7 p -47.29 -46.95 25.39 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 123.545 0.528 . . . . 0.0 111.713 -176.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -102.57 4.89 38.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.596 -176.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.467 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 4.1 p30 37.2 71.48 0.14 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 122.039 0.923 . . . . 0.0 110.89 -175.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.5 mt -64.51 0.26 1.13 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.443 -1.253 . . . . 0.0 112.103 -173.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.4 tp -61.62 -25.5 37.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.001 0.429 . . . . 0.0 110.442 177.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.512 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 17.0 pt-20 -74.26 -12.62 60.61 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.788 -178.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -86.89 -19.78 28.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.184 0.516 . . . . 0.0 110.538 178.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 47' ' ' VAL . 12.5 p -130.49 31.98 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.2 -173.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.512 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 58.4 mtm180 -54.99 116.63 2.87 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.971 0.891 . . . . 0.0 111.751 -176.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.403 ' HA3' HD21 ' A' ' 123' ' ' LEU . . . -178.54 173.03 45.45 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 114.055 -1.429 . . . . 0.0 111.193 -176.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.485 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 60.0 mt -105.04 129.47 57.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-O 120.971 0.415 . . . . 0.0 111.01 -178.063 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.464 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 5.4 m-85 -111.83 125.28 53.84 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.823 -178.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 88' ' ' THR . . . -104.06 121.55 7.06 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.421 -0.895 . . . . 0.0 111.408 176.301 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -107.31 109.38 21.13 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.135 0.493 . . . . 0.0 111.487 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -97.66 99.73 11.1 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.179 176.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.739 HG11 HG11 ' A' ' 25' ' ' VAL . 12.2 t -105.59 122.42 59.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.202 -171.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -107.21 -179.44 3.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.869 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.408 ' HB2' ' HB3' ' A' ' 92' ' ' SER . 4.5 m-20 61.92 47.81 5.71 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.137 0.494 . . . . 0.0 111.586 177.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.28 -167.06 20.36 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.699 177.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -40.66 -60.88 0.53 Allowed 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 124.126 3.218 . . . . 0.0 113.558 -176.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -108.93 42.2 1.46 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.091 0.472 . . . . 0.0 109.986 177.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 74.99 19.56 79.88 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.476 -176.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.23 171.47 8.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.973 0.416 . . . . 0.0 111.279 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -131.25 135.32 47.24 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.697 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -124.3 153.68 17.65 Favored Glycine 0 N--CA 1.443 -0.876 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -141.22 119.35 12.04 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.791 0.329 . . . . 0.0 110.622 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 14.8 m-90 -122.49 144.92 48.77 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 40.1 t -110.46 115.1 48.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.052 177.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.464 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 4.0 mp -89.21 99.17 8.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 176.302 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -90.66 98.7 11.93 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.447 0.641 . . . . 0.0 109.999 -176.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -110.91 15.64 21.68 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.604 175.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.438 ' HB2' ' CG1' ' A' ' 50' ' ' ILE . 34.2 tttm -56.28 -50.21 72.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.752 -177.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -86.01 0.14 54.08 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.676 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 94.21 12.04 56.71 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.641 -0.708 . . . . 0.0 112.437 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -76.36 -63.49 1.32 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.483 0.182 . . . . 0.0 111.237 -178.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.82 34.2 7.43 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 119.967 -1.111 . . . . 0.0 112.068 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.56 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 15.3 pttm -98.1 143.27 28.81 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.259 -0.275 . . . . 0.0 110.259 -178.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.8 OUTLIER -110.04 131.84 59.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.359 0.6 . . . . 0.0 109.832 178.717 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.6 t -131.21 133.54 45.6 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.49 -176.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -68.7 119.85 13.76 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -178.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 53.6 70.35 0.61 Allowed 'General case' 0 C--N 1.331 -0.199 0 O-C-N 123.79 0.681 . . . . 0.0 109.901 -175.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.1 -34.57 90.1 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.381 -0.827 . . . . 0.0 113.737 -173.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.14 -14.98 56.14 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.976 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.401 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 55.1 mm-40 -73.33 165.73 24.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.809 0.338 . . . . 0.0 110.369 177.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.486 ' N ' ' HD2' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -100.14 106.82 44.02 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.15 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.485 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 16.2 Cg_exo -68.92 139.76 44.07 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.695 2.263 . . . . 0.0 113.018 -177.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.456 ' HB3' ' HG ' ' A' ' 123' ' ' LEU . 31.0 m-20 -67.2 -31.2 71.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.566 173.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.636 HG12 ' HA3' ' A' ' 119' ' ' GLY . 4.6 m -139.78 149.26 22.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.516 172.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.616 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 54.8 m -135.3 128.33 31.6 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 175.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.632 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 61.4 m-85 -113.41 125.16 53.94 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.852 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.473 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 4.6 m -98.48 121.33 40.28 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 173.009 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.608 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -155.39 154.6 6.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 O-C-N 123.551 0.532 . . . . 0.0 109.618 -175.184 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.472 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 3.8 m -91.56 137.82 32.06 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.56 -178.146 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.533 ' OD1' HG13 ' A' ' 25' ' ' VAL . 27.7 t70 -43.28 -49.68 6.69 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.376 0.67 . . . . 0.0 111.495 -176.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -49.95 -38.79 38.1 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.067 -1.424 . . . . 0.0 111.772 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.472 ' OD2' ' HB2' ' A' ' 92' ' ' SER . 13.6 m-20 -91.02 -21.18 21.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.413 -175.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 1.048 HG11 HG12 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -60.88 -31.27 49.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 121.134 0.493 . . . . 0.0 110.447 -175.577 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.6 m -67.1 -28.7 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.088 -171.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -81.69 -35.26 30.04 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 176.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.44 HD23 ' O ' ' A' ' 104' ' ' LEU . 85.3 mt -66.07 -49.44 67.59 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.812 -178.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 96' ' ' VAL . 21.4 mt -70.03 -23.86 25.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.057 -176.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.1 t -91.55 -9.75 43.15 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.998 0.428 . . . . 0.0 110.972 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.97 17.57 69.6 Favored Glycine 0 C--N 1.329 0.182 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.257 -179.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -85.69 -41.58 15.03 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.05 0.452 . . . . 0.0 110.63 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.44 ' O ' HD23 ' A' ' 99' ' ' LEU . 38.9 tp -103.32 123.22 46.38 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.478 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.493 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 6.2 m-20 -69.09 120.75 78.59 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.548 177.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -65.41 -22.5 59.47 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.083 1.856 . . . . 0.0 111.241 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.49 -54.91 25.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.595 176.034 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.556 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 0.8 OUTLIER -67.4 -34.89 78.19 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.971 179.283 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.59 ' HB3' HD12 ' A' ' 115' ' ' ILE . . . -64.92 -34.34 78.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.178 178.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -61.58 -52.39 64.63 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 175.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -59.72 -39.68 85.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.546 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.468 ' HA ' ' OE1' ' A' ' 112' ' ' GLN . 13.4 mm-40 -85.05 17.08 3.08 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -174.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.42 12.12 76.73 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 121.105 -0.569 . . . . 0.0 113.563 173.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -87.47 -47.41 8.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.877 0.37 . . . . 0.0 110.71 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.626 HG23 HG22 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -96.03 121.4 46.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.994 -177.348 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.473 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 31.2 mmtp -116.52 99.06 6.9 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.877 173.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.632 ' HB ' ' CD2' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -115.96 128.85 73.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.356 0.598 . . . . 0.0 110.665 -178.659 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -134.03 81.28 1.91 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -174.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.636 ' HA3' HG12 ' A' ' 87' ' ' VAL . . . -161.51 171.94 37.6 Favored Glycine 0 N--CA 1.439 -1.148 0 C-N-CA 119.936 -1.125 . . . . 0.0 113.515 -170.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -49.23 123.9 8.14 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.339 0.67 . . . . 0.0 111.147 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.44 -45.25 88.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.655 -175.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.19 -32.02 79.01 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.521 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.456 ' HG ' ' HB3' ' A' ' 86' ' ' ASP . 1.2 tm? -60.97 -48.94 79.52 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.026 -0.587 . . . . 0.0 110.437 178.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.491 ' HB2' HG11 ' A' ' 87' ' ' VAL . . . -82.67 -23.94 33.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.635 -176.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 51.8 mmm -57.4 -36.2 70.99 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 120.758 0.314 . . . . 0.0 111.238 177.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.418 ' HA ' ' HB3' ' A' ' 129' ' ' ASP . 14.3 mttp -70.62 -18.71 62.87 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.52 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 68.3 mt -73.9 -45.39 51.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.893 0.378 . . . . 0.0 110.229 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.457 ' O ' ' HG3' ' A' ' 132' ' ' ARG . 15.0 t -78.11 -26.16 47.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.986 0.422 . . . . 0.0 109.956 178.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.418 ' HB3' ' HA ' ' A' ' 126' ' ' LYS . 32.1 t70 -64.23 -39.48 94.05 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.3 175.057 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.18 -45.41 79.77 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.941 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -76.61 -20.36 56.84 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.199 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 128' ' ' THR . 77.6 mtp180 -70.58 -51.01 31.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.804 0.335 . . . . 0.0 110.306 175.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -67.92 -22.04 65.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.227 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.21 -22.87 66.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.967 177.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -85.32 -17.81 35.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.22 0.533 . . . . 0.0 110.48 177.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 68.8 33.59 75.8 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 115.285 -0.87 . . . . 0.0 113.335 175.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 137' ' ' ARG . 49.5 mtt180 -127.64 135.82 50.77 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.954 0.377 . . . . 0.0 110.565 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.582 HG13 ' H ' ' A' ' 139' ' ' GLU . 5.5 tp -144.83 -171.43 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -178.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.582 ' H ' HG13 ' A' ' 138' ' ' ILE . 35.0 tt0 -32.47 123.62 0.33 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.545 0.738 . . . . 0.0 112.453 174.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 38.1 m -136.9 93.35 2.84 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.083 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 58.1 mt . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.457 -0.782 . . . . 0.0 110.16 -178.528 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.619 0 N-CA-C 112.053 -0.419 . . . . 0.0 112.053 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.8 m -93.37 86.35 5.25 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.178 0.513 . . . . 0.0 110.908 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.8 m -74.95 101.42 4.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.844 175.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.4 166.04 54.1 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 121.026 -0.606 . . . . 0.0 112.343 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.414 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 6.8 p30 -62.76 152.44 82.14 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-O 121.237 0.542 . . . . 0.0 110.801 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.465 ' HA ' ' CD1' ' A' ' 23' ' ' PHE . 4.9 Cg_exo -70.06 -17.56 36.13 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.695 2.263 . . . . 0.0 111.156 -177.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.467 ' HA ' ' CG ' ' A' ' 26' ' ' PHE . 13.3 mt-10 -74.09 -24.03 59.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.503 -178.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -74.67 -22.16 59.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.635 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.465 ' CD1' ' HA ' ' A' ' 20' ' ' PRO . 35.5 m-85 -65.64 145.53 55.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.667 177.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -74.77 -26.34 59.69 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.757 HG12 HG11 ' A' ' 96' ' ' VAL . 0.9 OUTLIER -68.85 -21.69 25.92 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.71 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.585 177.902 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.467 ' CG ' ' HA ' ' A' ' 21' ' ' GLU . 79.2 t80 -56.78 -47.5 80.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.774 0.321 . . . . 0.0 110.361 -178.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.85 -34.88 77.57 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.727 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.47 ' O ' HG12 ' A' ' 31' ' ' ILE . 37.4 m-85 -71.8 -53.5 13.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.756 0.312 . . . . 0.0 111.101 178.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.603 ' HB3' HG21 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -58.61 -32.8 69.35 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.104 176.939 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.2 mmtt -66.58 -41.78 88.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.601 177.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.47 HG12 ' O ' ' A' ' 28' ' ' TYR . 16.8 pt -78.09 -26.41 14.47 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 C-N-CA 120.294 -0.562 . . . . 0.0 109.865 177.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.6 tt -59.35 -47.94 83.5 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 173.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.54 ' HG2' ' HA ' ' A' ' 76' ' ' LYS . 0.8 OUTLIER -44.57 -50.9 9.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.522 176.021 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -78.64 -55.29 5.3 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.58 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.48 -40.21 74.53 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -167.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.4 mmt -61.29 -41.28 96.7 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -177.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -90.92 -16.82 27.47 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.582 177.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -71.27 -25.09 62.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.996 -176.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -52.85 135.22 36.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.212 0.53 . . . . 0.0 110.117 176.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 18.2 p -57.89 -29.24 64.9 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.621 -174.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -100.32 -5.3 27.6 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 122.467 0.307 . . . . 0.0 111.232 177.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.493 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 4.1 p-10 38.82 64.27 0.8 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.843 0.83 . . . . 0.0 111.294 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.4 mt -58.64 -11.32 2.94 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.137 -175.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.2 tp -57.35 -25.81 24.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.065 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.493 ' HG2' ' O ' ' A' ' 42' ' ' ASN . 3.7 pt-20 -60.03 -33.19 71.69 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.789 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -82.7 -18.84 39.47 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.865 0.364 . . . . 0.0 111.573 -173.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 47' ' ' VAL . 11.3 p -124.99 31.9 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 122.074 0.94 . . . . 0.0 109.813 -176.17 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 37.2 mtm180 -57.45 110.33 0.85 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.845 0.831 . . . . 0.0 112.118 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.554 ' HA3' HD11 ' A' ' 123' ' ' LEU . . . -165.78 170.91 40.79 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 114.086 -1.415 . . . . 0.0 110.701 -178.401 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.447 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 53.2 mt -105.27 126.64 60.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 117.717 0.758 . . . . 0.0 111.136 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.5 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 25.7 m-85 -107.92 117.59 34.51 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.994 -178.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.91 106.59 3.37 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.262 -0.971 . . . . 0.0 111.231 177.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -95.21 105.62 17.57 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.253 0.549 . . . . 0.0 111.261 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -91.31 99.79 12.7 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.383 176.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.735 HG11 HG11 ' A' ' 25' ' ' VAL . 7.6 t -99.84 127.47 52.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.911 -172.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 -112.74 -178.14 3.32 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.792 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 62.67 47.47 4.76 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.13 0.49 . . . . 0.0 111.124 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.39 -169.48 32.45 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.577 177.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -37.69 -61.07 0.37 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.546 3.498 . . . . 0.0 114.217 -174.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -125.05 61.12 1.19 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.86 16.09 74.31 Favored Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.53 -177.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.53 168.8 18.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.028 0.442 . . . . 0.0 110.749 -178.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -136.73 136.2 38.77 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.915 -176.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -120.19 162.46 14.22 Favored Glycine 0 N--CA 1.442 -0.94 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.387 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -150.26 115.18 5.32 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.712 0.291 . . . . 0.0 110.243 -178.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 26.1 m-90 -118.97 126.1 50.96 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.2 0.524 . . . . 0.0 110.279 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 51.3 t -94.4 110.4 23.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.743 177.354 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.5 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 4.4 mp -88.91 99.24 8.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -83.11 105.6 14.23 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.5 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -111.47 5.23 19.44 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 173.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.411 ' HE3' ' HA2' ' A' ' 49' ' ' GLY . 4.4 tppp? -64.67 -36.7 85.13 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.957 -176.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -77.4 -30.3 53.54 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.624 0.726 . . . . 0.0 109.9 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 111.82 10.11 19.45 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.344 -176.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.459 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 9.5 mmpt? -88.01 -49.72 6.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.56 -0.32 . . . . 0.0 111.397 -178.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.01 34.39 15.11 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.16 -1.019 . . . . 0.0 111.793 -177.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.54 ' HA ' ' HG2' ' A' ' 33' ' ' GLU . 14.2 pttm -96.82 145.15 26.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.545 0.212 . . . . 0.0 110.783 -172.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.603 HG21 ' HB3' ' A' ' 29' ' ' MET . 0.7 OUTLIER -107.41 138.18 34.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.069 0.461 . . . . 0.0 109.764 178.035 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.6 t -133.64 133.9 42.51 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.135 177.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -71.17 118.24 13.7 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.821 -179.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 55.96 61.48 2.76 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 123.918 0.762 . . . . 0.0 109.683 -175.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -61.31 -40.64 98.9 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.344 -0.844 . . . . 0.0 113.442 -175.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.12 -21.07 32.99 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.947 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.569 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 65.2 mm-40 -64.89 149.23 49.95 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 175.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.463 ' HD3' ' N ' ' A' ' 84' ' ' LYS . 3.7 mppt? -79.56 108.71 9.44 Favored Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.569 ' HD3' ' O ' ' A' ' 83' ' ' GLU . 16.5 Cg_exo -68.76 130.69 21.07 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.61 2.207 . . . . 0.0 112.164 179.019 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.525 ' HB2' HD22 ' A' ' 123' ' ' LEU . 5.1 m-20 -62.61 -38.2 89.25 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.57 174.296 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.772 HG12 ' HA3' ' A' ' 119' ' ' GLY . 3.6 m -136.95 134.29 48.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.592 174.196 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.602 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 30.8 m -113.53 137.19 51.92 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.217 177.403 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.652 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 41.0 m-85 -123.83 127.0 47.42 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.492 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 6.7 m -100.69 126.52 47.21 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 174.071 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.625 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -158.37 151.45 7.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.039 0.447 . . . . 0.0 110.536 -175.565 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.2 m -85.36 143.22 28.77 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.202 0.525 . . . . 0.0 110.977 -177.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.416 ' OD1' HG13 ' A' ' 25' ' ' VAL . 13.5 t70 -49.28 -33.75 13.75 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.625 -1.17 . . . . 0.0 112.121 -178.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -75.5 -32.46 60.55 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.899 -174.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -91.55 -21.27 20.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.904 -177.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.757 HG11 HG12 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -56.74 -33.19 40.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.101 0.477 . . . . 0.0 110.21 -177.855 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.3 m -68.07 -33.75 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.853 -173.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -77.47 -32.35 54.32 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.1 mt -69.39 -49.98 50.29 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.738 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 96' ' ' VAL . 28.3 mt -72.38 -30.38 34.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.577 -176.038 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 39.7 t -86.03 -4.8 59.25 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.671 0.249 . . . . 0.0 111.671 -178.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.03 43.53 16.67 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.301 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -116.03 -43.19 3.0 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.036 0.446 . . . . 0.0 110.898 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.4 tp -97.95 129.56 44.85 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.507 -179.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.522 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 94.4 m-20 -73.63 119.68 77.26 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.054 176.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -66.2 -20.26 56.17 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 121.942 1.762 . . . . 0.0 110.196 176.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -60.83 -57.42 12.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.534 173.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.522 ' HG2' ' HB2' ' A' ' 105' ' ' ASN . 0.2 OUTLIER -70.35 -31.4 68.66 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.901 -178.834 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.643 ' HB3' HD12 ' A' ' 115' ' ' ILE . . . -68.22 -35.59 78.2 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.618 -0.433 . . . . 0.0 109.986 178.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -64.98 -45.88 83.8 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 174.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -63.73 -41.03 98.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.347 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -80.12 7.06 9.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.919 -178.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.23 5.33 89.75 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.94 -0.647 . . . . 0.0 113.605 173.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp -78.91 -48.86 13.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.937 0.398 . . . . 0.0 111.07 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.643 HD12 ' HB3' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -87.72 118.24 33.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.539 -179.257 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.492 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 74.7 mmtt -114.73 98.77 7.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.659 174.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.652 ' HB ' ' CD2' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -114.72 131.29 67.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.264 0.554 . . . . 0.0 110.361 178.735 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -144.5 91.79 2.22 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -177.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.772 ' HA3' HG12 ' A' ' 87' ' ' VAL . . . -160.82 172.28 37.1 Favored Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 119.944 -1.122 . . . . 0.0 113.75 -169.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -48.43 113.32 0.73 Allowed 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.792 0.837 . . . . 0.0 110.978 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 24.7 ptm -60.07 -33.13 71.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.649 -178.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -70.78 -23.35 77.95 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.43 -176.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.554 HD11 ' HA3' ' A' ' 49' ' ' GLY . 1.4 tp -88.17 -46.81 8.96 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.979 0.418 . . . . 0.0 110.478 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.581 ' HB2' HG11 ' A' ' 87' ' ' VAL . . . -70.8 -23.02 62.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.166 -177.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 46.0 mtt -66.02 -28.98 69.28 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.066 173.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.606 ' HA ' ' HB3' ' A' ' 129' ' ' ASP . 9.5 mmtm -66.41 -26.53 67.28 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.45 176.067 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.0 mt -62.01 -38.41 88.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.532 177.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.661 ' O ' ' HG2' ' A' ' 132' ' ' ARG . 12.9 t -90.44 -25.49 20.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.073 0.463 . . . . 0.0 110.397 177.4 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.606 ' HB3' ' HA ' ' A' ' 126' ' ' LYS . 35.3 t70 -60.63 -49.95 75.46 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.781 177.081 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.96 -34.37 74.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.144 -177.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.589 ' HG2' ' O ' ' A' ' 128' ' ' THR . 4.5 pt20 -74.57 -28.12 60.79 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.496 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.661 ' HG2' ' O ' ' A' ' 128' ' ' THR . 24.1 mmt180 -70.94 -40.24 72.18 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 173.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.537 ' HG2' ' O ' ' A' ' 129' ' ' ASP . 34.4 mm-40 -62.12 -41.52 98.32 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.976 174.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.12 -43.63 95.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.097 178.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.97 -34.39 73.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.854 179.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.22 -30.73 8.97 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.036 177.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -107.88 125.54 51.59 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 179.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 7.6 tp -175.37 -43.64 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.859 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -87.32 150.05 24.11 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.43 -173.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 22.8 t -75.11 145.28 42.37 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.85 -176.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 55.1 mt . . . . . 0 C--O 1.247 0.965 0 O-C-N 123.896 0.747 . . . . 0.0 110.574 -178.223 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.794 0 N-CA-C 111.761 -0.536 . . . . 0.0 111.761 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.1 p -72.1 -41.73 66.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.05 0.452 . . . . 0.0 110.752 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.8 m -85.23 171.21 12.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.474 178.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -96.14 166.89 24.78 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.873 -0.679 . . . . 0.0 111.744 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.413 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 58.1 m-20 -70.66 143.58 89.99 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-O 120.903 0.382 . . . . 0.0 110.192 -178.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' A' ' 26' ' ' PHE . 21.5 Cg_exo -61.47 -34.57 85.73 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 123.184 2.589 . . . . 0.0 111.606 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.441 ' HA ' ' CG ' ' A' ' 26' ' ' PHE . 25.8 tt0 -65.53 -35.55 81.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.519 179.08 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -75.45 -4.41 39.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.564 -175.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -85.53 145.05 27.57 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 171.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -73.04 -20.29 61.02 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.975 HG12 HG11 ' A' ' 96' ' ' VAL . 1.0 OUTLIER -73.29 -16.01 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.152 179.126 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.441 ' CG ' ' HA ' ' A' ' 21' ' ' GLU . 80.2 t80 -58.02 -52.32 66.01 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.883 0.373 . . . . 0.0 110.455 -178.117 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -42.98 90.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.278 178.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.471 ' O ' HG12 ' A' ' 31' ' ' ILE . 19.4 m-85 -64.73 -47.75 77.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.165 -0.471 . . . . 0.0 112.097 -177.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.552 ' HB3' HG21 ' A' ' 77' ' ' VAL . 58.6 mtt -71.68 -26.21 62.43 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 122.208 -0.307 . . . . 0.0 111.019 -179.28 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 26' ' ' PHE . 7.8 mmtt -72.07 -35.37 69.24 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.445 175.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.471 HG12 ' O ' ' A' ' 28' ' ' TYR . 14.7 pt -78.93 -21.35 12.79 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.481 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.662 174.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.7 tt -67.17 -48.84 66.78 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 171.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -44.19 -38.59 3.83 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.086 173.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -83.53 -55.6 4.2 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.242 175.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.451 ' HA ' ' HB3' ' A' ' 38' ' ' ASN . . . -55.51 -42.25 74.23 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -167.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 24.0 mmt -56.65 -43.29 80.18 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -178.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -91.68 -25.84 18.92 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.242 179.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.451 ' HB3' ' HA ' ' A' ' 35' ' ' ALA . 46.9 t30 -65.92 -28.33 68.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.04 178.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -52.93 133.54 37.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.689 174.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 23.6 p -59.82 -27.49 66.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.206 -173.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -96.67 -21.29 17.7 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.513 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 35.69 62.48 0.62 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.867 0.841 . . . . 0.0 110.837 -174.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.411 HD22 ' HD3' ' A' ' 46' ' ' LYS . 80.6 mt -72.03 2.79 5.14 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.744 -1.117 . . . . 0.0 111.761 -174.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.414 HG13 ' HB1' ' A' ' 70' ' ' ALA . 3.0 tp -56.01 -27.18 22.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.108 0.48 . . . . 0.0 110.858 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.513 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 49.9 mt-10 -76.08 -13.24 60.21 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.719 -176.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.411 ' HD3' HD22 ' A' ' 43' ' ' LEU . 60.5 mtpt -85.93 -17.02 36.61 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.003 0.43 . . . . 0.0 111.04 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 47' ' ' VAL . 14.0 p -130.69 33.2 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.924 0.869 . . . . 0.0 109.804 -177.004 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.513 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 23.1 mtm180 -52.14 118.07 3.24 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.971 0.891 . . . . 0.0 112.279 -175.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.579 ' HA3' HD11 ' A' ' 123' ' ' LEU . . . -170.13 -174.87 38.62 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 113.8 -1.545 . . . . 0.0 109.751 -178.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.483 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 43.9 mt -121.74 124.84 72.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-N 118.214 1.007 . . . . 0.0 111.545 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.559 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 2.6 m-85 -107.42 109.49 21.22 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.781 -176.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.74 113.41 4.35 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.391 -0.909 . . . . 0.0 111.065 177.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -97.4 111.58 23.78 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.264 0.554 . . . . 0.0 111.647 -178.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -93.76 101.17 13.28 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.439 175.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.716 HG11 HG11 ' A' ' 25' ' ' VAL . 14.2 t -99.17 127.14 52.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.684 -175.311 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 30.2 mtp180 -118.55 -174.1 2.61 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.422 -177.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 61.74 39.93 13.58 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 123.449 0.468 . . . . 0.0 111.195 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.81 -164.47 26.78 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.095 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -39.12 -60.32 0.52 Allowed 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 124.342 3.361 . . . . 0.0 114.062 -176.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -109.88 41.9 1.62 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.065 0.459 . . . . 0.0 110.093 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.21 24.3 76.71 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -170.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.48 162.09 29.66 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 114.708 -0.746 . . . . 0.0 111.471 -175.111 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -124.89 140.74 52.65 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.877 -178.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -127.95 163.48 21.57 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.936 179.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -143.11 121.03 12.0 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 117.217 0.509 . . . . 0.0 111.375 -177.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 24.2 m-90 -125.96 134.29 51.56 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.924 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 40.3 t -99.78 114.4 37.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.247 178.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.66 HG13 HG12 ' A' ' 77' ' ' VAL . 4.1 mp -89.95 100.82 11.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 174.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -84.54 97.31 9.5 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.214 -176.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.414 ' HB1' HG13 ' A' ' 44' ' ' ILE . . . -95.26 -12.13 26.76 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.219 174.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.476 ' HD2' ' HG3' ' A' ' 72' ' ' GLU . 1.6 tmmt? -58.2 -40.85 82.66 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.273 -177.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.476 ' HG3' ' HD2' ' A' ' 71' ' ' LYS . 51.7 mt-10 -91.72 12.15 22.2 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.337 0.589 . . . . 0.0 111.313 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 76.46 11.14 85.37 Favored Glycine 0 C--O 1.228 -0.228 0 CA-C-N 115.402 -0.817 . . . . 0.0 113.394 173.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -91.58 -45.05 8.71 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 122.717 -0.284 . . . . 0.0 111.174 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.97 33.82 62.37 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -176.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 19.8 ptmt -98.35 154.68 17.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.365 -0.418 . . . . 0.0 109.948 -175.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.66 HG12 HG13 ' A' ' 68' ' ' ILE . 0.7 OUTLIER -107.77 137.36 39.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 178.733 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.5 t -140.53 134.18 30.24 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.113 178.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -66.6 116.43 7.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.669 -175.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 65.0 t30 51.17 68.29 0.81 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 123.9 0.75 . . . . 0.0 110.161 -176.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -56.82 -34.59 65.33 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.106 -0.952 . . . . 0.0 113.936 -172.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.47 -16.9 60.34 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -176.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.463 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 16.9 mm-40 -75.62 155.11 36.21 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 175.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -90.88 108.9 31.13 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-O 120.771 0.32 . . . . 0.0 110.194 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.483 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 20.1 Cg_exo -65.78 125.73 14.79 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.925 2.417 . . . . 0.0 112.879 -178.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.549 ' HB2' HD22 ' A' ' 123' ' ' LEU . 13.9 m-20 -65.57 -34.47 78.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.129 -0.942 . . . . 0.0 109.746 174.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.752 HG12 ' HA3' ' A' ' 119' ' ' GLY . 3.6 m -135.57 139.04 47.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.503 175.237 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.579 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 19.0 m -118.14 135.63 54.1 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.598 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 72.6 m-85 -122.58 125.02 44.84 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.585 ' HB ' ' HB3' ' A' ' 116' ' ' LYS . 35.8 m -101.77 114.2 28.06 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 177.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.594 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 73.1 mt -137.87 148.12 25.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.554 -174.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.0 m -85.34 139.25 31.73 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.087 0.47 . . . . 0.0 110.425 176.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.53 ' OD1' HG13 ' A' ' 25' ' ' VAL . 20.9 t70 -47.18 -34.26 6.11 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 114.504 -1.225 . . . . 0.0 112.427 -178.058 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -70.92 -41.74 70.81 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.103 -173.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -91.28 -18.6 24.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.591 -175.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.975 HG11 HG12 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -54.77 -31.55 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 121.121 0.486 . . . . 0.0 110.124 -179.801 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.0 m -67.05 -35.13 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.023 -173.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -77.08 -33.64 57.04 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.415 HD12 HG21 ' A' ' 91' ' ' ILE . 92.5 mt -69.08 -48.09 63.56 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.403 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 96' ' ' VAL . 32.0 mt -66.19 -36.68 77.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.125 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.2 t -75.82 -30.3 58.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.817 0.342 . . . . 0.0 111.2 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 102.8 10.56 37.24 Favored Glycine 0 N--CA 1.453 -0.167 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.876 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -81.11 -40.32 24.24 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.23 0.538 . . . . 0.0 111.0 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.728 HD11 ' NZ ' ' A' ' 108' ' ' LYS . 52.4 tp -101.08 133.78 45.08 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.339 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.418 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 94.1 m-20 -79.34 124.69 84.07 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.292 177.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -64.91 -24.86 60.27 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.124 1.882 . . . . 0.0 110.459 176.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -61.37 -60.18 4.12 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.627 173.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.728 ' NZ ' HD11 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -62.78 -35.11 78.78 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.124 0.487 . . . . 0.0 110.021 -177.763 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.561 ' HB3' HD12 ' A' ' 115' ' ' ILE . . . -70.93 -33.13 70.21 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.025 -177.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -61.27 -48.61 80.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.312 174.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -60.83 -44.01 97.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.943 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.407 ' HG3' ' HE3' ' A' ' 108' ' ' LYS . 74.8 mm-40 -74.39 -12.56 60.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.178 -176.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.77 18.25 45.09 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.158 175.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.35 -24.64 17.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.862 0.363 . . . . 0.0 110.868 176.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.582 HG23 HG22 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -109.79 111.11 34.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.807 0.813 . . . . 0.0 110.144 178.086 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.585 ' HB3' ' HB ' ' A' ' 90' ' ' THR . 13.8 tppt? -110.05 107.5 17.39 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.093 174.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.598 ' HB ' ' CD2' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -126.5 133.85 67.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.257 0.551 . . . . 0.0 110.184 -177.806 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 29.5 tp60 -143.57 92.27 2.34 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -176.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.752 ' HA3' HG12 ' A' ' 87' ' ' VAL . . . -160.37 171.97 36.7 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.092 -1.052 . . . . 0.0 113.258 -170.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -49.11 118.3 2.58 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 124.362 0.683 . . . . 0.0 111.236 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.472 ' O ' ' HB3' ' A' ' 125' ' ' MET . 24.6 ttt -60.31 -35.56 75.9 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.541 -177.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.478 ' HA2' ' SD ' ' A' ' 125' ' ' MET . . . -69.28 -17.62 72.42 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.829 -0.7 . . . . 0.0 111.908 -174.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.579 HD11 ' HA3' ' A' ' 49' ' ' GLY . 2.9 tp -90.79 -58.54 2.45 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.389 0.614 . . . . 0.0 110.073 178.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.649 ' HA ' HD23 ' A' ' 127' ' ' LEU . . . -68.75 -14.59 63.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.25 -175.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.478 ' SD ' ' HA2' ' A' ' 122' ' ' GLY . 25.0 ptm -65.63 -20.85 66.47 Favored 'General case' 0 C--N 1.332 -0.177 0 O-C-N 122.276 -0.265 . . . . 0.0 110.57 177.254 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -79.68 -30.29 41.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.404 0.621 . . . . 0.0 109.334 176.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.649 HD23 ' HA ' ' A' ' 124' ' ' ALA . 0.7 OUTLIER -62.86 -44.62 95.64 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 172.435 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.595 ' O ' ' HG2' ' A' ' 131' ' ' GLN . 6.4 m -61.95 -41.94 98.55 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 113.81 -1.541 . . . . 0.0 111.599 173.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.674 ' O ' ' HG2' ' A' ' 132' ' ' ARG . 25.9 t70 -53.89 -35.73 61.91 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.138 0.575 . . . . 0.0 111.738 -177.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.5 mt -58.83 -17.2 21.59 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -176.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.595 ' HG2' ' O ' ' A' ' 128' ' ' THR . 20.1 pt20 -63.36 -30.82 71.89 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -177.168 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.674 ' HG2' ' O ' ' A' ' 129' ' ' ASP . 15.3 ptt180 -65.48 -33.36 75.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.272 0.558 . . . . 0.0 110.055 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -79.86 -38.05 33.58 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.95 177.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.91 -46.54 68.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.993 -177.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -88.11 -25.83 22.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.914 0.387 . . . . 0.0 111.516 -177.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.35 6.51 83.9 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.226 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -101.06 126.71 47.76 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.941 0.401 . . . . 0.0 110.097 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.9 mp -101.46 -67.22 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.133 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -102.17 163.72 12.08 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.658 -176.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 6.9 t -146.41 53.96 1.13 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.246 0.546 . . . . 0.0 109.69 177.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 6.8 pt . . . . . 0 C--O 1.25 1.094 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.727 -178.813 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.823 0 N-CA-C 111.947 -0.461 . . . . 0.0 111.947 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.0 t -74.79 111.84 10.4 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.816 0.341 . . . . 0.0 110.673 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.9 m -67.05 136.71 55.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.275 177.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.414 ' H ' ' HB2' ' A' ' 62' ' ' ALA . . . -67.32 125.48 24.05 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.423 178.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.401 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 43.1 m-80 -72.28 148.29 90.96 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 120.866 0.365 . . . . 0.0 110.229 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.507 ' HA ' ' CD1' ' A' ' 23' ' ' PHE . 14.2 Cg_exo -64.46 -28.88 62.29 Favored 'Trans proline' 0 CA--C 1.518 -0.317 0 C-N-CA 123.276 2.651 . . . . 0.0 111.802 -177.039 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -65.9 -35.22 80.02 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.261 177.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -73.38 -14.62 61.31 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.562 -178.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.507 ' CD1' ' HA ' ' A' ' 20' ' ' PRO . 23.5 m-85 -66.25 148.76 51.36 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.404 0.621 . . . . 0.0 110.378 176.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -74.06 -26.36 60.35 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 176.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.857 HG12 HG11 ' A' ' 96' ' ' VAL . 0.8 OUTLIER -73.9 -15.51 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.97 -179.009 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -56.74 -50.04 73.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.768 0.318 . . . . 0.0 110.307 -177.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.452 ' HE2' HG23 ' A' ' 31' ' ' ILE . 1.1 tpmt? -72.7 -38.23 67.6 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.863 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -64.72 -50.91 65.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.569 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.584 ' HB3' HG21 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -62.9 -31.53 72.6 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.834 0.349 . . . . 0.0 110.928 177.289 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.423 ' HD2' ' HA ' ' A' ' 30' ' ' LYS . 21.6 mmmt -70.76 -37.81 73.43 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 178.154 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.452 HG23 ' HE2' ' A' ' 27' ' ' LYS . 10.5 pt -84.13 -19.69 9.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.133 176.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.6 tt -60.58 -46.85 88.69 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 171.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -46.85 -48.48 20.97 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.777 175.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -73.96 -50.41 20.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.706 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.89 -36.88 80.38 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -169.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 33.1 mmt -59.63 -44.11 93.58 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.587 0.217 . . . . 0.0 111.587 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -91.4 -8.36 48.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.19 0.519 . . . . 0.0 110.723 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -73.69 -23.36 59.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.037 0.446 . . . . 0.0 109.984 178.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -59.14 132.16 53.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.772 175.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 13.9 p -57.44 -37.42 72.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.562 -173.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -101.57 9.95 40.73 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 119.306 -0.378 . . . . 0.0 110.96 178.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.545 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 19.0 p-10 25.52 70.37 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.114 0.965 . . . . 0.0 111.275 -173.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.7 mt -58.4 -4.45 0.39 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 114.414 -1.267 . . . . 0.0 111.921 -176.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.55 HG13 ' HB1' ' A' ' 70' ' ' ALA . 4.2 tp -60.75 -25.42 35.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.663 178.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 42' ' ' ASN . 10.9 pt-20 -76.51 -16.7 59.57 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.237 -179.283 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -95.53 -13.24 24.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.263 0.554 . . . . 0.0 110.731 -177.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 47' ' ' VAL . 11.9 p -130.43 32.24 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.845 0.831 . . . . 0.0 109.562 -177.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 55.6 mtt180 -52.49 117.11 2.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.397 -175.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.564 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . -167.16 164.76 38.12 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.221 -178.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.524 HG13 ' HB2' ' A' ' 71' ' ' LYS . 63.8 mt -103.13 124.93 57.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 117.217 0.509 . . . . 0.0 109.988 176.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.512 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 37.3 m-85 -105.72 115.66 30.62 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.203 -176.363 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.97 111.35 4.23 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.396 -0.907 . . . . 0.0 110.835 177.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.445 ' O ' ' HA ' ' A' ' 65' ' ' TYR . 7.5 m-85 -98.18 108.37 21.06 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.024 0.44 . . . . 0.0 111.594 -178.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -95.71 99.69 11.5 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.638 175.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.725 HG11 HG11 ' A' ' 25' ' ' VAL . 17.4 t -98.12 119.78 46.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.782 -174.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -108.89 179.07 4.28 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.123 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.458 ' HB2' ' HB3' ' A' ' 92' ' ' SER . 3.3 m-20 60.23 42.23 15.53 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.93 0.395 . . . . 0.0 111.125 177.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.11 -166.59 28.93 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.572 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -31.5 -60.49 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 124.946 3.764 . . . . 0.0 114.404 -176.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -120.06 48.07 1.63 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.17 30.04 65.73 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -174.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.414 ' HB2' ' H ' ' A' ' 18' ' ' GLY . . . -81.47 165.46 21.21 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.224 0.535 . . . . 0.0 111.356 -176.13 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -132.7 125.74 30.96 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.129 -0.942 . . . . 0.0 110.856 -178.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -115.14 164.13 12.14 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.317 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 30.9 t80 -147.36 118.34 7.68 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.854 0.359 . . . . 0.0 110.624 -178.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 22.3 m-90 -122.99 132.07 53.98 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.992 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 46.6 t -100.89 117.61 46.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.224 177.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.549 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 4.1 mp -95.31 104.97 16.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.062 0.458 . . . . 0.0 109.88 176.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.448 HD21 ' HG3' ' A' ' 72' ' ' GLU . 19.1 t-20 -79.42 99.38 7.16 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.142 177.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -111.1 -1.68 16.14 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 172.267 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.524 ' HB2' HG13 ' A' ' 50' ' ' ILE . 2.2 tppp? -67.55 -38.09 83.66 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.385 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.448 ' HG3' HD21 ' A' ' 69' ' ' ASN . 42.6 mt-10 -84.79 -1.63 56.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.234 176.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.02 20.92 69.14 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.618 178.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -89.92 -37.53 14.33 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.953 0.406 . . . . 0.0 111.057 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.13 32.14 76.05 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.883 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 19.7 ptmt -98.7 163.1 12.78 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -177.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.584 HG21 ' HB3' ' A' ' 29' ' ' MET . 0.8 OUTLIER -124.42 139.64 50.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.784 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.0 t -135.38 134.7 40.01 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.284 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -68.65 119.23 12.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.975 -178.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 52.43 69.87 0.63 Allowed 'General case' 0 N--CA 1.464 0.258 0 O-C-N 123.745 0.653 . . . . 0.0 109.732 -175.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.37 -40.71 91.64 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.708 -0.678 . . . . 0.0 113.822 -173.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.63 -20.79 48.06 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.609 -177.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.539 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 34.8 mt-10 -65.86 143.26 57.57 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.468 -0.366 . . . . 0.0 110.085 175.46 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 24.5 pttm -78.64 108.82 8.8 Favored Pre-proline 0 N--CA 1.449 -0.525 0 CA-C-O 121.341 0.591 . . . . 0.0 110.278 175.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.539 ' HD3' ' O ' ' A' ' 83' ' ' GLU . 12.6 Cg_exo -71.36 129.18 15.54 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.581 2.187 . . . . 0.0 111.949 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -59.25 -31.67 69.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.184 174.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.603 HG11 ' HB2' ' A' ' 124' ' ' ALA . 2.7 m -141.12 128.9 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.629 175.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.749 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 35.5 m -118.13 121.85 41.58 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.885 177.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.432 ' HA ' ' HB ' ' A' ' 117' ' ' ILE . 5.5 m-85 -106.5 131.76 53.31 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -178.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.448 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 5.4 m -103.77 127.26 51.26 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 173.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.519 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -161.4 155.9 3.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -174.79 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.458 ' HB3' ' HB2' ' A' ' 57' ' ' ASN . 15.5 m -85.19 145.56 27.53 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.31 0.576 . . . . 0.0 111.502 -175.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -51.07 -32.35 21.81 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.734 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -73.68 -35.54 65.21 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.982 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.439 ' OD2' ' HB2' ' A' ' 92' ' ' SER . 12.3 m-20 -90.59 -22.55 21.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.535 -173.045 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.857 HG11 HG12 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -57.36 -33.06 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 121.086 0.47 . . . . 0.0 110.446 -178.155 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.5 m -68.09 -27.68 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.241 -170.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -86.54 -30.21 22.09 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 177.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.45 HD23 ' O ' ' A' ' 104' ' ' LEU . 77.2 mt -67.74 -45.82 73.9 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.201 0.524 . . . . 0.0 110.578 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 96' ' ' VAL . 23.5 mt -75.8 -23.26 16.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.381 -176.238 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 27.7 p -85.54 -22.4 28.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.811 0.339 . . . . 0.0 110.839 178.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 96.97 8.33 56.94 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.934 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -80.42 -41.01 25.31 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.149 0.499 . . . . 0.0 111.131 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.45 ' O ' HD23 ' A' ' 99' ' ' LEU . 42.2 tp -102.78 120.7 41.05 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.844 -178.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -69.41 124.46 90.53 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.207 175.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.485 ' HA ' ' HB3' ' A' ' 109' ' ' ALA . 1.0 OUTLIER -70.1 -14.11 34.6 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 121.816 1.678 . . . . 0.0 110.564 177.452 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -66.13 -58.42 5.47 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.257 171.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.518 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 1.1 ptmt -66.65 -31.46 72.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.653 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.518 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -66.8 -31.53 72.22 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.905 177.194 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.765 ' HA ' HG22 ' A' ' 115' ' ' ILE . 23.7 t80 -66.09 -50.85 62.65 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.047 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -63.27 -34.21 77.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.331 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -85.27 11.15 10.63 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.65 15.12 73.13 Favored Glycine 0 CA--C 1.517 0.185 0 C-N-CA 121.218 -0.515 . . . . 0.0 113.133 175.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -85.3 -45.07 12.29 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.91 0.386 . . . . 0.0 110.554 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.765 HG22 ' HA ' ' A' ' 110' ' ' PHE . 0.6 OUTLIER -97.39 122.96 49.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.93 -178.208 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.448 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 29.5 mmmt -120.71 99.34 6.48 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 173.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.749 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.2 OUTLIER -130.8 139.47 51.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.275 0.559 . . . . 0.0 111.68 -170.34 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.552 ' O ' HG12 ' A' ' 87' ' ' VAL . 61.4 tt0 -75.96 85.23 2.87 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.793 175.207 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -70.02 107.0 1.98 Allowed Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.828 -0.624 . . . . 0.0 113.26 -170.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -80.64 118.59 22.34 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 174.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 61.3 ttp -57.28 -35.97 70.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.688 -171.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -90.52 -44.7 4.53 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.02 -1.086 . . . . 0.0 112.956 -177.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.551 HD11 ' HA3' ' A' ' 49' ' ' GLY . 6.1 tt -77.41 -47.88 18.65 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.696 0.284 . . . . 0.0 111.496 -172.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.603 ' HB2' HG11 ' A' ' 87' ' ' VAL . . . -73.0 -20.52 61.0 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.486 -174.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 32.2 mtt -68.69 -18.54 64.28 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 120.872 0.368 . . . . 0.0 111.002 177.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.458 ' O ' ' HG ' ' A' ' 130' ' ' LEU . 2.1 mptm? -79.99 -27.31 39.65 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.489 175.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 78.2 mt -64.2 -42.0 96.82 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 174.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.536 ' O ' ' HG3' ' A' ' 132' ' ' ARG . 18.5 p -73.71 -30.41 62.84 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.172 -179.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -69.16 -36.19 77.11 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.264 177.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 126' ' ' LYS . 6.9 mt -65.65 -45.85 81.42 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.469 177.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.536 ' HA ' ' HB3' ' A' ' 134' ' ' ALA . 21.1 pt20 -65.54 -19.28 65.86 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.114 -176.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.536 ' HG3' ' O ' ' A' ' 128' ' ' THR . 85.1 mtp180 -55.38 -46.89 76.49 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.04 0.448 . . . . 0.0 110.313 175.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -90.26 -33.12 16.26 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.741 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.536 ' HB3' ' HA ' ' A' ' 131' ' ' GLN . . . -65.53 -35.43 80.83 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.683 -178.116 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -87.04 -8.02 57.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.263 0.554 . . . . 0.0 110.713 177.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 63.03 39.33 97.92 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.189 -0.914 . . . . 0.0 113.443 175.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.501 ' HG2' ' O ' ' A' ' 132' ' ' ARG . 15.3 ptm180 -69.47 117.28 10.89 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 117.037 0.419 . . . . 0.0 110.299 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.449 ' HB ' ' O ' ' A' ' 137' ' ' ARG . 29.5 mm 71.06 -73.54 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.923 -174.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -101.28 125.35 47.9 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.164 0.507 . . . . 0.0 110.74 -177.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 13.6 t -142.17 60.13 1.46 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.297 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 13.9 pt . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.158 -0.925 . . . . 0.0 111.016 -178.751 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.842 0 N-CA-C 112.052 -0.419 . . . . 0.0 112.052 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.7 t -79.69 -30.63 41.14 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.016 0.436 . . . . 0.0 110.333 -178.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.6 p -71.55 142.02 50.07 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.578 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.45 161.2 21.9 Favored Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.827 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -52.72 130.63 46.72 Favored Pre-proline 0 CA--C 1.518 -0.287 0 CA-C-O 121.968 0.889 . . . . 0.0 111.496 -176.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.445 ' HA ' ' CD1' ' A' ' 23' ' ' PHE . 38.0 Cg_endo -69.63 -15.9 37.82 Favored 'Trans proline' 0 C--N 1.329 -0.46 0 C-N-CA 123.956 3.104 . . . . 0.0 112.068 -177.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -75.01 -28.86 60.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.507 -177.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -82.83 -7.54 59.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.957 -176.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.445 ' CD1' ' HA ' ' A' ' 20' ' ' PRO . 40.3 m-85 -73.12 146.49 45.68 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 174.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.438 ' HD3' HG11 ' A' ' 97' ' ' VAL . 78.6 tttt -78.46 -21.76 48.6 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.898 HG12 HG11 ' A' ' 96' ' ' VAL . 1.3 m -71.83 -13.68 16.94 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.535 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.648 175.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -56.51 -58.17 9.17 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.135 -0.321 . . . . 0.0 110.135 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.35 -42.55 96.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.161 0.505 . . . . 0.0 110.494 178.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.528 ' HB3' HD12 ' A' ' 100' ' ' ILE . 18.0 m-85 -65.81 -42.04 91.13 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.613 -175.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.43 ' CE ' HD11 ' A' ' 68' ' ' ILE . 67.5 mtp -80.16 -24.29 40.49 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.117 -0.365 . . . . 0.0 110.354 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.413 ' HD3' ' HA ' ' A' ' 30' ' ' LYS . 50.5 mmtt -66.61 -41.53 88.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.506 173.414 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.471 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 4.8 pt -78.97 -26.08 13.23 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.56 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.188 176.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.408 ' C ' HD23 ' A' ' 32' ' ' LEU . 6.1 tt -55.15 -51.56 66.08 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 170.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.51 ' HG2' ' HA ' ' A' ' 76' ' ' LYS . 0.7 OUTLIER -47.24 -53.91 12.14 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.962 177.748 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 31' ' ' ILE . 7.6 pt-20 -74.01 -39.4 63.63 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.288 -175.344 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.01 -37.46 85.95 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.661 -174.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 19.8 mmt -58.48 -44.18 89.25 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.645 0.26 . . . . 0.0 111.543 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -91.24 -7.89 49.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.932 0.396 . . . . 0.0 110.578 177.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 22.0 t-20 -64.94 -34.56 78.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.304 -178.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -61.12 132.27 53.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.653 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.55 -24.85 65.72 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.463 -175.149 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -102.27 10.83 38.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 119.463 -0.304 . . . . 0.0 111.562 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 26.2 p30 30.86 70.8 0.08 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.382 1.073 . . . . 0.0 112.248 178.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.8 mt -62.64 -2.81 1.22 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.128 -174.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.8 tp -64.02 -27.45 42.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.274 0.559 . . . . 0.0 110.288 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -63.5 -25.62 68.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.396 -177.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -81.81 -19.75 40.51 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.164 -177.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.501 HG11 ' HB3' ' A' ' 126' ' ' LYS . 1.3 m -129.65 32.31 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.791 -175.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 72.3 mtt180 -49.45 112.03 0.58 Allowed 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.763 0.792 . . . . 0.0 111.04 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.518 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . -178.28 161.57 28.44 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.705 -175.12 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.565 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 64.9 mt -96.57 126.88 49.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 117.28 0.54 . . . . 0.0 110.865 -178.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.446 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 9.4 m-85 -106.07 118.89 37.79 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.708 -179.181 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.28 113.92 4.85 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.514 -0.85 . . . . 0.0 111.327 177.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -101.26 110.47 22.49 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.122 0.487 . . . . 0.0 111.694 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -94.3 99.75 11.92 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.312 174.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.804 HG11 HG11 ' A' ' 25' ' ' VAL . 19.9 t -100.83 112.49 33.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.045 0.45 . . . . 0.0 110.878 -174.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 76.2 mtp85 -104.05 179.71 4.19 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.577 -177.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 64.68 37.29 7.71 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 123.348 0.405 . . . . 0.0 111.311 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.38 -161.17 9.26 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.796 178.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -34.74 -60.72 0.27 Allowed 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 124.605 3.537 . . . . 0.0 114.493 -174.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -115.89 38.49 3.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.38 0.61 . . . . 0.0 110.343 178.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 78.38 24.46 63.21 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -171.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.79 156.34 39.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.14 -0.53 . . . . 0.0 110.725 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -118.3 116.0 25.86 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.182 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.41 161.09 16.27 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.019 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -145.95 118.83 8.7 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.977 0.418 . . . . 0.0 110.897 -176.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.402 ' CE2' ' HD1' ' A' ' 79' ' ' TYR . 20.9 m-90 -121.23 136.27 55.0 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.812 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 39.0 t -106.19 117.23 51.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.555 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.65 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 3.7 mp -93.56 99.79 10.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 175.39 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -86.25 98.35 10.89 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.348 -177.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -109.3 6.94 24.97 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.177 175.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.54 ' HB2' HG13 ' A' ' 50' ' ' ILE . 5.4 tppp? -60.49 -42.97 97.38 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.522 -178.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -94.27 5.34 52.06 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.223 -178.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.8 -13.51 59.21 Favored Glycine 0 C--N 1.318 -0.431 0 CA-C-N 115.703 -0.68 . . . . 0.0 113.63 174.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.43 -67.05 0.42 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.87 34.7 14.56 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 119.797 -1.192 . . . . 0.0 111.249 -175.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.65 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 54.6 pttt -98.0 148.64 23.28 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 -177.267 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.401 HG12 HG13 ' A' ' 68' ' ' ILE . 0.8 OUTLIER -107.04 135.12 46.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 177.652 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.4 t -140.11 132.86 29.03 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.606 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.402 ' HD1' ' CE2' ' A' ' 66' ' ' TRP . 45.5 t80 -68.93 121.42 16.56 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 56.49 74.75 0.38 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.552 0.692 . . . . 0.0 109.474 -173.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.86 -41.18 73.77 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.916 -176.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.45 -13.58 61.79 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.93 -179.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.513 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 12.9 mm-40 -81.15 159.41 24.66 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 177.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -87.68 109.08 23.92 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 123.18 0.3 . . . . 0.0 110.518 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.565 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 18.0 Cg_exo -67.26 134.2 32.95 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.815 2.343 . . . . 0.0 112.787 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -66.95 -33.26 75.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.493 -0.776 . . . . 0.0 108.949 172.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.742 HG12 ' HA3' ' A' ' 119' ' ' GLY . 8.5 m -140.58 134.27 33.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.256 178.088 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.632 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 27.9 m -119.4 132.77 55.89 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 175.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.524 ' CD1' ' HB ' ' A' ' 117' ' ' ILE . 68.2 m-85 -119.4 125.79 49.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.219 -179.053 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.437 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 25.4 m -99.83 126.16 45.89 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 173.238 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.554 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -157.31 144.26 9.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.888 -176.342 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.14 141.97 41.76 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.451 178.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.486 ' OD1' HG13 ' A' ' 25' ' ' VAL . 22.3 t70 -49.13 -27.47 3.5 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.707 1.203 . . . . 0.0 111.986 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -78.08 -34.44 50.27 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.226 -174.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -90.99 -20.45 22.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.239 -175.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.898 HG11 HG12 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -57.92 -31.73 41.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.023 -175.116 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.438 HG11 ' HD3' ' A' ' 24' ' ' LYS . 4.9 m -63.91 -29.53 47.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.461 -170.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -81.87 -32.63 30.98 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.505 HD23 ' O ' ' A' ' 104' ' ' LEU . 91.6 mt -69.36 -42.86 74.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.381 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.528 HD12 ' HB3' ' A' ' 28' ' ' TYR . 1.6 mm -65.34 -25.67 37.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.681 178.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.6 t -96.86 -11.41 24.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.646 -176.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.49 9.86 82.77 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.128 -177.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -77.76 -42.35 34.42 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.266 0.555 . . . . 0.0 110.261 178.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.505 ' O ' HD23 ' A' ' 99' ' ' LEU . 48.3 tp -100.02 125.1 46.03 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.723 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.529 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 6.1 m-20 -77.34 124.19 86.96 Favored Pre-proline 0 C--N 1.317 -0.805 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.013 178.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.416 ' HD3' ' NE2' ' A' ' 131' ' ' GLN . 2.6 Cg_exo -64.99 -22.28 62.74 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.022 1.815 . . . . 0.0 110.529 179.219 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -64.24 -56.7 12.84 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.133 173.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.529 ' HG2' ' HB2' ' A' ' 105' ' ' ASN . 0.1 OUTLIER -67.75 -31.37 71.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.078 -178.514 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.547 ' HB3' HD12 ' A' ' 115' ' ' ILE . . . -69.91 -32.79 71.28 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 177.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -62.51 -52.13 64.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.595 174.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -63.16 -42.14 99.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.88 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 75.5 mm-40 -71.33 -7.68 48.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.883 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 95.76 -5.02 66.45 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.667 -0.777 . . . . 0.0 113.432 173.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.408 ' HD2' ' HA ' ' A' ' 114' ' ' LYS . 28.3 mmmt -68.38 -53.16 25.75 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.95 0.405 . . . . 0.0 111.43 177.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.676 HG23 HG22 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -85.94 116.72 29.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.653 0.74 . . . . 0.0 111.038 -175.35 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.437 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 33.7 mmtp -108.37 104.27 13.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.987 175.046 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.676 HG22 HG23 ' A' ' 115' ' ' ILE . 0.1 OUTLIER -125.57 141.58 44.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.145 0.498 . . . . 0.0 111.101 -177.686 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -142.66 83.1 1.8 Allowed 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -177.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.742 ' HA3' HG12 ' A' ' 87' ' ' VAL . . . -161.05 172.56 37.34 Favored Glycine 0 N--CA 1.44 -1.059 0 C-N-CA 120.399 -0.905 . . . . 0.0 113.044 -170.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -49.31 117.01 1.94 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.522 0.677 . . . . 0.0 110.522 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -61.7 -51.13 69.68 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.994 -171.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -65.67 -26.97 72.21 Favored Glycine 0 CA--C 1.511 -0.163 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.764 -175.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.445 HD11 ' HA3' ' A' ' 49' ' ' GLY . 5.8 tt -72.54 -41.34 65.93 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.028 -0.586 . . . . 0.0 110.258 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.661 ' HB2' HG11 ' A' ' 87' ' ' VAL . . . -87.04 -28.48 22.57 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -177.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 68.7 mtm -67.71 -17.94 64.74 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.687 0.28 . . . . 0.0 111.618 -177.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.501 ' HB3' HG11 ' A' ' 47' ' ' VAL . 22.5 tptm -80.63 -30.63 36.69 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 175.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.0 mt -60.66 -44.68 96.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.757 -178.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.4 t -69.77 -26.36 64.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.904 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -80.84 -33.09 34.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.594 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.9 mt -56.59 -38.66 72.32 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.824 178.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.416 ' NE2' ' HD3' ' A' ' 106' ' ' PRO . 9.9 pt20 -77.11 -19.31 57.13 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.011 -178.274 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 52.6 mtp180 -65.47 -44.75 86.2 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 174.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -64.45 -41.01 96.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.351 177.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.39 -37.93 88.48 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.264 -178.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.46 -32.61 71.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.961 0.41 . . . . 0.0 110.77 178.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 93.95 -27.14 13.64 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.306 177.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 60.59 88.03 0.08 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.238 0.542 . . . . 0.0 110.745 -178.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 1.9 mp -81.33 -62.25 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.104 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -100.58 160.3 14.46 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.232 -178.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 22.8 t -134.75 93.74 3.07 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.015 0.436 . . . . 0.0 110.533 -178.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 6.9 tt . . . . . 0 C--O 1.246 0.876 0 CA-C-O 118.106 -0.95 . . . . 0.0 109.891 174.927 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.654 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.4 m -118.4 34.07 5.35 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.016 0.436 . . . . 0.0 110.627 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.0 m -129.82 -174.34 3.28 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.857 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.19 173.36 54.01 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.423 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.513 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 82.0 m-20 -63.01 131.49 94.73 Favored Pre-proline 0 CA--C 1.514 -0.418 0 CA-C-O 121.575 0.702 . . . . 0.0 110.509 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -68.54 -18.37 43.2 Favored 'Trans proline' 0 C--N 1.327 -0.598 0 C-N-CA 123.745 2.964 . . . . 0.0 112.346 -176.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.412 ' HA ' ' CG ' ' A' ' 26' ' ' PHE . 15.0 mt-10 -84.05 -27.29 28.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.438 -177.327 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.513 ' OD2' ' HB2' ' A' ' 19' ' ' ASN . 42.9 m-20 -76.49 -9.4 58.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.13 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -73.31 145.55 45.95 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.756 174.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -76.04 -17.7 59.55 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.759 HG12 HG11 ' A' ' 96' ' ' VAL . 1.2 m -78.02 -15.87 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.267 177.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.412 ' CG ' ' HA ' ' A' ' 21' ' ' GLU . 78.7 t80 -54.74 -55.93 24.7 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 123.123 0.264 . . . . 0.0 110.73 -174.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.459 ' O ' HG23 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -65.72 -35.33 80.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.647 -179.072 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.443 ' HB3' HD12 ' A' ' 100' ' ' ILE . 12.7 m-85 -66.89 -48.52 68.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.529 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 63.7 mtt -70.7 -30.79 67.45 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.017 178.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.423 ' HD2' ' HA ' ' A' ' 30' ' ' LYS . 27.7 mmmt -67.02 -34.74 78.38 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.236 176.353 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.459 HG23 ' O ' ' A' ' 27' ' ' LYS . 12.6 pt -86.55 -18.57 8.57 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.798 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.389 175.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.1 tt -63.74 -52.19 61.56 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 169.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.516 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 21.1 tt0 -42.11 -53.18 4.07 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.239 -1.346 . . . . 0.0 111.32 171.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -73.51 -62.45 1.48 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.336 -1.302 . . . . 0.0 112.175 -176.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.418 ' HA ' ' HB3' ' A' ' 38' ' ' ASN . . . -54.91 -42.63 72.43 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -169.081 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.6 mmt -61.21 -37.84 84.44 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -176.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -91.8 -23.54 19.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.139 0.495 . . . . 0.0 110.162 178.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.418 ' HB3' ' HA ' ' A' ' 35' ' ' ALA . 26.7 t-20 -64.28 -32.93 74.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.219 178.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -54.7 134.59 47.38 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.614 175.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.9 p -63.08 -28.97 70.45 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.539 -176.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -81.96 -25.16 35.06 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.652 176.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.9 p30 36.96 73.62 0.09 Allowed 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.984 0.897 . . . . 0.0 110.728 -174.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.453 ' O ' HG12 ' A' ' 47' ' ' VAL . 66.9 mt -63.16 -3.11 1.6 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.717 -175.062 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.473 HG13 ' HB1' ' A' ' 70' ' ' ALA . 4.1 tp -60.28 -26.48 36.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.268 -177.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.423 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 25.8 mt-10 -83.08 -14.49 53.63 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 120.823 0.344 . . . . 0.0 111.141 -178.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -92.65 -13.93 28.82 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.267 0.556 . . . . 0.0 110.183 178.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 47' ' ' VAL . 13.9 p -130.11 32.69 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.867 0.842 . . . . 0.0 109.872 -177.295 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.423 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 60.1 mtt180 -52.51 111.65 0.68 Allowed 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.556 -178.404 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.655 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . -175.37 147.56 8.95 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.818 -176.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.53 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 66.7 mt -89.18 126.94 42.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 117.39 0.595 . . . . 0.0 110.794 -177.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.496 ' CE1' HD21 ' A' ' 127' ' ' LEU . 5.0 m-85 -104.31 116.54 32.33 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.758 -177.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.96 111.58 4.28 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.116 177.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -100.48 103.43 14.78 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.164 0.507 . . . . 0.0 111.568 -178.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -88.36 99.5 12.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.397 175.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 10.8 t -98.13 134.92 34.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.127 -177.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 31.7 mtp-105 -125.58 175.78 7.32 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.475 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 57.51 42.88 23.68 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 123.426 0.454 . . . . 0.0 111.758 177.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.12 -160.52 8.24 Favored Glycine 0 CA--C 1.521 0.423 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.621 177.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -37.93 -60.82 0.4 Allowed 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 124.284 3.323 . . . . 0.0 113.737 -177.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.454 ' OD1' ' HB2' ' A' ' 62' ' ' ALA . 28.6 p-10 -109.52 34.92 3.53 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.295 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.38 28.54 59.66 Favored Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -173.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.454 ' HB2' ' OD1' ' A' ' 60' ' ' ASN . . . -76.45 146.91 38.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.662 0.744 . . . . 0.0 112.168 -175.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -108.4 108.16 19.01 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.186 176.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -100.58 152.55 19.16 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -137.76 116.47 12.21 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 117.089 0.445 . . . . 0.0 110.905 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 24.3 m-90 -119.3 139.84 51.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.709 178.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 30.5 t -109.85 113.43 44.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.152 178.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.495 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 3.9 mp -91.46 102.61 13.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.01 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -85.62 98.03 10.43 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.341 0.591 . . . . 0.0 110.341 -176.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -97.4 -4.5 38.19 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.758 174.187 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.447 ' HB2' HG13 ' A' ' 50' ' ' ILE . 15.8 tppt? -63.5 -42.74 98.51 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.162 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -73.71 -6.59 47.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.237 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.58 12.28 81.93 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.929 -177.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -91.37 -52.48 4.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.686 0.279 . . . . 0.0 110.766 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.84 34.45 24.56 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.349 -0.929 . . . . 0.0 111.504 -177.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.516 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 21.8 ptmt -97.54 150.42 21.12 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -176.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -108.02 125.38 64.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.312 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.449 HG23 ' HA2' ' A' ' 81' ' ' GLY . 3.8 t -128.38 134.49 48.85 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.784 -178.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -63.24 125.38 23.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.213 -176.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 74.08 -42.05 0.5 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.833 0.853 . . . . 0.0 111.699 -178.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.449 ' HA2' HG23 ' A' ' 78' ' ' THR . . . 70.82 -43.09 0.6 Allowed Glycine 0 CA--C 1.519 0.302 0 N-CA-C 114.483 0.553 . . . . 0.0 114.483 177.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 69.32 17.25 72.13 Favored Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 -174.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.404 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 38.7 mm-40 -117.82 162.94 17.28 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 122.576 0.35 . . . . 0.0 110.332 -176.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 95.4 mttt -95.34 109.04 42.97 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.98 176.147 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.53 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 17.2 Cg_exo -68.09 133.74 29.71 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.888 2.392 . . . . 0.0 112.73 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -65.32 -32.58 74.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.5 174.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.598 HG12 ' HA3' ' A' ' 119' ' ' GLY . 4.9 m -141.02 132.77 29.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.552 173.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.673 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 86.3 m -115.92 131.1 57.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.318 176.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.534 ' CD1' ' HB ' ' A' ' 117' ' ' ILE . 75.8 m-85 -116.56 123.55 47.65 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.003 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.438 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 3.5 m -99.7 119.74 38.59 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 176.244 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 59.0 mt -143.86 154.22 15.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -174.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.461 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 37.5 m -89.25 144.25 26.24 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.505 175.284 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -42.38 -52.09 4.7 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.378 0.671 . . . . 0.0 111.968 -177.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.97 -42.35 89.73 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.162 -176.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.461 ' OD2' ' HB2' ' A' ' 92' ' ' SER . 7.8 m-20 -80.4 -21.67 42.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.594 0.235 . . . . 0.0 111.535 -173.061 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.759 HG11 HG12 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -58.62 -34.23 50.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.085 -176.463 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.1 m -68.09 -30.46 48.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.22 -171.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -81.14 -33.46 33.15 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 177.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.477 HD23 ' O ' ' A' ' 104' ' ' LEU . 74.0 mt -69.77 -47.91 61.2 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.011 -177.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 96' ' ' VAL . 25.5 mt -70.34 -26.03 28.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.055 -178.061 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 27.3 t -88.2 -8.67 54.97 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.512 -178.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.51 19.6 61.75 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.322 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -94.2 -41.76 9.31 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.096 0.474 . . . . 0.0 110.979 -178.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.736 HD11 ' NZ ' ' A' ' 108' ' ' LYS . 37.6 tp -101.1 128.74 47.04 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.334 179.014 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.637 ' OD1' ' HB2' ' A' ' 107' ' ' GLN . 2.8 t-20 -69.68 122.33 85.45 Favored Pre-proline 0 C--N 1.321 -0.63 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.057 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -68.39 -24.44 36.9 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.896 1.731 . . . . 0.0 110.692 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.637 ' HB2' ' OD1' ' A' ' 105' ' ' ASN . 1.7 mp0 -64.83 -59.15 4.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.453 173.479 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.736 ' NZ ' HD11 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -60.41 -37.93 82.4 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.818 -179.365 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.533 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -68.83 -34.88 76.23 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.553 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.428 ' CD2' HG22 ' A' ' 115' ' ' ILE . 20.3 t80 -62.23 -52.93 61.78 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 174.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -56.9 -42.25 79.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.094 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -74.97 -1.69 23.75 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.963 -177.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 96.5 -12.94 66.07 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.32 173.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -62.41 -61.17 2.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.061 0.458 . . . . 0.0 111.77 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.605 HG23 HG22 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -80.85 121.8 34.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.062 -175.253 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.438 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 35.9 mmtm -115.4 99.63 7.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.319 172.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.673 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER -116.31 135.32 56.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.092 0.472 . . . . 0.0 110.155 177.631 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -144.01 80.26 1.65 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -174.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.598 ' HA3' HG12 ' A' ' 87' ' ' VAL . . . -160.47 173.89 37.1 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.324 -169.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -48.88 110.76 0.39 Allowed 'General case' 0 C--N 1.328 -0.327 0 O-C-N 124.066 0.51 . . . . 0.0 110.28 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.556 ' O ' ' HG3' ' A' ' 125' ' ' MET . 0.0 OUTLIER -65.1 -35.08 80.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.707 -173.96 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -70.0 -32.8 69.67 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.2 -178.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.494 ' O ' HD23 ' A' ' 127' ' ' LEU . 5.3 tt -71.07 -44.44 65.73 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.515 ' HB2' HG11 ' A' ' 87' ' ' VAL . . . -71.79 -15.5 62.16 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.21 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.556 ' HG3' ' O ' ' A' ' 121' ' ' MET . 78.2 mtp -68.34 -24.38 64.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.738 0.304 . . . . 0.0 110.767 175.543 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.482 ' O ' ' HG ' ' A' ' 130' ' ' LEU . 50.8 tptt -85.23 -33.06 22.3 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.234 174.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.496 HD21 ' CE1' ' A' ' 51' ' ' TYR . 1.4 mm? -53.55 -40.92 65.93 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 122.051 0.929 . . . . 0.0 108.664 168.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.496 ' HB ' ' O ' ' A' ' 125' ' ' MET . 72.8 m -62.02 -48.09 81.84 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 113.794 -1.548 . . . . 0.0 111.326 175.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.754 ' O ' ' HG2' ' A' ' 132' ' ' ARG . 36.1 t70 -67.33 -25.96 66.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.408 -177.562 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 126' ' ' LYS . 7.3 mt -54.06 -14.93 1.2 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.157 176.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -57.09 -25.17 58.29 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.483 176.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.754 ' HG2' ' O ' ' A' ' 129' ' ' ASP . 20.5 mmt180 -64.22 -43.62 94.42 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 177.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -69.55 -40.32 76.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.92 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.36 -31.76 71.65 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.403 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.1 0.57 47.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.306 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 73.32 43.0 40.16 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.861 -178.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 67.38 112.43 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.28 0.562 . . . . 0.0 110.98 -178.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.403 HG22 ' N ' ' A' ' 139' ' ' GLU . 55.9 mt -78.59 155.2 4.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.127 -178.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.403 ' N ' HG22 ' A' ' 138' ' ' ILE . 15.2 mm-40 -43.21 118.76 1.38 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.896 176.06 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.5 m -129.52 -11.22 4.51 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.254 178.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.3 tt . . . . . 0 C--O 1.246 0.881 0 CA-C-O 118.451 -0.785 . . . . 0.0 110.402 179.427 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 . . . . . 0 C--O 1.233 0.237 0 CA-C-O 121.14 0.495 . . . . 0.0 110.668 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.468 ' HA ' ' CD1' ' A' ' 23' ' ' PHE . 3.3 Cg_exo -70.45 -18.65 33.63 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 123.183 2.589 . . . . 0.0 112.628 -173.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -67.14 -28.21 67.95 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.745 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -77.37 -7.73 56.55 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.692 -177.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.468 ' CD1' ' HA ' ' A' ' 20' ' ' PRO . 27.7 m-85 -80.88 148.08 30.07 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 177.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -67.84 -31.21 70.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.142 0.496 . . . . 0.0 109.95 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.883 HG12 HG11 ' A' ' 96' ' ' VAL . 1.7 m -68.36 -16.82 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.563 -177.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -54.03 -57.17 12.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.006 0.431 . . . . 0.0 110.648 -177.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.421 ' HZ1' HD13 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -70.17 -33.06 71.28 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.741 -178.114 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.476 ' HB3' HD12 ' A' ' 100' ' ' ILE . 39.7 m-85 -69.92 -46.4 65.45 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.581 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.444 ' CE ' HD11 ' A' ' 68' ' ' ILE . 53.6 mtp -71.96 -26.15 62.15 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.949 0.404 . . . . 0.0 110.435 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.435 ' HD2' ' HA ' ' A' ' 30' ' ' LYS . 24.8 mmmt -68.45 -36.68 79.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.066 175.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.421 HD13 ' HZ1' ' A' ' 27' ' ' LYS . 17.6 pt -83.31 -26.72 7.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.171 176.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.0 tt -53.93 -50.56 66.16 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 171.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.594 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 10.5 tt0 -43.6 -55.19 4.46 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.69 176.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -71.17 -53.65 13.74 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.497 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.12 -40.19 80.6 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -167.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 91.3 mmm -56.89 -43.52 81.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.046 0.45 . . . . 0.0 111.291 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -91.37 -17.71 25.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.27 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -64.9 -22.51 67.01 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.009 -175.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -59.28 130.06 45.09 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 172.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.7 -27.39 62.88 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.827 -173.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -100.83 18.48 19.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.809 -0.178 . . . . 0.0 110.961 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 27.5 70.52 0.05 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.912 1.285 . . . . 0.0 112.568 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.1 mt -62.83 -6.14 3.46 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.392 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.1 tp -60.62 -27.14 39.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.665 178.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.49 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 22.9 mt-10 -74.28 -21.59 59.68 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-O 120.743 0.306 . . . . 0.0 111.255 -178.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -77.92 -36.97 48.77 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.475 0.655 . . . . 0.0 110.153 177.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 47' ' ' VAL . 14.6 p -112.29 31.73 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.657 -172.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.49 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 53.1 mtt180 -51.33 111.86 0.64 Allowed 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.62 0.724 . . . . 0.0 111.524 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.512 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . -170.14 168.67 41.61 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.752 -175.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.533 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 54.1 mt -108.7 124.42 65.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.455 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 12.8 m-85 -106.63 130.97 54.29 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.265 -174.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -107.87 117.36 5.13 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.303 176.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.415 ' O ' ' HA ' ' A' ' 65' ' ' TYR . 3.4 m-85 -103.65 100.07 9.89 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 120.978 0.418 . . . . 0.0 111.509 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 90' ' ' THR . 56.5 mtmt -89.32 101.99 14.66 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.453 174.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.698 HG11 HG11 ' A' ' 25' ' ' VAL . 16.1 t -104.71 124.71 59.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.588 -176.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 45.6 mtp180 -114.4 -179.75 3.72 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.99 -178.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 61.64 47.19 6.59 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.926 0.393 . . . . 0.0 110.876 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.71 -172.16 15.71 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.478 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -38.57 -60.43 0.48 Allowed 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 124.115 3.21 . . . . 0.0 113.497 -175.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -123.99 62.88 1.07 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.11 0.481 . . . . 0.0 110.326 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.84 22.61 78.95 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.846 -0.692 . . . . 0.0 111.926 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.36 169.77 17.28 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.31 0.576 . . . . 0.0 111.581 -177.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -141.61 139.07 33.0 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.69 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.45 162.82 24.08 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.648 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 26.0 t80 -150.3 115.29 5.34 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.949 0.404 . . . . 0.0 110.811 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 10.5 m-90 -117.81 145.05 44.82 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.437 HG11 ' HG3' ' A' ' 83' ' ' GLU . 40.6 t -113.3 124.68 70.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.52 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.464 HD12 ' N ' ' A' ' 68' ' ' ILE . 3.8 mp -100.36 107.02 20.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -83.48 98.35 9.48 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.031 0.443 . . . . 0.0 110.205 178.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -108.32 -2.61 19.07 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.971 175.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -61.25 -37.49 83.3 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -83.06 -2.44 55.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.106 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.38 18.2 67.13 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.005 -178.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.531 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 11.8 mmpt? -93.17 -61.44 1.57 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.683 -0.258 . . . . 0.0 110.786 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.6 35.52 6.48 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.154 -1.022 . . . . 0.0 112.34 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.594 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 19.1 pttm -96.35 142.34 28.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.692 0.246 . . . . 0.0 110.347 -176.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.7 OUTLIER -108.0 133.44 52.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.37 0.605 . . . . 0.0 109.555 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.2 t -138.11 134.33 34.51 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.641 -176.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -68.0 135.3 52.11 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 42.38 73.4 0.14 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.857 0.836 . . . . 0.0 111.064 -172.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.58 -40.02 97.28 Favored Glycine 0 C--N 1.33 0.212 0 CA-C-N 115.108 -0.951 . . . . 0.0 113.591 -173.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 92.18 -14.33 64.79 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.23 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.498 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 1.7 pt-20 -97.95 153.09 18.59 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 122.15 0.18 . . . . 0.0 110.925 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 60.4 pttt -79.2 110.11 13.7 Favored Pre-proline 0 N--CA 1.449 -0.477 0 CA-C-O 121.284 0.564 . . . . 0.0 111.323 178.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.533 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 14.3 Cg_exo -69.84 130.58 19.49 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.529 2.152 . . . . 0.0 111.579 177.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -58.87 -37.17 75.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.799 176.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.612 ' HB ' ' CD1' ' A' ' 117' ' ' ILE . 14.3 m -138.72 138.98 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.691 177.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.665 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 44.9 m -124.32 136.1 53.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.516 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.581 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 34.7 m-85 -111.31 153.32 26.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.766 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.556 ' HB ' ' HB3' ' A' ' 116' ' ' LYS . 1.1 m -132.26 108.39 9.2 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 175.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.454 HG12 HG13 ' A' ' 115' ' ' ILE . 64.4 mt -134.18 159.47 42.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.523 0.729 . . . . 0.0 109.36 -173.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.444 ' N ' HG22 ' A' ' 91' ' ' ILE . 15.4 m -89.02 139.67 30.22 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.907 0.384 . . . . 0.0 110.096 174.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.588 ' OD1' HG13 ' A' ' 25' ' ' VAL . 35.1 t70 -53.03 -25.83 13.68 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.176 0.991 . . . . 0.0 111.63 -179.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -78.71 -38.93 37.9 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.711 -177.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -89.16 -19.72 25.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.54 -172.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.883 HG11 HG12 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -55.4 -32.56 29.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.082 0.468 . . . . 0.0 110.527 -179.192 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.6 m -67.23 -28.93 44.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.269 -173.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -84.79 -32.94 23.1 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.423 HD12 HG21 ' A' ' 91' ' ' ILE . 74.0 mt -68.72 -47.9 65.18 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.826 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 96' ' ' VAL . 10.6 mt -74.98 -18.95 16.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.908 -177.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.6 t -88.47 -20.49 25.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.868 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.55 9.25 61.67 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.124 -177.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -83.0 -41.15 19.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.011 0.434 . . . . 0.0 110.843 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.6 tp -102.97 127.31 50.24 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.051 178.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -71.6 121.87 85.61 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.115 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.425 ' HA ' HD12 ' A' ' 115' ' ' ILE . 4.9 Cg_exo -64.35 -20.52 66.54 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.763 1.642 . . . . 0.0 110.708 175.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -64.91 -58.77 5.28 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.818 172.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.534 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -66.03 -32.92 74.68 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.335 0.588 . . . . 0.0 109.566 -178.503 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.534 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -66.79 -40.11 88.01 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.552 178.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -58.3 -47.55 83.31 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.359 0.6 . . . . 0.0 109.718 175.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -63.87 -38.54 91.48 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.276 -177.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.431 HE21 ' HB3' ' A' ' 112' ' ' GLN . 7.8 mt-30 -91.53 6.0 47.32 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -174.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.23 2.22 80.53 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.827 173.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.1 mmpt? -77.34 -19.85 55.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.172 0.51 . . . . 0.0 110.443 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.684 HG23 HG22 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -127.94 110.37 21.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.861 178.599 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.556 ' HB3' ' HB ' ' A' ' 90' ' ' THR . 19.3 tptm -111.75 99.78 8.42 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.114 174.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.684 HG22 HG23 ' A' ' 115' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.322 -0.597 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.946 -176.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.429 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 89.5 m-20 . . . . . 0 N--CA 1.455 -0.18 0 CA-C-O 121.036 0.446 . . . . 0.0 110.173 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 19' ' ' ASN . 15.1 Cg_exo -62.99 -30.26 76.39 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 123.173 2.582 . . . . 0.0 112.268 -173.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.406 ' HG3' ' H ' ' A' ' 21' ' ' GLU . 8.8 mt-10 -68.61 -23.36 64.44 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.794 -178.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.415 ' OD2' ' HB2' ' A' ' 19' ' ' ASN . 23.2 m-20 -76.06 -16.24 59.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.243 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -90.2 152.92 20.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.14 0.495 . . . . 0.0 110.525 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -80.46 -26.1 38.51 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.411 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.827 HG12 HG11 ' A' ' 96' ' ' VAL . 1.0 OUTLIER -66.62 -17.59 22.8 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.536 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.973 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -53.89 -51.9 62.23 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.814 0.34 . . . . 0.0 110.492 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.459 ' O ' HG23 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -67.25 -36.48 81.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.508 -179.246 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.408 ' O ' HG12 ' A' ' 31' ' ' ILE . 48.0 m-85 -70.17 -53.32 17.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.501 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.538 ' SD ' ' HB ' ' A' ' 25' ' ' VAL . 0.1 OUTLIER -61.04 -32.1 71.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.767 0.317 . . . . 0.0 110.898 177.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.475 ' HD3' ' HA ' ' A' ' 30' ' ' LYS . 34.0 mmtt -74.53 -27.94 60.75 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.459 HG23 ' O ' ' A' ' 27' ' ' LYS . 15.5 pt -89.77 -18.43 7.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.714 173.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.9 tt -62.69 -52.54 62.88 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 169.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.575 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 11.9 tt0 -42.47 -55.17 3.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.141 -1.39 . . . . 0.0 110.688 173.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -65.07 -53.82 39.68 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.757 -1.11 . . . . 0.0 111.876 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.68 -36.94 84.51 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -167.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.435 ' HA ' ' CE ' ' A' ' 36' ' ' MET . 5.1 mmt -60.92 -43.37 98.69 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.686 0.279 . . . . 0.0 111.304 -177.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -92.64 -15.1 27.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.988 0.423 . . . . 0.0 110.499 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -64.02 -35.35 80.42 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.064 0.459 . . . . 0.0 110.221 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -70.12 123.25 21.13 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 173.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.81 -24.07 65.55 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.652 -172.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -74.44 -17.58 60.77 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.7 p30 34.27 70.36 0.13 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.924 0.889 . . . . 0.0 112.391 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.4 mt -70.36 1.67 4.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.262 -178.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -62.05 -31.47 51.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.259 -177.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.577 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 46.3 mt-10 -73.13 -20.56 60.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.475 -173.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -72.81 -19.55 61.31 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.344 0.592 . . . . 0.0 110.241 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -131.01 33.44 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.338 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.577 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 57.8 mtt180 -45.31 110.31 0.23 Allowed 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.469 0.652 . . . . 0.0 111.853 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.507 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . -174.95 175.27 47.04 Favored Glycine 0 C--N 1.31 -0.867 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.306 -176.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.454 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 67.3 mt -107.98 124.83 64.46 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-O 121.284 0.564 . . . . 0.0 111.248 -177.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.491 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 4.3 m-85 -105.98 111.62 24.34 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.827 -176.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -93.16 126.92 8.79 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.691 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -111.28 103.04 11.41 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.05 0.452 . . . . 0.0 111.777 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -87.88 102.06 14.34 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.11 173.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.698 HG11 HG11 ' A' ' 25' ' ' VAL . 23.0 t -101.88 125.18 56.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.251 0.548 . . . . 0.0 111.238 -173.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.617 ' NE ' HG22 ' A' ' 90' ' ' THR . 51.6 mtm180 -109.77 175.53 5.41 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.985 -174.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 60.82 49.07 6.34 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 122.684 0.394 . . . . 0.0 111.849 176.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.88 -160.01 10.5 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.28 175.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 62' ' ' ALA . 80.2 Cg_exo -41.62 -61.4 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.678 2.919 . . . . 0.0 113.573 -177.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -125.1 63.78 1.15 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.368 0.604 . . . . 0.0 109.573 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.0 26.7 73.27 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.401 -177.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.464 ' HB3' ' HD2' ' A' ' 59' ' ' PRO . . . -77.72 152.86 33.46 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.182 0.515 . . . . 0.0 111.149 -178.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -129.38 112.84 14.24 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.043 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.06 164.93 18.41 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.106 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -147.75 117.06 6.92 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.874 0.368 . . . . 0.0 110.941 -176.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 16.0 m-90 -119.35 147.55 44.2 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.826 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 19.7 t -116.44 115.52 49.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.461 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.519 HG13 HG12 ' A' ' 77' ' ' VAL . 4.2 mp -91.29 103.56 14.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -84.88 97.88 10.0 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.168 0.509 . . . . 0.0 110.138 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -100.97 -0.47 36.55 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.472 174.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.426 ' HB2' HG13 ' A' ' 50' ' ' ILE . 15.9 tppt? -59.74 -40.3 87.62 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.318 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -74.88 -13.74 60.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.033 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.64 9.23 75.48 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -172.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -90.32 -59.79 2.09 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.356 -0.422 . . . . 0.0 110.872 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.55 36.45 5.86 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.066 -1.064 . . . . 0.0 112.149 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.575 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 16.3 pttm -95.72 144.47 26.09 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -175.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.519 HG12 HG13 ' A' ' 68' ' ' ILE . 0.7 OUTLIER -108.08 133.42 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-O 121.433 0.635 . . . . 0.0 109.866 -178.897 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.611 HG23 ' HA2' ' A' ' 81' ' ' GLY . 1.8 t -136.89 141.21 42.74 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.294 -177.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.42 ' CD1' ' HG3' ' A' ' 20' ' ' PRO . 80.1 t80 -62.38 123.6 18.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.349 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 72.75 -38.64 0.42 Allowed 'General case' 0 N--CA 1.471 0.623 0 O-C-N 123.984 0.802 . . . . 0.0 111.993 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.611 ' HA2' HG23 ' A' ' 78' ' ' THR . . . 76.0 -41.63 1.53 Allowed Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 114.158 0.423 . . . . 0.0 114.158 176.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.99 0.76 53.63 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.102 -176.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -107.08 166.83 10.32 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -98.25 108.39 46.94 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 175.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.454 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 21.3 Cg_exo -67.28 132.6 28.07 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 123.138 2.558 . . . . 0.0 113.194 -177.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -64.0 -39.94 95.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.001 174.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.403 ' HB ' ' CD1' ' A' ' 117' ' ' ILE . 6.2 m -136.21 134.18 50.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.656 175.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.619 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 21.2 m -122.81 132.35 54.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.627 -178.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.574 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 41.4 m-85 -111.68 136.86 50.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.917 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.617 HG22 ' NE ' ' A' ' 56' ' ' ARG . 2.2 m -109.04 99.67 8.95 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.057 0.456 . . . . 0.0 109.853 175.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 86.4 mt -122.72 159.07 26.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -176.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.476 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 4.9 m -99.34 138.38 36.52 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 177.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.414 ' OD2' HG13 ' A' ' 25' ' ' VAL . 13.2 t70 -44.54 -50.11 9.74 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.14 0.576 . . . . 0.0 111.376 -176.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -59.02 -34.6 72.08 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.5 -1.227 . . . . 0.0 111.575 -176.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.476 ' OD2' ' HB2' ' A' ' 92' ' ' SER . 23.0 m-20 -91.09 -21.72 21.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.064 -177.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.827 HG11 HG12 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -57.71 -34.21 47.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 121.221 0.534 . . . . 0.0 109.824 -179.101 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.0 m -67.21 -27.71 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.971 -174.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -83.68 -34.41 24.99 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.42 ' HG ' HD23 ' A' ' 104' ' ' LEU . 79.8 mt -71.45 -36.25 71.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.219 -177.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.583 HG13 ' O ' ' A' ' 96' ' ' VAL . 17.4 mt -85.15 -22.2 7.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.348 -177.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 37.0 p -85.29 -20.85 29.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.004 0.431 . . . . 0.0 111.062 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 96.17 11.99 53.09 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.663 -177.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -85.67 -41.98 14.69 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.941 0.401 . . . . 0.0 111.125 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.42 HD23 ' HG ' ' A' ' 99' ' ' LEU . 49.2 tp -102.89 131.29 49.91 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.274 177.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.489 ' HB2' ' HB2' ' A' ' 108' ' ' LYS . 16.1 m120 -78.73 118.32 71.7 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.475 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -65.45 -27.14 54.64 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 121.978 1.785 . . . . 0.0 111.001 177.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -66.93 -55.21 15.57 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.454 173.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.67 ' HE3' ' HG3' ' A' ' 112' ' ' GLN . 13.6 ttpt -53.51 -48.85 68.61 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.056 175.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.554 ' HB1' ' HB3' ' A' ' 114' ' ' LYS . . . -65.03 -31.71 73.07 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.68 -175.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -60.08 -45.7 92.04 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 174.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -67.08 -38.0 84.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.427 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.67 ' HG3' ' HE3' ' A' ' 108' ' ' LYS . 15.2 mm100 -71.06 -23.41 62.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.762 -177.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 101.39 8.67 46.2 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.399 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.606 ' HA ' ' HE3' ' A' ' 114' ' ' LYS . 1.1 tpmt? -83.31 -32.09 26.51 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-O 121.398 0.618 . . . . 0.0 110.386 -176.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.644 HG23 HG22 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -111.99 122.43 66.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.005 -174.163 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.412 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 47.3 mmtm -112.59 106.13 14.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.481 173.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.644 HG22 HG23 ' A' ' 115' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.319 -0.73 0 CA-C-O 120.986 0.422 . . . . 0.0 111.079 -178.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.436 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 95.6 m-20 . . . . . 0 C--O 1.234 0.26 0 CA-C-O 121.463 0.649 . . . . 0.0 111.569 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.531 ' HA ' ' CD1' ' A' ' 23' ' ' PHE . 15.4 Cg_exo -62.96 -26.72 74.2 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.644 2.896 . . . . 0.0 111.681 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -59.24 -37.52 77.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.718 177.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -81.04 -2.94 50.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.872 0.368 . . . . 0.0 111.46 -174.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.531 ' CD1' ' HA ' ' A' ' 20' ' ' PRO . 29.9 m-85 -73.95 144.06 45.42 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 172.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.432 ' O ' ' HD2' ' A' ' 28' ' ' TYR . 64.4 mmtt -66.94 -30.5 70.66 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 175.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 1.086 HG12 HG11 ' A' ' 96' ' ' VAL . 0.8 OUTLIER -65.01 -20.19 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.786 -178.03 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -59.02 -54.44 47.07 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.409 ' O ' HG23 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -71.32 -37.71 71.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.61 179.012 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.434 ' HB2' ' HA ' ' A' ' 25' ' ' VAL . 28.2 m-85 -69.35 -41.96 75.92 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.493 ' HB3' HG21 ' A' ' 77' ' ' VAL . 61.1 mtt -74.88 -27.95 60.45 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.359 178.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.431 ' HD2' ' HA ' ' A' ' 30' ' ' LYS . 19.4 mmmt -66.09 -34.24 77.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.078 175.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.409 HG23 ' O ' ' A' ' 27' ' ' LYS . 18.2 pt -86.32 -21.3 7.54 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.592 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.271 175.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.5 tt -61.83 -48.33 81.04 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 173.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.517 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 3.4 tt0 -45.62 -49.34 14.34 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.878 174.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -75.44 -61.48 1.89 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.755 -1.112 . . . . 0.0 111.703 -177.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.71 -38.95 73.02 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -167.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 95.3 mmm -59.64 -38.82 82.43 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.491 0.182 . . . . 0.0 111.491 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -91.48 -31.44 15.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.135 0.493 . . . . 0.0 111.049 176.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -65.3 -27.53 68.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.923 -176.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -56.67 142.03 41.46 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.414 177.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.3 p -48.99 -45.27 42.06 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.098 0.475 . . . . 0.0 111.406 -177.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -90.28 -8.59 50.55 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.227 -176.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.527 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 6.1 p30 36.51 71.77 0.12 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.865 0.841 . . . . 0.0 110.984 -175.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.5 mt -60.53 -5.34 1.17 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.945 -175.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.8 tp -62.14 -27.62 42.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.59 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.527 ' HG2' ' O ' ' A' ' 42' ' ' ASN . 14.5 pt-20 -67.13 -28.75 68.4 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.793 0.33 . . . . 0.0 111.259 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -78.53 -24.73 45.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.145 0.498 . . . . 0.0 110.642 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.704 HG22 ' OH ' ' A' ' 51' ' ' TYR . 8.3 p -124.91 32.39 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.759 0.79 . . . . 0.0 110.955 -168.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -65.6 125.34 24.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.568 0.699 . . . . 0.0 111.778 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.14 -174.29 46.3 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.38 -178.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.425 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 48.2 mt -111.42 125.71 68.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 117.978 0.889 . . . . 0.0 110.589 175.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.704 ' OH ' HG22 ' A' ' 47' ' ' VAL . 19.1 m-85 -115.99 111.29 20.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.609 -174.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.29 111.83 4.11 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.686 -0.769 . . . . 0.0 111.314 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -100.88 109.61 21.59 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.291 0.567 . . . . 0.0 111.141 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -97.41 99.88 11.31 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.116 176.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.806 HG11 HG11 ' A' ' 25' ' ' VAL . 12.2 t -99.14 127.22 52.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.656 -172.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.502 ' O ' ' HA ' ' A' ' 92' ' ' SER . 54.8 mtp180 -118.15 176.19 5.33 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.253 -177.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 59.44 46.71 12.02 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.127 0.489 . . . . 0.0 111.242 178.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -79.55 -148.75 4.87 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.081 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' A' ' 62' ' ' ALA . 94.7 Cg_exo -40.97 -60.72 0.58 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 124.261 3.307 . . . . 0.0 114.109 -176.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -132.02 66.19 1.56 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.127 0.489 . . . . 0.0 109.683 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.12 24.52 71.87 Favored Glycine 0 N--CA 1.453 -0.199 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 -176.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.439 ' HB3' ' HD2' ' A' ' 59' ' ' PRO . . . -81.43 165.08 21.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.354 -0.423 . . . . 0.0 111.652 -175.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.425 ' HG2' ' HA ' ' A' ' 56' ' ' ARG . 23.0 mt-10 -139.4 142.9 37.48 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.596 -178.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -140.11 168.54 25.06 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.699 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -147.45 116.09 6.72 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.801 0.334 . . . . 0.0 110.881 -176.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 14.1 m-90 -119.49 142.95 47.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.818 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 42.4 t -111.01 114.51 47.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.661 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.542 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 4.3 mp -89.05 99.78 9.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 174.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -89.16 103.08 15.73 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.793 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -115.1 17.19 16.87 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.827 175.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -66.44 -40.04 89.24 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.256 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -85.25 -13.99 48.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.927 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.81 12.6 39.96 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.543 -0.753 . . . . 0.0 113.014 176.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.608 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 8.5 mmpt? -86.3 -38.01 17.95 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.986 -0.285 . . . . 0.0 111.603 -178.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.2 35.42 23.81 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.251 -0.976 . . . . 0.0 112.724 177.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.517 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 58.5 pttt -96.72 148.08 23.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.891 0.346 . . . . 0.0 110.884 -172.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.493 HG21 ' HB3' ' A' ' 29' ' ' MET . 0.7 OUTLIER -111.75 137.18 45.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 176.766 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.3 t -140.57 132.68 27.95 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.962 0.411 . . . . 0.0 110.847 -178.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -69.29 121.27 16.52 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 56.86 73.02 0.47 Allowed 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -174.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.73 -35.64 85.95 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.56 -0.746 . . . . 0.0 113.576 -174.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.27 1.07 90.42 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.401 -176.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -91.52 169.82 10.45 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -100.25 107.28 46.81 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.943 173.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.425 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 12.4 Cg_exo -70.78 130.0 17.39 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.59 2.194 . . . . 0.0 112.203 178.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -67.59 -29.01 68.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.858 176.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.4 m -139.51 138.73 39.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.189 172.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.595 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 46.8 m -121.4 129.35 52.97 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.219 177.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.628 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 76.4 m-85 -116.51 126.39 53.28 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.091 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.503 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 2.8 m -102.85 125.53 49.64 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.614 ' CG1' HG13 ' A' ' 115' ' ' ILE . 0.3 OUTLIER -156.76 150.33 9.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.22 0.533 . . . . 0.0 111.104 -174.345 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.502 ' HA ' ' O ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -77.99 139.73 39.16 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.356 178.285 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -52.33 -29.8 25.35 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.263 177.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -68.97 -39.28 79.54 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.537 -178.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -90.14 -25.79 20.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.42 -174.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 1.086 HG11 HG12 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -57.66 -32.56 42.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.02 0.438 . . . . 0.0 110.444 -177.767 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.7 m -69.14 -28.2 38.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.748 -174.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -81.5 -37.19 28.27 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 176.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.414 HD23 ' O ' ' A' ' 104' ' ' LEU . 88.4 mt -64.15 -48.97 73.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.794 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 96' ' ' VAL . 20.2 mt -73.28 -24.96 20.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.543 -176.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.3 t -89.07 -9.81 49.76 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.779 0.324 . . . . 0.0 111.173 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 86.46 16.9 61.35 Favored Glycine 0 N--CA 1.453 -0.177 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.204 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -89.54 -42.72 11.27 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.99 0.424 . . . . 0.0 110.763 -178.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.723 HD11 ' NZ ' ' A' ' 108' ' ' LYS . 49.6 tp -105.59 127.97 53.35 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.846 -178.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -72.97 124.14 90.38 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.471 175.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -65.7 -25.17 54.19 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.347 2.031 . . . . 0.0 110.262 176.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -57.43 -61.41 2.51 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.897 173.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.723 ' NZ ' HD11 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -63.02 -35.63 80.88 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.138 -178.783 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.548 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -69.12 -32.29 71.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.971 -176.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -62.93 -50.49 70.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.701 174.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -64.94 -31.89 73.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.111 -177.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -83.93 1.53 43.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.984 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.98 12.3 82.78 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.833 -0.698 . . . . 0.0 113.446 174.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.502 ' HA ' ' HE3' ' A' ' 114' ' ' LYS . 0.3 OUTLIER -87.34 -42.88 12.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.822 0.344 . . . . 0.0 110.496 178.166 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.614 HG13 ' CG1' ' A' ' 91' ' ' ILE . 0.1 OUTLIER -91.05 114.44 28.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.554 0.692 . . . . 0.0 110.004 178.237 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.503 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 29.0 mmmt -111.73 99.79 8.43 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.411 176.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.628 ' HB ' ' CD2' ' A' ' 89' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--N 1.319 -0.76 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.442 -178.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 . . . . . 0 CA--C 1.517 -0.32 0 CA-C-O 121.142 0.496 . . . . 0.0 110.528 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -52.73 -36.97 74.96 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 124.229 3.286 . . . . 0.0 112.081 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -54.22 -37.34 64.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.81 176.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -79.2 -5.05 53.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.335 -175.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -78.9 148.58 32.68 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.128 0.489 . . . . 0.0 110.037 176.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.478 ' HD3' HG11 ' A' ' 97' ' ' VAL . 46.8 mttp -70.86 -25.71 62.94 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 176.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 1.08 HG12 HG11 ' A' ' 96' ' ' VAL . 0.9 OUTLIER -72.87 -17.75 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 114.988 -1.006 . . . . 0.0 111.022 -178.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -56.31 -53.78 53.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.825 0.345 . . . . 0.0 110.472 -176.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.447 ' HE2' HG23 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -70.59 -40.35 73.29 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.496 178.242 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.443 ' HB3' HD12 ' A' ' 100' ' ' ILE . 9.8 m-85 -64.67 -45.37 86.98 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -175.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.463 ' CE ' HD11 ' A' ' 68' ' ' ILE . 66.8 mtp -75.97 -22.81 55.5 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.371 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.461 ' HD2' ' HA ' ' A' ' 30' ' ' LYS . 24.4 mmmt -71.63 -36.78 70.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.933 174.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.447 HG23 ' HE2' ' A' ' 27' ' ' LYS . 16.1 pt -82.22 -25.25 9.13 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.485 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.122 175.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.8 tt -56.54 -53.04 62.21 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 171.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.488 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 14.1 tt0 -43.82 -49.09 8.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.267 -1.333 . . . . 0.0 111.725 175.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -75.15 -55.57 5.6 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.533 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.477 ' HA ' ' HB3' ' A' ' 38' ' ' ASN . . . -56.21 -36.28 68.26 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -168.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 25.2 mmt -61.41 -43.86 98.13 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.678 0.275 . . . . 0.0 111.483 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -91.7 -17.01 26.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.28 0.562 . . . . 0.0 110.602 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.477 ' HB3' ' HA ' ' A' ' 35' ' ' ALA . 4.3 t-20 -66.34 -36.26 82.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.781 177.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -56.91 125.94 24.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.31 175.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.79 -26.33 34.01 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -175.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -92.16 -16.6 26.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.476 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 35.87 69.02 0.2 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.904 0.859 . . . . 0.0 111.104 -177.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.1 mt -65.18 -0.73 1.83 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.731 -174.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.535 HG13 ' HB1' ' A' ' 70' ' ' ALA . 4.9 tp -61.83 -26.54 40.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.296 -177.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.467 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 44.6 mt-10 -76.51 -22.46 54.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.894 0.378 . . . . 0.0 111.053 -176.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -76.45 -19.18 58.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.654 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 47' ' ' VAL . 10.6 p -130.02 32.4 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.633 0.73 . . . . 0.0 110.076 -176.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.467 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 55.4 mtt180 -46.86 119.8 2.69 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.992 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . -179.88 166.64 35.9 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.314 -177.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.478 HG13 ' HB2' ' A' ' 71' ' ' LYS . 55.1 mt -102.79 122.93 55.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.142 0.496 . . . . 0.0 110.842 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.458 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 21.6 m-85 -103.32 118.56 37.05 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.933 -177.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.43 111.76 4.3 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.389 -0.91 . . . . 0.0 111.279 177.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -97.86 104.91 16.98 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.059 0.457 . . . . 0.0 111.458 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -92.7 99.07 11.83 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.691 175.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.792 HG11 HG11 ' A' ' 25' ' ' VAL . 6.0 t -102.34 145.42 12.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.673 -178.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.563 ' CB ' ' HG2' ' A' ' 63' ' ' GLU . 1.1 ptm180 -154.21 -174.2 4.87 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.544 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 64.71 38.17 7.11 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.082 0.468 . . . . 0.0 110.216 -174.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.24 -154.55 4.45 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.824 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo -36.6 -60.0 0.4 Allowed 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 124.326 3.351 . . . . 0.0 113.938 -174.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -128.57 54.88 1.73 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.221 0.534 . . . . 0.0 109.882 178.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 74.53 28.4 63.55 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.544 -176.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.06 156.24 30.15 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 121.391 0.615 . . . . 0.0 111.204 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.563 ' HG2' ' CB ' ' A' ' 56' ' ' ARG . 34.7 mt-10 -125.14 147.58 48.96 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.296 -178.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -143.12 162.91 27.5 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.343 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -150.63 114.9 5.11 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.819 0.342 . . . . 0.0 110.97 -177.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 15.5 m-90 -120.47 136.28 54.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.13 0.49 . . . . 0.0 109.835 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 14.6 t -103.49 116.66 47.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.425 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.463 HD11 ' CE ' ' A' ' 29' ' ' MET . 4.3 mp -93.38 101.21 12.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 175.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -85.69 98.38 10.66 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.246 -177.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.535 ' HB1' HG13 ' A' ' 44' ' ' ILE . . . -107.04 0.73 23.82 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.227 176.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.478 ' HB2' HG13 ' A' ' 50' ' ' ILE . 5.1 tppp? -63.54 -41.73 98.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.399 0.618 . . . . 0.0 109.918 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -76.47 -6.68 52.81 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.424 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.83 8.5 63.5 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.761 176.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -92.01 -55.73 3.34 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -176.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.2 34.93 7.81 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 119.824 -1.179 . . . . 0.0 111.889 -176.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.488 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 22.7 pttp -96.56 144.16 26.88 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -176.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.7 OUTLIER -107.63 131.7 57.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.536 0.684 . . . . 0.0 109.619 -178.787 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.549 HG23 ' HA2' ' A' ' 81' ' ' GLY . 1.8 t -139.83 135.35 32.89 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.563 -178.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -63.19 128.46 35.96 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -176.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 73.25 -42.69 0.53 Allowed 'General case' 0 N--CA 1.471 0.584 0 O-C-N 124.011 0.82 . . . . 0.0 111.578 -177.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.549 ' HA2' HG23 ' A' ' 78' ' ' THR . . . 73.81 -41.81 1.06 Allowed Glycine 0 N--CA 1.453 -0.189 0 N-CA-C 114.425 0.53 . . . . 0.0 114.425 175.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.81 5.94 76.38 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.659 -175.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.403 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 13.3 mm-40 -114.23 143.41 44.88 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -177.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -77.77 110.56 13.39 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 121.185 0.517 . . . . 0.0 110.792 174.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.427 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 13.4 Cg_exo -70.16 130.05 18.19 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.861 2.374 . . . . 0.0 112.452 -178.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -63.57 -34.3 77.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.485 176.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.516 ' HB ' ' CD1' ' A' ' 117' ' ' ILE . 9.0 m -139.4 133.93 39.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.556 176.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.662 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 53.9 m -116.77 139.33 50.7 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.517 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.49 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 54.4 m-85 -118.06 132.92 56.32 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.491 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 5.7 m -110.1 128.67 55.57 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 175.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.596 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -161.99 144.23 3.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.071 0.462 . . . . 0.0 109.862 -177.214 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -81.6 147.24 29.69 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.316 0.579 . . . . 0.0 111.154 177.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -51.25 -29.16 13.63 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 114.449 -1.251 . . . . 0.0 112.033 -177.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -73.51 -34.26 65.19 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.32 -176.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -90.08 -27.39 19.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.843 -175.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 1.08 HG11 HG12 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -56.82 -31.61 36.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.217 -174.889 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.478 HG11 ' HD3' ' A' ' 24' ' ' LYS . 12.8 m -69.34 -29.24 41.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.687 -170.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -83.96 -31.43 25.58 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 176.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.483 HD23 ' O ' ' A' ' 104' ' ' LEU . 91.2 mt -64.63 -51.55 62.05 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.269 0.557 . . . . 0.0 110.562 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 96' ' ' VAL . 14.9 mt -75.51 -16.75 15.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.395 -175.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 42.0 t -94.14 -4.29 49.47 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.207 -0.308 . . . . 0.0 111.322 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.57 30.92 55.73 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.705 -0.759 . . . . 0.0 111.939 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -106.7 -42.67 4.9 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.223 0.535 . . . . 0.0 110.571 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.483 ' O ' HD23 ' A' ' 99' ' ' LEU . 33.8 tp -103.32 120.74 41.35 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.694 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.46 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 5.9 m-20 -68.51 120.48 75.6 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.467 178.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -63.68 -21.47 69.98 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.21 1.94 . . . . 0.0 110.578 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -62.81 -58.69 6.55 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.958 174.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.526 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 1.2 ptmt -66.74 -33.95 76.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.015 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.526 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -65.87 -29.42 69.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.955 0.407 . . . . 0.0 110.098 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -65.39 -46.82 78.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.627 175.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -67.43 -37.2 82.64 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.1 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -79.71 10.92 3.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.857 -176.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.78 7.83 83.94 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 121.236 -0.507 . . . . 0.0 113.268 173.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -82.15 -53.4 6.11 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.117 0.484 . . . . 0.0 110.456 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.643 HG23 HG22 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -88.52 115.12 28.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.585 -177.633 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.491 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 31.2 mmmt -111.06 103.22 11.65 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.524 176.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.662 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.447 -0.588 0 CA-C-O 121.159 0.504 . . . . 0.0 110.955 -176.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 64.6 m-20 . . . . . 0 CA--C 1.519 -0.247 0 CA-C-O 121.353 0.597 . . . . 0.0 110.711 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 19' ' ' ASN . 25.6 Cg_exo -56.38 -35.29 96.02 Favored 'Trans proline' 0 CA--C 1.518 -0.293 0 C-N-CA 123.906 3.07 . . . . 0.0 112.397 -176.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.412 ' HA ' ' CD1' ' A' ' 26' ' ' PHE . 40.7 tt0 -60.49 -37.61 81.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.585 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -74.92 -18.14 60.45 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.683 0.278 . . . . 0.0 111.307 -173.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -67.84 154.82 40.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.501 0.667 . . . . 0.0 110.569 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.445 ' HD2' HG11 ' A' ' 97' ' ' VAL . 15.2 ttmm -80.43 -20.43 43.87 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.318 -0.855 . . . . 0.0 108.917 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.807 HG12 HG11 ' A' ' 96' ' ' VAL . 1.3 m -77.27 -14.11 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.934 178.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.412 ' CD1' ' HA ' ' A' ' 21' ' ' GLU . 69.1 t80 -51.86 -56.06 16.27 Favored 'General case' 0 N--CA 1.462 0.135 0 O-C-N 123.055 0.222 . . . . 0.0 111.418 -175.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.3 -40.6 96.26 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.037 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.427 ' HB3' HD12 ' A' ' 100' ' ' ILE . 32.8 m-85 -66.18 -49.2 68.15 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.548 -177.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.669 ' HB3' HG21 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -61.73 -33.23 73.68 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.825 0.345 . . . . 0.0 110.954 175.531 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.8 mmmt -69.67 -39.6 76.91 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 11.2 pt -81.45 -22.06 10.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.108 177.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.6 tt -58.27 -48.05 81.69 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 171.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -48.14 -50.81 27.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.757 175.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.456 ' O ' ' HB2' ' A' ' 38' ' ' ASN . 25.5 tt0 -69.63 -52.14 28.58 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.84 -178.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.36 -37.28 82.96 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -166.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.8 mmt -58.06 -47.32 83.52 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.757 0.281 . . . . 0.0 111.757 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -91.08 -8.66 48.29 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.073 0.463 . . . . 0.0 110.558 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -67.82 -25.95 65.82 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 176.558 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -54.33 122.35 10.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.798 176.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.86 -39.79 59.5 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.857 -1.065 . . . . 0.0 113.001 -173.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.588 ' C ' HD22 ' A' ' 42' ' ' ASN . 44.5 mt-10 -103.35 19.01 20.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.839 -0.164 . . . . 0.0 111.385 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.588 HD22 ' C ' ' A' ' 41' ' ' GLU . 0.1 OUTLIER 21.88 76.36 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.157 1.383 . . . . 0.0 112.736 -177.139 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.8 mt -65.91 -1.77 3.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.065 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.2 tp -58.7 -26.73 32.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.69 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.557 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 31.5 mt-10 -77.67 -14.58 59.58 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.358 -177.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.9 mttm -89.33 -12.74 39.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.175 0.512 . . . . 0.0 110.384 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 47' ' ' VAL . 9.7 p -131.3 33.07 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.776 0.798 . . . . 0.0 109.774 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.557 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 51.0 mtt180 -52.5 109.86 0.44 Allowed 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.645 0.736 . . . . 0.0 111.361 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.581 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . -171.42 155.8 24.95 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 114.419 -1.264 . . . . 0.0 111.292 -176.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.491 HG13 ' HB2' ' A' ' 71' ' ' LYS . 73.6 mt -96.79 126.56 49.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 117.132 0.466 . . . . 0.0 110.768 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.47 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 9.9 m-85 -104.66 117.47 34.19 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.91 -176.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -98.68 109.75 3.86 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.273 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -98.33 103.73 15.7 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.275 0.56 . . . . 0.0 111.457 -178.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -89.6 99.41 12.42 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.254 174.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.666 HG11 HG11 ' A' ' 25' ' ' VAL . 20.2 t -96.97 121.44 47.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.627 -174.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.46 ' HE ' ' CD ' ' A' ' 63' ' ' GLU . 51.7 mtp180 -108.37 178.24 4.55 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.874 -178.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 18.4 m120 61.05 43.74 11.01 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.242 0.544 . . . . 0.0 111.036 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.24 -155.94 7.31 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.531 -0.759 . . . . 0.0 113.239 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -43.53 -60.73 0.7 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.831 3.021 . . . . 0.0 113.486 -176.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -114.25 47.42 1.22 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 177.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.9 22.21 78.82 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.572 -0.823 . . . . 0.0 111.311 -174.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.94 169.73 16.27 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.441 0.638 . . . . 0.0 111.843 -175.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.46 ' CD ' ' HE ' ' A' ' 56' ' ' ARG . 20.5 mt-10 -131.66 110.54 10.99 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.844 -178.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -100.55 169.15 21.15 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.431 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -150.25 118.54 6.4 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.935 0.398 . . . . 0.0 111.087 -177.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 20.7 m-90 -122.0 137.5 54.78 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.832 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 37.2 t -109.61 115.47 49.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.57 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.502 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 4.2 mp -95.52 106.43 18.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -86.38 98.57 11.07 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.215 0.531 . . . . 0.0 110.148 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -101.42 -2.65 30.33 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.744 174.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.491 ' HB2' HG13 ' A' ' 50' ' ' ILE . 4.5 tppp? -64.24 -39.53 94.15 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.575 -178.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -87.03 9.38 19.8 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.995 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 76.3 23.32 71.29 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.913 175.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -100.41 -66.22 0.92 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.687 0.279 . . . . 0.0 111.249 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.48 34.63 5.98 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.093 -1.051 . . . . 0.0 111.323 -174.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 0.1 OUTLIER -96.82 145.46 25.83 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -177.705 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.669 HG21 ' HB3' ' A' ' 29' ' ' MET . 1.2 m -107.79 129.42 61.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.591 HG23 ' HA2' ' A' ' 81' ' ' GLY . 2.1 t -134.0 134.0 41.95 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.871 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.452 ' O ' ' HB3' ' A' ' 80' ' ' ASN . 51.8 t80 -61.93 123.35 17.81 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.208 -177.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.452 ' HB3' ' O ' ' A' ' 79' ' ' TYR . 9.4 t30 75.29 -40.57 0.43 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.485 0.714 . . . . 0.0 111.663 -177.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.591 ' HA2' HG23 ' A' ' 78' ' ' THR . . . 72.36 -42.64 0.83 Allowed Glycine 0 CA--C 1.517 0.158 0 N-CA-C 114.736 0.654 . . . . 0.0 114.736 174.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 71.93 19.89 78.53 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.337 -174.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -125.38 158.77 33.46 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -177.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -98.04 108.83 48.87 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-O 120.929 0.395 . . . . 0.0 110.231 175.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.481 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 21.1 Cg_exo -66.12 132.44 29.91 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 123.008 2.472 . . . . 0.0 112.911 -177.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -61.34 -32.68 72.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.746 174.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.9 m -139.73 131.67 34.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.82 174.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.646 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 32.2 m -114.43 133.28 55.85 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.104 177.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.623 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 72.0 m-85 -119.82 128.89 54.12 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.512 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 2.1 m -102.83 119.43 38.83 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 175.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.586 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 66.0 mt -143.01 151.7 17.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -173.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.51 146.75 27.41 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.325 0.584 . . . . 0.0 110.917 176.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -53.16 -26.06 15.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.679 179.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -80.75 -37.33 30.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.041 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -87.57 -22.89 24.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.341 -173.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.807 HG11 HG12 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -56.4 -34.64 41.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.0 0.428 . . . . 0.0 110.568 -179.178 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.445 HG11 ' HD2' ' A' ' 24' ' ' LYS . 6.3 m -69.76 -29.54 41.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.15 -172.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -82.82 -33.49 27.19 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.511 HD23 ' O ' ' A' ' 104' ' ' LEU . 80.8 mt -68.43 -45.36 72.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.84 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.577 HG13 ' O ' ' A' ' 96' ' ' VAL . 22.1 mt -77.09 -19.4 14.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.097 -177.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 31.4 t -94.56 -1.26 53.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.751 0.31 . . . . 0.0 110.955 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.68 20.35 76.6 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.232 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -94.78 -42.27 8.81 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.076 0.465 . . . . 0.0 110.972 -177.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.511 ' O ' HD23 ' A' ' 99' ' ' LEU . 42.8 tp -101.5 124.73 47.65 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.115 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -72.94 123.64 89.82 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.513 177.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -65.53 -21.39 59.98 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.043 1.829 . . . . 0.0 110.113 176.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -59.15 -61.51 2.58 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.795 172.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.529 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 0.6 OUTLIER -66.12 -33.81 76.63 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.054 -177.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.55 ' HB3' HD12 ' A' ' 115' ' ' ILE . . . -68.72 -31.27 70.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.408 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -65.77 -49.02 69.85 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 174.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -62.9 -43.65 98.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.153 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -77.26 9.35 3.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.875 -177.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.03 -19.65 44.81 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 121.039 -0.601 . . . . 0.0 113.68 170.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -57.98 -61.11 2.78 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.659 HG23 HG22 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -79.3 114.88 20.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.853 0.835 . . . . 0.0 111.233 -173.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.512 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 0.0 OUTLIER -107.03 98.99 8.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.801 -1.091 . . . . 0.0 109.163 173.128 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.659 HG22 HG23 ' A' ' 115' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.319 -0.757 0 CA-C-O 121.123 0.487 . . . . 0.0 110.304 178.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.408 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 51.1 m-80 . . . . . 0 C--O 1.232 0.151 0 CA-C-O 121.224 0.535 . . . . 0.0 110.989 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 19' ' ' ASN . 5.0 Cg_exo -66.13 -22.12 54.74 Favored 'Trans proline' 0 CA--C 1.517 -0.327 0 C-N-CA 123.193 2.595 . . . . 0.0 111.734 -175.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.444 ' HG3' ' H ' ' A' ' 21' ' ' GLU . 10.8 mt-10 -60.01 -36.54 77.43 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.028 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -76.39 -13.18 60.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.406 -174.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -77.75 141.4 39.31 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 177.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -74.97 -24.14 58.39 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.48 0.657 . . . . 0.0 109.261 -178.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.701 HG12 HG11 ' A' ' 96' ' ' VAL . 0.8 OUTLIER -69.34 -15.62 19.76 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.305 176.251 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -58.71 -56.39 22.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.802 0.334 . . . . 0.0 110.462 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.468 ' O ' HG23 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -69.4 -33.51 73.11 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.468 -178.666 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.45 ' O ' HG12 ' A' ' 31' ' ' ILE . 13.1 m-85 -70.21 -50.8 36.26 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.457 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.762 ' HB3' HG21 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -62.14 -33.14 73.93 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.68 0.276 . . . . 0.0 111.274 176.111 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -67.6 -34.16 76.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.715 -0.221 . . . . 0.0 111.57 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.468 HG23 ' O ' ' A' ' 27' ' ' LYS . 17.7 pt -85.59 -21.56 7.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.026 176.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.8 tt -61.86 -48.31 81.12 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 171.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.474 ' HG2' ' HA ' ' A' ' 76' ' ' LYS . 2.0 tm-20 -43.9 -50.53 8.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.843 173.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -72.04 -53.46 12.84 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.675 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.404 ' HA ' ' HB3' ' A' ' 38' ' ' ASN . . . -62.9 -39.31 94.12 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -166.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 20.9 mmt -55.14 -43.69 74.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.603 0.239 . . . . 0.0 111.628 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -92.09 -18.77 23.1 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.236 -0.585 . . . . 0.0 111.241 177.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.404 ' HB3' ' HA ' ' A' ' 35' ' ' ALA . 66.7 t30 -69.8 -22.95 63.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.972 0.415 . . . . 0.0 110.261 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -59.57 126.81 29.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.136 174.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 13.7 m -57.28 -23.89 51.32 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.508 -175.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -100.09 4.33 44.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 119.296 -0.383 . . . . 0.0 111.9 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 32.4 p30 28.57 60.73 0.13 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.397 1.079 . . . . 0.0 111.976 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 36.1 mt -59.67 -12.73 7.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.424 -1.262 . . . . 0.0 111.922 -174.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.419 HG13 ' HB1' ' A' ' 70' ' ' ALA . 3.8 tp -60.69 -27.06 39.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.818 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -68.92 -26.88 65.31 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.555 -175.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -83.94 -22.45 31.5 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.979 0.418 . . . . 0.0 111.052 -178.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 47' ' ' VAL . 12.0 p -123.54 33.34 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.755 0.788 . . . . 0.0 110.421 -175.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -49.81 117.58 2.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.585 0.707 . . . . 0.0 111.137 177.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . -173.4 -171.3 37.86 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.264 -176.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 76.4 mt -126.92 131.19 71.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 117.998 0.899 . . . . 0.0 111.24 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.516 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 33.7 m-85 -110.33 132.2 54.39 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.116 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -109.34 112.15 3.36 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.493 -0.86 . . . . 0.0 111.409 175.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -98.44 105.7 17.88 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.948 0.404 . . . . 0.0 111.28 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -91.28 99.78 12.7 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.175 173.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.682 HG11 HG11 ' A' ' 25' ' ' VAL . 19.4 t -97.84 123.95 50.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.663 -174.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 44.9 mtp180 -112.57 -178.53 3.42 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.3 m120 61.96 44.83 7.9 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.246 0.546 . . . . 0.0 110.792 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.01 -177.02 47.05 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.576 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -35.77 -61.12 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 124.849 3.699 . . . . 0.0 114.315 -175.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -110.91 41.91 1.72 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.159 0.504 . . . . 0.0 110.597 -177.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.45 30.94 63.8 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -173.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.27 173.35 10.43 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 114.769 -0.715 . . . . 0.0 111.836 -176.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -140.01 135.45 32.71 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.972 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -127.06 163.05 21.07 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.938 -0.648 . . . . 0.0 111.688 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -141.37 120.53 12.95 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.842 0.353 . . . . 0.0 110.642 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 22.7 m-90 -122.97 130.35 52.71 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.071 0.462 . . . . 0.0 109.805 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.1 t -101.84 118.91 49.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.34 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.637 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 4.3 mp -94.47 103.32 14.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.162 0.506 . . . . 0.0 109.816 178.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -85.87 98.3 10.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.986 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -95.94 -10.92 27.49 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.927 173.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.1 tttt -51.44 -46.55 63.05 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.533 -178.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -89.42 12.97 14.83 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.169 0.509 . . . . 0.0 111.84 -175.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 88.67 -1.39 83.69 Favored Glycine 0 C--N 1.319 -0.376 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.987 175.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.4 mmmp? -78.68 -74.62 0.27 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.79 0.329 . . . . 0.0 111.729 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.24 34.89 5.69 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 -167.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.637 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 16.3 ptmt -97.33 151.14 20.21 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.312 -0.444 . . . . 0.0 110.022 -174.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.762 HG21 ' HB3' ' A' ' 29' ' ' MET . 0.7 OUTLIER -107.4 143.08 18.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 120.311 -0.555 . . . . 0.0 109.743 176.765 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.2 t -139.22 132.4 29.76 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.188 177.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -68.34 121.63 16.68 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.161 -178.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 64.8 t30 52.21 62.64 2.6 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.993 -176.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -59.13 -36.58 89.21 Favored Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 115.329 -0.85 . . . . 0.0 113.416 -175.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.5 -16.04 51.43 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.061 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.427 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 8.5 mm-40 -75.68 148.18 38.85 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 176.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 29.9 mmmt -86.55 109.03 20.55 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-O 121.017 0.437 . . . . 0.0 110.128 177.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 84' ' ' LYS . 16.8 Cg_exo -67.65 142.5 58.69 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.018 2.479 . . . . 0.0 112.512 -176.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -62.38 -33.76 75.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.759 171.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.2 m -141.76 139.1 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.059 174.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.605 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 29.5 m -115.41 137.21 52.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.222 176.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.593 ' CD1' ' HB ' ' A' ' 117' ' ' ILE . 81.9 m-85 -121.27 136.09 55.02 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 178.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.44 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 3.6 m -110.36 116.76 32.01 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 176.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.532 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 69.9 mt -140.44 152.05 21.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.694 -172.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.12 145.47 25.92 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.184 0.516 . . . . 0.0 110.536 174.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -53.05 -25.6 13.08 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.416 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -75.29 -36.53 61.15 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.73 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -89.55 -23.86 21.9 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.153 -173.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.701 HG11 HG12 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -55.55 -35.86 39.72 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.337 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.903 -178.108 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 m -61.69 -30.78 49.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.589 -171.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.416 ' HB2' ' HB2' ' A' ' 104' ' ' LEU . 34.0 m-20 -91.46 -25.93 19.07 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.696 0.284 . . . . 0.0 110.404 177.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 89.3 mt -71.87 -39.96 69.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.99 0.424 . . . . 0.0 110.293 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.506 HG12 ' O ' ' A' ' 96' ' ' VAL . 3.0 mm -67.73 -44.49 85.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.039 177.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.587 ' OG ' ' HD3' ' A' ' 103' ' ' LYS . 58.2 p -76.87 -28.54 55.46 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.686 -174.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.97 -1.31 38.44 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.125 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.587 ' HD3' ' OG ' ' A' ' 101' ' ' SER . 1.8 mptm? -66.51 -40.08 89.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.831 0.348 . . . . 0.0 111.522 177.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.732 HD11 ' NZ ' ' A' ' 108' ' ' LYS . 47.9 tp -102.27 130.01 48.85 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.799 -176.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.46 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 19.2 m120 -77.65 123.29 86.61 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.07 176.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -64.49 -25.65 62.84 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.037 1.825 . . . . 0.0 110.419 175.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -60.38 -58.77 7.07 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.144 174.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.732 ' NZ ' HD11 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -63.82 -36.34 83.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.0 -179.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.534 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -66.75 -34.38 77.71 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.626 -0.43 . . . . 0.0 109.958 -177.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -57.84 -52.78 64.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.84 175.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -62.95 -32.01 73.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.921 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -84.87 -1.66 56.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.775 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.48 4.45 80.23 Favored Glycine 0 CA--C 1.517 0.19 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.24 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.621 ' CE ' ' HA ' ' A' ' 114' ' ' LYS . 1.4 mmpt? -94.85 10.91 33.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.084 0.469 . . . . 0.0 111.283 -177.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.601 HG23 HG22 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -146.83 109.66 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.828 0.823 . . . . 0.0 109.532 174.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.44 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 73.1 mmtt -109.09 99.74 9.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.99 -1.004 . . . . 0.0 108.963 176.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.605 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.319 -0.724 0 CA-C-O 121.25 0.547 . . . . 0.0 110.597 -177.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 13.8 m120 . . . . . 0 CA--C 1.519 -0.217 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 19' ' ' ASN . 31.2 Cg_exo -56.7 -42.71 62.08 Favored 'Trans proline' 0 N--CA 1.466 -0.097 0 C-N-CA 123.014 2.476 . . . . 0.0 112.244 -176.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -58.58 -33.73 70.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.606 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -70.32 -14.58 62.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.554 -178.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -80.39 144.58 32.57 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 174.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -79.18 -18.28 53.34 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.904 HG12 HG11 ' A' ' 96' ' ' VAL . 1.0 OUTLIER -75.73 -12.1 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.774 177.859 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.426 ' O ' ' HB2' ' A' ' 30' ' ' LYS . 78.8 t80 -58.77 -51.52 69.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.827 0.346 . . . . 0.0 110.793 -178.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.6 -26.8 64.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.846 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.41 ' O ' HG12 ' A' ' 31' ' ' ILE . 31.5 m-85 -79.88 -51.71 8.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.763 -178.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.561 ' SD ' ' HB ' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -59.83 -35.78 75.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.714 0.293 . . . . 0.0 111.266 177.829 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 26' ' ' PHE . 4.9 mmtp -68.94 -31.4 70.26 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.41 HG12 ' O ' ' A' ' 28' ' ' TYR . 10.4 pt -90.7 -16.79 8.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.308 176.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.6 tt -61.04 -47.28 87.15 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 171.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.652 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 7.6 tt0 -48.75 -48.73 40.54 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.562 175.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -64.77 -60.69 2.8 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.724 -1.126 . . . . 0.0 111.081 177.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.98 -46.7 75.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.395 -0.82 . . . . 0.0 113.156 -167.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 35.3 mtt -56.51 -43.62 79.94 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -177.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -92.39 -16.85 25.42 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.103 0.477 . . . . 0.0 110.419 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -63.97 -28.87 70.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.141 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -61.07 126.17 26.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.473 176.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.2 p -68.25 -16.8 64.11 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.315 -174.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -94.02 -3.63 51.0 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 177.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 24.34 72.75 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 O-C-N 124.689 1.243 . . . . 0.0 112.591 -177.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 66.5 mt -64.26 -8.58 13.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.577 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.423 HG13 ' HB1' ' A' ' 70' ' ' ALA . 3.5 tp -60.24 -27.97 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.62 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.475 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 60.7 mm-40 -70.35 -27.86 64.68 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-O 121.022 0.439 . . . . 0.0 111.338 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -85.19 -14.51 46.64 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.77 -176.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 47' ' ' VAL . 14.6 p -130.52 31.04 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.883 0.849 . . . . 0.0 110.221 -177.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.475 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 19.5 mtp180 -51.23 112.97 0.82 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.825 0.821 . . . . 0.0 111.991 -177.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.473 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . -168.88 171.1 42.76 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 114.131 -1.395 . . . . 0.0 111.356 -174.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.529 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 56.9 mt -106.32 127.61 61.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 117.375 0.587 . . . . 0.0 110.78 178.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.473 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 14.7 m-85 -108.69 114.44 28.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.017 -178.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.89 112.08 4.35 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.179 -1.01 . . . . 0.0 111.241 177.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -96.1 105.88 17.98 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.987 0.423 . . . . 0.0 111.343 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.623 ' NZ ' HG21 ' A' ' 88' ' ' THR . 54.6 mttp -91.09 101.46 14.21 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.261 174.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.793 HG11 HG11 ' A' ' 25' ' ' VAL . 21.2 t -100.78 111.54 30.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.679 -174.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' A' ' 92' ' ' SER . 46.9 mtp180 -104.96 176.85 5.03 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.851 -177.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 59.97 46.65 10.74 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.714 176.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.16 -157.47 9.98 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.203 174.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -41.47 -61.12 0.54 Allowed 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 124.028 3.152 . . . . 0.0 113.727 -175.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -115.29 44.16 1.89 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.08 23.17 72.3 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.705 -0.759 . . . . 0.0 111.231 -175.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.67 140.46 56.8 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.498 0.666 . . . . 0.0 111.156 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -114.09 109.48 18.5 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.335 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.08 165.43 16.02 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -148.58 120.54 8.21 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.954 0.406 . . . . 0.0 111.039 -176.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 19.9 m-90 -123.06 129.35 51.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.058 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 55.1 t -99.18 114.44 37.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.657 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.597 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 4.5 mp -92.32 100.21 10.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 175.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -87.93 98.73 11.66 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.297 -177.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -105.63 4.3 30.08 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.078 175.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.464 ' HB2' HG13 ' A' ' 50' ' ' ILE . 3.1 tppp? -60.89 -46.58 90.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.458 -177.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -90.59 20.82 4.34 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.329 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.79 16.43 78.04 Favored Glycine 0 C--N 1.32 -0.315 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.688 175.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -83.88 -55.24 4.35 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.787 -0.206 . . . . 0.0 111.51 -177.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.422 ' H ' ' HA ' ' A' ' 70' ' ' ALA . . . 74.54 33.62 55.66 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.375 -0.917 . . . . 0.0 111.542 -178.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.652 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -99.58 161.61 13.51 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.652 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.7 OUTLIER -120.8 138.84 49.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.8 t -137.61 136.9 37.96 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.485 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -70.33 117.55 12.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.872 -179.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 52.37 65.54 1.48 Allowed 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.655 0.597 . . . . 0.0 110.295 -175.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -61.0 -40.63 98.76 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.785 -173.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.63 -20.26 47.89 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.803 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.506 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 9.6 mm-40 -68.75 150.19 48.16 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 174.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -82.22 114.1 48.61 Favored Pre-proline 0 N--CA 1.437 -1.078 0 CA-C-O 121.289 0.566 . . . . 0.0 110.844 177.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.529 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 13.2 Cg_exo -68.75 129.61 19.02 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.108 2.539 . . . . 0.0 111.57 174.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -66.47 -32.1 73.26 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 173.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.549 ' HB ' ' CD1' ' A' ' 117' ' ' ILE . 15.6 m -140.7 131.66 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.39 175.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.676 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 59.5 m -111.81 130.07 55.93 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.261 177.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.583 ' CE2' HD13 ' A' ' 117' ' ' ILE . 58.7 m-85 -109.88 125.03 52.36 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 177.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.497 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 12.4 m -104.27 125.82 50.86 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 174.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -157.25 152.8 7.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 123.523 0.514 . . . . 0.0 109.708 -175.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 56' ' ' ARG . 11.7 m -85.47 148.0 26.19 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.983 -176.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -50.32 -27.47 6.25 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.067 -0.969 . . . . 0.0 111.118 177.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -74.95 -47.43 29.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.976 -177.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -79.99 -26.37 39.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.547 -173.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.904 HG11 HG12 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -55.2 -33.32 30.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.273 -174.509 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.1 m -69.46 -31.17 48.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.481 -169.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -82.95 -32.33 27.19 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 76.4 mt -65.37 -49.54 68.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.837 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.525 HG13 ' O ' ' A' ' 96' ' ' VAL . 18.7 mt -75.45 -21.35 16.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.6 -174.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.3 t -84.5 -26.19 28.3 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.019 0.438 . . . . 0.0 110.798 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.2 21.54 15.07 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.866 -176.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -97.9 -41.47 8.0 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.949 0.404 . . . . 0.0 111.336 -176.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.716 HD11 ' NZ ' ' A' ' 108' ' ' LYS . 37.0 tp -101.86 127.01 48.87 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.721 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.426 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 16.8 m120 -68.76 122.0 83.31 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.249 176.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -67.99 -21.21 43.69 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.067 1.845 . . . . 0.0 110.033 176.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -64.01 -56.28 16.18 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.685 175.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.716 ' NZ ' HD11 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -64.83 -37.37 87.39 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.78 178.186 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.547 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -67.25 -33.66 75.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.023 0.44 . . . . 0.0 109.956 -178.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -61.17 -50.78 71.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.052 175.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -61.87 -40.16 94.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.843 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -76.26 6.96 4.74 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.993 -177.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.79 6.66 82.35 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.895 175.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -79.39 -47.65 15.38 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.917 0.389 . . . . 0.0 110.585 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.592 HG23 HG22 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -92.02 110.78 23.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.025 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.559 ' HE2' ' HA ' ' A' ' 116' ' ' LYS . 10.8 mmpt? -108.11 105.32 15.02 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.663 176.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.676 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.32 -0.693 0 CA-C-O 121.322 0.582 . . . . 0.0 111.457 -173.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 13.3 m120 . . . . . 0 CA--C 1.517 -0.312 0 CA-C-O 121.694 0.759 . . . . 0.0 110.449 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -65.73 -21.27 58.68 Favored 'Trans proline' 0 C--N 1.328 -0.517 0 C-N-CA 123.84 3.027 . . . . 0.0 112.17 -174.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.634 ' HA ' ' CG ' ' A' ' 26' ' ' PHE . 8.6 mt-10 -86.17 -16.73 36.94 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.214 -178.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -84.61 -8.12 59.0 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.905 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -72.1 163.19 28.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.827 177.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.466 ' HG2' ' CG1' ' A' ' 97' ' ' VAL . 5.5 tppp? -79.34 -31.98 43.22 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 174.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.973 HG12 HG11 ' A' ' 96' ' ' VAL . 1.3 m -70.24 -14.88 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.85 -178.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.634 ' CG ' ' HA ' ' A' ' 21' ' ' GLU . 57.6 t80 -56.76 -55.2 37.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.691 0.282 . . . . 0.0 110.594 -178.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.422 ' HE2' HG23 ' A' ' 31' ' ' ILE . 0.6 OUTLIER -67.65 -40.78 84.52 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 120.765 0.317 . . . . 0.0 110.549 178.42 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.4 ' O ' HG12 ' A' ' 31' ' ' ILE . 14.4 m-85 -61.43 -45.85 92.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.794 -178.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 64.2 mtp -75.41 -26.56 58.5 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.67 0.271 . . . . 0.0 110.99 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.437 ' HD3' ' HA ' ' A' ' 30' ' ' LYS . 24.5 mmtp -67.73 -40.15 84.22 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 121.064 -0.254 . . . . 0.0 110.687 174.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.422 HG23 ' HE2' ' A' ' 27' ' ' LYS . 10.9 pt -79.67 -23.0 12.07 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.401 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.159 177.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.9 tt -57.23 -54.25 48.96 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 172.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.424 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 9.6 tt0 -44.2 -48.52 9.3 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.707 177.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -75.36 -61.18 1.99 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.511 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.402 ' HA ' ' HB3' ' A' ' 38' ' ' ASN . . . -55.79 -34.86 65.67 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -166.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 93.3 mmm -61.17 -43.04 99.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.69 0.281 . . . . 0.0 111.387 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -92.12 -27.03 17.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.158 0.504 . . . . 0.0 110.987 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.402 ' HB3' ' HA ' ' A' ' 35' ' ' ALA . 10.0 t30 -66.95 -27.38 67.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.763 -177.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -60.44 139.94 57.47 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 173.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 p -62.27 -13.95 33.73 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -174.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -97.03 -9.34 28.34 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 119.094 -0.479 . . . . 0.0 111.892 177.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.2 p30 35.49 66.26 0.35 Allowed 'General case' 0 C--N 1.348 0.54 0 CA-C-O 122.129 0.966 . . . . 0.0 110.588 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.5 mt -62.94 -12.02 22.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 113.884 -1.507 . . . . 0.0 112.014 -170.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.9 tp -64.69 -29.09 46.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.878 0.37 . . . . 0.0 111.01 -175.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -72.55 -29.04 63.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.037 -177.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -75.18 -21.48 58.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.312 0.577 . . . . 0.0 110.751 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 47' ' ' VAL . 13.3 p -130.06 32.02 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.701 -173.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -44.87 116.28 1.05 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.5 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.493 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . 179.86 164.27 31.87 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.878 -176.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.515 HG13 ' HB2' ' A' ' 71' ' ' LYS . 51.8 mt -97.05 127.51 49.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 117.467 0.633 . . . . 0.0 110.682 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.488 ' OH ' HG13 ' A' ' 47' ' ' VAL . 9.6 m-85 -108.95 122.48 47.32 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.671 -178.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.54 115.52 5.32 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.369 -0.92 . . . . 0.0 111.396 177.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -101.61 107.41 18.66 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.253 0.549 . . . . 0.0 111.545 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -97.54 99.14 10.54 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.54 176.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.728 HG11 HG11 ' A' ' 25' ' ' VAL . 20.4 t -102.42 125.21 56.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.025 0.441 . . . . 0.0 110.73 -175.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -115.41 177.84 4.52 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.174 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.6 m120 58.72 44.51 17.11 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.015 0.436 . . . . 0.0 111.562 177.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.93 -154.68 8.18 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.936 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 62' ' ' ALA . 71.4 Cg_exo -36.63 -59.94 0.41 Allowed 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 124.575 3.517 . . . . 0.0 114.298 -176.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -128.46 61.99 1.47 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 177.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.55 29.17 74.35 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.211 -176.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.411 ' HB3' ' HD2' ' A' ' 59' ' ' PRO . . . -76.89 154.09 34.09 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.184 0.516 . . . . 0.0 111.173 -177.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -132.55 110.59 10.58 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.494 -177.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.41 163.18 12.55 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.429 -177.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -147.89 116.89 6.8 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.88 0.371 . . . . 0.0 110.62 -178.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 18.9 m-90 -121.2 141.09 51.18 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.273 0.558 . . . . 0.0 109.682 179.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 16.4 t -107.63 117.98 54.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.164 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.447 HG13 HG12 ' A' ' 77' ' ' VAL . 4.1 mp -93.37 99.77 10.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -87.05 99.8 12.17 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.576 -176.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -113.54 13.97 18.9 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.175 175.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.515 ' HB2' HG13 ' A' ' 50' ' ' ILE . 17.8 tppt? -64.48 -44.82 89.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.221 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -82.13 -0.73 46.14 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.672 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.8 27.28 32.35 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.308 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -93.36 -62.67 1.32 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.687 0.279 . . . . 0.0 111.037 -178.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.54 34.26 8.04 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.15 -1.024 . . . . 0.0 111.893 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 59.0 pttt -97.86 146.27 25.6 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -177.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.7 OUTLIER -110.82 131.47 61.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.355 0.598 . . . . 0.0 109.859 178.448 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.488 HG23 ' HA2' ' A' ' 81' ' ' GLY . 3.6 t -137.97 139.23 39.6 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.984 -178.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.423 ' O ' ' HB3' ' A' ' 80' ' ' ASN . 24.2 t80 -65.1 128.11 34.42 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -178.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.423 ' HB3' ' O ' ' A' ' 79' ' ' TYR . 26.0 t-20 74.92 -45.8 0.58 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.677 0.791 . . . . 0.0 111.999 -178.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.488 ' HA2' HG23 ' A' ' 78' ' ' THR . . . 70.81 -43.14 0.6 Allowed Glycine 0 CA--C 1.52 0.387 0 N-CA-C 114.764 0.666 . . . . 0.0 114.764 177.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.58 -18.84 6.58 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.026 -175.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -82.63 157.89 23.23 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 122.602 0.361 . . . . 0.0 110.358 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -95.43 109.24 44.28 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 174.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.464 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 23.2 Cg_exo -64.72 137.18 52.87 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.034 2.489 . . . . 0.0 112.712 -177.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -68.53 -32.48 72.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.107 -0.952 . . . . 0.0 109.546 176.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.9 m -140.27 130.41 28.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.316 172.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.594 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 28.2 m -114.91 133.87 55.63 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.375 176.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.654 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 53.0 m-85 -118.18 128.71 54.97 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.542 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 5.9 m -106.4 128.34 53.97 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 174.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -159.27 149.52 7.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.172 0.51 . . . . 0.0 110.294 -175.146 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.38 143.53 36.75 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.329 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -49.01 -29.01 4.37 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 114.869 -1.059 . . . . 0.0 111.091 176.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -73.22 -44.38 59.69 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.217 -176.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -81.51 -25.74 35.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.036 -176.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.973 HG11 HG12 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -56.62 -33.92 41.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.303 -175.007 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.466 ' CG1' ' HG2' ' A' ' 24' ' ' LYS . 3.9 m -68.35 -27.94 38.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.992 -170.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -87.23 -29.86 21.37 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 177.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 77.9 mt -68.2 -46.5 70.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.799 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 96' ' ' VAL . 20.1 mt -75.1 -24.41 17.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.296 -176.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.1 p -85.48 -18.11 34.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.036 0.446 . . . . 0.0 111.022 178.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.39 13.24 58.78 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.084 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -85.39 -41.43 15.45 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.133 0.492 . . . . 0.0 111.164 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.702 HD11 ' NZ ' ' A' ' 108' ' ' LYS . 44.4 tp -99.46 125.54 45.21 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.426 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -71.99 122.23 86.74 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.561 177.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -64.87 -23.34 62.27 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.213 1.942 . . . . 0.0 110.385 176.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -54.96 -62.3 1.75 Allowed 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.935 171.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.702 ' NZ ' HD11 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -64.11 -36.06 82.81 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.314 -176.368 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.563 ' HB3' HD12 ' A' ' 115' ' ' ILE . . . -69.78 -33.64 72.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.154 -178.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -64.17 -49.89 70.3 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 175.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -58.79 -40.64 84.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.029 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.46 HE21 ' HB3' ' A' ' 112' ' ' GLN . 9.4 mt-30 -84.8 13.68 5.57 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.248 -176.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.546 ' O ' ' HE3' ' A' ' 116' ' ' LYS . . . 70.17 14.68 71.48 Favored Glycine 0 CA--C 1.519 0.293 0 CA-C-N 116.152 -0.476 . . . . 0.0 113.992 172.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.428 ' HA ' ' HE3' ' A' ' 114' ' ' LYS . 0.4 OUTLIER -87.55 -43.55 11.93 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 117.115 0.458 . . . . 0.0 110.219 177.578 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.574 HG23 HG22 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -89.14 114.18 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.703 176.471 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.546 ' HE3' ' O ' ' A' ' 113' ' ' GLY . 35.2 mmtp -110.79 99.4 8.33 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.474 175.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.654 ' HB ' ' CD2' ' A' ' 89' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--N 1.318 -0.79 0 CA-C-O 120.958 0.409 . . . . 0.0 110.153 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 12.6 m120 . . . . . 0 CA--C 1.517 -0.295 0 CA-C-O 121.656 0.741 . . . . 0.0 111.603 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.65 -38.25 62.85 Favored 'Trans proline' 0 CA--C 1.521 -0.142 0 C-N-CA 124.021 3.148 . . . . 0.0 111.947 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.453 ' HA ' ' CD1' ' A' ' 26' ' ' PHE . 35.5 tt0 -60.23 -31.33 70.08 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.713 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.35 -8.83 57.58 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.047 0.451 . . . . 0.0 111.058 -175.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -80.69 153.2 28.02 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.288 -0.414 . . . . 0.0 109.941 175.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 49.3 mmtm -70.56 -29.53 66.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.646 0.736 . . . . 0.0 109.234 177.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.997 HG12 HG11 ' A' ' 96' ' ' VAL . 0.7 OUTLIER -68.4 -17.39 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 114.526 -1.216 . . . . 0.0 111.056 -174.897 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.453 ' CD1' ' HA ' ' A' ' 21' ' ' GLU . 75.3 t80 -55.51 -54.52 42.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.369 -179.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.436 ' O ' HG23 ' A' ' 31' ' ' ILE . 0.5 OUTLIER -72.68 -43.7 62.76 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.56 177.363 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.463 ' HB2' ' HA ' ' A' ' 25' ' ' VAL . 12.9 m-85 -59.15 -46.25 88.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.416 . . . . 0.0 112.106 -175.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.495 ' HE1' ' HB2' ' A' ' 53' ' ' PHE . 73.4 mtp -77.53 -24.76 49.91 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.778 0.323 . . . . 0.0 110.894 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.48 ' HD3' ' HA ' ' A' ' 30' ' ' LYS . 43.0 mmtt -75.87 -31.28 59.18 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.268 177.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.436 HG23 ' O ' ' A' ' 27' ' ' LYS . 13.6 pt -82.94 -27.44 8.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 173.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.403 ' HB3' ' O ' ' A' ' 29' ' ' MET . 5.8 tt -54.16 -51.83 63.06 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 168.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.592 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 9.2 tt0 -43.6 -58.03 2.86 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 114.23 -1.35 . . . . 0.0 111.296 177.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -67.81 -54.12 21.58 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.546 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.44 ' HA ' ' HB3' ' A' ' 38' ' ' ASN . . . -54.49 -37.61 65.49 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -169.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 95.0 mmm -63.34 -37.36 86.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.668 0.271 . . . . 0.0 111.654 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -90.09 -20.64 22.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.439 0.638 . . . . 0.0 110.225 177.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.44 ' HB3' ' HA ' ' A' ' 35' ' ' ALA . 2.9 t-20 -69.31 -25.2 64.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.59 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -58.57 133.35 55.77 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 175.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.65 -30.12 41.56 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.752 -174.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -101.55 -5.46 25.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 119.468 -0.301 . . . . 0.0 111.538 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 36.11 73.67 0.08 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.718 0.77 . . . . 0.0 111.513 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 72.6 mt -64.36 -1.07 1.5 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.87 -174.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.447 HG13 ' HB1' ' A' ' 70' ' ' ALA . 4.2 tp -60.35 -25.91 35.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.699 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.43 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 32.9 mt-10 -79.78 -17.38 53.54 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.096 -177.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -86.58 -36.08 19.09 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.243 0.544 . . . . 0.0 110.188 177.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 47' ' ' VAL . 12.3 p -105.38 32.97 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.496 -178.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.43 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 51.7 mtt180 -53.33 109.96 0.5 Allowed 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.926 0.869 . . . . 0.0 111.523 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.52 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . -173.1 175.01 46.07 Favored Glycine 0 C--N 1.312 -0.788 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.788 -175.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.478 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 42.6 mt -113.09 127.13 70.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 117.904 0.852 . . . . 0.0 111.419 -177.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -109.39 129.16 55.55 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.438 -178.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -108.79 118.4 5.29 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.318 -0.944 . . . . 0.0 111.291 176.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.495 ' HB2' ' HE1' ' A' ' 29' ' ' MET . 4.0 m-85 -102.09 103.29 13.85 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.188 0.518 . . . . 0.0 111.312 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.473 ' NZ ' HG21 ' A' ' 88' ' ' THR . 58.4 mttp -89.95 99.46 12.47 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.151 174.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.753 HG11 HG11 ' A' ' 25' ' ' VAL . 18.4 t -101.78 117.09 46.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.151 -176.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 92' ' ' SER . 39.7 mtp180 -117.9 -179.72 3.84 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.496 -176.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.428 ' HB2' ' HB3' ' A' ' 92' ' ' SER . 92.7 m-20 59.06 46.75 12.91 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.229 0.538 . . . . 0.0 110.969 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.74 -159.0 11.07 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.529 178.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -37.5 -61.1 0.37 Allowed 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 124.324 3.349 . . . . 0.0 114.063 -174.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -130.59 68.11 1.48 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.171 0.51 . . . . 0.0 110.1 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.51 23.04 73.58 Favored Glycine 0 N--CA 1.452 -0.247 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.56 -178.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.4 167.48 20.8 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.071 0.462 . . . . 0.0 111.331 -177.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -142.5 143.81 32.7 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.462 -176.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -136.72 159.92 24.68 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 111.141 -0.783 . . . . 0.0 111.141 178.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.4 ' O ' ' HA ' ' A' ' 79' ' ' TYR . 16.2 t80 -148.08 113.11 5.48 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.936 0.368 . . . . 0.0 110.719 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 18.3 m-90 -118.25 134.85 54.66 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.867 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 25.1 t -104.56 119.92 54.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.547 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.52 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 3.7 mp -95.1 100.98 11.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -86.77 97.58 10.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.221 0.534 . . . . 0.0 109.967 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -98.56 -6.74 29.49 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.243 173.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.44 ' HB2' HG13 ' A' ' 50' ' ' ILE . 21.9 tttt -54.79 -49.4 71.02 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.898 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -80.13 3.48 20.38 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.008 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.14 11.83 83.13 Favored Glycine 0 N--CA 1.452 -0.274 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.956 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -83.26 -59.64 2.4 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.739 0.304 . . . . 0.0 110.803 -177.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.35 34.08 24.04 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.223 -0.989 . . . . 0.0 110.65 -173.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.592 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 14.8 ptmm? -98.03 145.68 26.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.427 -0.387 . . . . 0.0 109.969 -175.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.8 OUTLIER -111.91 132.9 59.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.234 0.54 . . . . 0.0 109.644 178.812 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.0 t -139.36 135.58 33.86 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.918 -176.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.4 ' HA ' ' O ' ' A' ' 65' ' ' TYR . 21.9 t80 -69.89 122.08 18.58 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 53.66 71.59 0.5 Allowed 'General case' 0 C--O 1.234 0.247 0 O-C-N 123.699 0.624 . . . . 0.0 109.83 -173.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -63.12 -34.48 90.07 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.259 -0.882 . . . . 0.0 113.656 -172.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.92 -2.28 87.77 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.526 -176.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.446 ' HB3' HD13 ' A' ' 50' ' ' ILE . 54.6 mm-40 -91.58 163.25 14.2 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.401 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 24.4 pttm -94.55 107.64 31.43 Favored Pre-proline 0 N--CA 1.445 -0.688 0 CA-C-O 121.281 0.562 . . . . 0.0 110.331 173.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.478 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 8.1 Cg_exo -73.79 121.86 7.33 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.657 2.238 . . . . 0.0 112.048 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -59.59 -43.41 93.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.863 176.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.402 ' HB ' ' CD1' ' A' ' 117' ' ' ILE . 13.5 m -126.32 127.61 70.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.601 176.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.746 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 43.1 m -117.35 129.42 55.86 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.087 178.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.587 ' CD1' ' HB ' ' A' ' 117' ' ' ILE . 61.7 m-85 -110.52 130.06 55.65 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.561 ' HB ' ' HB3' ' A' ' 116' ' ' LYS . 2.9 m -108.29 107.13 17.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.763 0.316 . . . . 0.0 110.249 178.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.453 HG21 HD12 ' A' ' 99' ' ' LEU . 47.2 mt -131.23 156.75 42.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.537 -174.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.428 ' HB3' ' HB2' ' A' ' 57' ' ' ASN . 23.7 m -92.7 140.72 29.24 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.355 175.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -43.29 -51.12 6.43 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.46 0.648 . . . . 0.0 111.66 -177.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.16 -35.61 69.75 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.441 -1.254 . . . . 0.0 112.205 -176.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.424 ' OD2' ' HB2' ' A' ' 92' ' ' SER . 12.0 m-20 -90.4 -23.13 21.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.697 0.284 . . . . 0.0 111.252 -175.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.997 HG11 HG12 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -59.02 -31.84 46.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.034 0.445 . . . . 0.0 110.434 -177.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.7 m -67.03 -30.9 51.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.182 -172.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -83.14 -32.37 26.71 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.453 HD12 HG21 ' A' ' 91' ' ' ILE . 75.7 mt -66.48 -51.24 58.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.472 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 96' ' ' VAL . 17.7 mt -70.97 -26.25 27.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.082 -176.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.6 t -82.04 -15.2 54.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.702 0.286 . . . . 0.0 111.059 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.23 20.49 48.88 Favored Glycine 0 N--CA 1.454 -0.16 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.005 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -96.9 -41.56 8.36 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.142 0.496 . . . . 0.0 111.023 -178.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.452 HD23 ' HG ' ' A' ' 99' ' ' LEU . 34.1 tp -100.3 125.24 46.49 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.385 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.469 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 12.1 m120 -69.67 122.5 85.99 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.252 177.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -65.81 -21.6 57.75 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.015 1.81 . . . . 0.0 110.843 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 tm0? -65.79 -56.86 9.75 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.722 175.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.497 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -64.99 -32.35 74.03 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.435 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.501 ' HB3' HD12 ' A' ' 115' ' ' ILE . . . -66.8 -39.49 87.78 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.9 177.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -57.16 -52.95 63.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.879 175.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -60.75 -42.83 98.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.53 -178.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.408 ' OE1' ' HA ' ' A' ' 112' ' ' GLN . 16.0 mm-40 -75.78 -11.54 60.01 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.025 -175.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.26 7.71 55.78 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.767 176.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.2 mmpt? -87.17 -14.24 41.73 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.99 0.424 . . . . 0.0 110.728 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.646 HG23 HG22 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -129.55 109.48 18.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.926 0.87 . . . . 0.0 110.251 179.164 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.561 ' HB3' ' HB ' ' A' ' 90' ' ' THR . 38.1 tptt -109.35 110.24 21.34 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.331 173.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.746 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.319 -0.737 0 CA-C-O 121.411 0.624 . . . . 0.0 111.604 -172.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 . . . . . 0 CA--C 1.52 -0.193 0 CA-C-O 122.03 0.919 . . . . 0.0 112.023 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.598 ' HA ' ' CD1' ' A' ' 23' ' ' PHE . 20.6 Cg_endo -63.65 -14.21 41.33 Favored 'Trans proline' 0 C--N 1.334 -0.189 0 C-N-CA 124.35 3.367 . . . . 0.0 112.864 -177.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.414 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 3.1 mm-40 -75.52 -20.44 58.72 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.345 -178.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -88.32 -10.93 47.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.371 -0.832 . . . . 0.0 111.175 -176.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.598 ' CD1' ' HA ' ' A' ' 20' ' ' PRO . 18.0 m-85 -69.08 158.65 34.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.671 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -77.05 -27.0 54.26 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 174.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.751 HG12 HG11 ' A' ' 96' ' ' VAL . 0.8 OUTLIER -72.04 -13.69 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.365 -179.06 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -57.02 -57.53 12.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.757 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.455 ' O ' HG23 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -72.0 -30.54 65.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.708 -178.449 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.477 ' HB3' HD12 ' A' ' 100' ' ' ILE . 21.4 m-85 -70.92 -52.11 21.98 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.588 0.218 . . . . 0.0 111.588 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.56 ' HB3' HG21 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -61.9 -31.14 71.41 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.734 0.302 . . . . 0.0 110.971 177.196 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.417 ' HA ' ' HD2' ' A' ' 30' ' ' LYS . 25.7 mmmt -69.3 -33.47 73.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.546 178.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 28' ' ' TYR . 13.3 pt -88.1 -24.37 6.2 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.451 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.2 176.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.5 tt -58.02 -47.22 83.74 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 171.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.642 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 6.8 tt0 -46.21 -50.9 15.24 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.489 175.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -75.0 -58.87 3.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.45 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.02 -40.17 66.78 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -167.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 95.6 mmm -60.6 -41.29 94.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.702 0.287 . . . . 0.0 111.493 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -90.79 -26.02 19.66 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.969 0.414 . . . . 0.0 110.072 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -65.04 -17.11 64.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.57 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -57.62 130.28 45.66 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.381 172.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 22.3 p -65.31 -21.92 66.77 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.952 -173.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -101.09 0.07 37.19 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.832 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 26.19 68.53 0.05 Allowed 'General case' 0 N--CA 1.472 0.63 0 O-C-N 124.481 1.113 . . . . 0.0 112.678 -177.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.4 mt -65.09 -4.12 4.48 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.201 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.9 tp -60.51 -26.33 37.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.748 178.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.417 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 41.3 mt-10 -72.65 -23.19 60.87 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.188 -178.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -79.23 -43.64 23.39 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.361 0.6 . . . . 0.0 110.535 178.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 47' ' ' VAL . 15.0 p -102.67 32.51 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.719 -176.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.417 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 41.8 mtm180 -51.2 117.14 2.39 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.633 0.73 . . . . 0.0 111.427 178.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . -172.89 176.28 45.73 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.616 -176.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 53.8 mt -115.17 124.42 71.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 117.669 0.734 . . . . 0.0 111.358 -178.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.488 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 27.7 m-85 -106.09 118.46 36.68 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.051 -177.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.49 111.51 4.18 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.322 177.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.419 ' O ' ' HA ' ' A' ' 65' ' ' TYR . 4.0 m-85 -96.27 111.14 23.31 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.955 0.407 . . . . 0.0 111.679 -178.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -95.47 105.42 17.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.34 173.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.682 HG11 HG11 ' A' ' 25' ' ' VAL . 22.6 t -105.83 107.39 22.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 120.972 0.415 . . . . 0.0 111.099 -174.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.434 ' HD2' ' N ' ' A' ' 56' ' ' ARG . 1.3 mpt_? -92.48 -179.64 5.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.628 176.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 13.8 m120 58.87 44.74 16.29 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.8 176.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -81.15 -165.02 33.42 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.33 176.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -35.6 -60.93 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 124.619 3.546 . . . . 0.0 114.696 -176.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.47 ' OD1' ' HB2' ' A' ' 62' ' ' ALA . 25.4 p-10 -114.22 43.51 1.86 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.353 0.596 . . . . 0.0 110.328 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.83 24.16 76.55 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 -170.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.47 ' HB2' ' OD1' ' A' ' 60' ' ' ASN . . . -70.7 155.53 40.64 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 114.511 -0.845 . . . . 0.0 111.754 -175.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -115.59 139.27 50.25 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.666 177.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -129.42 152.76 19.63 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 176.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.419 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 44.7 t80 -140.1 116.93 10.97 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.869 0.366 . . . . 0.0 110.656 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 26.9 m-90 -122.72 132.41 54.23 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.278 -178.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 55.4 t -102.76 112.22 35.34 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.201 178.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.488 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 4.3 mp -89.92 102.92 13.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.155 -0.684 . . . . 0.0 109.155 176.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.423 ' OD1' ' HB3' ' A' ' 71' ' ' LYS . 44.1 t-20 -85.59 96.94 9.82 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.868 -178.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -99.89 -2.18 35.46 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.829 173.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.423 ' HB3' ' OD1' ' A' ' 69' ' ' ASN . 65.4 tttt -51.4 -50.77 58.98 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.15 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -84.0 -3.54 58.08 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.143 -176.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.19 7.49 76.82 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.254 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.7 tppt? -83.3 -44.76 14.56 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-O 120.884 0.373 . . . . 0.0 110.652 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.07 35.07 35.62 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.756 175.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.642 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -97.0 165.34 12.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.113 0.456 . . . . 0.0 110.085 -177.178 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.56 HG21 ' HB3' ' A' ' 29' ' ' MET . 0.8 OUTLIER -123.02 136.89 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-O 121.177 0.513 . . . . 0.0 109.627 178.672 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.1 t -135.28 136.01 41.3 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.041 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -69.85 116.73 10.57 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 60.3 t30 52.76 74.08 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.836 0.71 . . . . 0.0 110.093 -173.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -63.59 -28.5 72.59 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.385 -0.825 . . . . 0.0 113.152 -177.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.61 -20.26 42.7 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.846 -0.692 . . . . 0.0 111.657 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.416 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 69.2 mm-40 -73.02 156.02 39.21 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 177.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -91.84 108.2 28.12 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 173.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 83' ' ' GLU . 22.1 Cg_exo -65.36 135.45 42.94 Favored 'Trans proline' 0 CA--C 1.517 -0.361 0 C-N-CA 122.95 2.433 . . . . 0.0 112.369 -176.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -62.69 -30.4 71.37 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.776 176.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.5 m -142.63 134.74 25.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.771 176.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.675 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 17.4 m -113.37 141.06 47.5 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.275 -0.421 . . . . 0.0 109.938 177.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.651 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 29.6 m-85 -126.21 134.6 51.19 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 176.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.7 m -111.14 118.64 36.53 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.899 0.381 . . . . 0.0 110.528 176.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.529 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 80.4 mt -141.51 157.2 21.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.484 -0.78 . . . . 0.0 108.933 -175.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.444 ' OG ' ' HE3' ' A' ' 114' ' ' LYS . 6.1 p -93.02 144.81 24.88 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 111.496 0.184 . . . . 0.0 111.496 176.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -41.18 -56.23 2.43 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 122.172 0.987 . . . . 0.0 111.714 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -60.26 -34.04 73.16 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 113.272 -1.785 . . . . 0.0 112.621 -171.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.68 -19.43 22.66 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -177.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.751 HG11 HG12 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -56.52 -34.13 40.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.21 0.529 . . . . 0.0 110.026 -178.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.3 m -66.36 -28.97 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.031 -173.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -84.69 -35.5 22.52 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.452 HD23 ' O ' ' A' ' 104' ' ' LEU . 74.8 mt -68.76 -42.25 77.76 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.96 -177.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.57 HG13 ' O ' ' A' ' 96' ' ' VAL . 15.4 mt -76.27 -22.54 15.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.808 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.2 t -88.58 -19.69 25.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.966 0.412 . . . . 0.0 110.776 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.32 0.11 65.57 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.831 -177.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -67.85 -42.11 81.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.027 0.441 . . . . 0.0 110.791 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.452 ' O ' HD23 ' A' ' 99' ' ' LEU . 36.8 tp -104.38 126.38 51.43 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.873 178.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.474 ' HB3' ' HG2' ' A' ' 108' ' ' LYS . 1.8 t-20 -72.97 121.41 85.02 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.828 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -65.68 -20.7 59.44 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.932 1.755 . . . . 0.0 110.775 177.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.11 -55.82 8.47 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.749 174.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.53 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 0.4 OUTLIER -62.06 -35.71 79.45 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.457 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.53 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -68.53 -35.58 77.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.33 177.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -59.85 -49.05 79.24 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 175.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -64.87 -33.53 76.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.93 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.555 ' HA ' HE21 ' A' ' 112' ' ' GLN . 0.0 OUTLIER -87.49 10.42 17.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.751 -178.168 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.37 1.76 82.34 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 121.285 -0.483 . . . . 0.0 113.661 172.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.643 ' HZ3' ' HB3' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -94.02 11.33 30.13 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -177.081 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.544 HG23 HG22 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -140.95 109.56 2.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-O 121.976 0.893 . . . . 0.0 109.19 172.551 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -109.0 98.45 7.93 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.744 -1.117 . . . . 0.0 109.274 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.675 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.319 -0.743 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.845 178.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.454 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 15.1 m120 . . . . . 0 CA--C 1.52 -0.186 0 CA-C-O 121.152 0.501 . . . . 0.0 111.003 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 19' ' ' ASN . 23.8 Cg_exo -58.98 -31.08 95.01 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 123.413 2.742 . . . . 0.0 111.529 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.496 ' HA ' ' CD1' ' A' ' 26' ' ' PHE . 24.5 tt0 -62.47 -35.44 79.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.254 176.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -81.25 1.54 31.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.96 -174.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -77.95 153.86 32.11 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 173.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -76.81 -24.27 52.8 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.986 HG12 HG11 ' A' ' 96' ' ' VAL . 1.3 m -73.84 -14.84 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.038 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.496 ' CD1' ' HA ' ' A' ' 21' ' ' GLU . 83.1 t80 -56.75 -50.25 72.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.718 0.294 . . . . 0.0 110.372 -176.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.61 -44.32 86.87 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.582 178.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -62.47 -46.7 87.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.866 -177.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.474 ' HB3' HG21 ' A' ' 77' ' ' VAL . 56.2 mtt -73.88 -26.69 60.69 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.059 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.44 ' HD3' ' HA ' ' A' ' 30' ' ' LYS . 40.8 mmtt -71.15 -38.9 72.22 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.19 176.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 13.6 pt -78.04 -25.17 14.18 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.427 0 C-N-CA 120.329 -0.548 . . . . 0.0 109.793 175.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.3 tt -60.3 -52.76 63.91 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 173.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.533 ' HG2' ' HA ' ' A' ' 76' ' ' LYS . 1.5 tm-20 -43.37 -48.05 6.92 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 114.814 -1.084 . . . . 0.0 111.018 176.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -77.19 -53.29 7.93 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.933 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.52 -38.9 82.18 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -168.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 25.9 mmt -60.01 -40.76 90.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.713 0.292 . . . . 0.0 111.624 -178.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -91.39 -19.52 22.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.099 0.476 . . . . 0.0 111.138 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -66.38 -23.5 66.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.247 0.546 . . . . 0.0 110.028 178.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -62.14 133.81 55.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.441 173.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.8 p -62.84 -32.88 74.19 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.037 -174.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -92.06 0.66 57.47 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-O 119.303 -0.379 . . . . 0.0 111.385 178.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.6 p30 34.11 63.32 0.42 Allowed 'General case' 0 N--CA 1.468 0.433 0 O-C-N 124.172 0.92 . . . . 0.0 110.557 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.5 mt -56.97 -12.12 1.84 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 114.427 -1.26 . . . . 0.0 112.056 -173.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.433 HG13 ' HB1' ' A' ' 70' ' ' ALA . 4.2 tp -61.48 -30.99 49.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.81 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.518 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 9.6 tt0 -75.2 -27.03 59.44 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.12 0.486 . . . . 0.0 110.909 -176.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -73.37 -15.92 61.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.592 -179.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 47' ' ' VAL . 15.0 p -131.07 31.84 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.276 -178.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.518 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 59.7 mtm180 -49.21 109.44 0.26 Allowed 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.942 0.877 . . . . 0.0 112.647 -176.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.495 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . -159.6 170.75 35.89 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 113.88 -1.509 . . . . 0.0 110.493 -178.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.513 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 54.6 mt -106.47 125.45 62.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 117.416 0.608 . . . . 0.0 110.749 179.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.509 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 16.5 m-85 -107.75 116.26 31.63 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.95 -178.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -97.76 111.72 4.31 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.024 177.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -101.32 104.52 15.53 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.061 0.457 . . . . 0.0 111.488 -178.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -91.95 101.51 14.07 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.449 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.711 HG11 HG11 ' A' ' 25' ' ' VAL . 10.4 t -100.98 118.21 47.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.888 -173.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.461 ' O ' ' HA ' ' A' ' 92' ' ' SER . 50.4 mtp180 -110.28 177.66 4.63 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.686 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.432 ' HB2' ' HB3' ' A' ' 92' ' ' SER . 3.3 m-20 57.91 41.7 24.19 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.954 0.407 . . . . 0.0 110.979 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -74.08 -153.28 2.91 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.603 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -32.18 -60.14 0.19 Allowed 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 124.499 3.466 . . . . 0.0 114.233 -177.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -141.51 70.37 1.34 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.045 0.45 . . . . 0.0 109.891 176.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.81 18.15 78.71 Favored Glycine 0 N--CA 1.453 -0.176 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.702 -177.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.58 162.22 26.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.011 0.434 . . . . 0.0 111.246 -177.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -136.25 132.3 35.62 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.788 -177.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -131.98 162.4 23.88 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.453 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -146.56 113.7 6.21 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.829 0.347 . . . . 0.0 110.917 -177.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 16.3 m-90 -113.45 140.21 48.28 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.867 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 45.7 t -106.97 114.53 46.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.902 177.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.534 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 3.9 mp -91.04 99.67 10.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 175.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -87.54 99.03 11.74 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.247 -177.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -101.18 -6.7 23.91 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.892 174.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.443 ' HB2' HG13 ' A' ' 50' ' ' ILE . 3.6 tppp? -58.76 -47.53 84.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.996 -176.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -73.52 -6.32 45.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.203 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 94.88 14.35 49.73 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.033 -0.603 . . . . 0.0 111.727 -178.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.501 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 9.1 mmpt? -86.32 -70.05 0.63 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.718 0.294 . . . . 0.0 111.112 -177.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.83 32.16 13.56 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -170.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.534 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 21.8 ptmt -99.16 147.21 25.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.234 -0.483 . . . . 0.0 109.948 -177.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.474 HG21 ' HB3' ' A' ' 29' ' ' MET . 0.6 OUTLIER -107.51 127.34 63.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 176.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.2 t -130.71 127.68 39.31 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.473 -178.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -67.59 122.5 18.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.96 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 56.3 t30 54.62 72.61 0.45 Allowed 'General case' 0 C--O 1.233 0.235 0 O-C-N 123.786 0.679 . . . . 0.0 109.928 -174.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.85 -40.34 64.1 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.948 -175.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.14 -20.52 45.51 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.974 -0.632 . . . . 0.0 111.641 -176.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.495 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 40.4 mm-40 -74.08 148.2 42.08 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.646 -0.277 . . . . 0.0 110.295 178.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 24.7 pttm -80.08 109.38 12.15 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-O 121.202 0.525 . . . . 0.0 110.915 176.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.513 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 17.9 Cg_exo -67.6 136.25 38.7 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.847 2.365 . . . . 0.0 112.566 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -69.93 -31.6 69.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.701 175.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.5 m -140.68 127.53 21.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.604 173.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.591 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 64.2 m -110.96 127.39 55.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.342 176.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.546 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 83.0 m-85 -113.6 120.36 40.66 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 177.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.447 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 5.0 m -96.6 122.21 39.28 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 175.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.567 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -155.64 155.95 5.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.05 0.452 . . . . 0.0 110.794 -172.891 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 56' ' ' ARG . 13.3 m -83.75 143.2 30.15 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.322 -177.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.524 ' OD1' HG13 ' A' ' 25' ' ' VAL . 31.2 t70 -53.66 -27.73 29.2 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.226 1.011 . . . . 0.0 110.908 178.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -77.14 -38.12 52.58 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.436 -178.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -90.78 -22.17 21.16 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.763 -173.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.986 HG11 HG12 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -57.31 -32.47 41.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.12 0.486 . . . . 0.0 110.383 -178.133 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.6 m -68.82 -32.62 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.739 -172.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -77.72 -35.69 51.72 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 177.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.456 HD23 ' O ' ' A' ' 104' ' ' LEU . 84.7 mt -65.92 -48.67 70.66 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.761 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 96' ' ' VAL . 29.9 mt -70.84 -29.9 39.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.112 -177.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.7 t -78.09 -30.15 49.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.865 178.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 102.5 11.96 34.35 Favored Glycine 0 CA--C 1.516 0.105 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.672 -176.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -84.01 -41.63 17.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.096 0.474 . . . . 0.0 110.82 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.456 ' O ' HD23 ' A' ' 99' ' ' LEU . 43.2 tp -102.95 123.85 47.35 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.981 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.478 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 6.1 m-20 -73.52 117.95 64.91 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.287 178.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -60.13 -22.45 69.93 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.009 1.806 . . . . 0.0 111.214 176.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -64.35 -55.44 21.18 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.002 173.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.479 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 0.7 OUTLIER -66.83 -31.54 72.22 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.767 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.594 ' HB3' HD12 ' A' ' 115' ' ' ILE . . . -70.61 -32.65 70.07 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.085 0.469 . . . . 0.0 109.945 177.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -65.83 -46.6 77.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.331 174.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -63.16 -44.48 95.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.205 178.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.474 ' HA ' ' OE1' ' A' ' 112' ' ' GLN . 14.5 mm-40 -79.63 2.24 23.23 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -176.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.31 6.75 89.08 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.774 171.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.09 -37.79 37.87 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.031 0.443 . . . . 0.0 110.767 177.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.675 HG23 HG22 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -93.13 117.27 36.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.942 178.736 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.447 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 23.9 mmmt -109.31 99.13 8.44 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.675 HG22 HG23 ' A' ' 115' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.321 -0.667 0 CA-C-O 121.081 0.467 . . . . 0.0 110.521 -177.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.408 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 6.3 m-20 . . . . . 0 C--O 1.232 0.172 0 CA-C-O 121.371 0.605 . . . . 0.0 111.794 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.504 ' O ' ' HB2' ' A' ' 26' ' ' PHE . 4.9 Cg_exo -67.63 -22.25 44.41 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.997 2.464 . . . . 0.0 111.025 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.423 ' HG3' ' H ' ' A' ' 21' ' ' GLU . 14.5 mt-10 -65.07 -31.64 72.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.743 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -73.77 -18.69 60.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.273 -178.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -77.65 142.33 38.92 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 174.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -70.38 -23.21 62.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.664 0.745 . . . . 0.0 109.16 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 1.036 HG12 HG11 ' A' ' 96' ' ' VAL . 1.0 OUTLIER -69.4 -17.36 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.002 -179.027 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.504 ' HB2' ' O ' ' A' ' 20' ' ' PRO . 75.3 t80 -58.15 -44.16 87.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.258 0.552 . . . . 0.0 110.232 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.456 ' O ' HG23 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -77.17 -42.33 38.14 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.475 178.851 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.461 ' O ' HG12 ' A' ' 31' ' ' ILE . 24.6 m-85 -66.56 -44.39 82.46 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -177.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.435 ' CE ' HD11 ' A' ' 68' ' ' ILE . 73.9 mtp -77.56 -20.27 54.34 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.835 0.35 . . . . 0.0 110.542 -178.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 26' ' ' PHE . 19.8 mmtt -76.4 -36.67 57.94 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.871 175.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 28' ' ' TYR . 14.1 pt -77.22 -23.87 14.79 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.354 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 174.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.4 tt -58.8 -51.66 69.02 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 171.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.432 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 3.6 tt0 -45.79 -47.6 15.62 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.293 176.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -75.04 -54.5 7.05 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.54 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.6 -33.83 73.32 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -169.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.2 mmt -62.28 -39.38 92.74 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -90.96 -29.41 17.43 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.088 0.47 . . . . 0.0 110.838 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -64.61 -32.08 73.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.377 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -57.04 138.36 54.51 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.097 177.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.2 p -58.31 -24.57 60.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.027 -0.988 . . . . 0.0 113.063 -172.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -94.04 -28.42 15.75 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.8 p30 36.11 63.28 0.61 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.763 0.792 . . . . 0.0 111.181 -176.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 93.0 mt -69.52 2.75 2.85 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.859 -175.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.466 HG13 ' HB1' ' A' ' 70' ' ' ALA . 1.9 tp -56.91 -31.38 36.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.262 -177.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.415 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 7.9 pt-20 -76.75 -19.81 57.21 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.901 0.381 . . . . 0.0 111.164 -177.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -85.54 -35.01 21.37 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.25 0.548 . . . . 0.0 110.137 177.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 47' ' ' VAL . 13.2 p -108.3 32.97 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.875 0.845 . . . . 0.0 110.472 -177.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.415 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 59.0 mtm180 -52.66 124.41 13.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.521 0.677 . . . . 0.0 111.309 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.406 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . 179.74 -174.84 46.38 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 114.524 -1.216 . . . . 0.0 110.663 -175.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 63.3 mt -123.66 125.72 71.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 117.853 0.826 . . . . 0.0 111.391 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.472 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 22.7 m-85 -106.09 116.02 31.23 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.788 -178.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.38 115.59 5.23 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.533 -0.842 . . . . 0.0 111.357 177.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.417 ' O ' ' HA ' ' A' ' 65' ' ' TYR . 4.3 m-85 -100.92 109.63 21.6 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.039 0.447 . . . . 0.0 111.448 -177.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -94.35 99.34 11.57 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 172.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.807 HG11 HG11 ' A' ' 25' ' ' VAL . 18.6 t -101.03 107.35 21.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.096 0.474 . . . . 0.0 110.582 -174.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.466 ' O ' ' HA ' ' A' ' 92' ' ' SER . 35.9 mtp180 -103.18 174.36 5.9 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.087 -176.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 61.47 48.48 5.87 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.095 0.474 . . . . 0.0 111.239 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.08 -145.27 1.58 Allowed Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.245 175.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 62' ' ' ALA . 73.8 Cg_exo -40.6 -60.91 0.53 Allowed 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.665 2.91 . . . . 0.0 113.633 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -146.94 77.48 1.46 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.311 0.576 . . . . 0.0 110.487 177.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.58 13.33 83.58 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.88 178.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.422 ' HB3' ' HD2' ' A' ' 59' ' ' PRO . . . -72.73 143.78 47.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.987 0.423 . . . . 0.0 110.823 179.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -129.53 114.46 16.12 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.13 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -107.98 168.88 14.06 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.636 -178.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.417 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 44.5 t80 -150.2 120.34 7.25 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.754 0.311 . . . . 0.0 110.765 -177.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 16.9 m-90 -123.49 149.94 44.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.976 0.417 . . . . 0.0 109.919 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 38.2 t -118.25 118.1 56.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.645 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.472 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 4.1 mp -92.56 105.45 16.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 175.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -91.15 97.47 11.16 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.514 -176.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.466 ' HB1' HG13 ' A' ' 44' ' ' ILE . . . -98.1 -10.32 24.45 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.322 174.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.59 ' HD2' ' HG3' ' A' ' 72' ' ' GLU . 1.2 tmmt? -59.71 -34.88 73.49 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.212 -178.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.59 ' HG3' ' HD2' ' A' ' 71' ' ' LYS . 40.5 mt-10 -95.09 12.61 28.03 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.334 0.587 . . . . 0.0 111.24 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.53 -12.96 43.91 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.401 -0.818 . . . . 0.0 113.507 174.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -74.11 -56.23 5.17 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.706 0.289 . . . . 0.0 111.22 -176.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.89 35.06 9.36 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.198 -1.001 . . . . 0.0 111.736 -177.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 16.3 pttm -96.89 151.43 19.69 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 -175.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.8 OUTLIER -108.22 132.3 56.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 108.984 -0.746 . . . . 0.0 108.984 177.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.3 t -136.53 134.33 37.41 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.186 -177.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -66.54 125.32 25.37 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.28 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 51.78 63.16 2.35 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.275 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -59.21 -40.41 95.76 Favored Glycine 0 C--N 1.33 0.224 0 CA-C-N 115.324 -0.853 . . . . 0.0 113.847 -173.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.65 -20.61 47.69 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.931 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.497 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 15.6 mm-40 -70.19 150.57 46.33 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 174.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -85.04 107.82 13.14 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 178.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 83' ' ' GLU . 16.6 Cg_exo -67.95 128.89 18.51 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.855 2.37 . . . . 0.0 112.425 -177.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -62.16 -33.43 74.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.775 175.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.505 ' HB ' ' CD1' ' A' ' 117' ' ' ILE . 2.9 m -137.68 142.45 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.406 175.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.703 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 34.1 m -126.11 126.15 43.71 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.472 -179.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.409 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 55.0 m-85 -108.85 124.96 51.45 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.404 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 6.7 m -98.98 114.62 27.35 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 173.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.531 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 89.3 mt -137.54 150.35 25.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.811 -174.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 56' ' ' ARG . 51.1 m -90.52 137.3 32.46 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.866 176.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -43.23 -51.72 6.01 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 123.658 0.599 . . . . 0.0 111.826 -177.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.03 -41.17 67.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.374 -177.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -90.18 -18.36 25.89 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -174.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 1.036 HG11 HG12 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -57.39 -31.02 37.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.078 0.466 . . . . 0.0 110.066 -178.55 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.9 m -69.29 -28.71 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.836 -174.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -79.46 -39.59 31.88 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 176.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.474 HD23 ' O ' ' A' ' 104' ' ' LEU . 86.8 mt -68.17 -41.88 80.84 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.814 -176.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 96' ' ' VAL . 19.5 mt -72.96 -25.35 21.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.35 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 10.3 t -95.75 -5.27 42.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.093 -178.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.49 15.12 76.94 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.139 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -82.22 -42.52 18.84 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.336 0.589 . . . . 0.0 110.408 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.474 ' O ' HD23 ' A' ' 99' ' ' LEU . 41.4 tp -104.76 124.18 48.95 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.867 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.495 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 17.5 m120 -71.05 116.32 45.44 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.353 178.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -60.37 -22.9 73.0 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.067 1.845 . . . . 0.0 111.301 178.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -62.15 -59.42 5.08 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.956 173.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.517 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -64.75 -33.58 76.31 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.888 -177.676 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.519 ' HB1' ' HB3' ' A' ' 114' ' ' LYS . . . -71.32 -29.9 65.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.395 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -66.31 -45.03 81.72 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 175.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -66.93 -37.67 84.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.363 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -82.02 -6.38 59.1 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.053 -177.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.03 15.41 61.03 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.261 175.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.519 ' HB3' ' HB1' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -81.76 -41.6 20.95 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.567 0.699 . . . . 0.0 109.266 176.671 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.663 HG23 HG22 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -104.25 126.88 58.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.601 -176.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.404 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 34.2 mmtp -120.58 99.63 6.66 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 174.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.703 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.484 0 CA-C-O 121.035 0.445 . . . . 0.0 111.567 -176.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.3 m120 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.985 0.422 . . . . 0.0 110.626 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' A' ' 26' ' ' PHE . 11.8 Cg_exo -64.76 -29.16 59.55 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.206 2.604 . . . . 0.0 112.005 -175.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -63.73 -34.87 78.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.544 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -70.23 -11.63 61.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.355 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -81.23 143.31 32.4 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.174 0.512 . . . . 0.0 110.186 177.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -74.29 -21.11 59.89 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.569 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.842 HG12 HG11 ' A' ' 96' ' ' VAL . 2.5 m -75.16 -17.23 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.075 177.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.457 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 73.2 t80 -54.19 -57.24 11.91 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.871 0.367 . . . . 0.0 110.57 -176.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.96 -32.68 74.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.8 -177.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.481 ' O ' HG12 ' A' ' 31' ' ' ILE . 10.5 m-85 -70.59 -46.75 62.84 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.298 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.426 ' HE2' ' HB2' ' A' ' 29' ' ' MET . 29.6 mtm -66.17 -30.51 70.99 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.833 176.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 26' ' ' PHE . 29.4 mmmt -64.63 -35.38 80.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.061 177.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 28' ' ' TYR . 9.6 pt -88.35 -16.18 8.93 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.565 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.231 176.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.3 tt -64.5 -51.42 63.02 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 168.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.581 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 6.3 tt0 -44.35 -45.51 8.86 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 114.447 -1.251 . . . . 0.0 110.865 173.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -73.16 -59.57 2.65 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.499 178.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.84 -37.23 68.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.668 -0.697 . . . . 0.0 112.769 -167.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.447 ' HB3' HD13 ' A' ' 44' ' ' ILE . 25.9 mmt -59.43 -42.76 92.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.788 -179.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -92.34 -24.15 19.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.094 0.473 . . . . 0.0 111.015 178.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -64.92 -30.02 70.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.01 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -54.64 135.96 46.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.559 0.695 . . . . 0.0 110.041 176.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 16.2 p -52.73 -38.58 61.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.257 -1.338 . . . . 0.0 112.973 -173.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -102.78 8.89 39.31 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 119.227 -0.416 . . . . 0.0 111.258 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 34.2 67.8 0.2 Allowed 'General case' 0 C--O 1.238 0.461 0 O-C-N 124.183 0.927 . . . . 0.0 110.752 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.401 ' O ' HG12 ' A' ' 47' ' ' VAL . 69.1 mt -62.08 -0.4 0.51 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.273 -1.33 . . . . 0.0 112.403 -171.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.447 HD13 ' HB3' ' A' ' 36' ' ' MET . 4.2 tp -63.23 -28.21 44.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.3 178.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -76.6 -10.86 59.69 Favored 'General case' 0 N--CA 1.46 0.053 0 CA-C-O 121.235 0.54 . . . . 0.0 110.645 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -100.53 -14.8 18.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.804 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 47' ' ' VAL . 14.6 p -131.18 33.05 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.662 0.744 . . . . 0.0 110.364 -177.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 50.8 mtt180 -51.89 109.45 0.37 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.738 0.78 . . . . 0.0 111.826 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.597 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . -167.41 167.38 39.88 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.398 -177.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.488 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 32.9 mt -105.89 125.71 61.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 118.481 1.14 . . . . 0.0 111.145 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.578 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 17.0 m-85 -104.25 122.55 45.64 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.607 -177.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.47 125.14 8.48 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.236 176.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.429 ' CD1' HD13 ' A' ' 68' ' ' ILE . 5.6 m-85 -108.12 99.85 9.24 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.171 0.51 . . . . 0.0 111.331 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -94.78 100.82 12.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.141 173.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.744 HG11 HG11 ' A' ' 25' ' ' VAL . 19.8 t -108.47 117.72 54.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.1 0.476 . . . . 0.0 111.141 -173.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 47.0 mtp180 -102.25 -179.72 4.07 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.218 -177.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.447 ' HB2' ' HB3' ' A' ' 92' ' ' SER . 3.5 m-20 59.89 44.72 13.29 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 123.288 0.368 . . . . 0.0 111.34 178.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.97 -157.27 6.9 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.692 177.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -43.3 -59.74 0.95 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.675 2.917 . . . . 0.0 112.888 -178.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -113.47 46.88 1.21 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 175.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.6 15.44 77.63 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.837 -176.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.0 143.44 57.77 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.729 0.776 . . . . 0.0 111.606 -177.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -107.98 109.63 21.15 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.917 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.65 154.03 19.63 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 35.1 t80 -139.25 117.38 11.82 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.95 0.405 . . . . 0.0 111.173 -178.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 10.2 m-90 -119.71 161.7 20.28 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.2 t -126.36 118.8 52.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.265 178.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.578 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 3.1 mp -96.36 100.54 11.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 176.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -82.4 98.22 8.76 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.166 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -100.64 -5.11 27.13 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.975 175.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.496 ' HE3' ' HA2' ' A' ' 49' ' ' GLY . 4.1 tppp? -66.05 -39.23 89.95 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.256 -178.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -81.0 0.54 35.18 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.019 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.75 13.59 83.29 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.198 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.513 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 10.8 mmpt? -86.22 -50.5 6.93 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.68 0.276 . . . . 0.0 110.566 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.44 33.07 61.57 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.455 -0.879 . . . . 0.0 111.004 -176.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.581 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 52.2 pttt -98.5 149.24 22.92 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.504 -0.348 . . . . 0.0 110.197 -177.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.49 HG12 HG13 ' A' ' 68' ' ' ILE . 0.9 OUTLIER -108.11 123.01 63.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.699 0.761 . . . . 0.0 109.565 -178.383 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.444 HG23 ' HA2' ' A' ' 81' ' ' GLY . 4.5 t -130.36 134.46 47.18 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.582 -178.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -64.68 129.66 40.63 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 -176.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 72.68 -43.19 0.56 Allowed 'General case' 0 N--CA 1.47 0.557 0 O-C-N 124.001 0.813 . . . . 0.0 111.944 -177.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.444 ' HA2' HG23 ' A' ' 78' ' ' THR . . . 71.91 -42.68 0.76 Allowed Glycine 0 CA--C 1.518 0.259 0 CA-C-N 116.151 -0.477 . . . . 0.0 114.222 177.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.79 13.22 78.6 Favored Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 -174.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -116.25 166.74 11.69 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -177.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -100.7 109.01 56.37 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.204 177.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.488 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 12.6 Cg_exo -71.48 127.95 13.88 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 122.994 2.462 . . . . 0.0 112.789 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -60.97 -46.5 90.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.587 173.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.455 ' HB ' ' CD1' ' A' ' 117' ' ' ILE . 8.7 m -125.11 125.12 68.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.65 178.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.718 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 15.2 m -122.77 125.69 45.98 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.35 -178.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.493 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 86.2 m-85 -105.18 136.24 45.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.609 0.242 . . . . 0.0 110.39 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.567 ' HB ' ' HB3' ' A' ' 116' ' ' LYS . 2.2 m -109.72 99.63 8.77 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 175.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.565 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 49.0 mt -125.46 162.47 28.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -175.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.487 ' N ' HG22 ' A' ' 91' ' ' ILE . 20.3 m -97.86 145.53 26.34 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.987 0.422 . . . . 0.0 110.364 176.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.583 ' OD1' HG13 ' A' ' 25' ' ' VAL . 36.6 t70 -54.18 -24.03 16.64 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.016 -176.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -82.83 -35.38 26.4 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.982 -177.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -90.11 -26.44 20.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.711 -172.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.842 HG11 HG12 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -54.5 -33.13 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.011 0.434 . . . . 0.0 111.453 -176.648 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.4 m -66.34 -27.51 40.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.639 -169.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.418 ' HA ' ' HG ' ' A' ' 101' ' ' SER . 33.5 m-20 -89.69 -27.44 20.1 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 176.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.467 HD12 HG21 ' A' ' 91' ' ' ILE . 76.1 mt -69.09 -42.97 75.46 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.204 0.526 . . . . 0.0 110.533 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 96' ' ' VAL . 16.7 mt -77.46 -27.64 15.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.137 -177.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.43 ' OG ' ' HD3' ' A' ' 103' ' ' LYS . 64.0 p -83.56 -27.55 29.21 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.978 0.418 . . . . 0.0 110.778 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.38 -5.23 31.5 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.876 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.43 ' HD3' ' OG ' ' A' ' 101' ' ' SER . 14.0 mptt -67.56 -42.06 83.24 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 179.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.464 ' O ' HD23 ' A' ' 99' ' ' LEU . 25.1 tp -99.93 119.88 38.92 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.141 0.495 . . . . 0.0 110.218 -177.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.489 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 15.3 m120 -67.62 118.06 53.58 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.183 178.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -64.16 -21.68 67.55 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.123 1.882 . . . . 0.0 110.989 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -64.02 -53.68 46.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.325 174.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.525 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -68.04 -33.39 74.49 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -178.861 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.526 ' HB3' HD12 ' A' ' 115' ' ' ILE . . . -67.46 -36.59 81.46 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.999 177.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -59.35 -48.01 83.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.845 176.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -67.96 -37.97 82.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.016 -177.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -82.84 2.9 31.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.969 -0.559 . . . . 0.0 112.275 -177.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 81.14 13.91 80.07 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.771 -0.728 . . . . 0.0 113.379 175.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -92.32 -10.58 37.8 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.196 0.522 . . . . 0.0 110.297 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.61 HG23 HG22 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -133.35 109.09 13.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.751 177.937 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.567 ' HB3' ' HB ' ' A' ' 90' ' ' THR . 45.9 tptt -112.77 107.1 15.61 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.3 174.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.718 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.323 -0.58 0 CA-C-O 121.058 0.456 . . . . 0.0 111.552 -170.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.431 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 38.9 m-80 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 121.029 0.442 . . . . 0.0 111.142 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.436 ' HA ' ' CD1' ' A' ' 23' ' ' PHE . 4.8 Cg_exo -68.21 -21.39 42.05 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 123.143 2.562 . . . . 0.0 111.578 -176.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -72.42 -20.73 61.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.247 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -81.95 -0.06 42.21 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.006 178.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.436 ' CD1' ' HA ' ' A' ' 20' ' ' PRO . 37.7 m-85 -90.12 152.56 21.07 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 175.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.408 ' O ' ' HD2' ' A' ' 28' ' ' TYR . 48.0 tptt -80.34 -26.05 38.92 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.718 HG12 HG11 ' A' ' 96' ' ' VAL . 0.8 OUTLIER -68.93 -15.19 19.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.57 178.15 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -53.75 -60.15 3.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.207 0.527 . . . . 0.0 110.572 178.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.0 -33.51 65.83 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.609 -177.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.512 ' O ' HG12 ' A' ' 31' ' ' ILE . 17.7 m-85 -67.76 -48.91 65.05 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.787 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.623 ' SD ' ' HB ' ' A' ' 25' ' ' VAL . 0.1 OUTLIER -63.25 -29.42 70.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.893 0.378 . . . . 0.0 110.74 175.889 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.44 ' HD3' ' HA ' ' A' ' 30' ' ' LYS . 37.8 mmtt -71.86 -34.36 69.16 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.787 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.512 HG12 ' O ' ' A' ' 28' ' ' TYR . 8.7 pt -82.24 -21.87 9.69 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.519 0 C-N-CA 119.971 -0.692 . . . . 0.0 109.705 174.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.405 ' O ' ' HG2' ' A' ' 36' ' ' MET . 6.5 tt -60.53 -50.97 71.4 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 170.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.521 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 6.4 tt0 -43.86 -48.51 8.36 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.183 174.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -76.33 -52.85 9.1 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.78 -177.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.433 ' HA ' ' HB3' ' A' ' 38' ' ' ASN . . . -63.21 -32.72 74.19 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -168.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.405 ' HG2' ' O ' ' A' ' 32' ' ' LEU . 94.5 mmm -62.35 -43.59 98.48 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.491 0.182 . . . . 0.0 111.491 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -91.09 -16.26 28.14 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.737 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.433 ' HB3' ' HA ' ' A' ' 35' ' ' ALA . 26.9 t-20 -65.81 -17.63 64.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.387 0.613 . . . . 0.0 109.943 175.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -54.83 128.94 35.33 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.055 172.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.6 p -62.38 -25.78 68.11 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.492 -0.777 . . . . 0.0 112.346 -175.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -100.09 -0.12 39.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.941 0.4 . . . . 0.0 111.02 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 39.22 52.84 2.18 Favored 'General case' 0 C--N 1.344 0.365 0 CA-C-N 114.614 -1.176 . . . . 0.0 111.742 -175.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.0 mt -60.9 -4.35 0.99 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.803 -175.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.425 HD11 ' CB ' ' A' ' 70' ' ' ALA . 1.1 tp -55.97 -30.16 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-O 120.766 0.317 . . . . 0.0 110.591 176.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.514 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 5.8 pt-20 -64.47 -36.03 82.87 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.346 -177.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -77.14 -15.8 59.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.996 0.427 . . . . 0.0 111.108 -175.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 47' ' ' VAL . 14.5 p -130.71 32.28 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.934 0.874 . . . . 0.0 110.24 -175.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.514 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 94.9 mtt180 -57.96 116.98 3.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.597 -0.728 . . . . 0.0 111.843 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.495 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . -171.23 173.98 44.84 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.188 -178.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.483 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 52.7 mt -104.99 125.42 59.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 117.485 0.642 . . . . 0.0 111.234 -178.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.573 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 3.1 m-85 -107.28 110.99 23.15 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.815 -177.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.15 116.29 5.32 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.419 -0.896 . . . . 0.0 111.47 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.428 ' O ' ' HA ' ' A' ' 65' ' ' TYR . 5.1 m-85 -100.61 109.41 21.48 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.027 0.441 . . . . 0.0 111.636 -178.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -94.35 99.84 11.98 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.378 175.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.675 HG11 HG11 ' A' ' 25' ' ' VAL . 19.0 t -98.58 133.11 42.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.811 -175.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -122.33 173.26 7.74 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.117 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 59.81 49.7 7.73 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.103 0.478 . . . . 0.0 111.395 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.42 -140.07 1.61 Allowed Glycine 0 CA--C 1.522 0.48 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.437 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 62' ' ' ALA . 54.1 Cg_exo -40.73 -61.6 0.46 Allowed 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.768 2.979 . . . . 0.0 114.098 178.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -152.06 82.23 1.26 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.187 0.518 . . . . 0.0 109.97 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 73.23 12.55 79.72 Favored Glycine 0 N--CA 1.453 -0.223 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.476 ' HB3' ' HD2' ' A' ' 59' ' ' PRO . . . -82.39 157.03 23.88 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.044 -0.578 . . . . 0.0 111.381 -175.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -133.22 143.08 48.92 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.667 -177.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.8 162.72 24.19 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.443 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.428 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 33.6 t80 -148.42 117.58 6.84 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.82 0.343 . . . . 0.0 110.881 -176.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 16.6 m-90 -120.82 139.32 53.31 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.9 t -107.65 112.75 41.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.448 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.573 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 3.9 mp -90.73 100.7 11.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 175.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -85.66 97.4 10.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.418 0.628 . . . . 0.0 109.887 -178.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -102.22 -0.43 33.07 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.404 174.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.451 ' HB2' HG13 ' A' ' 50' ' ' ILE . 4.9 tppp? -63.33 -45.48 91.05 Favored 'General case' 0 CA--C 1.523 -0.079 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.166 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -72.76 -8.79 57.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.615 176.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.34 -4.14 86.37 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.897 -178.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -71.64 -39.93 70.07 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.884 0.373 . . . . 0.0 111.417 -177.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.6 34.16 54.41 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.562 176.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.521 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 19.7 ptmt -98.2 149.19 22.82 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 -175.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.6 HG21 ' HB3' ' A' ' 29' ' ' MET . 0.7 OUTLIER -109.52 132.43 57.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.674 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.0 t -133.84 129.23 36.19 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.387 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -66.49 122.5 17.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.37 -178.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 54.81 65.73 1.42 Allowed 'General case' 0 N--CA 1.464 0.226 0 O-C-N 123.765 0.666 . . . . 0.0 109.813 -176.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.04 -40.25 88.6 Favored Glycine 0 C--N 1.33 0.207 0 CA-C-N 115.57 -0.741 . . . . 0.0 113.707 -173.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.11 -21.27 40.98 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.041 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.451 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 7.4 mm-40 -71.26 143.19 50.46 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 175.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? -76.88 114.47 39.61 Favored Pre-proline 0 N--CA 1.438 -1.037 0 CA-C-O 121.39 0.614 . . . . 0.0 110.827 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.483 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 13.9 Cg_exo -68.92 126.55 14.02 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.191 2.594 . . . . 0.0 112.16 177.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -60.66 -33.5 72.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.297 173.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.561 ' HB ' ' CD1' ' A' ' 117' ' ' ILE . 11.3 m -136.76 142.16 38.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.326 174.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.678 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 22.9 m -127.44 138.75 53.05 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.098 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.461 ' CE2' HD13 ' A' ' 117' ' ' ILE . 18.7 m-85 -122.69 120.92 35.1 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 123.177 0.298 . . . . 0.0 110.336 -177.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.2 m -93.56 113.18 25.24 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 171.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 81.5 mt -137.46 156.9 33.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -175.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.41 ' H ' ' HE2' ' A' ' 114' ' ' LYS . 17.7 m -100.25 144.53 29.17 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.196 0.522 . . . . 0.0 110.326 177.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -51.8 -34.91 42.07 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 114.607 -1.179 . . . . 0.0 112.291 -175.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -71.05 -36.16 72.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.11 -177.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.451 ' CG ' ' HD2' ' A' ' 114' ' ' LYS . 7.4 m-20 -90.91 -19.25 23.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.187 -174.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.718 HG11 HG12 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -56.72 -33.57 40.9 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 CA-C-O 120.899 0.381 . . . . 0.0 110.696 -178.452 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.7 m -64.1 -27.35 42.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.38 -172.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -86.67 -29.4 22.51 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 177.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.497 HD23 ' O ' ' A' ' 104' ' ' LEU . 85.1 mt -76.02 -39.87 54.73 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.918 -178.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.485 HG21 ' HD1' ' A' ' 28' ' ' TYR . 2.7 mm -67.39 -36.34 76.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.273 0.559 . . . . 0.0 110.374 177.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 36.4 p -79.92 -21.57 43.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.335 -176.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.66 11.32 60.74 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.62 -177.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -80.06 -42.85 22.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.047 0.451 . . . . 0.0 110.968 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.497 ' O ' HD23 ' A' ' 99' ' ' LEU . 43.3 tp -96.98 120.25 36.98 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.497 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 18.3 m120 -69.31 117.52 53.21 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.767 178.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -62.22 -22.91 74.92 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.013 1.809 . . . . 0.0 110.845 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -62.11 -56.14 21.84 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.191 173.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.547 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 0.7 OUTLIER -67.12 -33.95 76.56 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -177.942 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.591 ' HB3' HD12 ' A' ' 115' ' ' ILE . . . -69.5 -32.13 70.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.002 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -61.99 -50.93 70.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.469 175.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -64.19 -39.76 94.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.921 -178.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -76.69 -8.48 57.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.09 -177.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 95.34 -4.18 66.84 Favored Glycine 0 CA--C 1.517 0.181 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.346 173.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.451 ' HD2' ' CG ' ' A' ' 95' ' ' ASP . 0.2 OUTLIER -66.72 -39.62 88.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.112 0.482 . . . . 0.0 111.107 177.45 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.705 HG23 HG22 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -107.55 131.99 56.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.302 -174.113 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -120.88 99.37 6.48 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.042 173.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.705 HG22 HG23 ' A' ' 115' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.455 0 CA-C-O 120.991 0.424 . . . . 0.0 111.534 -178.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 . . . . . 0 CA--C 1.515 -0.388 0 CA-C-O 121.794 0.807 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.03 -19.26 35.09 Favored 'Trans proline' 0 C--N 1.328 -0.502 0 C-N-CA 124.095 3.197 . . . . 0.0 111.922 -175.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.496 ' HA ' ' CG ' ' A' ' 26' ' ' PHE . 17.1 mt-10 -76.65 -23.86 53.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.368 -176.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -91.65 28.84 1.65 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.338 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -110.58 160.18 16.88 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.086 174.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -74.17 -35.49 64.02 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 172.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 1.048 HG12 HG11 ' A' ' 96' ' ' VAL . 0.8 OUTLIER -65.15 -20.54 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.568 -178.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.496 ' CG ' ' HA ' ' A' ' 21' ' ' GLU . 67.5 t80 -56.95 -46.59 82.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.963 0.411 . . . . 0.0 110.593 -179.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.426 ' HE2' HG23 ' A' ' 31' ' ' ILE . 0.6 OUTLIER -75.91 -44.99 37.65 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.474 177.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -63.9 -43.73 95.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.342 -175.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.458 ' CE ' HD11 ' A' ' 68' ' ' ILE . 71.9 mtp -76.59 -20.32 56.92 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.78 0.324 . . . . 0.0 110.811 -178.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -75.13 -46.67 32.88 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 175.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.426 HG23 ' HE2' ' A' ' 27' ' ' LYS . 10.8 pt -70.74 -24.53 25.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.782 175.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.0 tt -60.47 -56.03 26.38 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 171.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.56 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 11.2 tt0 -42.33 -52.95 4.37 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.169 176.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -69.64 -58.99 3.25 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.877 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.84 -38.53 72.8 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -168.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.2 mmt -59.21 -39.26 82.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.851 0.358 . . . . 0.0 111.592 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -90.62 -31.78 16.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.197 0.522 . . . . 0.0 110.698 178.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -66.57 -18.66 65.49 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.209 -174.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -55.98 145.17 26.07 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.045 177.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.7 p -47.29 -46.95 25.39 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 123.545 0.528 . . . . 0.0 111.713 -176.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -102.57 4.89 38.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.596 -176.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.467 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 4.1 p30 37.2 71.48 0.14 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 122.039 0.923 . . . . 0.0 110.89 -175.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.5 mt -64.51 0.26 1.13 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.443 -1.253 . . . . 0.0 112.103 -173.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.4 tp -61.62 -25.5 37.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.001 0.429 . . . . 0.0 110.442 177.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.512 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 17.0 pt-20 -74.26 -12.62 60.61 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.788 -178.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -86.89 -19.78 28.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.184 0.516 . . . . 0.0 110.538 178.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 47' ' ' VAL . 12.5 p -130.49 31.98 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.2 -173.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.512 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 58.4 mtm180 -54.99 116.63 2.87 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.971 0.891 . . . . 0.0 111.751 -176.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -178.54 173.03 45.45 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 114.055 -1.429 . . . . 0.0 111.193 -176.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.485 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 60.0 mt -105.04 129.47 57.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-O 120.971 0.415 . . . . 0.0 111.01 -178.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.464 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 5.4 m-85 -111.83 125.28 53.84 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.823 -178.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 88' ' ' THR . . . -104.06 121.55 7.06 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.421 -0.895 . . . . 0.0 111.408 176.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -107.31 109.38 21.13 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.135 0.493 . . . . 0.0 111.487 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -97.66 99.73 11.1 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.179 176.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.739 HG11 HG11 ' A' ' 25' ' ' VAL . 12.2 t -105.59 122.42 59.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.202 -171.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -107.21 -179.44 3.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.869 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.408 ' HB2' ' HB3' ' A' ' 92' ' ' SER . 4.5 m-20 61.92 47.81 5.71 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.137 0.494 . . . . 0.0 111.586 177.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.28 -167.06 20.36 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.699 177.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -40.66 -60.88 0.53 Allowed 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 124.126 3.218 . . . . 0.0 113.558 -176.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -108.93 42.2 1.46 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.091 0.472 . . . . 0.0 109.986 177.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 74.99 19.56 79.88 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.476 -176.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.23 171.47 8.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.973 0.416 . . . . 0.0 111.279 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -131.25 135.32 47.24 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.697 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -124.3 153.68 17.65 Favored Glycine 0 N--CA 1.443 -0.876 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -141.22 119.35 12.04 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.791 0.329 . . . . 0.0 110.622 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 14.8 m-90 -122.49 144.92 48.77 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 40.1 t -110.46 115.1 48.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.052 177.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.464 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 4.0 mp -89.21 99.17 8.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 176.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -90.66 98.7 11.93 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.447 0.641 . . . . 0.0 109.999 -176.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -110.91 15.64 21.68 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.604 175.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.438 ' HB2' ' CG1' ' A' ' 50' ' ' ILE . 34.2 tttm -56.28 -50.21 72.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.752 -177.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -86.01 0.14 54.08 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.676 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 94.21 12.04 56.71 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.641 -0.708 . . . . 0.0 112.437 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -76.36 -63.49 1.32 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.483 0.182 . . . . 0.0 111.237 -178.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.82 34.2 7.43 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 119.967 -1.111 . . . . 0.0 112.068 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.56 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 15.3 pttm -98.1 143.27 28.81 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.259 -0.275 . . . . 0.0 110.259 -178.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.8 OUTLIER -110.04 131.84 59.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.359 0.6 . . . . 0.0 109.832 178.717 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.6 t -131.21 133.54 45.6 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.49 -176.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -68.7 119.85 13.76 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -178.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 53.6 70.35 0.61 Allowed 'General case' 0 C--N 1.331 -0.199 0 O-C-N 123.79 0.681 . . . . 0.0 109.901 -175.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.1 -34.57 90.1 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.381 -0.827 . . . . 0.0 113.737 -173.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.14 -14.98 56.14 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.976 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.401 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 55.1 mm-40 -73.33 165.73 24.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.809 0.338 . . . . 0.0 110.369 177.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.486 ' HD2' ' N ' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -100.14 106.82 44.02 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.15 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.485 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 16.2 Cg_exo -68.92 139.76 44.07 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.695 2.263 . . . . 0.0 113.018 -177.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -67.2 -31.2 71.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.566 173.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.6 m -139.78 149.26 22.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.516 172.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.616 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 54.8 m -135.3 128.33 31.6 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 175.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.632 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 61.4 m-85 -113.41 125.16 53.94 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.852 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.473 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 4.6 m -98.48 121.33 40.28 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 173.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.608 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -155.39 154.6 6.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 O-C-N 123.551 0.532 . . . . 0.0 109.618 -175.184 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.472 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 3.8 m -91.56 137.82 32.06 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.56 -178.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.533 ' OD1' HG13 ' A' ' 25' ' ' VAL . 27.7 t70 -43.28 -49.68 6.69 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.376 0.67 . . . . 0.0 111.495 -176.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -49.95 -38.79 38.1 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.067 -1.424 . . . . 0.0 111.772 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.472 ' OD2' ' HB2' ' A' ' 92' ' ' SER . 13.6 m-20 -91.02 -21.18 21.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.413 -175.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 1.048 HG11 HG12 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -60.88 -31.27 49.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 121.134 0.493 . . . . 0.0 110.447 -175.577 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.6 m -67.1 -28.7 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.088 -171.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -81.69 -35.26 30.04 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 176.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.44 HD23 ' O ' ' A' ' 104' ' ' LEU . 85.3 mt -66.07 -49.44 67.59 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.812 -178.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 96' ' ' VAL . 21.4 mt -70.03 -23.86 25.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.057 -176.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.1 t -91.55 -9.75 43.15 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.998 0.428 . . . . 0.0 110.972 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.97 17.57 69.6 Favored Glycine 0 C--N 1.329 0.182 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.257 -179.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -85.69 -41.58 15.03 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.05 0.452 . . . . 0.0 110.63 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.44 ' O ' HD23 ' A' ' 99' ' ' LEU . 38.9 tp -103.32 123.22 46.38 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.478 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.493 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 6.2 m-20 -69.09 120.75 78.59 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.548 177.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -65.41 -22.5 59.47 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.083 1.856 . . . . 0.0 111.241 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.49 -54.91 25.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.595 176.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.556 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 0.8 OUTLIER -67.4 -34.89 78.19 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.971 179.283 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.59 ' HB3' HD12 ' A' ' 115' ' ' ILE . . . -64.92 -34.34 78.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.178 178.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -61.58 -52.39 64.63 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 175.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -59.72 -39.68 85.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.546 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.468 ' HA ' ' OE1' ' A' ' 112' ' ' GLN . 13.4 mm-40 -85.05 17.08 3.08 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -174.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.42 12.12 76.73 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 121.105 -0.569 . . . . 0.0 113.563 173.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -87.47 -47.41 8.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.877 0.37 . . . . 0.0 110.71 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.626 HG23 HG22 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -96.03 121.4 46.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.994 -177.348 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.473 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 31.2 mmtp -116.52 99.06 6.9 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.877 173.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.632 ' HB ' ' CD2' ' A' ' 89' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--N 1.322 -0.625 0 CA-C-O 121.356 0.598 . . . . 0.0 110.665 -178.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.414 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 6.8 p30 . . . . . 0 C--O 1.232 0.169 0 CA-C-O 121.237 0.542 . . . . 0.0 110.801 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.465 ' HA ' ' CD1' ' A' ' 23' ' ' PHE . 4.9 Cg_exo -70.06 -17.56 36.13 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.695 2.263 . . . . 0.0 111.156 -177.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.467 ' HA ' ' CG ' ' A' ' 26' ' ' PHE . 13.3 mt-10 -74.09 -24.03 59.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.503 -178.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -74.67 -22.16 59.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.635 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.465 ' CD1' ' HA ' ' A' ' 20' ' ' PRO . 35.5 m-85 -65.64 145.53 55.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.667 177.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -74.77 -26.34 59.69 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.757 HG12 HG11 ' A' ' 96' ' ' VAL . 0.9 OUTLIER -68.85 -21.69 25.92 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.71 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.585 177.902 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.467 ' CG ' ' HA ' ' A' ' 21' ' ' GLU . 79.2 t80 -56.78 -47.5 80.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.774 0.321 . . . . 0.0 110.361 -178.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.85 -34.88 77.57 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.727 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.47 ' O ' HG12 ' A' ' 31' ' ' ILE . 37.4 m-85 -71.8 -53.5 13.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.756 0.312 . . . . 0.0 111.101 178.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.603 ' HB3' HG21 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -58.61 -32.8 69.35 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.104 176.939 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.2 mmtt -66.58 -41.78 88.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.601 177.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.47 HG12 ' O ' ' A' ' 28' ' ' TYR . 16.8 pt -78.09 -26.41 14.47 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 C-N-CA 120.294 -0.562 . . . . 0.0 109.865 177.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.6 tt -59.35 -47.94 83.5 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 173.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.54 ' HG2' ' HA ' ' A' ' 76' ' ' LYS . 0.8 OUTLIER -44.57 -50.9 9.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.522 176.021 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -78.64 -55.29 5.3 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.58 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.48 -40.21 74.53 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -167.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.4 mmt -61.29 -41.28 96.7 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -177.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -90.92 -16.82 27.47 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.582 177.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -71.27 -25.09 62.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.996 -176.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -52.85 135.22 36.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.212 0.53 . . . . 0.0 110.117 176.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 18.2 p -57.89 -29.24 64.9 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.621 -174.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -100.32 -5.3 27.6 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 122.467 0.307 . . . . 0.0 111.232 177.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.493 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 4.1 p-10 38.82 64.27 0.8 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.843 0.83 . . . . 0.0 111.294 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.4 mt -58.64 -11.32 2.94 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.137 -175.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.2 tp -57.35 -25.81 24.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.065 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.493 ' HG2' ' O ' ' A' ' 42' ' ' ASN . 3.7 pt-20 -60.03 -33.19 71.69 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.789 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -82.7 -18.84 39.47 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.865 0.364 . . . . 0.0 111.573 -173.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 47' ' ' VAL . 11.3 p -124.99 31.9 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 122.074 0.94 . . . . 0.0 109.813 -176.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 37.2 mtm180 -57.45 110.33 0.85 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.845 0.831 . . . . 0.0 112.118 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.484 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . -165.78 170.91 40.79 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 114.086 -1.415 . . . . 0.0 110.701 -178.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.447 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 53.2 mt -105.27 126.64 60.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 117.717 0.758 . . . . 0.0 111.136 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.5 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 25.7 m-85 -107.92 117.59 34.51 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.994 -178.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.91 106.59 3.37 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.262 -0.971 . . . . 0.0 111.231 177.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -95.21 105.62 17.57 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.253 0.549 . . . . 0.0 111.261 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -91.31 99.79 12.7 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.383 176.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.735 HG11 HG11 ' A' ' 25' ' ' VAL . 7.6 t -99.84 127.47 52.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.911 -172.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 -112.74 -178.14 3.32 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.792 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 62.67 47.47 4.76 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.13 0.49 . . . . 0.0 111.124 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.39 -169.48 32.45 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.577 177.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -37.69 -61.07 0.37 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.546 3.498 . . . . 0.0 114.217 -174.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -125.05 61.12 1.19 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.86 16.09 74.31 Favored Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.53 -177.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.53 168.8 18.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.028 0.442 . . . . 0.0 110.749 -178.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -136.73 136.2 38.77 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.915 -176.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -120.19 162.46 14.22 Favored Glycine 0 N--CA 1.442 -0.94 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.387 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -150.26 115.18 5.32 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.712 0.291 . . . . 0.0 110.243 -178.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 26.1 m-90 -118.97 126.1 50.96 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.2 0.524 . . . . 0.0 110.279 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 51.3 t -94.4 110.4 23.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.743 177.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.5 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 4.4 mp -88.91 99.24 8.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -83.11 105.6 14.23 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.5 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -111.47 5.23 19.44 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 173.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.411 ' HE3' ' HA2' ' A' ' 49' ' ' GLY . 4.4 tppp? -64.67 -36.7 85.13 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.957 -176.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -77.4 -30.3 53.54 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.624 0.726 . . . . 0.0 109.9 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 111.82 10.11 19.45 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.344 -176.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.459 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 9.5 mmpt? -88.01 -49.72 6.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.56 -0.32 . . . . 0.0 111.397 -178.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.01 34.39 15.11 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.16 -1.019 . . . . 0.0 111.793 -177.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.54 ' HA ' ' HG2' ' A' ' 33' ' ' GLU . 14.2 pttm -96.82 145.15 26.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.545 0.212 . . . . 0.0 110.783 -172.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.603 HG21 ' HB3' ' A' ' 29' ' ' MET . 0.7 OUTLIER -107.41 138.18 34.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.069 0.461 . . . . 0.0 109.764 178.035 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.6 t -133.64 133.9 42.51 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.135 177.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -71.17 118.24 13.7 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.821 -179.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 55.96 61.48 2.76 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 123.918 0.762 . . . . 0.0 109.683 -175.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -61.31 -40.64 98.9 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.344 -0.844 . . . . 0.0 113.442 -175.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.12 -21.07 32.99 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.947 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.569 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 65.2 mm-40 -64.89 149.23 49.95 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 175.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.463 ' HD3' ' N ' ' A' ' 84' ' ' LYS . 3.7 mppt? -79.56 108.71 9.44 Favored Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.569 ' HD3' ' O ' ' A' ' 83' ' ' GLU . 16.5 Cg_exo -68.76 130.69 21.07 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.61 2.207 . . . . 0.0 112.164 179.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -62.61 -38.2 89.25 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.57 174.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.6 m -136.95 134.29 48.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.592 174.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.602 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 30.8 m -113.53 137.19 51.92 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.217 177.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.652 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 41.0 m-85 -123.83 127.0 47.42 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.492 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 6.7 m -100.69 126.52 47.21 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 174.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.625 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -158.37 151.45 7.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.039 0.447 . . . . 0.0 110.536 -175.565 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.2 m -85.36 143.22 28.77 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.202 0.525 . . . . 0.0 110.977 -177.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.416 ' OD1' HG13 ' A' ' 25' ' ' VAL . 13.5 t70 -49.28 -33.75 13.75 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.625 -1.17 . . . . 0.0 112.121 -178.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -75.5 -32.46 60.55 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.899 -174.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -91.55 -21.27 20.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.904 -177.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.757 HG11 HG12 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -56.74 -33.19 40.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.101 0.477 . . . . 0.0 110.21 -177.855 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.3 m -68.07 -33.75 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.853 -173.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -77.47 -32.35 54.32 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.1 mt -69.39 -49.98 50.29 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.738 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 96' ' ' VAL . 28.3 mt -72.38 -30.38 34.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.577 -176.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 39.7 t -86.03 -4.8 59.25 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.671 0.249 . . . . 0.0 111.671 -178.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.03 43.53 16.67 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.301 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -116.03 -43.19 3.0 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.036 0.446 . . . . 0.0 110.898 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.4 tp -97.95 129.56 44.85 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.507 -179.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.522 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 11.6 m120 -73.63 119.68 77.26 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.054 176.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -66.2 -20.26 56.17 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 121.942 1.762 . . . . 0.0 110.196 176.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -60.83 -57.42 12.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.534 173.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.522 ' HG2' ' HB2' ' A' ' 105' ' ' ASN . 0.2 OUTLIER -70.35 -31.4 68.66 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.901 -178.834 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.643 ' HB3' HD12 ' A' ' 115' ' ' ILE . . . -68.22 -35.59 78.2 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.618 -0.433 . . . . 0.0 109.986 178.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -64.98 -45.88 83.8 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 174.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -63.73 -41.03 98.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.347 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -80.12 7.06 9.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.919 -178.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.23 5.33 89.75 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.94 -0.647 . . . . 0.0 113.605 173.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp -78.91 -48.86 13.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.937 0.398 . . . . 0.0 111.07 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.643 HD12 ' HB3' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -87.72 118.24 33.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.539 -179.257 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.492 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 74.7 mmtt -114.73 98.77 7.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.659 174.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.652 ' HB ' ' CD2' ' A' ' 89' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--N 1.323 -0.583 0 CA-C-O 121.264 0.554 . . . . 0.0 110.361 178.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.413 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 58.1 m-20 . . . . . 0 CA--C 1.517 -0.304 0 CA-C-O 120.903 0.382 . . . . 0.0 110.192 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' A' ' 26' ' ' PHE . 21.5 Cg_exo -61.47 -34.57 85.73 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 123.184 2.589 . . . . 0.0 111.606 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.441 ' HA ' ' CG ' ' A' ' 26' ' ' PHE . 25.8 tt0 -65.53 -35.55 81.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.519 179.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -75.45 -4.41 39.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.564 -175.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -85.53 145.05 27.57 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 171.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -73.04 -20.29 61.02 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.975 HG12 HG11 ' A' ' 96' ' ' VAL . 1.0 OUTLIER -73.29 -16.01 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.152 179.126 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.441 ' CG ' ' HA ' ' A' ' 21' ' ' GLU . 80.2 t80 -58.02 -52.32 66.01 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.883 0.373 . . . . 0.0 110.455 -178.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -42.98 90.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.278 178.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.471 ' O ' HG12 ' A' ' 31' ' ' ILE . 19.4 m-85 -64.73 -47.75 77.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.165 -0.471 . . . . 0.0 112.097 -177.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.552 ' HB3' HG21 ' A' ' 77' ' ' VAL . 58.6 mtt -71.68 -26.21 62.43 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 122.208 -0.307 . . . . 0.0 111.019 -179.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 26' ' ' PHE . 7.8 mmtt -72.07 -35.37 69.24 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.445 175.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.471 HG12 ' O ' ' A' ' 28' ' ' TYR . 14.7 pt -78.93 -21.35 12.79 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.481 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.662 174.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.7 tt -67.17 -48.84 66.78 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 171.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -44.19 -38.59 3.83 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.086 173.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -83.53 -55.6 4.2 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.242 175.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.451 ' HA ' ' HB3' ' A' ' 38' ' ' ASN . . . -55.51 -42.25 74.23 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -167.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 24.0 mmt -56.65 -43.29 80.18 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -178.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -91.68 -25.84 18.92 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.242 179.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.451 ' HB3' ' HA ' ' A' ' 35' ' ' ALA . 3.4 t-20 -65.92 -28.33 68.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.04 178.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -52.93 133.54 37.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.689 174.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 23.6 p -59.82 -27.49 66.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.206 -173.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -96.67 -21.29 17.7 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.513 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 35.69 62.48 0.62 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.867 0.841 . . . . 0.0 110.837 -174.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.411 HD22 ' HD3' ' A' ' 46' ' ' LYS . 80.6 mt -72.03 2.79 5.14 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.744 -1.117 . . . . 0.0 111.761 -174.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.414 HG13 ' HB1' ' A' ' 70' ' ' ALA . 3.0 tp -56.01 -27.18 22.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.108 0.48 . . . . 0.0 110.858 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.513 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 49.9 mt-10 -76.08 -13.24 60.21 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.719 -176.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.411 ' HD3' HD22 ' A' ' 43' ' ' LEU . 60.5 mtpt -85.93 -17.02 36.61 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.003 0.43 . . . . 0.0 111.04 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 47' ' ' VAL . 14.0 p -130.69 33.2 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.924 0.869 . . . . 0.0 109.804 -177.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.513 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 23.1 mtm180 -52.14 118.07 3.24 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.971 0.891 . . . . 0.0 112.279 -175.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.4 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . -170.13 -174.87 38.62 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 113.8 -1.545 . . . . 0.0 109.751 -178.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.483 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 43.9 mt -121.74 124.84 72.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-N 118.214 1.007 . . . . 0.0 111.545 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.559 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 2.6 m-85 -107.42 109.49 21.22 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.781 -176.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.74 113.41 4.35 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.391 -0.909 . . . . 0.0 111.065 177.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -97.4 111.58 23.78 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.264 0.554 . . . . 0.0 111.647 -178.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -93.76 101.17 13.28 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.439 175.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.716 HG11 HG11 ' A' ' 25' ' ' VAL . 14.2 t -99.17 127.14 52.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.684 -175.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 30.2 mtp180 -118.55 -174.1 2.61 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.422 -177.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 61.74 39.93 13.58 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 123.449 0.468 . . . . 0.0 111.195 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.81 -164.47 26.78 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.095 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -39.12 -60.32 0.52 Allowed 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 124.342 3.361 . . . . 0.0 114.062 -176.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -109.88 41.9 1.62 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.065 0.459 . . . . 0.0 110.093 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.21 24.3 76.71 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -170.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.48 162.09 29.66 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 114.708 -0.746 . . . . 0.0 111.471 -175.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -124.89 140.74 52.65 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.877 -178.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -127.95 163.48 21.57 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.936 179.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -143.11 121.03 12.0 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 117.217 0.509 . . . . 0.0 111.375 -177.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 24.2 m-90 -125.96 134.29 51.56 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.924 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 40.3 t -99.78 114.4 37.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.247 178.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.66 HG13 HG12 ' A' ' 77' ' ' VAL . 4.1 mp -89.95 100.82 11.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 174.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -84.54 97.31 9.5 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.214 -176.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.414 ' HB1' HG13 ' A' ' 44' ' ' ILE . . . -95.26 -12.13 26.76 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.219 174.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.476 ' HD2' ' HG3' ' A' ' 72' ' ' GLU . 1.6 tmmt? -58.2 -40.85 82.66 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.273 -177.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.476 ' HG3' ' HD2' ' A' ' 71' ' ' LYS . 51.7 mt-10 -91.72 12.15 22.2 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.337 0.589 . . . . 0.0 111.313 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 76.46 11.14 85.37 Favored Glycine 0 C--O 1.228 -0.228 0 CA-C-N 115.402 -0.817 . . . . 0.0 113.394 173.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -91.58 -45.05 8.71 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 122.717 -0.284 . . . . 0.0 111.174 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.97 33.82 62.37 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -176.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 19.8 ptmt -98.35 154.68 17.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.365 -0.418 . . . . 0.0 109.948 -175.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.66 HG12 HG13 ' A' ' 68' ' ' ILE . 0.7 OUTLIER -107.77 137.36 39.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 178.733 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.5 t -140.53 134.18 30.24 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.113 178.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -66.6 116.43 7.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.669 -175.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 65.0 t30 51.17 68.29 0.81 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 123.9 0.75 . . . . 0.0 110.161 -176.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -56.82 -34.59 65.33 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.106 -0.952 . . . . 0.0 113.936 -172.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.47 -16.9 60.34 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -176.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.463 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 16.9 mm-40 -75.62 155.11 36.21 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 175.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -90.88 108.9 31.13 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-O 120.771 0.32 . . . . 0.0 110.194 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.483 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 20.1 Cg_exo -65.78 125.73 14.79 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.925 2.417 . . . . 0.0 112.879 -178.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -65.57 -34.47 78.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.129 -0.942 . . . . 0.0 109.746 174.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.6 m -135.57 139.04 47.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.503 175.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.579 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 19.0 m -118.14 135.63 54.1 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.598 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 72.6 m-85 -122.58 125.02 44.84 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.585 ' HB ' ' HB3' ' A' ' 116' ' ' LYS . 35.8 m -101.77 114.2 28.06 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 177.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.594 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 73.1 mt -137.87 148.12 25.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.554 -174.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.0 m -85.34 139.25 31.73 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.087 0.47 . . . . 0.0 110.425 176.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.53 ' OD1' HG13 ' A' ' 25' ' ' VAL . 20.9 t70 -47.18 -34.26 6.11 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 114.504 -1.225 . . . . 0.0 112.427 -178.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -70.92 -41.74 70.81 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.103 -173.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -91.28 -18.6 24.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.591 -175.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.975 HG11 HG12 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -54.77 -31.55 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 121.121 0.486 . . . . 0.0 110.124 -179.801 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.0 m -67.05 -35.13 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.023 -173.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -77.08 -33.64 57.04 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.415 HD12 HG21 ' A' ' 91' ' ' ILE . 92.5 mt -69.08 -48.09 63.56 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.403 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 96' ' ' VAL . 32.0 mt -66.19 -36.68 77.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.125 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.2 t -75.82 -30.3 58.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.817 0.342 . . . . 0.0 111.2 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 102.8 10.56 37.24 Favored Glycine 0 N--CA 1.453 -0.167 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.876 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -81.11 -40.32 24.24 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.23 0.538 . . . . 0.0 111.0 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.728 HD11 ' NZ ' ' A' ' 108' ' ' LYS . 52.4 tp -101.08 133.78 45.08 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.339 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.418 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 12.7 m120 -79.34 124.69 84.07 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.292 177.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -64.91 -24.86 60.27 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.124 1.882 . . . . 0.0 110.459 176.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -61.37 -60.18 4.12 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.627 173.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.728 ' NZ ' HD11 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -62.78 -35.11 78.78 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.124 0.487 . . . . 0.0 110.021 -177.763 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.561 ' HB3' HD12 ' A' ' 115' ' ' ILE . . . -70.93 -33.13 70.21 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.025 -177.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -61.27 -48.61 80.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.312 174.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -60.83 -44.01 97.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.943 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.407 ' HG3' ' HE3' ' A' ' 108' ' ' LYS . 74.8 mm-40 -74.39 -12.56 60.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.178 -176.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.77 18.25 45.09 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.158 175.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.35 -24.64 17.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.862 0.363 . . . . 0.0 110.868 176.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.582 HG23 HG22 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -109.79 111.11 34.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.807 0.813 . . . . 0.0 110.144 178.086 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.585 ' HB3' ' HB ' ' A' ' 90' ' ' THR . 13.8 tppt? -110.05 107.5 17.39 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.093 174.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.598 ' HB ' ' CD2' ' A' ' 89' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--N 1.318 -0.775 0 CA-C-O 121.257 0.551 . . . . 0.0 110.184 -177.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.401 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 43.1 m-80 . . . . . 0 N--CA 1.456 -0.127 0 CA-C-O 120.866 0.365 . . . . 0.0 110.229 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.507 ' HA ' ' CD1' ' A' ' 23' ' ' PHE . 14.2 Cg_exo -64.46 -28.88 62.29 Favored 'Trans proline' 0 CA--C 1.518 -0.317 0 C-N-CA 123.276 2.651 . . . . 0.0 111.802 -177.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -65.9 -35.22 80.02 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.261 177.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -73.38 -14.62 61.31 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.562 -178.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.507 ' CD1' ' HA ' ' A' ' 20' ' ' PRO . 23.5 m-85 -66.25 148.76 51.36 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.404 0.621 . . . . 0.0 110.378 176.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -74.06 -26.36 60.35 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 176.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.857 HG12 HG11 ' A' ' 96' ' ' VAL . 0.8 OUTLIER -73.9 -15.51 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.97 -179.009 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -56.74 -50.04 73.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.768 0.318 . . . . 0.0 110.307 -177.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.452 ' HE2' HG23 ' A' ' 31' ' ' ILE . 1.1 tpmt? -72.7 -38.23 67.6 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.863 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -64.72 -50.91 65.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.569 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.584 ' HB3' HG21 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -62.9 -31.53 72.6 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.834 0.349 . . . . 0.0 110.928 177.289 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.423 ' HD2' ' HA ' ' A' ' 30' ' ' LYS . 21.6 mmmt -70.76 -37.81 73.43 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 178.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.452 HG23 ' HE2' ' A' ' 27' ' ' LYS . 10.5 pt -84.13 -19.69 9.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.133 176.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.6 tt -60.58 -46.85 88.69 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 171.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -46.85 -48.48 20.97 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.777 175.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -73.96 -50.41 20.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.706 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.89 -36.88 80.38 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -169.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 33.1 mmt -59.63 -44.11 93.58 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.587 0.217 . . . . 0.0 111.587 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -91.4 -8.36 48.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.19 0.519 . . . . 0.0 110.723 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -73.69 -23.36 59.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.037 0.446 . . . . 0.0 109.984 178.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -59.14 132.16 53.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.772 175.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 13.9 p -57.44 -37.42 72.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.562 -173.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.542 ' C ' HD22 ' A' ' 42' ' ' ASN . 46.1 mt-10 -101.57 9.95 40.73 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 119.306 -0.378 . . . . 0.0 110.96 178.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.545 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 0.1 OUTLIER 25.52 70.37 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.114 0.965 . . . . 0.0 111.275 -173.59 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.7 mt -58.4 -4.45 0.39 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 114.414 -1.267 . . . . 0.0 111.921 -176.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.55 HG13 ' HB1' ' A' ' 70' ' ' ALA . 4.2 tp -60.75 -25.42 35.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.663 178.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 42' ' ' ASN . 10.9 pt-20 -76.51 -16.7 59.57 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.237 -179.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -95.53 -13.24 24.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.263 0.554 . . . . 0.0 110.731 -177.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 47' ' ' VAL . 11.9 p -130.43 32.24 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.845 0.831 . . . . 0.0 109.562 -177.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 55.6 mtt180 -52.49 117.11 2.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.397 -175.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.564 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . -167.16 164.76 38.12 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.221 -178.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.524 HG13 ' HB2' ' A' ' 71' ' ' LYS . 63.8 mt -103.13 124.93 57.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 117.217 0.509 . . . . 0.0 109.988 176.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.512 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 37.3 m-85 -105.72 115.66 30.62 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.203 -176.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.97 111.35 4.23 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.396 -0.907 . . . . 0.0 110.835 177.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.445 ' O ' ' HA ' ' A' ' 65' ' ' TYR . 7.5 m-85 -98.18 108.37 21.06 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.024 0.44 . . . . 0.0 111.594 -178.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -95.71 99.69 11.5 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.638 175.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.725 HG11 HG11 ' A' ' 25' ' ' VAL . 17.4 t -98.12 119.78 46.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.782 -174.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -108.89 179.07 4.28 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.123 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.458 ' HB2' ' HB3' ' A' ' 92' ' ' SER . 3.3 m-20 60.23 42.23 15.53 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.93 0.395 . . . . 0.0 111.125 177.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.11 -166.59 28.93 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.572 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -31.5 -60.49 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 124.946 3.764 . . . . 0.0 114.404 -176.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -120.06 48.07 1.63 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.17 30.04 65.73 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -174.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.47 165.46 21.21 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.224 0.535 . . . . 0.0 111.356 -176.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -132.7 125.74 30.96 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.129 -0.942 . . . . 0.0 110.856 -178.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -115.14 164.13 12.14 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.317 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 30.9 t80 -147.36 118.34 7.68 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.854 0.359 . . . . 0.0 110.624 -178.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 22.3 m-90 -122.99 132.07 53.98 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.992 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 46.6 t -100.89 117.61 46.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.224 177.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.549 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 4.1 mp -95.31 104.97 16.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.062 0.458 . . . . 0.0 109.88 176.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.448 HD21 ' HG3' ' A' ' 72' ' ' GLU . 19.1 t-20 -79.42 99.38 7.16 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.142 177.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -111.1 -1.68 16.14 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 172.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.524 ' HB2' HG13 ' A' ' 50' ' ' ILE . 2.2 tppp? -67.55 -38.09 83.66 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.385 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.448 ' HG3' HD21 ' A' ' 69' ' ' ASN . 42.6 mt-10 -84.79 -1.63 56.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.234 176.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.02 20.92 69.14 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.618 178.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -89.92 -37.53 14.33 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.953 0.406 . . . . 0.0 111.057 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.13 32.14 76.05 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.883 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 19.7 ptmt -98.7 163.1 12.78 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -177.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.584 HG21 ' HB3' ' A' ' 29' ' ' MET . 0.8 OUTLIER -124.42 139.64 50.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.784 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.0 t -135.38 134.7 40.01 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.284 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -68.65 119.23 12.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.975 -178.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 52.43 69.87 0.63 Allowed 'General case' 0 N--CA 1.464 0.258 0 O-C-N 123.745 0.653 . . . . 0.0 109.732 -175.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.37 -40.71 91.64 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.708 -0.678 . . . . 0.0 113.822 -173.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.63 -20.79 48.06 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.609 -177.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.539 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 34.8 mt-10 -65.86 143.26 57.57 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.468 -0.366 . . . . 0.0 110.085 175.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 24.5 pttm -78.64 108.82 8.8 Favored Pre-proline 0 N--CA 1.449 -0.525 0 CA-C-O 121.341 0.591 . . . . 0.0 110.278 175.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.539 ' HD3' ' O ' ' A' ' 83' ' ' GLU . 12.6 Cg_exo -71.36 129.18 15.54 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.581 2.187 . . . . 0.0 111.949 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -59.25 -31.67 69.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.184 174.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.442 ' HB ' ' CD1' ' A' ' 117' ' ' ILE . 2.7 m -141.12 128.9 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.629 175.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.749 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 35.5 m -118.13 121.85 41.58 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.885 177.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.432 ' HA ' ' HB ' ' A' ' 117' ' ' ILE . 5.5 m-85 -106.5 131.76 53.31 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -178.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.448 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 5.4 m -103.77 127.26 51.26 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 173.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.519 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -161.4 155.9 3.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -174.79 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.458 ' HB3' ' HB2' ' A' ' 57' ' ' ASN . 15.5 m -85.19 145.56 27.53 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.31 0.576 . . . . 0.0 111.502 -175.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -51.07 -32.35 21.81 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.734 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -73.68 -35.54 65.21 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.982 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.439 ' OD2' ' HB2' ' A' ' 92' ' ' SER . 12.3 m-20 -90.59 -22.55 21.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.535 -173.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.857 HG11 HG12 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -57.36 -33.06 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 121.086 0.47 . . . . 0.0 110.446 -178.155 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.5 m -68.09 -27.68 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.241 -170.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -86.54 -30.21 22.09 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 177.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.45 HD23 ' O ' ' A' ' 104' ' ' LEU . 77.2 mt -67.74 -45.82 73.9 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.201 0.524 . . . . 0.0 110.578 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 96' ' ' VAL . 23.5 mt -75.8 -23.26 16.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.381 -176.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 27.7 p -85.54 -22.4 28.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.811 0.339 . . . . 0.0 110.839 178.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 96.97 8.33 56.94 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.934 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -80.42 -41.01 25.31 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.149 0.499 . . . . 0.0 111.131 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.45 ' O ' HD23 ' A' ' 99' ' ' LEU . 42.2 tp -102.78 120.7 41.05 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.844 -178.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -69.41 124.46 90.53 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.207 175.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.485 ' HA ' ' HB3' ' A' ' 109' ' ' ALA . 1.0 OUTLIER -70.1 -14.11 34.6 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 121.816 1.678 . . . . 0.0 110.564 177.452 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -66.13 -58.42 5.47 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.257 171.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.518 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 1.1 ptmt -66.65 -31.46 72.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.653 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.518 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -66.8 -31.53 72.22 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.905 177.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.765 ' HA ' HG22 ' A' ' 115' ' ' ILE . 23.7 t80 -66.09 -50.85 62.65 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -63.27 -34.21 77.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.331 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -85.27 11.15 10.63 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.65 15.12 73.13 Favored Glycine 0 CA--C 1.517 0.185 0 C-N-CA 121.218 -0.515 . . . . 0.0 113.133 175.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -85.3 -45.07 12.29 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.91 0.386 . . . . 0.0 110.554 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.765 HG22 ' HA ' ' A' ' 110' ' ' PHE . 0.6 OUTLIER -97.39 122.96 49.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.93 -178.208 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.448 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 29.5 mmmt -120.71 99.34 6.48 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 173.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.749 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.318 -0.762 0 CA-C-O 121.275 0.559 . . . . 0.0 111.68 -170.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 CA--C 1.518 -0.287 0 CA-C-O 121.968 0.889 . . . . 0.0 111.496 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.445 ' HA ' ' CD1' ' A' ' 23' ' ' PHE . 38.0 Cg_endo -69.63 -15.9 37.82 Favored 'Trans proline' 0 C--N 1.329 -0.46 0 C-N-CA 123.956 3.104 . . . . 0.0 112.068 -177.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -75.01 -28.86 60.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.507 -177.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -82.83 -7.54 59.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.957 -176.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.445 ' CD1' ' HA ' ' A' ' 20' ' ' PRO . 40.3 m-85 -73.12 146.49 45.68 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 174.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.438 ' HD3' HG11 ' A' ' 97' ' ' VAL . 78.6 tttt -78.46 -21.76 48.6 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.898 HG12 HG11 ' A' ' 96' ' ' VAL . 1.3 m -71.83 -13.68 16.94 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.535 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.648 175.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -56.51 -58.17 9.17 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.135 -0.321 . . . . 0.0 110.135 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.35 -42.55 96.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.161 0.505 . . . . 0.0 110.494 178.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.528 ' HB3' HD12 ' A' ' 100' ' ' ILE . 18.0 m-85 -65.81 -42.04 91.13 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.613 -175.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.43 ' CE ' HD11 ' A' ' 68' ' ' ILE . 67.5 mtp -80.16 -24.29 40.49 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.117 -0.365 . . . . 0.0 110.354 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.413 ' HD3' ' HA ' ' A' ' 30' ' ' LYS . 50.5 mmtt -66.61 -41.53 88.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.506 173.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.471 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 4.8 pt -78.97 -26.08 13.23 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.56 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.188 176.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.408 HD23 ' C ' ' A' ' 32' ' ' LEU . 6.1 tt -55.15 -51.56 66.08 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 170.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.51 ' HG2' ' HA ' ' A' ' 76' ' ' LYS . 0.7 OUTLIER -47.24 -53.91 12.14 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.962 177.748 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 31' ' ' ILE . 7.6 pt-20 -74.01 -39.4 63.63 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.288 -175.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.01 -37.46 85.95 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.661 -174.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 19.8 mmt -58.48 -44.18 89.25 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.645 0.26 . . . . 0.0 111.543 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -91.24 -7.89 49.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.932 0.396 . . . . 0.0 110.578 177.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 22.0 t-20 -64.94 -34.56 78.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.304 -178.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -61.12 132.27 53.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.653 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.55 -24.85 65.72 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.463 -175.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -102.27 10.83 38.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 119.463 -0.304 . . . . 0.0 111.562 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 26.2 p30 30.86 70.8 0.08 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.382 1.073 . . . . 0.0 112.248 178.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.8 mt -62.64 -2.81 1.22 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.128 -174.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.8 tp -64.02 -27.45 42.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.274 0.559 . . . . 0.0 110.288 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -63.5 -25.62 68.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.396 -177.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -81.81 -19.75 40.51 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.164 -177.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.3 m -129.65 32.31 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.791 -175.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 72.3 mtt180 -49.45 112.03 0.58 Allowed 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.763 0.792 . . . . 0.0 111.04 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.518 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . -178.28 161.57 28.44 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.705 -175.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.565 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 64.9 mt -96.57 126.88 49.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 117.28 0.54 . . . . 0.0 110.865 -178.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.446 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 9.4 m-85 -106.07 118.89 37.79 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.708 -179.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.28 113.92 4.85 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.514 -0.85 . . . . 0.0 111.327 177.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -101.26 110.47 22.49 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.122 0.487 . . . . 0.0 111.694 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -94.3 99.75 11.92 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.312 174.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.804 HG11 HG11 ' A' ' 25' ' ' VAL . 19.9 t -100.83 112.49 33.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.045 0.45 . . . . 0.0 110.878 -174.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 76.2 mtp85 -104.05 179.71 4.19 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.577 -177.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 64.68 37.29 7.71 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 123.348 0.405 . . . . 0.0 111.311 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.38 -161.17 9.26 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.796 178.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -34.74 -60.72 0.27 Allowed 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 124.605 3.537 . . . . 0.0 114.493 -174.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -115.89 38.49 3.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.38 0.61 . . . . 0.0 110.343 178.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 78.38 24.46 63.21 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -171.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.79 156.34 39.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.14 -0.53 . . . . 0.0 110.725 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -118.3 116.0 25.86 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.182 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.41 161.09 16.27 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.019 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -145.95 118.83 8.7 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.977 0.418 . . . . 0.0 110.897 -176.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.402 ' CE2' ' HD1' ' A' ' 79' ' ' TYR . 20.9 m-90 -121.23 136.27 55.0 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.812 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 39.0 t -106.19 117.23 51.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.555 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.65 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 3.7 mp -93.56 99.79 10.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 175.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -86.25 98.35 10.89 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.348 -177.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -109.3 6.94 24.97 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.177 175.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.54 ' HB2' HG13 ' A' ' 50' ' ' ILE . 5.4 tppp? -60.49 -42.97 97.38 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.522 -178.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -94.27 5.34 52.06 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.223 -178.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.8 -13.51 59.21 Favored Glycine 0 C--N 1.318 -0.431 0 CA-C-N 115.703 -0.68 . . . . 0.0 113.63 174.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.43 -67.05 0.42 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.87 34.7 14.56 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 119.797 -1.192 . . . . 0.0 111.249 -175.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.65 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 54.6 pttt -98.0 148.64 23.28 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 -177.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.401 HG12 HG13 ' A' ' 68' ' ' ILE . 0.8 OUTLIER -107.04 135.12 46.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 177.652 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.4 t -140.11 132.86 29.03 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.606 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.402 ' HD1' ' CE2' ' A' ' 66' ' ' TRP . 45.5 t80 -68.93 121.42 16.56 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 56.49 74.75 0.38 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.552 0.692 . . . . 0.0 109.474 -173.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.86 -41.18 73.77 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.916 -176.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.45 -13.58 61.79 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.93 -179.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.513 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 12.9 mm-40 -81.15 159.41 24.66 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 177.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -87.68 109.08 23.92 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 123.18 0.3 . . . . 0.0 110.518 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.565 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 18.0 Cg_exo -67.26 134.2 32.95 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.815 2.343 . . . . 0.0 112.787 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -66.95 -33.26 75.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.493 -0.776 . . . . 0.0 108.949 172.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 8.5 m -140.58 134.27 33.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.256 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.632 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 27.9 m -119.4 132.77 55.89 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 175.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.524 ' CD1' ' HB ' ' A' ' 117' ' ' ILE . 68.2 m-85 -119.4 125.79 49.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.219 -179.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.437 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 25.4 m -99.83 126.16 45.89 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 173.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.554 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -157.31 144.26 9.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.888 -176.342 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.14 141.97 41.76 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.451 178.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.486 ' OD1' HG13 ' A' ' 25' ' ' VAL . 22.3 t70 -49.13 -27.47 3.5 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.707 1.203 . . . . 0.0 111.986 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -78.08 -34.44 50.27 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.226 -174.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -90.99 -20.45 22.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.239 -175.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.898 HG11 HG12 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -57.92 -31.73 41.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.023 -175.116 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.438 HG11 ' HD3' ' A' ' 24' ' ' LYS . 4.9 m -63.91 -29.53 47.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.461 -170.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -81.87 -32.63 30.98 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.505 HD23 ' O ' ' A' ' 104' ' ' LEU . 91.6 mt -69.36 -42.86 74.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.381 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.528 HD12 ' HB3' ' A' ' 28' ' ' TYR . 1.6 mm -65.34 -25.67 37.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.681 178.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.6 t -96.86 -11.41 24.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.646 -176.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.49 9.86 82.77 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.128 -177.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -77.76 -42.35 34.42 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.266 0.555 . . . . 0.0 110.261 178.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.505 ' O ' HD23 ' A' ' 99' ' ' LEU . 48.3 tp -100.02 125.1 46.03 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.723 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.529 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 6.1 m-20 -77.34 124.19 86.96 Favored Pre-proline 0 C--N 1.317 -0.805 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.013 178.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -64.99 -22.28 62.74 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.022 1.815 . . . . 0.0 110.529 179.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 77.0 mm-40 -64.24 -56.7 12.84 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.133 173.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.529 ' HG2' ' HB2' ' A' ' 105' ' ' ASN . 0.1 OUTLIER -67.75 -31.37 71.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.078 -178.514 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.547 ' HB3' HD12 ' A' ' 115' ' ' ILE . . . -69.91 -32.79 71.28 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 177.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -62.51 -52.13 64.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.595 174.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -63.16 -42.14 99.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.88 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -71.33 -7.68 48.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.883 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 95.76 -5.02 66.45 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.667 -0.777 . . . . 0.0 113.432 173.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.408 ' HD2' ' HA ' ' A' ' 114' ' ' LYS . 28.3 mmmt -68.38 -53.16 25.75 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.95 0.405 . . . . 0.0 111.43 177.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.676 HG23 HG22 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -85.94 116.72 29.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.653 0.74 . . . . 0.0 111.038 -175.35 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.437 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 33.7 mmtp -108.37 104.27 13.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.987 175.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.676 HG22 HG23 ' A' ' 115' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.321 -0.635 0 CA-C-O 121.145 0.498 . . . . 0.0 111.101 -177.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.513 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 82.0 m-20 . . . . . 0 CA--C 1.514 -0.418 0 CA-C-O 121.575 0.702 . . . . 0.0 110.509 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -68.54 -18.37 43.2 Favored 'Trans proline' 0 C--N 1.327 -0.598 0 C-N-CA 123.745 2.964 . . . . 0.0 112.346 -176.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.412 ' HA ' ' CG ' ' A' ' 26' ' ' PHE . 15.0 mt-10 -84.05 -27.29 28.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.438 -177.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.513 ' OD2' ' HB2' ' A' ' 19' ' ' ASN . 42.9 m-20 -76.49 -9.4 58.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.13 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -73.31 145.55 45.95 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.756 174.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -76.04 -17.7 59.55 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.759 HG12 HG11 ' A' ' 96' ' ' VAL . 1.2 m -78.02 -15.87 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.267 177.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.412 ' CG ' ' HA ' ' A' ' 21' ' ' GLU . 78.7 t80 -54.74 -55.93 24.7 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 123.123 0.264 . . . . 0.0 110.73 -174.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.459 ' O ' HG23 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -65.72 -35.33 80.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.647 -179.072 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.443 ' HB3' HD12 ' A' ' 100' ' ' ILE . 12.7 m-85 -66.89 -48.52 68.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.529 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 63.7 mtt -70.7 -30.79 67.45 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.017 178.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.423 ' HD2' ' HA ' ' A' ' 30' ' ' LYS . 27.7 mmmt -67.02 -34.74 78.38 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.236 176.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.459 HG23 ' O ' ' A' ' 27' ' ' LYS . 12.6 pt -86.55 -18.57 8.57 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.798 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.389 175.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.1 tt -63.74 -52.19 61.56 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 169.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.516 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 21.1 tt0 -42.11 -53.18 4.07 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.239 -1.346 . . . . 0.0 111.32 171.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -73.51 -62.45 1.48 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.336 -1.302 . . . . 0.0 112.175 -176.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.418 ' HA ' ' HB3' ' A' ' 38' ' ' ASN . . . -54.91 -42.63 72.43 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -169.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.6 mmt -61.21 -37.84 84.44 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -176.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -91.8 -23.54 19.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.139 0.495 . . . . 0.0 110.162 178.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.418 ' HB3' ' HA ' ' A' ' 35' ' ' ALA . 26.7 t-20 -64.28 -32.93 74.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.219 178.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -54.7 134.59 47.38 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.614 175.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.9 p -63.08 -28.97 70.45 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.539 -176.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -81.96 -25.16 35.06 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.652 176.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.9 p30 36.96 73.62 0.09 Allowed 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.984 0.897 . . . . 0.0 110.728 -174.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.453 ' O ' HG12 ' A' ' 47' ' ' VAL . 66.9 mt -63.16 -3.11 1.6 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.717 -175.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.473 HG13 ' HB1' ' A' ' 70' ' ' ALA . 4.1 tp -60.28 -26.48 36.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.268 -177.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.423 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 25.8 mt-10 -83.08 -14.49 53.63 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 120.823 0.344 . . . . 0.0 111.141 -178.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -92.65 -13.93 28.82 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.267 0.556 . . . . 0.0 110.183 178.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 47' ' ' VAL . 13.9 p -130.11 32.69 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.867 0.842 . . . . 0.0 109.872 -177.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.423 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 60.1 mtt180 -52.51 111.65 0.68 Allowed 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.556 -178.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.655 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . -175.37 147.56 8.95 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.818 -176.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.53 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 66.7 mt -89.18 126.94 42.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 117.39 0.595 . . . . 0.0 110.794 -177.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.455 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 5.0 m-85 -104.31 116.54 32.33 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.758 -177.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.96 111.58 4.28 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.116 177.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -100.48 103.43 14.78 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.164 0.507 . . . . 0.0 111.568 -178.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -88.36 99.5 12.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.397 175.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 10.8 t -98.13 134.92 34.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.127 -177.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 31.7 mtp-105 -125.58 175.78 7.32 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.475 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 57.51 42.88 23.68 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 123.426 0.454 . . . . 0.0 111.758 177.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.12 -160.52 8.24 Favored Glycine 0 CA--C 1.521 0.423 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.621 177.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -37.93 -60.82 0.4 Allowed 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 124.284 3.323 . . . . 0.0 113.737 -177.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.454 ' OD1' ' HB2' ' A' ' 62' ' ' ALA . 28.6 p-10 -109.52 34.92 3.53 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.295 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.38 28.54 59.66 Favored Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -173.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.454 ' HB2' ' OD1' ' A' ' 60' ' ' ASN . . . -76.45 146.91 38.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.662 0.744 . . . . 0.0 112.168 -175.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -108.4 108.16 19.01 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.186 176.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -100.58 152.55 19.16 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -137.76 116.47 12.21 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 117.089 0.445 . . . . 0.0 110.905 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 24.3 m-90 -119.3 139.84 51.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.709 178.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 30.5 t -109.85 113.43 44.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.152 178.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.495 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 3.9 mp -91.46 102.61 13.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -85.62 98.03 10.43 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.341 0.591 . . . . 0.0 110.341 -176.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -97.4 -4.5 38.19 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.758 174.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.447 ' HB2' HG13 ' A' ' 50' ' ' ILE . 15.8 tppt? -63.5 -42.74 98.51 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.162 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -73.71 -6.59 47.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.237 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.58 12.28 81.93 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.929 -177.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -91.37 -52.48 4.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.686 0.279 . . . . 0.0 110.766 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.84 34.45 24.56 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.349 -0.929 . . . . 0.0 111.504 -177.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.516 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 21.8 ptmt -97.54 150.42 21.12 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -176.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -108.02 125.38 64.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.449 HG23 ' HA2' ' A' ' 81' ' ' GLY . 3.8 t -128.38 134.49 48.85 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.784 -178.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -63.24 125.38 23.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.213 -176.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 74.08 -42.05 0.5 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.833 0.853 . . . . 0.0 111.699 -178.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.449 ' HA2' HG23 ' A' ' 78' ' ' THR . . . 70.82 -43.09 0.6 Allowed Glycine 0 CA--C 1.519 0.302 0 N-CA-C 114.483 0.553 . . . . 0.0 114.483 177.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 69.32 17.25 72.13 Favored Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 -174.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.404 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 38.7 mm-40 -117.82 162.94 17.28 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 122.576 0.35 . . . . 0.0 110.332 -176.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 95.4 mttt -95.34 109.04 42.97 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.98 176.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.53 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 17.2 Cg_exo -68.09 133.74 29.71 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.888 2.392 . . . . 0.0 112.73 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -65.32 -32.58 74.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.5 174.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.9 m -141.02 132.77 29.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.552 173.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.673 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 86.3 m -115.92 131.1 57.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.318 176.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.534 ' CD1' ' HB ' ' A' ' 117' ' ' ILE . 75.8 m-85 -116.56 123.55 47.65 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.438 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 3.5 m -99.7 119.74 38.59 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 176.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 59.0 mt -143.86 154.22 15.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -174.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.461 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 37.5 m -89.25 144.25 26.24 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.505 175.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -42.38 -52.09 4.7 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.378 0.671 . . . . 0.0 111.968 -177.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.97 -42.35 89.73 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.162 -176.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.461 ' OD2' ' HB2' ' A' ' 92' ' ' SER . 7.8 m-20 -80.4 -21.67 42.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.594 0.235 . . . . 0.0 111.535 -173.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.759 HG11 HG12 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -58.62 -34.23 50.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.085 -176.463 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.1 m -68.09 -30.46 48.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.22 -171.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -81.14 -33.46 33.15 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 177.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.477 HD23 ' O ' ' A' ' 104' ' ' LEU . 74.0 mt -69.77 -47.91 61.2 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.011 -177.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 96' ' ' VAL . 25.5 mt -70.34 -26.03 28.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.055 -178.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 27.3 t -88.2 -8.67 54.97 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.512 -178.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.51 19.6 61.75 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.322 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -94.2 -41.76 9.31 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.096 0.474 . . . . 0.0 110.979 -178.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.736 HD11 ' NZ ' ' A' ' 108' ' ' LYS . 37.6 tp -101.1 128.74 47.04 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.334 179.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.637 ' OD1' ' HB2' ' A' ' 107' ' ' GLN . 2.8 t-20 -69.68 122.33 85.45 Favored Pre-proline 0 C--N 1.321 -0.63 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.057 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -68.39 -24.44 36.9 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.896 1.731 . . . . 0.0 110.692 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.637 ' HB2' ' OD1' ' A' ' 105' ' ' ASN . 1.7 mp0 -64.83 -59.15 4.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.453 173.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.736 ' NZ ' HD11 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -60.41 -37.93 82.4 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.818 -179.365 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.533 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -68.83 -34.88 76.23 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.553 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.428 ' CD2' HG22 ' A' ' 115' ' ' ILE . 20.3 t80 -62.23 -52.93 61.78 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 174.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -56.9 -42.25 79.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.094 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.454 ' HA ' HE21 ' A' ' 112' ' ' GLN . 0.0 OUTLIER -74.97 -1.69 23.75 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.963 -177.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 96.5 -12.94 66.07 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.32 173.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -62.41 -61.17 2.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.061 0.458 . . . . 0.0 111.77 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.605 HG23 HG22 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -80.85 121.8 34.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.062 -175.253 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.438 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 35.9 mmtm -115.4 99.63 7.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.319 172.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.673 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.322 -0.614 0 CA-C-O 121.092 0.472 . . . . 0.0 110.155 177.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.763 0 N-CA-C 112.166 -0.374 . . . . 0.0 112.166 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.677 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 17.0 p -57.74 116.42 3.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.655 0.264 . . . . 0.0 110.718 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.5 m -124.37 100.52 6.72 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.111 0.481 . . . . 0.0 111.283 -177.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.39 174.26 47.91 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.118 175.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -60.36 146.69 83.81 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 121.14 0.495 . . . . 0.0 110.668 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.468 ' HA ' ' CD1' ' A' ' 23' ' ' PHE . 3.3 Cg_exo -70.45 -18.65 33.63 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 123.183 2.589 . . . . 0.0 112.628 -173.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -67.14 -28.21 67.95 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.745 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -77.37 -7.73 56.55 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.692 -177.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.468 ' CD1' ' HA ' ' A' ' 20' ' ' PRO . 27.7 m-85 -80.88 148.08 30.07 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 177.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -67.84 -31.21 70.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.142 0.496 . . . . 0.0 109.95 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.883 HG12 HG11 ' A' ' 96' ' ' VAL . 1.7 m -68.36 -16.82 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.563 -177.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -54.03 -57.17 12.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.006 0.431 . . . . 0.0 110.648 -177.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.421 ' HZ1' HD13 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -70.17 -33.06 71.28 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.741 -178.114 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.476 ' HB3' HD12 ' A' ' 100' ' ' ILE . 39.7 m-85 -69.92 -46.4 65.45 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.581 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.444 ' CE ' HD11 ' A' ' 68' ' ' ILE . 53.6 mtp -71.96 -26.15 62.15 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.949 0.404 . . . . 0.0 110.435 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.435 ' HD2' ' HA ' ' A' ' 30' ' ' LYS . 24.8 mmmt -68.45 -36.68 79.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.066 175.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.421 HD13 ' HZ1' ' A' ' 27' ' ' LYS . 17.6 pt -83.31 -26.72 7.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.171 176.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.0 tt -53.93 -50.56 66.16 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 171.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.594 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 10.5 tt0 -43.6 -55.19 4.46 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.69 176.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -71.17 -53.65 13.74 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.497 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.12 -40.19 80.6 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -167.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 91.3 mmm -56.89 -43.52 81.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.046 0.45 . . . . 0.0 111.291 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -91.37 -17.71 25.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.27 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -64.9 -22.51 67.01 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.009 -175.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -59.28 130.06 45.09 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 172.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.7 -27.39 62.88 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.827 -173.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -100.83 18.48 19.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.809 -0.178 . . . . 0.0 110.961 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 27.5 70.52 0.05 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.912 1.285 . . . . 0.0 112.568 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.1 mt -62.83 -6.14 3.46 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.392 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.1 tp -60.62 -27.14 39.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.665 178.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.49 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 22.9 mt-10 -74.28 -21.59 59.68 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-O 120.743 0.306 . . . . 0.0 111.255 -178.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.533 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 95.1 mttt -77.92 -36.97 48.77 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.475 0.655 . . . . 0.0 110.153 177.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 47' ' ' VAL . 14.6 p -112.29 31.73 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.657 -172.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.49 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 53.1 mtt180 -51.33 111.86 0.64 Allowed 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.62 0.724 . . . . 0.0 111.524 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.569 ' HA3' HD11 ' A' ' 123' ' ' LEU . . . -170.14 168.67 41.61 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.752 -175.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.533 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 54.1 mt -108.7 124.42 65.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.455 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 12.8 m-85 -106.63 130.97 54.29 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.265 -174.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -107.87 117.36 5.13 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.303 176.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.415 ' O ' ' HA ' ' A' ' 65' ' ' TYR . 3.4 m-85 -103.65 100.07 9.89 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 120.978 0.418 . . . . 0.0 111.509 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 90' ' ' THR . 56.5 mtmt -89.32 101.99 14.66 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.453 174.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.698 HG11 HG11 ' A' ' 25' ' ' VAL . 16.1 t -104.71 124.71 59.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.588 -176.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 45.6 mtp180 -114.4 -179.75 3.72 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.99 -178.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 61.64 47.19 6.59 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.926 0.393 . . . . 0.0 110.876 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.71 -172.16 15.71 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.478 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -38.57 -60.43 0.48 Allowed 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 124.115 3.21 . . . . 0.0 113.497 -175.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -123.99 62.88 1.07 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.11 0.481 . . . . 0.0 110.326 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.84 22.61 78.95 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.846 -0.692 . . . . 0.0 111.926 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.677 ' HA ' ' O ' ' A' ' 16' ' ' SER . . . -80.36 169.77 17.28 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.31 0.576 . . . . 0.0 111.581 -177.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -141.61 139.07 33.0 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.69 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.45 162.82 24.08 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.648 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 26.0 t80 -150.3 115.29 5.34 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.949 0.404 . . . . 0.0 110.811 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 10.5 m-90 -117.81 145.05 44.82 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.437 HG11 ' HG3' ' A' ' 83' ' ' GLU . 40.6 t -113.3 124.68 70.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.52 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.464 HD12 ' N ' ' A' ' 68' ' ' ILE . 3.8 mp -100.36 107.02 20.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -83.48 98.35 9.48 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.031 0.443 . . . . 0.0 110.205 178.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -108.32 -2.61 19.07 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.971 175.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -61.25 -37.49 83.3 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -83.06 -2.44 55.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.106 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.38 18.2 67.13 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.005 -178.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.531 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 11.8 mmpt? -93.17 -61.44 1.57 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.683 -0.258 . . . . 0.0 110.786 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.6 35.52 6.48 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.154 -1.022 . . . . 0.0 112.34 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.594 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 19.1 pttm -96.35 142.34 28.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.692 0.246 . . . . 0.0 110.347 -176.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.7 OUTLIER -108.0 133.44 52.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.37 0.605 . . . . 0.0 109.555 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.2 t -138.11 134.33 34.51 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.641 -176.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -68.0 135.3 52.11 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 42.38 73.4 0.14 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.857 0.836 . . . . 0.0 111.064 -172.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.58 -40.02 97.28 Favored Glycine 0 C--N 1.33 0.212 0 CA-C-N 115.108 -0.951 . . . . 0.0 113.591 -173.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 92.18 -14.33 64.79 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.23 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.498 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 1.7 pt-20 -97.95 153.09 18.59 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 122.15 0.18 . . . . 0.0 110.925 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 60.4 pttt -79.2 110.11 13.7 Favored Pre-proline 0 N--CA 1.449 -0.477 0 CA-C-O 121.284 0.564 . . . . 0.0 111.323 178.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.533 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 14.3 Cg_exo -69.84 130.58 19.49 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.529 2.152 . . . . 0.0 111.579 177.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -58.87 -37.17 75.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.799 176.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.612 ' HB ' ' CD1' ' A' ' 117' ' ' ILE . 14.3 m -138.72 138.98 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.691 177.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.665 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 44.9 m -124.32 136.1 53.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.516 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.581 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 34.7 m-85 -111.31 153.32 26.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.766 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.556 ' HB ' ' HB3' ' A' ' 116' ' ' LYS . 1.1 m -132.26 108.39 9.2 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 175.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.454 HG12 HG13 ' A' ' 115' ' ' ILE . 64.4 mt -134.18 159.47 42.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.523 0.729 . . . . 0.0 109.36 -173.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.444 ' N ' HG22 ' A' ' 91' ' ' ILE . 15.4 m -89.02 139.67 30.22 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.907 0.384 . . . . 0.0 110.096 174.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.588 ' OD1' HG13 ' A' ' 25' ' ' VAL . 35.1 t70 -53.03 -25.83 13.68 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.176 0.991 . . . . 0.0 111.63 -179.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -78.71 -38.93 37.9 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.711 -177.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -89.16 -19.72 25.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.54 -172.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.883 HG11 HG12 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -55.4 -32.56 29.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.082 0.468 . . . . 0.0 110.527 -179.192 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.6 m -67.23 -28.93 44.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.269 -173.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -84.79 -32.94 23.1 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.423 HD12 HG21 ' A' ' 91' ' ' ILE . 74.0 mt -68.72 -47.9 65.18 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.826 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 96' ' ' VAL . 10.6 mt -74.98 -18.95 16.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.908 -177.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.6 t -88.47 -20.49 25.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.868 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.55 9.25 61.67 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.124 -177.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -83.0 -41.15 19.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.011 0.434 . . . . 0.0 110.843 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.6 tp -102.97 127.31 50.24 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.051 178.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -71.6 121.87 85.61 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.115 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.425 ' HA ' HD12 ' A' ' 115' ' ' ILE . 4.9 Cg_exo -64.35 -20.52 66.54 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.763 1.642 . . . . 0.0 110.708 175.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -64.91 -58.77 5.28 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.818 172.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.534 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -66.03 -32.92 74.68 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.335 0.588 . . . . 0.0 109.566 -178.503 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.534 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -66.79 -40.11 88.01 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.552 178.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -58.3 -47.55 83.31 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.359 0.6 . . . . 0.0 109.718 175.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -63.87 -38.54 91.48 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.276 -177.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.431 HE21 ' HB3' ' A' ' 112' ' ' GLN . 7.8 mt-30 -91.53 6.0 47.32 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -174.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.23 2.22 80.53 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.827 173.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.1 mmpt? -77.34 -19.85 55.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.172 0.51 . . . . 0.0 110.443 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.684 HG23 HG22 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -127.94 110.37 21.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.861 178.599 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.556 ' HB3' ' HB ' ' A' ' 90' ' ' THR . 19.3 tptm -111.75 99.78 8.42 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.114 174.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.684 HG22 HG23 ' A' ' 115' ' ' ILE . 0.1 OUTLIER -124.78 133.34 69.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.946 -176.065 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.547 ' O ' HG12 ' A' ' 87' ' ' VAL . 44.0 mt-30 -85.57 96.55 9.68 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 176.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -70.99 124.63 11.62 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.985 -0.626 . . . . 0.0 114.185 -170.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -90.41 123.97 34.57 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 168.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 24.2 mmt -57.95 -32.28 67.66 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -169.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -91.62 -53.47 2.11 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.251 -0.976 . . . . 0.0 112.695 177.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.569 HD11 ' HA3' ' A' ' 49' ' ' GLY . 2.8 tt -70.74 -47.24 60.72 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 122.908 0.483 . . . . 0.0 112.228 -169.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.658 ' HA ' HD23 ' A' ' 127' ' ' LEU . . . -70.5 -15.52 62.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.598 0.237 . . . . 0.0 111.401 -174.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.605 ' O ' ' HB ' ' A' ' 128' ' ' THR . 17.1 mmt -77.7 -31.79 52.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.969 0.414 . . . . 0.0 110.207 175.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.533 ' HD2' ' O ' ' A' ' 46' ' ' LYS . 13.3 mttp -78.63 -27.77 45.48 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.232 0.539 . . . . 0.0 110.075 174.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.658 HD23 ' HA ' ' A' ' 124' ' ' ALA . 0.1 OUTLIER -66.93 -36.38 82.11 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 170.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.605 ' HB ' ' O ' ' A' ' 125' ' ' MET . 23.8 m -61.53 -31.71 71.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.919 172.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' A' ' 132' ' ' ARG . 20.6 t70 -71.47 -43.59 66.35 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.376 176.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -66.1 -38.82 89.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.21 -178.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.486 ' HG3' ' O ' ' A' ' 128' ' ' THR . 5.2 pp0? -65.11 -22.84 67.0 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.816 -0.353 . . . . 0.0 110.724 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 129' ' ' ASP . 75.1 mtp180 -62.14 -38.0 87.34 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 120.95 0.405 . . . . 0.0 109.924 173.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -76.09 -35.13 59.49 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.316 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.2 -20.03 63.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.351 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.18 -32.4 73.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.353 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 72.99 26.7 70.37 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.691 -0.686 . . . . 0.0 113.032 174.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -95.53 135.45 37.17 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.214 0.531 . . . . 0.0 110.934 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 8.5 tp -114.94 -22.35 4.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.532 0.682 . . . . 0.0 110.25 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -99.04 160.33 14.34 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.355 -170.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 35.5 p -100.0 137.82 37.92 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.223 176.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.4 tp . . . . . 0 C--O 1.25 1.099 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.856 179.272 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.685 ' N ' ' HH ' ' A' ' 79' ' ' TYR . . . . . . . . 0 N--CA 1.483 1.785 0 N-CA-C 112.171 -0.372 . . . . 0.0 112.171 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.2 p -81.47 51.37 1.64 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.02 0.438 . . . . 0.0 111.568 -177.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.9 m -136.78 -172.37 3.16 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.202 -178.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -55.38 148.44 25.61 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.406 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.429 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 89.5 m-20 -70.57 148.22 95.09 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 121.036 0.446 . . . . 0.0 110.173 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 19' ' ' ASN . 15.1 Cg_exo -62.99 -30.26 76.39 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 123.173 2.582 . . . . 0.0 112.268 -173.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.406 ' HG3' ' H ' ' A' ' 21' ' ' GLU . 8.8 mt-10 -68.61 -23.36 64.44 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.794 -178.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.415 ' OD2' ' HB2' ' A' ' 19' ' ' ASN . 23.2 m-20 -76.06 -16.24 59.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.243 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -90.2 152.92 20.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.14 0.495 . . . . 0.0 110.525 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -80.46 -26.1 38.51 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.411 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.827 HG12 HG11 ' A' ' 96' ' ' VAL . 1.0 OUTLIER -66.62 -17.59 22.8 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.536 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.973 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -53.89 -51.9 62.23 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.814 0.34 . . . . 0.0 110.492 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.459 ' O ' HG23 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -67.25 -36.48 81.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.508 -179.246 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.408 ' O ' HG12 ' A' ' 31' ' ' ILE . 48.0 m-85 -70.17 -53.32 17.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.501 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.538 ' SD ' ' HB ' ' A' ' 25' ' ' VAL . 0.1 OUTLIER -61.04 -32.1 71.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.767 0.317 . . . . 0.0 110.898 177.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.475 ' HD3' ' HA ' ' A' ' 30' ' ' LYS . 34.0 mmtt -74.53 -27.94 60.75 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.459 HG23 ' O ' ' A' ' 27' ' ' LYS . 15.5 pt -89.77 -18.43 7.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.714 173.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.9 tt -62.69 -52.54 62.88 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 169.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.575 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 11.9 tt0 -42.47 -55.17 3.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.141 -1.39 . . . . 0.0 110.688 173.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -65.07 -53.82 39.68 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.757 -1.11 . . . . 0.0 111.876 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.68 -36.94 84.51 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -167.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.435 ' HA ' ' CE ' ' A' ' 36' ' ' MET . 5.1 mmt -60.92 -43.37 98.69 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.686 0.279 . . . . 0.0 111.304 -177.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -92.64 -15.1 27.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.988 0.423 . . . . 0.0 110.499 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -64.02 -35.35 80.42 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.064 0.459 . . . . 0.0 110.221 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -70.12 123.25 21.13 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 173.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.81 -24.07 65.55 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.652 -172.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -74.44 -17.58 60.77 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.7 p30 34.27 70.36 0.13 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.924 0.889 . . . . 0.0 112.391 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.4 mt -70.36 1.67 4.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.262 -178.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -62.05 -31.47 51.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.259 -177.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.577 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 46.3 mt-10 -73.13 -20.56 60.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.475 -173.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -72.81 -19.55 61.31 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.344 0.592 . . . . 0.0 110.241 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -131.01 33.44 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.338 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.577 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 57.8 mtt180 -45.31 110.31 0.23 Allowed 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.469 0.652 . . . . 0.0 111.853 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.578 ' HA3' HD11 ' A' ' 123' ' ' LEU . . . -174.95 175.27 47.04 Favored Glycine 0 C--N 1.31 -0.867 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.306 -176.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.454 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 67.3 mt -107.98 124.83 64.46 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-O 121.284 0.564 . . . . 0.0 111.248 -177.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.491 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 4.3 m-85 -105.98 111.62 24.34 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.827 -176.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -93.16 126.92 8.79 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.691 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -111.28 103.04 11.41 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.05 0.452 . . . . 0.0 111.777 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -87.88 102.06 14.34 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.11 173.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.698 HG11 HG11 ' A' ' 25' ' ' VAL . 23.0 t -101.88 125.18 56.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.251 0.548 . . . . 0.0 111.238 -173.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.617 ' NE ' HG22 ' A' ' 90' ' ' THR . 51.6 mtm180 -109.77 175.53 5.41 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.985 -174.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 60.82 49.07 6.34 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 122.684 0.394 . . . . 0.0 111.849 176.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.88 -160.01 10.5 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.28 175.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 62' ' ' ALA . 80.2 Cg_exo -41.62 -61.4 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.678 2.919 . . . . 0.0 113.573 -177.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -125.1 63.78 1.15 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.368 0.604 . . . . 0.0 109.573 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.0 26.7 73.27 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.401 -177.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.464 ' HB3' ' HD2' ' A' ' 59' ' ' PRO . . . -77.72 152.86 33.46 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.182 0.515 . . . . 0.0 111.149 -178.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -129.38 112.84 14.24 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.043 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.06 164.93 18.41 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.106 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -147.75 117.06 6.92 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.874 0.368 . . . . 0.0 110.941 -176.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 16.0 m-90 -119.35 147.55 44.2 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.826 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 19.7 t -116.44 115.52 49.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.461 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.519 HG13 HG12 ' A' ' 77' ' ' VAL . 4.2 mp -91.29 103.56 14.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -84.88 97.88 10.0 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.168 0.509 . . . . 0.0 110.138 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -100.97 -0.47 36.55 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.472 174.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.426 ' HB2' HG13 ' A' ' 50' ' ' ILE . 15.9 tppt? -59.74 -40.3 87.62 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.318 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -74.88 -13.74 60.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.033 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.64 9.23 75.48 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -172.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -90.32 -59.79 2.09 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.356 -0.422 . . . . 0.0 110.872 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.55 36.45 5.86 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.066 -1.064 . . . . 0.0 112.149 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.575 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 16.3 pttm -95.72 144.47 26.09 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -175.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.519 HG12 HG13 ' A' ' 68' ' ' ILE . 0.7 OUTLIER -108.08 133.42 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-O 121.433 0.635 . . . . 0.0 109.866 -178.897 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.611 HG23 ' HA2' ' A' ' 81' ' ' GLY . 1.8 t -136.89 141.21 42.74 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.294 -177.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.685 ' HH ' ' N ' ' A' ' 15' ' ' GLY . 80.1 t80 -62.38 123.6 18.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.349 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 72.75 -38.64 0.42 Allowed 'General case' 0 N--CA 1.471 0.623 0 O-C-N 123.984 0.802 . . . . 0.0 111.993 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.611 ' HA2' HG23 ' A' ' 78' ' ' THR . . . 76.0 -41.63 1.53 Allowed Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 114.158 0.423 . . . . 0.0 114.158 176.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.99 0.76 53.63 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.102 -176.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -107.08 166.83 10.32 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -98.25 108.39 46.94 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 175.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.454 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 21.3 Cg_exo -67.28 132.6 28.07 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 123.138 2.558 . . . . 0.0 113.194 -177.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.575 ' HB2' HD22 ' A' ' 123' ' ' LEU . 8.3 m-20 -64.0 -39.94 95.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.001 174.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.726 HG11 ' HB2' ' A' ' 124' ' ' ALA . 6.2 m -136.21 134.18 50.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.656 175.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.619 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 21.2 m -122.81 132.35 54.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.627 -178.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.574 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 41.4 m-85 -111.68 136.86 50.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.917 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.617 HG22 ' NE ' ' A' ' 56' ' ' ARG . 2.2 m -109.04 99.67 8.95 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.057 0.456 . . . . 0.0 109.853 175.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 86.4 mt -122.72 159.07 26.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -176.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.476 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 4.9 m -99.34 138.38 36.52 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 177.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.414 ' OD2' HG13 ' A' ' 25' ' ' VAL . 13.2 t70 -44.54 -50.11 9.74 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.14 0.576 . . . . 0.0 111.376 -176.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -59.02 -34.6 72.08 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.5 -1.227 . . . . 0.0 111.575 -176.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.476 ' OD2' ' HB2' ' A' ' 92' ' ' SER . 23.0 m-20 -91.09 -21.72 21.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.064 -177.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.827 HG11 HG12 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -57.71 -34.21 47.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 121.221 0.534 . . . . 0.0 109.824 -179.101 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.0 m -67.21 -27.71 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.971 -174.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -83.68 -34.41 24.99 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.42 ' HG ' HD23 ' A' ' 104' ' ' LEU . 79.8 mt -71.45 -36.25 71.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.219 -177.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.583 HG13 ' O ' ' A' ' 96' ' ' VAL . 17.4 mt -85.15 -22.2 7.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.348 -177.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 37.0 p -85.29 -20.85 29.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.004 0.431 . . . . 0.0 111.062 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 96.17 11.99 53.09 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.663 -177.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -85.67 -41.98 14.69 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.941 0.401 . . . . 0.0 111.125 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.42 HD23 ' HG ' ' A' ' 99' ' ' LEU . 49.2 tp -102.89 131.29 49.91 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.274 177.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.489 ' HB2' ' HB2' ' A' ' 108' ' ' LYS . 16.1 m120 -78.73 118.32 71.7 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.475 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -65.45 -27.14 54.64 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 121.978 1.785 . . . . 0.0 111.001 177.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -66.93 -55.21 15.57 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.454 173.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.67 ' HE3' ' HG3' ' A' ' 112' ' ' GLN . 13.6 ttpt -53.51 -48.85 68.61 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.056 175.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.554 ' HB1' ' HB3' ' A' ' 114' ' ' LYS . . . -65.03 -31.71 73.07 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.68 -175.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -60.08 -45.7 92.04 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 174.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -67.08 -38.0 84.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.427 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.67 ' HG3' ' HE3' ' A' ' 108' ' ' LYS . 15.2 mm100 -71.06 -23.41 62.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.762 -177.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 101.39 8.67 46.2 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.399 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.606 ' HA ' ' HE3' ' A' ' 114' ' ' LYS . 1.1 tpmt? -83.31 -32.09 26.51 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-O 121.398 0.618 . . . . 0.0 110.386 -176.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.644 HG23 HG22 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -111.99 122.43 66.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.005 -174.163 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.412 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 47.3 mmtm -112.59 106.13 14.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.481 173.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.644 HG22 HG23 ' A' ' 115' ' ' ILE . 0.1 OUTLIER -128.08 129.17 69.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 120.986 0.422 . . . . 0.0 111.079 -178.148 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.575 ' O ' HG12 ' A' ' 87' ' ' VAL . 1.1 tm0? -86.46 117.16 25.06 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 176.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -85.84 98.93 2.33 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.741 -0.743 . . . . 0.0 113.893 -172.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.445 ' H ' HG12 ' A' ' 87' ' ' VAL . 26.2 t-20 -64.95 120.39 12.49 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 167.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.548 ' O ' ' HB3' ' A' ' 125' ' ' MET . 2.0 mpt? -57.86 -30.38 65.76 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.758 0.661 . . . . 0.0 112.472 -169.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -92.25 -27.21 16.25 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.527 -0.844 . . . . 0.0 113.181 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.578 HD11 ' HA3' ' A' ' 49' ' ' GLY . 0.6 OUTLIER -91.77 -61.72 1.58 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.693 0.759 . . . . 0.0 110.755 -173.613 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.726 ' HB2' HG11 ' A' ' 87' ' ' VAL . . . -74.62 -5.56 43.67 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.493 -173.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.548 ' HB3' ' O ' ' A' ' 121' ' ' MET . 26.0 ptt? -66.28 -21.4 66.27 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.189 176.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -85.23 -26.08 26.92 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.011 -0.675 . . . . 0.0 110.059 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 39.4 mt -70.13 -27.91 64.95 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 169.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.521 ' HB ' ' O ' ' A' ' 125' ' ' MET . 43.4 m -73.4 -20.02 60.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 113.801 -1.545 . . . . 0.0 111.313 177.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -58.22 -25.94 62.25 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.283 0.563 . . . . 0.0 111.374 -175.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.6 mt -61.72 -23.18 65.96 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.915 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' A' ' 128' ' ' THR . 1.8 pt20 -70.49 -17.48 62.96 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 120.567 0.223 . . . . 0.0 110.878 -178.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -62.92 -22.75 66.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.039 0.447 . . . . 0.0 110.893 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -90.36 -21.08 22.17 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.466 0.65 . . . . 0.0 109.861 175.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -106.72 19.29 20.7 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.915 -176.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.79 -13.69 62.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.484 -175.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 95.37 28.57 9.61 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.07 178.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 67.63 -172.42 0.19 Allowed 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 122.654 0.382 . . . . 0.0 111.081 178.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 10.4 tp -66.47 -33.67 65.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.271 0.557 . . . . 0.0 110.981 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -100.38 119.65 38.77 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.798 -174.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 31.7 p -166.43 20.86 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.338 -177.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 48.0 mm . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.784 -0.627 . . . . 0.0 110.237 -178.638 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.69 0 N-CA-C 111.775 -0.53 . . . . 0.0 111.775 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.7 p -71.54 -38.03 71.07 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.977 0.389 . . . . 0.0 111.165 -178.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.6 p -92.01 110.33 21.69 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.683 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.427 ' H ' ' HB2' ' A' ' 62' ' ' ALA . . . -62.31 149.79 47.61 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 173.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.436 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 95.6 m-20 -66.87 145.74 98.97 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 121.463 0.649 . . . . 0.0 111.569 -174.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.531 ' HA ' ' CD1' ' A' ' 23' ' ' PHE . 15.4 Cg_exo -62.96 -26.72 74.2 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.644 2.896 . . . . 0.0 111.681 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -59.24 -37.52 77.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.718 177.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -81.04 -2.94 50.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.872 0.368 . . . . 0.0 111.46 -174.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.531 ' CD1' ' HA ' ' A' ' 20' ' ' PRO . 29.9 m-85 -73.95 144.06 45.42 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 172.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.432 ' O ' ' HD2' ' A' ' 28' ' ' TYR . 64.4 mmtt -66.94 -30.5 70.66 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 175.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 1.086 HG12 HG11 ' A' ' 96' ' ' VAL . 0.8 OUTLIER -65.01 -20.19 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.786 -178.03 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -59.02 -54.44 47.07 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.409 ' O ' HG23 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -71.32 -37.71 71.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.61 179.012 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.434 ' HB2' ' HA ' ' A' ' 25' ' ' VAL . 28.2 m-85 -69.35 -41.96 75.92 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.493 ' HB3' HG21 ' A' ' 77' ' ' VAL . 61.1 mtt -74.88 -27.95 60.45 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.359 178.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.431 ' HD2' ' HA ' ' A' ' 30' ' ' LYS . 19.4 mmmt -66.09 -34.24 77.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.078 175.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.409 HG23 ' O ' ' A' ' 27' ' ' LYS . 18.2 pt -86.32 -21.3 7.54 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.592 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.271 175.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.5 tt -61.83 -48.33 81.04 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 173.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.517 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 3.4 tt0 -45.62 -49.34 14.34 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.878 174.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -75.44 -61.48 1.89 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.755 -1.112 . . . . 0.0 111.703 -177.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.71 -38.95 73.02 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -167.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 95.3 mmm -59.64 -38.82 82.43 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.491 0.182 . . . . 0.0 111.491 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -91.48 -31.44 15.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.135 0.493 . . . . 0.0 111.049 176.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -65.3 -27.53 68.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.923 -176.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -56.67 142.03 41.46 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.414 177.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.3 p -48.99 -45.27 42.06 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.098 0.475 . . . . 0.0 111.406 -177.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -90.28 -8.59 50.55 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.227 -176.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.527 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 6.1 p30 36.51 71.77 0.12 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.865 0.841 . . . . 0.0 110.984 -175.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.5 mt -60.53 -5.34 1.17 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.945 -175.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.8 tp -62.14 -27.62 42.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.59 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.527 ' HG2' ' O ' ' A' ' 42' ' ' ASN . 14.5 pt-20 -67.13 -28.75 68.4 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.793 0.33 . . . . 0.0 111.259 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.439 ' O ' ' HG2' ' A' ' 126' ' ' LYS . 52.2 mtpt -78.53 -24.73 45.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.145 0.498 . . . . 0.0 110.642 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.704 HG22 ' OH ' ' A' ' 51' ' ' TYR . 8.3 p -124.91 32.39 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.759 0.79 . . . . 0.0 110.955 -168.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -65.6 125.34 24.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.568 0.699 . . . . 0.0 111.778 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.14 -174.29 46.3 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.38 -178.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.425 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 48.2 mt -111.42 125.71 68.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 117.978 0.889 . . . . 0.0 110.589 175.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.704 ' OH ' HG22 ' A' ' 47' ' ' VAL . 19.1 m-85 -115.99 111.29 20.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.609 -174.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.29 111.83 4.11 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.686 -0.769 . . . . 0.0 111.314 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -100.88 109.61 21.59 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.291 0.567 . . . . 0.0 111.141 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -97.41 99.88 11.31 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.116 176.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.806 HG11 HG11 ' A' ' 25' ' ' VAL . 12.2 t -99.14 127.22 52.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.656 -172.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.502 ' O ' ' HA ' ' A' ' 92' ' ' SER . 54.8 mtp180 -118.15 176.19 5.33 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.253 -177.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 59.44 46.71 12.02 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.127 0.489 . . . . 0.0 111.242 178.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -79.55 -148.75 4.87 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.081 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' A' ' 62' ' ' ALA . 94.7 Cg_exo -40.97 -60.72 0.58 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 124.261 3.307 . . . . 0.0 114.109 -176.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -132.02 66.19 1.56 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.127 0.489 . . . . 0.0 109.683 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.12 24.52 71.87 Favored Glycine 0 N--CA 1.453 -0.199 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 -176.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.439 ' HB3' ' HD2' ' A' ' 59' ' ' PRO . . . -81.43 165.08 21.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.354 -0.423 . . . . 0.0 111.652 -175.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.425 ' HG2' ' HA ' ' A' ' 56' ' ' ARG . 23.0 mt-10 -139.4 142.9 37.48 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.596 -178.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -140.11 168.54 25.06 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.699 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -147.45 116.09 6.72 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.801 0.334 . . . . 0.0 110.881 -176.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 14.1 m-90 -119.49 142.95 47.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.818 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 42.4 t -111.01 114.51 47.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.661 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.542 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 4.3 mp -89.05 99.78 9.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 174.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -89.16 103.08 15.73 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.793 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -115.1 17.19 16.87 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.827 175.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -66.44 -40.04 89.24 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.256 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -85.25 -13.99 48.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.927 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.81 12.6 39.96 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.543 -0.753 . . . . 0.0 113.014 176.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.608 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 8.5 mmpt? -86.3 -38.01 17.95 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.986 -0.285 . . . . 0.0 111.603 -178.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.2 35.42 23.81 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.251 -0.976 . . . . 0.0 112.724 177.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.517 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 58.5 pttt -96.72 148.08 23.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.891 0.346 . . . . 0.0 110.884 -172.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.493 HG21 ' HB3' ' A' ' 29' ' ' MET . 0.7 OUTLIER -111.75 137.18 45.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 176.766 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.3 t -140.57 132.68 27.95 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.962 0.411 . . . . 0.0 110.847 -178.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -69.29 121.27 16.52 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 56.86 73.02 0.47 Allowed 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -174.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.73 -35.64 85.95 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.56 -0.746 . . . . 0.0 113.576 -174.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.27 1.07 90.42 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.401 -176.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -91.52 169.82 10.45 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -100.25 107.28 46.81 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.943 173.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.425 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 12.4 Cg_exo -70.78 130.0 17.39 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.59 2.194 . . . . 0.0 112.203 178.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.632 ' HB2' HD22 ' A' ' 123' ' ' LEU . 30.8 m-20 -67.59 -29.01 68.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.858 176.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.54 ' HA ' ' HA3' ' A' ' 119' ' ' GLY . 4.4 m -139.51 138.73 39.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.189 172.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.595 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 46.8 m -121.4 129.35 52.97 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.219 177.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.628 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 76.4 m-85 -116.51 126.39 53.28 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.091 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.503 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 2.8 m -102.85 125.53 49.64 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.614 ' CG1' HG13 ' A' ' 115' ' ' ILE . 0.3 OUTLIER -156.76 150.33 9.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.22 0.533 . . . . 0.0 111.104 -174.345 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.502 ' HA ' ' O ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -77.99 139.73 39.16 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.356 178.285 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -52.33 -29.8 25.35 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.263 177.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -68.97 -39.28 79.54 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.537 -178.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -90.14 -25.79 20.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.42 -174.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 1.086 HG11 HG12 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -57.66 -32.56 42.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.02 0.438 . . . . 0.0 110.444 -177.767 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.7 m -69.14 -28.2 38.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.748 -174.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -81.5 -37.19 28.27 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 176.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.414 HD23 ' O ' ' A' ' 104' ' ' LEU . 88.4 mt -64.15 -48.97 73.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.794 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 96' ' ' VAL . 20.2 mt -73.28 -24.96 20.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.543 -176.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.3 t -89.07 -9.81 49.76 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.779 0.324 . . . . 0.0 111.173 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 86.46 16.9 61.35 Favored Glycine 0 N--CA 1.453 -0.177 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.204 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -89.54 -42.72 11.27 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.99 0.424 . . . . 0.0 110.763 -178.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.723 HD11 ' NZ ' ' A' ' 108' ' ' LYS . 49.6 tp -105.59 127.97 53.35 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.846 -178.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -72.97 124.14 90.38 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.471 175.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -65.7 -25.17 54.19 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.347 2.031 . . . . 0.0 110.262 176.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -57.43 -61.41 2.51 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.897 173.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.723 ' NZ ' HD11 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -63.02 -35.63 80.88 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.138 -178.783 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.548 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -69.12 -32.29 71.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.971 -176.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -62.93 -50.49 70.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.701 174.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -64.94 -31.89 73.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.111 -177.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -83.93 1.53 43.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.984 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.98 12.3 82.78 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.833 -0.698 . . . . 0.0 113.446 174.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.502 ' HA ' ' HE3' ' A' ' 114' ' ' LYS . 0.3 OUTLIER -87.34 -42.88 12.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.822 0.344 . . . . 0.0 110.496 178.166 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.614 HG13 ' CG1' ' A' ' 91' ' ' ILE . 0.1 OUTLIER -91.05 114.44 28.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.554 0.692 . . . . 0.0 110.004 178.237 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.503 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 29.0 mmmt -111.73 99.79 8.43 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.411 176.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.628 ' HB ' ' CD2' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -118.58 138.49 49.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.442 -178.497 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.4 ' N ' HD12 ' A' ' 117' ' ' ILE . 52.3 tt0 -146.31 82.1 1.59 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -174.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.54 ' HA3' ' HA ' ' A' ' 87' ' ' VAL . . . -161.03 172.69 37.35 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.959 -171.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -50.37 113.66 0.93 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.066 0.46 . . . . 0.0 110.211 178.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.543 ' O ' ' HG3' ' A' ' 125' ' ' MET . 50.0 ttm -63.78 -29.75 70.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.564 -173.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -66.95 -38.1 92.6 Favored Glycine 0 C--O 1.226 -0.359 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.921 -176.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.632 HD22 ' HB2' ' A' ' 86' ' ' ASP . 3.4 tp -63.48 -49.35 73.96 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.322 0.582 . . . . 0.0 109.75 176.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -68.98 -20.36 64.17 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.968 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.543 ' HG3' ' O ' ' A' ' 121' ' ' MET . 78.4 mtp -66.14 -24.34 66.65 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.13 177.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.699 ' HB2' HG23 ' A' ' 47' ' ' VAL . 13.7 mptt -76.53 -16.25 59.68 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.472 176.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 78.7 mt -75.77 -35.6 60.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.102 0.477 . . . . 0.0 109.875 176.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.453 HG22 ' O ' ' A' ' 125' ' ' MET . 5.8 t -83.67 -17.46 41.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.957 178.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.527 ' O ' ' HG3' ' A' ' 132' ' ' ARG . 18.0 t70 -59.08 -29.18 67.15 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.476 0.655 . . . . 0.0 110.26 175.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.1 mt -56.09 -16.3 4.88 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.998 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.447 ' HA ' ' HB3' ' A' ' 134' ' ' ALA . 3.5 pt20 -58.97 -19.75 46.12 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 122.6 0.36 . . . . 0.0 111.799 -178.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.527 ' HG3' ' O ' ' A' ' 129' ' ' ASP . 47.8 mtt180 -53.43 -54.61 34.45 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 120.906 0.384 . . . . 0.0 110.529 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -91.24 -32.64 15.68 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.826 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.447 ' HB3' ' HA ' ' A' ' 131' ' ' GLN . . . -66.74 -11.05 53.07 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -174.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -83.63 12.6 5.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.926 0.393 . . . . 0.0 111.231 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.1 13.54 66.05 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.982 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -82.01 88.81 6.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.161 0.505 . . . . 0.0 110.198 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 9.4 tp -128.28 -28.31 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.411 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -100.06 162.73 12.79 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.781 -172.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.6 m -138.16 82.9 1.94 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.462 0.649 . . . . 0.0 110.305 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.1 mt . . . . . 0 C--O 1.246 0.911 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.846 179.715 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.759 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.0 m -77.22 95.36 4.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.014 0.435 . . . . 0.0 110.152 176.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.3 m -93.75 -168.58 1.92 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.392 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -51.99 139.89 27.93 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 121.272 -0.49 . . . . 0.0 112.775 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -72.3 142.68 84.81 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-O 121.142 0.496 . . . . 0.0 110.528 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -52.73 -36.97 74.96 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 124.229 3.286 . . . . 0.0 112.081 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -54.22 -37.34 64.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.81 176.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -79.2 -5.05 53.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.335 -175.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -78.9 148.58 32.68 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.128 0.489 . . . . 0.0 110.037 176.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.478 ' HD3' HG11 ' A' ' 97' ' ' VAL . 46.8 mttp -70.86 -25.71 62.94 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 176.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 1.08 HG12 HG11 ' A' ' 96' ' ' VAL . 0.9 OUTLIER -72.87 -17.75 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 114.988 -1.006 . . . . 0.0 111.022 -178.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -56.31 -53.78 53.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.825 0.345 . . . . 0.0 110.472 -176.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.447 ' HE2' HG23 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -70.59 -40.35 73.29 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.496 178.242 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.443 ' HB3' HD12 ' A' ' 100' ' ' ILE . 9.8 m-85 -64.67 -45.37 86.98 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -175.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.463 ' CE ' HD11 ' A' ' 68' ' ' ILE . 66.8 mtp -75.97 -22.81 55.5 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.371 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.461 ' HD2' ' HA ' ' A' ' 30' ' ' LYS . 24.4 mmmt -71.63 -36.78 70.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.933 174.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.447 HG23 ' HE2' ' A' ' 27' ' ' LYS . 16.1 pt -82.22 -25.25 9.13 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.485 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.122 175.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.8 tt -56.54 -53.04 62.21 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 171.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.488 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 14.1 tt0 -43.82 -49.09 8.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.267 -1.333 . . . . 0.0 111.725 175.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -75.15 -55.57 5.6 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.533 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.477 ' HA ' ' HB3' ' A' ' 38' ' ' ASN . . . -56.21 -36.28 68.26 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -168.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 25.2 mmt -61.41 -43.86 98.13 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.678 0.275 . . . . 0.0 111.483 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -91.7 -17.01 26.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.28 0.562 . . . . 0.0 110.602 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.477 ' HB3' ' HA ' ' A' ' 35' ' ' ALA . 4.3 t-20 -66.34 -36.26 82.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.781 177.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -56.91 125.94 24.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.31 175.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.79 -26.33 34.01 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -175.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -92.16 -16.6 26.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.476 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 35.87 69.02 0.2 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.904 0.859 . . . . 0.0 111.104 -177.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.1 mt -65.18 -0.73 1.83 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.731 -174.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.535 HG13 ' HB1' ' A' ' 70' ' ' ALA . 4.9 tp -61.83 -26.54 40.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.296 -177.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.467 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 44.6 mt-10 -76.51 -22.46 54.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.894 0.378 . . . . 0.0 111.053 -176.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -76.45 -19.18 58.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.654 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 47' ' ' VAL . 10.6 p -130.02 32.4 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.633 0.73 . . . . 0.0 110.076 -176.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.467 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 55.4 mtt180 -46.86 119.8 2.69 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.992 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.615 ' HA3' HD11 ' A' ' 123' ' ' LEU . . . -179.88 166.64 35.9 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.314 -177.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.478 HG13 ' HB2' ' A' ' 71' ' ' LYS . 55.1 mt -102.79 122.93 55.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.142 0.496 . . . . 0.0 110.842 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.458 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 21.6 m-85 -103.32 118.56 37.05 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.933 -177.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.43 111.76 4.3 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.389 -0.91 . . . . 0.0 111.279 177.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -97.86 104.91 16.98 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.059 0.457 . . . . 0.0 111.458 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -92.7 99.07 11.83 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.691 175.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.792 HG11 HG11 ' A' ' 25' ' ' VAL . 6.0 t -102.34 145.42 12.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.673 -178.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.563 ' CB ' ' HG2' ' A' ' 63' ' ' GLU . 1.1 ptm180 -154.21 -174.2 4.87 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.544 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 64.71 38.17 7.11 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.082 0.468 . . . . 0.0 110.216 -174.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.24 -154.55 4.45 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.824 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo -36.6 -60.0 0.4 Allowed 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 124.326 3.351 . . . . 0.0 113.938 -174.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -128.57 54.88 1.73 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.221 0.534 . . . . 0.0 109.882 178.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 74.53 28.4 63.55 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.544 -176.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.06 156.24 30.15 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 121.391 0.615 . . . . 0.0 111.204 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.563 ' HG2' ' CB ' ' A' ' 56' ' ' ARG . 34.7 mt-10 -125.14 147.58 48.96 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.296 -178.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -143.12 162.91 27.5 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.343 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -150.63 114.9 5.11 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.819 0.342 . . . . 0.0 110.97 -177.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 15.5 m-90 -120.47 136.28 54.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.13 0.49 . . . . 0.0 109.835 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 14.6 t -103.49 116.66 47.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.425 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.463 HD11 ' CE ' ' A' ' 29' ' ' MET . 4.3 mp -93.38 101.21 12.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 175.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -85.69 98.38 10.66 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.246 -177.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.535 ' HB1' HG13 ' A' ' 44' ' ' ILE . . . -107.04 0.73 23.82 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.227 176.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.478 ' HB2' HG13 ' A' ' 50' ' ' ILE . 5.1 tppp? -63.54 -41.73 98.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.399 0.618 . . . . 0.0 109.918 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -76.47 -6.68 52.81 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.424 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.83 8.5 63.5 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.761 176.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -92.01 -55.73 3.34 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -176.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.2 34.93 7.81 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 119.824 -1.179 . . . . 0.0 111.889 -176.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.488 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 22.7 pttp -96.56 144.16 26.88 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -176.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.7 OUTLIER -107.63 131.7 57.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.536 0.684 . . . . 0.0 109.619 -178.787 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.549 HG23 ' HA2' ' A' ' 81' ' ' GLY . 1.8 t -139.83 135.35 32.89 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.563 -178.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -63.19 128.46 35.96 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -176.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 73.25 -42.69 0.53 Allowed 'General case' 0 N--CA 1.471 0.584 0 O-C-N 124.011 0.82 . . . . 0.0 111.578 -177.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.549 ' HA2' HG23 ' A' ' 78' ' ' THR . . . 73.81 -41.81 1.06 Allowed Glycine 0 N--CA 1.453 -0.189 0 N-CA-C 114.425 0.53 . . . . 0.0 114.425 175.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.81 5.94 76.38 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.659 -175.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.403 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 13.3 mm-40 -114.23 143.41 44.88 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -177.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -77.77 110.56 13.39 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 121.185 0.517 . . . . 0.0 110.792 174.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.427 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 13.4 Cg_exo -70.16 130.05 18.19 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.861 2.374 . . . . 0.0 112.452 -178.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -63.57 -34.3 77.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.485 176.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.588 HG11 ' HB2' ' A' ' 124' ' ' ALA . 9.0 m -139.4 133.93 39.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.556 176.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.662 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 53.9 m -116.77 139.33 50.7 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.517 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.49 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 54.4 m-85 -118.06 132.92 56.32 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.491 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 5.7 m -110.1 128.67 55.57 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 175.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.596 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -161.99 144.23 3.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.071 0.462 . . . . 0.0 109.862 -177.214 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -81.6 147.24 29.69 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.316 0.579 . . . . 0.0 111.154 177.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -51.25 -29.16 13.63 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 114.449 -1.251 . . . . 0.0 112.033 -177.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -73.51 -34.26 65.19 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.32 -176.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -90.08 -27.39 19.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.843 -175.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 1.08 HG11 HG12 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -56.82 -31.61 36.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.217 -174.889 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.478 HG11 ' HD3' ' A' ' 24' ' ' LYS . 12.8 m -69.34 -29.24 41.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.687 -170.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -83.96 -31.43 25.58 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 176.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.483 HD23 ' O ' ' A' ' 104' ' ' LEU . 91.2 mt -64.63 -51.55 62.05 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.269 0.557 . . . . 0.0 110.562 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 96' ' ' VAL . 14.9 mt -75.51 -16.75 15.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.395 -175.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 42.0 t -94.14 -4.29 49.47 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.207 -0.308 . . . . 0.0 111.322 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.57 30.92 55.73 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.705 -0.759 . . . . 0.0 111.939 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -106.7 -42.67 4.9 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.223 0.535 . . . . 0.0 110.571 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.483 ' O ' HD23 ' A' ' 99' ' ' LEU . 33.8 tp -103.32 120.74 41.35 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.694 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.46 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 5.9 m-20 -68.51 120.48 75.6 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.467 178.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -63.68 -21.47 69.98 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.21 1.94 . . . . 0.0 110.578 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -62.81 -58.69 6.55 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.958 174.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.526 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 1.2 ptmt -66.74 -33.95 76.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.015 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.526 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -65.87 -29.42 69.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.955 0.407 . . . . 0.0 110.098 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -65.39 -46.82 78.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.627 175.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -67.43 -37.2 82.64 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.1 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -79.71 10.92 3.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.857 -176.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.78 7.83 83.94 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 121.236 -0.507 . . . . 0.0 113.268 173.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -82.15 -53.4 6.11 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.117 0.484 . . . . 0.0 110.456 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.643 HG23 HG22 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -88.52 115.12 28.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.585 -177.633 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.491 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 31.2 mmmt -111.06 103.22 11.65 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.524 176.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.662 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER -130.95 130.27 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-O 121.159 0.504 . . . . 0.0 110.955 -176.665 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.49 ' O ' HG12 ' A' ' 87' ' ' VAL . 0.8 OUTLIER -83.48 94.24 7.98 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 175.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -71.08 100.54 0.86 Allowed Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.969 -0.559 . . . . 0.0 113.643 -172.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 39.1 t-20 -64.71 115.57 5.38 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 171.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 25.2 ptt? -57.53 -27.79 62.92 Favored 'General case' 0 C--O 1.223 -0.342 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -171.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -90.8 -37.11 6.52 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.017 -1.087 . . . . 0.0 113.076 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.615 HD11 ' HA3' ' A' ' 49' ' ' GLY . 4.0 tt -90.82 -48.39 7.06 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.704 0.288 . . . . 0.0 111.461 -172.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.588 ' HB2' HG11 ' A' ' 87' ' ' VAL . . . -76.58 -15.26 59.89 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.556 -173.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 46.5 mtt -71.71 -18.12 62.17 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.722 177.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.548 ' O ' ' HG ' ' A' ' 130' ' ' LEU . 5.6 mptp? -76.77 -22.45 53.74 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.36 176.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.71 -46.15 86.72 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.056 177.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.673 ' O ' ' HG2' ' A' ' 132' ' ' ARG . 9.0 t -75.26 -36.65 61.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.027 177.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -54.85 -42.76 72.36 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.921 0.391 . . . . 0.0 111.022 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 126' ' ' LYS . 7.4 mt -55.68 -40.64 72.61 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.132 178.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -88.22 -19.91 26.22 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.275 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.673 ' HG2' ' O ' ' A' ' 128' ' ' THR . 21.5 mmt180 -64.86 -43.98 91.21 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.06 0.457 . . . . 0.0 109.851 175.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.433 ' HA ' ' HG2' ' A' ' 137' ' ' ARG . 12.7 pt20 -79.1 -7.25 58.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.944 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -101.36 0.42 37.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.111 174.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -96.16 -6.98 37.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.045 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.62 48.76 3.13 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.841 178.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.433 ' HG2' ' HA ' ' A' ' 133' ' ' GLN . 11.4 ptm180 -88.66 106.7 18.5 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.365 0.603 . . . . 0.0 110.142 178.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.3 mp -76.37 -68.41 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.09 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -101.4 150.44 23.03 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.366 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.8 m -76.51 94.84 3.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.399 -175.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 49.0 mm . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.282 -0.866 . . . . 0.0 109.516 176.315 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.595 0 N-CA-C 111.787 -0.525 . . . . 0.0 111.787 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.2 m -68.38 -23.46 64.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.1 0.476 . . . . 0.0 110.811 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.1 m -75.65 149.38 38.19 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.5 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.42 165.87 49.18 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.276 174.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 64.6 m-20 -67.72 138.71 93.35 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-O 121.353 0.597 . . . . 0.0 110.711 -176.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 19' ' ' ASN . 25.6 Cg_exo -56.38 -35.29 96.02 Favored 'Trans proline' 0 CA--C 1.518 -0.293 0 C-N-CA 123.906 3.07 . . . . 0.0 112.397 -176.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.412 ' HA ' ' CD1' ' A' ' 26' ' ' PHE . 40.7 tt0 -60.49 -37.61 81.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.585 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -74.92 -18.14 60.45 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.683 0.278 . . . . 0.0 111.307 -173.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -67.84 154.82 40.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.501 0.667 . . . . 0.0 110.569 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.445 ' HD2' HG11 ' A' ' 97' ' ' VAL . 15.2 ttmm -80.43 -20.43 43.87 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.318 -0.855 . . . . 0.0 108.917 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.807 HG12 HG11 ' A' ' 96' ' ' VAL . 1.3 m -77.27 -14.11 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.934 178.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.412 ' CD1' ' HA ' ' A' ' 21' ' ' GLU . 69.1 t80 -51.86 -56.06 16.27 Favored 'General case' 0 N--CA 1.462 0.135 0 O-C-N 123.055 0.222 . . . . 0.0 111.418 -175.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.3 -40.6 96.26 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.037 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.427 ' HB3' HD12 ' A' ' 100' ' ' ILE . 32.8 m-85 -66.18 -49.2 68.15 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.548 -177.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.669 ' HB3' HG21 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -61.73 -33.23 73.68 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.825 0.345 . . . . 0.0 110.954 175.531 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.8 mmmt -69.67 -39.6 76.91 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 11.2 pt -81.45 -22.06 10.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.108 177.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.6 tt -58.27 -48.05 81.69 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 171.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -48.14 -50.81 27.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.757 175.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.456 ' O ' ' HB2' ' A' ' 38' ' ' ASN . 25.5 tt0 -69.63 -52.14 28.58 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.84 -178.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.36 -37.28 82.96 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -166.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.8 mmt -58.06 -47.32 83.52 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.757 0.281 . . . . 0.0 111.757 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -91.08 -8.66 48.29 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.073 0.463 . . . . 0.0 110.558 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -67.82 -25.95 65.82 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 176.558 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -54.33 122.35 10.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.798 176.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.86 -39.79 59.5 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.857 -1.065 . . . . 0.0 113.001 -173.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.588 ' C ' HD22 ' A' ' 42' ' ' ASN . 44.5 mt-10 -103.35 19.01 20.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.839 -0.164 . . . . 0.0 111.385 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.588 HD22 ' C ' ' A' ' 41' ' ' GLU . 0.1 OUTLIER 21.88 76.36 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.157 1.383 . . . . 0.0 112.736 -177.139 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.8 mt -65.91 -1.77 3.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.065 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.2 tp -58.7 -26.73 32.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.69 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.557 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 31.5 mt-10 -77.67 -14.58 59.58 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.358 -177.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.9 mttm -89.33 -12.74 39.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.175 0.512 . . . . 0.0 110.384 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 47' ' ' VAL . 9.7 p -131.3 33.07 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.776 0.798 . . . . 0.0 109.774 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.557 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 51.0 mtt180 -52.5 109.86 0.44 Allowed 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.645 0.736 . . . . 0.0 111.361 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.581 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . -171.42 155.8 24.95 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 114.419 -1.264 . . . . 0.0 111.292 -176.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.491 HG13 ' HB2' ' A' ' 71' ' ' LYS . 73.6 mt -96.79 126.56 49.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 117.132 0.466 . . . . 0.0 110.768 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.47 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 9.9 m-85 -104.66 117.47 34.19 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.91 -176.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -98.68 109.75 3.86 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.273 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -98.33 103.73 15.7 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.275 0.56 . . . . 0.0 111.457 -178.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -89.6 99.41 12.42 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.254 174.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.666 HG11 HG11 ' A' ' 25' ' ' VAL . 20.2 t -96.97 121.44 47.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.627 -174.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.46 ' HE ' ' CD ' ' A' ' 63' ' ' GLU . 51.7 mtp180 -108.37 178.24 4.55 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.874 -178.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 18.4 m120 61.05 43.74 11.01 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.242 0.544 . . . . 0.0 111.036 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.24 -155.94 7.31 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.531 -0.759 . . . . 0.0 113.239 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -43.53 -60.73 0.7 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.831 3.021 . . . . 0.0 113.486 -176.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -114.25 47.42 1.22 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 177.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.9 22.21 78.82 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.572 -0.823 . . . . 0.0 111.311 -174.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.94 169.73 16.27 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.441 0.638 . . . . 0.0 111.843 -175.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.46 ' CD ' ' HE ' ' A' ' 56' ' ' ARG . 20.5 mt-10 -131.66 110.54 10.99 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.844 -178.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -100.55 169.15 21.15 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.431 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -150.25 118.54 6.4 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.935 0.398 . . . . 0.0 111.087 -177.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 20.7 m-90 -122.0 137.5 54.78 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.832 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 37.2 t -109.61 115.47 49.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.57 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.502 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 4.2 mp -95.52 106.43 18.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -86.38 98.57 11.07 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.215 0.531 . . . . 0.0 110.148 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -101.42 -2.65 30.33 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.744 174.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.491 ' HB2' HG13 ' A' ' 50' ' ' ILE . 4.5 tppp? -64.24 -39.53 94.15 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.575 -178.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -87.03 9.38 19.8 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.995 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 76.3 23.32 71.29 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.913 175.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -100.41 -66.22 0.92 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.687 0.279 . . . . 0.0 111.249 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.48 34.63 5.98 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.093 -1.051 . . . . 0.0 111.323 -174.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 0.1 OUTLIER -96.82 145.46 25.83 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -177.705 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.669 HG21 ' HB3' ' A' ' 29' ' ' MET . 1.2 m -107.79 129.42 61.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.591 HG23 ' HA2' ' A' ' 81' ' ' GLY . 2.1 t -134.0 134.0 41.95 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.871 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.452 ' O ' ' HB3' ' A' ' 80' ' ' ASN . 51.8 t80 -61.93 123.35 17.81 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.208 -177.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.452 ' HB3' ' O ' ' A' ' 79' ' ' TYR . 9.4 t30 75.29 -40.57 0.43 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.485 0.714 . . . . 0.0 111.663 -177.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.591 ' HA2' HG23 ' A' ' 78' ' ' THR . . . 72.36 -42.64 0.83 Allowed Glycine 0 CA--C 1.517 0.158 0 N-CA-C 114.736 0.654 . . . . 0.0 114.736 174.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 71.93 19.89 78.53 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.337 -174.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -125.38 158.77 33.46 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -177.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -98.04 108.83 48.87 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-O 120.929 0.395 . . . . 0.0 110.231 175.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.481 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 21.1 Cg_exo -66.12 132.44 29.91 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 123.008 2.472 . . . . 0.0 112.911 -177.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -61.34 -32.68 72.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.746 174.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.652 HG12 ' HA3' ' A' ' 119' ' ' GLY . 3.9 m -139.73 131.67 34.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.82 174.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.646 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 32.2 m -114.43 133.28 55.85 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.104 177.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.623 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 72.0 m-85 -119.82 128.89 54.12 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.512 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 2.1 m -102.83 119.43 38.83 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 175.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.586 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 66.0 mt -143.01 151.7 17.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -173.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.51 146.75 27.41 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.325 0.584 . . . . 0.0 110.917 176.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -53.16 -26.06 15.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.679 179.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -80.75 -37.33 30.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.041 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -87.57 -22.89 24.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.341 -173.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.807 HG11 HG12 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -56.4 -34.64 41.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.0 0.428 . . . . 0.0 110.568 -179.178 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.445 HG11 ' HD2' ' A' ' 24' ' ' LYS . 6.3 m -69.76 -29.54 41.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.15 -172.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -82.82 -33.49 27.19 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.511 HD23 ' O ' ' A' ' 104' ' ' LEU . 80.8 mt -68.43 -45.36 72.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.84 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.577 HG13 ' O ' ' A' ' 96' ' ' VAL . 22.1 mt -77.09 -19.4 14.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.097 -177.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 31.4 t -94.56 -1.26 53.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.751 0.31 . . . . 0.0 110.955 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.68 20.35 76.6 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.232 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -94.78 -42.27 8.81 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.076 0.465 . . . . 0.0 110.972 -177.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.511 ' O ' HD23 ' A' ' 99' ' ' LEU . 42.8 tp -101.5 124.73 47.65 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.115 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -72.94 123.64 89.82 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.513 177.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -65.53 -21.39 59.98 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.043 1.829 . . . . 0.0 110.113 176.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -59.15 -61.51 2.58 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.795 172.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.529 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 0.6 OUTLIER -66.12 -33.81 76.63 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.054 -177.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.55 ' HB3' HD12 ' A' ' 115' ' ' ILE . . . -68.72 -31.27 70.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.408 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -65.77 -49.02 69.85 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 174.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -62.9 -43.65 98.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.153 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -77.26 9.35 3.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.875 -177.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.03 -19.65 44.81 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 121.039 -0.601 . . . . 0.0 113.68 170.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -57.98 -61.11 2.78 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.659 HG23 HG22 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -79.3 114.88 20.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.853 0.835 . . . . 0.0 111.233 -173.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.512 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 0.0 OUTLIER -107.03 98.99 8.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.801 -1.091 . . . . 0.0 109.163 173.128 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.659 HG22 HG23 ' A' ' 115' ' ' ILE . 0.1 OUTLIER -116.48 133.7 62.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.123 0.487 . . . . 0.0 110.304 178.354 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.86 83.7 1.81 Allowed 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 -175.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.652 ' HA3' HG12 ' A' ' 87' ' ' VAL . . . -160.75 172.58 37.11 Favored Glycine 0 N--CA 1.439 -1.166 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.461 -170.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -53.57 107.69 0.27 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 123.998 0.469 . . . . 0.0 110.365 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.526 ' O ' ' HG3' ' A' ' 125' ' ' MET . 26.2 mmt -73.53 -23.17 59.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.498 -174.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.01 -21.83 75.61 Favored Glycine 0 N--CA 1.451 -0.322 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.494 HD11 ' HA3' ' A' ' 49' ' ' GLY . 8.3 tt -90.31 -43.06 10.61 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.381 -0.909 . . . . 0.0 109.395 178.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.596 ' HB2' HG11 ' A' ' 87' ' ' VAL . . . -69.04 -23.15 64.03 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.409 -178.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.526 ' HG3' ' O ' ' A' ' 121' ' ' MET . 54.3 mtm -61.73 -23.76 66.35 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.549 0.214 . . . . 0.0 111.189 177.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.488 ' HB2' HG23 ' A' ' 47' ' ' VAL . 30.5 mmmt -78.7 -21.99 47.32 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.995 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.2 mt -69.19 -44.14 72.77 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.158 0.504 . . . . 0.0 109.939 177.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 7.7 t -73.33 -14.97 61.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.476 0.655 . . . . 0.0 110.258 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -85.54 -44.03 13.02 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.301 175.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 126' ' ' LYS . 3.9 mt -63.39 -37.37 87.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.439 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -62.91 -17.93 62.39 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.159 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.515 ' NE ' ' HA ' ' A' ' 132' ' ' ARG . 3.5 mmp_? -68.81 -40.09 79.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.89 0.376 . . . . 0.0 110.295 177.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.467 ' HG2' ' NH1' ' A' ' 137' ' ' ARG . 44.5 mt-30 -85.64 -30.85 22.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.242 177.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.97 15.94 3.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.564 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -89.57 22.7 2.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.004 0.431 . . . . 0.0 110.475 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 78.57 44.64 10.49 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 111.119 -0.793 . . . . 0.0 111.119 -176.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.467 ' NH1' ' HG2' ' A' ' 133' ' ' GLN . 39.8 ttm180 -73.53 89.29 1.68 Allowed 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.754 0.788 . . . . 0.0 110.658 -176.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.405 HD13 ' HA ' ' A' ' 138' ' ' ILE . 14.2 mm -74.48 -55.01 13.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.309 177.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -101.0 160.65 14.2 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.822 -173.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.3 m -154.78 -38.71 0.09 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.303 178.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 48.7 mt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.279 -0.867 . . . . 0.0 109.95 -179.107 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.627 0 N-CA-C 111.832 -0.507 . . . . 0.0 111.832 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.2 t -143.55 108.59 4.97 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.493 ' HA ' ' HB1' ' A' ' 62' ' ' ALA . 49.0 m -136.83 103.85 5.31 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.123 178.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.03 174.45 40.52 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 173.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.408 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 51.1 m-80 -56.92 144.2 68.55 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 121.224 0.535 . . . . 0.0 110.989 -178.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 19' ' ' ASN . 5.0 Cg_exo -66.13 -22.12 54.74 Favored 'Trans proline' 0 CA--C 1.517 -0.327 0 C-N-CA 123.193 2.595 . . . . 0.0 111.734 -175.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.444 ' HG3' ' H ' ' A' ' 21' ' ' GLU . 10.8 mt-10 -60.01 -36.54 77.43 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.028 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -76.39 -13.18 60.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.406 -174.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -77.75 141.4 39.31 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 177.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -74.97 -24.14 58.39 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.48 0.657 . . . . 0.0 109.261 -178.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.701 HG12 HG11 ' A' ' 96' ' ' VAL . 0.8 OUTLIER -69.34 -15.62 19.76 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.305 176.251 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -58.71 -56.39 22.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.802 0.334 . . . . 0.0 110.462 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.468 ' O ' HG23 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -69.4 -33.51 73.11 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.468 -178.666 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.45 ' O ' HG12 ' A' ' 31' ' ' ILE . 13.1 m-85 -70.21 -50.8 36.26 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.457 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.762 ' HB3' HG21 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -62.14 -33.14 73.93 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.68 0.276 . . . . 0.0 111.274 176.111 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -67.6 -34.16 76.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.715 -0.221 . . . . 0.0 111.57 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.468 HG23 ' O ' ' A' ' 27' ' ' LYS . 17.7 pt -85.59 -21.56 7.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.026 176.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.8 tt -61.86 -48.31 81.12 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 171.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.474 ' HG2' ' HA ' ' A' ' 76' ' ' LYS . 2.0 tm-20 -43.9 -50.53 8.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.843 173.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -72.04 -53.46 12.84 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.675 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.404 ' HA ' ' HB3' ' A' ' 38' ' ' ASN . . . -62.9 -39.31 94.12 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -166.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 20.9 mmt -55.14 -43.69 74.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.603 0.239 . . . . 0.0 111.628 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -92.09 -18.77 23.1 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.236 -0.585 . . . . 0.0 111.241 177.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.404 ' HB3' ' HA ' ' A' ' 35' ' ' ALA . 66.7 t30 -69.8 -22.95 63.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.972 0.415 . . . . 0.0 110.261 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -59.57 126.81 29.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.136 174.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 13.7 m -57.28 -23.89 51.32 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.508 -175.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -100.09 4.33 44.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 119.296 -0.383 . . . . 0.0 111.9 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 32.4 p30 28.57 60.73 0.13 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.397 1.079 . . . . 0.0 111.976 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 36.1 mt -59.67 -12.73 7.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.424 -1.262 . . . . 0.0 111.922 -174.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.419 HG13 ' HB1' ' A' ' 70' ' ' ALA . 3.8 tp -60.69 -27.06 39.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.818 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -68.92 -26.88 65.31 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.555 -175.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -83.94 -22.45 31.5 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.979 0.418 . . . . 0.0 111.052 -178.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 47' ' ' VAL . 12.0 p -123.54 33.34 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.755 0.788 . . . . 0.0 110.421 -175.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -49.81 117.58 2.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.585 0.707 . . . . 0.0 111.137 177.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . -173.4 -171.3 37.86 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.264 -176.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 76.4 mt -126.92 131.19 71.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 117.998 0.899 . . . . 0.0 111.24 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.516 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 33.7 m-85 -110.33 132.2 54.39 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.116 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -109.34 112.15 3.36 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.493 -0.86 . . . . 0.0 111.409 175.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -98.44 105.7 17.88 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.948 0.404 . . . . 0.0 111.28 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -91.28 99.78 12.7 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.175 173.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.682 HG11 HG11 ' A' ' 25' ' ' VAL . 19.4 t -97.84 123.95 50.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.663 -174.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 44.9 mtp180 -112.57 -178.53 3.42 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.3 m120 61.96 44.83 7.9 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.246 0.546 . . . . 0.0 110.792 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.01 -177.02 47.05 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.576 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -35.77 -61.12 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 124.849 3.699 . . . . 0.0 114.315 -175.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -110.91 41.91 1.72 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.159 0.504 . . . . 0.0 110.597 -177.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.45 30.94 63.8 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -173.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.493 ' HB1' ' HA ' ' A' ' 17' ' ' SER . . . -85.27 173.35 10.43 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 114.769 -0.715 . . . . 0.0 111.836 -176.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -140.01 135.45 32.71 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.972 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -127.06 163.05 21.07 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.938 -0.648 . . . . 0.0 111.688 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -141.37 120.53 12.95 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.842 0.353 . . . . 0.0 110.642 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 22.7 m-90 -122.97 130.35 52.71 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.071 0.462 . . . . 0.0 109.805 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.1 t -101.84 118.91 49.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.34 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.637 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 4.3 mp -94.47 103.32 14.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.162 0.506 . . . . 0.0 109.816 178.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -85.87 98.3 10.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.986 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -95.94 -10.92 27.49 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.927 173.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.1 tttt -51.44 -46.55 63.05 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.533 -178.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -89.42 12.97 14.83 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.169 0.509 . . . . 0.0 111.84 -175.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 88.67 -1.39 83.69 Favored Glycine 0 C--N 1.319 -0.376 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.987 175.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.4 mmmp? -78.68 -74.62 0.27 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.79 0.329 . . . . 0.0 111.729 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.24 34.89 5.69 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 -167.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.637 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 16.3 ptmt -97.33 151.14 20.21 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.312 -0.444 . . . . 0.0 110.022 -174.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.762 HG21 ' HB3' ' A' ' 29' ' ' MET . 0.7 OUTLIER -107.4 143.08 18.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 120.311 -0.555 . . . . 0.0 109.743 176.765 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.2 t -139.22 132.4 29.76 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.188 177.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -68.34 121.63 16.68 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.161 -178.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 64.8 t30 52.21 62.64 2.6 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.993 -176.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -59.13 -36.58 89.21 Favored Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 115.329 -0.85 . . . . 0.0 113.416 -175.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.5 -16.04 51.43 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.061 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.427 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 8.5 mm-40 -75.68 148.18 38.85 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 176.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 29.9 mmmt -86.55 109.03 20.55 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-O 121.017 0.437 . . . . 0.0 110.128 177.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 84' ' ' LYS . 16.8 Cg_exo -67.65 142.5 58.69 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.018 2.479 . . . . 0.0 112.512 -176.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.53 ' CB ' ' HG ' ' A' ' 123' ' ' LEU . 6.7 m-20 -62.38 -33.76 75.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.759 171.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.829 HG12 ' HA3' ' A' ' 119' ' ' GLY . 4.2 m -141.76 139.1 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.059 174.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.605 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 29.5 m -115.41 137.21 52.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.222 176.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.593 ' CD1' ' HB ' ' A' ' 117' ' ' ILE . 81.9 m-85 -121.27 136.09 55.02 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 178.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.44 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 3.6 m -110.36 116.76 32.01 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 176.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.532 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 69.9 mt -140.44 152.05 21.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.694 -172.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.12 145.47 25.92 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.184 0.516 . . . . 0.0 110.536 174.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -53.05 -25.6 13.08 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.416 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -75.29 -36.53 61.15 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.73 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -89.55 -23.86 21.9 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.153 -173.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.701 HG11 HG12 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -55.55 -35.86 39.72 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.337 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.903 -178.108 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 m -61.69 -30.78 49.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.589 -171.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.416 ' HB2' ' HB2' ' A' ' 104' ' ' LEU . 34.0 m-20 -91.46 -25.93 19.07 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.696 0.284 . . . . 0.0 110.404 177.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 89.3 mt -71.87 -39.96 69.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.99 0.424 . . . . 0.0 110.293 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.506 HG12 ' O ' ' A' ' 96' ' ' VAL . 3.0 mm -67.73 -44.49 85.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.039 177.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.587 ' OG ' ' HD3' ' A' ' 103' ' ' LYS . 58.2 p -76.87 -28.54 55.46 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.686 -174.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.97 -1.31 38.44 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.125 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.587 ' HD3' ' OG ' ' A' ' 101' ' ' SER . 1.8 mptm? -66.51 -40.08 89.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.831 0.348 . . . . 0.0 111.522 177.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.732 HD11 ' NZ ' ' A' ' 108' ' ' LYS . 47.9 tp -102.27 130.01 48.85 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.799 -176.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.46 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 19.2 m120 -77.65 123.29 86.61 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.07 176.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -64.49 -25.65 62.84 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.037 1.825 . . . . 0.0 110.419 175.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.55 ' NE2' HE22 ' A' ' 131' ' ' GLN . 44.9 mt-30 -60.38 -58.77 7.07 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.144 174.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.732 ' NZ ' HD11 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -63.82 -36.34 83.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.0 -179.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.534 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -66.75 -34.38 77.71 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.626 -0.43 . . . . 0.0 109.958 -177.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -57.84 -52.78 64.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.84 175.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -62.95 -32.01 73.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.921 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -84.87 -1.66 56.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.775 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.48 4.45 80.23 Favored Glycine 0 CA--C 1.517 0.19 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.24 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.621 ' CE ' ' HA ' ' A' ' 114' ' ' LYS . 1.4 mmpt? -94.85 10.91 33.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.084 0.469 . . . . 0.0 111.283 -177.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.601 HG23 HG22 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -146.83 109.66 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.828 0.823 . . . . 0.0 109.532 174.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.44 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 73.1 mmtt -109.09 99.74 9.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.99 -1.004 . . . . 0.0 108.963 176.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.605 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER -115.49 137.43 49.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.25 0.547 . . . . 0.0 110.597 -177.737 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -147.95 96.48 2.65 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -177.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.829 ' HA3' HG12 ' A' ' 87' ' ' VAL . . . -161.1 173.5 37.55 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 119.827 -1.177 . . . . 0.0 113.599 -169.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.433 ' HB3' ' HB2' ' A' ' 123' ' ' LEU . 54.5 t-20 -48.38 119.9 3.31 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.735 -0.733 . . . . 0.0 110.134 176.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 89.2 mtp -64.03 -43.95 94.0 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.155 -176.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -66.09 -26.44 72.41 Favored Glycine 0 CA--C 1.509 -0.308 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.603 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.53 ' HG ' ' CB ' ' A' ' 86' ' ' ASP . 1.6 tm? -70.97 -56.41 6.26 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.931 -0.634 . . . . 0.0 109.861 177.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.602 ' HB2' HG11 ' A' ' 87' ' ' VAL . . . -73.6 -16.06 61.25 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.703 -177.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 52.4 mtp -65.44 -28.57 69.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.803 0.335 . . . . 0.0 110.192 173.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 19.7 mttt -72.05 -27.2 62.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.781 176.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.549 ' HB2' ' O ' ' A' ' 124' ' ' ALA . 0.5 OUTLIER -67.83 -48.36 66.42 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.866 178.494 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.451 ' O ' ' HG2' ' A' ' 131' ' ' GLN . 5.2 t -77.83 -12.77 60.01 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.475 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -80.83 -47.21 14.16 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.597 173.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.422 ' HA ' HD22 ' A' ' 130' ' ' LEU . 0.4 OUTLIER -60.0 -37.35 79.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.951 -179.01 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.55 HE22 ' NE2' ' A' ' 107' ' ' GLN . 18.6 pt20 -61.55 -24.79 66.88 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.511 0.196 . . . . 0.0 111.283 -178.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -72.55 -40.47 66.69 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 177.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -66.5 -39.39 88.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.793 174.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.73 -26.77 68.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.64 176.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -82.48 -18.47 41.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.757 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 126.93 -30.2 4.21 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.388 -0.911 . . . . 0.0 114.091 174.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -124.6 106.43 10.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.921 0.86 . . . . 0.0 112.209 -176.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 10.6 tp -115.74 -38.11 2.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.067 174.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -100.89 169.86 8.69 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.961 -177.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 13.2 t -146.91 109.23 4.5 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.801 0.334 . . . . 0.0 110.209 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 37.1 mm . . . . . 0 C--O 1.245 0.867 0 CA-C-O 118.538 -0.744 . . . . 0.0 109.634 178.059 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.761 0 N-CA-C 112.063 -0.415 . . . . 0.0 112.063 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.9 m -62.61 111.5 2.1 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.942 0.401 . . . . 0.0 110.442 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.7 m -109.7 -179.78 3.91 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.386 -176.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -57.08 131.52 52.09 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.157 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 13.8 m120 -68.88 146.8 97.67 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 19' ' ' ASN . 31.2 Cg_exo -56.7 -42.71 62.08 Favored 'Trans proline' 0 N--CA 1.466 -0.097 0 C-N-CA 123.014 2.476 . . . . 0.0 112.244 -176.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -58.58 -33.73 70.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.606 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -70.32 -14.58 62.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.554 -178.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -80.39 144.58 32.57 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 174.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -79.18 -18.28 53.34 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.904 HG12 HG11 ' A' ' 96' ' ' VAL . 1.0 OUTLIER -75.73 -12.1 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.774 177.859 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.426 ' O ' ' HB2' ' A' ' 30' ' ' LYS . 78.8 t80 -58.77 -51.52 69.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.827 0.346 . . . . 0.0 110.793 -178.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.6 -26.8 64.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.846 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.41 ' O ' HG12 ' A' ' 31' ' ' ILE . 31.5 m-85 -79.88 -51.71 8.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.763 -178.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.561 ' SD ' ' HB ' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -59.83 -35.78 75.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.714 0.293 . . . . 0.0 111.266 177.829 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 26' ' ' PHE . 4.9 mmtp -68.94 -31.4 70.26 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.41 HG12 ' O ' ' A' ' 28' ' ' TYR . 10.4 pt -90.7 -16.79 8.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.308 176.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.6 tt -61.04 -47.28 87.15 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 171.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.652 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 7.6 tt0 -48.75 -48.73 40.54 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.562 175.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -64.77 -60.69 2.8 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.724 -1.126 . . . . 0.0 111.081 177.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.98 -46.7 75.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.395 -0.82 . . . . 0.0 113.156 -167.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 35.3 mtt -56.51 -43.62 79.94 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -177.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -92.39 -16.85 25.42 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.103 0.477 . . . . 0.0 110.419 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -63.97 -28.87 70.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.141 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -61.07 126.17 26.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.473 176.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.2 p -68.25 -16.8 64.11 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.315 -174.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -94.02 -3.63 51.0 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 177.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 24.34 72.75 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 O-C-N 124.689 1.243 . . . . 0.0 112.591 -177.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 66.5 mt -64.26 -8.58 13.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.577 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.423 HG13 ' HB1' ' A' ' 70' ' ' ALA . 3.5 tp -60.24 -27.97 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.62 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.475 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 60.7 mm-40 -70.35 -27.86 64.68 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-O 121.022 0.439 . . . . 0.0 111.338 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -85.19 -14.51 46.64 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.77 -176.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.508 ' HB ' ' HG2' ' A' ' 126' ' ' LYS . 14.6 p -130.52 31.04 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.883 0.849 . . . . 0.0 110.221 -177.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.475 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 19.5 mtp180 -51.23 112.97 0.82 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.825 0.821 . . . . 0.0 111.991 -177.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.535 ' HA3' HD11 ' A' ' 123' ' ' LEU . . . -168.88 171.1 42.76 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 114.131 -1.395 . . . . 0.0 111.356 -174.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.529 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 56.9 mt -106.32 127.61 61.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 117.375 0.587 . . . . 0.0 110.78 178.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.473 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 14.7 m-85 -108.69 114.44 28.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.017 -178.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.89 112.08 4.35 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.179 -1.01 . . . . 0.0 111.241 177.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -96.1 105.88 17.98 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.987 0.423 . . . . 0.0 111.343 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.623 ' NZ ' HG21 ' A' ' 88' ' ' THR . 54.6 mttp -91.09 101.46 14.21 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.261 174.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.793 HG11 HG11 ' A' ' 25' ' ' VAL . 21.2 t -100.78 111.54 30.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.679 -174.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' A' ' 92' ' ' SER . 46.9 mtp180 -104.96 176.85 5.03 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.851 -177.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 59.97 46.65 10.74 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.714 176.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.16 -157.47 9.98 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.203 174.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -41.47 -61.12 0.54 Allowed 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 124.028 3.152 . . . . 0.0 113.727 -175.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -115.29 44.16 1.89 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.08 23.17 72.3 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.705 -0.759 . . . . 0.0 111.231 -175.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.67 140.46 56.8 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.498 0.666 . . . . 0.0 111.156 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -114.09 109.48 18.5 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.335 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.08 165.43 16.02 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -148.58 120.54 8.21 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.954 0.406 . . . . 0.0 111.039 -176.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 19.9 m-90 -123.06 129.35 51.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.058 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 55.1 t -99.18 114.44 37.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.657 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.597 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 4.5 mp -92.32 100.21 10.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 175.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -87.93 98.73 11.66 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.297 -177.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -105.63 4.3 30.08 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.078 175.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.464 ' HB2' HG13 ' A' ' 50' ' ' ILE . 3.1 tppp? -60.89 -46.58 90.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.458 -177.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -90.59 20.82 4.34 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.329 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.79 16.43 78.04 Favored Glycine 0 C--N 1.32 -0.315 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.688 175.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -83.88 -55.24 4.35 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.787 -0.206 . . . . 0.0 111.51 -177.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.422 ' H ' ' HA ' ' A' ' 70' ' ' ALA . . . 74.54 33.62 55.66 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.375 -0.917 . . . . 0.0 111.542 -178.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.652 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -99.58 161.61 13.51 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.652 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.7 OUTLIER -120.8 138.84 49.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.8 t -137.61 136.9 37.96 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.485 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -70.33 117.55 12.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.872 -179.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 52.37 65.54 1.48 Allowed 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.655 0.597 . . . . 0.0 110.295 -175.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -61.0 -40.63 98.76 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.785 -173.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.63 -20.26 47.89 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.803 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.506 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 9.6 mm-40 -68.75 150.19 48.16 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 174.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -82.22 114.1 48.61 Favored Pre-proline 0 N--CA 1.437 -1.078 0 CA-C-O 121.289 0.566 . . . . 0.0 110.844 177.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.529 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 13.2 Cg_exo -68.75 129.61 19.02 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.108 2.539 . . . . 0.0 111.57 174.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -66.47 -32.1 73.26 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 173.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.599 HG11 ' HB2' ' A' ' 124' ' ' ALA . 15.6 m -140.7 131.66 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.39 175.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.676 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 59.5 m -111.81 130.07 55.93 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.261 177.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.583 ' CE2' HD13 ' A' ' 117' ' ' ILE . 58.7 m-85 -109.88 125.03 52.36 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 177.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.497 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 12.4 m -104.27 125.82 50.86 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 174.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -157.25 152.8 7.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 123.523 0.514 . . . . 0.0 109.708 -175.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 56' ' ' ARG . 11.7 m -85.47 148.0 26.19 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.983 -176.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -50.32 -27.47 6.25 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.067 -0.969 . . . . 0.0 111.118 177.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -74.95 -47.43 29.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.976 -177.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -79.99 -26.37 39.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.547 -173.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.904 HG11 HG12 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -55.2 -33.32 30.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.273 -174.509 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.1 m -69.46 -31.17 48.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.481 -169.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -82.95 -32.33 27.19 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 76.4 mt -65.37 -49.54 68.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.837 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.525 HG13 ' O ' ' A' ' 96' ' ' VAL . 18.7 mt -75.45 -21.35 16.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.6 -174.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.3 t -84.5 -26.19 28.3 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.019 0.438 . . . . 0.0 110.798 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.2 21.54 15.07 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.866 -176.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -97.9 -41.47 8.0 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.949 0.404 . . . . 0.0 111.336 -176.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.716 HD11 ' NZ ' ' A' ' 108' ' ' LYS . 37.0 tp -101.86 127.01 48.87 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.721 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.426 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 16.8 m120 -68.76 122.0 83.31 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.249 176.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -67.99 -21.21 43.69 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.067 1.845 . . . . 0.0 110.033 176.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -64.01 -56.28 16.18 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.685 175.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.716 ' NZ ' HD11 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -64.83 -37.37 87.39 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.78 178.186 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.547 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -67.25 -33.66 75.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.023 0.44 . . . . 0.0 109.956 -178.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -61.17 -50.78 71.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.052 175.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -61.87 -40.16 94.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.843 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -76.26 6.96 4.74 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.993 -177.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.79 6.66 82.35 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.895 175.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -79.39 -47.65 15.38 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.917 0.389 . . . . 0.0 110.585 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.592 HG23 HG22 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -92.02 110.78 23.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.025 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.559 ' HE2' ' HA ' ' A' ' 116' ' ' LYS . 10.8 mmpt? -108.11 105.32 15.02 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.663 176.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.676 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER -123.6 129.65 74.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.322 0.582 . . . . 0.0 111.457 -173.864 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -61.99 131.03 48.31 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.692 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -78.94 88.52 1.17 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.455 -0.879 . . . . 0.0 114.061 -172.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.419 ' HB3' ' CG1' ' A' ' 87' ' ' VAL . 47.0 t-20 -107.48 89.79 3.1 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 166.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -45.44 -58.38 3.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.757 -1.11 . . . . 0.0 113.113 -168.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -70.14 -22.38 77.32 Favored Glycine 0 C--N 1.321 -0.265 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.823 -170.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.535 HD11 ' HA3' ' A' ' 49' ' ' GLY . 2.2 tt -91.14 -53.86 4.19 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.012 0.434 . . . . 0.0 110.63 -176.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.599 ' HB2' HG11 ' A' ' 87' ' ' VAL . . . -74.04 -14.0 60.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.838 -175.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 16.4 mmt -72.06 -21.36 61.53 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.925 174.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.508 ' HG2' ' HB ' ' A' ' 47' ' ' VAL . 0.1 OUTLIER -84.88 -31.06 23.93 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 174.5 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.466 HD23 ' O ' ' A' ' 123' ' ' LEU . 1.2 mm? -56.26 -45.38 80.08 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 167.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.549 ' O ' ' HG3' ' A' ' 131' ' ' GLN . 52.2 m -61.33 -45.3 95.02 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 113.892 -1.504 . . . . 0.0 110.814 173.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -58.07 -38.77 76.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.82 -178.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.7 mt -58.47 -46.21 87.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.344 178.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.549 ' HG3' ' O ' ' A' ' 128' ' ' THR . 0.3 OUTLIER -79.9 -18.52 50.37 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.932 179.426 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' ' 128' ' ' THR . 34.8 mmt180 -68.98 -51.16 42.35 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.8 0.333 . . . . 0.0 110.328 174.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -65.78 -31.55 72.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.033 0.444 . . . . 0.0 110.359 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -76.9 4.46 9.82 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.689 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.53 15.69 5.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.852 0.358 . . . . 0.0 110.94 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 76.41 48.41 9.32 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.028 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -79.09 135.37 36.84 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.198 0.523 . . . . 0.0 111.129 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.5 mp -88.06 -64.46 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.002 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -101.41 154.79 18.5 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.603 -177.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 7.5 t 65.24 57.9 0.9 Allowed 'General case' 0 C--O 1.232 0.137 0 O-C-N 123.792 0.683 . . . . 0.0 109.718 -178.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.0 tp . . . . . 0 C--O 1.247 0.966 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.532 -176.22 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.772 0 N-CA-C 111.76 -0.536 . . . . 0.0 111.76 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.4 m -82.44 74.75 9.4 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.305 0.574 . . . . 0.0 110.808 -178.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.4 t -121.47 -166.96 1.44 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.526 178.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.73 151.18 51.12 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.046 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -57.69 130.96 82.25 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.694 0.759 . . . . 0.0 110.449 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -65.73 -21.27 58.68 Favored 'Trans proline' 0 C--N 1.328 -0.517 0 C-N-CA 123.84 3.027 . . . . 0.0 112.17 -174.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.634 ' HA ' ' CG ' ' A' ' 26' ' ' PHE . 8.6 mt-10 -86.17 -16.73 36.94 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.214 -178.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -84.61 -8.12 59.0 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.905 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -72.1 163.19 28.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.827 177.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.466 ' HG2' ' CG1' ' A' ' 97' ' ' VAL . 5.5 tppp? -79.34 -31.98 43.22 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 174.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.973 HG12 HG11 ' A' ' 96' ' ' VAL . 1.3 m -70.24 -14.88 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.85 -178.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.634 ' CG ' ' HA ' ' A' ' 21' ' ' GLU . 57.6 t80 -56.76 -55.2 37.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.691 0.282 . . . . 0.0 110.594 -178.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.422 ' HE2' HG23 ' A' ' 31' ' ' ILE . 0.6 OUTLIER -67.65 -40.78 84.52 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 120.765 0.317 . . . . 0.0 110.549 178.42 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.4 ' O ' HG12 ' A' ' 31' ' ' ILE . 14.4 m-85 -61.43 -45.85 92.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.794 -178.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 64.2 mtp -75.41 -26.56 58.5 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.67 0.271 . . . . 0.0 110.99 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.437 ' HD3' ' HA ' ' A' ' 30' ' ' LYS . 24.5 mmtp -67.73 -40.15 84.22 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 121.064 -0.254 . . . . 0.0 110.687 174.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.422 HG23 ' HE2' ' A' ' 27' ' ' LYS . 10.9 pt -79.67 -23.0 12.07 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.401 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.159 177.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.9 tt -57.23 -54.25 48.96 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 172.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.424 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 9.6 tt0 -44.2 -48.52 9.3 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.707 177.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -75.36 -61.18 1.99 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.511 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.402 ' HA ' ' HB3' ' A' ' 38' ' ' ASN . . . -55.79 -34.86 65.67 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -166.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 93.3 mmm -61.17 -43.04 99.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.69 0.281 . . . . 0.0 111.387 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -92.12 -27.03 17.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.158 0.504 . . . . 0.0 110.987 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.402 ' HB3' ' HA ' ' A' ' 35' ' ' ALA . 10.0 t30 -66.95 -27.38 67.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.763 -177.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -60.44 139.94 57.47 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 173.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 p -62.27 -13.95 33.73 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -174.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -97.03 -9.34 28.34 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 119.094 -0.479 . . . . 0.0 111.892 177.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.2 p30 35.49 66.26 0.35 Allowed 'General case' 0 C--N 1.348 0.54 0 CA-C-O 122.129 0.966 . . . . 0.0 110.588 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.5 mt -62.94 -12.02 22.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 113.884 -1.507 . . . . 0.0 112.014 -170.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.9 tp -64.69 -29.09 46.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.878 0.37 . . . . 0.0 111.01 -175.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -72.55 -29.04 63.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.037 -177.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -75.18 -21.48 58.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.312 0.577 . . . . 0.0 110.751 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 47' ' ' VAL . 13.3 p -130.06 32.02 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.701 -173.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -44.87 116.28 1.05 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.5 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.493 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . 179.86 164.27 31.87 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.878 -176.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.515 HG13 ' HB2' ' A' ' 71' ' ' LYS . 51.8 mt -97.05 127.51 49.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 117.467 0.633 . . . . 0.0 110.682 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.488 ' OH ' HG13 ' A' ' 47' ' ' VAL . 9.6 m-85 -108.95 122.48 47.32 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.671 -178.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.54 115.52 5.32 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.369 -0.92 . . . . 0.0 111.396 177.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -101.61 107.41 18.66 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.253 0.549 . . . . 0.0 111.545 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -97.54 99.14 10.54 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.54 176.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.728 HG11 HG11 ' A' ' 25' ' ' VAL . 20.4 t -102.42 125.21 56.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.025 0.441 . . . . 0.0 110.73 -175.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -115.41 177.84 4.52 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.174 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.6 m120 58.72 44.51 17.11 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.015 0.436 . . . . 0.0 111.562 177.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.93 -154.68 8.18 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.936 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 62' ' ' ALA . 71.4 Cg_exo -36.63 -59.94 0.41 Allowed 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 124.575 3.517 . . . . 0.0 114.298 -176.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -128.46 61.99 1.47 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 177.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.55 29.17 74.35 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.211 -176.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.411 ' HB3' ' HD2' ' A' ' 59' ' ' PRO . . . -76.89 154.09 34.09 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.184 0.516 . . . . 0.0 111.173 -177.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -132.55 110.59 10.58 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.494 -177.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.41 163.18 12.55 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.429 -177.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -147.89 116.89 6.8 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.88 0.371 . . . . 0.0 110.62 -178.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 18.9 m-90 -121.2 141.09 51.18 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.273 0.558 . . . . 0.0 109.682 179.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 16.4 t -107.63 117.98 54.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.164 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.447 HG13 HG12 ' A' ' 77' ' ' VAL . 4.1 mp -93.37 99.77 10.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -87.05 99.8 12.17 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.576 -176.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -113.54 13.97 18.9 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.175 175.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.515 ' HB2' HG13 ' A' ' 50' ' ' ILE . 17.8 tppt? -64.48 -44.82 89.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.221 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -82.13 -0.73 46.14 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.672 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.8 27.28 32.35 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.308 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -93.36 -62.67 1.32 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.687 0.279 . . . . 0.0 111.037 -178.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.54 34.26 8.04 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.15 -1.024 . . . . 0.0 111.893 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 59.0 pttt -97.86 146.27 25.6 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -177.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.7 OUTLIER -110.82 131.47 61.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.355 0.598 . . . . 0.0 109.859 178.448 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.488 HG23 ' HA2' ' A' ' 81' ' ' GLY . 3.6 t -137.97 139.23 39.6 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.984 -178.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.423 ' O ' ' HB3' ' A' ' 80' ' ' ASN . 24.2 t80 -65.1 128.11 34.42 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -178.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.423 ' HB3' ' O ' ' A' ' 79' ' ' TYR . 26.0 t-20 74.92 -45.8 0.58 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.677 0.791 . . . . 0.0 111.999 -178.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.488 ' HA2' HG23 ' A' ' 78' ' ' THR . . . 70.81 -43.14 0.6 Allowed Glycine 0 CA--C 1.52 0.387 0 N-CA-C 114.764 0.666 . . . . 0.0 114.764 177.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.58 -18.84 6.58 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.026 -175.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -82.63 157.89 23.23 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 122.602 0.361 . . . . 0.0 110.358 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -95.43 109.24 44.28 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 174.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.464 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 23.2 Cg_exo -64.72 137.18 52.87 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.034 2.489 . . . . 0.0 112.712 -177.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -68.53 -32.48 72.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.107 -0.952 . . . . 0.0 109.546 176.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.645 HG12 ' HA3' ' A' ' 119' ' ' GLY . 4.9 m -140.27 130.41 28.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.316 172.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.594 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 28.2 m -114.91 133.87 55.63 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.375 176.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.654 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 53.0 m-85 -118.18 128.71 54.97 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.542 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 5.9 m -106.4 128.34 53.97 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 174.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -159.27 149.52 7.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.172 0.51 . . . . 0.0 110.294 -175.146 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.38 143.53 36.75 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.329 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -49.01 -29.01 4.37 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 114.869 -1.059 . . . . 0.0 111.091 176.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -73.22 -44.38 59.69 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.217 -176.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -81.51 -25.74 35.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.036 -176.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.973 HG11 HG12 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -56.62 -33.92 41.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.303 -175.007 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.466 ' CG1' ' HG2' ' A' ' 24' ' ' LYS . 3.9 m -68.35 -27.94 38.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.992 -170.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -87.23 -29.86 21.37 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 177.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 77.9 mt -68.2 -46.5 70.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.799 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 96' ' ' VAL . 20.1 mt -75.1 -24.41 17.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.296 -176.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.1 p -85.48 -18.11 34.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.036 0.446 . . . . 0.0 111.022 178.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.39 13.24 58.78 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.084 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -85.39 -41.43 15.45 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.133 0.492 . . . . 0.0 111.164 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.702 HD11 ' NZ ' ' A' ' 108' ' ' LYS . 44.4 tp -99.46 125.54 45.21 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.426 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -71.99 122.23 86.74 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.561 177.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -64.87 -23.34 62.27 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.213 1.942 . . . . 0.0 110.385 176.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -54.96 -62.3 1.75 Allowed 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.935 171.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.702 ' NZ ' HD11 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -64.11 -36.06 82.81 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.314 -176.368 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.563 ' HB3' HD12 ' A' ' 115' ' ' ILE . . . -69.78 -33.64 72.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.154 -178.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -64.17 -49.89 70.3 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 175.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -58.79 -40.64 84.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.029 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.46 HE21 ' HB3' ' A' ' 112' ' ' GLN . 9.4 mt-30 -84.8 13.68 5.57 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.248 -176.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.546 ' O ' ' HE3' ' A' ' 116' ' ' LYS . . . 70.17 14.68 71.48 Favored Glycine 0 CA--C 1.519 0.293 0 CA-C-N 116.152 -0.476 . . . . 0.0 113.992 172.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.428 ' HA ' ' HE3' ' A' ' 114' ' ' LYS . 0.4 OUTLIER -87.55 -43.55 11.93 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 117.115 0.458 . . . . 0.0 110.219 177.578 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.574 HG23 HG22 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -89.14 114.18 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.703 176.471 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.546 ' HE3' ' O ' ' A' ' 113' ' ' GLY . 35.2 mmtp -110.79 99.4 8.33 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.474 175.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.654 ' HB ' ' CD2' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -115.18 136.41 51.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 120.958 0.409 . . . . 0.0 110.153 179.346 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -145.87 85.74 1.7 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -175.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.645 ' HA3' HG12 ' A' ' 87' ' ' VAL . . . -160.63 171.81 36.85 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.928 -170.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.47 ' ND2' ' HB2' ' A' ' 123' ' ' LEU . 30.6 t30 -52.45 108.51 0.3 Allowed 'General case' 0 C--N 1.327 -0.385 0 O-C-N 124.076 0.515 . . . . 0.0 110.481 178.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.475 ' O ' ' HG3' ' A' ' 125' ' ' MET . 94.8 mmm -67.82 -28.14 67.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.311 -174.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.77 -20.47 75.92 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.405 -0.903 . . . . 0.0 111.086 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.47 ' HB2' ' ND2' ' A' ' 120' ' ' ASN . 7.0 tt -88.67 -41.28 12.7 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.877 -0.661 . . . . 0.0 109.405 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.55 ' HB2' HG11 ' A' ' 87' ' ' VAL . . . -75.18 -15.36 60.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.197 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.475 ' HG3' ' O ' ' A' ' 121' ' ' MET . 64.0 mtp -64.8 -21.22 66.73 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.739 0.304 . . . . 0.0 111.102 175.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.607 ' O ' ' HG ' ' A' ' 130' ' ' LEU . 15.8 tppt? -85.22 -32.95 22.35 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.151 -0.62 . . . . 0.0 109.423 174.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.1 mt -61.56 -40.71 95.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.055 0.455 . . . . 0.0 110.328 176.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.5 t -73.12 -13.93 61.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.799 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -88.01 -46.27 9.49 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 173.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.607 ' HG ' ' O ' ' A' ' 126' ' ' LYS . 9.7 mt -57.69 -34.17 69.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.242 -177.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -59.21 -22.24 60.72 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -177.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -67.54 -43.91 79.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.187 0.518 . . . . 0.0 109.876 177.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -82.39 -32.63 29.08 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.37 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -78.56 17.55 0.67 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.437 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -87.51 -3.37 59.0 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.002 0.43 . . . . 0.0 110.734 178.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 65.8 30.33 76.98 Favored Glycine 0 C--N 1.332 0.332 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.634 177.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 53.38 88.27 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.297 0.57 . . . . 0.0 111.401 -177.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.43 HG23 ' N ' ' A' ' 139' ' ' GLU . 7.9 tp -126.27 -46.71 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.051 0.453 . . . . 0.0 110.519 178.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.43 ' N ' HG23 ' A' ' 138' ' ' ILE . 12.9 pt-20 -102.47 143.78 31.75 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.415 -178.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 22.3 t -86.98 66.15 9.29 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.096 0.474 . . . . 0.0 109.911 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.401 HG22 ' H ' ' A' ' 141' ' ' ILE . 4.0 tp . . . . . 0 C--O 1.249 1.059 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.783 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.703 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.3 t -72.86 -14.94 61.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.426 0.632 . . . . 0.0 109.295 174.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.441 ' HB3' ' H ' ' A' ' 63' ' ' GLU . 48.7 m -151.14 -169.3 3.35 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.501 175.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.61 171.17 9.11 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 121.188 -0.529 . . . . 0.0 113.206 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -64.57 133.24 95.63 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 121.656 0.741 . . . . 0.0 111.603 -176.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.65 -38.25 62.85 Favored 'Trans proline' 0 CA--C 1.521 -0.142 0 C-N-CA 124.021 3.148 . . . . 0.0 111.947 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.453 ' HA ' ' CD1' ' A' ' 26' ' ' PHE . 35.5 tt0 -60.23 -31.33 70.08 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.713 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.35 -8.83 57.58 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.047 0.451 . . . . 0.0 111.058 -175.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -80.69 153.2 28.02 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.288 -0.414 . . . . 0.0 109.941 175.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 49.3 mmtm -70.56 -29.53 66.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.646 0.736 . . . . 0.0 109.234 177.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.997 HG12 HG11 ' A' ' 96' ' ' VAL . 0.7 OUTLIER -68.4 -17.39 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 114.526 -1.216 . . . . 0.0 111.056 -174.897 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.453 ' CD1' ' HA ' ' A' ' 21' ' ' GLU . 75.3 t80 -55.51 -54.52 42.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.369 -179.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.436 ' O ' HG23 ' A' ' 31' ' ' ILE . 0.5 OUTLIER -72.68 -43.7 62.76 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.56 177.363 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.463 ' HB2' ' HA ' ' A' ' 25' ' ' VAL . 12.9 m-85 -59.15 -46.25 88.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.416 . . . . 0.0 112.106 -175.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.495 ' HE1' ' HB2' ' A' ' 53' ' ' PHE . 73.4 mtp -77.53 -24.76 49.91 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.778 0.323 . . . . 0.0 110.894 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.48 ' HD3' ' HA ' ' A' ' 30' ' ' LYS . 43.0 mmtt -75.87 -31.28 59.18 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.268 177.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.436 HG23 ' O ' ' A' ' 27' ' ' LYS . 13.6 pt -82.94 -27.44 8.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 173.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.403 ' HB3' ' O ' ' A' ' 29' ' ' MET . 5.8 tt -54.16 -51.83 63.06 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 168.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.592 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 9.2 tt0 -43.6 -58.03 2.86 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 114.23 -1.35 . . . . 0.0 111.296 177.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -67.81 -54.12 21.58 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.546 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.44 ' HA ' ' HB3' ' A' ' 38' ' ' ASN . . . -54.49 -37.61 65.49 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -169.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 95.0 mmm -63.34 -37.36 86.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.668 0.271 . . . . 0.0 111.654 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -90.09 -20.64 22.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.439 0.638 . . . . 0.0 110.225 177.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.44 ' HB3' ' HA ' ' A' ' 35' ' ' ALA . 2.9 t-20 -69.31 -25.2 64.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.59 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -58.57 133.35 55.77 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 175.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.65 -30.12 41.56 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.752 -174.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -101.55 -5.46 25.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 119.468 -0.301 . . . . 0.0 111.538 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 36.11 73.67 0.08 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.718 0.77 . . . . 0.0 111.513 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 72.6 mt -64.36 -1.07 1.5 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.87 -174.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.447 HG13 ' HB1' ' A' ' 70' ' ' ALA . 4.2 tp -60.35 -25.91 35.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.699 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.43 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 32.9 mt-10 -79.78 -17.38 53.54 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.096 -177.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -86.58 -36.08 19.09 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.243 0.544 . . . . 0.0 110.188 177.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.611 HG23 ' HB2' ' A' ' 126' ' ' LYS . 12.3 p -105.38 32.97 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.496 -178.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.43 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 51.7 mtt180 -53.33 109.96 0.5 Allowed 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.926 0.869 . . . . 0.0 111.523 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.52 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . -173.1 175.01 46.07 Favored Glycine 0 C--N 1.312 -0.788 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.788 -175.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.478 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 42.6 mt -113.09 127.13 70.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 117.904 0.852 . . . . 0.0 111.419 -177.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -109.39 129.16 55.55 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.438 -178.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -108.79 118.4 5.29 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.318 -0.944 . . . . 0.0 111.291 176.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.495 ' HB2' ' HE1' ' A' ' 29' ' ' MET . 4.0 m-85 -102.09 103.29 13.85 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.188 0.518 . . . . 0.0 111.312 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.473 ' NZ ' HG21 ' A' ' 88' ' ' THR . 58.4 mttp -89.95 99.46 12.47 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.151 174.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.753 HG11 HG11 ' A' ' 25' ' ' VAL . 18.4 t -101.78 117.09 46.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.151 -176.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 92' ' ' SER . 39.7 mtp180 -117.9 -179.72 3.84 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.496 -176.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.428 ' HB2' ' HB3' ' A' ' 92' ' ' SER . 92.7 m-20 59.06 46.75 12.91 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.229 0.538 . . . . 0.0 110.969 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.74 -159.0 11.07 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.529 178.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -37.5 -61.1 0.37 Allowed 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 124.324 3.349 . . . . 0.0 114.063 -174.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -130.59 68.11 1.48 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.171 0.51 . . . . 0.0 110.1 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.51 23.04 73.58 Favored Glycine 0 N--CA 1.452 -0.247 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.56 -178.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.4 167.48 20.8 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.071 0.462 . . . . 0.0 111.331 -177.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.441 ' H ' ' HB3' ' A' ' 17' ' ' SER . 27.7 mt-10 -142.5 143.81 32.7 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.462 -176.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -136.72 159.92 24.68 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 111.141 -0.783 . . . . 0.0 111.141 178.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.4 ' O ' ' HA ' ' A' ' 79' ' ' TYR . 16.2 t80 -148.08 113.11 5.48 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.936 0.368 . . . . 0.0 110.719 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 18.3 m-90 -118.25 134.85 54.66 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.867 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 25.1 t -104.56 119.92 54.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.547 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.52 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 3.7 mp -95.1 100.98 11.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -86.77 97.58 10.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.221 0.534 . . . . 0.0 109.967 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -98.56 -6.74 29.49 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.243 173.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.44 ' HB2' HG13 ' A' ' 50' ' ' ILE . 21.9 tttt -54.79 -49.4 71.02 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.898 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -80.13 3.48 20.38 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.008 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.14 11.83 83.13 Favored Glycine 0 N--CA 1.452 -0.274 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.956 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -83.26 -59.64 2.4 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.739 0.304 . . . . 0.0 110.803 -177.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.35 34.08 24.04 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.223 -0.989 . . . . 0.0 110.65 -173.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.592 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 14.8 ptmm? -98.03 145.68 26.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.427 -0.387 . . . . 0.0 109.969 -175.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.8 OUTLIER -111.91 132.9 59.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.234 0.54 . . . . 0.0 109.644 178.812 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.0 t -139.36 135.58 33.86 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.918 -176.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.4 ' HA ' ' O ' ' A' ' 65' ' ' TYR . 21.9 t80 -69.89 122.08 18.58 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 53.66 71.59 0.5 Allowed 'General case' 0 C--O 1.234 0.247 0 O-C-N 123.699 0.624 . . . . 0.0 109.83 -173.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -63.12 -34.48 90.07 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.259 -0.882 . . . . 0.0 113.656 -172.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.92 -2.28 87.77 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.526 -176.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.446 ' HB3' HD13 ' A' ' 50' ' ' ILE . 54.6 mm-40 -91.58 163.25 14.2 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.401 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 24.4 pttm -94.55 107.64 31.43 Favored Pre-proline 0 N--CA 1.445 -0.688 0 CA-C-O 121.281 0.562 . . . . 0.0 110.331 173.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.478 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 8.1 Cg_exo -73.79 121.86 7.33 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.657 2.238 . . . . 0.0 112.048 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -59.59 -43.41 93.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.863 176.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.484 HG11 ' HB2' ' A' ' 124' ' ' ALA . 13.5 m -126.32 127.61 70.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.601 176.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.746 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 43.1 m -117.35 129.42 55.86 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.087 178.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.587 ' CD1' ' HB ' ' A' ' 117' ' ' ILE . 61.7 m-85 -110.52 130.06 55.65 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.561 ' HB ' ' HB3' ' A' ' 116' ' ' LYS . 2.9 m -108.29 107.13 17.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.763 0.316 . . . . 0.0 110.249 178.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.453 HG21 HD12 ' A' ' 99' ' ' LEU . 47.2 mt -131.23 156.75 42.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.537 -174.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.428 ' HB3' ' HB2' ' A' ' 57' ' ' ASN . 23.7 m -92.7 140.72 29.24 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.355 175.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -43.29 -51.12 6.43 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.46 0.648 . . . . 0.0 111.66 -177.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.16 -35.61 69.75 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.441 -1.254 . . . . 0.0 112.205 -176.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.424 ' OD2' ' HB2' ' A' ' 92' ' ' SER . 12.0 m-20 -90.4 -23.13 21.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.697 0.284 . . . . 0.0 111.252 -175.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.997 HG11 HG12 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -59.02 -31.84 46.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.034 0.445 . . . . 0.0 110.434 -177.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.7 m -67.03 -30.9 51.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.182 -172.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -83.14 -32.37 26.71 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.453 HD12 HG21 ' A' ' 91' ' ' ILE . 75.7 mt -66.48 -51.24 58.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.472 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 96' ' ' VAL . 17.7 mt -70.97 -26.25 27.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.082 -176.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.6 t -82.04 -15.2 54.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.702 0.286 . . . . 0.0 111.059 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.23 20.49 48.88 Favored Glycine 0 N--CA 1.454 -0.16 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.005 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -96.9 -41.56 8.36 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.142 0.496 . . . . 0.0 111.023 -178.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.452 HD23 ' HG ' ' A' ' 99' ' ' LEU . 34.1 tp -100.3 125.24 46.49 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.385 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.469 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 12.1 m120 -69.67 122.5 85.99 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.252 177.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -65.81 -21.6 57.75 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.015 1.81 . . . . 0.0 110.843 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 tm0? -65.79 -56.86 9.75 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.722 175.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.497 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -64.99 -32.35 74.03 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.435 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.501 ' HB3' HD12 ' A' ' 115' ' ' ILE . . . -66.8 -39.49 87.78 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.9 177.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -57.16 -52.95 63.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.879 175.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -60.75 -42.83 98.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.53 -178.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.408 ' OE1' ' HA ' ' A' ' 112' ' ' GLN . 16.0 mm-40 -75.78 -11.54 60.01 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.025 -175.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.26 7.71 55.78 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.767 176.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.2 mmpt? -87.17 -14.24 41.73 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.99 0.424 . . . . 0.0 110.728 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.646 HG23 HG22 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -129.55 109.48 18.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.926 0.87 . . . . 0.0 110.251 179.164 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.561 ' HB3' ' HB ' ' A' ' 90' ' ' THR . 38.1 tptt -109.35 110.24 21.34 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.331 173.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.746 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER -125.65 131.43 72.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.411 0.624 . . . . 0.0 111.604 -172.083 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -67.97 121.26 15.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.324 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -70.85 90.11 0.4 Allowed Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 114.479 0.552 . . . . 0.0 114.479 -169.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.46 89.63 3.15 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 165.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.55 ' O ' ' HG3' ' A' ' 125' ' ' MET . 92.9 mmm -60.51 -46.65 89.35 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.197 -168.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.02 -26.14 73.3 Favored Glycine 0 CA--C 1.511 -0.21 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.164 -171.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.411 HD11 ' HA3' ' A' ' 49' ' ' GLY . 4.2 tt -90.46 -40.37 12.07 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.987 0.422 . . . . 0.0 110.617 -176.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.484 ' HB2' HG11 ' A' ' 87' ' ' VAL . . . -79.14 -13.76 59.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.204 -177.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.55 ' HG3' ' O ' ' A' ' 121' ' ' MET . 50.1 mtt -60.63 -35.11 75.37 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.975 0.417 . . . . 0.0 110.198 173.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.611 ' HB2' HG23 ' A' ' 47' ' ' VAL . 15.3 mttm -76.43 -16.63 59.65 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.587 179.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.6 mt -80.14 -41.78 24.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.935 176.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.543 ' O ' ' HG2' ' A' ' 131' ' ' GLN . 3.2 t -75.32 -17.48 60.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.537 0.684 . . . . 0.0 109.432 177.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -64.48 -41.85 96.24 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.123 171.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.431 HD22 ' HA ' ' A' ' 130' ' ' LEU . 0.7 OUTLIER -58.84 -46.68 87.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.754 178.72 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.543 ' HG2' ' O ' ' A' ' 128' ' ' THR . 18.1 pt20 -66.58 -24.27 66.32 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 121.216 -0.194 . . . . 0.0 111.326 -175.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -65.26 -47.17 77.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.21 0.529 . . . . 0.0 109.693 176.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -69.25 -33.52 73.39 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.471 177.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.8 -35.33 80.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.152 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.1 -31.69 61.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.05 0.452 . . . . 0.0 110.748 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 101.48 -20.57 46.14 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.297 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 75.2 mtt180 -85.98 87.9 7.49 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.236 0.541 . . . . 0.0 110.187 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 16.0 tt -114.37 -27.92 2.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.546 176.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.75 169.69 8.84 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.141 -172.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.0 m -113.81 92.69 4.07 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.948 0.404 . . . . 0.0 110.853 -177.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.1 tp . . . . . 0 C--O 1.249 1.06 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.122 176.785 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.67 0 N-CA-C 111.898 -0.481 . . . . 0.0 111.898 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.8 m -76.42 81.38 3.14 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.282 0.563 . . . . 0.0 110.676 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 63.0 m -97.2 138.91 33.96 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.793 -178.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.02 160.66 34.42 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.591 176.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -54.53 135.65 62.7 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 122.03 0.919 . . . . 0.0 112.023 -176.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.598 ' HA ' ' CD1' ' A' ' 23' ' ' PHE . 20.6 Cg_endo -63.65 -14.21 41.33 Favored 'Trans proline' 0 C--N 1.334 -0.189 0 C-N-CA 124.35 3.367 . . . . 0.0 112.864 -177.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.414 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 3.1 mm-40 -75.52 -20.44 58.72 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.345 -178.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -88.32 -10.93 47.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.371 -0.832 . . . . 0.0 111.175 -176.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.598 ' CD1' ' HA ' ' A' ' 20' ' ' PRO . 18.0 m-85 -69.08 158.65 34.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.671 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -77.05 -27.0 54.26 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 174.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.751 HG12 HG11 ' A' ' 96' ' ' VAL . 0.8 OUTLIER -72.04 -13.69 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.365 -179.06 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -57.02 -57.53 12.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.757 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.455 ' O ' HG23 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -72.0 -30.54 65.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.708 -178.449 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.477 ' HB3' HD12 ' A' ' 100' ' ' ILE . 21.4 m-85 -70.92 -52.11 21.98 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.588 0.218 . . . . 0.0 111.588 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.56 ' HB3' HG21 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -61.9 -31.14 71.41 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.734 0.302 . . . . 0.0 110.971 177.196 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.417 ' HA ' ' HD2' ' A' ' 30' ' ' LYS . 25.7 mmmt -69.3 -33.47 73.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.546 178.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 28' ' ' TYR . 13.3 pt -88.1 -24.37 6.2 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.451 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.2 176.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.5 tt -58.02 -47.22 83.74 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 171.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.642 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 6.8 tt0 -46.21 -50.9 15.24 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.489 175.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -75.0 -58.87 3.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.45 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.02 -40.17 66.78 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -167.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 95.6 mmm -60.6 -41.29 94.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.702 0.287 . . . . 0.0 111.493 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -90.79 -26.02 19.66 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.969 0.414 . . . . 0.0 110.072 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -65.04 -17.11 64.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.57 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -57.62 130.28 45.66 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.381 172.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 22.3 p -65.31 -21.92 66.77 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.952 -173.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -101.09 0.07 37.19 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.832 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 26.19 68.53 0.05 Allowed 'General case' 0 N--CA 1.472 0.63 0 O-C-N 124.481 1.113 . . . . 0.0 112.678 -177.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.4 mt -65.09 -4.12 4.48 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.201 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.9 tp -60.51 -26.33 37.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.748 178.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.417 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 41.3 mt-10 -72.65 -23.19 60.87 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.188 -178.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -79.23 -43.64 23.39 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.361 0.6 . . . . 0.0 110.535 178.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 47' ' ' VAL . 15.0 p -102.67 32.51 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.719 -176.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.417 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 41.8 mtm180 -51.2 117.14 2.39 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.633 0.73 . . . . 0.0 111.427 178.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . -172.89 176.28 45.73 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.616 -176.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 53.8 mt -115.17 124.42 71.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 117.669 0.734 . . . . 0.0 111.358 -178.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.488 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 27.7 m-85 -106.09 118.46 36.68 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.051 -177.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.49 111.51 4.18 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.322 177.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.419 ' O ' ' HA ' ' A' ' 65' ' ' TYR . 4.0 m-85 -96.27 111.14 23.31 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.955 0.407 . . . . 0.0 111.679 -178.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -95.47 105.42 17.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.34 173.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.682 HG11 HG11 ' A' ' 25' ' ' VAL . 22.6 t -105.83 107.39 22.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 120.972 0.415 . . . . 0.0 111.099 -174.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.434 ' HD2' ' N ' ' A' ' 56' ' ' ARG . 1.3 mpt_? -92.48 -179.64 5.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.628 176.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 13.8 m120 58.87 44.74 16.29 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.8 176.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -81.15 -165.02 33.42 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.33 176.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -35.6 -60.93 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 124.619 3.546 . . . . 0.0 114.696 -176.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.47 ' OD1' ' HB2' ' A' ' 62' ' ' ALA . 25.4 p-10 -114.22 43.51 1.86 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.353 0.596 . . . . 0.0 110.328 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.83 24.16 76.55 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 -170.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.47 ' HB2' ' OD1' ' A' ' 60' ' ' ASN . . . -70.7 155.53 40.64 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 114.511 -0.845 . . . . 0.0 111.754 -175.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -115.59 139.27 50.25 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.666 177.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -129.42 152.76 19.63 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 176.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.419 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 44.7 t80 -140.1 116.93 10.97 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.869 0.366 . . . . 0.0 110.656 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 26.9 m-90 -122.72 132.41 54.23 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.278 -178.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 55.4 t -102.76 112.22 35.34 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.201 178.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.488 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 4.3 mp -89.92 102.92 13.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.155 -0.684 . . . . 0.0 109.155 176.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.423 ' OD1' ' HB3' ' A' ' 71' ' ' LYS . 44.1 t-20 -85.59 96.94 9.82 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.868 -178.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -99.89 -2.18 35.46 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.829 173.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.423 ' HB3' ' OD1' ' A' ' 69' ' ' ASN . 65.4 tttt -51.4 -50.77 58.98 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.15 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -84.0 -3.54 58.08 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.143 -176.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.19 7.49 76.82 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.254 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.7 tppt? -83.3 -44.76 14.56 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-O 120.884 0.373 . . . . 0.0 110.652 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.07 35.07 35.62 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.756 175.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.642 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -97.0 165.34 12.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.113 0.456 . . . . 0.0 110.085 -177.178 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.56 HG21 ' HB3' ' A' ' 29' ' ' MET . 0.8 OUTLIER -123.02 136.89 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-O 121.177 0.513 . . . . 0.0 109.627 178.672 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.1 t -135.28 136.01 41.3 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.041 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -69.85 116.73 10.57 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 60.3 t30 52.76 74.08 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.836 0.71 . . . . 0.0 110.093 -173.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -63.59 -28.5 72.59 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.385 -0.825 . . . . 0.0 113.152 -177.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.61 -20.26 42.7 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.846 -0.692 . . . . 0.0 111.657 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.416 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 69.2 mm-40 -73.02 156.02 39.21 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 177.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -91.84 108.2 28.12 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 173.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 83' ' ' GLU . 22.1 Cg_exo -65.36 135.45 42.94 Favored 'Trans proline' 0 CA--C 1.517 -0.361 0 C-N-CA 122.95 2.433 . . . . 0.0 112.369 -176.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -62.69 -30.4 71.37 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.776 176.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.816 HG12 ' HA3' ' A' ' 119' ' ' GLY . 3.5 m -142.63 134.74 25.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.771 176.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.675 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 17.4 m -113.37 141.06 47.5 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.275 -0.421 . . . . 0.0 109.938 177.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.651 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 29.6 m-85 -126.21 134.6 51.19 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 176.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.7 m -111.14 118.64 36.53 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.899 0.381 . . . . 0.0 110.528 176.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.529 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 80.4 mt -141.51 157.2 21.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.484 -0.78 . . . . 0.0 108.933 -175.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.444 ' OG ' ' HE3' ' A' ' 114' ' ' LYS . 6.1 p -93.02 144.81 24.88 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 111.496 0.184 . . . . 0.0 111.496 176.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -41.18 -56.23 2.43 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 122.172 0.987 . . . . 0.0 111.714 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -60.26 -34.04 73.16 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 113.272 -1.785 . . . . 0.0 112.621 -171.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.68 -19.43 22.66 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -177.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.751 HG11 HG12 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -56.52 -34.13 40.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.21 0.529 . . . . 0.0 110.026 -178.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.3 m -66.36 -28.97 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.031 -173.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -84.69 -35.5 22.52 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.452 HD23 ' O ' ' A' ' 104' ' ' LEU . 74.8 mt -68.76 -42.25 77.76 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.96 -177.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.57 HG13 ' O ' ' A' ' 96' ' ' VAL . 15.4 mt -76.27 -22.54 15.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.808 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.2 t -88.58 -19.69 25.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.966 0.412 . . . . 0.0 110.776 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.32 0.11 65.57 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.831 -177.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -67.85 -42.11 81.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.027 0.441 . . . . 0.0 110.791 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.452 ' O ' HD23 ' A' ' 99' ' ' LEU . 36.8 tp -104.38 126.38 51.43 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.873 178.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.474 ' HB3' ' HG2' ' A' ' 108' ' ' LYS . 1.8 t-20 -72.97 121.41 85.02 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.828 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -65.68 -20.7 59.44 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.932 1.755 . . . . 0.0 110.775 177.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.11 -55.82 8.47 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.749 174.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.53 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 0.4 OUTLIER -62.06 -35.71 79.45 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.457 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.53 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -68.53 -35.58 77.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.33 177.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -59.85 -49.05 79.24 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 175.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -64.87 -33.53 76.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.93 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.555 ' HA ' HE21 ' A' ' 112' ' ' GLN . 0.0 OUTLIER -87.49 10.42 17.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.751 -178.168 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.37 1.76 82.34 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 121.285 -0.483 . . . . 0.0 113.661 172.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.643 ' HZ3' ' HB3' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -94.02 11.33 30.13 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -177.081 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.544 HG23 HG22 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -140.95 109.56 2.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-O 121.976 0.893 . . . . 0.0 109.19 172.551 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -109.0 98.45 7.93 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.744 -1.117 . . . . 0.0 109.274 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.675 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER -114.27 125.02 71.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.845 178.597 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -138.46 91.22 2.53 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -174.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.816 ' HA3' HG12 ' A' ' 87' ' ' VAL . . . -160.98 172.81 37.34 Favored Glycine 0 N--CA 1.438 -1.202 0 C-N-CA 120.403 -0.903 . . . . 0.0 113.166 -170.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -48.95 110.76 0.39 Allowed 'General case' 0 C--N 1.328 -0.335 0 O-C-N 124.248 0.617 . . . . 0.0 110.5 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -63.43 -33.17 74.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.952 -175.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -71.95 -20.59 78.94 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.684 -0.77 . . . . 0.0 111.488 -177.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.456 HD11 ' HA3' ' A' ' 49' ' ' GLY . 6.2 tt -90.5 -46.81 8.09 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.7 ' HB2' HG11 ' A' ' 87' ' ' VAL . . . -72.99 -17.36 61.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.581 -177.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -68.36 -21.1 64.74 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.549 -0.461 . . . . 0.0 110.621 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.496 ' HB2' HG23 ' A' ' 47' ' ' VAL . 11.5 mttp -69.16 -25.0 64.15 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.882 0.372 . . . . 0.0 110.744 175.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.4 mt -68.81 -23.71 64.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.482 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.463 ' O ' ' HG2' ' A' ' 131' ' ' GLN . 27.8 p -82.25 -22.94 35.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.186 0.517 . . . . 0.0 110.71 -178.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.58 ' O ' ' HG2' ' A' ' 133' ' ' GLN . 30.0 t70 -55.08 -42.53 72.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.38 -176.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.451 ' H ' HD22 ' A' ' 130' ' ' LEU . 3.2 mm? -54.78 -35.74 64.16 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.272 -176.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' A' ' 128' ' ' THR . 20.3 pt20 -91.1 -31.08 16.39 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -177.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.523 ' CG ' ' HA ' ' A' ' 129' ' ' ASP . 0.1 OUTLIER -71.69 -36.49 70.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.844 0.354 . . . . 0.0 110.677 179.847 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.58 ' HG2' ' O ' ' A' ' 129' ' ' ASP . 7.9 pt20 -73.48 -26.85 61.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.975 175.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.79 -39.87 87.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.08 176.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.89 -55.19 11.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.288 176.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 108.73 -11.91 35.29 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.199 175.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 61.24 90.43 0.07 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.131 0.491 . . . . 0.0 110.938 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.63 -35.92 8.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.173 0.511 . . . . 0.0 109.918 178.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -100.33 132.77 45.52 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.019 -174.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 94.8 p 57.45 -178.51 0.06 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.264 1.026 . . . . 0.0 112.609 176.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.414 HG13 ' OXT' ' A' ' 141' ' ' ILE . 18.8 pt . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.114 -0.946 . . . . 0.0 110.161 174.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.733 0 N-CA-C 111.865 -0.494 . . . . 0.0 111.865 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.6 m -107.23 -54.45 2.47 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.99 0.424 . . . . 0.0 110.26 178.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.2 p -162.17 107.53 1.24 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.289 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.85 155.28 34.43 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.927 175.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.454 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 15.1 m120 -58.79 144.84 80.15 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-O 121.152 0.501 . . . . 0.0 111.003 -178.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 19' ' ' ASN . 23.8 Cg_exo -58.98 -31.08 95.01 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 123.413 2.742 . . . . 0.0 111.529 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.496 ' HA ' ' CD1' ' A' ' 26' ' ' PHE . 24.5 tt0 -62.47 -35.44 79.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.254 176.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -81.25 1.54 31.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.96 -174.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -77.95 153.86 32.11 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 173.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -76.81 -24.27 52.8 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.986 HG12 HG11 ' A' ' 96' ' ' VAL . 1.3 m -73.84 -14.84 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.038 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.496 ' CD1' ' HA ' ' A' ' 21' ' ' GLU . 83.1 t80 -56.75 -50.25 72.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.718 0.294 . . . . 0.0 110.372 -176.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.61 -44.32 86.87 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.582 178.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -62.47 -46.7 87.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.866 -177.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.474 ' HB3' HG21 ' A' ' 77' ' ' VAL . 56.2 mtt -73.88 -26.69 60.69 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.059 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.44 ' HD3' ' HA ' ' A' ' 30' ' ' LYS . 40.8 mmtt -71.15 -38.9 72.22 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.19 176.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 13.6 pt -78.04 -25.17 14.18 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.427 0 C-N-CA 120.329 -0.548 . . . . 0.0 109.793 175.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.3 tt -60.3 -52.76 63.91 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 173.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.533 ' HG2' ' HA ' ' A' ' 76' ' ' LYS . 1.5 tm-20 -43.37 -48.05 6.92 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 114.814 -1.084 . . . . 0.0 111.018 176.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -77.19 -53.29 7.93 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.933 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.52 -38.9 82.18 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -168.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 25.9 mmt -60.01 -40.76 90.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.713 0.292 . . . . 0.0 111.624 -178.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -91.39 -19.52 22.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.099 0.476 . . . . 0.0 111.138 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -66.38 -23.5 66.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.247 0.546 . . . . 0.0 110.028 178.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -62.14 133.81 55.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.441 173.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.8 p -62.84 -32.88 74.19 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.037 -174.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -92.06 0.66 57.47 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-O 119.303 -0.379 . . . . 0.0 111.385 178.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.6 p30 34.11 63.32 0.42 Allowed 'General case' 0 N--CA 1.468 0.433 0 O-C-N 124.172 0.92 . . . . 0.0 110.557 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.5 mt -56.97 -12.12 1.84 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 114.427 -1.26 . . . . 0.0 112.056 -173.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.433 HG13 ' HB1' ' A' ' 70' ' ' ALA . 4.2 tp -61.48 -30.99 49.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.81 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.518 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 9.6 tt0 -75.2 -27.03 59.44 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.12 0.486 . . . . 0.0 110.909 -176.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -73.37 -15.92 61.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.592 -179.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 47' ' ' VAL . 15.0 p -131.07 31.84 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.276 -178.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.518 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 59.7 mtm180 -49.21 109.44 0.26 Allowed 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.942 0.877 . . . . 0.0 112.647 -176.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.497 ' HA3' HD11 ' A' ' 123' ' ' LEU . . . -159.6 170.75 35.89 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 113.88 -1.509 . . . . 0.0 110.493 -178.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.513 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 54.6 mt -106.47 125.45 62.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 117.416 0.608 . . . . 0.0 110.749 179.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.509 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 16.5 m-85 -107.75 116.26 31.63 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.95 -178.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -97.76 111.72 4.31 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.024 177.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -101.32 104.52 15.53 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.061 0.457 . . . . 0.0 111.488 -178.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -91.95 101.51 14.07 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.449 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.711 HG11 HG11 ' A' ' 25' ' ' VAL . 10.4 t -100.98 118.21 47.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.888 -173.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.461 ' O ' ' HA ' ' A' ' 92' ' ' SER . 50.4 mtp180 -110.28 177.66 4.63 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.686 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.432 ' HB2' ' HB3' ' A' ' 92' ' ' SER . 3.3 m-20 57.91 41.7 24.19 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.954 0.407 . . . . 0.0 110.979 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -74.08 -153.28 2.91 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.603 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -32.18 -60.14 0.19 Allowed 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 124.499 3.466 . . . . 0.0 114.233 -177.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -141.51 70.37 1.34 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.045 0.45 . . . . 0.0 109.891 176.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.81 18.15 78.71 Favored Glycine 0 N--CA 1.453 -0.176 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.702 -177.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.58 162.22 26.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.011 0.434 . . . . 0.0 111.246 -177.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -136.25 132.3 35.62 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.788 -177.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -131.98 162.4 23.88 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.453 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -146.56 113.7 6.21 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.829 0.347 . . . . 0.0 110.917 -177.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 16.3 m-90 -113.45 140.21 48.28 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.867 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 45.7 t -106.97 114.53 46.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.902 177.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.534 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 3.9 mp -91.04 99.67 10.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 175.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -87.54 99.03 11.74 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.247 -177.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -101.18 -6.7 23.91 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.892 174.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.443 ' HB2' HG13 ' A' ' 50' ' ' ILE . 3.6 tppp? -58.76 -47.53 84.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.996 -176.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -73.52 -6.32 45.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.203 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 94.88 14.35 49.73 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.033 -0.603 . . . . 0.0 111.727 -178.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.501 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 9.1 mmpt? -86.32 -70.05 0.63 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.718 0.294 . . . . 0.0 111.112 -177.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.83 32.16 13.56 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -170.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.534 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 21.8 ptmt -99.16 147.21 25.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.234 -0.483 . . . . 0.0 109.948 -177.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.474 HG21 ' HB3' ' A' ' 29' ' ' MET . 0.6 OUTLIER -107.51 127.34 63.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 176.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.2 t -130.71 127.68 39.31 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.473 -178.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -67.59 122.5 18.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.96 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 56.3 t30 54.62 72.61 0.45 Allowed 'General case' 0 C--O 1.233 0.235 0 O-C-N 123.786 0.679 . . . . 0.0 109.928 -174.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.85 -40.34 64.1 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.948 -175.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.14 -20.52 45.51 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.974 -0.632 . . . . 0.0 111.641 -176.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.495 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 40.4 mm-40 -74.08 148.2 42.08 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.646 -0.277 . . . . 0.0 110.295 178.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 24.7 pttm -80.08 109.38 12.15 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-O 121.202 0.525 . . . . 0.0 110.915 176.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.513 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 17.9 Cg_exo -67.6 136.25 38.7 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.847 2.365 . . . . 0.0 112.566 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.501 ' HB2' HD22 ' A' ' 123' ' ' LEU . 11.8 m-20 -69.93 -31.6 69.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.701 175.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.602 HG12 ' HA3' ' A' ' 119' ' ' GLY . 4.5 m -140.68 127.53 21.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.604 173.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.591 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 64.2 m -110.96 127.39 55.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.342 176.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.546 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 83.0 m-85 -113.6 120.36 40.66 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 177.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.447 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 5.0 m -96.6 122.21 39.28 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 175.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.567 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -155.64 155.95 5.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.05 0.452 . . . . 0.0 110.794 -172.891 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 56' ' ' ARG . 13.3 m -83.75 143.2 30.15 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.322 -177.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.524 ' OD1' HG13 ' A' ' 25' ' ' VAL . 31.2 t70 -53.66 -27.73 29.2 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.226 1.011 . . . . 0.0 110.908 178.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -77.14 -38.12 52.58 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.436 -178.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -90.78 -22.17 21.16 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.763 -173.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.986 HG11 HG12 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -57.31 -32.47 41.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.12 0.486 . . . . 0.0 110.383 -178.133 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.6 m -68.82 -32.62 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.739 -172.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -77.72 -35.69 51.72 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 177.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.456 HD23 ' O ' ' A' ' 104' ' ' LEU . 84.7 mt -65.92 -48.67 70.66 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.761 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 96' ' ' VAL . 29.9 mt -70.84 -29.9 39.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.112 -177.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.7 t -78.09 -30.15 49.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.865 178.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 102.5 11.96 34.35 Favored Glycine 0 CA--C 1.516 0.105 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.672 -176.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -84.01 -41.63 17.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.096 0.474 . . . . 0.0 110.82 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.456 ' O ' HD23 ' A' ' 99' ' ' LEU . 43.2 tp -102.95 123.85 47.35 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.981 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.548 HD21 ' HB2' ' A' ' 135' ' ' ALA . 6.1 m-20 -73.52 117.95 64.91 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.287 178.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -60.13 -22.45 69.93 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.009 1.806 . . . . 0.0 111.214 176.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.462 ' HB2' ' OE1' ' A' ' 131' ' ' GLN . 5.5 tt0 -64.35 -55.44 21.18 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.002 173.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.479 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 0.7 OUTLIER -66.83 -31.54 72.22 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.767 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.594 ' HB3' HD12 ' A' ' 115' ' ' ILE . . . -70.61 -32.65 70.07 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.085 0.469 . . . . 0.0 109.945 177.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -65.83 -46.6 77.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.331 174.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -63.16 -44.48 95.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.205 178.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.474 ' HA ' ' OE1' ' A' ' 112' ' ' GLN . 14.5 mm-40 -79.63 2.24 23.23 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -176.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.31 6.75 89.08 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.774 171.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.09 -37.79 37.87 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.031 0.443 . . . . 0.0 110.767 177.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.675 HG23 HG22 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -93.13 117.27 36.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.942 178.736 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.447 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 23.9 mmmt -109.31 99.13 8.44 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.675 HG22 HG23 ' A' ' 115' ' ' ILE . 0.1 OUTLIER -123.57 136.46 60.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.081 0.467 . . . . 0.0 110.521 -177.93 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -147.14 81.73 1.54 Allowed 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -175.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.602 ' HA3' HG12 ' A' ' 87' ' ' VAL . . . -154.56 171.86 33.02 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 120.406 -0.902 . . . . 0.0 113.482 -169.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -51.59 112.88 0.83 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.446 0.698 . . . . 0.0 110.849 -178.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -66.5 -29.94 70.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.735 -176.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -70.56 -14.12 71.97 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.563 -178.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.501 HD22 ' HB2' ' A' ' 86' ' ' ASP . 3.5 tp -92.61 -51.15 5.25 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.789 0.804 . . . . 0.0 109.365 176.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.545 ' HB2' HG11 ' A' ' 87' ' ' VAL . . . -70.97 -12.39 61.51 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.869 -1.059 . . . . 0.0 111.253 -174.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 27.7 ptm -61.81 -24.12 66.66 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.842 0.353 . . . . 0.0 110.646 175.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 52.9 mmtt -83.44 -20.18 34.56 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 120.999 0.428 . . . . 0.0 110.597 177.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.9 mt -83.81 -41.75 17.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.964 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.574 ' O ' ' HG3' ' A' ' 132' ' ' ARG . 15.2 t -66.84 -22.16 66.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.348 0.594 . . . . 0.0 109.986 177.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -59.58 -47.28 86.18 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.705 175.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.9 mt -61.67 -41.92 98.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.404 -0.817 . . . . 0.0 112.06 -177.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.462 ' OE1' ' HB2' ' A' ' 107' ' ' GLN . 25.1 pt20 -67.91 -24.25 65.18 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.29 -175.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.574 ' HG3' ' O ' ' A' ' 128' ' ' THR . 65.7 mtm180 -63.84 -42.41 97.6 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 176.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -67.94 -39.45 83.45 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.746 177.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.88 -23.5 66.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.336 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.548 ' HB2' HD21 ' A' ' 105' ' ' ASN . . . -97.23 -3.81 40.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.017 0.437 . . . . 0.0 111.234 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 68.42 31.63 74.33 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.939 -177.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 18.7 tpp180 -94.65 105.91 17.87 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.952 0.406 . . . . 0.0 110.084 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 3.0 mp -68.21 -68.24 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.496 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -102.41 128.2 49.1 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.012 -178.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.57 ' OG ' ' HD2' ' A' ' 132' ' ' ARG . 12.2 m -94.26 139.01 31.59 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.764 -176.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 41.8 mm . . . . . 0 C--O 1.246 0.893 0 CA-C-O 118.568 -0.729 . . . . 0.0 109.786 -178.159 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.584 0 N-CA-C 111.771 -0.532 . . . . 0.0 111.771 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 45.8 t -102.4 -49.22 3.93 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.086 0.469 . . . . 0.0 110.362 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 52.2 m -154.46 -161.6 1.25 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.075 -176.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.07 172.32 4.39 Favored Glycine 0 CA--C 1.52 0.397 0 C-N-CA 121.31 -0.471 . . . . 0.0 112.785 175.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.408 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 6.3 m-20 -55.45 150.04 25.88 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.371 0.605 . . . . 0.0 111.794 -178.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.504 ' O ' ' HB2' ' A' ' 26' ' ' PHE . 4.9 Cg_exo -67.63 -22.25 44.41 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.997 2.464 . . . . 0.0 111.025 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.423 ' HG3' ' H ' ' A' ' 21' ' ' GLU . 14.5 mt-10 -65.07 -31.64 72.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.743 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -73.77 -18.69 60.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.273 -178.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -77.65 142.33 38.92 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 174.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -70.38 -23.21 62.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.664 0.745 . . . . 0.0 109.16 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 1.036 HG12 HG11 ' A' ' 96' ' ' VAL . 1.0 OUTLIER -69.4 -17.36 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.002 -179.027 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.504 ' HB2' ' O ' ' A' ' 20' ' ' PRO . 75.3 t80 -58.15 -44.16 87.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.258 0.552 . . . . 0.0 110.232 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.456 ' O ' HG23 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -77.17 -42.33 38.14 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.475 178.851 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.461 ' O ' HG12 ' A' ' 31' ' ' ILE . 24.6 m-85 -66.56 -44.39 82.46 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -177.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.435 ' CE ' HD11 ' A' ' 68' ' ' ILE . 73.9 mtp -77.56 -20.27 54.34 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.835 0.35 . . . . 0.0 110.542 -178.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 26' ' ' PHE . 19.8 mmtt -76.4 -36.67 57.94 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.871 175.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 28' ' ' TYR . 14.1 pt -77.22 -23.87 14.79 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.354 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 174.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.4 tt -58.8 -51.66 69.02 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 171.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.432 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 3.6 tt0 -45.79 -47.6 15.62 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.293 176.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -75.04 -54.5 7.05 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.54 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.6 -33.83 73.32 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -169.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.2 mmt -62.28 -39.38 92.74 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -90.96 -29.41 17.43 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.088 0.47 . . . . 0.0 110.838 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -64.61 -32.08 73.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.377 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -57.04 138.36 54.51 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.097 177.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.2 p -58.31 -24.57 60.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.027 -0.988 . . . . 0.0 113.063 -172.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -94.04 -28.42 15.75 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.8 p30 36.11 63.28 0.61 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.763 0.792 . . . . 0.0 111.181 -176.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 93.0 mt -69.52 2.75 2.85 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.859 -175.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.466 HG13 ' HB1' ' A' ' 70' ' ' ALA . 1.9 tp -56.91 -31.38 36.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.262 -177.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.415 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 7.9 pt-20 -76.75 -19.81 57.21 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.901 0.381 . . . . 0.0 111.164 -177.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -85.54 -35.01 21.37 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.25 0.548 . . . . 0.0 110.137 177.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.522 HG23 ' HB2' ' A' ' 126' ' ' LYS . 13.2 p -108.3 32.97 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.875 0.845 . . . . 0.0 110.472 -177.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.415 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 59.0 mtm180 -52.66 124.41 13.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.521 0.677 . . . . 0.0 111.309 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.52 ' HA3' HD11 ' A' ' 123' ' ' LEU . . . 179.74 -174.84 46.38 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 114.524 -1.216 . . . . 0.0 110.663 -175.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 63.3 mt -123.66 125.72 71.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 117.853 0.826 . . . . 0.0 111.391 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.472 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 22.7 m-85 -106.09 116.02 31.23 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.788 -178.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.38 115.59 5.23 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.533 -0.842 . . . . 0.0 111.357 177.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.417 ' O ' ' HA ' ' A' ' 65' ' ' TYR . 4.3 m-85 -100.92 109.63 21.6 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.039 0.447 . . . . 0.0 111.448 -177.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -94.35 99.34 11.57 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 172.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.807 HG11 HG11 ' A' ' 25' ' ' VAL . 18.6 t -101.03 107.35 21.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.096 0.474 . . . . 0.0 110.582 -174.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.466 ' O ' ' HA ' ' A' ' 92' ' ' SER . 35.9 mtp180 -103.18 174.36 5.9 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.087 -176.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 61.47 48.48 5.87 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.095 0.474 . . . . 0.0 111.239 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.08 -145.27 1.58 Allowed Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.245 175.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 62' ' ' ALA . 73.8 Cg_exo -40.6 -60.91 0.53 Allowed 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.665 2.91 . . . . 0.0 113.633 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -146.94 77.48 1.46 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.311 0.576 . . . . 0.0 110.487 177.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.58 13.33 83.58 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.88 178.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.422 ' HB3' ' HD2' ' A' ' 59' ' ' PRO . . . -72.73 143.78 47.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.987 0.423 . . . . 0.0 110.823 179.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -129.53 114.46 16.12 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.13 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -107.98 168.88 14.06 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.636 -178.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.417 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 44.5 t80 -150.2 120.34 7.25 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.754 0.311 . . . . 0.0 110.765 -177.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 16.9 m-90 -123.49 149.94 44.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.976 0.417 . . . . 0.0 109.919 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 38.2 t -118.25 118.1 56.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.645 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.472 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 4.1 mp -92.56 105.45 16.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 175.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -91.15 97.47 11.16 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.514 -176.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.466 ' HB1' HG13 ' A' ' 44' ' ' ILE . . . -98.1 -10.32 24.45 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.322 174.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.59 ' HD2' ' HG3' ' A' ' 72' ' ' GLU . 1.2 tmmt? -59.71 -34.88 73.49 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.212 -178.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.59 ' HG3' ' HD2' ' A' ' 71' ' ' LYS . 40.5 mt-10 -95.09 12.61 28.03 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.334 0.587 . . . . 0.0 111.24 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.53 -12.96 43.91 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.401 -0.818 . . . . 0.0 113.507 174.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -74.11 -56.23 5.17 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.706 0.289 . . . . 0.0 111.22 -176.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.89 35.06 9.36 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.198 -1.001 . . . . 0.0 111.736 -177.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 16.3 pttm -96.89 151.43 19.69 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 -175.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.8 OUTLIER -108.22 132.3 56.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 108.984 -0.746 . . . . 0.0 108.984 177.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.3 t -136.53 134.33 37.41 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.186 -177.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -66.54 125.32 25.37 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.28 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 51.78 63.16 2.35 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.275 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -59.21 -40.41 95.76 Favored Glycine 0 C--N 1.33 0.224 0 CA-C-N 115.324 -0.853 . . . . 0.0 113.847 -173.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.65 -20.61 47.69 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.931 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.497 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 15.6 mm-40 -70.19 150.57 46.33 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 174.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -85.04 107.82 13.14 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 178.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 83' ' ' GLU . 16.6 Cg_exo -67.95 128.89 18.51 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.855 2.37 . . . . 0.0 112.425 -177.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -62.16 -33.43 74.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.775 175.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.608 HG11 ' HB2' ' A' ' 124' ' ' ALA . 2.9 m -137.68 142.45 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.406 175.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.703 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 34.1 m -126.11 126.15 43.71 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.472 -179.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.409 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 55.0 m-85 -108.85 124.96 51.45 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.404 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 6.7 m -98.98 114.62 27.35 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 173.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.531 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 89.3 mt -137.54 150.35 25.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.811 -174.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 56' ' ' ARG . 51.1 m -90.52 137.3 32.46 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.866 176.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -43.23 -51.72 6.01 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 123.658 0.599 . . . . 0.0 111.826 -177.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.03 -41.17 67.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.374 -177.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -90.18 -18.36 25.89 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -174.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 1.036 HG11 HG12 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -57.39 -31.02 37.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.078 0.466 . . . . 0.0 110.066 -178.55 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.9 m -69.29 -28.71 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.836 -174.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -79.46 -39.59 31.88 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 176.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.474 HD23 ' O ' ' A' ' 104' ' ' LEU . 86.8 mt -68.17 -41.88 80.84 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.814 -176.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 96' ' ' VAL . 19.5 mt -72.96 -25.35 21.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.35 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 10.3 t -95.75 -5.27 42.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.093 -178.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.49 15.12 76.94 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.139 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -82.22 -42.52 18.84 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.336 0.589 . . . . 0.0 110.408 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.474 ' O ' HD23 ' A' ' 99' ' ' LEU . 41.4 tp -104.76 124.18 48.95 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.867 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.495 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 17.5 m120 -71.05 116.32 45.44 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.353 178.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -60.37 -22.9 73.0 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.067 1.845 . . . . 0.0 111.301 178.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -62.15 -59.42 5.08 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.956 173.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.517 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -64.75 -33.58 76.31 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.888 -177.676 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.519 ' HB1' ' HB3' ' A' ' 114' ' ' LYS . . . -71.32 -29.9 65.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.395 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -66.31 -45.03 81.72 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 175.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -66.93 -37.67 84.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.363 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -82.02 -6.38 59.1 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.053 -177.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.03 15.41 61.03 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.261 175.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.519 ' HB3' ' HB1' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -81.76 -41.6 20.95 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.567 0.699 . . . . 0.0 109.266 176.671 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.663 HG23 HG22 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -104.25 126.88 58.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.601 -176.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.404 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 34.2 mmtp -120.58 99.63 6.66 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 174.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.703 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER -126.06 131.3 71.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.035 0.445 . . . . 0.0 111.567 -176.727 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.537 ' O ' HG12 ' A' ' 87' ' ' VAL . 22.6 mt-30 -75.3 110.7 9.86 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 174.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -78.47 89.68 1.13 Allowed Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.44 -172.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -64.58 109.71 2.08 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 170.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.491 ' O ' ' HG3' ' A' ' 125' ' ' MET . 28.1 ttt -46.43 -53.17 11.62 Favored 'General case' 0 C--O 1.224 -0.271 0 O-C-N 124.281 0.988 . . . . 0.0 112.32 -168.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -82.5 -37.79 13.63 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.035 -1.079 . . . . 0.0 112.878 -173.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.52 HD11 ' HA3' ' A' ' 49' ' ' GLY . 5.0 tt -80.59 -44.25 19.27 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.601 0.239 . . . . 0.0 111.445 -170.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.608 ' HB2' HG11 ' A' ' 87' ' ' VAL . . . -78.69 -16.0 57.8 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.654 -175.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.491 ' HG3' ' O ' ' A' ' 121' ' ' MET . 44.9 mtm -66.76 -28.46 68.42 Favored 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.39 175.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.522 ' HB2' HG23 ' A' ' 47' ' ' VAL . 12.4 mttp -65.93 -20.5 66.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.942 0.401 . . . . 0.0 110.931 177.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 68.9 mt -78.42 -24.15 46.33 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.456 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 21.4 p -79.76 -23.77 41.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.256 0.55 . . . . 0.0 110.423 -178.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -51.11 -43.95 61.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.133 177.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -59.88 -65.15 0.72 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.081 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -57.52 -36.93 72.22 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -176.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -55.94 -56.51 19.81 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.769 0.318 . . . . 0.0 111.156 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -76.54 -22.66 54.08 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.149 -178.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.37 -50.24 64.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.807 0.337 . . . . 0.0 110.808 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -77.79 -33.76 52.49 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.902 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 88.78 -31.05 5.12 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.83 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 12.0 ptt180 -159.04 132.87 7.5 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 175.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 88.1 mt -122.25 -75.26 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.403 -179.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -101.84 151.44 22.08 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.578 -175.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 29.1 t -146.78 152.53 38.93 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -177.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 74.8 mt . . . . . 0 C--O 1.251 1.161 0 CA-C-O 118.414 -0.803 . . . . 0.0 110.115 179.376 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.893 0 N-CA-C 112.086 -0.406 . . . . 0.0 112.086 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.3 t -107.92 29.88 6.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.594 0.712 . . . . 0.0 110.3 -177.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.5 p -88.52 161.56 16.9 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.506 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -83.78 166.44 43.12 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.545 177.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -63.61 147.46 95.58 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-O 120.985 0.422 . . . . 0.0 110.626 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' A' ' 26' ' ' PHE . 11.8 Cg_exo -64.76 -29.16 59.55 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.206 2.604 . . . . 0.0 112.005 -175.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -63.73 -34.87 78.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.544 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -70.23 -11.63 61.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.355 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -81.23 143.31 32.4 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.174 0.512 . . . . 0.0 110.186 177.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -74.29 -21.11 59.89 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.569 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.842 HG12 HG11 ' A' ' 96' ' ' VAL . 2.5 m -75.16 -17.23 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.075 177.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.457 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 73.2 t80 -54.19 -57.24 11.91 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.871 0.367 . . . . 0.0 110.57 -176.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.96 -32.68 74.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.8 -177.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.481 ' O ' HG12 ' A' ' 31' ' ' ILE . 10.5 m-85 -70.59 -46.75 62.84 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.298 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.426 ' HE2' ' HB2' ' A' ' 29' ' ' MET . 29.6 mtm -66.17 -30.51 70.99 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.833 176.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 26' ' ' PHE . 29.4 mmmt -64.63 -35.38 80.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.061 177.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 28' ' ' TYR . 9.6 pt -88.35 -16.18 8.93 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.565 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.231 176.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.3 tt -64.5 -51.42 63.02 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 168.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.581 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 6.3 tt0 -44.35 -45.51 8.86 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 114.447 -1.251 . . . . 0.0 110.865 173.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -73.16 -59.57 2.65 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.499 178.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.84 -37.23 68.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.668 -0.697 . . . . 0.0 112.769 -167.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.447 ' HB3' HD13 ' A' ' 44' ' ' ILE . 25.9 mmt -59.43 -42.76 92.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.788 -179.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -92.34 -24.15 19.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.094 0.473 . . . . 0.0 111.015 178.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -64.92 -30.02 70.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.01 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -54.64 135.96 46.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.559 0.695 . . . . 0.0 110.041 176.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 16.2 p -52.73 -38.58 61.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.257 -1.338 . . . . 0.0 112.973 -173.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -102.78 8.89 39.31 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 119.227 -0.416 . . . . 0.0 111.258 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 34.2 67.8 0.2 Allowed 'General case' 0 C--O 1.238 0.461 0 O-C-N 124.183 0.927 . . . . 0.0 110.752 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.401 ' O ' HG12 ' A' ' 47' ' ' VAL . 69.1 mt -62.08 -0.4 0.51 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.273 -1.33 . . . . 0.0 112.403 -171.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.447 HD13 ' HB3' ' A' ' 36' ' ' MET . 4.2 tp -63.23 -28.21 44.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.3 178.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -76.6 -10.86 59.69 Favored 'General case' 0 N--CA 1.46 0.053 0 CA-C-O 121.235 0.54 . . . . 0.0 110.645 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -100.53 -14.8 18.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.804 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 47' ' ' VAL . 14.6 p -131.18 33.05 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.662 0.744 . . . . 0.0 110.364 -177.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 50.8 mtt180 -51.89 109.45 0.37 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.738 0.78 . . . . 0.0 111.826 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.597 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . -167.41 167.38 39.88 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.398 -177.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.488 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 32.9 mt -105.89 125.71 61.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 118.481 1.14 . . . . 0.0 111.145 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.578 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 17.0 m-85 -104.25 122.55 45.64 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.607 -177.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.47 125.14 8.48 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.236 176.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.429 ' CD1' HD13 ' A' ' 68' ' ' ILE . 5.6 m-85 -108.12 99.85 9.24 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.171 0.51 . . . . 0.0 111.331 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -94.78 100.82 12.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.141 173.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.744 HG11 HG11 ' A' ' 25' ' ' VAL . 19.8 t -108.47 117.72 54.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.1 0.476 . . . . 0.0 111.141 -173.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 47.0 mtp180 -102.25 -179.72 4.07 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.218 -177.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.447 ' HB2' ' HB3' ' A' ' 92' ' ' SER . 3.5 m-20 59.89 44.72 13.29 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 123.288 0.368 . . . . 0.0 111.34 178.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.97 -157.27 6.9 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.692 177.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -43.3 -59.74 0.95 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.675 2.917 . . . . 0.0 112.888 -178.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -113.47 46.88 1.21 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 175.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.6 15.44 77.63 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.837 -176.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.0 143.44 57.77 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.729 0.776 . . . . 0.0 111.606 -177.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -107.98 109.63 21.15 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.917 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.65 154.03 19.63 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 35.1 t80 -139.25 117.38 11.82 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.95 0.405 . . . . 0.0 111.173 -178.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 10.2 m-90 -119.71 161.7 20.28 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.2 t -126.36 118.8 52.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.265 178.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.578 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 3.1 mp -96.36 100.54 11.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 176.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -82.4 98.22 8.76 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.166 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -100.64 -5.11 27.13 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.975 175.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.496 ' HE3' ' HA2' ' A' ' 49' ' ' GLY . 4.1 tppp? -66.05 -39.23 89.95 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.256 -178.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -81.0 0.54 35.18 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.019 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.75 13.59 83.29 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.198 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.513 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 10.8 mmpt? -86.22 -50.5 6.93 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.68 0.276 . . . . 0.0 110.566 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.44 33.07 61.57 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.455 -0.879 . . . . 0.0 111.004 -176.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.581 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 52.2 pttt -98.5 149.24 22.92 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.504 -0.348 . . . . 0.0 110.197 -177.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.49 HG12 HG13 ' A' ' 68' ' ' ILE . 0.9 OUTLIER -108.11 123.01 63.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.699 0.761 . . . . 0.0 109.565 -178.383 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.444 HG23 ' HA2' ' A' ' 81' ' ' GLY . 4.5 t -130.36 134.46 47.18 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.582 -178.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -64.68 129.66 40.63 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 -176.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 72.68 -43.19 0.56 Allowed 'General case' 0 N--CA 1.47 0.557 0 O-C-N 124.001 0.813 . . . . 0.0 111.944 -177.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.444 ' HA2' HG23 ' A' ' 78' ' ' THR . . . 71.91 -42.68 0.76 Allowed Glycine 0 CA--C 1.518 0.259 0 CA-C-N 116.151 -0.477 . . . . 0.0 114.222 177.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.79 13.22 78.6 Favored Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 -174.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -116.25 166.74 11.69 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -177.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -100.7 109.01 56.37 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.204 177.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.488 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 12.6 Cg_exo -71.48 127.95 13.88 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 122.994 2.462 . . . . 0.0 112.789 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -60.97 -46.5 90.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.587 173.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.597 HG11 ' HB2' ' A' ' 124' ' ' ALA . 8.7 m -125.11 125.12 68.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.65 178.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.718 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 15.2 m -122.77 125.69 45.98 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.35 -178.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.493 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 86.2 m-85 -105.18 136.24 45.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.609 0.242 . . . . 0.0 110.39 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.567 ' HB ' ' HB3' ' A' ' 116' ' ' LYS . 2.2 m -109.72 99.63 8.77 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 175.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.565 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 49.0 mt -125.46 162.47 28.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -175.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.487 ' N ' HG22 ' A' ' 91' ' ' ILE . 20.3 m -97.86 145.53 26.34 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.987 0.422 . . . . 0.0 110.364 176.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.583 ' OD1' HG13 ' A' ' 25' ' ' VAL . 36.6 t70 -54.18 -24.03 16.64 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.016 -176.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -82.83 -35.38 26.4 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.982 -177.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -90.11 -26.44 20.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.711 -172.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.842 HG11 HG12 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -54.5 -33.13 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.011 0.434 . . . . 0.0 111.453 -176.648 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.4 m -66.34 -27.51 40.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.639 -169.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.418 ' HA ' ' HG ' ' A' ' 101' ' ' SER . 33.5 m-20 -89.69 -27.44 20.1 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 176.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.467 HD12 HG21 ' A' ' 91' ' ' ILE . 76.1 mt -69.09 -42.97 75.46 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.204 0.526 . . . . 0.0 110.533 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 96' ' ' VAL . 16.7 mt -77.46 -27.64 15.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.137 -177.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.43 ' OG ' ' HD3' ' A' ' 103' ' ' LYS . 64.0 p -83.56 -27.55 29.21 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.978 0.418 . . . . 0.0 110.778 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.38 -5.23 31.5 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.876 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.43 ' HD3' ' OG ' ' A' ' 101' ' ' SER . 14.0 mptt -67.56 -42.06 83.24 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 179.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.464 ' O ' HD23 ' A' ' 99' ' ' LEU . 25.1 tp -99.93 119.88 38.92 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.141 0.495 . . . . 0.0 110.218 -177.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.489 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 15.3 m120 -67.62 118.06 53.58 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.183 178.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -64.16 -21.68 67.55 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.123 1.882 . . . . 0.0 110.989 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -64.02 -53.68 46.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.325 174.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.525 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -68.04 -33.39 74.49 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -178.861 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.526 ' HB3' HD12 ' A' ' 115' ' ' ILE . . . -67.46 -36.59 81.46 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.999 177.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -59.35 -48.01 83.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.845 176.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -67.96 -37.97 82.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.016 -177.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -82.84 2.9 31.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.969 -0.559 . . . . 0.0 112.275 -177.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 81.14 13.91 80.07 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.771 -0.728 . . . . 0.0 113.379 175.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -92.32 -10.58 37.8 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.196 0.522 . . . . 0.0 110.297 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.61 HG23 HG22 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -133.35 109.09 13.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.751 177.937 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.567 ' HB3' ' HB ' ' A' ' 90' ' ' THR . 45.9 tptt -112.77 107.1 15.61 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.3 174.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.718 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER -133.9 136.94 53.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.058 0.456 . . . . 0.0 111.552 -170.147 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -67.89 123.36 20.36 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.163 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -77.0 88.64 0.97 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.221 -175.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.401 HD22 ' N ' ' A' ' 120' ' ' ASN . 0.9 OUTLIER -107.05 97.02 6.84 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 170.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.541 ' O ' ' HB3' ' A' ' 125' ' ' MET . 26.9 ttt -59.34 -50.72 72.9 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.562 -168.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -73.48 -9.66 78.2 Favored Glycine 0 N--CA 1.459 0.232 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.15 -175.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 123' ' ' LEU . 0.5 OUTLIER -93.34 -55.86 3.15 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.65 0.738 . . . . 0.0 109.809 -177.93 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.597 ' HB2' HG11 ' A' ' 87' ' ' VAL . . . -90.49 -3.72 57.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.311 -172.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.541 ' HB3' ' O ' ' A' ' 121' ' ' MET . 27.1 ptt? -62.28 -24.09 67.09 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.214 178.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.535 ' O ' ' HG ' ' A' ' 130' ' ' LEU . 30.0 mmmt -73.87 -16.54 61.12 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.283 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 75.6 mt -74.55 -52.29 12.28 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 176.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.484 ' HA ' ' HG2' ' A' ' 131' ' ' GLN . 8.8 t -66.59 -33.26 75.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.856 177.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -55.19 -47.59 75.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.804 177.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 126' ' ' LYS . 5.0 mt -66.25 -47.55 73.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.954 -178.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.484 ' HG2' ' HA ' ' A' ' 128' ' ' THR . 16.5 pt20 -71.38 -35.37 71.04 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -175.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 24.8 mtp180 -67.91 -38.87 83.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.175 0.512 . . . . 0.0 110.076 176.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -71.19 -26.94 63.17 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.041 177.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.87 -32.83 74.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.689 177.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -94.42 -12.41 27.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.675 177.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 65.92 17.2 65.04 Favored Glycine 0 C--N 1.332 0.313 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.419 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 65.5 mtm180 -150.43 -177.85 6.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.805 0.336 . . . . 0.0 110.237 -173.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.446 HG22 ' N ' ' A' ' 139' ' ' GLU . 40.5 mt -90.39 164.07 2.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 171.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.446 ' N ' HG22 ' A' ' 138' ' ' ILE . 7.8 mm-40 -42.23 118.21 1.12 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.217 0.532 . . . . 0.0 111.685 174.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 19.0 m -115.59 101.86 9.25 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.669 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 pt . . . . . 0 C--O 1.247 0.926 0 CA-C-O 118.364 -0.827 . . . . 0.0 110.968 -176.047 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.849 0 N-CA-C 111.74 -0.544 . . . . 0.0 111.74 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 24.8 m -69.22 -49.56 55.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.058 0.456 . . . . 0.0 110.453 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.2 m -96.17 118.63 33.13 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.534 177.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.12 173.22 15.06 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.629 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.431 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 38.9 m-80 -54.22 147.35 27.2 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.029 0.442 . . . . 0.0 111.142 -177.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.436 ' HA ' ' CD1' ' A' ' 23' ' ' PHE . 4.8 Cg_exo -68.21 -21.39 42.05 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 123.143 2.562 . . . . 0.0 111.578 -176.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -72.42 -20.73 61.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.247 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -81.95 -0.06 42.21 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.006 178.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.436 ' CD1' ' HA ' ' A' ' 20' ' ' PRO . 37.7 m-85 -90.12 152.56 21.07 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 175.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.408 ' O ' ' HD2' ' A' ' 28' ' ' TYR . 48.0 tptt -80.34 -26.05 38.92 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.718 HG12 HG11 ' A' ' 96' ' ' VAL . 0.8 OUTLIER -68.93 -15.19 19.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.57 178.15 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -53.75 -60.15 3.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.207 0.527 . . . . 0.0 110.572 178.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.0 -33.51 65.83 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.609 -177.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.512 ' O ' HG12 ' A' ' 31' ' ' ILE . 17.7 m-85 -67.76 -48.91 65.05 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.787 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.623 ' SD ' ' HB ' ' A' ' 25' ' ' VAL . 0.1 OUTLIER -63.25 -29.42 70.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.893 0.378 . . . . 0.0 110.74 175.889 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.44 ' HD3' ' HA ' ' A' ' 30' ' ' LYS . 37.8 mmtt -71.86 -34.36 69.16 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.787 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.512 HG12 ' O ' ' A' ' 28' ' ' TYR . 8.7 pt -82.24 -21.87 9.69 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.519 0 C-N-CA 119.971 -0.692 . . . . 0.0 109.705 174.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.405 ' O ' ' HG2' ' A' ' 36' ' ' MET . 6.5 tt -60.53 -50.97 71.4 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 170.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.521 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 6.4 tt0 -43.86 -48.51 8.36 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.183 174.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -76.33 -52.85 9.1 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.78 -177.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.433 ' HA ' ' HB3' ' A' ' 38' ' ' ASN . . . -63.21 -32.72 74.19 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -168.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.405 ' HG2' ' O ' ' A' ' 32' ' ' LEU . 94.5 mmm -62.35 -43.59 98.48 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.491 0.182 . . . . 0.0 111.491 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -91.09 -16.26 28.14 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.737 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.433 ' HB3' ' HA ' ' A' ' 35' ' ' ALA . 26.9 t-20 -65.81 -17.63 64.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.387 0.613 . . . . 0.0 109.943 175.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -54.83 128.94 35.33 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.055 172.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.6 p -62.38 -25.78 68.11 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.492 -0.777 . . . . 0.0 112.346 -175.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -100.09 -0.12 39.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.941 0.4 . . . . 0.0 111.02 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 39.22 52.84 2.18 Favored 'General case' 0 C--N 1.344 0.365 0 CA-C-N 114.614 -1.176 . . . . 0.0 111.742 -175.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.0 mt -60.9 -4.35 0.99 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.803 -175.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.425 HD11 ' CB ' ' A' ' 70' ' ' ALA . 1.1 tp -55.97 -30.16 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-O 120.766 0.317 . . . . 0.0 110.591 176.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.514 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 5.8 pt-20 -64.47 -36.03 82.87 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.346 -177.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -77.14 -15.8 59.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.996 0.427 . . . . 0.0 111.108 -175.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 47' ' ' VAL . 14.5 p -130.71 32.28 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.934 0.874 . . . . 0.0 110.24 -175.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.514 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 94.9 mtt180 -57.96 116.98 3.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.597 -0.728 . . . . 0.0 111.843 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.556 ' HA3' HD11 ' A' ' 123' ' ' LEU . . . -171.23 173.98 44.84 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.188 -178.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.483 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 52.7 mt -104.99 125.42 59.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 117.485 0.642 . . . . 0.0 111.234 -178.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.573 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 3.1 m-85 -107.28 110.99 23.15 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.815 -177.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.15 116.29 5.32 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.419 -0.896 . . . . 0.0 111.47 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.428 ' O ' ' HA ' ' A' ' 65' ' ' TYR . 5.1 m-85 -100.61 109.41 21.48 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.027 0.441 . . . . 0.0 111.636 -178.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -94.35 99.84 11.98 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.378 175.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.675 HG11 HG11 ' A' ' 25' ' ' VAL . 19.0 t -98.58 133.11 42.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.811 -175.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -122.33 173.26 7.74 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.117 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 59.81 49.7 7.73 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.103 0.478 . . . . 0.0 111.395 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.42 -140.07 1.61 Allowed Glycine 0 CA--C 1.522 0.48 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.437 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 62' ' ' ALA . 54.1 Cg_exo -40.73 -61.6 0.46 Allowed 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.768 2.979 . . . . 0.0 114.098 178.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -152.06 82.23 1.26 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.187 0.518 . . . . 0.0 109.97 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 73.23 12.55 79.72 Favored Glycine 0 N--CA 1.453 -0.223 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.476 ' HB3' ' HD2' ' A' ' 59' ' ' PRO . . . -82.39 157.03 23.88 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.044 -0.578 . . . . 0.0 111.381 -175.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -133.22 143.08 48.92 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.667 -177.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.8 162.72 24.19 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.443 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.428 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 33.6 t80 -148.42 117.58 6.84 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.82 0.343 . . . . 0.0 110.881 -176.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 16.6 m-90 -120.82 139.32 53.31 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.9 t -107.65 112.75 41.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.448 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.573 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 3.9 mp -90.73 100.7 11.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 175.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -85.66 97.4 10.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.418 0.628 . . . . 0.0 109.887 -178.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -102.22 -0.43 33.07 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.404 174.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.451 ' HB2' HG13 ' A' ' 50' ' ' ILE . 4.9 tppp? -63.33 -45.48 91.05 Favored 'General case' 0 CA--C 1.523 -0.079 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.166 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -72.76 -8.79 57.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.615 176.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.34 -4.14 86.37 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.897 -178.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -71.64 -39.93 70.07 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.884 0.373 . . . . 0.0 111.417 -177.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.6 34.16 54.41 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.562 176.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.521 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 19.7 ptmt -98.2 149.19 22.82 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 -175.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.6 HG21 ' HB3' ' A' ' 29' ' ' MET . 0.7 OUTLIER -109.52 132.43 57.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.674 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.0 t -133.84 129.23 36.19 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.387 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -66.49 122.5 17.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.37 -178.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 54.81 65.73 1.42 Allowed 'General case' 0 N--CA 1.464 0.226 0 O-C-N 123.765 0.666 . . . . 0.0 109.813 -176.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.04 -40.25 88.6 Favored Glycine 0 C--N 1.33 0.207 0 CA-C-N 115.57 -0.741 . . . . 0.0 113.707 -173.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.11 -21.27 40.98 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.041 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.451 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 7.4 mm-40 -71.26 143.19 50.46 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 175.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? -76.88 114.47 39.61 Favored Pre-proline 0 N--CA 1.438 -1.037 0 CA-C-O 121.39 0.614 . . . . 0.0 110.827 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.483 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 13.9 Cg_exo -68.92 126.55 14.02 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.191 2.594 . . . . 0.0 112.16 177.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.552 ' HB2' HD22 ' A' ' 123' ' ' LEU . 5.1 m-20 -60.66 -33.5 72.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.297 173.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.562 HG11 ' HB2' ' A' ' 124' ' ' ALA . 11.3 m -136.76 142.16 38.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.326 174.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.678 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 22.9 m -127.44 138.75 53.05 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.098 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.461 ' CE2' HD13 ' A' ' 117' ' ' ILE . 18.7 m-85 -122.69 120.92 35.1 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 123.177 0.298 . . . . 0.0 110.336 -177.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.2 m -93.56 113.18 25.24 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 171.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 81.5 mt -137.46 156.9 33.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -175.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.41 ' H ' ' HE2' ' A' ' 114' ' ' LYS . 17.7 m -100.25 144.53 29.17 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.196 0.522 . . . . 0.0 110.326 177.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -51.8 -34.91 42.07 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 114.607 -1.179 . . . . 0.0 112.291 -175.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -71.05 -36.16 72.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.11 -177.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.451 ' CG ' ' HD2' ' A' ' 114' ' ' LYS . 7.4 m-20 -90.91 -19.25 23.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.187 -174.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.718 HG11 HG12 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -56.72 -33.57 40.9 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 CA-C-O 120.899 0.381 . . . . 0.0 110.696 -178.452 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.7 m -64.1 -27.35 42.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.38 -172.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -86.67 -29.4 22.51 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 177.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.497 HD23 ' O ' ' A' ' 104' ' ' LEU . 85.1 mt -76.02 -39.87 54.73 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.918 -178.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.485 HG21 ' HD1' ' A' ' 28' ' ' TYR . 2.7 mm -67.39 -36.34 76.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.273 0.559 . . . . 0.0 110.374 177.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 36.4 p -79.92 -21.57 43.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.335 -176.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.66 11.32 60.74 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.62 -177.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -80.06 -42.85 22.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.047 0.451 . . . . 0.0 110.968 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.497 ' O ' HD23 ' A' ' 99' ' ' LEU . 43.3 tp -96.98 120.25 36.98 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.497 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 18.3 m120 -69.31 117.52 53.21 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.767 178.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -62.22 -22.91 74.92 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.013 1.809 . . . . 0.0 110.845 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.509 ' NE2' HE22 ' A' ' 131' ' ' GLN . 92.1 mt-30 -62.11 -56.14 21.84 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.191 173.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.547 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 0.7 OUTLIER -67.12 -33.95 76.56 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -177.942 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.591 ' HB3' HD12 ' A' ' 115' ' ' ILE . . . -69.5 -32.13 70.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.002 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -61.99 -50.93 70.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.469 175.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -64.19 -39.76 94.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.921 -178.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -76.69 -8.48 57.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.09 -177.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 95.34 -4.18 66.84 Favored Glycine 0 CA--C 1.517 0.181 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.346 173.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.451 ' HD2' ' CG ' ' A' ' 95' ' ' ASP . 0.2 OUTLIER -66.72 -39.62 88.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.112 0.482 . . . . 0.0 111.107 177.45 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.705 HG23 HG22 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -107.55 131.99 56.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.302 -174.113 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -120.88 99.37 6.48 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.042 173.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.705 HG22 HG23 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -127.34 130.48 70.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.991 0.424 . . . . 0.0 111.534 -178.587 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.513 ' O ' HG12 ' A' ' 87' ' ' VAL . 45.4 tt0 -82.35 99.36 9.33 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 173.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -72.91 103.07 1.3 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.81 -0.71 . . . . 0.0 113.525 -172.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -68.18 123.55 21.02 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 171.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 65.6 mtt -54.69 -29.72 53.7 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 123.951 0.782 . . . . 0.0 112.631 -171.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -92.27 -51.11 2.45 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.259 -0.972 . . . . 0.0 112.316 177.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.556 HD11 ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -68.52 -67.12 0.49 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.094 -0.553 . . . . 0.0 112.233 -171.821 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.768 ' HA ' HD23 ' A' ' 127' ' ' LEU . . . -64.41 -24.74 67.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.976 -173.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -71.12 -31.18 67.44 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.728 178.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.402 ' O ' HD23 ' A' ' 130' ' ' LEU . 8.4 mmtm -71.13 -46.15 62.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.483 0.659 . . . . 0.0 109.247 169.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.768 HD23 ' HA ' ' A' ' 124' ' ' ALA . 0.1 OUTLIER -59.42 -43.29 93.07 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.289 -175.943 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.424 ' N ' ' HG ' ' A' ' 127' ' ' LEU . 6.8 t -76.61 -22.25 54.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.122 0.487 . . . . 0.0 110.79 -178.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -75.45 -25.5 57.51 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.396 0.617 . . . . 0.0 110.613 -178.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.402 HD23 ' O ' ' A' ' 126' ' ' LYS . 3.5 mm? -65.89 -13.37 59.54 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.41 178.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.509 HE22 ' NE2' ' A' ' 107' ' ' GLN . 10.5 pt20 -60.52 -19.6 57.58 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -175.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -61.04 -60.52 3.64 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.035 0.445 . . . . 0.0 110.216 -178.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -74.96 -20.62 59.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.704 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.4 ' HB3' ' HA ' ' A' ' 131' ' ' GLN . . . -65.18 -32.58 74.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.198 0.523 . . . . 0.0 110.303 175.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -93.25 -8.64 41.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.483 175.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 75.19 30.64 58.56 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.578 178.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 60.5 mtm180 -121.09 106.77 11.87 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.734 0.302 . . . . 0.0 110.875 -179.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 15.7 tt -84.9 -29.18 6.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.606 0.717 . . . . 0.0 109.5 175.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -100.13 132.95 45.19 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.923 -175.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 36.5 p -108.96 -31.39 7.66 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.413 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 63.7 mt . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.67 -0.681 . . . . 0.0 110.11 -179.814 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.746 0 N-CA-C 112.086 -0.406 . . . . 0.0 112.086 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.4 m -94.17 -35.1 12.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.354 0.597 . . . . 0.0 110.011 177.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.9 m -153.38 -163.38 1.66 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.474 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -54.88 149.93 19.68 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.853 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -62.49 126.88 89.13 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 121.794 0.807 . . . . 0.0 111.092 -176.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.03 -19.26 35.09 Favored 'Trans proline' 0 C--N 1.328 -0.502 0 C-N-CA 124.095 3.197 . . . . 0.0 111.922 -175.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.496 ' HA ' ' CG ' ' A' ' 26' ' ' PHE . 17.1 mt-10 -76.65 -23.86 53.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.368 -176.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -91.65 28.84 1.65 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.338 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -110.58 160.18 16.88 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.086 174.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -74.17 -35.49 64.02 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 172.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 1.048 HG12 HG11 ' A' ' 96' ' ' VAL . 0.8 OUTLIER -65.15 -20.54 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.568 -178.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.496 ' CG ' ' HA ' ' A' ' 21' ' ' GLU . 67.5 t80 -56.95 -46.59 82.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.963 0.411 . . . . 0.0 110.593 -179.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.426 ' HE2' HG23 ' A' ' 31' ' ' ILE . 0.6 OUTLIER -75.91 -44.99 37.65 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.474 177.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -63.9 -43.73 95.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.342 -175.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.458 ' CE ' HD11 ' A' ' 68' ' ' ILE . 71.9 mtp -76.59 -20.32 56.92 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.78 0.324 . . . . 0.0 110.811 -178.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -75.13 -46.67 32.88 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 175.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.426 HG23 ' HE2' ' A' ' 27' ' ' LYS . 10.8 pt -70.74 -24.53 25.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.782 175.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.0 tt -60.47 -56.03 26.38 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 171.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.56 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 11.2 tt0 -42.33 -52.95 4.37 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.169 176.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -69.64 -58.99 3.25 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.877 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.84 -38.53 72.8 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -168.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.2 mmt -59.21 -39.26 82.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.851 0.358 . . . . 0.0 111.592 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -90.62 -31.78 16.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.197 0.522 . . . . 0.0 110.698 178.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -66.57 -18.66 65.49 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.209 -174.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -55.98 145.17 26.07 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.045 177.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.7 p -47.29 -46.95 25.39 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 123.545 0.528 . . . . 0.0 111.713 -176.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -102.57 4.89 38.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.596 -176.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.467 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 4.1 p30 37.2 71.48 0.14 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 122.039 0.923 . . . . 0.0 110.89 -175.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.5 mt -64.51 0.26 1.13 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.443 -1.253 . . . . 0.0 112.103 -173.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.4 tp -61.62 -25.5 37.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.001 0.429 . . . . 0.0 110.442 177.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.512 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 17.0 pt-20 -74.26 -12.62 60.61 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.788 -178.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -86.89 -19.78 28.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.184 0.516 . . . . 0.0 110.538 178.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 47' ' ' VAL . 12.5 p -130.49 31.98 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.2 -173.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.512 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 58.4 mtm180 -54.99 116.63 2.87 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.971 0.891 . . . . 0.0 111.751 -176.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.403 ' HA3' HD21 ' A' ' 123' ' ' LEU . . . -178.54 173.03 45.45 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 114.055 -1.429 . . . . 0.0 111.193 -176.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.485 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 60.0 mt -105.04 129.47 57.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-O 120.971 0.415 . . . . 0.0 111.01 -178.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.464 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 5.4 m-85 -111.83 125.28 53.84 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.823 -178.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 88' ' ' THR . . . -104.06 121.55 7.06 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.421 -0.895 . . . . 0.0 111.408 176.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -107.31 109.38 21.13 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.135 0.493 . . . . 0.0 111.487 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -97.66 99.73 11.1 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.179 176.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.739 HG11 HG11 ' A' ' 25' ' ' VAL . 12.2 t -105.59 122.42 59.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.202 -171.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -107.21 -179.44 3.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.869 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.408 ' HB2' ' HB3' ' A' ' 92' ' ' SER . 4.5 m-20 61.92 47.81 5.71 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.137 0.494 . . . . 0.0 111.586 177.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.28 -167.06 20.36 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.699 177.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -40.66 -60.88 0.53 Allowed 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 124.126 3.218 . . . . 0.0 113.558 -176.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -108.93 42.2 1.46 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.091 0.472 . . . . 0.0 109.986 177.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 74.99 19.56 79.88 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.476 -176.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.23 171.47 8.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.973 0.416 . . . . 0.0 111.279 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -131.25 135.32 47.24 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.697 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -124.3 153.68 17.65 Favored Glycine 0 N--CA 1.443 -0.876 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -141.22 119.35 12.04 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.791 0.329 . . . . 0.0 110.622 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 14.8 m-90 -122.49 144.92 48.77 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 40.1 t -110.46 115.1 48.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.052 177.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.464 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 4.0 mp -89.21 99.17 8.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 176.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -90.66 98.7 11.93 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.447 0.641 . . . . 0.0 109.999 -176.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -110.91 15.64 21.68 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.604 175.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.438 ' HB2' ' CG1' ' A' ' 50' ' ' ILE . 34.2 tttm -56.28 -50.21 72.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.752 -177.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -86.01 0.14 54.08 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.676 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 94.21 12.04 56.71 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.641 -0.708 . . . . 0.0 112.437 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -76.36 -63.49 1.32 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.483 0.182 . . . . 0.0 111.237 -178.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.82 34.2 7.43 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 119.967 -1.111 . . . . 0.0 112.068 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.56 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 15.3 pttm -98.1 143.27 28.81 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.259 -0.275 . . . . 0.0 110.259 -178.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.8 OUTLIER -110.04 131.84 59.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.359 0.6 . . . . 0.0 109.832 178.717 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.6 t -131.21 133.54 45.6 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.49 -176.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -68.7 119.85 13.76 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -178.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 53.6 70.35 0.61 Allowed 'General case' 0 C--N 1.331 -0.199 0 O-C-N 123.79 0.681 . . . . 0.0 109.901 -175.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.1 -34.57 90.1 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.381 -0.827 . . . . 0.0 113.737 -173.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.14 -14.98 56.14 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.976 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.401 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 55.1 mm-40 -73.33 165.73 24.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.809 0.338 . . . . 0.0 110.369 177.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.486 ' HD2' ' N ' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -100.14 106.82 44.02 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.15 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.485 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 16.2 Cg_exo -68.92 139.76 44.07 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.695 2.263 . . . . 0.0 113.018 -177.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.456 ' HB3' ' HG ' ' A' ' 123' ' ' LEU . 31.0 m-20 -67.2 -31.2 71.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.566 173.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.636 HG12 ' HA3' ' A' ' 119' ' ' GLY . 4.6 m -139.78 149.26 22.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.516 172.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.616 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 54.8 m -135.3 128.33 31.6 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 175.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.632 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 61.4 m-85 -113.41 125.16 53.94 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.852 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.473 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 4.6 m -98.48 121.33 40.28 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 173.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.608 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -155.39 154.6 6.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 O-C-N 123.551 0.532 . . . . 0.0 109.618 -175.184 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.472 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 3.8 m -91.56 137.82 32.06 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.56 -178.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.533 ' OD1' HG13 ' A' ' 25' ' ' VAL . 27.7 t70 -43.28 -49.68 6.69 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.376 0.67 . . . . 0.0 111.495 -176.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -49.95 -38.79 38.1 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.067 -1.424 . . . . 0.0 111.772 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.472 ' OD2' ' HB2' ' A' ' 92' ' ' SER . 13.6 m-20 -91.02 -21.18 21.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.413 -175.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 1.048 HG11 HG12 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -60.88 -31.27 49.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 121.134 0.493 . . . . 0.0 110.447 -175.577 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.6 m -67.1 -28.7 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.088 -171.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -81.69 -35.26 30.04 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 176.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.44 HD23 ' O ' ' A' ' 104' ' ' LEU . 85.3 mt -66.07 -49.44 67.59 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.812 -178.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 96' ' ' VAL . 21.4 mt -70.03 -23.86 25.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.057 -176.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.1 t -91.55 -9.75 43.15 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.998 0.428 . . . . 0.0 110.972 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.97 17.57 69.6 Favored Glycine 0 C--N 1.329 0.182 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.257 -179.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -85.69 -41.58 15.03 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.05 0.452 . . . . 0.0 110.63 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.44 ' O ' HD23 ' A' ' 99' ' ' LEU . 38.9 tp -103.32 123.22 46.38 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.478 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.493 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 6.2 m-20 -69.09 120.75 78.59 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.548 177.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -65.41 -22.5 59.47 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.083 1.856 . . . . 0.0 111.241 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.49 -54.91 25.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.595 176.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.556 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 0.8 OUTLIER -67.4 -34.89 78.19 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.971 179.283 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.59 ' HB3' HD12 ' A' ' 115' ' ' ILE . . . -64.92 -34.34 78.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.178 178.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -61.58 -52.39 64.63 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 175.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -59.72 -39.68 85.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.546 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.468 ' HA ' ' OE1' ' A' ' 112' ' ' GLN . 13.4 mm-40 -85.05 17.08 3.08 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -174.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.42 12.12 76.73 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 121.105 -0.569 . . . . 0.0 113.563 173.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -87.47 -47.41 8.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.877 0.37 . . . . 0.0 110.71 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.626 HG23 HG22 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -96.03 121.4 46.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.994 -177.348 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.473 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 31.2 mmtp -116.52 99.06 6.9 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.877 173.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.632 ' HB ' ' CD2' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -115.96 128.85 73.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.356 0.598 . . . . 0.0 110.665 -178.659 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -134.03 81.28 1.91 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -174.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.636 ' HA3' HG12 ' A' ' 87' ' ' VAL . . . -161.51 171.94 37.6 Favored Glycine 0 N--CA 1.439 -1.148 0 C-N-CA 119.936 -1.125 . . . . 0.0 113.515 -170.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -49.23 123.9 8.14 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.339 0.67 . . . . 0.0 111.147 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.44 -45.25 88.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.655 -175.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.19 -32.02 79.01 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.521 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.456 ' HG ' ' HB3' ' A' ' 86' ' ' ASP . 1.2 tm? -60.97 -48.94 79.52 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.026 -0.587 . . . . 0.0 110.437 178.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.491 ' HB2' HG11 ' A' ' 87' ' ' VAL . . . -82.67 -23.94 33.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.635 -176.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 51.8 mmm -57.4 -36.2 70.99 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 120.758 0.314 . . . . 0.0 111.238 177.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.418 ' HA ' ' HB3' ' A' ' 129' ' ' ASP . 14.3 mttp -70.62 -18.71 62.87 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.52 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 68.3 mt -73.9 -45.39 51.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.893 0.378 . . . . 0.0 110.229 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.457 ' O ' ' HG3' ' A' ' 132' ' ' ARG . 15.0 t -78.11 -26.16 47.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.986 0.422 . . . . 0.0 109.956 178.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.418 ' HB3' ' HA ' ' A' ' 126' ' ' LYS . 32.1 t70 -64.23 -39.48 94.05 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.3 175.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.18 -45.41 79.77 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.941 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -76.61 -20.36 56.84 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.199 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 128' ' ' THR . 77.6 mtp180 -70.58 -51.01 31.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.804 0.335 . . . . 0.0 110.306 175.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -67.92 -22.04 65.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.227 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.21 -22.87 66.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.967 177.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -85.32 -17.81 35.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.22 0.533 . . . . 0.0 110.48 177.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 68.8 33.59 75.8 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 115.285 -0.87 . . . . 0.0 113.335 175.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 137' ' ' ARG . 49.5 mtt180 -127.64 135.82 50.77 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.954 0.377 . . . . 0.0 110.565 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.582 HG13 ' H ' ' A' ' 139' ' ' GLU . 5.5 tp -144.83 -171.43 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -178.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.582 ' H ' HG13 ' A' ' 138' ' ' ILE . 35.0 tt0 -32.47 123.62 0.33 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.545 0.738 . . . . 0.0 112.453 174.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 38.1 m -136.9 93.35 2.84 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.083 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 58.1 mt . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.457 -0.782 . . . . 0.0 110.16 -178.528 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.619 0 N-CA-C 112.053 -0.419 . . . . 0.0 112.053 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.8 m -93.37 86.35 5.25 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.178 0.513 . . . . 0.0 110.908 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.8 m -74.95 101.42 4.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.844 175.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.4 166.04 54.1 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 121.026 -0.606 . . . . 0.0 112.343 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.414 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 6.8 p30 -62.76 152.44 82.14 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-O 121.237 0.542 . . . . 0.0 110.801 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.465 ' HA ' ' CD1' ' A' ' 23' ' ' PHE . 4.9 Cg_exo -70.06 -17.56 36.13 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.695 2.263 . . . . 0.0 111.156 -177.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.467 ' HA ' ' CG ' ' A' ' 26' ' ' PHE . 13.3 mt-10 -74.09 -24.03 59.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.503 -178.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -74.67 -22.16 59.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.635 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.465 ' CD1' ' HA ' ' A' ' 20' ' ' PRO . 35.5 m-85 -65.64 145.53 55.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.667 177.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -74.77 -26.34 59.69 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.757 HG12 HG11 ' A' ' 96' ' ' VAL . 0.9 OUTLIER -68.85 -21.69 25.92 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.71 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.585 177.902 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.467 ' CG ' ' HA ' ' A' ' 21' ' ' GLU . 79.2 t80 -56.78 -47.5 80.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.774 0.321 . . . . 0.0 110.361 -178.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.85 -34.88 77.57 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.727 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.47 ' O ' HG12 ' A' ' 31' ' ' ILE . 37.4 m-85 -71.8 -53.5 13.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.756 0.312 . . . . 0.0 111.101 178.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.603 ' HB3' HG21 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -58.61 -32.8 69.35 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.104 176.939 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.2 mmtt -66.58 -41.78 88.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.601 177.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.47 HG12 ' O ' ' A' ' 28' ' ' TYR . 16.8 pt -78.09 -26.41 14.47 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 C-N-CA 120.294 -0.562 . . . . 0.0 109.865 177.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.6 tt -59.35 -47.94 83.5 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 173.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.54 ' HG2' ' HA ' ' A' ' 76' ' ' LYS . 0.8 OUTLIER -44.57 -50.9 9.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.522 176.021 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -78.64 -55.29 5.3 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.58 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.48 -40.21 74.53 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -167.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.4 mmt -61.29 -41.28 96.7 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -177.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -90.92 -16.82 27.47 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.582 177.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -71.27 -25.09 62.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.996 -176.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -52.85 135.22 36.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.212 0.53 . . . . 0.0 110.117 176.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 18.2 p -57.89 -29.24 64.9 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.621 -174.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -100.32 -5.3 27.6 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 122.467 0.307 . . . . 0.0 111.232 177.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.493 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 4.1 p-10 38.82 64.27 0.8 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.843 0.83 . . . . 0.0 111.294 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.4 mt -58.64 -11.32 2.94 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.137 -175.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.2 tp -57.35 -25.81 24.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.065 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.493 ' HG2' ' O ' ' A' ' 42' ' ' ASN . 3.7 pt-20 -60.03 -33.19 71.69 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.789 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -82.7 -18.84 39.47 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.865 0.364 . . . . 0.0 111.573 -173.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 47' ' ' VAL . 11.3 p -124.99 31.9 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 122.074 0.94 . . . . 0.0 109.813 -176.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 37.2 mtm180 -57.45 110.33 0.85 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.845 0.831 . . . . 0.0 112.118 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.554 ' HA3' HD11 ' A' ' 123' ' ' LEU . . . -165.78 170.91 40.79 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 114.086 -1.415 . . . . 0.0 110.701 -178.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.447 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 53.2 mt -105.27 126.64 60.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 117.717 0.758 . . . . 0.0 111.136 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.5 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 25.7 m-85 -107.92 117.59 34.51 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.994 -178.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.91 106.59 3.37 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.262 -0.971 . . . . 0.0 111.231 177.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -95.21 105.62 17.57 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.253 0.549 . . . . 0.0 111.261 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -91.31 99.79 12.7 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.383 176.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.735 HG11 HG11 ' A' ' 25' ' ' VAL . 7.6 t -99.84 127.47 52.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.911 -172.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 -112.74 -178.14 3.32 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.792 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 62.67 47.47 4.76 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.13 0.49 . . . . 0.0 111.124 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.39 -169.48 32.45 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.577 177.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -37.69 -61.07 0.37 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.546 3.498 . . . . 0.0 114.217 -174.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -125.05 61.12 1.19 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.86 16.09 74.31 Favored Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.53 -177.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.53 168.8 18.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.028 0.442 . . . . 0.0 110.749 -178.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -136.73 136.2 38.77 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.915 -176.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -120.19 162.46 14.22 Favored Glycine 0 N--CA 1.442 -0.94 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.387 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -150.26 115.18 5.32 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.712 0.291 . . . . 0.0 110.243 -178.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 26.1 m-90 -118.97 126.1 50.96 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.2 0.524 . . . . 0.0 110.279 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 51.3 t -94.4 110.4 23.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.743 177.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.5 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 4.4 mp -88.91 99.24 8.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -83.11 105.6 14.23 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.5 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -111.47 5.23 19.44 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 173.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.411 ' HE3' ' HA2' ' A' ' 49' ' ' GLY . 4.4 tppp? -64.67 -36.7 85.13 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.957 -176.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -77.4 -30.3 53.54 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.624 0.726 . . . . 0.0 109.9 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 111.82 10.11 19.45 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.344 -176.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.459 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 9.5 mmpt? -88.01 -49.72 6.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.56 -0.32 . . . . 0.0 111.397 -178.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.01 34.39 15.11 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.16 -1.019 . . . . 0.0 111.793 -177.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.54 ' HA ' ' HG2' ' A' ' 33' ' ' GLU . 14.2 pttm -96.82 145.15 26.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.545 0.212 . . . . 0.0 110.783 -172.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.603 HG21 ' HB3' ' A' ' 29' ' ' MET . 0.7 OUTLIER -107.41 138.18 34.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.069 0.461 . . . . 0.0 109.764 178.035 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.6 t -133.64 133.9 42.51 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.135 177.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -71.17 118.24 13.7 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.821 -179.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 55.96 61.48 2.76 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 123.918 0.762 . . . . 0.0 109.683 -175.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -61.31 -40.64 98.9 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.344 -0.844 . . . . 0.0 113.442 -175.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.12 -21.07 32.99 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.947 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.569 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 65.2 mm-40 -64.89 149.23 49.95 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 175.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.463 ' HD3' ' N ' ' A' ' 84' ' ' LYS . 3.7 mppt? -79.56 108.71 9.44 Favored Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.569 ' HD3' ' O ' ' A' ' 83' ' ' GLU . 16.5 Cg_exo -68.76 130.69 21.07 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.61 2.207 . . . . 0.0 112.164 179.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.525 ' HB2' HD22 ' A' ' 123' ' ' LEU . 5.1 m-20 -62.61 -38.2 89.25 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.57 174.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.772 HG12 ' HA3' ' A' ' 119' ' ' GLY . 3.6 m -136.95 134.29 48.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.592 174.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.602 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 30.8 m -113.53 137.19 51.92 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.217 177.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.652 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 41.0 m-85 -123.83 127.0 47.42 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.492 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 6.7 m -100.69 126.52 47.21 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 174.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.625 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -158.37 151.45 7.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.039 0.447 . . . . 0.0 110.536 -175.565 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.2 m -85.36 143.22 28.77 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.202 0.525 . . . . 0.0 110.977 -177.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.416 ' OD1' HG13 ' A' ' 25' ' ' VAL . 13.5 t70 -49.28 -33.75 13.75 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.625 -1.17 . . . . 0.0 112.121 -178.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -75.5 -32.46 60.55 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.899 -174.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -91.55 -21.27 20.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.904 -177.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.757 HG11 HG12 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -56.74 -33.19 40.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.101 0.477 . . . . 0.0 110.21 -177.855 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.3 m -68.07 -33.75 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.853 -173.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -77.47 -32.35 54.32 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.1 mt -69.39 -49.98 50.29 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.738 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 96' ' ' VAL . 28.3 mt -72.38 -30.38 34.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.577 -176.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 39.7 t -86.03 -4.8 59.25 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.671 0.249 . . . . 0.0 111.671 -178.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.03 43.53 16.67 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.301 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -116.03 -43.19 3.0 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.036 0.446 . . . . 0.0 110.898 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.4 tp -97.95 129.56 44.85 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.507 -179.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.522 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 11.6 m120 -73.63 119.68 77.26 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.054 176.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -66.2 -20.26 56.17 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 121.942 1.762 . . . . 0.0 110.196 176.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -60.83 -57.42 12.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.534 173.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.522 ' HG2' ' HB2' ' A' ' 105' ' ' ASN . 0.2 OUTLIER -70.35 -31.4 68.66 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.901 -178.834 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.643 ' HB3' HD12 ' A' ' 115' ' ' ILE . . . -68.22 -35.59 78.2 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.618 -0.433 . . . . 0.0 109.986 178.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -64.98 -45.88 83.8 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 174.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -63.73 -41.03 98.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.347 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -80.12 7.06 9.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.919 -178.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.23 5.33 89.75 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.94 -0.647 . . . . 0.0 113.605 173.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp -78.91 -48.86 13.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.937 0.398 . . . . 0.0 111.07 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.643 HD12 ' HB3' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -87.72 118.24 33.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.539 -179.257 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.492 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 74.7 mmtt -114.73 98.77 7.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.659 174.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.652 ' HB ' ' CD2' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -114.72 131.29 67.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.264 0.554 . . . . 0.0 110.361 178.735 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.567 ' HA ' HE21 ' A' ' 118' ' ' GLN . 0.0 OUTLIER -144.5 91.79 2.22 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -177.317 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.772 ' HA3' HG12 ' A' ' 87' ' ' VAL . . . -160.82 172.28 37.1 Favored Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 119.944 -1.122 . . . . 0.0 113.75 -169.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -48.43 113.32 0.73 Allowed 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.792 0.837 . . . . 0.0 110.978 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 24.7 ptm -60.07 -33.13 71.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.649 -178.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -70.78 -23.35 77.95 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.43 -176.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.554 HD11 ' HA3' ' A' ' 49' ' ' GLY . 1.4 tp -88.17 -46.81 8.96 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.979 0.418 . . . . 0.0 110.478 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.581 ' HB2' HG11 ' A' ' 87' ' ' VAL . . . -70.8 -23.02 62.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.166 -177.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 46.0 mtt -66.02 -28.98 69.28 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.066 173.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.606 ' HA ' ' HB3' ' A' ' 129' ' ' ASP . 9.5 mmtm -66.41 -26.53 67.28 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.45 176.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.0 mt -62.01 -38.41 88.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.532 177.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.661 ' O ' ' HG2' ' A' ' 132' ' ' ARG . 12.9 t -90.44 -25.49 20.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.073 0.463 . . . . 0.0 110.397 177.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.606 ' HB3' ' HA ' ' A' ' 126' ' ' LYS . 35.3 t70 -60.63 -49.95 75.46 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.781 177.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.96 -34.37 74.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.144 -177.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.589 ' HG2' ' O ' ' A' ' 128' ' ' THR . 4.5 pt20 -74.57 -28.12 60.79 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.496 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.661 ' HG2' ' O ' ' A' ' 128' ' ' THR . 24.1 mmt180 -70.94 -40.24 72.18 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 173.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.537 ' HG2' ' O ' ' A' ' 129' ' ' ASP . 34.4 mm-40 -62.12 -41.52 98.32 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.976 174.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.12 -43.63 95.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.097 178.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.97 -34.39 73.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.854 179.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.22 -30.73 8.97 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.036 177.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -107.88 125.54 51.59 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 179.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 7.6 tp -175.37 -43.64 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.859 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -87.32 150.05 24.11 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.43 -173.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 22.8 t -75.11 145.28 42.37 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.85 -176.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 55.1 mt . . . . . 0 C--O 1.247 0.965 0 O-C-N 123.896 0.747 . . . . 0.0 110.574 -178.223 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.794 0 N-CA-C 111.761 -0.536 . . . . 0.0 111.761 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.1 p -72.1 -41.73 66.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.05 0.452 . . . . 0.0 110.752 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.8 m -85.23 171.21 12.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.474 178.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -96.14 166.89 24.78 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.873 -0.679 . . . . 0.0 111.744 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.413 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 58.1 m-20 -70.66 143.58 89.99 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-O 120.903 0.382 . . . . 0.0 110.192 -178.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' A' ' 26' ' ' PHE . 21.5 Cg_exo -61.47 -34.57 85.73 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 123.184 2.589 . . . . 0.0 111.606 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.441 ' HA ' ' CG ' ' A' ' 26' ' ' PHE . 25.8 tt0 -65.53 -35.55 81.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.519 179.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -75.45 -4.41 39.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.564 -175.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -85.53 145.05 27.57 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 171.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -73.04 -20.29 61.02 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.975 HG12 HG11 ' A' ' 96' ' ' VAL . 1.0 OUTLIER -73.29 -16.01 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.152 179.126 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.441 ' CG ' ' HA ' ' A' ' 21' ' ' GLU . 80.2 t80 -58.02 -52.32 66.01 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.883 0.373 . . . . 0.0 110.455 -178.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -42.98 90.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.278 178.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.471 ' O ' HG12 ' A' ' 31' ' ' ILE . 19.4 m-85 -64.73 -47.75 77.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.165 -0.471 . . . . 0.0 112.097 -177.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.552 ' HB3' HG21 ' A' ' 77' ' ' VAL . 58.6 mtt -71.68 -26.21 62.43 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 122.208 -0.307 . . . . 0.0 111.019 -179.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 26' ' ' PHE . 7.8 mmtt -72.07 -35.37 69.24 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.445 175.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.471 HG12 ' O ' ' A' ' 28' ' ' TYR . 14.7 pt -78.93 -21.35 12.79 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.481 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.662 174.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.7 tt -67.17 -48.84 66.78 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 171.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -44.19 -38.59 3.83 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.086 173.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -83.53 -55.6 4.2 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.242 175.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.451 ' HA ' ' HB3' ' A' ' 38' ' ' ASN . . . -55.51 -42.25 74.23 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -167.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 24.0 mmt -56.65 -43.29 80.18 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -178.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -91.68 -25.84 18.92 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.242 179.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.451 ' HB3' ' HA ' ' A' ' 35' ' ' ALA . 3.4 t-20 -65.92 -28.33 68.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.04 178.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -52.93 133.54 37.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.689 174.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 23.6 p -59.82 -27.49 66.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.206 -173.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -96.67 -21.29 17.7 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.513 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 35.69 62.48 0.62 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.867 0.841 . . . . 0.0 110.837 -174.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.411 HD22 ' HD3' ' A' ' 46' ' ' LYS . 80.6 mt -72.03 2.79 5.14 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.744 -1.117 . . . . 0.0 111.761 -174.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.414 HG13 ' HB1' ' A' ' 70' ' ' ALA . 3.0 tp -56.01 -27.18 22.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.108 0.48 . . . . 0.0 110.858 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.513 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 49.9 mt-10 -76.08 -13.24 60.21 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.719 -176.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.411 ' HD3' HD22 ' A' ' 43' ' ' LEU . 60.5 mtpt -85.93 -17.02 36.61 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.003 0.43 . . . . 0.0 111.04 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 47' ' ' VAL . 14.0 p -130.69 33.2 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.924 0.869 . . . . 0.0 109.804 -177.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.513 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 23.1 mtm180 -52.14 118.07 3.24 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.971 0.891 . . . . 0.0 112.279 -175.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.579 ' HA3' HD11 ' A' ' 123' ' ' LEU . . . -170.13 -174.87 38.62 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 113.8 -1.545 . . . . 0.0 109.751 -178.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.483 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 43.9 mt -121.74 124.84 72.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-N 118.214 1.007 . . . . 0.0 111.545 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.559 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 2.6 m-85 -107.42 109.49 21.22 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.781 -176.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.74 113.41 4.35 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.391 -0.909 . . . . 0.0 111.065 177.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -97.4 111.58 23.78 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.264 0.554 . . . . 0.0 111.647 -178.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -93.76 101.17 13.28 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.439 175.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.716 HG11 HG11 ' A' ' 25' ' ' VAL . 14.2 t -99.17 127.14 52.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.684 -175.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 30.2 mtp180 -118.55 -174.1 2.61 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.422 -177.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 61.74 39.93 13.58 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 123.449 0.468 . . . . 0.0 111.195 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.81 -164.47 26.78 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.095 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -39.12 -60.32 0.52 Allowed 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 124.342 3.361 . . . . 0.0 114.062 -176.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -109.88 41.9 1.62 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.065 0.459 . . . . 0.0 110.093 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.21 24.3 76.71 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -170.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.48 162.09 29.66 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 114.708 -0.746 . . . . 0.0 111.471 -175.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -124.89 140.74 52.65 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.877 -178.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -127.95 163.48 21.57 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.936 179.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -143.11 121.03 12.0 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 117.217 0.509 . . . . 0.0 111.375 -177.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 24.2 m-90 -125.96 134.29 51.56 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.924 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 40.3 t -99.78 114.4 37.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.247 178.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.66 HG13 HG12 ' A' ' 77' ' ' VAL . 4.1 mp -89.95 100.82 11.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 174.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -84.54 97.31 9.5 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.214 -176.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.414 ' HB1' HG13 ' A' ' 44' ' ' ILE . . . -95.26 -12.13 26.76 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.219 174.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.476 ' HD2' ' HG3' ' A' ' 72' ' ' GLU . 1.6 tmmt? -58.2 -40.85 82.66 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.273 -177.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.476 ' HG3' ' HD2' ' A' ' 71' ' ' LYS . 51.7 mt-10 -91.72 12.15 22.2 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.337 0.589 . . . . 0.0 111.313 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 76.46 11.14 85.37 Favored Glycine 0 C--O 1.228 -0.228 0 CA-C-N 115.402 -0.817 . . . . 0.0 113.394 173.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -91.58 -45.05 8.71 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 122.717 -0.284 . . . . 0.0 111.174 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.97 33.82 62.37 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -176.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 19.8 ptmt -98.35 154.68 17.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.365 -0.418 . . . . 0.0 109.948 -175.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.66 HG12 HG13 ' A' ' 68' ' ' ILE . 0.7 OUTLIER -107.77 137.36 39.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 178.733 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.5 t -140.53 134.18 30.24 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.113 178.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -66.6 116.43 7.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.669 -175.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 65.0 t30 51.17 68.29 0.81 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 123.9 0.75 . . . . 0.0 110.161 -176.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -56.82 -34.59 65.33 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.106 -0.952 . . . . 0.0 113.936 -172.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.47 -16.9 60.34 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -176.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.463 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 16.9 mm-40 -75.62 155.11 36.21 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 175.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -90.88 108.9 31.13 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-O 120.771 0.32 . . . . 0.0 110.194 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.483 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 20.1 Cg_exo -65.78 125.73 14.79 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.925 2.417 . . . . 0.0 112.879 -178.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.549 ' HB2' HD22 ' A' ' 123' ' ' LEU . 13.9 m-20 -65.57 -34.47 78.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.129 -0.942 . . . . 0.0 109.746 174.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.752 HG12 ' HA3' ' A' ' 119' ' ' GLY . 3.6 m -135.57 139.04 47.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.503 175.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.579 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 19.0 m -118.14 135.63 54.1 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.598 ' CD2' ' HB ' ' A' ' 117' ' ' ILE . 72.6 m-85 -122.58 125.02 44.84 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.585 ' HB ' ' HB3' ' A' ' 116' ' ' LYS . 35.8 m -101.77 114.2 28.06 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 177.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.594 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 73.1 mt -137.87 148.12 25.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.554 -174.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.0 m -85.34 139.25 31.73 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.087 0.47 . . . . 0.0 110.425 176.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.53 ' OD1' HG13 ' A' ' 25' ' ' VAL . 20.9 t70 -47.18 -34.26 6.11 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 114.504 -1.225 . . . . 0.0 112.427 -178.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -70.92 -41.74 70.81 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.103 -173.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -91.28 -18.6 24.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.591 -175.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.975 HG11 HG12 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -54.77 -31.55 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 121.121 0.486 . . . . 0.0 110.124 -179.801 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.0 m -67.05 -35.13 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.023 -173.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -77.08 -33.64 57.04 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.415 HD12 HG21 ' A' ' 91' ' ' ILE . 92.5 mt -69.08 -48.09 63.56 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.403 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 96' ' ' VAL . 32.0 mt -66.19 -36.68 77.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.125 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.2 t -75.82 -30.3 58.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.817 0.342 . . . . 0.0 111.2 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 102.8 10.56 37.24 Favored Glycine 0 N--CA 1.453 -0.167 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.876 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -81.11 -40.32 24.24 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.23 0.538 . . . . 0.0 111.0 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.728 HD11 ' NZ ' ' A' ' 108' ' ' LYS . 52.4 tp -101.08 133.78 45.08 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.339 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.418 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 12.7 m120 -79.34 124.69 84.07 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.292 177.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -64.91 -24.86 60.27 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.124 1.882 . . . . 0.0 110.459 176.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -61.37 -60.18 4.12 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.627 173.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.728 ' NZ ' HD11 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -62.78 -35.11 78.78 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.124 0.487 . . . . 0.0 110.021 -177.763 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.561 ' HB3' HD12 ' A' ' 115' ' ' ILE . . . -70.93 -33.13 70.21 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.025 -177.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -61.27 -48.61 80.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.312 174.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -60.83 -44.01 97.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.943 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.407 ' HG3' ' HE3' ' A' ' 108' ' ' LYS . 74.8 mm-40 -74.39 -12.56 60.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.178 -176.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.77 18.25 45.09 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.158 175.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.35 -24.64 17.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.862 0.363 . . . . 0.0 110.868 176.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.582 HG23 HG22 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -109.79 111.11 34.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.807 0.813 . . . . 0.0 110.144 178.086 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.585 ' HB3' ' HB ' ' A' ' 90' ' ' THR . 13.8 tppt? -110.05 107.5 17.39 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.093 174.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.598 ' HB ' ' CD2' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -126.5 133.85 67.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.257 0.551 . . . . 0.0 110.184 -177.806 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 29.5 tp60 -143.57 92.27 2.34 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -176.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.752 ' HA3' HG12 ' A' ' 87' ' ' VAL . . . -160.37 171.97 36.7 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.092 -1.052 . . . . 0.0 113.258 -170.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -49.11 118.3 2.58 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 124.362 0.683 . . . . 0.0 111.236 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.472 ' O ' ' HB3' ' A' ' 125' ' ' MET . 24.6 ttt -60.31 -35.56 75.9 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.541 -177.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.478 ' HA2' ' SD ' ' A' ' 125' ' ' MET . . . -69.28 -17.62 72.42 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.829 -0.7 . . . . 0.0 111.908 -174.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.579 HD11 ' HA3' ' A' ' 49' ' ' GLY . 2.9 tp -90.79 -58.54 2.45 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.389 0.614 . . . . 0.0 110.073 178.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.649 ' HA ' HD23 ' A' ' 127' ' ' LEU . . . -68.75 -14.59 63.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.25 -175.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.478 ' SD ' ' HA2' ' A' ' 122' ' ' GLY . 25.0 ptm -65.63 -20.85 66.47 Favored 'General case' 0 C--N 1.332 -0.177 0 O-C-N 122.276 -0.265 . . . . 0.0 110.57 177.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -79.68 -30.29 41.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.404 0.621 . . . . 0.0 109.334 176.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.649 HD23 ' HA ' ' A' ' 124' ' ' ALA . 0.7 OUTLIER -62.86 -44.62 95.64 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 172.435 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.595 ' O ' ' HG2' ' A' ' 131' ' ' GLN . 6.4 m -61.95 -41.94 98.55 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 113.81 -1.541 . . . . 0.0 111.599 173.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.674 ' O ' ' HG2' ' A' ' 132' ' ' ARG . 25.9 t70 -53.89 -35.73 61.91 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.138 0.575 . . . . 0.0 111.738 -177.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.5 mt -58.83 -17.2 21.59 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -176.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.595 ' HG2' ' O ' ' A' ' 128' ' ' THR . 10.9 pt20 -63.36 -30.82 71.89 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -177.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.674 ' HG2' ' O ' ' A' ' 129' ' ' ASP . 15.3 ptt180 -65.48 -33.36 75.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.272 0.558 . . . . 0.0 110.055 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -79.86 -38.05 33.58 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.95 177.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.91 -46.54 68.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.993 -177.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -88.11 -25.83 22.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.914 0.387 . . . . 0.0 111.516 -177.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.35 6.51 83.9 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.226 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -101.06 126.71 47.76 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.941 0.401 . . . . 0.0 110.097 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.9 mp -101.46 -67.22 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.133 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -102.17 163.72 12.08 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.658 -176.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 6.9 t -146.41 53.96 1.13 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.246 0.546 . . . . 0.0 109.69 177.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 6.8 pt . . . . . 0 C--O 1.25 1.094 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.727 -178.813 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.823 0 N-CA-C 111.947 -0.461 . . . . 0.0 111.947 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.0 t -74.79 111.84 10.4 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.816 0.341 . . . . 0.0 110.673 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.9 m -67.05 136.71 55.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.275 177.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.414 ' H ' ' HB2' ' A' ' 62' ' ' ALA . . . -67.32 125.48 24.05 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.423 178.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.401 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 43.1 m-80 -72.28 148.29 90.96 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 120.866 0.365 . . . . 0.0 110.229 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.507 ' HA ' ' CD1' ' A' ' 23' ' ' PHE . 14.2 Cg_exo -64.46 -28.88 62.29 Favored 'Trans proline' 0 CA--C 1.518 -0.317 0 C-N-CA 123.276 2.651 . . . . 0.0 111.802 -177.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -65.9 -35.22 80.02 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.261 177.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -73.38 -14.62 61.31 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.562 -178.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.507 ' CD1' ' HA ' ' A' ' 20' ' ' PRO . 23.5 m-85 -66.25 148.76 51.36 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.404 0.621 . . . . 0.0 110.378 176.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -74.06 -26.36 60.35 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 176.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.857 HG12 HG11 ' A' ' 96' ' ' VAL . 0.8 OUTLIER -73.9 -15.51 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.97 -179.009 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -56.74 -50.04 73.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.768 0.318 . . . . 0.0 110.307 -177.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.452 ' HE2' HG23 ' A' ' 31' ' ' ILE . 1.1 tpmt? -72.7 -38.23 67.6 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.863 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -64.72 -50.91 65.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.569 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.584 ' HB3' HG21 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -62.9 -31.53 72.6 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.834 0.349 . . . . 0.0 110.928 177.289 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.423 ' HD2' ' HA ' ' A' ' 30' ' ' LYS . 21.6 mmmt -70.76 -37.81 73.43 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 178.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.452 HG23 ' HE2' ' A' ' 27' ' ' LYS . 10.5 pt -84.13 -19.69 9.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.133 176.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.6 tt -60.58 -46.85 88.69 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 171.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -46.85 -48.48 20.97 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.777 175.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -73.96 -50.41 20.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.706 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.89 -36.88 80.38 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -169.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 33.1 mmt -59.63 -44.11 93.58 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.587 0.217 . . . . 0.0 111.587 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -91.4 -8.36 48.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.19 0.519 . . . . 0.0 110.723 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -73.69 -23.36 59.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.037 0.446 . . . . 0.0 109.984 178.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -59.14 132.16 53.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.772 175.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 13.9 p -57.44 -37.42 72.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.562 -173.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.542 ' C ' HD22 ' A' ' 42' ' ' ASN . 46.1 mt-10 -101.57 9.95 40.73 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 119.306 -0.378 . . . . 0.0 110.96 178.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.545 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 0.1 OUTLIER 25.52 70.37 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.114 0.965 . . . . 0.0 111.275 -173.59 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.7 mt -58.4 -4.45 0.39 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 114.414 -1.267 . . . . 0.0 111.921 -176.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.55 HG13 ' HB1' ' A' ' 70' ' ' ALA . 4.2 tp -60.75 -25.42 35.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.663 178.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 42' ' ' ASN . 10.9 pt-20 -76.51 -16.7 59.57 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.237 -179.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -95.53 -13.24 24.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.263 0.554 . . . . 0.0 110.731 -177.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 47' ' ' VAL . 11.9 p -130.43 32.24 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.845 0.831 . . . . 0.0 109.562 -177.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 55.6 mtt180 -52.49 117.11 2.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.397 -175.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.564 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . -167.16 164.76 38.12 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.221 -178.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.524 HG13 ' HB2' ' A' ' 71' ' ' LYS . 63.8 mt -103.13 124.93 57.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 117.217 0.509 . . . . 0.0 109.988 176.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.512 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 37.3 m-85 -105.72 115.66 30.62 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.203 -176.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.97 111.35 4.23 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.396 -0.907 . . . . 0.0 110.835 177.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.445 ' O ' ' HA ' ' A' ' 65' ' ' TYR . 7.5 m-85 -98.18 108.37 21.06 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.024 0.44 . . . . 0.0 111.594 -178.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -95.71 99.69 11.5 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.638 175.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.725 HG11 HG11 ' A' ' 25' ' ' VAL . 17.4 t -98.12 119.78 46.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.782 -174.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -108.89 179.07 4.28 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.123 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.458 ' HB2' ' HB3' ' A' ' 92' ' ' SER . 3.3 m-20 60.23 42.23 15.53 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.93 0.395 . . . . 0.0 111.125 177.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.11 -166.59 28.93 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.572 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -31.5 -60.49 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 124.946 3.764 . . . . 0.0 114.404 -176.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -120.06 48.07 1.63 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.17 30.04 65.73 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -174.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.414 ' HB2' ' H ' ' A' ' 18' ' ' GLY . . . -81.47 165.46 21.21 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.224 0.535 . . . . 0.0 111.356 -176.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -132.7 125.74 30.96 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.129 -0.942 . . . . 0.0 110.856 -178.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -115.14 164.13 12.14 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.317 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 30.9 t80 -147.36 118.34 7.68 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.854 0.359 . . . . 0.0 110.624 -178.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 22.3 m-90 -122.99 132.07 53.98 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.992 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 46.6 t -100.89 117.61 46.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.224 177.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.549 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 4.1 mp -95.31 104.97 16.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.062 0.458 . . . . 0.0 109.88 176.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.448 HD21 ' HG3' ' A' ' 72' ' ' GLU . 19.1 t-20 -79.42 99.38 7.16 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.142 177.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -111.1 -1.68 16.14 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 172.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.524 ' HB2' HG13 ' A' ' 50' ' ' ILE . 2.2 tppp? -67.55 -38.09 83.66 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.385 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.448 ' HG3' HD21 ' A' ' 69' ' ' ASN . 42.6 mt-10 -84.79 -1.63 56.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.234 176.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.02 20.92 69.14 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.618 178.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -89.92 -37.53 14.33 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.953 0.406 . . . . 0.0 111.057 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.13 32.14 76.05 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.883 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 19.7 ptmt -98.7 163.1 12.78 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -177.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.584 HG21 ' HB3' ' A' ' 29' ' ' MET . 0.8 OUTLIER -124.42 139.64 50.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.784 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.0 t -135.38 134.7 40.01 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.284 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -68.65 119.23 12.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.975 -178.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 52.43 69.87 0.63 Allowed 'General case' 0 N--CA 1.464 0.258 0 O-C-N 123.745 0.653 . . . . 0.0 109.732 -175.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.37 -40.71 91.64 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.708 -0.678 . . . . 0.0 113.822 -173.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.63 -20.79 48.06 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.609 -177.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.539 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 34.8 mt-10 -65.86 143.26 57.57 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.468 -0.366 . . . . 0.0 110.085 175.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 24.5 pttm -78.64 108.82 8.8 Favored Pre-proline 0 N--CA 1.449 -0.525 0 CA-C-O 121.341 0.591 . . . . 0.0 110.278 175.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.539 ' HD3' ' O ' ' A' ' 83' ' ' GLU . 12.6 Cg_exo -71.36 129.18 15.54 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.581 2.187 . . . . 0.0 111.949 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -59.25 -31.67 69.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.184 174.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.603 HG11 ' HB2' ' A' ' 124' ' ' ALA . 2.7 m -141.12 128.9 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.629 175.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.749 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 35.5 m -118.13 121.85 41.58 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.885 177.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.432 ' HA ' ' HB ' ' A' ' 117' ' ' ILE . 5.5 m-85 -106.5 131.76 53.31 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -178.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.448 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 5.4 m -103.77 127.26 51.26 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 173.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.519 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -161.4 155.9 3.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -174.79 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.458 ' HB3' ' HB2' ' A' ' 57' ' ' ASN . 15.5 m -85.19 145.56 27.53 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.31 0.576 . . . . 0.0 111.502 -175.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -51.07 -32.35 21.81 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.734 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -73.68 -35.54 65.21 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.982 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.439 ' OD2' ' HB2' ' A' ' 92' ' ' SER . 12.3 m-20 -90.59 -22.55 21.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.535 -173.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.857 HG11 HG12 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -57.36 -33.06 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 121.086 0.47 . . . . 0.0 110.446 -178.155 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.5 m -68.09 -27.68 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.241 -170.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -86.54 -30.21 22.09 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 177.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.45 HD23 ' O ' ' A' ' 104' ' ' LEU . 77.2 mt -67.74 -45.82 73.9 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.201 0.524 . . . . 0.0 110.578 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 96' ' ' VAL . 23.5 mt -75.8 -23.26 16.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.381 -176.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 27.7 p -85.54 -22.4 28.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.811 0.339 . . . . 0.0 110.839 178.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 96.97 8.33 56.94 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.934 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -80.42 -41.01 25.31 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.149 0.499 . . . . 0.0 111.131 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.45 ' O ' HD23 ' A' ' 99' ' ' LEU . 42.2 tp -102.78 120.7 41.05 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.844 -178.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -69.41 124.46 90.53 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.207 175.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.485 ' HA ' ' HB3' ' A' ' 109' ' ' ALA . 1.0 OUTLIER -70.1 -14.11 34.6 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 121.816 1.678 . . . . 0.0 110.564 177.452 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -66.13 -58.42 5.47 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.257 171.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.518 ' HG3' ' N ' ' A' ' 109' ' ' ALA . 1.1 ptmt -66.65 -31.46 72.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.653 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.518 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -66.8 -31.53 72.22 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.905 177.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.765 ' HA ' HG22 ' A' ' 115' ' ' ILE . 23.7 t80 -66.09 -50.85 62.65 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -63.27 -34.21 77.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.331 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -85.27 11.15 10.63 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.65 15.12 73.13 Favored Glycine 0 CA--C 1.517 0.185 0 C-N-CA 121.218 -0.515 . . . . 0.0 113.133 175.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -85.3 -45.07 12.29 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.91 0.386 . . . . 0.0 110.554 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.765 HG22 ' HA ' ' A' ' 110' ' ' PHE . 0.6 OUTLIER -97.39 122.96 49.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.93 -178.208 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.448 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 29.5 mmmt -120.71 99.34 6.48 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 173.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.749 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.2 OUTLIER -130.8 139.47 51.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.275 0.559 . . . . 0.0 111.68 -170.34 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.552 ' O ' HG12 ' A' ' 87' ' ' VAL . 61.4 tt0 -75.96 85.23 2.87 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.793 175.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -70.02 107.0 1.98 Allowed Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.828 -0.624 . . . . 0.0 113.26 -170.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -80.64 118.59 22.34 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 174.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 61.3 ttp -57.28 -35.97 70.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.688 -171.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -90.52 -44.7 4.53 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.02 -1.086 . . . . 0.0 112.956 -177.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.551 HD11 ' HA3' ' A' ' 49' ' ' GLY . 6.1 tt -77.41 -47.88 18.65 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.696 0.284 . . . . 0.0 111.496 -172.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.603 ' HB2' HG11 ' A' ' 87' ' ' VAL . . . -73.0 -20.52 61.0 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.486 -174.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 32.2 mtt -68.69 -18.54 64.28 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 120.872 0.368 . . . . 0.0 111.002 177.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.458 ' O ' ' HG ' ' A' ' 130' ' ' LEU . 2.1 mptm? -79.99 -27.31 39.65 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.489 175.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 78.2 mt -64.2 -42.0 96.82 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 174.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.536 ' O ' ' HG3' ' A' ' 132' ' ' ARG . 18.5 p -73.71 -30.41 62.84 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.172 -179.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -69.16 -36.19 77.11 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.264 177.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 126' ' ' LYS . 6.9 mt -65.65 -45.85 81.42 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.469 177.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.536 ' HA ' ' HB3' ' A' ' 134' ' ' ALA . 21.1 pt20 -65.54 -19.28 65.86 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.114 -176.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.536 ' HG3' ' O ' ' A' ' 128' ' ' THR . 85.1 mtp180 -55.38 -46.89 76.49 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.04 0.448 . . . . 0.0 110.313 175.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -90.26 -33.12 16.26 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.741 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.536 ' HB3' ' HA ' ' A' ' 131' ' ' GLN . . . -65.53 -35.43 80.83 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.683 -178.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -87.04 -8.02 57.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.263 0.554 . . . . 0.0 110.713 177.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 63.03 39.33 97.92 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.189 -0.914 . . . . 0.0 113.443 175.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.501 ' HG2' ' O ' ' A' ' 132' ' ' ARG . 15.3 ptm180 -69.47 117.28 10.89 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 117.037 0.419 . . . . 0.0 110.299 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.449 ' HB ' ' O ' ' A' ' 137' ' ' ARG . 29.5 mm 71.06 -73.54 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.923 -174.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -101.28 125.35 47.9 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.164 0.507 . . . . 0.0 110.74 -177.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 13.6 t -142.17 60.13 1.46 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.297 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 13.9 pt . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.158 -0.925 . . . . 0.0 111.016 -178.751 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.842 0 N-CA-C 112.052 -0.419 . . . . 0.0 112.052 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.7 t -79.69 -30.63 41.14 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.016 0.436 . . . . 0.0 110.333 -178.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.6 p -71.55 142.02 50.07 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.578 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.45 161.2 21.9 Favored Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.827 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -52.72 130.63 46.72 Favored Pre-proline 0 CA--C 1.518 -0.287 0 CA-C-O 121.968 0.889 . . . . 0.0 111.496 -176.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.445 ' HA ' ' CD1' ' A' ' 23' ' ' PHE . 38.0 Cg_endo -69.63 -15.9 37.82 Favored 'Trans proline' 0 C--N 1.329 -0.46 0 C-N-CA 123.956 3.104 . . . . 0.0 112.068 -177.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -75.01 -28.86 60.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.507 -177.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -82.83 -7.54 59.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.957 -176.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.445 ' CD1' ' HA ' ' A' ' 20' ' ' PRO . 40.3 m-85 -73.12 146.49 45.68 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 174.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.438 ' HD3' HG11 ' A' ' 97' ' ' VAL . 78.6 tttt -78.46 -21.76 48.6 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.898 HG12 HG11 ' A' ' 96' ' ' VAL . 1.3 m -71.83 -13.68 16.94 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.535 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.648 175.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -56.51 -58.17 9.17 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.135 -0.321 . . . . 0.0 110.135 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.35 -42.55 96.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.161 0.505 . . . . 0.0 110.494 178.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.528 ' HB3' HD12 ' A' ' 100' ' ' ILE . 18.0 m-85 -65.81 -42.04 91.13 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.613 -175.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.43 ' CE ' HD11 ' A' ' 68' ' ' ILE . 67.5 mtp -80.16 -24.29 40.49 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.117 -0.365 . . . . 0.0 110.354 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.413 ' HD3' ' HA ' ' A' ' 30' ' ' LYS . 50.5 mmtt -66.61 -41.53 88.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.506 173.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.471 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 4.8 pt -78.97 -26.08 13.23 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.56 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.188 176.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.408 HD23 ' C ' ' A' ' 32' ' ' LEU . 6.1 tt -55.15 -51.56 66.08 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 170.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.51 ' HG2' ' HA ' ' A' ' 76' ' ' LYS . 0.7 OUTLIER -47.24 -53.91 12.14 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.962 177.748 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 31' ' ' ILE . 7.6 pt-20 -74.01 -39.4 63.63 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.288 -175.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.01 -37.46 85.95 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.661 -174.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 19.8 mmt -58.48 -44.18 89.25 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.645 0.26 . . . . 0.0 111.543 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -91.24 -7.89 49.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.932 0.396 . . . . 0.0 110.578 177.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 22.0 t-20 -64.94 -34.56 78.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.304 -178.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -61.12 132.27 53.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.653 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.55 -24.85 65.72 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.463 -175.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -102.27 10.83 38.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 119.463 -0.304 . . . . 0.0 111.562 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 26.2 p30 30.86 70.8 0.08 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.382 1.073 . . . . 0.0 112.248 178.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.8 mt -62.64 -2.81 1.22 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.128 -174.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.8 tp -64.02 -27.45 42.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.274 0.559 . . . . 0.0 110.288 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -63.5 -25.62 68.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.396 -177.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -81.81 -19.75 40.51 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.164 -177.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.501 HG11 ' HB3' ' A' ' 126' ' ' LYS . 1.3 m -129.65 32.31 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.791 -175.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 72.3 mtt180 -49.45 112.03 0.58 Allowed 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.763 0.792 . . . . 0.0 111.04 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.518 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . -178.28 161.57 28.44 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.705 -175.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.565 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 64.9 mt -96.57 126.88 49.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 117.28 0.54 . . . . 0.0 110.865 -178.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.446 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 9.4 m-85 -106.07 118.89 37.79 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.708 -179.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.28 113.92 4.85 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.514 -0.85 . . . . 0.0 111.327 177.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -101.26 110.47 22.49 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.122 0.487 . . . . 0.0 111.694 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -94.3 99.75 11.92 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.312 174.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.804 HG11 HG11 ' A' ' 25' ' ' VAL . 19.9 t -100.83 112.49 33.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.045 0.45 . . . . 0.0 110.878 -174.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 76.2 mtp85 -104.05 179.71 4.19 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.577 -177.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 64.68 37.29 7.71 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 123.348 0.405 . . . . 0.0 111.311 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.38 -161.17 9.26 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.796 178.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -34.74 -60.72 0.27 Allowed 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 124.605 3.537 . . . . 0.0 114.493 -174.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -115.89 38.49 3.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.38 0.61 . . . . 0.0 110.343 178.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 78.38 24.46 63.21 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -171.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.79 156.34 39.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.14 -0.53 . . . . 0.0 110.725 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -118.3 116.0 25.86 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.182 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.41 161.09 16.27 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.019 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -145.95 118.83 8.7 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.977 0.418 . . . . 0.0 110.897 -176.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.402 ' CE2' ' HD1' ' A' ' 79' ' ' TYR . 20.9 m-90 -121.23 136.27 55.0 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.812 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 39.0 t -106.19 117.23 51.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.555 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.65 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 3.7 mp -93.56 99.79 10.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 175.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -86.25 98.35 10.89 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.348 -177.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -109.3 6.94 24.97 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.177 175.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.54 ' HB2' HG13 ' A' ' 50' ' ' ILE . 5.4 tppp? -60.49 -42.97 97.38 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.522 -178.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -94.27 5.34 52.06 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.223 -178.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.8 -13.51 59.21 Favored Glycine 0 C--N 1.318 -0.431 0 CA-C-N 115.703 -0.68 . . . . 0.0 113.63 174.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.43 -67.05 0.42 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.87 34.7 14.56 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 119.797 -1.192 . . . . 0.0 111.249 -175.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.65 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 54.6 pttt -98.0 148.64 23.28 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 -177.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.401 HG12 HG13 ' A' ' 68' ' ' ILE . 0.8 OUTLIER -107.04 135.12 46.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 177.652 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.4 t -140.11 132.86 29.03 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.606 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.402 ' HD1' ' CE2' ' A' ' 66' ' ' TRP . 45.5 t80 -68.93 121.42 16.56 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 56.49 74.75 0.38 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.552 0.692 . . . . 0.0 109.474 -173.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.86 -41.18 73.77 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.916 -176.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.45 -13.58 61.79 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.93 -179.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.513 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 12.9 mm-40 -81.15 159.41 24.66 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 177.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -87.68 109.08 23.92 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 123.18 0.3 . . . . 0.0 110.518 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.565 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 18.0 Cg_exo -67.26 134.2 32.95 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.815 2.343 . . . . 0.0 112.787 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -66.95 -33.26 75.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.493 -0.776 . . . . 0.0 108.949 172.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.742 HG12 ' HA3' ' A' ' 119' ' ' GLY . 8.5 m -140.58 134.27 33.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.256 178.088 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.632 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 27.9 m -119.4 132.77 55.89 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 175.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.524 ' CD1' ' HB ' ' A' ' 117' ' ' ILE . 68.2 m-85 -119.4 125.79 49.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.219 -179.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.437 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 25.4 m -99.83 126.16 45.89 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 173.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.554 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -157.31 144.26 9.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.888 -176.342 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.14 141.97 41.76 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.451 178.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.486 ' OD1' HG13 ' A' ' 25' ' ' VAL . 22.3 t70 -49.13 -27.47 3.5 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.707 1.203 . . . . 0.0 111.986 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -78.08 -34.44 50.27 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.226 -174.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -90.99 -20.45 22.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.239 -175.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.898 HG11 HG12 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -57.92 -31.73 41.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.023 -175.116 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.438 HG11 ' HD3' ' A' ' 24' ' ' LYS . 4.9 m -63.91 -29.53 47.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.461 -170.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -81.87 -32.63 30.98 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.505 HD23 ' O ' ' A' ' 104' ' ' LEU . 91.6 mt -69.36 -42.86 74.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.381 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.528 HD12 ' HB3' ' A' ' 28' ' ' TYR . 1.6 mm -65.34 -25.67 37.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.681 178.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.6 t -96.86 -11.41 24.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.646 -176.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.49 9.86 82.77 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.128 -177.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -77.76 -42.35 34.42 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.266 0.555 . . . . 0.0 110.261 178.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.505 ' O ' HD23 ' A' ' 99' ' ' LEU . 48.3 tp -100.02 125.1 46.03 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.723 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.529 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 6.1 m-20 -77.34 124.19 86.96 Favored Pre-proline 0 C--N 1.317 -0.805 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.013 178.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.416 ' HD3' ' NE2' ' A' ' 131' ' ' GLN . 2.6 Cg_exo -64.99 -22.28 62.74 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.022 1.815 . . . . 0.0 110.529 179.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.557 HE21 HG21 ' A' ' 128' ' ' THR . 77.0 mm-40 -64.24 -56.7 12.84 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.133 173.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.529 ' HG2' ' HB2' ' A' ' 105' ' ' ASN . 0.1 OUTLIER -67.75 -31.37 71.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.078 -178.514 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.547 ' HB3' HD12 ' A' ' 115' ' ' ILE . . . -69.91 -32.79 71.28 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 177.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -62.51 -52.13 64.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.595 174.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -63.16 -42.14 99.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.88 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -71.33 -7.68 48.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.883 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 95.76 -5.02 66.45 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.667 -0.777 . . . . 0.0 113.432 173.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.408 ' HD2' ' HA ' ' A' ' 114' ' ' LYS . 28.3 mmmt -68.38 -53.16 25.75 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.95 0.405 . . . . 0.0 111.43 177.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.676 HG23 HG22 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -85.94 116.72 29.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.653 0.74 . . . . 0.0 111.038 -175.35 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.437 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 33.7 mmtp -108.37 104.27 13.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.987 175.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.676 HG22 HG23 ' A' ' 115' ' ' ILE . 0.1 OUTLIER -125.57 141.58 44.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.145 0.498 . . . . 0.0 111.101 -177.686 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -142.66 83.1 1.8 Allowed 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -177.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.742 ' HA3' HG12 ' A' ' 87' ' ' VAL . . . -161.05 172.56 37.34 Favored Glycine 0 N--CA 1.44 -1.059 0 C-N-CA 120.399 -0.905 . . . . 0.0 113.044 -170.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -49.31 117.01 1.94 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.522 0.677 . . . . 0.0 110.522 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -61.7 -51.13 69.68 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.994 -171.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -65.67 -26.97 72.21 Favored Glycine 0 CA--C 1.511 -0.163 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.764 -175.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.445 HD11 ' HA3' ' A' ' 49' ' ' GLY . 5.8 tt -72.54 -41.34 65.93 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.028 -0.586 . . . . 0.0 110.258 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.661 ' HB2' HG11 ' A' ' 87' ' ' VAL . . . -87.04 -28.48 22.57 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -177.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 68.7 mtm -67.71 -17.94 64.74 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.687 0.28 . . . . 0.0 111.618 -177.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.501 ' HB3' HG11 ' A' ' 47' ' ' VAL . 22.5 tptm -80.63 -30.63 36.69 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 175.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.0 mt -60.66 -44.68 96.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.757 -178.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.557 HG21 HE21 ' A' ' 107' ' ' GLN . 14.4 t -69.77 -26.36 64.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.904 -178.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -80.84 -33.09 34.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.594 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.9 mt -56.59 -38.66 72.32 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.824 178.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.416 ' NE2' ' HD3' ' A' ' 106' ' ' PRO . 9.9 pt20 -77.11 -19.31 57.13 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.011 -178.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 52.6 mtp180 -65.47 -44.75 86.2 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 174.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -64.45 -41.01 96.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.351 177.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.39 -37.93 88.48 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.264 -178.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.46 -32.61 71.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.961 0.41 . . . . 0.0 110.77 178.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 93.95 -27.14 13.64 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.306 177.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 60.59 88.03 0.08 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.238 0.542 . . . . 0.0 110.745 -178.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 1.9 mp -81.33 -62.25 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.104 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -100.58 160.3 14.46 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.232 -178.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 22.8 t -134.75 93.74 3.07 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.015 0.436 . . . . 0.0 110.533 -178.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 6.9 tt . . . . . 0 C--O 1.246 0.876 0 CA-C-O 118.106 -0.95 . . . . 0.0 109.891 174.927 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.654 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.4 m -118.4 34.07 5.35 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.016 0.436 . . . . 0.0 110.627 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.0 m -129.82 -174.34 3.28 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.857 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.19 173.36 54.01 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.423 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.513 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 82.0 m-20 -63.01 131.49 94.73 Favored Pre-proline 0 CA--C 1.514 -0.418 0 CA-C-O 121.575 0.702 . . . . 0.0 110.509 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -68.54 -18.37 43.2 Favored 'Trans proline' 0 C--N 1.327 -0.598 0 C-N-CA 123.745 2.964 . . . . 0.0 112.346 -176.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.412 ' HA ' ' CG ' ' A' ' 26' ' ' PHE . 15.0 mt-10 -84.05 -27.29 28.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.438 -177.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.513 ' OD2' ' HB2' ' A' ' 19' ' ' ASN . 42.9 m-20 -76.49 -9.4 58.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.13 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -73.31 145.55 45.95 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.756 174.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -76.04 -17.7 59.55 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.759 HG12 HG11 ' A' ' 96' ' ' VAL . 1.2 m -78.02 -15.87 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.267 177.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.412 ' CG ' ' HA ' ' A' ' 21' ' ' GLU . 78.7 t80 -54.74 -55.93 24.7 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 123.123 0.264 . . . . 0.0 110.73 -174.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.459 ' O ' HG23 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -65.72 -35.33 80.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.647 -179.072 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.443 ' HB3' HD12 ' A' ' 100' ' ' ILE . 12.7 m-85 -66.89 -48.52 68.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.529 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 63.7 mtt -70.7 -30.79 67.45 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.017 178.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.423 ' HD2' ' HA ' ' A' ' 30' ' ' LYS . 27.7 mmmt -67.02 -34.74 78.38 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.236 176.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.459 HG23 ' O ' ' A' ' 27' ' ' LYS . 12.6 pt -86.55 -18.57 8.57 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.798 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.389 175.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.1 tt -63.74 -52.19 61.56 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 169.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.516 ' HG3' ' HA ' ' A' ' 76' ' ' LYS . 21.1 tt0 -42.11 -53.18 4.07 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.239 -1.346 . . . . 0.0 111.32 171.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -73.51 -62.45 1.48 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.336 -1.302 . . . . 0.0 112.175 -176.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.418 ' HA ' ' HB3' ' A' ' 38' ' ' ASN . . . -54.91 -42.63 72.43 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -169.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.6 mmt -61.21 -37.84 84.44 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -176.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -91.8 -23.54 19.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.139 0.495 . . . . 0.0 110.162 178.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.418 ' HB3' ' HA ' ' A' ' 35' ' ' ALA . 26.7 t-20 -64.28 -32.93 74.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.219 178.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -54.7 134.59 47.38 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.614 175.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.9 p -63.08 -28.97 70.45 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.539 -176.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -81.96 -25.16 35.06 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.652 176.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.9 p30 36.96 73.62 0.09 Allowed 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.984 0.897 . . . . 0.0 110.728 -174.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.453 ' O ' HG12 ' A' ' 47' ' ' VAL . 66.9 mt -63.16 -3.11 1.6 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.717 -175.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.473 HG13 ' HB1' ' A' ' 70' ' ' ALA . 4.1 tp -60.28 -26.48 36.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.268 -177.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.423 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 25.8 mt-10 -83.08 -14.49 53.63 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 120.823 0.344 . . . . 0.0 111.141 -178.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -92.65 -13.93 28.82 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.267 0.556 . . . . 0.0 110.183 178.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 47' ' ' VAL . 13.9 p -130.11 32.69 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.867 0.842 . . . . 0.0 109.872 -177.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.423 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 60.1 mtt180 -52.51 111.65 0.68 Allowed 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.556 -178.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.655 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . -175.37 147.56 8.95 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.818 -176.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.53 ' HB ' ' HA ' ' A' ' 85' ' ' PRO . 66.7 mt -89.18 126.94 42.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 117.39 0.595 . . . . 0.0 110.794 -177.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.496 ' CE1' HD21 ' A' ' 127' ' ' LEU . 5.0 m-85 -104.31 116.54 32.33 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.758 -177.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.96 111.58 4.28 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.116 177.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -100.48 103.43 14.78 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.164 0.507 . . . . 0.0 111.568 -178.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -88.36 99.5 12.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.397 175.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 10.8 t -98.13 134.92 34.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.127 -177.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 31.7 mtp-105 -125.58 175.78 7.32 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.475 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 57.51 42.88 23.68 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 123.426 0.454 . . . . 0.0 111.758 177.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.12 -160.52 8.24 Favored Glycine 0 CA--C 1.521 0.423 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.621 177.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -37.93 -60.82 0.4 Allowed 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 124.284 3.323 . . . . 0.0 113.737 -177.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.454 ' OD1' ' HB2' ' A' ' 62' ' ' ALA . 28.6 p-10 -109.52 34.92 3.53 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.295 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.38 28.54 59.66 Favored Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -173.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.454 ' HB2' ' OD1' ' A' ' 60' ' ' ASN . . . -76.45 146.91 38.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.662 0.744 . . . . 0.0 112.168 -175.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -108.4 108.16 19.01 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.186 176.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -100.58 152.55 19.16 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -137.76 116.47 12.21 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 117.089 0.445 . . . . 0.0 110.905 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 24.3 m-90 -119.3 139.84 51.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.709 178.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 30.5 t -109.85 113.43 44.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.152 178.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.495 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 3.9 mp -91.46 102.61 13.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -85.62 98.03 10.43 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.341 0.591 . . . . 0.0 110.341 -176.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . -97.4 -4.5 38.19 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.758 174.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.447 ' HB2' HG13 ' A' ' 50' ' ' ILE . 15.8 tppt? -63.5 -42.74 98.51 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.162 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -73.71 -6.59 47.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.237 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.58 12.28 81.93 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.929 -177.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -91.37 -52.48 4.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.686 0.279 . . . . 0.0 110.766 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.84 34.45 24.56 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.349 -0.929 . . . . 0.0 111.504 -177.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.516 ' HA ' ' HG3' ' A' ' 33' ' ' GLU . 21.8 ptmt -97.54 150.42 21.12 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -176.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -108.02 125.38 64.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.449 HG23 ' HA2' ' A' ' 81' ' ' GLY . 3.8 t -128.38 134.49 48.85 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.784 -178.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -63.24 125.38 23.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.213 -176.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 74.08 -42.05 0.5 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.833 0.853 . . . . 0.0 111.699 -178.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.449 ' HA2' HG23 ' A' ' 78' ' ' THR . . . 70.82 -43.09 0.6 Allowed Glycine 0 CA--C 1.519 0.302 0 N-CA-C 114.483 0.553 . . . . 0.0 114.483 177.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 69.32 17.25 72.13 Favored Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 -174.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.404 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 38.7 mm-40 -117.82 162.94 17.28 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 122.576 0.35 . . . . 0.0 110.332 -176.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 95.4 mttt -95.34 109.04 42.97 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.98 176.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.53 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 17.2 Cg_exo -68.09 133.74 29.71 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.888 2.392 . . . . 0.0 112.73 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -65.32 -32.58 74.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.5 174.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.598 HG12 ' HA3' ' A' ' 119' ' ' GLY . 4.9 m -141.02 132.77 29.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.552 173.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.673 ' O ' ' HA ' ' A' ' 117' ' ' ILE . 86.3 m -115.92 131.1 57.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.318 176.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.534 ' CD1' ' HB ' ' A' ' 117' ' ' ILE . 75.8 m-85 -116.56 123.55 47.65 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.438 ' HB ' ' HB2' ' A' ' 116' ' ' LYS . 3.5 m -99.7 119.74 38.59 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 176.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 59.0 mt -143.86 154.22 15.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -174.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.461 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 37.5 m -89.25 144.25 26.24 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.505 175.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -42.38 -52.09 4.7 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.378 0.671 . . . . 0.0 111.968 -177.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.97 -42.35 89.73 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.162 -176.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.461 ' OD2' ' HB2' ' A' ' 92' ' ' SER . 7.8 m-20 -80.4 -21.67 42.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.594 0.235 . . . . 0.0 111.535 -173.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.759 HG11 HG12 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -58.62 -34.23 50.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.085 -176.463 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.1 m -68.09 -30.46 48.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.22 -171.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -81.14 -33.46 33.15 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 177.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.477 HD23 ' O ' ' A' ' 104' ' ' LEU . 74.0 mt -69.77 -47.91 61.2 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.011 -177.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 96' ' ' VAL . 25.5 mt -70.34 -26.03 28.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.055 -178.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 27.3 t -88.2 -8.67 54.97 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.512 -178.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.51 19.6 61.75 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.322 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -94.2 -41.76 9.31 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.096 0.474 . . . . 0.0 110.979 -178.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.736 HD11 ' NZ ' ' A' ' 108' ' ' LYS . 37.6 tp -101.1 128.74 47.04 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.334 179.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.637 ' OD1' ' HB2' ' A' ' 107' ' ' GLN . 2.8 t-20 -69.68 122.33 85.45 Favored Pre-proline 0 C--N 1.321 -0.63 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.057 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -68.39 -24.44 36.9 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.896 1.731 . . . . 0.0 110.692 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.637 ' HB2' ' OD1' ' A' ' 105' ' ' ASN . 1.7 mp0 -64.83 -59.15 4.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.453 173.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.736 ' NZ ' HD11 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -60.41 -37.93 82.4 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.818 -179.365 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.533 ' N ' ' HG3' ' A' ' 108' ' ' LYS . . . -68.83 -34.88 76.23 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.553 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.428 ' CD2' HG22 ' A' ' 115' ' ' ILE . 20.3 t80 -62.23 -52.93 61.78 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 174.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -56.9 -42.25 79.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.094 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.454 ' HA ' HE21 ' A' ' 112' ' ' GLN . 0.0 OUTLIER -74.97 -1.69 23.75 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.963 -177.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 96.5 -12.94 66.07 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.32 173.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -62.41 -61.17 2.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.061 0.458 . . . . 0.0 111.77 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.605 HG23 HG22 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -80.85 121.8 34.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.062 -175.253 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.438 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 35.9 mmtm -115.4 99.63 7.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.319 172.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.673 ' HA ' ' O ' ' A' ' 88' ' ' THR . 0.1 OUTLIER -116.31 135.32 56.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.092 0.472 . . . . 0.0 110.155 177.631 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -144.01 80.26 1.65 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -174.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.598 ' HA3' HG12 ' A' ' 87' ' ' VAL . . . -160.47 173.89 37.1 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.324 -169.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -48.88 110.76 0.39 Allowed 'General case' 0 C--N 1.328 -0.327 0 O-C-N 124.066 0.51 . . . . 0.0 110.28 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.556 ' O ' ' HG3' ' A' ' 125' ' ' MET . 0.0 OUTLIER -65.1 -35.08 80.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.707 -173.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -70.0 -32.8 69.67 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.2 -178.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.494 ' O ' HD23 ' A' ' 127' ' ' LEU . 5.3 tt -71.07 -44.44 65.73 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.515 ' HB2' HG11 ' A' ' 87' ' ' VAL . . . -71.79 -15.5 62.16 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.21 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.556 ' HG3' ' O ' ' A' ' 121' ' ' MET . 78.2 mtp -68.34 -24.38 64.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.738 0.304 . . . . 0.0 110.767 175.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.482 ' O ' ' HG ' ' A' ' 130' ' ' LEU . 50.8 tptt -85.23 -33.06 22.3 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.234 174.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.496 HD21 ' CE1' ' A' ' 51' ' ' TYR . 1.4 mm? -53.55 -40.92 65.93 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 122.051 0.929 . . . . 0.0 108.664 168.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.496 ' HB ' ' O ' ' A' ' 125' ' ' MET . 72.8 m -62.02 -48.09 81.84 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 113.794 -1.548 . . . . 0.0 111.326 175.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.754 ' O ' ' HG2' ' A' ' 132' ' ' ARG . 36.1 t70 -67.33 -25.96 66.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.408 -177.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 126' ' ' LYS . 7.3 mt -54.06 -14.93 1.2 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.157 176.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -57.09 -25.17 58.29 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.483 176.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.754 ' HG2' ' O ' ' A' ' 129' ' ' ASP . 20.5 mmt180 -64.22 -43.62 94.42 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 177.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -69.55 -40.32 76.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.92 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.36 -31.76 71.65 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.403 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.1 0.57 47.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.306 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 73.32 43.0 40.16 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.861 -178.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 67.38 112.43 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.28 0.562 . . . . 0.0 110.98 -178.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.403 HG22 ' N ' ' A' ' 139' ' ' GLU . 55.9 mt -78.59 155.2 4.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.127 -178.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.403 ' N ' HG22 ' A' ' 138' ' ' ILE . 15.2 mm-40 -43.21 118.76 1.38 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.896 176.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.5 m -129.52 -11.22 4.51 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.254 178.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.3 tt . . . . . 0 C--O 1.246 0.881 0 CA-C-O 118.451 -0.785 . . . . 0.0 110.402 179.427 . . . . . . . . 0 0 . 1 stop_ save_